
<html lang="en"     class="pb-page"  data-request-id="ac56f3c6-92f4-4519-a33d-0e9a2e8dde9d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-18;article:article:10.1021/acs.jmedchem.9b00188;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies" /></meta><meta name="dc.Creator" content="Ilya  Galperin" /></meta><meta name="dc.Creator" content="Lukas  Dempwolff" /></meta><meta name="dc.Creator" content="Wibke E.  Diederich" /></meta><meta name="dc.Creator" content="Matthias  Lauth" /></meta><meta name="dc.Description" content="Important steps in embryonic development are governed by the Hedgehog (Hh) signaling pathway, an evolutionary conserved signal transduction cascade. However, Hh activity not only is crucial during ..." /></meta><meta name="Description" content="Important steps in embryonic development are governed by the Hedgehog (Hh) signaling pathway, an evolutionary conserved signal transduction cascade. However, Hh activity not only is crucial during ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 15, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00188" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00188" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00188" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00188" /></link>
        
    
    

<title>Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00188" /></meta><meta property="og:title" content="Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0015.jpeg" /></meta><meta property="og:description" content="Important steps in embryonic development are governed by the Hedgehog (Hh) signaling pathway, an evolutionary conserved signal transduction cascade. However, Hh activity not only is crucial during embryo formation but also is involved in adult tissue repair and in several malignancies. Particularly due to its link to cancer, small molecule Hh pathway inhibitors have been developed and the first compounds have been approved for use in Hh-driven basal cell carcinoma. Almost all advanced Hh inhibitors target the critical signaling component Smoothened (SMO), but preclinical research has identified additional compounds that can block the Hh pathway along its entire signaling cascade, which, in light of emerging drug resistance occurring with SMO inhibitors, is of high importance. Herein we give an overview on currently known Hh pathway inhibitors, delineating their respective strengths and weaknesses and describing potential drug targeting strategies to interfere with Hh signaling in different cancer settings." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00188"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00188">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00188&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00188&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00188&amp;href=/doi/10.1021/acs.jmedchem.9b00188" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 8392-8411</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00182" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00246" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ilya Galperin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ilya Galperin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Tumor and Immune Biology (ZTI), Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ilya++Galperin">Ilya Galperin</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lukas Dempwolff</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lukas Dempwolff</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Center for Tumor and Immune Biology (ZTI), Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lukas++Dempwolff">Lukas Dempwolff</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wibke E. Diederich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wibke E. Diederich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Center for Tumor and Immune Biology (ZTI), Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</div><div class="loa-info-affiliations-info">Core Facility Medicinal Chemistry, Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wibke+E.++Diederich">Wibke E. Diederich</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Matthias Lauth</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Lauth</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Tumor and Immune Biology (ZTI), Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e985889c9d81a99a9d888f8fc79c8780c484889b8b9c9b8ec78d8c"><span class="__cf_email__" data-cfemail="6a060b1f1e022a191e0b0c0c441f040347070b18081f180d440e0f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Lauth">Matthias Lauth</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5922-5384" title="Orcid link">http://orcid.org/0000-0001-5922-5384</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00188&amp;href=/doi/10.1021%2Facs.jmedchem.9b00188" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 8392–8411</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 15, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 January 2019</li><li><span class="item_label"><b>Published</b> online</span>15 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00188" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00188</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8392%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIlya%2BGalperin%252C%2BLukas%2BDempwolff%252C%2BWibke%2BE.%2BDiederich%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D18%26contentID%3Dacs.jmedchem.9b00188%26title%3DInhibiting%2BHedgehog%253A%2BAn%2BUpdate%2Bon%2BPharmacological%2BCompounds%2Band%2BTargeting%2BStrategies%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8411%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00188"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1912</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00188" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ilya&quot;,&quot;last_name&quot;:&quot;Galperin&quot;},{&quot;first_name&quot;:&quot;Lukas&quot;,&quot;last_name&quot;:&quot;Dempwolff&quot;},{&quot;first_name&quot;:&quot;Wibke&quot;,&quot;last_name&quot;:&quot;E. Diederich&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Lauth&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8392-8411&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00188&quot;},&quot;abstract&quot;:&quot;Important steps in embryonic development are governed by the Hedgehog (Hh) signaling pathway, an evolutionary conserved signal transduction cascade. However, Hh activity not only is crucial during embryo formation but also is involved in adult tissue repair and in several malignancies. Particularly due to its link to cancer, small molecule Hh pathway inhibitors have been developed and the first compounds have been approved for use in Hh-driven basal cell carcinoma. Almost all advanced Hh inhibitors target the critical signaling component Smoothened (SMO), but preclinical research has identified additional compounds that can block the Hh pathway along its entire signaling cascade, which, in light of emerging drug resistance occurring with SMO inhibitors, is of high importance. Herein we give an overview on currently known Hh pathway inhibitors, delineating their respective strengths and weaknesses and describing potential drug targeting strategies to interfere with Hh signaling in different cancer settings.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00188&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00188" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00188&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00188" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00188&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00188" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00188&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00188&amp;href=/doi/10.1021/acs.jmedchem.9b00188" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00188" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00188" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00188%26sid%3Dliteratum%253Aachs%26pmid%3D30986059%26genre%3Darticle%26aulast%3DGalperin%26date%3D2019%26atitle%3DInhibiting%2BHedgehog%253A%2BAn%2BUpdate%2Bon%2BPharmacological%2BCompounds%2Band%2BTargeting%2BStrategies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D18%26spage%3D8392%26epage%3D8411%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290951" title="Soil organic matter">Soil organic matter</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/jmcmar.2019.62.issue-18/20190926/jmcmar.2019.62.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Important steps in embryonic development are governed by the Hedgehog (Hh) signaling pathway, an evolutionary conserved signal transduction cascade. However, Hh activity not only is crucial during embryo formation but also is involved in adult tissue repair and in several malignancies. Particularly due to its link to cancer, small molecule Hh pathway inhibitors have been developed and the first compounds have been approved for use in Hh-driven basal cell carcinoma. Almost all advanced Hh inhibitors target the critical signaling component Smoothened (SMO), but preclinical research has identified additional compounds that can block the Hh pathway along its entire signaling cascade, which, in light of emerging drug resistance occurring with SMO inhibitors, is of high importance. Herein we give an overview on currently known Hh pathway inhibitors, delineating their respective strengths and weaknesses and describing potential drug targeting strategies to interfere with Hh signaling in different cancer settings.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction to Mammalian Hedgehog Signaling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The Hedgehog (Hh) pathway is a developmentally important signaling cascade that is conserved throughout evolution from flies to men.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Exact Hh concentrations as well as signaling duration times are crucial for the correct development, specification, and patterning of many tissues in our body, and failures to execute proper Hh signal transduction during development are associated with severe embryonic malformations, such as holoprosencephaly.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In the adult mammalian organism, Hh signaling is mostly inactive, with the exception of its reactivation in tissue repair processes and in stem cell compartments. In agreement with the concept that processes in tumors closely resemble those in wound healing and stem cell biology, it might not come as a surprise that active Hh signaling can be found in numerous malignancies. While certain cancers such as basal cell carcinoma (BCC, a non-melanoma skin tumor) or the Hh-subtype of medulloblastoma (MB, a pediatric cancer affecting the cerebellum) can be caused by the sole overactivation of Hh, other tumor types utilize the Hh system for modification of certain aspects of their biology. This includes the regulation of migration and metastasis, the development of chemo- or radioresistance or the establishment and activation of an abundant tumor stroma. The fact that Hh signaling is to a large degree absent in healthy adult tissue but selectively reactivated in malignant and repair conditions makes this pathway an ideal target in drug development as side effects should be minor. Indeed, large efforts have been undertaken by both pharmaceutical industry and academia to delineate the mechanisms of Hh signal transduction and to identify small molecule regulators. To date, an impressive number of compounds modulating the Hh cascade have been described. Of these, two substances have been approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for their use in advanced BCC. This review aims at summarizing and describing a selection of Hh pathway inhibitors, allowing the reader to get an impression of currently available subclasses of inhibitory molecules and their potential applications in cancer therapy.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Conveying the Hh Signal: The Signal Transduction Cascade</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hh signaling relies on secreted ligands that are sensed either by the releasing cell itself (autocrine) or by neighboring cells (paracrine) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> graphically outlines the signaling cascade). Mammalian genomes contain three Hh genes (Sonic Hh (SHH), Indian Hh (IHH), and Desert Hh (DHH)), which are functionally highly similar but are expressed in different spatiotemporal patterns between tissues.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of canonical Hh signaling in mammalian cells. Please refer to the main text for details.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hh ligands are unusual signaling molecules in that they are subject to both palmitoylation and cholesteroylation, rendering them highly lipophilic. These posttranslational modifications are required for full functionality and for extracellular transport of the Hh ligands. Specialized proteins such as members of the Dispatched family (DISP1 and DISP2) and SCUBE2 are needed to release these lipophilic proteins from secreting cells. On the receiving cell, Hh proteins bind to 12-transmembrane (12-TM) receptors of the Patched family (PTCH1 and PTCH2, with PTCH1 being the more dominant). PTCH1 resides in a specialized organelle, the primary cilium (a solitary microtubule-held protrusion of the cell membrane), which serves as an antenna to sense environmental cues. The ciliary compartment is continuous with the cell membrane/cytoplasm, yet it still possesses a unique composition of soluble and membrane proteins which is distinct from the rest of the cell. One example is the selective distribution of different phosphoinositides between the ciliary membrane and the cellular plasma membrane, which is established by the ciliary enzyme inositol polyphosphate-5-phosphatase E (INPP5E) and which impacts the ciliary presence of signaling proteins. Import and export of proteins into the cilia compartment can be mediated via lateral membrane diffusion or via microtubule-based transport proteins, such as through the kinesin KIF7 in case of several Hh signaling components.</div><div class="NLM_p">In the absence of Hh ligands, PTCH1 antagonizes the activation of Smoothened (SMO), a 7-TM signaling protein belonging to the G-protein-coupled receptor (GPCR) superfamily. Without ligands, SMO is blocked from entering the primary cilium, preventing the activation of the canonical Hh signaling cascade. Upon Hh ligand binding, the PTCH1 receptor is exported from the cilium allowing SMO to enter and to transmit the signal to downstream elements of the pathway. Hh ligand perception by PTCH1 is further modulated by co-receptors acting in a positive (CDO, BOC, GAS1) or negative (HHIP) manner on the signal transduction. A central question in recent years has been the molecular mechanism of how PTCH1 actually inhibits SMO. Earlier data had shown that this functionally negative interaction is nonstoichiometric and probably requires some catalytic pumping function of PTCH1 across the membrane.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In light of recent data, the most likely candidate molecule to be pumped by PTCH1 is cholesterol<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> or a modified version of cholesterol (e.g., oxysterols). The close association between Hh signaling and cholesterol is stunning as not only the Hh ligands themselves are cholesterol-modified but also DISP and PTCH proteins contain so-called sterol-sensing domains. PTCH is able to remove cholesterol from the inner leaflet of cellular membranes and, in turn,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> SMO requires cholesterol binding to its cysteine-rich domain (CRD) for full activity (see later), suggesting that regulated cholesterol transport is a central feature of coordinated PTCH/SMO signal transduction. The current hypothesis envisions PTCH1 to pump away membrane inner leaflet-localized cholesterol, which would otherwise bind and activate SMO.</div><div class="NLM_p">The final effectors of canonical Hh signaling are the GLI transcription factors, of which there are three in mammals: GLI1, GLI2, and GLI3. GLI1 is a target gene of the pathway and cannot or only at very low levels be detected in unstimulated cells. GLI2 and GLI3 however are latent transcription factors and are regulated in their activity by Hh ligands. GLI3 is controlled through limited proteolysis by the proteasome. It is constantly synthesized as a full-length protein (GLI3<sup>FL</sup>) containing transcriptional activator and repressor domains. In the absence of ligands, however, the activator domain is cleaved off rendering GLI3 a potent repressor (GLI3<sup>R</sup>).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In contrast, GLI2 is primarily regulated by complete and not by partial degradation as in the case of GLI3.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The partial degradation process is triggered by PKA/GSK3β/CK1α-mediated phosphorylation and is supported by Suppressor-of-Fused (SUFU), a major negative regulator of the pathway. Besides PTCH1, SUFU is an important tumor suppressor affected by mutational inactivation in certain Hh-dependent cancer types (e.g., MB).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> As protein kinase A (PKA)-mediated phosphorylation of GLI3 is central to Hh signal transduction, the pathway is significantly dependent on the levels of cAMP in/around the primary cilium. Without ligands, the ciliary compartment (and the basal body from which the cilium emanates) is enriched for cAMP generated through the action of the ciliary G-protein-coupled receptor GPR161.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Cyclic AMP can activate basal body-localized PKA, resulting in generation of GLI3<sup>R</sup>, which can enter the nucleus to block target gene expression. Hh ligands, however, induce the SMO-dependent removal of GPR161 from the primary cilium, subsequently lowering the cAMP levels and PKA activity, thus stabilizing GLI3<sup>FL</sup>. Experimental small molecules (e.g., forskolin, eggmanone) affecting the production or degradation of cyclic AMP can therefore be used to modify Hh signaling.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Full-length GLI3 and GLI2 can further be activated at the ciliary tip by a not well understood mechanism and can then promote target gene induction in the nucleus. Some target genes (e.g., <i>GLI1</i>, <i>PTCH1</i>, <i>HHIP</i>) serve to control the Hh pathway by feedback loops, whereas others are more tissue- or cell type-specific (e.g., <i>MYCN</i> in MB).</div><div class="NLM_p">It is important to note that the signal transduction cascade outlined above is considered the <i>canonical</i> Hh pathway as it was the first to be described and as it represents the most widely used mode of signal transduction during normal development. Nevertheless, studies mostly done in cancer settings have revealed that several <i>noncanonical</i> signal transduction mechanisms exist which cells are also utilizing.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> These include, but are not limited to, SMO-dependent yet GLI-independent effects (or vice versa) or even primary cilia-independent effects of SHH.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19">(14−19)</a></div><div class="NLM_p">The generally less-well understood noncanonical signaling modes often utilize a coupling of the GPCR SMO to G-proteins, in particular to the G<sub>i</sub> family of small heterotrimeric G-proteins. While in some cell types the activation of G<sub>i</sub> proteins contributes to GLI-mediated transcription, this is not the case in all cell types studied so far.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, G-protein stimulation mediates the effects of Hh ligands on Rho/Rac and the cytoskeleton, which is important for Hh-induced cell migration and endothelial tube formation.<a onclick="showRef(event, 'ref15 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref15 ref21 ref22">(15,21,22)</a> G-protein-mediated noncanonical signaling by SMO is much faster than GLI-mediated transcription and is also crucial for Hh regulation of cellular metabolism. Specifically, Hh promotes a shift toward increased glucose uptake and aerobic glycolysis (Warburg effect) by promoting a calcium influx, activation of CAMKK2 and subsequently of AMP-activated protein kinase (AMPK), the latter being a master energy sensor within the cell.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The complexity and diversity of noncanonical signaling routes can be exemplified by these two G<sub>i</sub>-mediated cellular effects where Hh-mediated metabolic regulation requires the presence of a primary cilium whereas Rho/Rac activation does not.<a onclick="showRef(event, 'ref14 ref15 ref19 ref23'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref19 ref23">(14,15,19,23)</a> In addition, G-protein-independent noncanonical mechanisms have also been explored, such as the SMAD-dependent activation of <i>GLI2</i> transcription by TGFß without the need for upstream pathway elements such as PTCH1 or SMO.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Furthermore, not only SMO is capable of eliciting noncanonical signaling but also PTCH1. The Hh receptor has been proposed to function as a dependence receptor which initiates apoptosis as long as it is not being associated with its cognate ligand, in this case SHH. Overexpressed unliganded PTCH1 is able to recruit a pro-caspase 9 complex by means of its intracellular C-terminal tail, followed by caspase 3 activation and the induction of apoptosis.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> This GLI- and SMO-independent process is blocked in the presence of Hh ligands binding to PTCH1.</div><div class="NLM_p last">As small molecule inhibitors have been developed that target specific but distinct steps in the (canonical) Hh signaling cascade, the knowledge about the actual mode of signal transduction is crucial for the interpretation of the results obtained with the respective inhibitor. This also applies to the development of drug resistance, a common clinical problem with the use of SMO inhibitors. Mechanistically, this includes the outgrowth of SMO mutant subclones which do not allow SMO antagonists to bind to their target or the activation of SMO-bypassing mechanisms such as downstream pathway activation, thereby phenocopying the outcome of some noncanonical mechanisms.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> In general, however, well-established noncanonical signaling mechanisms (e.g., the coupling of SMO to G<sub>i</sub> proteins) have so far not been considered for pharmacological targeting approaches, but this might be worth doing so in the future.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Small Molecules Targeting the Hh Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In general, Hh pathway inhibitors can be broadly subdivided into a group of small molecules directly targeting a central Hh pathway component (e.g., SMO or GLI) and into another group not specifically targeting a core Hh pathway member but Hh-modulating proteins (e.g., kinases, chromatin factors, or cytoskeletal structures). The following text assembles examples from both categories but is instead structured based on the eventual target in the Hh pathway which will be affected by the therapeutic drug.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Compounds Interfering with Hh Ligand Functions</h3><div class="NLM_p">Many cancer types display an elevated level of Hh ligand expression with SHH being the most frequently encountered family member. A SHH-inactivating antibody (5E1) has been very informative in preclinical studies on the function of Hh ligands, but pharmacologically targeting the ligands directly has been difficult. Stanton and colleagues were the first to describe the discovery of a macrocyclic small molecule which they termed robotnikinin, <b>1</b> (named after Dr. Robotnik, the opponent of the video game character Sonic the Hedgehog).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> A summarizing table encompassing all drug molecules discussed in this review can be found in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Drug Molecules Discussed in This Review</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd in manuscript</th><th class="colsep0 rowsep0" align="center">name in literature</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">robotnikinin</td><td class="colsep0 rowsep0" align="left">SHH</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">RU-SKI43</td><td class="colsep0 rowsep0" align="left">HHAT</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">RU-SKI201</td><td class="colsep0 rowsep0" align="left">HHAT</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">cyclopamine</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">IPI-926 (saridegib)</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49">(47−49)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">vismodegib (GDC-0449)</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref51 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref53">(51,53)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">sonidegib (NVP-LDE-225)</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref52 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref54">(52,54)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">itraconazole</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">BMS-833923 (XL-139)</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">PF-04449913 (glasdegib)</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">PF-5274857</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref58 ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60">(58−60)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">compound 12</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref61 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref63">(61,63)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Anta XV</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref61 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref63">(61,63)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">compound 13</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref61 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref63">(61,63)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">NVP-LEQ506</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">taladegib (LY-2940680)</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">compound 23b</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">compound 21</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">20(S)-OHC</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">22-NHC</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">budesonide</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">Allo-1</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">compound 5</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">chalcone-12</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Hh78</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">MRT-92</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">TAK-441</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">JK184</td><td class="colsep0 rowsep0" align="left">microtubules (cilia)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114">(112−114)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">CA1</td><td class="colsep0 rowsep0" align="left">ciliogenesis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">SA1</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">GANT58</td><td class="colsep0 rowsep0" align="left">GLI1, GLI2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">GANT61</td><td class="colsep0 rowsep0" align="left">GLI1, GLI2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref129 ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref129 ref131 ref132">(129,131,132)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">glabrescione B</td><td class="colsep0 rowsep0" align="left">GLI1, GLI2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">genistein</td><td class="colsep0 rowsep0" align="left">GLI?</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref134 ref135'); return false;" href="javascript:void(0);" class="ref ref134 ref135">(134,135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">compound 12</td><td class="colsep0 rowsep0" align="left">GLI1</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">compound 13</td><td class="colsep0 rowsep0" align="left">SMO</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">HP-1</td><td class="colsep0 rowsep0" align="left">GLI1, GLI2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">HP-2</td><td class="colsep0 rowsep0" align="left">GLI2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">zerumbone</td><td class="colsep0 rowsep0" align="left">GLI</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">staurosporinone</td><td class="colsep0 rowsep0" align="left">GLI</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">physalin B</td><td class="colsep0 rowsep0" align="left">GLI</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">solasonine</td><td class="colsep0 rowsep0" align="left">GLI?</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144,145)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">cynanbungeigenin C</td><td class="colsep0 rowsep0" align="left">GLI?</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">taepeenin D</td><td class="colsep0 rowsep0" align="left">GLI</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">pyrvinium</td><td class="colsep0 rowsep0" align="left">CK1α</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref167 ref168'); return false;" href="javascript:void(0);" class="ref ref167 ref168">(167,168)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">pirfenidone</td><td class="colsep0 rowsep0" align="left">GLI2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></td></tr></tbody></table></div></div><div class="NLM_p"><b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) directly binds the biologically active N-terminal part of SHH with a <i>K</i><sub>d</sub> of 3.1 μM, blocks its function, and inhibits Hh signaling in cell culture with an IC<sub>50</sub> of 4 μM. Furthermore, it also proved active in a synthetic organotypic skin explant model system. So far, this experimental compound is the only known small molecule to directly inactivate Hh ligands.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural representation of compounds <b>1</b> (robotnikinin), <b>2</b> (RU-SKI43), and <b>3</b> (RU-SKI201) antagonizing Hh ligand function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another approach targeting Hh ligands aims at blocking the biologically important addition of palmitic acid to the Hh protein, a reaction catalyzed by the Hh acyl-transferase (HHAT, also known as Skinny Hedgehog (SKI1)). HHAT is inhibited by 5-acyl-6,7-dihydrothieno[3,2-<i>c</i>]pyridines,<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> which were discovered through screening of 63 885 compounds from different, mostly commercially available compound libraries. Most published data are available on RU-SKI43, <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), one compound of this series.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a><b>2</b> inhibits HHAT with an IC<sub>50</sub> of 0.85 μM in vitro and interferes with tumor cell growth in cell culture and in vivo. An even more selective analogue (RU-SKI201, <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)) with a lower IC<sub>50</sub> (0.2 μM in vitro) has also been described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p last">In the future, one might envision targeting additional Hh ligand-focused proteins such as DISP1,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> against which there is currently no inhibitor available. In general, Hh ligand-targeting drugs could be very informative when deciphering the modes of Hh signaling or when drug resistance against other Hh inhibitors is a problem. It should be noted however that they might be ineffective in situations of pathway activation downstream of the ligands, as occurring for instance in the majority of BCC and MB cases with inactivating <i>PTCH1</i> mutations.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> The Gold Standard: SMO Inhibitors</h3><div class="NLM_p last">The Smoothened protein represents a bottleneck in the canonical Hh signal transduction system, and its genetic deletion or pharmacological blockade is associated with a complete abrogation of ligand-induced target gene expression. Intriguingly, many unbiased cellular screens for Hh pathway inhibitors revealed SMO (and not GLI) blockers, suggesting that SMO represents a well-suited structure for drug development approaches. This might be due to the fact that SMO belongs to the F-class of GPCRs, and members of the GPCR-superfamily generally constitute very good drug targets due to structural reasons. Overall, SMO inhibitors currently represent the largest class of Hh pathway inhibitors and, at least in terms of their specificity and pharmacological properties, are also the most advanced compound class. On the molecular side, SMO contains two binding sites for small molecules: one in the extracellular cysteine-rich domain (CRD) and another one in the 7-transmembrane (7-TM) region. The CRD site possesses sterol-binding properties, and cholesterol was in fact recently identified as an endogenous activator of SMO function.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> In line with these findings, oxysterols (hydroxylated cholesterol variants that also occur endogenously) can modulate SMO in a positive or negative manner by binding to the CRD.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> In contrast, the heptahelical bundle (7-TM) site functions instead as the binding pocket for several synthetic SMO modulators which will be discussed below.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cyclopamine and Related Compounds</h3><div class="NLM_p">The first compound to be discovered as selective Hh inhibitor was the naturally occurring cyclopamine (<b>4</b>, 11-deoxyjervine) from the plant <i>Veratrum californicum</i> (also known as false hellebore).<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a><b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) has a sterol backbone and can bind to both, the CRD, as well as the 7-TM of SMO (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Paradoxically, it possesses opposing functions at these two sites: While it exerts antagonistic effects on Hh signal transduction through the 7-TM site, it displays partial agonistic effects through the CRD binding site. As a result, <b>4</b> induces the ciliary localization of SMO (which is controlled by the CRD and is considered a sign of active Hh signaling) but still blocks signal transduction and Hh target gene expression. <b>4</b> has never reached the clinical stage of drug development due to solubility issues, the acid sensitivity of the spirotetrahydrofuran ring system (E-ring), and furthermore, unwanted side effects in mouse models. However, a series of cyclopamine analogues were generated by semisynthesis which showed improved pharmacological properties. Structural modification of the D-ring (homologue), reduction to the cis-decane (A–B ring), as well as conversion of the 3-hydroxy functionality into a methanesulfonamide finally resulted in IPI-926, <b>5</b>, the most advanced compound (saridegib, phase II) from Infinity Pharmaceuticals (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a><b>5</b> has been shown to induce significant tumor regression and extension of lifespan in a mouse model of medulloblastoma.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><b>5</b> has also been the subject of clinical trials in several solid malignancies (phase I) and myelofibrosis (phase II).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of SMO antagonists <b>4</b> (cyclopamine) and <b>5</b> (saridegib).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystallographically determined binding mode of <b>4</b> (cyclopamine) to Smo (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a>) according to ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and visualized in PyMOL 0.99 (<contrib-group><span class="NLM_string-name">DeLano, W. L.</span></contrib-group> (<span class="NLM_year">2002</span>)   <cite><i>The PyMOL Molecular Graphics System</i></cite>; DeLano Scientific: San Carlos, CA, U.S.). For clarity of presentation some residues of the 7-TM have been omitted. The protein backbone is shown as cartoon (wheat), the ligand as well as important amino acids in stick representation, color coded by atom type. For the ligand: carbon, green; nitrogen, blue; oxygen, red. For the protein: carbon, wheat; nitrogen, blue; oxygen, red. Potential hydrogen bonds are indicated by black dashes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> SMO-Inhibiting Compounds Approved by the FDA</h3><div class="NLM_p">Of all specific Hh inhibitors available, there are only two that have so far been approved by the FDA/EMA: vismodegib (<b>6</b>, aka GDC-0449, marketing name Erivedge, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c) by Roche and sonidegib (<b>7</b>, aka NVP-LDE-225, erismodegib, marketing name Odomzo, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>d) by Novartis. Both compounds are antagonizing the function of SMO by binding to the 7-TM site, and both have been approved for use in locally advanced or recurrent/metastatic BCC. Numerous clinical trials (75 in the case of <b>6</b>; 40 in the case of <b>7</b>) with these drugs are currently underway. Chemically, <b>6</b> bears a <i>N</i>-(3-(2-pyridinyl)phenyl)benzamide core and is accessible via a four-step synthesis starting from 2-chloro-5-nitroaniline.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Screening of a combinatorial in-house library in a cell-based assay and further structural optimization of the initial screening hit, a biphenylcarboxamide, resulted in identification of <b>7</b>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Despite having a low aqueous solubility and a moderate bioavailability, <b>6</b> proved very effective in a phase II BCC study (ERIVANCE) with an overall response rate (ORR) of 43% in locally advanced BCC patients.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Similarly, <b>7</b> demonstrated significant antitumor activity with comparable ORR to <b>6</b> in BCC studies.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Intriguingly, a sonidegib/docetaxel combination has recently shown therapeutic benefit in patients with metastatic triple-negative breast cancer with one patient even demonstrating complete remission.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The authors identified the Hh-activated tumor stroma as the prime target, which secondarily affected the mammary cancer stem cell compartment and led to improved chemotherapy sensitivity. Although the patient number was small in this study, the results were encouraging for the use of SMO antagonists in selected solid tumors other than BCC and MB.</div><div class="NLM_p last">Another FDA-approved drug capable of inhibiting SMO and Hh signal transduction came from a repurposing approach and revealed the antifungal drug itraconazole, <b>8</b>.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> This orally administered drug (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) blocks the Hh pathway in reporter cells with an IC<sub>50</sub> of 800 nM and has the major advantage that it is already clinically approved and shows only very little toxicity in patients. Competition experiments suggest that <b>8</b> has a distinct binding site on SMO compared to <b>4</b> (cyclopamine), but the exact identity of this site has not been elucidated so far. <b>8</b> interferes with the import of SMO into the primary cilium and suppresses the Hh-dependent growth of allografted MB cells. A phase II trial has shown clinical efficacy in the treatment of BCC.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Additional Pharmaceutical SMO Antagonists</h3><div class="NLM_p">Today, basically all major pharmaceutical companies have developed highly potent and selective SMO antagonists, which are involved in numerous clinical trials. These include BMS-833923 (<b>9</b>, aka XL-139, phase II, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) from Bristol-Myers-Squibb or Pfizer’s PF-04449913 (<b>10</b>, aka glasdegib, phase II, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and PF-5274857 (<b>11</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> The latter compound is able to efficiently penetrate the blood–brain barrier and is therefore a good candidate for use in brain malignancies such as MB or for the treatment of brain metastases.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of selected SMO antagonists <b>6</b> (vismodegib), <b>7</b> (sonidegib), <b>8</b> (itraconazole), <b>9</b> (BMS-833923), <b>10</b> (glasdegib), <b>11</b> (PF-5274857).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other small molecule SMO inhibitors were developed by Novartis (NVP-LEQ506, <b>15</b>, phase I, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and by Eli Lilly (Taladegib, <b>16</b>, aka LY-2940680, phase II, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>),<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> both compounds being based on phthalazine as core structure. On the basis of the initial screening hit <b>12</b>, first SAR studies led to the discovery of Anta XV, <b>13</b>, which was further optimized regarding aqueous solubility, hERG activity, as well as potency, rendering <b>14</b> and finally <b>15</b>.<a onclick="showRef(event, 'ref61 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref63">(61,63)</a> Further structural optimization of <b>16</b> resulted in <b>17</b> (originally termed compound 23b), which proved to be 35-fold more potent than <b>16</b> and 23-fold more potent than <b>6</b> (vismodegib) displaying an IC<sub>50</sub> of 0.17 nM in a cellular Hh reporter assay.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Another improved taladegib derivative, <b>18</b> (originally termed compound 21), could be developed following a structure-based approach (“dissection-then-evolution”).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Additional molecules were also described in the patent literature by various pharmaceutical companies (e.g., reviewed in refs <a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> and <a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Optimization of the screening hit <b>12</b> leading to <b>15</b> (NVP-LEQ506).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Further structural optimization of <b>16</b> resulting in compounds <b>17</b> and <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compounds Binding to the CRD of SMO</h3><div class="NLM_p">As mentioned above, SMO contains two major sites recognized by endogenous as well as synthetic small molecules. Besides the central 7-TM site region to which most synthetic compounds bind, SMO is controlled by the extracellular cysteine-rich domain (CRD). The CRD is crucial for high pathway activity and for ciliary translocation of SMO. Cholesterol has been identified as a potential endogenous molecule required for SMO activity, and different hydroxylated variants of cholesterol (oxysterols, OHC) can modulate SMO activity through the CRD.<a onclick="showRef(event, 'ref41 ref42 ref43 ref68'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref68">(41−43,68)</a> Most oxysterols stimulate SMO activity, such as 20(S)-OHC (<b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> However, an inhibitory sterol is also known (the aza-sterol analogue 22-NHC, <b>20</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), which competes with <b>19</b> for CRD binding and suppresses SMO function.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The degree to which oxysterols actually represent endogenous Hh modulators remains currently undefined, and the micromolar concentrations required to impact SMO in combination with their high lipophility probably preclude their widespread use as pharmacological agents.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structures of CRD-binding SMO modulators <b>19</b>, <b>20</b>, <b>21</b>, and <b>22</b>. All compounds except <b>19</b> function as antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another class of SMO CRD-targeting compounds are glucocorticoids,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> and stimulating as well as inhibitory glucocorticoids have been identified.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The latter include the two FDA-approved antiasthmatic drugs budesonide (<b>21</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) and ciclesonide, which interfere with SMO ciliary translocation and function also on vismodegib-resistant mutant SMO. Although the cross-reactivity with the glucocorticoid receptor (GR) precludes a selective targeting of SMO at this point, it might lay ground for the future development of SMO-CRD specific glucocorticoids which have no or only little activity on the GR.</div><div class="NLM_p last">Another reported compound that presumably binds to the SMO CRD and blocks Hh signaling as well as in vitro MB cell proliferation is Allo-1 (<b>22</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), bearing an imidazoline-2,4-dione (hydantoin) as core-structure.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> This compound was discovered in a cellular compound screen demonstrating that novel and synthetic molecules not binding to the 7-TM site can be identified. Where tested, CRD-binding antagonists were capable of inhibiting vismodegib-resistant SMO because the responsible resistance-mediating mutations lie within the 7-TM site and it can be assumed that drug binding to the CRD site is not grossly affected. Hence, the development of clinically usable CRD-binding compounds is definitely of interest and a viable approach to combat <i>SMO</i> mutation-driven drug resistance.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Some General Considerations about SMO Inhibitors</h3><div class="NLM_p">SMO-selective drugs represent the most advanced group of Hh pathway inhibitors and have caused a lot of excitement when they first entered clinical trials, initially for treatment of BCC and MB. It was therefore very disappointing to see that acquired drug resistance is a major issue with this class of drugs.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Approximately 30% of patients with locally advanced BCC showed secondary resistance to SMO inhibitor therapy.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Mechanistically, this is brought about by selection of tumor cell clones harboring point mutations in the drug binding pocket of SMO. The best studied example is a missense mutation of residue 473 of human SMO (D473H), which interferes with the binding of <b>6</b> (vismodegib) to SMO. The side chain of aspartate 473 is part of a hydrogen bond interaction network with two other residues (R400 and Q477) which keeps the SMO binding pocket in the correct shape and which stabilizes binding of <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Mutation of D473 disrupts this interaction network, thereby compromising the binding pocket due to conformational changes affecting the orientation of the SMO transmembrane helices.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Crystallographically determined binding mode of <b>6</b> (vismodegib) in Smo (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L7I">5L7I</a>) according to ref <a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and visualized in PyMOL 0.99 (<contrib-group><span class="NLM_string-name">DeLano, W. L.</span></contrib-group> (<span class="NLM_year">2002</span>)   <cite><i>The PyMOL Molecular Graphics System</i></cite>; DeLano Scientific: San Carlos, CA, U.S.). For clarity of presentation some residues of the 7-TM have been omitted. The protein backbone is shown as cartoon (wheat), the ligand as well as important amino acids in stick representation, color coded by atom type. For the ligand: carbon, orange; nitrogen, blue; oxygen, red; chlorine, green; sulfur, yellow. For the protein: carbon, wheat; nitrogen, blue; oxygen, red. Potential hydrogen bonds are indicated by black dashes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various resistance-causing <i>SMO</i> point mutations have been identified so far, and they can occur within the same tumor. Less frequent resistance mechanisms include the activation of signaling molecules downstream of SMO, such as genetic amplification of <i>GLI2</i> or <i>CCND1</i>, activation of GLI-enhancing SRF/MKL1 signaling or loss of <i>SUFU</i>.<a onclick="showRef(event, 'ref73 ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref73 ref76 ref77 ref78">(73,76−78)</a> Furthermore, several kinases have been identified as druggable additional positive (e.g., atypical PKCι/λ, DYRK1B) and negative (e.g., CK1α) modulators downstream of SMO.<a onclick="showRef(event, 'ref79 ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81 ref82">(79−82)</a></div><div class="NLM_p">The occurrence of drug resistance necessitates the identification of additional SMO antagonists capable of retaining their activity even on mutant SMO or of Hh pathway inhibitors which block signaling at another step in the cascade, preferentially inhibiting a downstream element. Alternatively, targeting pathways critical in drug-resistant cells such as PI3K-AKT signaling has helped to overcome resistance against SMO inhibitors in preclinical models.<a onclick="showRef(event, 'ref26 ref83'); return false;" href="javascript:void(0);" class="ref ref26 ref83">(26,83)</a> Moreover, an activated RAS pathway was reported to suppress Hh signaling in MB, rendering tumor cells Hh inhibitor-independent and switching cellular dependencies away from Hh and toward the RAS signaling system.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> Along these lines, resistance-associated cellular transdifferentiation in BCC has been shown to be associated with altered Wnt and Notch pathways.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> Therefore, modulating additional pathways such as PI3K, RAS, Wnt, or Notch might alleviate Hh inhibitor resistance in certain settings.</div><div class="NLM_p">Nevertheless, screening approaches have also revealed SMO inhibitors that could overcome drug resistance and still function on vismodegib-resistant mutant SMO. Examples include the preclinical substances <b>23</b> (originally termed compound <b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Chalcone-12 (<b>24</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Hh78 (<b>25</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> MRT-92 (<b>26</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a><b>15</b> (NVP-LEQ506, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> the clinically tested TAK-441 (<b>27</b>, Takeda Pharmaceutical, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> and the phthalazine derivative <b>16</b> (Taladegib, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). With respect to pharmacological activity, the acylguanidine <b>26</b> is noteworthy as it displayed a very low nanomolar activity in cultured Hh-dependent cerebellar granule cells, making it one the most potent SMO inhibitors known. The high potency of this drug candidate is probably caused by its bridging of two distinct subsites within the 7-TM region of SMO. However, despite the fact that the compounds mentioned in this section can compensate for other SMO targeting drugs such as <b>6</b> (vismodegib) in certain mutational settings, it remains open whether additional cancer mutations exist that would interfere with binding of these compounds as well.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of SMO inhibitors reported to retain activity against vismodegib-resistant SMO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In clinical trials, common adverse side effects encountered with SMO inhibitors were gastrointestinal disorders (nausea, vomiting, and diarrhea), muscle spasms, fatigue, hair loss, and dysgeusia (taste sense distortion). At least some of these effects are likely to be <i>on-target</i> adverse effects caused by a systemic Hh blockade. For instance, Hh activity is known to play significant roles in hair follicle biology and in taste buds.<a onclick="showRef(event, 'ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94">(92−94)</a> Pregnancy represents a contraindication of Hh inhibitor use due to the widespread involvement of this pathway in embryogenesis. Moreover, certain postnatal processes such as bone growth are also affected by Hh, and it was recommended that SMO antagonists may be used only in skeletally mature patients, which is of high importance in pediatric cancers such as SHH-driven MB.<a onclick="showRef(event, 'ref95 ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref95 ref96 ref97">(95−97)</a> An unexpected mechanism seems to link the use of SMO inhibitors and the occurrence of muscle spasms, and it was attributed to a selective partial agonism demonstrated for some drug molecules. Vismodegib, cyclopamine, and others allow SMO to enrich at the ciliary base but prevent its trafficking to the tip. As a result, SMO is able to couple to G<sub>i</sub> proteins at the base of cilia and to induce noncanonical signaling, leading to calcium influx and muscle contractions. Coadministration of L-type calcium channel blockers might solve this unforeseen problem.</div><div class="NLM_p">Despite the occurrence of acquired drug resistance, targeting Hh signaling in BCC and MB (both of which frequently harbor inactivating mutations in <i>PTCH1</i>, rendering them Hh pathway dependent) is per se a straightforward and reasonable approach. It was however quite unexpected to also observe a clinical failure of SMO antagonists in several additional types of solid cancer (for an excellent discussion on the reasons for failure see also ref <a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a>). In one particular example, a pancreatic cancer trial had to be prematurely terminated because the cohort receiving the Hh inhibitor saridegib displayed a worse survival compared to the control group (Web page info from Infinity Pharmaceuticals, <a href="http://www.infi.com" class="extLink">www.infi.com</a>, Jan 2012). Other clinical trials were not that alarming but also could not manifest a significant benefit of using SMO antagonists in combination with conventional chemotherapy in pancreatic ductal adenocarcinoma (PDAC).<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> What was going wrong? It turned out that pharmacological SMO inhibition targets primarily stromal Hh signaling in PDAC, which is elicited by tumor cell-derived secretion of Hh ligands.<a onclick="showRef(event, 'ref85 ref101 ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref85 ref101 ref102 ref103">(85,101−103)</a> This stromal cell population is activated by Hh signaling and, against previous expectations, exerts tumor-suppressive functions in PDAC, at least in mouse models of the disease.<a onclick="showRef(event, 'ref104 ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106">(104−106)</a> The depletion of stromal elements by Hh inhibition surprisingly favored tumor growth by enhancing tumor angiogenesis and infiltration with tumor-promoting immune-suppressive T-regulatory cells (Tregs). A tumor-restrictive role of Hh-activated stroma not only is limited to pancreatic cancer but also has been reported in preclinical models of colon, prostate, and lung cancer.<a onclick="showRef(event, 'ref107 ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref107 ref108 ref109">(107−109)</a> Thus, it remains to be seen whether Hh inhibitors are suited for treatment in malignancies other than BCC and MB, tumor types that are known to be Hh-dependent. It could very well be that in other cancers, Hh pathway blockers will be used in the future only as combination therapy with drugs such as immune checkpoint inhibitors or antiangiogenic therapies. These findings underscore the importance of knowing the exact modalities of Hh signal transmission (autocrine vs paracrine, canonical vs noncanonical) in a given tumor type in order to be able to appropriately design the best targeting strategy. As many epithelial tumors utilize both canonical (mostly in the tumor stroma) and noncanonical (mostly in the tumor cells) modes of signal transmission, this task can be demanding and might explain the current lack of clear effectiveness of SMO antagonists in clinical trials.</div><div class="NLM_p last">Finally, from a mechanistic point of view it should be mentioned that a nuclear pool of SMO has been described recently that also impacted on Hh target gene expression.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> It is however currently not fully clear what the exact physiological contribution of nuclear versus ciliary SMO is and to which extent available SMO inhibitors would target nuclear SMO in different cell types and cancer settings. Similar issues also apply to nonciliary pools of SMO, which can function in a noncanonical manner to impact on cell migration<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and which have even been described as being competent for some degree of signaling.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Strategies and Compounds Indirectly Affecting SMO</h3><div class="NLM_p">The Smoothened protein is a bottleneck in canonical Hh signaling, and targeting SMO is therefore a logical approach. In light of the occurrence of drug resistance, however, other targeting strategies might be envisioned. One such approach focuses on the primary cilium as a target structure. Regulated ciliary import and export are crucial for Hh signaling, and SMO translocation is a key step in its signal transduction. Hence, compounds interfering with either ciliogenesis or ciliary trafficking will indirectly also affect canonical Hh signaling. One example of such a compound is the imidazopyridine derivate JK184 (<b>28</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>),<a onclick="showRef(event, 'ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114">(112−114)</a> which is capable of depolymerizing microtubules and therefore blocks ciliogenesis and Hh signaling. Other examples include compounds CA1 (<b>29</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) and CA2 which abrogate cilia formation and were discovered together with the preclinical compound series SA1 (<b>30</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) to SA7 which preserved cilia structure but bound to SMO and interfered with ciliary SMO import.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Many direct SMO binders interfere with cilia translocation. However, additional compounds inhibiting the SMO transport protein GPCR-associated sorting protein 2 (GPRASP2) have also been identified.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> GPRASP2 binds to the ciliary targeting motif in SMO which is responsible for cilia translocation and the identified small molecules interrupt this protein–protein interaction, suppressing SMO transport. Intriguingly, many of these compounds are known for other mechanisms, such as targeting receptors for dopamine (D2; bromopride, droperidol), histamine (H1; tripelennamin, cyclizine), serotonin (5-HT3; palonosetron), or opiods (μ; tramadol).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> It therefore comes as a surprise that these structurally diverse molecules all bind to the SMO-GPRASP2 interface and block SMO transport. However, this discovery might allow for a future development of SMO transport-selective compounds not affecting other receptor systems.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Examples of compounds indirectly affecting Hh signaling by interference with microtubules, primary cilia formation, and/or SMO transport.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Another class of indirectly Hh suppressing drug molecules are the cholesterol-lowering statins (3-hydroxy-3-methylglutaryl-coenzyme-A reductase (HMG-CoA) inhibitors). Given that cholesterol is crucial for Hh signaling at several levels (Hh ligands, SMO function), interfering with cellular cholesterol availability does impact Hh signaling.<a onclick="showRef(event, 'ref117 ref118 ref119 ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref117 ref118 ref119 ref120 ref121">(117−121)</a> As such, statins might be used clinically to synergize with selective Hh pathway inhibitors.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Circumventing SMO: Downstream Inhibition of Hh Signaling</h3><div class="NLM_p">In vitro studies on cultured cancer cells derived from different tumor types (e.g., colorectal, pancreatic, prostate, lung) have shown that despite the fact that these cells frequently expressed the Hh target gene <i>GLI1</i> (and therefore are considered to have active Hh signaling), they did not respond to either recombinant SHH protein or, even more importantly, to inactivating anti-Hh antibody or synthetic SMO antagonists.<a onclick="showRef(event, 'ref101 ref123'); return false;" href="javascript:void(0);" class="ref ref101 ref123">(101,123)</a> This suggested that the tumor cells had lost their ability to respond to Hh ligands and/or that the intracellular signal transduction cascade was altered in a way precluding signal conveyance. Indeed, subsequent work revealed that several mechanisms in tumor cells block canonical Hh signaling, yet still allowing for the activation of GLI transcription factors by noncanonical means.<a onclick="showRef(event, 'ref80 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref80 ref84 ref85">(80,84,85)</a> As one example, primary cilia are lost in many epithelial tumor cells, such as in pancreatic, renal, prostate, and breast cancer,<a onclick="showRef(event, 'ref124 ref125 ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref124 ref125 ref126 ref127">(124−127)</a> interfering with proper reception and transmission of Hh signals. In contrast, cancer cells have activated a number of oncogenes promoting signaling elements which lie downstream of SMO. Most notably, the GLI1 and GLI2 transcription factors function to integrate many noncanonical inputs elicited by RAS, AKT, aPKC-ι/λ, DYRK1B, TGF-β, MRTF-A (MKL1).<a onclick="showRef(event, 'ref18 ref77 ref78 ref79 ref80 ref81 ref84 ref85 ref103 ref128'); return false;" href="javascript:void(0);" class="ref ref18 ref77 ref78 ref79 ref80 ref81 ref84 ref85 ref103 ref128">(18,77−81,84,85,103,128)</a> These alternative and ligand-independent activation modes bypass upstream signaling components like PTCH1 or SMO and render inhibitors noneffective, at least when the aim is reduction of GLI-mediated transcription. Targeting GLI transcription factors can be achieved by blocking stimulating kinases with small molecule kinase inhibitors, and a large plethora of potential candidates has been identified, but should not be the topic of this review.</div><div class="NLM_p">The first small molecule antagonists of GLI function to be described were GANT58 (GLI-antagonist 58, <b>31</b>) (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) and GANT61 (<b>32</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) which inhibit GLI1 and GLI2 with an IC<sub>50</sub> of approximately 5 μM in cellular assays.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> These inhibitors function in in vitro and in vivo situations of elevated <i>GLI1</i> expression which are insensitive to upstream pathway inhibition, demonstrating their use in cancer and in Hh-driven organ fibrosis.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Due to the fact that by now <b>32</b> has become a widely used tool in the field, most of the available data are on this compound. <b>32</b> directly binds to GLI1/2 between the zinc fingers 2 and 3, preventing DNA binding.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Chemically, <b>32</b> is a hydrolysis-labile structure, and as core the diamine moiety has been identified which is responsible for the GLI-inhibitory effects.<a onclick="showRef(event, 'ref118 ref132'); return false;" href="javascript:void(0);" class="ref ref118 ref132">(118,132)</a> As the pharmacodynamics of <b>32</b> necessitate the use of relatively high compound concentrations, numerous attempts were undertaken to identify additional GLI antagonists with submicromolar efficacy. Unfortunately, however, to date, none of these identified preclinical small molecules displayed a huge step forward in terms of potency and selectivity. This might be due to the fact that transcription factors typically possess rather shallow structures which serve as interfaces for protein–protein or protein–DNA interactions. Such structures are, in contrast to ATP-binding pockets in kinases, difficult to target with small molecules. However, virtual screening and structural docking revealed a GLI-associating molecule, the prenylated isoflavone glabrescione B (GlaB) (<b>33</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), which binds to GLI1’s zinc finger domain and thereby interferes with GLI-DNA binding and is comparably potent to <b>32</b>.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Intriguingly, other isoflavone structures (such as genistein (<b>34</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) and daidzein) have also been proposed as Hh pathway inhibitors, although their exact mode of action is currently not fully elucidated.<a onclick="showRef(event, 'ref134 ref135'); return false;" href="javascript:void(0);" class="ref ref134 ref135">(134,135)</a> This suggests that the isoflavone core can potentially serve as a starting point in the development of novel Hh/GLI inhibitors. Surprisingly, specific substitutions at the isoflavone B-ring generated Hh inhibitory molecules which selectively targeted either SMO or GLI:<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Isoflavones bearing a 4-(trifluoromethyl)phenoxy substituent in 3′-position preferentially bound to the zinc finger of GLI1, <b>35</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), whereas compounds harboring this substituent in 4′-position preferentially were proposed to bind to the heptahelical bundle of SMO, <b>36</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Compounds inhibiting Hh signaling at the level of the GLI transcription factors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Furthermore, a series of four small molecules (HPI-1 to HPI-4) were discovered which block GLI function in cells in the lower micromolar range.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Interestingly, one compound (HPI-1, <b>37</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) was able to suppress exogenous GLI1/GLI2 activity, whereas another one (HPI-2, <b>38</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) lacked an inhibitory effect on GLI1 but retained the capability to antagonize transfected GLI2, implying that it might be possible to discover GLI1/2-selective modulators. Collectively, the four compounds displayed different modes of action affecting GLI processing, trafficking, and/or protein stability. This suggests that multiple physiological steps in the GLI biology are amenable to drug targeting.</div><div class="NLM_p">In addition, a large number of natural products have been described as GLI antagonists up to now, but the precise mechanisms of action of these molecules are often unresolved. These substances include the sesquiterpene zerumbone (<b>39</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), the bisindole alkaloids staurosporinone (<b>40</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), and arcryaflavin C as well as physalin B (<b>41</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) and physalin F.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Albeit being the most potent of this series, the physalins are also challenging from a chemical point of view as they bear an unusual 13,14-<i>seco</i>-16,24-cyclo modification of the underlying steroidal core for which up to now no total synthesis has been reported.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><div class="NLM_p">The same group also identified a series of pentacyclic triterpenes (colubrinic acid, betulinic acid, alphitolic acid) as potential GLI inhibitors, although the reported IC<sub>50</sub> values were quite high (approximately 30–40 μM) and drug optimization would be needed for future use.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> They also described additional natural compounds with GLI inhibitory potential and lower IC<sub>50</sub> values, suggesting that natural substances can indeed be a viable source for new lead compounds.<a onclick="showRef(event, 'ref141 ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref141 ref142 ref143">(141−143)</a></div><div class="NLM_p">Molecular docking predictions have also identified naturally occurring substances such as the glycoalkaloid solasonine (<b>42</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) as compounds capable of interfering with GLI-mediated transcription.<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144,145)</a> Although more work is required to elucidate the exact mode of action as well as the Hh/GLI specificity of solasonine, the reported IC<sub>50</sub> is in the lower micromolar range. A comparable efficacy was reported for two natural epimeric compounds possessing a sterol backbone, isolated from the plant <i>Cynanchum bungei</i> Decne (cynanbungeigenin C (CBC, <b>43</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) and D (CBD)).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Interestingly, these compounds were able to cross the blood–brain barrier in mice and to inhibit signaling and cell growth in Hh-dependent MB cells. In line with their activity against GLI transcription factors, they could also block signaling in conditions of SMO inhibitor resistance. Although being quite different in overall chemical structure, solasonine, physalin B, and cynanbungeigenin all display resemblance to a sterol scaffold, raising the putative question whether some forms of cholesterol-dependent processes might be involved at the GLI level of Hh signal transduction.</div><div class="NLM_p last">Another natural product with GLI inhibitory potential (taepeenin D, <b>44</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>) was isolated from <i>Acacia pennata</i>, a plant that can be found in Thailand.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> This terpenoid blocked GLI activity with an IC<sub>50</sub> value in the low micromolar activity, but a thorough characterization of this compound awaits further studies. Several additional natural compounds have been described in the literature as Hh pathway inhibitors, but more work is required to faithfully assess their mode of action, specificity, and toxicity.<a onclick="showRef(event, 'ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref148 ref149 ref150">(148−150)</a></div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Indirect GLI Inhibitors with Known Mechanism of Action</h3><div class="NLM_p">With the exceptions of GANT61 and GlaB which have been shown to directly bind GLI transcription factors, the exact mechanism of action is currently unknown for the majority of Hh pathway inhibitors acting at the GLI-level of signal transduction. Nevertheless, specific compounds impacting on GLI-mediated gene transcription through indirect mechanisms are known. One such inhibitor category is represented by histone deacetylase (HDAC) inhibitors. Although HDACs are well appreciated for their transcriptionally repressive role, their impact on Hh signaling is opposite: HDACs deacetylate GLI1 and GLI2, retaining these factors in the nucleus and resulting in enhanced target gene transcription.<a onclick="showRef(event, 'ref151 ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref151 ref152 ref153">(151−153)</a> Hence, downstream Hh pathway inhibition by HDAC inhibitors was able to block Hh-driven MB growth in murine cancer models and to overcome resistance against SMO antagonists.<a onclick="showRef(event, 'ref154 ref155'); return false;" href="javascript:void(0);" class="ref ref154 ref155">(154,155)</a> As HDAC inhibitors are far advanced in the drug development pipelines and in clinical trials, it will be interesting to learn whether they can also be used in Hh-dependent malignancies.</div><div class="NLM_p">Another example of a selective chromatin-directed Hh pathway blocker is the BET-domain inhibitor (+)-JQ1 (only the (+)-enantiomer shows bioactivity).<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> BET domains serve as reader domains for acetylated histones, and their association with acetylated histones (such as H3K27ac) makes them intimately involved in transcriptional activation. In terms of Hh signaling, BRD4 has been shown to be crucial for transcription of the <i>GLI1</i> and <i>GLI2</i> genes and blocking BRD4 function exerts strong negative impact on GLI-mediated target genes and cancer growth.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156,157)</a></div><div class="NLM_p">A preclinical compound targeting the class of Jumonji histone demethylases is JIB-04.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> This compound was shown to suppress Hh signaling by reducing the protein stability of GLI1. Intriguingly, this effect seems to be mediated by JIB-04 binding to the GLI1-interactor JMJD1A (encoded by the <i>KDM3A</i> gene) and appears to be independent of the inhibition of JMJD1A’s histone demethylase function, potentially implying structural changes evoked upon drug binding as a putative cause. A comparable scenario has for instance been described for Aurora kinase inhibitors impinging on N-MYC protein stability in an allosteric mechanism independent of their enzyme inhibitory function,<a onclick="showRef(event, 'ref159 ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref159 ref160 ref161">(159−161)</a> suggesting novel approaches for GLI targeting.</div><div class="NLM_p last">All of the above-mentioned inhibitors of chromatin factors represent promising and potent Hh/GLI antagonists, but due to their multiple GLI-unrelated effects on chromatin (e.g., on <i>MYC</i> expression in the case of JQ1), they possess a certain degree of expected nonspecificity. The big advantage of these compounds, however, is that HDAC and BET inhibitors are far advanced in drug development and are already included in numerous clinical trials.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Downstream Hh Inhibitors Approved for Clinical Use</h3><div class="NLM_p">As in the case of itraconazole and SMO (see above), certain clinically approved medications have been identified as Hh inhibitors at the level of GLI. The fact that these compounds are already approved and that the safety profiles are well-known makes them strong candidates for a straightforward and rapid inclusion into clinical trials. One of such compounds is arsenic trioxide (ATO), which is approved for the treatment of acute promyelocytic leukemia.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> ATO (chemically As<sub>2</sub>O<sub>3</sub>, the anhydride of arsenic acid (H<sub>3</sub>AsO<sub>3</sub>)) has been reported to directly bind to GLI1 and to interfere with the stability and the ciliary transport of GLI2, thereby blocking the central mediators of Hh-induced gene activation.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> As such, ATO is functional in vismodegib-resistant experimental settings in vitro and in vivo.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> However, subsequent work revealed a more complicated picture of ATO function, and it appears that this drug does antagonize the activator function not only of GLI transcription factors but also of their repressor functions (contributed by GLI3).<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Hence, ATO can also induce low-level Hh/GLI signaling, particularly in situations of weak intrinsic GLI activation in which GLI repressors play a dominant role.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a></div><div class="NLM_p">Another example of an FDA-approved drug with Hh-antagonistic properties is the anthelmintic substance pyrvinium (<b>45</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), an allosteric activator of casein kinase 1α (CK1α).<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a><b>45</b> is very potent and blocks cellular Hh signaling in the nanomolar concentration range, functioning also on vismodegib-resistant SMO and in settings of downstream pathway activation upon <i>SUFU</i> depletion. Mechanistically, pyrvinium-induced CK1α stimulation drives enhanced GLI1/GLI2 phosphorylation and proteasomal degradation. On the downside, <b>45</b> affects all other CK1α-directed processes unrelated to Hh, which, however, can sometimes be beneficial as CK1α activation also blocks oncogenic Wnt signaling.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Clinically approved drugs with GLI-inhibitory ability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">GLI2 stability is also targeted by pirfenidone (<b>46</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), a 2-pyridone approved for use in idiopathic pulmonary fibrosis (IPF), a life-threatening fibrotic condition of the lung in which Hh signaling plays an important etiologic role.<a onclick="showRef(event, 'ref130 ref169'); return false;" href="javascript:void(0);" class="ref ref130 ref169">(130,169)</a><b>46</b> inhibits Hh signaling at a downstream level in human and murine fibroblasts by promoting the proteasomal degradation of GLI2.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> As GLI2 functions as a signaling platform connecting Hh with other profibrotic pathways such as TGFβ, pirfenidone treatment exerts strong antifibrotic effects. However, this drug needs to be given at relatively high doses, potentially causing difficulties in a future application as cancer therapeutic.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mammalian Hh signaling can be activated by canonical and noncanonical mechanisms. The former mode of pathway activation is predominantly utilized during normal embryonic development, in the Hh-dependent tumors BCC and MB as well as in the mesenchymal tumor stroma. In contrast, noncanonical modes of signal transduction can often be encountered in epithelial tumor compartments of various solid cancers. The plasticity in signaling cascades becomes obvious in cases of drug resistance against small molecule inhibitors targeting the signaling bottleneck SMO (see <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a> for a graphical overview of Hh inhibitors and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for a summary of all inhibitors discussed). SMO represents a formidable drug target with structurally deep pockets to accomplish efficient and selective drug binding, and highly potent antagonists are now approved for clinical use. However, the selective outgrowth of resistant clones harboring SMO mutations or the induction of functions bypassing the need for SMO necessitates the detailed knowledge about cancer-specific noncanonical activation forms and the development of additional Hh pathway targeting drugs. Unfortunately, as of now, non-SMO drug targets in the Hh pathway have proved difficult to inhibit, but preclinical proof-of-concept studies have strengthened the principle of pharmacological inhibition of Hh downstream elements. Along these lines, the drug development process as well as the introduction of new substances for Hh-driven malignancies might be accelerated by repurposing approaches utilizing approved drugs with a known safety profile which also target the Hh system. In general, it will be important to generate a toolbox of inhibitors that can be combined to overcome resistance and that can be utilized in a personalized manner based on the signaling mode in the specific tumor type and patient. This said, it would mean that future Hh drug development activities would have to include as well as go beyond the well-established SMO.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Schematic outline of an active Hh pathway and the points at which known small molecule inhibitors interfere with signal transduction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00188" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Lauth</span> - <span class="hlFld-Affiliation affiliation">Center
for Tumor and Immune Biology (ZTI), Philipps
University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5922-5384" title="Orcid link">http://orcid.org/0000-0001-5922-5384</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a8c4c9dddcc0e8dbdcc9cece86ddc6c185c5c9dacadddacf86cccd"><span class="__cf_email__" data-cfemail="fe929f8b8a96be8d8a9f9898d08b9097d3939f8c9c8b8c99d09a9b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ilya Galperin</span> - <span class="hlFld-Affiliation affiliation">Center
for Tumor and Immune Biology (ZTI), Philipps
University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lukas Dempwolff</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Center for Tumor and Immune Biology (ZTI), Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wibke E. Diederich</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Center for Tumor and Immune Biology (ZTI), Philipps University Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Core
Facility Medicinal Chemistry, Philipps University
Marburg, Hans-Meerwein-Straße 3, 35043 Marburg, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Ilya Galperin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=BIO-d7e2146-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ilya Galperin</b> studied biology with a focus on human and molecular biology at Saarland University (Germany), where he obtained his Diploma title in 2012. From 2012 to 2017 he worked at the Institute of Food Chemistry and Food Biotechnology at the Justus Liebig University in Giessen (Germany), where he obtained his Ph.D. (2018). Since 2018, he has been working at the Center for Tumor and Immune Biology at the Philips University in Marburg (Germany) with a focus on the reprogramming of pancreatic tumor cells.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Lukas Dempwolff</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=BIO-d7e2151-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lukas Dempwolff</b> studied chemistry at the Leibniz University Hannover (Germany), where he received his B.Sc. (2012) and M.Sc. degrees (2014), in addition to an Erasmus internship at the University of Stockholm, Sweden. He obtained his Ph.D. (2019) on ligand-based drug design of novel transcription modulators under the guidance of Prof. Dr. Wibke Diederich at the Philipps University Marburg.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Wibke E. Diederich</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=BIO-d7e2156-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Wibke E. Diederich</b> studied pharmacy at the Philipps University of Marburg (Germany) where, in 1999, she also obtained her Ph.D. in Pharmaceutical Chemistry under the guidance of Prof. Manfred Haake. After a 2-year postdoctoral stay in the group of Prof. Gunda Georg at the University of Kansas (U.S.), she returned to the Philipps University of Marburg, where she initially became Assistant Professor and in 2010 was appointed Full Professor of Medicinal Chemistry. Since 2013 she also heads the Core-Facility of Medicinal Chemistry at the Center for Tumor and Immune Biology. Her research focuses on the structure-based design and synthesis of small molecules especially in the field of neglected diseases and cancer.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Matthias Lauth</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=BIO-d7e2161-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Matthias Lauth</b> studied biochemistry at the Goethe University of Frankfurt (Germany), followed by a Ph.D. period at the Max-Planck Institute for Neurobiology (Martinsried, Germany) and the University College London (U.K.). After completion of his Ph.D. thesis in 2003, he went to the Karolinska Institute (Stockholm, Sweden) for a postdoctoral period in the laboratory of Prof. Rune Toftgård, focusing on Hedgehog signaling and the development of small molecule inhibitors. In 2009, he returned to Germany to start his own research group at the University of Marburg. The research interests of his group are on Hedgehog signaling and the pharmacological modulation of tumor–stroma interactions. M.L. also coordinates the activities of a DFG-funded research consortium focusing on the pancreatic cancer microenvironment (Grant DFG-KFO325).</p></figure></div><div class="ack" id="ACK-d7e2385-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We apologize to all the numerous colleagues who have contributed excellent work to the field but whose work we could not cite due to space constraints. We are grateful for funding obtained from the German Research Foundation (Grants DFG-KFO325, DFG-LA2829/9-1, DFG-DI827/5-1, DFG-DI827/6-1), the German Cancer Aid, and the University Hospital Giessen-Marburg (UKGM).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">AKT serine/threonine kinase 1 (PKB)</p></td></tr><tr><td class="NLM_term">BCC</td><td class="NLM_def"><p class="first last">basal cell carcinoma</p></td></tr><tr><td class="NLM_term">BRD</td><td class="NLM_def"><p class="first last">bromodomain-containing protein</p></td></tr><tr><td class="NLM_term">CCND1</td><td class="NLM_def"><p class="first last">cyclin D1</p></td></tr><tr><td class="NLM_term">CK1α</td><td class="NLM_def"><p class="first last">casein kinase 1 α</p></td></tr><tr><td class="NLM_term">CRD</td><td class="NLM_def"><p class="first last">cysteine-rich domain</p></td></tr><tr><td class="NLM_term">DHH</td><td class="NLM_def"><p class="first last">Desert Hedgehog</p></td></tr><tr><td class="NLM_term">DISP1</td><td class="NLM_def"><p class="first last">dispatched RND transporter family member 1</p></td></tr><tr><td class="NLM_term">GLI</td><td class="NLM_def"><p class="first last">GLI family zinc finger</p></td></tr><tr><td class="NLM_term">GLI3<sup>FL</sup></td><td class="NLM_def"><p class="first last">GLI3 full-length protein</p></td></tr><tr><td class="NLM_term">GLI3<sup>R</sup></td><td class="NLM_def"><p class="first last">GLI3 repressor form</p></td></tr><tr><td class="NLM_term">GPRASP2</td><td class="NLM_def"><p class="first last">GPCR-associated sorting protein 2</p></td></tr><tr><td class="NLM_term">GSK3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3β</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">Hh</td><td class="NLM_def"><p class="first last">Hedgehog</p></td></tr><tr><td class="NLM_term">HHAT (=SKI1)</td><td class="NLM_def"><p class="first last">Hh acyl-transferase (Skinny Hedgehog)</p></td></tr><tr><td class="NLM_term">IHH</td><td class="NLM_def"><p class="first last">Indian Hh</p></td></tr><tr><td class="NLM_term">INPP5E</td><td class="NLM_def"><p class="first last">inositol polyphosphate-5-phosphatase E</p></td></tr><tr><td class="NLM_term">JMJD1A</td><td class="NLM_def"><p class="first last">Jumonji domain containing 1A</p></td></tr><tr><td class="NLM_term">KIF7</td><td class="NLM_def"><p class="first last">kinesin family member 7</p></td></tr><tr><td class="NLM_term">MB</td><td class="NLM_def"><p class="first last">medulloblastoma</p></td></tr><tr><td class="NLM_term">MYCN</td><td class="NLM_def"><p class="first last">gene encoding N-MYC</p></td></tr><tr><td class="NLM_term">MKL1 (=MRTF-A)</td><td class="NLM_def"><p class="first last">myocardin related transcription factor A</p></td></tr><tr><td class="NLM_term">N-MYC</td><td class="NLM_def"><p class="first last"><i>N</i>-myc proto-oncogene protein</p></td></tr><tr><td class="NLM_term">PDAC</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 4,5-bisphosphate 3-kinase/protein kinase B</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">Protein kinase A</p></td></tr><tr><td class="NLM_term">PTCH</td><td class="NLM_def"><p class="first last">Patched family</p></td></tr><tr><td class="NLM_term">SCUBE2</td><td class="NLM_def"><p class="first last">signal peptide, CUB domain, and EGF-like domain containing 2</p></td></tr><tr><td class="NLM_term">SHH</td><td class="NLM_def"><p class="first last">Sonic Hh</p></td></tr><tr><td class="NLM_term">SMO</td><td class="NLM_def"><p class="first last">Smoothened</p></td></tr><tr><td class="NLM_term">SRF</td><td class="NLM_def"><p class="first last">serum response factor</p></td></tr><tr><td class="NLM_term">SUFU</td><td class="NLM_def"><p class="first last">Suppressor-of-Fused</p></td></tr><tr><td class="NLM_term">TREG</td><td class="NLM_def"><p class="first last">immune-suppressive T-regulatory cell</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 170 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbottom, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pownall, M. E.</span></span> <span> </span><span class="NLM_article-title">Regulation of hedgehog signalling inside and outside the cell</span>. <i>J. Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.3390/jdb4030023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fjdb4030023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27547735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=23&author=S.+A.+Ramsbottomauthor=M.+E.+Pownall&title=Regulation+of+hedgehog+signalling+inside+and+outside+the+cell&doi=10.3390%2Fjdb4030023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of hedgehog signalling inside and outside the cell</span></div><div class="casAuthors">Ramsbottom, Simon A.; Pownall, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Developmental Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">23/1-23/20</span>CODEN:
                <span class="NLM_cas:coden">JDBOAX</span>;
        ISSN:<span class="NLM_cas:issn">2221-3759</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The hedgehog (Hh) signalling pathway is conserved throughout metazoans and plays an important regulatory role in both embryonic development and adult homeostasis.  Many levels of regulation exist that control the release, reception, and interpretation of the hedgehog signal.  The fatty nature of the Shh ligand means that it tends to assoc. tightly with the cell membrane, and yet it is known to act as a morphogen that diffuses to elicit pattern formation.  Heparan sulfate proteoglycans (HSPGs) play a major role in the regulation of Hh distribution outside the cell.  Inside the cell, the primary cilium provides an important hub for processing the Hh signal in vertebrates.  This review will summarise the current understanding of how the Hh pathway is regulated from ligand prodn., release, and diffusion, through to signal reception and intracellular transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hYUdRByfuLVg90H21EOLACvtfcHk0lgTmYIoPimNYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsV2gsLk%253D&md5=5b3b26639d6c0bc1707f49b9ea26efcb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fjdb4030023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjdb4030023%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbottom%26aufirst%3DS.%2BA.%26aulast%3DPownall%26aufirst%3DM.%2BE.%26atitle%3DRegulation%2520of%2520hedgehog%2520signalling%2520inside%2520and%2520outside%2520the%2520cell%26jtitle%3DJ.%2520Dev.%2520Biol.%26date%3D2016%26volume%3D4%26spage%3D23%26doi%3D10.3390%2Fjdb4030023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, R. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signal transduction: Key players, oncogenic drivers, and cancer therapy</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2016.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.devcel.2016.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27554855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWlu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=333-344&author=E.+Pakauthor=R.+A.+Segal&title=Hedgehog+signal+transduction%3A+Key+players%2C+oncogenic+drivers%2C+and+cancer+therapy&doi=10.1016%2Fj.devcel.2016.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy</span></div><div class="casAuthors">Pak, Ekaterina; Segal, Rosalind A.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-344</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) signaling pathway governs complex developmental processes, including proliferation and patterning within diverse tissues.  These activities rely on a tightly regulated transduction system that converts graded Hh input signals into specific levels of pathway activity.  Uncontrolled activation of Hh signaling drives tumor initiation and maintenance.  However, recent entry of pathway-specific inhibitors into the clinic reveals mixed patient responses and thus prompts further exploration of pathway activation and inhibition.  In this review, we share emerging insights into regulated and oncogenic Hh signaling, supplemented with updates on the development and use of Hh pathway-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Ps2jrlOu37Vg90H21EOLACvtfcHk0lgTmYIoPimNYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWlu7bI&md5=297d0d71e402c66eac0b9233a0a575ef</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2016.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2016.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DPak%26aufirst%3DE.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DHedgehog%2520signal%2520transduction%253A%2520Key%2520players%252C%2520oncogenic%2520drivers%252C%2520and%2520cancer%2520therapy%26jtitle%3DDev.%2520Cell%26date%3D2016%26volume%3D38%26spage%3D333%26epage%3D344%26doi%3D10.1016%2Fj.devcel.2016.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roessler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruszka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullikin, J. C.</span></span>; <span class="NLM_contrib-group">NISC Comparative Sequencing Program</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhuber, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richieri-Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro-Bicudo, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muenke, M.</span></span> <span> </span><span class="NLM_article-title">Common genetic causes of holoprosencephaly are limited to a small set of evolutionarily conserved driver genes of midline development coordinated by tgf-beta, hedgehog, and fgf signaling</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">1427</span>, <span class="refDoi"> DOI: 10.1002/humu.23590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fhumu.23590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29992659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=1416-1427&author=E.+Roesslerauthor=P.+Huauthor=J.+Marinoauthor=S.+Hongauthor=R.+Hartauthor=S.+Bergerauthor=A.+Martinezauthor=Y.+Abeauthor=P.+Kruszkaauthor=J.+W.+Thomasauthor=J.+C.+Mullikinauthor=NISC+Comparative+Sequencing+Programauthor=Y.+Wangauthor=W.+S.+W.+Wongauthor=J.+E.+Niederhuberauthor=B.+D.+Solomonauthor=A.+Richieri-Costaauthor=L.+A.+Ribeiro-Bicudoauthor=M.+Muenke&title=Common+genetic+causes+of+holoprosencephaly+are+limited+to+a+small+set+of+evolutionarily+conserved+driver+genes+of+midline+development+coordinated+by+tgf-beta%2C+hedgehog%2C+and+fgf+signaling&doi=10.1002%2Fhumu.23590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Common genetic causes of holoprosencephaly are limited to a small set of evolutionarily conserved driver genes of midline development coordinated by TGF-β, hedgehog, and FGF signaling</span></div><div class="casAuthors">Roessler, Erich; Hu, Ping; Marino, Juliana; Hong, Sungkook; Hart, Rachel; Berger, Seth; Martinez, Ariel; Abe, Yu; Kruszka, Paul; Thomas, James W.; Mullikin, James C.; Wang, Yupeng; Wong, Wendy S. W.; Niederhuber, John E.; Solomon, Benjamin D.; Richieri-Costa, Antonio; Ribeiro-Bicudo, L. A.; Muenke, Maximilian</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1416-1427</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Here, we applied targeted capture to examine 153 genes representative of all the major vertebrate developmental pathways among 333 probands to rank their relative significance as causes for holoprosencephaly (HPE).  We now show that comparisons of variant transmission vs. nontransmission among 136 HPE Trios indicates some reported genes now lack confirmation, while novel genes are implicated.  Furthermore, we demonstrate that variation of modest intrinsic effect can synergize with these driver mutations as gene modifiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpxRzeYOTWNbVg90H21EOLACvtfcHk0lgTmYIoPimNYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnsrvJ&md5=f9c09f1f95446b9fcaf0bf5001b7c31a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fhumu.23590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.23590%26sid%3Dliteratum%253Aachs%26aulast%3DRoessler%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DMarino%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DHart%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKruszka%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DJ.%2BW.%26aulast%3DMullikin%26aufirst%3DJ.%2BC.%26aulast%3D%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DW.%2BS.%2BW.%26aulast%3DNiederhuber%26aufirst%3DJ.%2BE.%26aulast%3DSolomon%26aufirst%3DB.%2BD.%26aulast%3DRichieri-Costa%26aufirst%3DA.%26aulast%3DRibeiro-Bicudo%26aufirst%3DL.%2BA.%26aulast%3DMuenke%26aufirst%3DM.%26atitle%3DCommon%2520genetic%2520causes%2520of%2520holoprosencephaly%2520are%2520limited%2520to%2520a%2520small%2520set%2520of%2520evolutionarily%2520conserved%2520driver%2520genes%2520of%2520midline%2520development%2520coordinated%2520by%2520tgf-beta%252C%2520hedgehog%252C%2520and%2520fgf%2520signaling%26jtitle%3DHum.%2520Mutat.%26date%3D2018%26volume%3D39%26spage%3D1416%26epage%3D1427%26doi%3D10.1002%2Fhumu.23590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Patched acts catalytically to suppress the activity of smoothened</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>418</i></span>,  <span class="NLM_fpage">892</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1038/nature00989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature00989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12192414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2002&pages=892-897&author=J.+Taipaleauthor=M.+K.+Cooperauthor=T.+Maitiauthor=P.+A.+Beachy&title=Patched+acts+catalytically+to+suppress+the+activity+of+smoothened&doi=10.1038%2Fnature00989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Patched acts catalytically to suppress the activity of Smoothened</span></div><div class="casAuthors">Taipale, J.; Cooper, M. K.; Maiti, T.; Beachy, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">6900</span>),
    <span class="NLM_cas:pages">892-896</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations affecting the transmembrane proteins Patched (Ptc) or Smoothened (Smo) that trigger ligand-independent activity of the Hedgehog (Hh) signaling pathway are assocd. with human tumors such as basal cell carcinoma (BCC) and medulloblastoma.  Despite extensive genetic studies demonstrating the importance of these receptor components in embryonic patterning and cancer, the mechanism by which Ptc regulates Smo is not understood.  Here we report that Ptc and Smo are not significantly assocd. within Hh-responsive cells.  Furthermore, we show that free Ptc (unbound by Hh) acts sub-stoichiometrically to suppress Smo activity and thus is crit. in specifying the level of pathway activity.  Patched is a twelve-transmembrane protein with homol. to bacterial proton-driven transmembrane mol. transporters; we demonstrate that the function of Ptc is impaired by alterations of residues that are conserved in and required for function of these bacterial transporters.  These results suggest that the Ptc tumor suppressor functions normally as a transmembrane mol. transporter, which acts indirectly to inhibit Smo activity, possibly through changes in distribution or concn. of a small mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc5RyHcisDXrVg90H21EOLACvtfcHk0lgdrC-C2Qm2yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlWltb0%253D&md5=61ba9ffee2e91889b09d900910ac3af5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature00989%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DMaiti%26aufirst%3DT.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DPatched%2520acts%2520catalytically%2520to%2520suppress%2520the%2520activity%2520of%2520smoothened%26jtitle%3DNature%26date%3D2002%26volume%3D418%26spage%3D892%26epage%3D897%26doi%3D10.1038%2Fnature00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulkley, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asarnow, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Structural basis for cholesterol transport-like activity of the hedgehog receptor patched</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1352</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2018.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30415841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=1352-1364&author=Y.+Zhangauthor=D.+P.+Bulkleyauthor=Y.+Xinauthor=K.+J.+Robertsauthor=D.+E.+Asarnowauthor=A.+Sharmaauthor=B.+R.+Myersauthor=W.+Choauthor=Y.+Chengauthor=P.+A.+Beachy&title=Structural+basis+for+cholesterol+transport-like+activity+of+the+hedgehog+receptor+patched&doi=10.1016%2Fj.cell.2018.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Cholesterol Transport-like Activity of the Hedgehog Receptor Patched</span></div><div class="casAuthors">Zhang, Yunxiao; Bulkley, David P.; Xin, Yao; Roberts, Kelsey J.; Asarnow, Daniel E.; Sharma, Ashutosh; Myers, Benjamin R.; Cho, Wonhwa; Cheng, Yifan; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1352-1364.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hedgehog protein signals mediate tissue patterning and maintenance by binding to and inactivating their common receptor Patched, a 12-transmembrane protein that otherwise would suppress the activity of the 7-transmembrane protein Smoothened (SMO).  Loss of Patched function, the most common cause of basal cell carcinoma, permits unregulated activation of Smoothened and of the Hedgehog pathway.  A cryo-EM structure of the Patched protein reveals striking transmembrane domain similarities to prokaryotic RND transporters.  A central hydrophobic conduit with cholesterol-like contents courses through the extracellular domain and resembles that used by other RND proteins to transport substrates, suggesting Patched activity in cholesterol transport.  Cholesterol activity in the inner leaflet of the plasma membrane is reduced by Patched1 (PTCH1) expression but rapidly restored by Hedgehog stimulation, suggesting that PTCH1 regulates Smoothened by controlling cholesterol availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiSFavoTDQI7Vg90H21EOLACvtfcHk0lgdrC-C2Qm2yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCgsbzO&md5=1543ef948bd093d4b3e716faad9538e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBulkley%26aufirst%3DD.%2BP.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRoberts%26aufirst%3DK.%2BJ.%26aulast%3DAsarnow%26aufirst%3DD.%2BE.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DMyers%26aufirst%3DB.%2BR.%26aulast%3DCho%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DStructural%2520basis%2520for%2520cholesterol%2520transport-like%2520activity%2520of%2520the%2520hedgehog%2520receptor%2520patched%26jtitle%3DCell%26date%3D2018%26volume%3D175%26spage%3D1352%26epage%3D1364%26doi%3D10.1016%2Fj.cell.2018.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog-regulated processing of gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80678-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2FS0092-8674%2800%2980678-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10693759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVOltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=423-434&author=B.+Wangauthor=J.+F.+Fallonauthor=P.+A.+Beachy&title=Hedgehog-regulated+processing+of+gli3+produces+an+anterior%2Fposterior+repressor+gradient+in+the+developing+vertebrate+limb&doi=10.1016%2FS0092-8674%2800%2980678-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb</span></div><div class="casAuthors">Wang, Baolin; Fallon, John F.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-434</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ci/Gli zinc finger proteins mediate the transcriptional effects of Hedgehog protein signals.  In Drosophila, Ci action as transcriptional repressor or activator is contingent upon Hedgehog-regulated, PKA-dependent proteolytic processing.  We demonstrate that PKA-dependent processing of vertebrate Gli3 in developing limb similarly generates a potent repressor in a manner antagonized by apparent long-range signaling from posteriorly localized Sonic hedgehog protein.  The resulting anterior/posterior Gli3 repressor gradient can be perturbed by mutations of Gli3 in human genetic syndromes or by misregulation of Gli3 processing in the chicken mutant talpid2, producing a range of limb patterning malformations.  The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for neg. Hedgehog pathway regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9O-Nv76-hO7Vg90H21EOLACvtfcHk0lgdrC-C2Qm2yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVOltbc%253D&md5=cb4f06af63a1572e9eafaf29d0aceff2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980678-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980678-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DFallon%26aufirst%3DJ.%2BF.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DHedgehog-regulated%2520processing%2520of%2520gli3%2520produces%2520an%2520anterior%252Fposterior%2520repressor%2520gradient%2520in%2520the%2520developing%2520vertebrate%2520limb%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D423%26epage%3D434%26doi%3D10.1016%2FS0092-8674%2800%2980678-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog signaling regulates gli2 transcriptional activity by suppressing its processing and degradation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3365</span>– <span class="NLM_lpage">3377</span>, <span class="refDoi"> DOI: 10.1128/MCB.26.9.3365-3377.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1128%2FMCB.26.9.3365-3377.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16611981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVKks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=3365-3377&author=Y.+Panauthor=C.+B.+Baiauthor=A.+L.+Joynerauthor=B.+Wang&title=Sonic+hedgehog+signaling+regulates+gli2+transcriptional+activity+by+suppressing+its+processing+and+degradation&doi=10.1128%2FMCB.26.9.3365-3377.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation</span></div><div class="casAuthors">Pan, Yong; Bai, Chunyang Brian; Joyner, Alexandra L.; Wang, Baolin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3365-3377</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Gli2 and Gli3 are the primary transcription factors that mediate Sonic hedgehog (Shh) signals in the mouse.  Gli3 mainly acts as a transcriptional repressor, because the majority of full-length Gli3 protein is proteolytically processed.  Gli2 is mostly regarded as a transcriptional activator, even though it is also suggested to have a weak repressing activity.  What the mol. basis for its possible dual function is and how its activity is regulated by Shh signaling are largely unknown.  Here we demonstrate that unlike the results seen with Gli3 and Cubitus Interruptus, the fly homolog of Gli, only a minor fraction of Gli2 is proteolytically processed to form a transcriptional repressor in vivo and that in addn. to being processed, Gli2 full-length protein is readily degraded.  The degrdn. of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.  The phosphorylated Gli2 interacts directly with βTrCP in the SCF ubiquitin-ligase complex through two binding sites, which results in Gli2 ubiquitination and subsequent degrdn. by the proteasome.  Both processing and degrdn. of Gli2 are suppressed by Shh signaling in vivo.  Our findings provide the first demonstration of a mol. mechanism by which the Gli2 transcriptional activity is regulated by Shh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXmdqHoGF1H7Vg90H21EOLACvtfcHk0lgcEjq-4TBDCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVKks70%253D&md5=7e6039db518abf4a62154f11b2d29884</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.9.3365-3377.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.9.3365-3377.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DC.%2BB.%26aulast%3DJoyner%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DSonic%2520hedgehog%2520signaling%2520regulates%2520gli2%2520transcriptional%2520activity%2520by%2520suppressing%2520its%2520processing%2520and%2520degradation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D3365%26epage%3D3377%26doi%3D10.1128%2FMCB.26.9.3365-3377.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainprize, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agatep, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiappa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowrance, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavrou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dura, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutka, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, D.</span></span> <span> </span><span class="NLM_article-title">Mutations in sufu predispose to medulloblastoma</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1038/ng916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fng916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12068298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2002&pages=306-310&author=M.+D.+Taylorauthor=L.+Liuauthor=C.+Raffelauthor=C.+C.+Huiauthor=T.+G.+Mainprizeauthor=X.+Zhangauthor=R.+Agatepauthor=S.+Chiappaauthor=L.+Gaoauthor=A.+Lowranceauthor=A.+Haoauthor=A.+M.+Goldsteinauthor=T.+Stavrouauthor=S.+W.+Schererauthor=W.+T.+Duraauthor=B.+Wainwrightauthor=J.+A.+Squireauthor=J.+T.+Rutkaauthor=D.+Hogg&title=Mutations+in+sufu+predispose+to+medulloblastoma&doi=10.1038%2Fng916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SUFU predispose to medulloblastoma</span></div><div class="casAuthors">Taylor, Michael D.; Liu, Ling; Raffel, Corey; Hui, Chi-chung; Mainprize, Todd G.; Zhang, Xiaoyun; Agatep, Ron; Chiappa, Sharon; Gao, Luzhang; Lowrance, Anja; Hao, Aihau; Goldstein, Alisa M.; Stavrou, Theodora; Scherer, Stephen W.; Dura, Wieslaw T.; Wainwright, Brandon; Squire, Jeremy A.; Rutka, James T.; Hogg, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-310</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms and is disrupted in a variety of malignancies.  Pathway activation is triggered by binding of hedgehog proteins to the multipass Patched-1 (PTCH) receptor, which in the absence of hedgehog suppresses the activity of the seven-pass membrane protein Smoothened (SMOH).  De-repression of SMOH culminates in the activation of one or more of the GLI transcription factors that regulate the transcription of downstream targets.  Individuals with germline mutations of the SHH receptor gene PTCH are at high risk of developmental anomalies and of basal-cell carcinomas, medulloblastomas and other cancers (a pattern consistent with nevoid basal-cell carcinoma syndrome, NBCCS).  In keeping with the role of PTCH as a tumor-suppressor gene, somatic mutations of this gene occur in sporadic basal-cell carcinomas and medulloblastomas.  We report here that a subset of children with medulloblastoma carry germline and somatic mutations in SUFU (encoding the human suppressor of fused) of the SHH pathway, accompanied by loss of heterozygosity of the wildtype allele.  Several of these mutations encode truncated proteins that are unable to export the GLI transcription factor from nucleus to cytoplasm, resulting in the activation of SHH signaling.  SUFU is a newly identified tumor-suppressor gene that predisposes individuals to medulloblastoma by modulating the SHH signaling pathway through a newly identified mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohQT7TDk1-EbVg90H21EOLACvtfcHk0lgcEjq-4TBDCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLY%253D&md5=cc8df5599e8e37a0b8c992a31ecc3cca</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng916%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRaffel%26aufirst%3DC.%26aulast%3DHui%26aufirst%3DC.%2BC.%26aulast%3DMainprize%26aufirst%3DT.%2BG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAgatep%26aufirst%3DR.%26aulast%3DChiappa%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLowrance%26aufirst%3DA.%26aulast%3DHao%26aufirst%3DA.%26aulast%3DGoldstein%26aufirst%3DA.%2BM.%26aulast%3DStavrou%26aufirst%3DT.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DDura%26aufirst%3DW.%2BT.%26aulast%3DWainwright%26aufirst%3DB.%26aulast%3DSquire%26aufirst%3DJ.%2BA.%26aulast%3DRutka%26aufirst%3DJ.%2BT.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DMutations%2520in%2520sufu%2520predispose%2520to%2520medulloblastoma%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D31%26spage%3D306%26epage%3D310%26doi%3D10.1038%2Fng916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heby Henricson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson-Lek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teglund, S.</span></span> <span> </span><span class="NLM_article-title">Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian hedgehog signaling pathway</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2005.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.devcel.2005.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16459298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BD28%252Fnt1GgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=187-197&author=J.+Svardauthor=K.+Heby+Henricsonauthor=M.+Persson-Lekauthor=B.+Rozellauthor=M.+Lauthauthor=A.+Bergstromauthor=J.+Ericsonauthor=R.+Toftgardauthor=S.+Teglund&title=Genetic+elimination+of+suppressor+of+fused+reveals+an+essential+repressor+function+in+the+mammalian+hedgehog+signaling+pathway&doi=10.1016%2Fj.devcel.2005.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway</span></div><div class="casAuthors">Svard Jessica; Heby-Henricson Karin; Henricson Karin Heby; Persson-Lek Madelen; Rozell Bjorn; Lauth Matthias; Bergstrom Asa; Ericson Johan; Toftgard Rune; Teglund Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Developmental cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-97</span>
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    </div><div class="casAbstract">The Hedgehog (Hh) pathway plays important roles during embryogenesis and carcinogenesis.  Here, we show that ablation of the mouse Suppressor of fused (Sufu), an intracellular pathway component, leads to embryonic lethality at approximately E9.5 with cephalic and neural tube defects.  Fibroblasts derived from Sufu(-/-) embryos showed high Gli-mediated Hh pathway activity that could not be modulated at the level of Smoothened and could only partially be blocked by PKA activation.  Despite the robust constitutive pathway activation in the Sufu(-/-) fibroblasts, the GLI1 steady-state localization remained largely cytoplasmic, implying the presence of an effective nuclear export mechanism.  Sufu(+/-) mice develop a skin phenotype with basaloid changes and jaw keratocysts, characteristic features of Gorlin syndrome, a human genetic disease linked to enhanced Hh signaling.  Our data demonstrate that, in striking contrast to Drosophila, in mammals, Sufu has a central role, and its loss of function leads to potent ligand-independent activation of the Hh pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZ5qTpwY0ADY3yKPtYViAGfW6udTcc2eZCcWcay4zKs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252Fnt1GgtQ%253D%253D&md5=29ca37c5c29c080311a1b9a4386bff2e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2005.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2005.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DSvard%26aufirst%3DJ.%26aulast%3DHeby%2BHenricson%26aufirst%3DK.%26aulast%3DPersson-Lek%26aufirst%3DM.%26aulast%3DRozell%26aufirst%3DB.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DEricson%26aufirst%3DJ.%26aulast%3DToftgard%26aufirst%3DR.%26aulast%3DTeglund%26aufirst%3DS.%26atitle%3DGenetic%2520elimination%2520of%2520suppressor%2520of%2520fused%2520reveals%2520an%2520essential%2520repressor%2520function%2520in%2520the%2520mammalian%2520hedgehog%2520signaling%2520pathway%26jtitle%3DDev.%2520Cell%26date%3D2006%26volume%3D10%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.devcel.2005.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loktev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. K.</span></span> <span> </span><span class="NLM_article-title">The ciliary g-protein-coupled receptor gpr161 negatively regulates the sonic hedgehog pathway via camp signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2012.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23332756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Olurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2013&pages=210-223&author=S.+Mukhopadhyayauthor=X.+Wenauthor=N.+Rattiauthor=A.+Loktevauthor=L.+Rangellauthor=S.+J.+Scalesauthor=P.+K.+Jackson&title=The+ciliary+g-protein-coupled+receptor+gpr161+negatively+regulates+the+sonic+hedgehog+pathway+via+camp+signaling&doi=10.1016%2Fj.cell.2012.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Ciliary G-Protein-Coupled Receptor Gpr161 Negatively Regulates the Sonic Hedgehog Pathway via cAMP Signaling</span></div><div class="casAuthors">Mukhopadhyay, Saikat; Wen, Xiaohui; Ratti, Navneet; Loktev, Alexander; Rangell, Linda; Scales, Suzie J.; Jackson, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">210-223</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The primary cilium is required for Sonic hedgehog (Shh) signaling in vertebrates.  In contrast to mutants affecting ciliary assembly, mutations in the intraflagellar transport complex A (IFT-A) paradoxically cause increased Shh signaling.  We previously showed that the IFT-A complex, in addn. to its canonical role in retrograde IFT, binds to the tubby-like protein, Tulp3, and recruits it to cilia.  Here, we describe a conserved vertebrate G-protein-coupled receptor, Gpr161, which localizes to primary cilia in a Tulp3/IFT-A-dependent manner.  Complete loss of Gpr161 in mouse causes midgestation lethality and increased Shh signaling in the neural tube, phenocopying Tulp3/IFT-A mutants.  Constitutive Gpr161 activity increases cAMP levels and represses Shh signaling by detg. the processing of Gli3 to its repressor form.  Conversely, Shh signaling directs Gpr161 to be internalized from cilia, preventing its activity.  Thus, Gpr161 defines a morphogenetic pathway coupling protein kinase A activation to Shh signaling during neural tube development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsxiCVAB3Iq7Vg90H21EOLACvtfcHk0lik2gtJdPHW2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Olurs%253D&md5=07b27a576840f6259d38f4fa907a4db4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DRatti%26aufirst%3DN.%26aulast%3DLoktev%26aufirst%3DA.%26aulast%3DRangell%26aufirst%3DL.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26atitle%3DThe%2520ciliary%2520g-protein-coupled%2520receptor%2520gpr161%2520negatively%2520regulates%2520the%2520sonic%2520hedgehog%2520pathway%2520via%2520camp%2520signaling%26jtitle%3DCell%26date%3D2013%26volume%3D152%26spage%3D210%26epage%3D223%26doi%3D10.1016%2Fj.cell.2012.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hempel, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frist, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. C.</span></span> <span> </span><span class="NLM_article-title">An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.celrep.2015.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25818300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=43-50&author=C.+H.+Williamsauthor=J.+E.+Hempelauthor=J.+Haoauthor=A.+Y.+Fristauthor=M.+M.+Williamsauthor=J.+T.+Flemingauthor=G.+A.+Sulikowskiauthor=M.+K.+Cooperauthor=C.+Chiangauthor=C.+C.+Hong&title=An+in+vivo+chemical+genetic+screen+identifies+phosphodiesterase+4+as+a+pharmacological+target+for+hedgehog+signaling+inhibition&doi=10.1016%2Fj.celrep.2015.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">An In Vivo Chemical Genetic Screen Identifies Phosphodiesterase 4 as a Pharmacological Target for Hedgehog Signaling Inhibition</span></div><div class="casAuthors">Williams, Charles H.; Hempel, Jonathan E.; Hao, Jijun; Frist, Audrey Y.; Williams, Michelle M.; Fleming, Jonathan T.; Sulikowski, Gary A.; Cooper, Michael K.; Chiang, Chin; Hong, Charles C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hedgehog (Hh) signaling plays an integral role in vertebrate development, and its dysregulation has been accepted widely as a driver of numerous malignancies.  While a variety of small mols. target Smoothened (Smo) as a strategy for Hh inhibition, Smo gain-of-function mutations have limited their clin. implementation.  Modulation of targets downstream of Smo could define a paradigm for treatment of Hh-dependent cancers.  Here, we describe eggmanone, a small mol. identified from a chem. genetic zebrafish screen, which induced an Hh-null phenotype.  Eggmanone exerts its Hh-inhibitory effects through selective antagonism of phosphodiesterase 4 (PDE4), leading to protein kinase A activation and subsequent Hh blockade.  Our study implicates PDE4 as a target for Hh inhibition, suggests an improved strategy for Hh-dependent cancer therapy, and identifies a unique probe of downstream-of-Smo Hh modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohObViSNfnH7Vg90H21EOLACvtfcHk0lik2gtJdPHW2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOis7g%253D&md5=54fdb4541c7911021467cea8d00cbd64</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DC.%2BH.%26aulast%3DHempel%26aufirst%3DJ.%2BE.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DFrist%26aufirst%3DA.%2BY.%26aulast%3DWilliams%26aufirst%3DM.%2BM.%26aulast%3DFleming%26aufirst%3DJ.%2BT.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DChiang%26aufirst%3DC.%26aulast%3DHong%26aufirst%3DC.%2BC.%26atitle%3DAn%2520in%2520vivo%2520chemical%2520genetic%2520screen%2520identifies%2520phosphodiesterase%25204%2520as%2520a%2520pharmacological%2520target%2520for%2520hedgehog%2520signaling%2520inhibition%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D11%26spage%3D43%26epage%3D50%26doi%3D10.1016%2Fj.celrep.2015.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Non-canonical activation of gli transcription factors: Implications for targeted anti-cancer therapy</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2458</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.4161/cc.6.20.4808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.4161%2Fcc.6.20.4808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17726373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVahtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2458-2463&author=M.+Lauthauthor=R.+Toftgard&title=Non-canonical+activation+of+gli+transcription+factors%3A+Implications+for+targeted+anti-cancer+therapy&doi=10.4161%2Fcc.6.20.4808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical activation of GLI transcription factors: Implications for targeted anti-cancer therapy</span></div><div class="casAuthors">Lauth, Matthias; Toftgaard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2458-2463</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  GLI transcription factors constitute the final effectors of the Hedgehog (HH) signaling pathway.  In many tumors, such as those of the pancreas, prostate, skin or lung, ectopic activation of GLI proteins has been linked to tumorigenesis.  In several of these cases, HH ligand- or receptor-induced signaling (canonical HH signaling) was found to be the cause underlying GLI activation.  Recent evidence points towards addnl., non-canonical, mechanisms of GLI activation.  Here we review findings on the crosstalk of two HH-unrelated signaling pathways (RAS and Transforming growth factor β) to the HH pathway downstream of the signaling component Smoothened.  Both pathways stimulate and/or induce GLI1 and GLI2 activity independent of the presence of HH ligands.  We also discuss the putative roles of these crosstalk mechanisms for tumor cell metastasis.  The emerging picture of GLI transcription factors as an integrative platform of numerous signaling inputs has important implications for the understanding of tumor development and argues for inclusion of targets acting downstream of the receptor level in the design of current drug development programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot0x1m1SK_irVg90H21EOLACvtfcHk0lhMnrl34pFVSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVahtr7J&md5=fa6f9f21f43ef6e463981ce0d87b7488</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4161%2Fcc.6.20.4808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.6.20.4808%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DNon-canonical%2520activation%2520of%2520gli%2520transcription%2520factors%253A%2520Implications%2520for%2520targeted%2520anti-cancer%2520therapy%26jtitle%3DCell%2520Cycle%26date%3D2007%26volume%3D6%26spage%3D2458%26epage%3D2463%26doi%3D10.4161%2Fcc.6.20.4808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, D.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signalling: Emerging evidence for non-canonical pathways</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2009.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cellsig.2009.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19399989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFelu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=1023-1034&author=D.+Jenkins&title=Hedgehog+signalling%3A+Emerging+evidence+for+non-canonical+pathways&doi=10.1016%2Fj.cellsig.2009.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signalling: Emerging evidence for non-canonical pathways</span></div><div class="casAuthors">Jenkins, Dagan</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1023-1034</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hedgehog (HH) signalling is involved in the development of numerous embryonic tissues.  In humans, germline mutations in hedgehog pathway components cause congenital malformations and somatic mutations are assocd. with cancers.  The basic framework of the HH pathway was elucidated in the fruit fly, Drosophila melanogaster, and this pathway is largely conserved in vertebrates, although some important differences have been noted.  The current paradigm of the 'canonical' pathway views HH signalling as a series of repressive interactions which culminates in GLI-mediated transcriptional regulation of a variety of cellular processes.  Definitions of 'non-canonical' signalling stem from examples where the response to HH morphogen deviates from this paradigm and, according to current reports, three general scenarios of non-canonical HH signalling can be defined: (1) Signalling that involves HH pathway components but which is independent of GLI-mediated transcription; (2) Direct interaction of HH signalling components with components of other mol. pathways; and (3) 'Non-contiguous' or 'atypical' interaction of core HH pathway components with one another.  Currently, the evidence supporting non-canonical HH signalling is not conclusive.  However, Sonic hedgehog (SHH) has been shown to regulate cell migration and axon guidance in several contexts, and some of these processes are independent of downstream components of the HH pathway, and presumably the transcriptional response to morphogen.  Furthermore, biochem. studies have shown that the HH receptor, PTCH1, can directly interact both with Cyclin B1 and caspases, to inhibit cell proliferation and to promote apoptosis, resp., and that these functions are inhibited in the presence of morphogen.  Genetic anal. of orthologues of the HH pathway in nematode worms further supports the notion that PTCH1-related mols. can function independently of other components of the canonical HH pathway, and the phenotypes of mice with point mutations in the Ptch1 gene offer clues as to the processes that non-canonical HH signalling might regulate.  While none of these evidences are conclusive, collectively they point to the existence of added complexity in the HH pathway in the form of non-canonical pathways.  A major difficulty in studying this problem is that canonical and non-canonical pathways are likely to act in parallel, and so in many situations it will not be possible to implicate non-canonical responses in certain cellular processes simply by excluding a role for the canonical pathway-directed analyses of non-canonical HH signalling are therefore necessary.  The aim of this review is to present the cumulative evidence supporting non-canonical HH signalling, with the hope of promoting further enquiry into this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWDRKosNHurVg90H21EOLACvtfcHk0lhMnrl34pFVSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFelu7g%253D&md5=9e81fa8b39143ccef27f6e5204be82c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2009.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2009.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DJenkins%26aufirst%3DD.%26atitle%3DHedgehog%2520signalling%253A%2520Emerging%2520evidence%2520for%2520non-canonical%2520pathways%26jtitle%3DCell.%2520Signalling%26date%3D2009%26volume%3D21%26spage%3D1023%26epage%3D1034%26doi%3D10.1016%2Fj.cellsig.2009.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bijlsma, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damhofer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelink, H.</span></span> <span> </span><span class="NLM_article-title">Hedgehog-stimulated chemotaxis is mediated by smoothened located outside the primary cilium</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">ra60</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2002798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscisignal.2002798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22912493" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=ra60&author=M.+F.+Bijlsmaauthor=H.+Damhoferauthor=H.+Roelink&title=Hedgehog-stimulated+chemotaxis+is+mediated+by+smoothened+located+outside+the+primary+cilium&doi=10.1126%2Fscisignal.2002798"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002798%26sid%3Dliteratum%253Aachs%26aulast%3DBijlsma%26aufirst%3DM.%2BF.%26aulast%3DDamhofer%26aufirst%3DH.%26aulast%3DRoelink%26aufirst%3DH.%26atitle%3DHedgehog-stimulated%2520chemotaxis%2520is%2520mediated%2520by%2520smoothened%2520located%2520outside%2520the%2520primary%2520cilium%26jtitle%3DSci.%2520Signaling%26date%3D2012%26volume%3D5%26spage%3Dra60%26doi%3D10.1126%2Fscisignal.2002798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinchilla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazanietz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.4161/cc.9.3.10591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.4161%2Fcc.9.3.10591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20081366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1Cgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=570-579&author=P.+Chinchillaauthor=L.+Xiaoauthor=M.+G.+Kazanietzauthor=N.+A.+Riobo&title=Hedgehog+proteins+activate+pro-angiogenic+responses+in+endothelial+cells+through+non-canonical+signaling+pathways&doi=10.4161%2Fcc.9.3.10591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways</span></div><div class="casAuthors">Chinchilla, Pilar; Xiao, Liqing; Kazanietz, Marcelo G.; Riobo, Natalia A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">570-579</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway orchestrates developmental and homeostatic angiogenesis.  The three Hh isoforms-Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh)-signal through Patched-1 (PTCH1) and Smoothened (SMO), to activate the Gli transcription factors with a characteristic rank of potency (Shh >> Ihh > Dhh).  To dissect the mechanisms through which Hh proteins promote angiogenesis, we analyzed processes inherent to vessel formation in endothelial cells.  We found that none of the Hh ligands were able to induce Gli-target genes in human umbilical vein (HUVEC) or human cardiac microvascular endothelial cells (HMVEC), suggesting that endothelial cells do not respond to Hh through the canonical pathway.  However, our results show that the three Hh proteins promote endothelial cell tubulogenesis in 3D cultures in a SMO- and Gi protein-dependent manner.  Consistent with the required cytoskeletal rearrangement for tubulogenesis, Shh, Ihh and Dhh all stimulated the small GTPase RhoA and the formation of actin stress fibers.  This effect, which was mediated by SMO, Gi proteins and Rac1, defines a new non-canonical Hh pathway.  In addn. to regulating the actin cytoskeleton, the Hh ligands promoted survival through inhibition of the pro-apoptotic effect of PTCH1 in a SMO-independent manner.  Altogether, our results support the existence of Gli-independent Hh responses in endothelial cells that regulate tubulogenesis and apoptosis.  The identification of novel non-canonical responses elicited by Hh proteins in endothelial cells highlights the complexity of the Hh signaling pathway and reveals striking differences in ligand strength for transcriptional and non-transcriptional responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR_GJfExrnl7Vg90H21EOLACvtfcHk0lhMnrl34pFVSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1Cgs7g%253D&md5=2c6761de5117c5313355a029634143fd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4161%2Fcc.9.3.10591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.9.3.10591%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DKazanietz%26aufirst%3DM.%2BG.%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26atitle%3DHedgehog%2520proteins%2520activate%2520pro-angiogenic%2520responses%2520in%2520endothelial%2520cells%2520through%2520non-canonical%2520signaling%2520pathways%26jtitle%3DCell%2520Cycle%26date%3D2010%26volume%3D9%26spage%3D570%26epage%3D579%26doi%3D10.4161%2Fcc.9.3.10591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yam, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, F.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog guides axons through a noncanonical, src-family-kinase-dependent signaling pathway</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2009.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.neuron.2009.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19447091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2009&pages=349-362&author=P.+T.+Yamauthor=S.+D.+Langloisauthor=S.+Morinauthor=F.+Charron&title=Sonic+hedgehog+guides+axons+through+a+noncanonical%2C+src-family-kinase-dependent+signaling+pathway&doi=10.1016%2Fj.neuron.2009.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sonic hedgehog guides axons through a noncanonical, Src-family-kinase-dependent signaling pathway</span></div><div class="casAuthors">Yam, Patricia T.; Langlois, Sebastien D.; Morin, Steves; Charron, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-362</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Sonic hedgehog (Shh) plays essential roles in developmental events such as cell fate specification and axon guidance.  Shh induces cell fate specification through canonical Shh signaling, mediated by transcription.  However, the mechanism by which Shh guides axons is unknown.  To study this, we developed an in vitro assay for axon guidance, in which neurons can be imaged while responding to a defined gradient of a chem. cue.  Axons of dissocd. commissural neurons placed in a Shh gradient turned rapidly toward increasing concns. of Shh.  Consistent with this rapid response, we showed that attraction by Shh does not require transcription.  Instead, Shh stimulates the activity of Src family kinase (SFK) members in a Smoothened-dependent manner.  Moreover, SFK activity is required for Shh-mediated guidance of commissural axons, but not for induction of Gli transcriptional reporter activity.  Together, these results indicate that Shh acts via a rapidly acting, noncanonical signaling pathway to guide axons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxhsXx7pQxQbVg90H21EOLACvtfcHk0liJcUA3iRGirw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWjtL4%253D&md5=9c19e9dcff31e1a5cef0cd2c7baedeca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2009.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2009.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DYam%26aufirst%3DP.%2BT.%26aulast%3DLanglois%26aufirst%3DS.%2BD.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DCharron%26aufirst%3DF.%26atitle%3DSonic%2520hedgehog%2520guides%2520axons%2520through%2520a%2520noncanonical%252C%2520src-family-kinase-dependent%2520signaling%2520pathway%26jtitle%3DNeuron%26date%3D2009%26volume%3D62%26spage%3D349%26epage%3D362%26doi%3D10.1016%2Fj.neuron.2009.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Roche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angus, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earnshaw, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, G. M.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signaling controls t cell killing at the immunological synapse</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1126/science.1244689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.1244689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24311692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1247-1250&author=M.+de%0Ala+Rocheauthor=A.+T.+Ritterauthor=K.+L.+Angusauthor=C.+Dinsmoreauthor=C.+H.+Earnshawauthor=J.+F.+Reiterauthor=G.+M.+Griffiths&title=Hedgehog+signaling+controls+t+cell+killing+at+the+immunological+synapse&doi=10.1126%2Fscience.1244689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signaling controls T cell killing at the immunological synapse</span></div><div class="casAuthors">De la Roche, Maike; Ritter, Alex T.; Angus, Karen L.; Dinsmore, Colin; Earnshaw, Charles H.; Reiter, Jeremy F.; Griffiths, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6163</span>),
    <span class="NLM_cas:pages">1247-1250</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The centrosome is essential for cytotoxic T lymphocyte (CTL) function, contacting the plasma membrane and directing cytotoxic granules for secretion at the immunol. synapse.  Centrosome docking at the plasma membrane also occurs during cilia formation.  The primary cilium, formed in nonhematopoietic cells, is essential for vertebrate Hedgehog (Hh) signaling.  Lymphocytes do not form primary cilia, but we found and describe here that Hh signaling played an important role in CTL killing.  T cell receptor activation, which "prearms" CTLs with cytotoxic granules, also initiated Hh signaling.  Hh pathway activation occurred intracellularly and triggered Rac1 synthesis.  These events "prearmed" CTLs for action by promoting the actin remodeling required for centrosome polarization and granule release.  Thus, Hh signaling plays a role in CTL function, and the immunol. synapse may represent a modified cilium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3-gydGTacyrVg90H21EOLACvtfcHk0liJcUA3iRGirw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhtLjI&md5=769f3e31cacdae3f0375196f86b983f6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1244689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1244689%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BRoche%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DA.%2BT.%26aulast%3DAngus%26aufirst%3DK.%2BL.%26aulast%3DDinsmore%26aufirst%3DC.%26aulast%3DEarnshaw%26aufirst%3DC.%2BH.%26aulast%3DReiter%26aufirst%3DJ.%2BF.%26aulast%3DGriffiths%26aufirst%3DG.%2BM.%26atitle%3DHedgehog%2520signaling%2520controls%2520t%2520cell%2520killing%2520at%2520the%2520immunological%2520synapse%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1247%26epage%3D1250%26doi%3D10.1126%2Fscience.1244689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dennler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexaki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnaldo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ten Dijke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrecchia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauviel, A.</span></span> <span> </span><span class="NLM_article-title">Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of gli2 and gli1 expression in vitro and in vivo</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6981</span>– <span class="NLM_lpage">6986</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-0491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-07-0491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17638910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6981-6986&author=S.+Dennlerauthor=J.+Andreauthor=I.+Alexakiauthor=A.+Liauthor=T.+Magnaldoauthor=P.+ten+Dijkeauthor=X.+J.+Wangauthor=F.+Verrecchiaauthor=A.+Mauviel&title=Induction+of+sonic+hedgehog+mediators+by+transforming+growth+factor-beta%3A+Smad3-dependent+activation+of+gli2+and+gli1+expression+in+vitro+and+in+vivo&doi=10.1158%2F0008-5472.CAN-07-0491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Sonic Hedgehog Mediators by Transforming Growth Factor-β: Smad3-Dependent Activation of Gli2 and Gli1 Expression In vitro and In vivo</span></div><div class="casAuthors">Dennler, Sylviane; Andre, Jocelyne; Alexaki, Ismini; Li, Allen; Magnaldo, Thierry; ten Dijke, Peter; Wang, Xiao-Jing; Verrecchia, Franck; Mauviel, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6981-6986</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hedgehog (Hh) and transforming growth factor-β (TGF-β) family members are involved in numerous overlapping processes during embryonic development, hair cycle, and cancer.  Herein, we show that TGF-β induces the expression of the Hh signaling mols. Gli1 and Gli2 in various human cell types, including normal fibroblasts and keratinocytes, as well as various cancer cell lines.  Gli2 induction by TGF-β is rapid, independent from Hh receptor signaling, and requires a functional Smad pathway.  Gli1 expression is subsequently activated in a Gli2-dependent manner.  In transgenic mice overexpressing TGF-β1 in the skin, Gli1 and Gli2 expression is also elevated and depends on Smad3.  In pancreatic adenocarcinoma cell lines resistant to Hh inhibition, pharmacol. blockade of TGF-β signaling leads to repression of cell proliferation accompanied with a redn. in Gli2 expression.  We thus identify TGF-β as a potent transcriptional inducer of Gli transcription factors.  Targeting the cooperation of Hh and TGF-β signaling may provide new therapeutic opportunities for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt2lbvXxU-zLVg90H21EOLACvtfcHk0liJcUA3iRGirw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOit7c%253D&md5=99c473dff43c00b5ef20d6937fa69cf6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0491%26sid%3Dliteratum%253Aachs%26aulast%3DDennler%26aufirst%3DS.%26aulast%3DAndre%26aufirst%3DJ.%26aulast%3DAlexaki%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DMagnaldo%26aufirst%3DT.%26aulast%3Dten%2BDijke%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DVerrecchia%26aufirst%3DF.%26aulast%3DMauviel%26aufirst%3DA.%26atitle%3DInduction%2520of%2520sonic%2520hedgehog%2520mediators%2520by%2520transforming%2520growth%2520factor-beta%253A%2520Smad3-dependent%2520activation%2520of%2520gli2%2520and%2520gli1%2520expression%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6981%26epage%3D6986%26doi%3D10.1158%2F0008-5472.CAN-07-0491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teperino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loipetzberger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kammerer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgaard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee-Young, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Febbraio, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pospisilik, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esterbauer, H.</span></span> <span> </span><span class="NLM_article-title">Hedgehog partial agonism drives warburg-like metabolism in muscle and brown fat</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2012.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23063129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2qurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2012&pages=414-426&author=R.+Teperinoauthor=S.+Amannauthor=M.+Bayerauthor=S.+L.+McGeeauthor=A.+Loipetzbergerauthor=T.+Connorauthor=C.+Jaegerauthor=B.+Kammererauthor=L.+Winterauthor=G.+Wicheauthor=K.+Dalgaardauthor=M.+Selvarajauthor=M.+Gasterauthor=R.+S.+Lee-Youngauthor=M.+A.+Febbraioauthor=C.+Knaufauthor=P.+D.+Caniauthor=F.+Abergerauthor=J.+M.+Penningerauthor=J.+A.+Pospisilikauthor=H.+Esterbauer&title=Hedgehog+partial+agonism+drives+warburg-like+metabolism+in+muscle+and+brown+fat&doi=10.1016%2Fj.cell.2012.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat</span></div><div class="casAuthors">Teperino, Raffaele; Amann, Sabine; Bayer, Martina; McGee, Sean L.; Loipetzberger, Andrea; Connor, Timothy; Jaeger, Carsten; Kammerer, Bernd; Winter, Lilli; Wiche, Gerhard; Dalgaard, Kevin; Selvaraj, Madhan; Gaster, Michael; Lee-Young, Robert S.; Febbraio, Mark A.; Knauf, Claude; Cani, Patrice D.; Aberger, Fritz; Penninger, Josef M.; Pospisilik, J. Andrew; Esterbauer, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">414-426</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diabetes, obesity, and cancer affect upward of 15% of the world's population.  Interestingly, all three diseases juxtapose dysregulated intracellular signaling with altered metabolic state.  Exactly which genetic factors define stable metabolic set points in vivo remains poorly understood.  Here, we show that hedgehog signaling rewires cellular metab.  We identify a cilium-dependent Smo-Ca2+-Ampk axis that triggers rapid Warburg-like metabolic reprogramming within minutes of activation and is required for proper metabolic selectivity and flexibility.  We show that Smo modulators can uncouple the Smo-Ampk axis from canonical signaling and identify cyclopamine as one of a new class of "selective partial agonists," capable of concomitant inhibition of canonical and activation of noncanonical hedgehog signaling.  Intriguingly, activation of the Smo-Ampk axis in vivo drives robust insulin-independent glucose uptake in muscle and brown adipose tissue.  These data identify multiple noncanonical endpoints that are pivotal for rational design of hedgehog modulators and provide a new therapeutic avenue for obesity and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzbRse8OoQE7Vg90H21EOLACvtfcHk0lgX3FxQNuw66g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2qurbE&md5=e37290b31326d087be98372541060d40</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DTeperino%26aufirst%3DR.%26aulast%3DAmann%26aufirst%3DS.%26aulast%3DBayer%26aufirst%3DM.%26aulast%3DMcGee%26aufirst%3DS.%2BL.%26aulast%3DLoipetzberger%26aufirst%3DA.%26aulast%3DConnor%26aufirst%3DT.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DKammerer%26aufirst%3DB.%26aulast%3DWinter%26aufirst%3DL.%26aulast%3DWiche%26aufirst%3DG.%26aulast%3DDalgaard%26aufirst%3DK.%26aulast%3DSelvaraj%26aufirst%3DM.%26aulast%3DGaster%26aufirst%3DM.%26aulast%3DLee-Young%26aufirst%3DR.%2BS.%26aulast%3DFebbraio%26aufirst%3DM.%2BA.%26aulast%3DKnauf%26aufirst%3DC.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DAberger%26aufirst%3DF.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DPospisilik%26aufirst%3DJ.%2BA.%26aulast%3DEsterbauer%26aufirst%3DH.%26atitle%3DHedgehog%2520partial%2520agonism%2520drives%2520warburg-like%2520metabolism%2520in%2520muscle%2520and%2520brown%2520fat%26jtitle%3DCell%26date%3D2012%26volume%3D151%26spage%3D414%26epage%3D426%26doi%3D10.1016%2Fj.cell.2012.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almada, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Zapico, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, D. R.</span></span> <span> </span><span class="NLM_article-title">The alpha subunit of the g protein g13 regulates activity of one or more gli transcription factors independently of smoothened</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">30714</span>– <span class="NLM_lpage">30722</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.219279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1074%2Fjbc.M111.219279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21757753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOktL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=30714-30722&author=A.+E.+Douglasauthor=J.+A.+Heimauthor=F.+Shenauthor=L.+L.+Almadaauthor=N.+A.+Rioboauthor=M.+E.+Fernandez-Zapicoauthor=D.+R.+Manning&title=The+alpha+subunit+of+the+g+protein+g13+regulates+activity+of+one+or+more+gli+transcription+factors+independently+of+smoothened&doi=10.1074%2Fjbc.M111.219279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The α subunit of the G protein G13 regulates activity of one or more Gli transcription factors independently of smoothened</span></div><div class="casAuthors">Douglas, Andrew E.; Heim, Jennifer A.; Shen, Feng; Almada, Luciana L.; Riobo, Natalia A.; Fernandez-Zapico, Martin E.; Manning, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30714-30722, S30714/1-S30714/3</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Smoothened (Smo) is a seven-transmembrane (7-TM) receptor that is essential to most actions of the Hedgehog family of morphogens.  We found previously that Smo couples to members of the Gi family of heterotrimeric G proteins, which in some cases are integral although alone insufficient in the activation of Gli transcription factors through Hedgehog signaling.  In response to a report that the G12/13 family is relevant to Hedgehog signaling as well, we re-evaluated the coupling of Smo to one member of this family, G13, and investigated the capacity of this and other G proteins to activate one or more of forms of Gli.  We found no evidence that Smo couples directly to G13.  We found nonetheless that Gα13 and to some extent Gαq and Gα12 are able to effect activation of Gli(s).  This capacity is realized in some cells, e.g. C3H10T1/2, MC3T3, and pancreatic cancer cells, but not all cells.  The mechanism employed is distinct from that achieved through canonical Hedgehog signaling, as the activation does not involve autocrine signaling or in any other way require active Smo and does not necessarily involve enhanced transcription of Gli1.  The activation by Gα13 can be replicated through a Gq/G12/13-coupled receptor, CCKA, and is attenuated by inhibitors of p38 mitogen-activated protein kinase and Tec tyrosine kinases.  We posit that G proteins, and perhaps G13 in particular, provide access to Gli that is independent of Smo and that they thus establish a basis for control of at least some forms of Gli-mediated transcription apart from Hedgehogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6MYsbdhzO37Vg90H21EOLACvtfcHk0lgX3FxQNuw66g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOktL%252FJ&md5=6321aff87babb03854f252e1faeec15e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.219279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.219279%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DA.%2BE.%26aulast%3DHeim%26aufirst%3DJ.%2BA.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DAlmada%26aufirst%3DL.%2BL.%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DManning%26aufirst%3DD.%2BR.%26atitle%3DThe%2520alpha%2520subunit%2520of%2520the%2520g%2520protein%2520g13%2520regulates%2520activity%2520of%2520one%2520or%2520more%2520gli%2520transcription%2520factors%2520independently%2520of%2520smoothened%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D30714%26epage%3D30722%26doi%3D10.1074%2Fjbc.M111.219279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saucy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilizio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, D. R.</span></span> <span> </span><span class="NLM_article-title">Activation of heterotrimeric g proteins by smoothened</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">12607</span>– <span class="NLM_lpage">12612</span>, <span class="refDoi"> DOI: 10.1073/pnas.0600880103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0600880103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16885213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=12607-12612&author=N.+A.+Rioboauthor=B.+Saucyauthor=C.+Dilizioauthor=D.+R.+Manning&title=Activation+of+heterotrimeric+g+proteins+by+smoothened&doi=10.1073%2Fpnas.0600880103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of heterotrimeric G proteins by Smoothened</span></div><div class="casAuthors">Riobo, Natalia A.; Saucy, Berangere; DiLizio, Cherisse; Manning, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12607-12612</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mechanisms by which the activation of Smoothened (Smo), a protein essential to the actions of the Hedgehog family of secreted proteins, is translated into signals that converge on the Gli transcription factors are not fully understood.  The seven-transmembrane structure of SMO has long implied the utilization of heterotrimeric GTP-binding regulatory proteins (G proteins); however, evidence in this regard has been indirect and contradictory.  In the current study we evaluated the capacity of mammalian Smo to couple to G proteins directly.  We found that Smo, by virtue of what appears to be constitutive activity, activates all members of the Gi family but does not activate members of the Gs, Gq, and G12 families.  The activation is suppressed by cyclopamine and other inhibitors of Hedgehog (Hh) signaling and is enhanced by the Smo agonist purmorphamine.  Activation of Gi by Smo is essential in the activation of Gli in fibroblasts, because disruption of coupling to Gi with pertussis toxin inhibits the activation of Gli by Sonic hedgehog and a constitutively active form of Smo (SmoM2).  However, Gi does not provide a sufficient signal because a truncated form of Smo, although capable of activating Gi, does not effect activation of Gli.  Rescue of pertussis toxin-inhibited activation of Gli by Sonic hedgehog can be achieved with a constitutively active Gαi-subunit.  The data suggest that Smo is in fact the source of two signals relevant to the activation of Gli: one involving Gi and the other involving events at Smo's C-tail independent of Gi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSUAJeGdwtrrVg90H21EOLACvtfcHk0lhiuRiVqpY51Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslSnsrY%253D&md5=63b4035a1249181b2ab089237df284d0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600880103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600880103%26sid%3Dliteratum%253Aachs%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26aulast%3DSaucy%26aufirst%3DB.%26aulast%3DDilizio%26aufirst%3DC.%26aulast%3DManning%26aufirst%3DD.%2BR.%26atitle%3DActivation%2520of%2520heterotrimeric%2520g%2520proteins%2520by%2520smoothened%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D12607%26epage%3D12612%26doi%3D10.1073%2Fpnas.0600880103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polizio, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinchilla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog activates the gtpases rac1 and rhoa in a gli-independent manner through coupling of smoothened to gi proteins</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">pt7</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2002396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscisignal.2002396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22114142" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=pt7&author=A.+H.+Polizioauthor=P.+Chinchillaauthor=X.+Chenauthor=D.+R.+Manningauthor=N.+A.+Riobo&title=Sonic+hedgehog+activates+the+gtpases+rac1+and+rhoa+in+a+gli-independent+manner+through+coupling+of+smoothened+to+gi+proteins&doi=10.1126%2Fscisignal.2002396"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002396%26sid%3Dliteratum%253Aachs%26aulast%3DPolizio%26aufirst%3DA.%2BH.%26aulast%3DChinchilla%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DManning%26aufirst%3DD.%2BR.%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26atitle%3DSonic%2520hedgehog%2520activates%2520the%2520gtpases%2520rac1%2520and%2520rhoa%2520in%2520a%2520gli-independent%2520manner%2520through%2520coupling%2520of%2520smoothened%2520to%2520gi%2520proteins%26jtitle%3DSci.%2520Signaling%26date%3D2011%26volume%3D4%26spage%3Dpt7%26doi%3D10.1126%2Fscisignal.2002396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teperino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esterbauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pospisilik, J. A.</span></span> <span> </span><span class="NLM_article-title">Canonical and non-canonical hedgehog signalling and the control of metabolism</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2014.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.semcdb.2014.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24862854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSrurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=81-92&author=R.+Teperinoauthor=F.+Abergerauthor=H.+Esterbauerauthor=N.+Rioboauthor=J.+A.+Pospisilik&title=Canonical+and+non-canonical+hedgehog+signalling+and+the+control+of+metabolism&doi=10.1016%2Fj.semcdb.2014.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Canonical and non-canonical Hedgehog signalling and the control of metabolism</span></div><div class="casAuthors">Teperino, Raffaele; Aberger, Fritz; Esterbauer, Harald; Riobo, Natalia; Pospisilik, John Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Obesity and diabetes represent key healthcare challenges of our day, affecting upwards of one billion people worldwide.  These individuals are at higher risk for cancer, stroke, blindness, heart and cardiovascular disease, and to date, have no effective long-term treatment options available.  Recent and accumulating evidence has implicated the developmental morphogen Hedgehog and its downstream signalling in metabolic control.  Generally thought to be quiescent in adults, Hedgehog is assocd. with several human cancers, and as such, has already emerged as a therapeutic target in oncol.  Here, we attempt to give a comprehensive overview of the key signalling events assocd. with both canonical and non-canonical Hedgehog signalling, and highlight the increasingly complex regulatory modalities that appear to link Hedgehog and control metab.  We highlight these key findings and discuss their impact for therapeutic development, cancer and metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLpgXFCdjDgrVg90H21EOLACvtfcHk0lhiuRiVqpY51Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSrurbI&md5=29c8fbfb6780e73da155f4fb8800a5c9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2014.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2014.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DTeperino%26aufirst%3DR.%26aulast%3DAberger%26aufirst%3DF.%26aulast%3DEsterbauer%26aufirst%3DH.%26aulast%3DRiobo%26aufirst%3DN.%26aulast%3DPospisilik%26aufirst%3DJ.%2BA.%26atitle%3DCanonical%2520and%2520non-canonical%2520hedgehog%2520signalling%2520and%2520the%2520control%2520of%2520metabolism%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2014%26volume%3D33%26spage%3D81%26epage%3D92%26doi%3D10.1016%2Fj.semcdb.2014.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fombonne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guix, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corset, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span> <span> </span><span class="NLM_article-title">The patched dependence receptor triggers apoptosis through a dral-caspase-9 complex</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1038/ncb1880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncb1880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19465923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1als70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=739-746&author=F.+Milleauthor=C.+Thibertauthor=J.+Fombonneauthor=N.+Ramaauthor=C.+Guixauthor=H.+Hayashiauthor=V.+Corsetauthor=J.+C.+Reedauthor=P.+Mehlen&title=The+patched+dependence+receptor+triggers+apoptosis+through+a+dral-caspase-9+complex&doi=10.1038%2Fncb1880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex</span></div><div class="casAuthors">Mille, Frederic; Thibert, Chantal; Fombonne, Joanna; Rama, Nicolas; Guix, Catherine; Hayashi, Hideki; Corset, Veronique; Reed, John C.; Mehlen, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">739-746</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sonic hedgehog (Shh) and its main receptor, Patched (Ptc), are implicated in both neural development and tumorigenesis.  Besides its classic morphogenic activity, Shh is also a survival factor.  Along this line, Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh.  Here we show that, in the absence of its ligand, Ptc interacts with the adaptor protein DRAL (downregulated in rhabdomyosarcoma LIM-domain protein; also known as FHL2).  DRAL is required for the pro-apoptotic activity of Ptc both in immortalized cells and during neural tube development in chick embryos.  We demonstrate that, in the absence of Shh, Ptc recruits a protein complex that includes DRAL, one of the caspase recruitment (CARD)-domain contg. proteins TUCAN (family member, 8) or NALP1 (NLR family, pyrin domain contg. 1) and apical caspase-9.  Ptc triggers caspase-9 activation and enhances cell death through a caspase-9-dependent mechanism.  Thus, we propose that in the absence of its ligand Shh the dependence receptor Ptc serves as the anchor for a caspase-activating complex that includes DRAL, and caspase-9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT8nEmIBVT_7Vg90H21EOLACvtfcHk0lhqbTtuvUWtFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1als70%253D&md5=31135731b7f12a87c47d3525ce0e828a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncb1880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1880%26sid%3Dliteratum%253Aachs%26aulast%3DMille%26aufirst%3DF.%26aulast%3DThibert%26aufirst%3DC.%26aulast%3DFombonne%26aufirst%3DJ.%26aulast%3DRama%26aufirst%3DN.%26aulast%3DGuix%26aufirst%3DC.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DCorset%26aufirst%3DV.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DMehlen%26aufirst%3DP.%26atitle%3DThe%2520patched%2520dependence%2520receptor%2520triggers%2520apoptosis%2520through%2520a%2520dral-caspase-9%2520complex%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2009%26volume%3D11%26spage%3D739%26epage%3D746%26doi%3D10.1038%2Fncb1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thibert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teillet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazelin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Douarin, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1126/science.1085405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.1085405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12907805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=843-846&author=C.+Thibertauthor=M.+A.+Teilletauthor=F.+Lapointeauthor=L.+Mazelinauthor=N.+M.+Le+Douarinauthor=P.+Mehlen&title=Inhibition+of+neuroepithelial+patched-induced+apoptosis+by+sonic+hedgehog&doi=10.1126%2Fscience.1085405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of neuroepithelial Patched-induced apoptosis by Sonic hedgehog</span></div><div class="casAuthors">Thibert, Chantal; Teillet, Marie-Aimee; Lapointe, Francoise; Mazelin, Laetitia; Le Douarin, Nicole M.; Mehlen, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">5634</span>),
    <span class="NLM_cas:pages">843-846</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">During early development in vertebrates, Sonic hedgehog (Shh) is produced by the notochord and the floor plate.  A ventrodorsal gradient of Shh directs ventrodorsal patterning of the neural tube.  However, Shh is also required for the survival of neuroepithelial cells.  We show that Patched (Ptc) induces apoptotic cell death unless its ligand Shh is present to block the signal.  Moreover, the blockade of Ptc-induced cell death partly rescues the chick spinal cord defect provoked by Shh deprivation.  Thus, the proapoptotic activity of unbound Ptc and the pos. effect of Shh-bound Ptc on cell differentiation probably cooperate to achieve the appropriate spinal cord development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcQYG2X3MPV7Vg90H21EOLACvtfcHk0lhqbTtuvUWtFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVGqsL4%253D&md5=0d87a08ac670f8e912fa0ad46374ff20</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1085405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1085405%26sid%3Dliteratum%253Aachs%26aulast%3DThibert%26aufirst%3DC.%26aulast%3DTeillet%26aufirst%3DM.%2BA.%26aulast%3DLapointe%26aufirst%3DF.%26aulast%3DMazelin%26aufirst%3DL.%26aulast%3DLe%2BDouarin%26aufirst%3DN.%2BM.%26aulast%3DMehlen%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520neuroepithelial%2520patched-induced%2520apoptosis%2520by%2520sonic%2520hedgehog%26jtitle%3DScience%26date%3D2003%26volume%3D301%26spage%3D843%26epage%3D846%26doi%3D10.1126%2Fscience.1085405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buonamici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrissey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ospina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fordjour, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span> <span> </span><span class="NLM_article-title">Interfering with resistance to smoothened antagonists by inhibition of the pi3k pathway in medulloblastoma</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">51ra70</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscitranslmed.3001599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20881279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmtFensQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=51ra70&author=S.+Buonamiciauthor=J.+Williamsauthor=M.+Morrisseyauthor=A.+Wangauthor=R.+Guoauthor=A.+Vattayauthor=K.+Hsiaoauthor=J.+Yuanauthor=J.+Greenauthor=B.+Ospinaauthor=Q.+Yuauthor=L.+Ostromauthor=P.+Fordjourauthor=D.+L.+Andersonauthor=J.+E.+Monahanauthor=J.+F.+Kelleherauthor=S.+Peukertauthor=S.+Panauthor=X.+Wuauthor=S.+M.+Mairaauthor=C.+Garcia-Echeverriaauthor=K.+J.+Briggsauthor=D.+N.+Watkinsauthor=Y.+M.+Yaoauthor=C.+Lengauerauthor=M.+Warmuthauthor=W.+R.+Sellersauthor=M.+Dorsch&title=Interfering+with+resistance+to+smoothened+antagonists+by+inhibition+of+the+pi3k+pathway+in+medulloblastoma&doi=10.1126%2Fscitranslmed.3001599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma</span></div><div class="casAuthors">Buonamici Silvia; Williams Juliet; Morrissey Michael; Wang Anlai; Guo Ribo; Vattay Anthony; Hsiao Kathy; Yuan Jing; Green John; Ospina Beatriz; Yu Qunyan; Ostrom Lance; Fordjour Paul; Anderson Dustin L; Monahan John E; Kelleher Joseph F; Peukert Stefan; Pan Shifeng; Wu Xu; Maira Sauveur-Michel; Garcia-Echeverria Carlos; Briggs Kimberly J; Watkins D Neil; Yao Yung-mae; Lengauer Christoph; Warmuth Markus; Sellers William R; Dorsch Marion</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">51ra70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The malignant brain cancer medulloblastoma is characterized by mutations in Hedgehog (Hh) signaling pathway genes, which lead to constitutive activation of the G protein (heterotrimeric guanosine triphosphate-binding protein)-coupled receptor Smoothened (Smo).  The Smo antagonist NVP-LDE225 inhibits Hh signaling and induces tumor regression in animal models of medulloblastoma.  However, evidence of resistance was observed during the course of treatment.  Molecular analysis of resistant tumors revealed several resistance mechanisms.  We noted chromosomal amplification of Gli2, a downstream effector of Hh signaling, and, more rarely, point mutations in Smo that led to reactivated Hh signaling and restored tumor growth.  Analysis of pathway gene expression signatures also, unexpectedly, identified up-regulation of phosphatidylinositol 3-kinase (PI3K) signaling in resistant tumors as another potential mechanism of resistance.  Probing the relevance of increased PI3K signaling, we demonstrated that addition of the PI3K inhibitor NVP-BKM120 or the dual PI3K-mTOR (mammalian target of rapamycin) inhibitor NVP-BEZ235 to the initial treatment with the Smo antagonist markedly delayed the development of resistance.  Our findings may be useful in informing treatment strategies for medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFGV5VGgi31Q5nADWVYHg1fW6udTcc2ebUSwqm3HgMDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmtFensQ%253D%253D&md5=54560688e5f56b311350ed46837935de</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001599%26sid%3Dliteratum%253Aachs%26aulast%3DBuonamici%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DMorrissey%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DOspina%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DOstrom%26aufirst%3DL.%26aulast%3DFordjour%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DMonahan%26aufirst%3DJ.%2BE.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DBriggs%26aufirst%3DK.%2BJ.%26aulast%3DWatkins%26aufirst%3DD.%2BN.%26aulast%3DYao%26aufirst%3DY.%2BM.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DInterfering%2520with%2520resistance%2520to%2520smoothened%2520antagonists%2520by%2520inhibition%2520of%2520the%2520pi3k%2520pathway%2520in%2520medulloblastoma%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D51ra70%26doi%3D10.1126%2Fscitranslmed.3001599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>326</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1126/science.1179386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.1179386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19726788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ymsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2009&pages=572-574&author=R.+L.+Yauchauthor=G.+J.+Dijkgraafauthor=B.+Alickeauthor=T.+Januarioauthor=C.+P.+Ahnauthor=T.+Holcombauthor=K.+Pujaraauthor=J.+Stinsonauthor=C.+A.+Callahanauthor=T.+Tangauthor=J.+F.+Bazanauthor=Z.+Kanauthor=S.+Seshagiriauthor=C.+L.+Hannauthor=S.+E.+Gouldauthor=J.+A.+Lowauthor=C.+M.+Rudinauthor=F.+J.+de+Sauvage&title=Smoothened+mutation+confers+resistance+to+a+hedgehog+pathway+inhibitor+in+medulloblastoma&doi=10.1126%2Fscience.1179386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma</span></div><div class="casAuthors">Yauch, Robert L.; Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Januario, Thomas; Ahn, Christina P.; Holcomb, Thomas; Pujara, Kanan; Stinson, Jeremy; Callahan, Christopher A.; Tang, Tracy; Bazan, J. Fernando; Kan, Zhengyan; Seshagiri, Somasekar; Hann, Christine L.; Gould, Stephen E.; Low, Jennifer A.; Rudin, Charles M.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">5952</span>),
    <span class="NLM_cas:pages">572-574</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) signaling pathway is inappropriately activated in certain human cancers, including medulloblastoma, an aggressive brain tumor.  GDC-0449, a drug that inhibits Hh signaling by targeting the serpentine receptor Smoothened (SMO), has produced promising anti-tumor responses in early clin. studies of cancers driven by mutations in this pathway.  To evaluate the mechanism of resistance in a medulloblastoma patient who had relapsed after an initial response to GDC-0449, we detd. the mutational status of Hh signaling genes in the tumor after disease progression.  We identified an amino acid substitution at a conserved aspartic acid residue of SMO that had no effect on Hh signaling but disrupted the ability of GDC-0449 to bind SMO and suppress this pathway.  A mutation altering the same amino acid also arose in a GDC-0449-resistant mouse model of medulloblastoma.  These findings show that acquired mutations in a serpentine receptor with features of a G protein-coupled receptor can serve as a mechanism of drug resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMTHlVjB62IbVg90H21EOLACvtfcHk0liXxD8y-4fifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ymsrbM&md5=5e19833f47e248ad0a6d43bd4684bade</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1179386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1179386%26sid%3Dliteratum%253Aachs%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DAhn%26aufirst%3DC.%2BP.%26aulast%3DHolcomb%26aufirst%3DT.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DCallahan%26aufirst%3DC.%2BA.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DKan%26aufirst%3DZ.%26aulast%3DSeshagiri%26aufirst%3DS.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DSmoothened%2520mutation%2520confers%2520resistance%2520to%2520a%2520hedgehog%2520pathway%2520inhibitor%2520in%2520medulloblastoma%26jtitle%3DScience%26date%3D2009%26volume%3D326%26spage%3D572%26epage%3D574%26doi%3D10.1126%2Fscience.1179386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarin, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ally, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span> <span> </span><span class="NLM_article-title">Smoothened variants explain the majority of drug resistance in basal cell carcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccell.2015.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25759020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFOgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=342-353&author=S.+X.+Atwoodauthor=K.+Y.+Sarinauthor=R.+J.+Whitsonauthor=J.+R.+Liauthor=G.+Kimauthor=M.+Rezaeeauthor=M.+S.+Allyauthor=J.+Kimauthor=C.+Yaoauthor=A.+L.+Changauthor=A.+E.+Oroauthor=J.+Y.+Tang&title=Smoothened+variants+explain+the+majority+of+drug+resistance+in+basal+cell+carcinoma&doi=10.1016%2Fj.ccell.2015.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma</span></div><div class="casAuthors">Atwood, Scott X.; Sarin, Kavita Y.; Whitson, Ramon J.; Li, Jiang R.; Kim, Geurim; Rezaee, Melika; Ally, Mina S.; Kim, Jinah; Yao, Catherine; Chang, Anne Lynn S.; Oro, Anthony E.; Tang, Jean Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-353</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms.  Here we identify SMO mutations in 50% (22 of 44) of resistant BCCs and show that these mutations maintain Hedgehog signaling in the presence of SMO inhibitors.  Alterations include four ligand binding pocket mutations defining sites of inhibitor binding and four variants conferring constitutive activity and inhibitor resistance, illuminating pivotal residues that ensure receptor autoinhibition.  In the presence of a SMO inhibitor, tumor cells contg. either class of SMO mutants effectively outcompete cells contg. the wild-type SMO.  Finally, we show that both classes of SMO variants respond to aPKC-ι/λ or GLI2 inhibitors that operate downstream of SMO, setting the stage for the clin. use of GLI antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLWuAsc6vYLVg90H21EOLACvtfcHk0liXxD8y-4fifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFOgt70%253D&md5=550299c250d49e0b1df749cbf279e017</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DSarin%26aufirst%3DK.%2BY.%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DRezaee%26aufirst%3DM.%26aulast%3DAlly%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DA.%2BL.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26atitle%3DSmoothened%2520variants%2520explain%2520the%2520majority%2520of%2520drug%2520resistance%2520in%2520basal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26spage%3D342%26epage%3D353%26doi%3D10.1016%2Fj.ccell.2015.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloof, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffner, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveras, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandinova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">A small molecule that binds hedgehog and blocks its signaling in human cells</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/nchembio.142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19151731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFGrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=154-156&author=B.+Z.+Stantonauthor=L.+F.+Pengauthor=N.+Maloofauthor=K.+Nakaiauthor=X.+Wangauthor=J.+L.+Duffnerauthor=K.+M.+Taverasauthor=J.+M.+Hymanauthor=S.+W.+Leeauthor=A.+N.+Koehlerauthor=J.+K.+Chenauthor=J.+L.+Foxauthor=A.+Mandinovaauthor=S.+L.+Schreiber&title=A+small+molecule+that+binds+hedgehog+and+blocks+its+signaling+in+human+cells&doi=10.1038%2Fnchembio.142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule that binds Hedgehog and blocks its signaling in human cells</span></div><div class="casAuthors">Stanton, Benjamin Z.; Peng, Lee F.; Maloof, Nicole; Nakai, Kazuo; Wang, Xiang; Duffner, Jay L.; Taveras, Kennedy M.; Hyman, Joel M.; Lee, Sam W.; Koehler, Angela N.; Chen, James K.; Fox, Julia L.; Mandinova, Anna; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">154-156</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. inhibition of extracellular proteins that activate membrane receptors has proven to be extremely challenging.  Diversity-oriented synthesis and small-mol. microarrays enabled the discovery of robotnikinin, a small mol. that binds the extracellular Sonic hedgehog (Shh) protein and blocks Shh signaling in cell lines, human primary keratinocytes and a synthetic model of human skin.  Shh pathway activity is rescued by small-mol. agonists of Smoothened, which functions immediately downstream of the Shh receptor Patched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonRF64xivBNLVg90H21EOLACvtfcHk0lgM90cONrgCMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFGrtw%253D%253D&md5=a94abdb674167ae2bc3feb719b30a683</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.142%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DB.%2BZ.%26aulast%3DPeng%26aufirst%3DL.%2BF.%26aulast%3DMaloof%26aufirst%3DN.%26aulast%3DNakai%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDuffner%26aufirst%3DJ.%2BL.%26aulast%3DTaveras%26aufirst%3DK.%2BM.%26aulast%3DHyman%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DKoehler%26aufirst%3DA.%2BN.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26aulast%3DFox%26aufirst%3DJ.%2BL.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DA%2520small%2520molecule%2520that%2520binds%2520hedgehog%2520and%2520blocks%2520its%2520signaling%2520in%2520human%2520cells%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D154%26epage%3D156%26doi%3D10.1038%2Fnchembio.142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodakh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konitsiotis, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterisation of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine inhibitors of hedgehog acyltransferase</span>. <i>Data Brief</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1016/j.dib.2016.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.dib.2016.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27077078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC28fpvFyitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=257-281&author=T.+Lanyon-Hoggauthor=N.+Masumotoauthor=G.+Bodakhauthor=A.+D.+Konitsiotisauthor=E.+Thinonauthor=U.+R.+Rodgersauthor=R.+J.+Owensauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Synthesis+and+characterisation+of+5-acyl-6%2C7-dihydrothieno%5B3%2C2-c%5Dpyridine+inhibitors+of+hedgehog+acyltransferase&doi=10.1016%2Fj.dib.2016.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterisation of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine inhibitors of Hedgehog acyltransferase</span></div><div class="casAuthors">Lanyon-Hogg Thomas; Masumoto Naoko; Bodakh George; Thinon Emmanuelle; Tate Edward W; Konitsiotis Antonio D; Rodgers Ursula R; Magee Anthony I; Owens Raymond J</div><div class="citationInfo"><span class="NLM_cas:title">Data in brief</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-81</span>
        ISSN:<span class="NLM_cas:issn">2352-3409</span>.
    </div><div class="casAbstract">In this data article we describe synthetic and characterisation data for four members of the 5-acyl-6,7-dihydrothieno[3,2-c]pyridine (termed "RU-SKI") class of inhibitors of Hedgehog acyltransferase, including associated NMR spectra for final compounds.  RU-SKI compounds were selected for synthesis based on their published high potencies against the enzyme target.  RU-SKI 41 (9a), RU-SKI 43 (9b), RU-SKI 101 (9c), and RU-SKI 201 (9d) were profiled for activity in the related article "Click chemistry armed enzyme linked immunosorbent assay to measure palmitoylation by Hedgehog acyltransferase" (Lanyon-Hogg et al., 2015) [1]. (1)H NMR spectral data indicate different amide conformational ratios between the RU-SKI inhibitors, as has been observed in other 5-acyl-6,7-dihydrothieno[3,2-c]pyridines.  The synthetic and characterisation data supplied in the current article provide validated access to the class of RU-SKI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdUsQUE1cAM-xsqfvU0ziafW6udTcc2eZtvPsnheMI6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fpvFyitw%253D%253D&md5=2bf25f879ec935325c29c250ea256102</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.dib.2016.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dib.2016.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DBodakh%26aufirst%3DG.%26aulast%3DKonitsiotis%26aufirst%3DA.%2BD.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DRodgers%26aufirst%3DU.%2BR.%26aulast%3DOwens%26aufirst%3DR.%2BJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520characterisation%2520of%25205-acyl-6%252C7-dihydrothieno%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520hedgehog%2520acyltransferase%26jtitle%3DData%2520Brief%26date%3D2016%26volume%3D7%26spage%3D257%26epage%3D281%26doi%3D10.1016%2Fj.dib.2016.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodakh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konitsiotis, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Click chemistry armed enzyme-linked immunosorbent assay to measure palmitoylation by hedgehog acyltransferase</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2015.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ab.2015.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26334609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeit77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2015&pages=66-72&author=T.+Lanyon-Hoggauthor=N.+Masumotoauthor=G.+Bodakhauthor=A.+D.+Konitsiotisauthor=E.+Thinonauthor=U.+R.+Rodgersauthor=R.+J.+Owensauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Click+chemistry+armed+enzyme-linked+immunosorbent+assay+to+measure+palmitoylation+by+hedgehog+acyltransferase&doi=10.1016%2Fj.ab.2015.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry armed enzyme-linked immunosorbent assay to measure palmitoylation by hedgehog acyltransferase</span></div><div class="casAuthors">Lanyon-Hogg, Thomas; Masumoto, Naoko; Bodakh, George; Konitsiotis, Antonio D.; Thinon, Emmanuelle; Rodgers, Ursula R.; Owens, Raymond J.; Magee, Anthony I.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hedgehog signaling is crit. for correct embryogenesis and tissue development.  However, on maturation, signaling is also found to be aberrantly activated in many cancers.  Palmitoylation of the secreted signaling protein sonic hedgehog (Shh) by the enzyme hedgehog acyltransferase (Hhat) is required for functional signaling.  To quantify this important posttranslational modification, many in vitro Shh palmitoylation assays employ radiolabeled fatty acids, which have limitations in terms of cost and safety.  Here we present a click chem. armed ELISA (click-ELISA) for assessment of Hhat activity through acylation of biotinylated Shh peptide with an alkyne-tagged palmitoyl-CoA analog.  Click chem. functionalization of the alkyne tag with azido-FLAG peptide allows anal. through an ELISA protocol and colorimetric readout.  This assay format identified the detergent n-dodecyl β-D-maltopyranoside as an improved solubilizing agent for Hhat activity.  Quantification of the potency of RU-SKI small mol. Hhat inhibitors by click-ELISA indicated IC50 values in the low- or sub-micromolar range.  A stopped assay format was also employed that allows measurement of Hhat kinetic parameters where satg. substrate concns. exceed the binding capacity of the streptavidin-coated plate.  Therefore, click-ELISA represents a nonradioactive method for assessing protein palmitoylation in vitro that is readily expandable to other classes of protein lipidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3LQxDvK4jGLVg90H21EOLACvtfcHk0lgCx6BQK-gHPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeit77E&md5=d52dcffd605d5b7010c24013c01df184</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2015.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2015.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DBodakh%26aufirst%3DG.%26aulast%3DKonitsiotis%26aufirst%3DA.%2BD.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DRodgers%26aufirst%3DU.%2BR.%26aulast%3DOwens%26aufirst%3DR.%2BJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DClick%2520chemistry%2520armed%2520enzyme-linked%2520immunosorbent%2520assay%2520to%2520measure%2520palmitoylation%2520by%2520hedgehog%2520acyltransferase%26jtitle%3DAnal.%2520Biochem.%26date%3D2015%26volume%3D490%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.ab.2015.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzepa, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Modulation of amide bond rotamers in 5-acyl-6,7-dihydrothieno[3,2-c]pyridines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">4370</span>– <span class="NLM_lpage">4377</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.5b00205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b00205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtlSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=4370-4377&author=T.+Lanyon-Hoggauthor=M.+Ritzefeldauthor=N.+Masumotoauthor=A.+I.+Mageeauthor=H.+S.+Rzepaauthor=E.+W.+Tate&title=Modulation+of+amide+bond+rotamers+in+5-acyl-6%2C7-dihydrothieno%5B3%2C2-c%5Dpyridines&doi=10.1021%2Facs.joc.5b00205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Amide Bond Rotamers in 5-Acyl-6,7-dihydrothieno[3,2-c]pyridines</span></div><div class="casAuthors">Lanyon-Hogg, Thomas; Ritzefeld, Markus; Masumoto, Naoko; Magee, Anthony I.; Rzepa, Henry S.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4370-4377</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Substituted N-acyl-piperidine is a widespread and important structural motif, found in approx. 500 currently available structures, and present in nearly 30 pharmaceutically active compds.  Restricted rotation of the acyl substituent in such mols. can give rise to two distinct chem. environments.  Here we demonstrate, using NMR studies and d. functional theory modeling of the lowest energy structures of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine derivs., that the amide E:Z equil. is affected by non-covalent interactions between the amide oxygen and adjacent arom. protons.  Structural predictions were used to design mols. that promote either the E- or Z-amide conformation, enabling prepn. of compds. with a tailored conformational ratio, as proven by NMR studies.  Anal. of the available X-ray data of a variety of published N-acyl-piperidine-contg. compds. further indicates that these mols. are also clustered in the two obsd. conformations.  This finding emphasizes that directed conformational isomerism has significant implications for the design of both small mols. and larger amide-contg. mol. architectures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnBdTZoqyDS7Vg90H21EOLACvtfcHk0lgCx6BQK-gHPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtlSms7Y%253D&md5=595a2080f90ebc8ed201d5e0b5d3e6a5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b00205%26sid%3Dliteratum%253Aachs%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DRzepa%26aufirst%3DH.%2BS.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DModulation%2520of%2520amide%2520bond%2520rotamers%2520in%25205-acyl-6%252C7-dihydrothieno%255B3%252C2-c%255Dpyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D4370%26epage%3D4377%26doi%3D10.1021%2Facs.joc.5b00205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matevossian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resh, M. D.</span></span> <span> </span><span class="NLM_article-title">Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1038/onc.2013.575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fonc.2013.575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24469057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1yks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=263-268&author=E.+Petrovaauthor=A.+Matevossianauthor=M.+D.+Resh&title=Hedgehog+acyltransferase+as+a+target+in+pancreatic+ductal+adenocarcinoma&doi=10.1038%2Fonc.2013.575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma</span></div><div class="casAuthors">Petrova, E.; Matevossian, A.; Resh, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-268</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sonic Hedgehog (Shh) is abnormally expressed in pancreatic cancer and is assocd. with disease onset and progression.  Inhibition of Shh signaling is thus an attractive clin. target for therapeutic intervention.  Most efforts to block Shh signaling have focused on inhibitors of Smoothened, which target the canonical Shh signaling pathway.  These approaches have met with limited success, in part due to development of resistance-conferring mutations and contributions from non-canonical signaling pathways.  Here, we show that Hedgehog acyltransferase (Hhat), the enzyme responsible for the attachment of palmitate onto Shh, is a novel target for inhibition of Shh signaling in pancreatic cancer cells.  Depletion of Hhat with lentivirally delivered small hairpin RNA decreased both anchorage-dependent and independent proliferation of human pancreatic cancer cells.  In vivo, Hhat knockdown led to redn. of tumor growth in a mouse xenograft model of pancreatic cancer.  RU-SKI 43, a small mol. inhibitor of Hhat recently developed by our group, reduced pancreatic cancer cell proliferation and Gli-1 activation through Smoothened-independent non-canonical signaling.  In addn., RU-SKI 43 treatment inhibited two key proliferative pathways regulated by Akt and mTOR.  This work demonstrates that Hhat has a crit. role in pancreatic cancer and that a small mol. inhibitor of Hhat can successfully block pancreatic cancer cell proliferation.  It also highlights the importance of developing optimized Hhat inhibitors to be used as therapeutics in pancreatic cancer, as well as in other malignancies characterized by Shh overexpression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6IOPXTpklJbVg90H21EOLACvtfcHk0lgCx6BQK-gHPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1yks7c%253D&md5=b54973ce86f9e5aa5f59f0b01955e056</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.575%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DE.%26aulast%3DMatevossian%26aufirst%3DA.%26aulast%3DResh%26aufirst%3DM.%2BD.%26atitle%3DHedgehog%2520acyltransferase%2520as%2520a%2520target%2520in%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D263%26epage%3D268%26doi%3D10.1038%2Fonc.2013.575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rios-Esteves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouerfelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resh, M. D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of hedgehog acyltransferase block sonic hedgehog signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23416332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=247-249&author=E.+Petrovaauthor=J.+Rios-Estevesauthor=O.+Ouerfelliauthor=J.+F.+Glickmanauthor=M.+D.+Resh&title=Inhibitors+of+hedgehog+acyltransferase+block+sonic+hedgehog+signaling&doi=10.1038%2Fnchembio.1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling</span></div><div class="casAuthors">Petrova, Elissaveta; Rios-Esteves, Jessica; Ouerfelli, Ouathek; Glickman, J. Fraser; Resh, Marilyn D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-249</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of Sonic hedgehog (Shh) signaling is of great clin. interest.  Here we exploit Hedgehog acyltransferase (Hhat)-mediated Shh palmitoylation, a modification crit. for Shh signaling, as a new target for Shh pathway inhibition.  A target-oriented high-throughput screen was used to identify small-mol. inhibitors of Hhat.  In cells, these Hhat inhibitors specifically block Shh palmitoylation and inhibit autocrine and paracrine Shh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF48ZjslUQFbVg90H21EOLACvtfcHk0lhad8gf4_86uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLw%253D&md5=38dd997bbbf7f29d6d38e727d48fa797</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1184%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DE.%26aulast%3DRios-Esteves%26aufirst%3DJ.%26aulast%3DOuerfelli%26aufirst%3DO.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DResh%26aufirst%3DM.%2BD.%26atitle%3DInhibitors%2520of%2520hedgehog%2520acyltransferase%2520block%2520sonic%2520hedgehog%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D247%26epage%3D249%26doi%3D10.1038%2Fnchembio.1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Characterization of hedgehog acyltransferase inhibitors identifies a small molecule probe for hedgehog signaling by cancer cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3256</span>– <span class="NLM_lpage">3262</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00896</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWhurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3256-3262&author=U.+R.+Rodgersauthor=T.+Lanyon-Hoggauthor=N.+Masumotoauthor=M.+Ritzefeldauthor=R.+Burkeauthor=J.+Blaggauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Characterization+of+hedgehog+acyltransferase+inhibitors+identifies+a+small+molecule+probe+for+hedgehog+signaling+by+cancer+cells&doi=10.1021%2Facschembio.6b00896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Hedgehog Acyltransferase Inhibitors Identifies a Small Molecule Probe for Hedgehog Signaling by Cancer Cells</span></div><div class="casAuthors">Rodgers, Ursula R.; Lanyon-Hogg, Thomas; Masumoto, Naoko; Ritzefeld, Markus; Burke, Rosemary; Blagg, Julian; Magee, Anthony I.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3256-3262</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Sonic Hedgehog (Shh) signaling pathway plays a crit. role during embryonic development and cancer progression.  N-terminal palmitoylation of Shh by Hedgehog acyltransferase (Hhat) is essential for efficient signaling, raising interest in Hhat as a novel drug target.  A recently identified series of dihydrothienopyridines has been proposed to function via this mode of action; however, the lead compd. in this series (RUSKI-43) was subsequently shown to possess cytotoxic activity unrelated to canonical Shh signaling.  To identify a selective chem. probe for cellular studies, we profiled three RUSKI compds. in orthogonal cell-based assays.  We found that RUSKI-43 exhibits off-target cytotoxicity, masking its effect on Hhat-dependent signaling, hence results obtained with this compd. in cells should be treated with caution.  In contrast, RUSKI-201 showed no off-target cytotoxicity, and quant. whole-proteome palmitoylation profiling with a bioorthogonal alkyne-palmitate reporter demonstrated specific inhibition of Hhat in cells.  RUSKI-201 is the first selective Hhat chem. probe in cells and should be used in future studies of Hhat catalytic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3CiPlcZE8rVg90H21EOLACvtfcHk0lhad8gf4_86uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWhurnK&md5=aa2a9668bf0f3cc06751ac39f34e061f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00896%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DU.%2BR.%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DCharacterization%2520of%2520hedgehog%2520acyltransferase%2520inhibitors%2520identifies%2520a%2520small%2520molecule%2520probe%2520for%2520hedgehog%2520signaling%2520by%2520cancer%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D3256%26epage%3D3262%26doi%3D10.1021%2Facschembio.6b00896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokhunts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giambelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang Fei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galimberti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejarano, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glassberg, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockwood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmitrovsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">The hedgehog processing pathway is required for nsclc growth and survival</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2335</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fonc.2012.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22733134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVKlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2335-2345&author=J.+Rodriguez-Blancoauthor=N.+S.+Schillingauthor=R.+Tokhuntsauthor=C.+Giambelliauthor=J.+Longauthor=D.+Liang+Feiauthor=S.+Singhauthor=K.+E.+Blackauthor=Z.+Wangauthor=F.+Galimbertiauthor=P.+A.+Bejaranoauthor=S.+Elliotauthor=M.+K.+Glassbergauthor=D.+M.+Nguyenauthor=W.+W.+Lockwoodauthor=W.+L.+Lamauthor=E.+Dmitrovskyauthor=A.+J.+Capobiancoauthor=D.+J.+Robbins&title=The+hedgehog+processing+pathway+is+required+for+nsclc+growth+and+survival&doi=10.1038%2Fonc.2012.243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The hedgehog processing pathway is required for NSCLC growth and survival</span></div><div class="casAuthors">Rodriguez-Blanco, J.; Schilling, N. S.; Tokhunts, R.; Giambelli, C.; Long, J.; Fei, D. Liang; Singh, S.; Black, K. E.; Wang, Z.; Galimberti, F.; Bejarano, P. A.; Elliot, S.; Glassberg, M. K.; Nguyen, D. M.; Lockwood, W. W.; Lam, W. L.; Dmitrovsky, E.; Capobianco, A. J.; Robbins, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2335-2345</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Considerable interest has been generated from the results of recent clin. trials using smoothened (SMO) antagonists to inhibit the growth of hedgehog (HH) signaling-dependent tumors.  This interest is tempered by the discovery of SMO mutations mediating resistance, underscoring the rationale for developing therapeutic strategies that interrupt HH signaling at levels distinct from those inhibiting SMO function.  Here, we demonstrate that HH-dependent non-small cell lung carcinoma (NSCLC) growth is sensitive to blockade of the HH pathway upstream of SMO, at the level of HH ligand processing.  Individually, the use of different lentivirally delivered shRNA constructs targeting two functionally distinct HH-processing proteins, skinny hedgehog (SKN) or dispatched-1 (DISP-1), in NSCLC cell lines produced similar decreases in cell proliferation and increased cell death.  Further, providing either an exogenous source of processed HH or a SMO agonist reverses these effects.  The attenuation of HH processing, by knocking down either of these gene products, also abrogated tumor growth in mouse xenografts.  Finally, we extended these findings to primary clin. specimens, showing that SKN is frequently overexpressed in NSCLC and that higher DISP-1 expression is assocd. with an unfavorable clin. outcome.  Our results show a crit. role for HH processing in HH-dependent tumors, identifies two potential druggable targets in the HH pathway, and suggest that similar therapeutic strategies could be explored to treat patients harboring HH ligand-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyuEIV9duCo7Vg90H21EOLACvtfcHk0lhad8gf4_86uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVKlsbw%253D&md5=deee60126b2bb9266b44fba6b7f55a48</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.243%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DSchilling%26aufirst%3DN.%2BS.%26aulast%3DTokhunts%26aufirst%3DR.%26aulast%3DGiambelli%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DLiang%2BFei%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGalimberti%26aufirst%3DF.%26aulast%3DBejarano%26aufirst%3DP.%2BA.%26aulast%3DElliot%26aufirst%3DS.%26aulast%3DGlassberg%26aufirst%3DM.%2BK.%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DLockwood%26aufirst%3DW.%2BW.%26aulast%3DLam%26aufirst%3DW.%2BL.%26aulast%3DDmitrovsky%26aufirst%3DE.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520hedgehog%2520processing%2520pathway%2520is%2520required%2520for%2520nsclc%2520growth%2520and%2520survival%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D2335%26epage%3D2345%26doi%3D10.1038%2Fonc.2012.243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicking, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaphiropoulos, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gailani, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidambaram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vorechovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unden, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pressman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenevix-Trench, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, A. E.</span></span> <span> </span><span class="NLM_article-title">Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">841</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81268-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2FS0092-8674%2800%2981268-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=8681379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK28XjslSku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=841-851&author=H.+Hahnauthor=C.+Wickingauthor=P.+G.+Zaphiropoulosauthor=M.+R.+Gailaniauthor=S.+Shanleyauthor=A.+Chidambaramauthor=I.+Vorechovskyauthor=E.+Holmbergauthor=A.+B.+Undenauthor=S.+Gilliesauthor=K.+Negusauthor=I.+Smythauthor=C.+Pressmanauthor=D.+J.+Leffellauthor=B.+Gerrardauthor=A.+M.+Goldsteinauthor=M.+Deanauthor=R.+Toftgardauthor=G.+Chenevix-Trenchauthor=B.+Wainwrightauthor=A.+E.+Bale&title=Mutations+of+the+human+homolog+of+drosophila+patched+in+the+nevoid+basal+cell+carcinoma+syndrome&doi=10.1016%2FS0092-8674%2800%2981268-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome</span></div><div class="casAuthors">Hahn, Heidi; Wicking, Carol; Zaphiropoulos, Peter G.; Gailani, Mae R.; Shanley, Susan; Chidambaram, Abirami; Vorechovsky, Igor; Holmberg, Erika; Unden, Anne Birgitte; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">841-851</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by multiple basal cell carcinomas (BCCs), pits of the palms and soles, jaw keratocysts, a variety of other tumors, and developmental abnormalities.  NBCCS maps to chromosome 9q22.3.  Familial and sporadic BCCs display loss of heterozygosity in this region, consistent with the gene being a tumor suppressor.  A human sequence (PTC) with strong homol. to the Drosophila segment polarity gene, patched, was isolated from a YAC and cosmid contig of the NBCCS region.  Mutation anal. revealed alterations of PTC in NBCCS patients and in related tumors.  The authors propose that a redn. in expression of the patched gene can lead to the developmental abnormalities obsd. in the syndrome and that complete loss of patched function contributes to transformation of certain cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJn67md4sIDbVg90H21EOLACvtfcHk0lhGG9yYTrY48g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslSku74%253D&md5=5e27d796adffc4374b08347bb972c083</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981268-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981268-4%26sid%3Dliteratum%253Aachs%26aulast%3DHahn%26aufirst%3DH.%26aulast%3DWicking%26aufirst%3DC.%26aulast%3DZaphiropoulos%26aufirst%3DP.%2BG.%26aulast%3DGailani%26aufirst%3DM.%2BR.%26aulast%3DShanley%26aufirst%3DS.%26aulast%3DChidambaram%26aufirst%3DA.%26aulast%3DVorechovsky%26aufirst%3DI.%26aulast%3DHolmberg%26aufirst%3DE.%26aulast%3DUnden%26aufirst%3DA.%2BB.%26aulast%3DGillies%26aufirst%3DS.%26aulast%3DNegus%26aufirst%3DK.%26aulast%3DSmyth%26aufirst%3DI.%26aulast%3DPressman%26aufirst%3DC.%26aulast%3DLeffell%26aufirst%3DD.%2BJ.%26aulast%3DGerrard%26aufirst%3DB.%26aulast%3DGoldstein%26aufirst%3DA.%2BM.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DToftgard%26aufirst%3DR.%26aulast%3DChenevix-Trench%26aufirst%3DG.%26aulast%3DWainwright%26aufirst%3DB.%26aulast%3DBale%26aufirst%3DA.%2BE.%26atitle%3DMutations%2520of%2520the%2520human%2520homolog%2520of%2520drosophila%2520patched%2520in%2520the%2520nevoid%2520basal%2520cell%2520carcinoma%2520syndrome%26jtitle%3DCell%26date%3D1996%26volume%3D85%26spage%3D841%26epage%3D851%26doi%3D10.1016%2FS0092-8674%2800%2981268-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrich, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bare, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. P.</span></span> <span> </span><span class="NLM_article-title">Human homolog of patched, a candidate gene for the basal cell nevus syndrome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.1126/science.272.5268.1668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.272.5268.1668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=8658145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1eju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1996&pages=1668-1671&author=R.+L.+Johnsonauthor=A.+L.+Rothmanauthor=J.+Xieauthor=L.+V.+Goodrichauthor=J.+W.+Bareauthor=J.+M.+Bonifasauthor=A.+G.+Quinnauthor=R.+M.+Myersauthor=D.+R.+Coxauthor=E.+H.+Epsteinauthor=M.+P.+Scott&title=Human+homolog+of+patched%2C+a+candidate+gene+for+the+basal+cell+nevus+syndrome&doi=10.1126%2Fscience.272.5268.1668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human homolog of patched, a candidate gene for the basal cell nevus syndrome</span></div><div class="casAuthors">Johnson, Ronald L.; Rothman, Alana L.; Xie, Jingwu; Goodrich, Lisa V.; Bare, John W.; Bonifas, Jeannette M.; Quinn, Anthony G.; Myers, Richard M.; Cox, David R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5268</span>),
    <span class="NLM_cas:pages">1668-1671</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The basal cell nevus syndrome (BCNS) is characterized by developmental abnormalities and by the postnatal occurrence of cancers, esp. basal cell carcinomas (BCCs), the most common human cancer.  Heritable mutations in BCNS patients and a somatic mutation in a sporadic BCC were identified in a human homolog of the Drosophila patched (ptc) gene.  The ptc gene encodes a transmembrane protein that in Drosophila acts in opposition to the Hedgehog signaling protein, controlling cell fates, patterning, and growth in numerous tissues.  The human PTC gene appears to be crucial for proper embryonic development and for tumor suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-dJmVRHdewbVg90H21EOLACvtfcHk0lhGG9yYTrY48g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1eju78%253D&md5=818093d8a7cf966e1c8e98810b47628f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.272.5268.1668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.272.5268.1668%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DRothman%26aufirst%3DA.%2BL.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGoodrich%26aufirst%3DL.%2BV.%26aulast%3DBare%26aufirst%3DJ.%2BW.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DQuinn%26aufirst%3DA.%2BG.%26aulast%3DMyers%26aufirst%3DR.%2BM.%26aulast%3DCox%26aufirst%3DD.%2BR.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DScott%26aufirst%3DM.%2BP.%26atitle%3DHuman%2520homolog%2520of%2520patched%252C%2520a%2520candidate%2520gene%2520for%2520the%2520basal%2520cell%2520nevus%2520syndrome%26jtitle%3DScience%26date%3D1996%26volume%3D272%26spage%3D1668%26epage%3D1671%26doi%3D10.1126%2Fscience.272.5268.1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weeraratne, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeranz
Krummel, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auclair, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochicchio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cibulskis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlich, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennon, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russ, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shefler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivachenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogoloff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teider, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcott, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kautzman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. J.</span></span> <span> </span><span class="NLM_article-title">Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1038/nature11329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature11329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22820256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=106-110&author=T.+J.+Pughauthor=S.+D.+Weeraratneauthor=T.+C.+Archerauthor=D.+A.+Pomeranz%0AKrummelauthor=D.+Auclairauthor=J.+Bochicchioauthor=M.+O.+Carneiroauthor=S.+L.+Carterauthor=K.+Cibulskisauthor=R.+L.+Erlichauthor=H.+Greulichauthor=M.+S.+Lawrenceauthor=N.+J.+Lennonauthor=A.+McKennaauthor=J.+Meldrimauthor=A.+H.+Ramosauthor=M.+G.+Rossauthor=C.+Russauthor=E.+Sheflerauthor=A.+Sivachenkoauthor=B.+Sogoloffauthor=P.+Stojanovauthor=P.+Tamayoauthor=J.+P.+Mesirovauthor=V.+Amaniauthor=N.+Teiderauthor=S.+Senguptaauthor=J.+P.+Francoisauthor=P.+A.+Northcottauthor=M.+D.+Taylorauthor=F.+Yuauthor=G.+R.+Crabtreeauthor=A.+G.+Kautzmanauthor=S.+B.+Gabrielauthor=G.+Getzauthor=N.+Jagerauthor=D.+T.+Jonesauthor=P.+Lichterauthor=S.+M.+Pfisterauthor=T.+M.+Robertsauthor=M.+Meyersonauthor=S.+L.+Pomeroyauthor=Y.+J.+Cho&title=Medulloblastoma+exome+sequencing+uncovers+subtype-specific+somatic+mutations&doi=10.1038%2Fnature11329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations</span></div><div class="casAuthors">Pugh, Trevor J.; Weeraratne, Shyamal Dilhan; Archer, Tenley C.; Pomeranz Krummel, Daniel A.; Auclair, Daniel; Bochicchio, James; Carneiro, Mauricio O.; Carter, Scott L.; Cibulskis, Kristian; Erlich, Rachel L.; Greulich, Heidi; Lawrence, Michael S.; Lennon, Niall J.; McKenna, Aaron; Meldrim, James; Ramos, Alex H.; Ross, Michael G.; Russ, Carsten; Shefler, Erica; Sivachenko, Andrey; Sogoloff, Brian; Stojanov, Petar; Tamayo, Pablo; Mesirov, Jill P.; Amani, Vladimir; Teider, Natalia; Sengupta, Soma; Francois, Jessica Pierre; Northcott, Paul A.; Taylor, Michael D.; Yu, Furong; Crabtree, Gerald R.; Kautzman, Amanda G.; Gabriel, Stacey B.; Getz, Gad; Jaeger, Natalie; Jones, David T. W.; Lichter, Peter; Pfister, Stefan M.; Roberts, Thomas M.; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">106-110</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Medulloblastomas are the most common malignant brain tumors in children.  Identifying and understanding the genetic events that drive these tumors is crit. for the development of more effective diagnostic, prognostic and therapeutic strategies.  Recently, our group and others described distinct mol. subtypes of medulloblastoma on the basis of transcriptional and copy no. profiles.  Here we use whole-exome hybrid capture and deep sequencing to identify somatic mutations across the coding regions of 92 primary medulloblastoma/normal pairs.  Overall, medulloblastomas have low mutation rates consistent with other pediatric tumors, with a median of 0.35 non-silent mutations per megabase.  We identified twelve genes mutated at statistically significant frequencies, including previously known mutated genes in medulloblastoma such as CTNNB1, PTCH1, MLL2, SMARCA4 and TP53.  Recurrent somatic mutations were newly identified in an RNA helicase gene, DDX3X, often concurrent with CTNNB1 mutations, and in the nuclear co-repressor (N-CoR) complex genes GPS2, BCOR and LDB1.  We show that mutant DDX3X potentiates transactivation of a TCF promoter and enhances cell viability in combination with mutant, but not wild-type, β-catenin.  Together, our study reveals the alteration of WNT, hedgehog, histone methyltransferase and now N-CoR pathways across medulloblastomas and within specific subtypes of this disease, and nominates the RNA helicase DDX3X as a component of pathogenic β-catenin signaling in medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocg21WjMOyX7Vg90H21EOLACvtfcHk0lh6F-X6TL9ZBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmsrvJ&md5=d5ed22d294da53187713b060ac587fe2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnature11329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11329%26sid%3Dliteratum%253Aachs%26aulast%3DPugh%26aufirst%3DT.%2BJ.%26aulast%3DWeeraratne%26aufirst%3DS.%2BD.%26aulast%3DArcher%26aufirst%3DT.%2BC.%26aulast%3DPomeranz%2BKrummel%26aufirst%3DD.%2BA.%26aulast%3DAuclair%26aufirst%3DD.%26aulast%3DBochicchio%26aufirst%3DJ.%26aulast%3DCarneiro%26aufirst%3DM.%2BO.%26aulast%3DCarter%26aufirst%3DS.%2BL.%26aulast%3DCibulskis%26aufirst%3DK.%26aulast%3DErlich%26aufirst%3DR.%2BL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DLennon%26aufirst%3DN.%2BJ.%26aulast%3DMcKenna%26aufirst%3DA.%26aulast%3DMeldrim%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DA.%2BH.%26aulast%3DRoss%26aufirst%3DM.%2BG.%26aulast%3DRuss%26aufirst%3DC.%26aulast%3DShefler%26aufirst%3DE.%26aulast%3DSivachenko%26aufirst%3DA.%26aulast%3DSogoloff%26aufirst%3DB.%26aulast%3DStojanov%26aufirst%3DP.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DAmani%26aufirst%3DV.%26aulast%3DTeider%26aufirst%3DN.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DFrancois%26aufirst%3DJ.%2BP.%26aulast%3DNorthcott%26aufirst%3DP.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DCrabtree%26aufirst%3DG.%2BR.%26aulast%3DKautzman%26aufirst%3DA.%2BG.%26aulast%3DGabriel%26aufirst%3DS.%2BB.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DJager%26aufirst%3DN.%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DLichter%26aufirst%3DP.%26aulast%3DPfister%26aufirst%3DS.%2BM.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26atitle%3DMedulloblastoma%2520exome%2520sequencing%2520uncovers%2520subtype-specific%2520somatic%2520mutations%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D106%26epage%3D110%26doi%3D10.1038%2Fnature11329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B. L.</span></span> <span> </span><span class="NLM_article-title">Cholesterol modification of smoothened is required for hedgehog signaling</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2017.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.molcel.2017.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28344083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=154-162&author=X.+Xiaoauthor=J.+J.+Tangauthor=C.+Pengauthor=Y.+Wangauthor=L.+Fuauthor=Z.+P.+Qiuauthor=Y.+Xiongauthor=L.+F.+Yangauthor=H.+W.+Cuiauthor=X.+L.+Heauthor=L.+Yinauthor=W.+Qiauthor=C.+C.+Wongauthor=Y.+Zhaoauthor=B.+L.+Liauthor=W.+W.+Qiuauthor=B.+L.+Song&title=Cholesterol+modification+of+smoothened+is+required+for+hedgehog+signaling&doi=10.1016%2Fj.molcel.2017.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling</span></div><div class="casAuthors">Xiao, Xu; Tang, Jing-Jie; Peng, Chao; Wang, Yan; Fu, Lin; Qiu, Zhi-Ping; Xiong, Yue; Yang, Lian-Fang; Cui, Hai-Wei; He, Xiao-Long; Yin, Lei; Qi, Wei; Wong, Catherine C. L.; Zhao, Yun; Li, Bo-Liang; Qiu, Wen-Wei; Song, Bao-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-162.e10</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hedgehog (Hh) has been known as the only cholesterol-modified morphogen playing pivotal roles in development and tumorigenesis.  A major unsolved question is how Hh signaling regulates the activity of Smoothened (SMO).  Here, we performed an unbiased biochem. screen and identified that SMO was covalently modified by cholesterol on the Asp95 (D95) residue through an ester bond.  This modification was inhibited by Patched-1 (Ptch1) but enhanced by Hh.  The SMO(D95N) mutation, which could not be cholesterol modified, was refractory to Hh-stimulated ciliary localization and failed to activate downstream signaling.  Furthermore, homozygous SmoD99N/D99N (the equiv. residue in mouse) knockin mice were embryonic lethal with severe cardiac defects, phenocopying the Smo-/- mice.  Together, the results of our study suggest that Hh signaling transduces to SMO through modulating its cholesterylation and provides a therapeutic opportunity to treat Hh-pathway-related cancers by targeting SMO cholesterylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0HDMdKzJbybVg90H21EOLACvtfcHk0lh6F-X6TL9ZBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWqtb0%253D&md5=fb6d980d86b459c066a7e75e7e1da6e4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2017.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2017.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DJ.%2BJ.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DZ.%2BP.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%2BF.%26aulast%3DCui%26aufirst%3DH.%2BW.%26aulast%3DHe%26aufirst%3DX.%2BL.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DC.%2BC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%2BL.%26aulast%3DQiu%26aufirst%3DW.%2BW.%26aulast%3DSong%26aufirst%3DB.%2BL.%26atitle%3DCholesterol%2520modification%2520of%2520smoothened%2520is%2520required%2520for%2520hedgehog%2520signaling%26jtitle%3DMol.%2520Cell%26date%3D2017%26volume%3D66%26spage%3D154%26epage%3D162%26doi%3D10.1016%2Fj.molcel.2017.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span> <span> </span><span class="NLM_article-title">Cellular cholesterol directly activates smoothened in hedgehog signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2016.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27545348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyjtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2016&pages=1176-1187&author=P.+Huangauthor=D.+Nedelcuauthor=M.+Watanabeauthor=C.+Jaoauthor=Y.+Kimauthor=J.+Liuauthor=A.+Salic&title=Cellular+cholesterol+directly+activates+smoothened+in+hedgehog+signaling&doi=10.1016%2Fj.cell.2016.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling</span></div><div class="casAuthors">Huang, Pengxiang; Nedelcu, Daniel; Watanabe, Miyako; Jao, Cindy; Kim, Youngchang; Liu, Jing; Salic, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1176-1187.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In vertebrates, sterols are necessary for Hedgehog signaling, a pathway crit. in embryogenesis and cancer.  Sterols activate the membrane protein Smoothened by binding its extracellular, cysteine-rich domain (CRD).  Major unanswered questions concern the nature of the endogenous, activating sterol and the mechanism by which it regulates Smoothened.  We report crystal structures of CRD complexed with sterols and alone, revealing that sterols induce a dramatic conformational change of the binding site, which is sufficient for Smoothened activation and is unique among CRD-contg. receptors.  We demonstrate that Hedgehog signaling requires sterol binding to Smoothened and define key residues for sterol recognition and activity.  We also show that cholesterol itself binds and activates Smoothened.  Furthermore, the effect of oxysterols is abolished in Smoothened mutants that retain activation by cholesterol and Hedgehog.  We propose that the endogenous Smoothened activator is cholesterol, not oxysterols, and that vertebrate Hedgehog signaling controls Smoothened by regulating its access to cholesterol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNyYx88XIFgrVg90H21EOLACvtfcHk0lh6F-X6TL9ZBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyjtbzK&md5=ddcbbf7fc8ac442cbd3d43d6aa885217</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DNedelcu%26aufirst%3DD.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DJao%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSalic%26aufirst%3DA.%26atitle%3DCellular%2520cholesterol%2520directly%2520activates%2520smoothened%2520in%2520hedgehog%2520signaling%26jtitle%3DCell%26date%3D2016%26volume%3D166%26spage%3D1176%26epage%3D1187%26doi%3D10.1016%2Fj.cell.2016.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. P.</span></span> <span> </span><span class="NLM_article-title">Oxysterols stimulate sonic hedgehog signal transduction and proliferation of medulloblastoma cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8408</span>– <span class="NLM_lpage">8413</span>, <span class="refDoi"> DOI: 10.1073/pnas.0602852103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0602852103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16707575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=8408-8413&author=R.+B.+Corcoranauthor=M.+P.+Scott&title=Oxysterols+stimulate+sonic+hedgehog+signal+transduction+and+proliferation+of+medulloblastoma+cells&doi=10.1073%2Fpnas.0602852103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterols stimulate sonic hedgehog signal transduction and proliferation of medulloblastoma cells</span></div><div class="casAuthors">Corcoran, Ryan B.; Scott, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8408-8413</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sterol synthesis is required for Sonic hedgehog (Shh) signal transduction.  Errors in Shh signal transduction play important roles in the formation of human tumors, including medulloblastoma (MB).  It is not clear which products of sterol synthesis are necessary for Shh signal transduction or how they act.  Here we show that cholesterol or specific oxysterols are the crit. products of sterol synthesis required for Shh pathway signal transduction in MB cells.  In MB cells, sterol synthesis inhibitors reduce Shh target gene transcription and block Shh pathway-dependent proliferation.  These effects of sterol synthesis inhibitors can be reversed by exogenous cholesterol or specific oxysterols.  We also show that certain oxysterols can maximally activate Shh target gene transcription through the Smoothened (Smo) protein as effectively as the known Smo full agonist, SAG.  Thus, sterols are required and sufficient for Shh pathway activation.  These results suggest that oxysterols may be crit. regulators of Smo, and thereby Shh signal transduction.  Inhibition of Shh signaling by sterol synthesis inhibitors may offer a novel approach to the treatment of MB and other Shh pathway-dependent human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8vnFl_Fs9wrVg90H21EOLACvtfcHk0lh9p0ihAnWUnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFCht7o%253D&md5=5cecabdc971028ebd3f5c450c1963a7a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0602852103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0602852103%26sid%3Dliteratum%253Aachs%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26aulast%3DScott%26aufirst%3DM.%2BP.%26atitle%3DOxysterols%2520stimulate%2520sonic%2520hedgehog%2520signal%2520transduction%2520and%2520proliferation%2520of%2520medulloblastoma%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D8408%26epage%3D8413%26doi%3D10.1073%2Fpnas.0602852103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nachtergaele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rammohan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlesinger, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohatgi, R.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are allosteric activators of the oncoprotein smoothened</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nchembio.765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22231273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsF2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=211-220&author=S.+Nachtergaeleauthor=L.+K.+Mydockauthor=K.+Krishnanauthor=J.+Rammohanauthor=P.+H.+Schlesingerauthor=D.+F.+Coveyauthor=R.+Rohatgi&title=Oxysterols+are+allosteric+activators+of+the+oncoprotein+smoothened&doi=10.1038%2Fnchembio.765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterols are allosteric activators of the oncoprotein Smoothened</span></div><div class="casAuthors">Nachtergaele, Sigrid; Mydock, Laurel K.; Krishnan, Kathiresan; Rammohan, Jayan; Schlesinger, Paul H.; Covey, Douglas F.; Rohatgi, Rajat</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-220</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oxysterols are a class of endogenous signaling mols. that can activate the Hedgehog pathway, which has crit. roles in development, regeneration and cancer.  However, it has been unclear how oxysterols influence Hedgehog signaling, including whether their effects are mediated through a protein target or indirectly through effects on membrane properties.  To answer this question, we synthesized the enantiomer and an epimer of the most potent oxysterol, 20(S)-hydroxycholesterol.  Using these mols., we show that the effects of oxysterols on Hedgehog signaling are exquisitely stereoselective, consistent with the hypothesis that they function through a specific protein target.  We present several lines of evidence that this protein target is the seven-pass transmembrane protein Smoothened (Smo), a major drug target in oncol.  Our work suggests that these enigmatic sterols, which have multiple effects on cell physiol., may act as ligands for signaling receptors and provides a generally applicable framework for probing sterol signaling mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8G-Fryjj6ebVg90H21EOLACvtfcHk0lh9p0ihAnWUnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsF2mtg%253D%253D&md5=c4aef9019e715a2df6c5ae6567007198</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.765%26sid%3Dliteratum%253Aachs%26aulast%3DNachtergaele%26aufirst%3DS.%26aulast%3DMydock%26aufirst%3DL.%2BK.%26aulast%3DKrishnan%26aufirst%3DK.%26aulast%3DRammohan%26aufirst%3DJ.%26aulast%3DSchlesinger%26aufirst%3DP.%2BH.%26aulast%3DCovey%26aufirst%3DD.%2BF.%26aulast%3DRohatgi%26aufirst%3DR.%26atitle%3DOxysterols%2520are%2520allosteric%2520activators%2520of%2520the%2520oncoprotein%2520smoothened%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D211%26epage%3D220%26doi%3D10.1038%2Fnchembio.765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myers, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sever, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belani, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rychnovsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2013.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.devcel.2013.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23954590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ylt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=346-357&author=B.+R.+Myersauthor=N.+Severauthor=Y.+C.+Chongauthor=J.+Kimauthor=J.+D.+Belaniauthor=S.+Rychnovskyauthor=J.+F.+Bazanauthor=P.+A.+Beachy&title=Hedgehog+pathway+modulation+by+multiple+lipid+binding+sites+on+the+smoothened+effector+of+signal+response&doi=10.1016%2Fj.devcel.2013.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog Pathway Modulation by Multiple Lipid Binding Sites on the Smoothened Effector of Signal Response</span></div><div class="casAuthors">Myers, Benjamin R.; Sever, Navdar; Chong, Yong Chun; Kim, James; Belani, Jitendra D.; Rychnovsky, Scott; Bazan, J. Fernando; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">346-357</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hedgehog (Hh) signaling during development and in postembryonic tissues requires activation of the 7TM oncoprotein Smoothened (Smo) by mechanisms that may involve endogenous lipidic modulators.  Exogenous Smo ligands previously identified include the plant sterol cyclopamine (and its therapeutically useful synthetic mimics) and hydroxylated cholesterol derivs. (oxysterols); Smo is also highly sensitive to cellular sterol levels.  The relationships between these effects are unclear because the relevant Smo structural determinants are unknown.  We identify the conserved extracellular cysteine-rich domain (CRD) as the site of action for oxysterols on Smo, involving residues structurally analogous to those contacting the Wnt lipid adduct in the homologous Frizzled CRD; this modulatory effect is distinct from that of cyclopamine mimics, from Hh-mediated regulation, and from the permissive action of cellular sterol pools.  These results imply that Hh pathway activity is sensitive to lipid binding at several Smo sites, suggesting mechanisms for tuning by multiple physiol. inputs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHl687XdSYgLVg90H21EOLACvtfcHk0lh9p0ihAnWUnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ylt73M&md5=63900d9ed6d0a1291da7f39edfe3f13d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2013.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2013.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DB.%2BR.%26aulast%3DSever%26aufirst%3DN.%26aulast%3DChong%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DBelani%26aufirst%3DJ.%2BD.%26aulast%3DRychnovsky%26aufirst%3DS.%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DHedgehog%2520pathway%2520modulation%2520by%2520multiple%2520lipid%2520binding%2520sites%2520on%2520the%2520smoothened%2520effector%2520of%2520signal%2520response%26jtitle%3DDev.%2520Cell%26date%3D2013%26volume%3D26%26spage%3D346%26epage%3D357%26doi%3D10.1016%2Fj.devcel.2013.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Incardona, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaffield, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelink, H.</span></span> <span> </span><span class="NLM_article-title">The teratogenic veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=9716521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK1cXmslKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1998&pages=3553-3562&author=J.+P.+Incardonaauthor=W.+Gaffieldauthor=R.+P.+Kapurauthor=H.+Roelink&title=The+teratogenic+veratrum+alkaloid+cyclopamine+inhibits+sonic+hedgehog+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction</span></div><div class="casAuthors">Incardona, John P.; Gaffield, William; Kapur, Raj P.; Roelink, Henk</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3553-3562</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The steroidal alkaloid cyclopamine produces cyclopia and holoprosencephaly when administered to gastrulation-stage amniote embryos.  Cyclopamine-induced malformations in chick embryos are assocd. with interruption of Sonic hedgehog (Shh)-mediated dorsoventral patterning of the neural tube and somites.  Cell types normally induced in the ventral neural tube by Shh are either absent or appear aberrantly at the ventral midline after cyclopamine treatment, while dorsal cell types normally repressed by Shh appear ventrally.  Somites in cyclopamine-treated embryos show Pax7 expression throughout, indicating failure of sclerotome induction.  Cyclopamine at concns. of 20-100 nM blocks the response of neural plate explants to recombinant Shh-N in a dose-dependent manner.  Similar concns. have no effect on the post-translational modification of Shh by cholesterol in transfected COS-1 cells.  Comparison of the effects of cyclopamine to those of the holoprosencephaly-inducing cholesterol synthesis inhibitor AY-9944 shows that cyclopamine does not induce malformations by interfering with cholesterol metab.  Although AY-9944 does not interrupt Shh signaling in ovo, it blocks the response to Shh-N in explants cultured without an exogenous cholesterol source.  As predicted by current models of the regulation of cholesterol metab., the response to Shh-N in AY-9944-treated explants is restored by providing exogenous cholesterol.  However, exogenous cholesterol does not restore Shh signaling in cyclopamine-treated explants.  These findings suggest that cyclopamine-induced teratogenesis is due to a more direct antagonism of Shh signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcBtoDosJpI7Vg90H21EOLACvtfcHk0lj91sthj-pZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslKmtbk%253D&md5=ee8613c71aa3a2b556b3653d74b6e9f3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIncardona%26aufirst%3DJ.%2BP.%26aulast%3DGaffield%26aufirst%3DW.%26aulast%3DKapur%26aufirst%3DR.%2BP.%26aulast%3DRoelink%26aufirst%3DH.%26atitle%3DThe%2520teratogenic%2520veratrum%2520alkaloid%2520cyclopamine%2520inhibits%2520sonic%2520hedgehog%2520signal%2520transduction%26jtitle%3DDevelopment%26date%3D1998%26volume%3D125%26spage%3D3553%26epage%3D3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Teratogen-mediated inhibition of target tissue response to shh signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">1603</span>– <span class="NLM_lpage">1607</span>, <span class="refDoi"> DOI: 10.1126/science.280.5369.1603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.280.5369.1603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=9616123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=1603-1607&author=M.+K.+Cooperauthor=J.+A.+Porterauthor=K.+E.+Youngauthor=P.+A.+Beachy&title=Teratogen-mediated+inhibition+of+target+tissue+response+to+shh+signaling&doi=10.1126%2Fscience.280.5369.1603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Teratogen-mediated inhibition of target tissue response to Shh signaling</span></div><div class="casAuthors">Cooper, Michael K.; Porter, Jeffery A.; Young, Keith E.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">5369</span>),
    <span class="NLM_cas:pages">1603-1607</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Veratrum alkaloids and distal inhibitors of cholesterol biosynthesis have been studied for more than 30 yr as potent teratogens capable of inducing cyclopia and other birth defects.  Here, it is shown that these compds. specifically block the Sonic hedgehog (Shh) signaling pathway.  These teratogens did not prevent the sterol modification of Shh during autoprocessing but rather inhibited the response of target tissues to Shh, possibly acting through the sterol sensing domain within the Patched protein regulator of Shh response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPwaA3YwN2S7Vg90H21EOLACvtfcHk0lj91sthj-pZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKjurY%253D&md5=9428d88e53a145d6924fcdee4b4e3621</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.280.5369.1603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.280.5369.1603%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DYoung%26aufirst%3DK.%2BE.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DTeratogen-mediated%2520inhibition%2520of%2520target%2520tissue%2520response%2520to%2520shh%2520signaling%26jtitle%3DScience%26date%3D1998%26volume%3D280%26spage%3D1603%26epage%3D1607%26doi%3D10.1126%2Fscience.280.5369.1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescarbeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grogan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austad, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Diez, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and orally active hedgehog pathway antagonist (ipi-926)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4400</span>– <span class="NLM_lpage">4418</span>, <span class="refDoi"> DOI: 10.1021/jm900305z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900305z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4400-4418&author=M.+R.+Tremblayauthor=A.+Lescarbeauauthor=M.+J.+Groganauthor=E.+Tanauthor=G.+Linauthor=B.+C.+Austadauthor=L.+C.+Yuauthor=M.+L.+Behnkeauthor=S.+J.+Nairauthor=M.+Hagelauthor=K.+Whiteauthor=J.+Conleyauthor=J.+D.+Mannaauthor=T.+M.+Alvarez-Diezauthor=J.+Hoytauthor=C.+N.+Woodwardauthor=J.+R.+Sydorauthor=M.+Pinkauthor=J.+MacDougallauthor=M.+J.+Campbellauthor=J.+Cushingauthor=J.+Fergusonauthor=M.+S.+Curtisauthor=K.+McGovernauthor=M.+A.+Readauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=A.+C.+Castro&title=Discovery+of+a+potent+and+orally+active+hedgehog+pathway+antagonist+%28ipi-926%29&doi=10.1021%2Fjm900305z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)</span></div><div class="casAuthors">Tremblay, Martin R.; Lescarbeau, Andre; Grogan, Michael J.; Tan, Eddy; Lin, Grace; Austad, Brian C.; Yu, Lin-Chen; Behnke, Mark L.; Nair, Somarajan J.; Hagel, Margit; White, Kerry; Conley, James; Manna, Joseph D.; Alvarez-Diez, Teresa M.; Hoyt, Jennifer; Woodward, Caroline N.; Sydor, Jens R.; Pink, Melissa; MacDougall, John; Campbell, Matthew J.; Cushing, Jill; Ferguson, Jeanne; Curtis, Michael S.; McGovern, Karen; Read, Margaret A.; Palombella, Vito J.; Adams, Julian; Castro, Alfredo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4400-4418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent evidence suggests that blocking aberrant hedgehog pathway signaling may be a promising therapeutic strategy for the treatment of several types of cancer.  Cyclopamine, a plant Veratrum alkaloid, is a natural product antagonist of the hedgehog pathway.  In a previous report, a seven-membered D-ring semisynthetic analog of cyclopamine, IPI-269609 (2), was shown to have greater acid stability and better aq. soly. compared to cyclopamine.  Further modifications of the A-ring system generated three series of analogs with improved potency and/or soly.  Lead compds. from each series were characterized in vitro and evaluated in vivo for biol. activity and pharmacokinetic properties.  These studies led to the discovery of IPI-926 (compd. 28), a novel semisynthetic cyclopamine analog with substantially improved pharmaceutical properties and potency and a favorable pharmacokinetic profile relative to cyclopamine and compd. 2.  As a result, complete tumor regression was obsd. in a Hh-dependent medulloblastoma allograft model after daily oral administration of 40 mg/kg of compd. 28.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-f15bWq7kM7Vg90H21EOLACvtfcHk0lj91sthj-pZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D&md5=9455ee5eadb8293fdb3bd5cdec0e5d67</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900305z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900305z%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DLescarbeau%26aufirst%3DA.%26aulast%3DGrogan%26aufirst%3DM.%2BJ.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DAustad%26aufirst%3DB.%2BC.%26aulast%3DYu%26aufirst%3DL.%2BC.%26aulast%3DBehnke%26aufirst%3DM.%2BL.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DConley%26aufirst%3DJ.%26aulast%3DManna%26aufirst%3DJ.%2BD.%26aulast%3DAlvarez-Diez%26aufirst%3DT.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%2BN.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DMacDougall%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DM.%2BJ.%26aulast%3DCushing%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DM.%2BS.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520orally%2520active%2520hedgehog%2520pathway%2520antagonist%2520%2528ipi-926%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4400%26epage%3D4418%26doi%3D10.1021%2Fjm900305z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevalainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faia, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span> <span> </span><span class="NLM_article-title">Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6646</span>– <span class="NLM_lpage">6649</span>, <span class="refDoi"> DOI: 10.1021/jm8008508</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8008508" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ahs7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6646-6649&author=M.+R.+Tremblayauthor=M.+Nevalainenauthor=S.+J.+Nairauthor=J.+R.+Porterauthor=A.+C.+Castroauthor=M.+L.+Behnkeauthor=L.+C.+Yuauthor=M.+Hagelauthor=K.+Whiteauthor=K.+Faiaauthor=L.+Grenierauthor=M.+J.+Campbellauthor=J.+Cushingauthor=C.+N.+Woodwardauthor=J.+Hoytauthor=M.+A.+Foleyauthor=M.+A.+Readauthor=J.+R.+Sydorauthor=J.+K.+Tongauthor=V.+J.+Palombellaauthor=K.+McGovernauthor=J.+Adams&title=Semisynthetic+cyclopamine+analogues+as+potent+and+orally+bioavailable+hedgehog+pathway+antagonists&doi=10.1021%2Fjm8008508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Semisynthetic Cyclopamine Analogues as Potent and Orally Bioavailable Hedgehog Pathway Antagonists</span></div><div class="casAuthors">Tremblay, Martin R.; Nevalainen, Marta; Nair, Somarajan J.; Porter, James R.; Castro, Alfredo C.; Behnke, Mark L.; Yu, Lin-Chen; Hagel, Margit; White, Kerry; Faia, Kerrie; Grenier, Louis; Campbell, Matthew J.; Cushing, Jill; Woodward, Caroline N.; Hoyt, Jennifer; Foley, Michael A.; Read, Margaret A.; Sydor, Jens R.; Tong, Jeffrey K.; Palombella, Vito J.; McGovern, Karen; Adams, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6646-6649</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein is reported the synthesis of a novel class of hedgehog antagonists derived from cyclopamine.  The acid sensitive D-ring of cyclopamine was homologated utilizing a sequence of chemoselective cyclopropanation and stereoselective acid-catalyzed rearrangement.  Further modification of the A/B-ring homoallylic alc. to the conjugated ketone led to the discovery of new cyclopamine analogs, e.g. I, with improved pharmaceutical properties and in vitro potency (EC50) ranging from 10 to 1000 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquaq3irKGMhrVg90H21EOLACvtfcHk0ljTyPMrrPRTag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ahs7jM&md5=e1bf29e85ba30baa517d587739ea0297</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm8008508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008508%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DNevalainen%26aufirst%3DM.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26aulast%3DBehnke%26aufirst%3DM.%2BL.%26aulast%3DYu%26aufirst%3DL.%2BC.%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DFaia%26aufirst%3DK.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DM.%2BJ.%26aulast%3DCushing%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%2BN.%26aulast%3DHoyt%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DM.%2BA.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DSemisynthetic%2520cyclopamine%2520analogues%2520as%2520potent%2520and%2520orally%2520bioavailable%2520hedgehog%2520pathway%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6646%26epage%3D6649%26doi%3D10.1021%2Fjm8008508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villavicencio, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditzler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunkey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBlanc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph-Habecker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoblaugh, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. M.</span></span> <span> </span><span class="NLM_article-title">Hedgehog pathway inhibitor saridegib (ipi-926) increases lifespan in a mouse medulloblastoma model</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">7859</span>– <span class="NLM_lpage">7864</span>, <span class="refDoi"> DOI: 10.1073/pnas.1114718109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1114718109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22550175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1Knt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=7859-7864&author=M.+J.+Leeauthor=B.+A.+Hattonauthor=E.+H.+Villavicencioauthor=P.+C.+Khannaauthor=S.+D.+Friedmanauthor=S.+Ditzlerauthor=B.+Pullarauthor=K.+Robisonauthor=K.+F.+Whiteauthor=C.+Tunkeyauthor=M.+LeBlancauthor=J.+Randolph-Habeckerauthor=S.+E.+Knoblaughauthor=S.+Hansenauthor=A.+Richardsauthor=B.+J.+Wainwrightauthor=K.+McGovernauthor=J.+M.+Olson&title=Hedgehog+pathway+inhibitor+saridegib+%28ipi-926%29+increases+lifespan+in+a+mouse+medulloblastoma+model&doi=10.1073%2Fpnas.1114718109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model</span></div><div class="casAuthors">Lee, Michelle J.; Hatton, Beryl A.; Villavicencio, Elisabeth H.; Khanna, Paritosh C.; Friedman, Seth D.; Ditzler, Sally; Pullar, Barbara; Robison, Keith; White, Kerry F.; Tunkey, Chris; LeBlanc, Michael; Randolph-Habecker, Julie; Knoblaugh, Sue E.; Hansen, Stacey; Richards, Andrew; Wainwright, Brandon J.; McGovern, Karen; Olson, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7859-7864, S7859/1-S7859/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Sonic Hedgehog (Shh) pathway drives a subset of medulloblastomas, a malignant neuroectodermal brain cancer, and other cancers.  Small-mol. Shh pathway inhibitors have induced tumor regression in mice and patients with medulloblastoma; however, drug resistance rapidly emerges, in some cases via de novo mutation of the drug target.  Here we assess the response and resistance mechanisms to the natural product deriv. saridegib in an aggressive Shh-driven mouse medulloblastoma model.  In this model, saridegib treatment induced tumor redn. and significantly prolonged survival.  Furthermore, the effect of saridegib on tumor-initiating capacity was demonstrated by reduced tumor in- cidence, slower growth, and spontaneous tumor regression that occurred in allografts generated from previously treated autochthonous medulloblastomas compared with those from untreated donors.  Saridegib, a known P-glycoprotein (Pgp) substrate, induced Pgp activity in treated tumors, which likely contributed to emergence of drug resistance.  Unlike other Smoothened (Smo) inhibitors, the drug resistance was neither mutation-dependent nor Gli2 amplification-dependent, and saridegib was found to be active in cells with the D473H point mutation that rendered them resistant to another Smo inhibitor, GDC-0449.  The fivefold increase in lifespan in mice treated with saridegib as a single agent compares favorably with both targeted and cytotoxic therapies.  The absence of genetic mutations that confer resistance distinguishes saridegib from other Smo inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEe1PqkK6YPbVg90H21EOLACvtfcHk0ljTyPMrrPRTag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1Knt7Y%253D&md5=29d439813c9bae6c6b355b4161c7e268</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1114718109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1114718109%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DHatton%26aufirst%3DB.%2BA.%26aulast%3DVillavicencio%26aufirst%3DE.%2BH.%26aulast%3DKhanna%26aufirst%3DP.%2BC.%26aulast%3DFriedman%26aufirst%3DS.%2BD.%26aulast%3DDitzler%26aufirst%3DS.%26aulast%3DPullar%26aufirst%3DB.%26aulast%3DRobison%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DK.%2BF.%26aulast%3DTunkey%26aufirst%3DC.%26aulast%3DLeBlanc%26aufirst%3DM.%26aulast%3DRandolph-Habecker%26aufirst%3DJ.%26aulast%3DKnoblaugh%26aufirst%3DS.%2BE.%26aulast%3DHansen%26aufirst%3DS.%26aulast%3DRichards%26aufirst%3DA.%26aulast%3DWainwright%26aufirst%3DB.%2BJ.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DOlson%26aufirst%3DJ.%2BM.%26atitle%3DHedgehog%2520pathway%2520inhibitor%2520saridegib%2520%2528ipi-926%2529%2520increases%2520lifespan%2520in%2520a%2520mouse%2520medulloblastoma%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D7859%26epage%3D7864%26doi%3D10.1073%2Fpnas.1114718109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce Doak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotjohann, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koglin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvin Seibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoeman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirian, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyerlein, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3309</span>, <span class="refDoi"> DOI: 10.1038/ncomms4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24525480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3309&author=U.+Weierstallauthor=D.+Jamesauthor=C.+Wangauthor=T.+A.+Whiteauthor=D.+Wangauthor=W.+Liuauthor=J.+C.+Spenceauthor=R.+Bruce+Doakauthor=G.+Nelsonauthor=P.+Frommeauthor=R.+Frommeauthor=I.+Grotjohannauthor=C.+Kupitzauthor=N.+A.+Zatsepinauthor=H.+Liuauthor=S.+Basuauthor=D.+Wackerauthor=G.+W.+Hanauthor=V.+Katritchauthor=S.+Boutetauthor=M.+Messerschmidtauthor=G.+J.+Williamsauthor=J.+E.+Koglinauthor=M.+Marvin+Seibertauthor=M.+Klinkerauthor=C.+Gatiauthor=R.+L.+Shoemanauthor=A.+Bartyauthor=H.+N.+Chapmanauthor=R.+A.+Kirianauthor=K.+R.+Beyerleinauthor=R.+C.+Stevensauthor=D.+Liauthor=S.+T.+Shahauthor=N.+Howeauthor=M.+Caffreyauthor=V.+Cherezov&title=Lipidic+cubic+phase+injector+facilitates+membrane+protein+serial+femtosecond+crystallography&doi=10.1038%2Fncomms4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span></div><div class="casAuthors">Weierstall Uwe; James Daniel; Wang Dingjie; Spence John C H; Bruce Doak R; Nelson Garrett; Zatsepin Nadia A; Liu Haiguang; Wang Chong; Liu Wei; Wacker Daniel; Han Gye Won; Katritch Vsevolod; Stevens Raymond C; Cherezov Vadim; White Thomas A; Gati Cornelius; Barty Anton; Beyerlein Kenneth R; Fromme Petra; Fromme Raimund; Grotjohann Ingo; Kupitz Christopher; Basu Shibom; Boutet Sebastien; Messerschmidt Marc; Williams Garth J; Koglin Jason E; Marvin Seibert M; Klinker Markus; Shoeman Robert L; Chapman Henry N; Kirian Richard A; Li Dianfan; Shah Syed T A; Howe Nicole; Caffrey Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3309</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lipidic cubic phase (LCP) crystallization has proven successful for high-resolution structure determination of challenging membrane proteins.  Here we present a technique for extruding gel-like LCP with embedded membrane protein microcrystals, providing a continuously renewed source of material for serial femtosecond crystallography.  Data collected from sub-10-μm-sized crystals produced with less than 0.5 mg of purified protein yield structural insights regarding cyclopamine binding to the Smoothened receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDUg0uqQckxOWhZTslLrfffW6udTcc2eYt85zmPqublLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D&md5=ce335fa0a5bfeb8990c836e7f425e2d2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fncomms4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4309%26sid%3Dliteratum%253Aachs%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSpence%26aufirst%3DJ.%2BC.%26aulast%3DBruce%2BDoak%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DG.%26aulast%3DFromme%26aufirst%3DP.%26aulast%3DFromme%26aufirst%3DR.%26aulast%3DGrotjohann%26aufirst%3DI.%26aulast%3DKupitz%26aufirst%3DC.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DBoutet%26aufirst%3DS.%26aulast%3DMesserschmidt%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DKoglin%26aufirst%3DJ.%2BE.%26aulast%3DMarvin%2BSeibert%26aufirst%3DM.%26aulast%3DKlinker%26aufirst%3DM.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DShoeman%26aufirst%3DR.%2BL.%26aulast%3DBarty%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DH.%2BN.%26aulast%3DKirian%26aufirst%3DR.%2BA.%26aulast%3DBeyerlein%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DS.%2BT.%26aulast%3DHowe%26aufirst%3DN.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DLipidic%2520cubic%2520phase%2520injector%2520facilitates%2520membrane%2520protein%2520serial%2520femtosecond%2520crystallography%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3309%26doi%3D10.1038%2Fncomms4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunton, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dina, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichert, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunzner, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotkow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsters, J. C.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stibbard, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubhayaker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.</span></span> <span> </span><span class="NLM_article-title">Gdc-0449-a potent inhibitor of the hedgehog pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5576</span>– <span class="NLM_lpage">5581</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2009.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19716296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5576-5581&author=K.+D.+Robargeauthor=S.+A.+Bruntonauthor=G.+M.+Castanedoauthor=Y.+Cuiauthor=M.+S.+Dinaauthor=R.+Goldsmithauthor=S.+E.+Gouldauthor=O.+Guichertauthor=J.+L.+Gunznerauthor=J.+Halladayauthor=W.+Jiaauthor=C.+Khojastehauthor=M.+F.+Koehlerauthor=K.+Kotkowauthor=H.+Laauthor=R.+L.+Lalondeauthor=K.+Lauauthor=L.+Leeauthor=D.+Marshallauthor=J.+C.+Marstersauthor=L.+J.+Murrayauthor=C.+Qianauthor=L.+L.+Rubinauthor=L.+Salphatiauthor=M.+S.+Stanleyauthor=J.+H.+Stibbardauthor=D.+P.+Sutherlinauthor=S.+Ubhayakerauthor=S.+Wangauthor=S.+Wongauthor=M.+Xie&title=Gdc-0449-a+potent+inhibitor+of+the+hedgehog+pathway&doi=10.1016%2Fj.bmcl.2009.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">GDC-0449-A potent inhibitor of the hedgehog pathway</span></div><div class="casAuthors">Robarge, Kirk D.; Brunton, Shirley A.; Castanedo, Georgette M.; Cui, Yong; Dina, Michael S.; Goldsmith, Richard; Gould, Stephen E.; Guichert, Oivin; Gunzner, Janet L.; Halladay, Jason; Jia, Wei; Khojasteh, Cyrus; Koehler, Michael F. T.; Kotkow, Karen; La, Hank; La Londe, Rebecca L.; Lau, Kevin; Lee, Leslie; Marshall, Derek; Marsters, James C.; Murray, Lesley J.; Qian, Changgeng; Rubin, Lee L.; Salphati, Laurent; Stanley, Mark S.; Stibbard, John H. A.; Sutherlin, Daniel P.; Ubhayaker, Savita; Wang, Shumei; Wong, Susan; Xie, Minli</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5576-5581</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SAR for a wide variety of heterocyclic replacements for a benzimidazole led to the discovery of functionalized 2-pyridyl amides as novel inhibitors of the hedgehog pathway.  The 2-pyridyl amides were optimized for potency, PK, and drug-like properties by modifications to the amide portion of the mol. resulting in I (GDC-0449).  Amide I produced complete tumor regression at doses as low as 12.5 mg/kg BID in a medulloblastoma allograft mouse model that is wholly dependent on the Hh pathway for growth and is currently in human clin. trials, where it is initially being evaluated for the treatment of BCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZfOHMTd5tXbVg90H21EOLACvtfcHk0lgDaAy5OLhbYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7O&md5=cb8fb6e6b99bd85abd9359b04de33898</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DRobarge%26aufirst%3DK.%2BD.%26aulast%3DBrunton%26aufirst%3DS.%2BA.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DDina%26aufirst%3DM.%2BS.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DGuichert%26aufirst%3DO.%26aulast%3DGunzner%26aufirst%3DJ.%2BL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DKhojasteh%26aufirst%3DC.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DKotkow%26aufirst%3DK.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLalonde%26aufirst%3DR.%2BL.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DMarsters%26aufirst%3DJ.%2BC.%26aulast%3DMurray%26aufirst%3DL.%2BJ.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DStanley%26aufirst%3DM.%2BS.%26aulast%3DStibbard%26aufirst%3DJ.%2BH.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DUbhayaker%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DM.%26atitle%3DGdc-0449-a%2520potent%2520inhibitor%2520of%2520the%2520hedgehog%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5576%26epage%3D5581%26doi%3D10.1016%2Fj.bmcl.2009.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pferdekamper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of nvp-lde225, a potent and selective smoothened antagonist</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1021/ml1000307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=130-134&author=S.+Panauthor=X.+Wuauthor=J.+Jiangauthor=W.+Gaoauthor=Y.+Wanauthor=D.+Chengauthor=D.+Hanauthor=J.+Liuauthor=N.+P.+Englundauthor=Y.+Wangauthor=S.+Peukertauthor=K.+Miller-Moslinauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=Y.+Jiangauthor=J.+Tsaoauthor=F.+Sunauthor=A.+C.+Pferdekamperauthor=S.+Doddauthor=T.+Tuntlandauthor=W.+Maniaraauthor=J.+F.+Kelleherauthor=Y.+M.+Yaoauthor=M.+Warmuthauthor=J.+Williamsauthor=M.+Dorsch&title=Discovery+of+nvp-lde225%2C+a+potent+and+selective+smoothened+antagonist&doi=10.1021%2Fml1000307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist</span></div><div class="casAuthors">Pan, Shifeng; Wu, Xu; Jiang, Jiqing; Gao, Wenqi; Wan, Yongqin; Cheng, Dai; Han, Dong; Liu, Jun; Englund, Nathan P.; Wang, Yan; Peukert, Stefan; Miller-Moslin, Karen; Yuan, Jing; Guo, Ribo; Matsumoto, Melissa; Vattay, Anthony; Jiang, Yun; Tsao, Jeffrey; Sun, Fangxian; Pferdekamper, AnneMarie C.; Dodd, Stephanie; Tuntland, Tove; Maniara, Wieslawa; Kelleher, Joseph F., III; Yao, Yung-mae; Warmuth, Markus; Williams, Juliet; Dorsch, Marion</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-134</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer.  A cell-based phenotypic high-throughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo).  Structure-activity relation studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide (5m, NVP-LDE225), which is currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXrdZB74WfbVg90H21EOLACvtfcHk0lhEFATXe5V0ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D&md5=c4d1348e8d47ed9561151ce59305531e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fml1000307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000307%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEnglund%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DTsao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DPferdekamper%26aufirst%3DA.%2BC.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DYao%26aufirst%3DY.%2BM.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520nvp-lde225%252C%2520a%2520potent%2520and%2520selective%2520smoothened%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D130%26epage%3D134%26doi%3D10.1021%2Fml1000307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekulic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migden, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirix, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainsworth, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arron, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedlander, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauschild, A.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of vismodegib in advanced basal-cell carcinoma</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">2171</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1113713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1056%2FNEJMoa1113713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22670903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=2171-2179&author=A.+Sekulicauthor=M.+R.+Migdenauthor=A.+E.+Oroauthor=L.+Dirixauthor=K.+D.+Lewisauthor=J.+D.+Hainsworthauthor=J.+A.+Solomonauthor=S.+Yooauthor=S.+T.+Arronauthor=P.+A.+Friedlanderauthor=E.+Marmurauthor=C.+M.+Rudinauthor=A.+L.+Changauthor=J.+A.+Lowauthor=H.+M.+Mackeyauthor=R.+L.+Yauchauthor=R.+A.+Grahamauthor=J.+C.+Reddyauthor=A.+Hauschild&title=Efficacy+and+safety+of+vismodegib+in+advanced+basal-cell+carcinoma&doi=10.1056%2FNEJMoa1113713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of vismodegib in advanced basal-cell carcinoma</span></div><div class="casAuthors">Sekulic, Aleksandar; Migden, Michael R.; Oro, Anthony E.; Dirix, Luc; Lewis, Karl D.; Hainsworth, John D.; Solomon, James A.; Yoo, Simon; Arron, Sarah T.; Friedlander, Philip A.; Marmur, Ellen; Rudin, Charles M.; Chang, Anne Lynn S.; Low, Jennifer A.; Mackey, Howard M.; Yauch, Robert L.; Graham, Richard A.; Reddy, Josina C.; Hauschild, Axel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2171-2179</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Alterations in hedgehog signaling are implicated in the pathogenesis of basal-cell carcinoma.  Although most basal-cell carcinomas are treated surgically, no effective therapy exists for locally advanced or metastatic basal-cell carcinoma.  A phase 1 study of vismodegib (GDC-0449), a 1st-in-class, small-mol. inhibitor of the hedgehog pathway, showed a 58% response rate among patients with advanced basal-cell carcinoma.  In this multicenter, international, 2-cohort, nonrandomized study, we enrolled patients with metastatic basal-cell carcinoma and those with locally advanced basal-cell carcinoma who had inoperable disease or for whom surgery was inappropriate (because of multiple recurrences and a low likelihood of surgical cure, or substantial anticipated disfigurement).  All patients received 150 mg of oral vismodegib daily.  The primary end point was the independently assessed objective response rate; the primary hypotheses were that the response rate would be greater than 20% for patients with locally advanced basal-cell carcinoma and greater than 10% for those with metastatic basal-cell carcinoma.  In 33 patients with metastatic basal-cell carcinoma, the independently assessed response rate was 30% (95% confidence interval [CI], 16 to 48; P = 0.001).  In 63 patients with locally advanced basal-cell carcinoma, the independently assessed response rate was 43% (95% CI, 31 to 56; P < 0.001), with complete responses in 13 patients (21%/).  The median duration of response was 7.6 mo in both cohorts.  Adverse events occurring in more than 30% of patients were muscle spasms, alopecia, dysgeusia (taste disturbance), wt. loss, and fatigue.  Serious adverse events were reported in 25% of patients; 7 deaths due to adverse events were noted.  Vismodegib is assocd. with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDSfP7MPfQNbVg90H21EOLACvtfcHk0liLiEba_jsFrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVehsb8%253D&md5=e4bb30e44c79f77841fa63b15f88ce6e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1113713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1113713%26sid%3Dliteratum%253Aachs%26aulast%3DSekulic%26aufirst%3DA.%26aulast%3DMigden%26aufirst%3DM.%2BR.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DDirix%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DK.%2BD.%26aulast%3DHainsworth%26aufirst%3DJ.%2BD.%26aulast%3DSolomon%26aufirst%3DJ.%2BA.%26aulast%3DYoo%26aufirst%3DS.%26aulast%3DArron%26aufirst%3DS.%2BT.%26aulast%3DFriedlander%26aufirst%3DP.%2BA.%26aulast%3DMarmur%26aufirst%3DE.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DChang%26aufirst%3DA.%2BL.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26aulast%3DMackey%26aufirst%3DH.%2BM.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DGraham%26aufirst%3DR.%2BA.%26aulast%3DReddy%26aufirst%3DJ.%2BC.%26aulast%3DHauschild%26aufirst%3DA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520vismodegib%2520in%2520advanced%2520basal-cell%2520carcinoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D2171%26epage%3D2179%26doi%3D10.1056%2FNEJMoa1113713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancois, P.</span></span> <span> </span><span class="NLM_article-title">Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2018.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.jaad.2018.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30003981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFyns7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2018&pages=1089-1100&author=P.+Xieauthor=P.+Lefrancois&title=Efficacy%2C+safety%2C+and+comparison+of+sonic+hedgehog+inhibitors+in+basal+cell+carcinomas%3A+A+systematic+review+and+meta-analysis&doi=10.1016%2Fj.jaad.2018.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis</span></div><div class="casAuthors">Xie, Pingxing; Lefrancois, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1089-1100.e17</span>CODEN:
                <span class="NLM_cas:coden">JAADDB</span>;
        ISSN:<span class="NLM_cas:issn">0190-9622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Sonic hedgehog inhibitors (SHHis) provide an addnl. treatment option for basal cell carcinomas (BCCs), esp. for metastatic or locally advanced BCC.  However, studies have been heterogeneous and lacked direct comparisons between mols.  To det. the efficacy and safety of the class of mols. SHHi for treating BCC and to compare them individually.  We performed a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-compliant systematic review of studies followed by a meta-anal.  Eighteen articles were included in our meta-anal.; 16 articles were combined for efficacy and 16 for safety.  In locally advanced BCC, overall response rates (ORRs) were similar for vismodegib and sonidegib (69% vs 57%, resp.) but not complete response rates (31% vs 3%, resp.).  In metastatic disease, the ORR of vismodegib was 2.7-fold higher than the ORR of sonidegib (39% vs 15%, resp.).  For side effects affecting a majority of patients, prevalences for muscle spasms (67.1%), dysgeusia (54.1%), and alopecia (57.7%) were in similar proportions for sonidegib and vismodegib.  Patients receiving sonidegib experienced more upper gastrointestinal distress than patients receiving vismodegib.  SHHis induce a partial response to locally advanced BCC disease.  Side effects are common, similar across mols., assocd. with high discontinuation rates, and warrant discussion beforehand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrac1BL82VL5rVg90H21EOLACvtfcHk0liLiEba_jsFrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFyns7zO&md5=d5daa7c6b08ad5231aed6a729cd78c85</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2018.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DP.%26aulast%3DLefrancois%26aufirst%3DP.%26atitle%3DEfficacy%252C%2520safety%252C%2520and%2520comparison%2520of%2520sonic%2520hedgehog%2520inhibitors%2520in%2520basal%2520cell%2520carcinomas%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2018%26volume%3D79%26spage%3D1089%26epage%3D1100%26doi%3D10.1016%2Fj.jaad.2018.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cazet, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsworth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skhinas, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johan, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Borrego, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezares, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caballero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Toole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swarbrick, A.</span></span> <span> </span><span class="NLM_article-title">Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2897</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05220-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fs41467-018-05220-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30042390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BB3c7hsF2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2897&author=A.+S.+Cazetauthor=M.+N.+Huiauthor=B.+L.+Elsworthauthor=S.+Z.+Wuauthor=D.+Rodenauthor=C.+L.+Chanauthor=J.+N.+Skhinasauthor=R.+Collotauthor=J.+Yangauthor=K.+Harveyauthor=M.+Z.+Johanauthor=C.+Cooperauthor=R.+Nairauthor=D.+Herrmannauthor=A.+McFarlandauthor=N.+Dengauthor=M.+Ruiz-Borregoauthor=F.+Rojoauthor=J.+M.+Trigoauthor=S.+Bezaresauthor=R.+Caballeroauthor=E.+Limauthor=P.+Timpsonauthor=S.+O%E2%80%99Tooleauthor=D.+N.+Watkinsauthor=T.+R.+Coxauthor=M.+S.+Samuelauthor=M.+Martinauthor=A.+Swarbrick&title=Targeting+stromal+remodeling+and+cancer+stem+cell+plasticity+overcomes+chemoresistance+in+triple+negative+breast+cancer&doi=10.1038%2Fs41467-018-05220-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer</span></div><div class="casAuthors">Cazet Aurelie S; Hui Mun N; Wu Sunny Z; Roden Daniel; Chan Chia-Ling; Skhinas Joanna N; Collot Raphael; Yang Jessica; Harvey Kate; Herrmann David; McFarland Andrea; Deng Niantao; Lim Elgene; Timpson Paul; O'Toole Sandra; Watkins D Neil; Cox Thomas R; Swarbrick Alexander; Cazet Aurelie S; Hui Mun N; Wu Sunny Z; Roden Daniel; Chan Chia-Ling; Skhinas Joanna N; Collot Raphael; Yang Jessica; Harvey Kate; Herrmann David; McFarland Andrea; Deng Niantao; Lim Elgene; Timpson Paul; O'Toole Sandra; Watkins D Neil; Cox Thomas R; Swarbrick Alexander; Cazet Aurelie S; Wu Sunny Z; Roden Daniel; Herrmann David; Deng Niantao; Lim Elgene; Timpson Paul; Watkins D Neil; Cox Thomas R; Swarbrick Alexander; Hui Mun N; Hui Mun N; O'Toole Sandra; Elsworth Benjamin L; Johan M Zahied; Samuel Michael S; Johan M Zahied; Samuel Michael S; Cooper Caroline; Nair Radhika; Ruiz-Borrego Manuel; Rojo Federico; Trigo Jose M; Bezares Susana; Caballero Rosalia; Lim Elgene; Watkins D Neil; Martin Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2897</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies.  In mouse models of triple negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms cancer-associated fibroblasts (CAFs) to provide a supportive niche for the acquisition of a chemo-resistant, cancer stem cell (CSC) phenotype via FGF5 expression and production of fibrillar collagen.  Stromal treatment of patient-derived xenografts with smoothened inhibitors (SMOi) downregulates CSC markers expression and sensitizes tumors to docetaxel, leading to markedly improved survival and reduced metastatic burden.  In the phase I clinical trial EDALINE, 3 of 12 patients with metastatic TNBC derived clinical benefit from combination therapy with the SMOi Sonidegib and docetaxel chemotherapy, with one patient experiencing a complete response.  These studies identify Hedgehog signaling to CAFs as a novel mediator of CSC plasticity and an exciting new therapeutic target in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFrTPyJmXj_5NiNltV31zlfW6udTcc2eaeze3EfRqkd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7hsF2lsA%253D%253D&md5=4b7d1416c3872d1b72e261b75ca614e5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05220-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05220-6%26sid%3Dliteratum%253Aachs%26aulast%3DCazet%26aufirst%3DA.%2BS.%26aulast%3DHui%26aufirst%3DM.%2BN.%26aulast%3DElsworth%26aufirst%3DB.%2BL.%26aulast%3DWu%26aufirst%3DS.%2BZ.%26aulast%3DRoden%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DC.%2BL.%26aulast%3DSkhinas%26aufirst%3DJ.%2BN.%26aulast%3DCollot%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DJohan%26aufirst%3DM.%2BZ.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DNair%26aufirst%3DR.%26aulast%3DHerrmann%26aufirst%3DD.%26aulast%3DMcFarland%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DRuiz-Borrego%26aufirst%3DM.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DTrigo%26aufirst%3DJ.%2BM.%26aulast%3DBezares%26aufirst%3DS.%26aulast%3DCaballero%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DE.%26aulast%3DTimpson%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DS.%26aulast%3DWatkins%26aufirst%3DD.%2BN.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DSamuel%26aufirst%3DM.%2BS.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DSwarbrick%26aufirst%3DA.%26atitle%3DTargeting%2520stromal%2520remodeling%2520and%2520cancer%2520stem%2520cell%2520plasticity%2520overcomes%2520chemoresistance%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D2897%26doi%3D10.1038%2Fs41467-018-05220-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fereshteh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2010.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20385363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsF2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=388-399&author=J.+Kimauthor=J.+Y.+Tangauthor=R.+Gongauthor=J.+Kimauthor=J.+J.+Leeauthor=K.+V.+Clemonsauthor=C.+R.+Chongauthor=K.+S.+Changauthor=M.+Fereshtehauthor=D.+Gardnerauthor=T.+Reyaauthor=J.+O.+Liuauthor=E.+H.+Epsteinauthor=D.+A.+Stevensauthor=P.+A.+Beachy&title=Itraconazole%2C+a+commonly+used+antifungal+that+inhibits+hedgehog+pathway+activity+and+cancer+growth&doi=10.1016%2Fj.ccr.2010.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth</span></div><div class="casAuthors">Kim, James; Tang, Jean Y.; Gong, Ruoyu; Kim, Jynho; Lee, John J.; Clemons, Karl V.; Chong, Curtis R.; Chang, Kris S.; Fereshteh, Mark; Gardner, Dale; Reya, Tannishtha; Liu, Jun O.; Epstein, Ervin H.; Stevens, David A.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">388-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In a screen of drugs previously tested in humans we identified itraconazole, a systemic antifungal, as a potent antagonist of the Hedgehog (Hh) signaling pathway that acts by a mechanism distinct from its inhibitory effect on fungal sterol biosynthesis.  Systemically administered itraconazole, like other Hh pathway antagonists, can suppress Hh pathway activity and the growth of medulloblastoma in a mouse allograft model and does so at serum levels comparable to those in patients undergoing antifungal therapy.  Mechanistically, itraconazole appears to act on the essential Hh pathway component Smoothened (SMO) by a mechanism distinct from that of cyclopamine and other known SMO antagonists, and prevents the ciliary accumulation of SMO normally caused by Hh stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXBQNwOfKF77Vg90H21EOLACvtfcHk0lg59nq3DB5j8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsF2msb4%253D&md5=2c69fff20561231b43dfd020c588534f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DGong%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DClemons%26aufirst%3DK.%2BV.%26aulast%3DChong%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DK.%2BS.%26aulast%3DFereshteh%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DD.%26aulast%3DReya%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DStevens%26aufirst%3DD.%2BA.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DItraconazole%252C%2520a%2520commonly%2520used%2520antifungal%2520that%2520inhibits%2520hedgehog%2520pathway%2520activity%2520and%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D388%26epage%3D399%26doi%3D10.1016%2Fj.ccr.2010.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaunhurst, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodosh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span> <span> </span><span class="NLM_article-title">Open-label, exploratory phase ii trial of oral itraconazole for the treatment of basal cell carcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1200/JCO.2013.49.9525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1200%2FJCO.2013.49.9525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24493717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2itbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=745-751&author=D.+J.+Kimauthor=J.+Kimauthor=K.+Spaunhurstauthor=J.+Montoyaauthor=R.+Khodoshauthor=K.+Chandraauthor=T.+Fuauthor=A.+Gilliamauthor=M.+Molgoauthor=P.+A.+Beachyauthor=J.+Y.+Tang&title=Open-label%2C+exploratory+phase+ii+trial+of+oral+itraconazole+for+the+treatment+of+basal+cell+carcinoma&doi=10.1200%2FJCO.2013.49.9525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma</span></div><div class="casAuthors">Kim, Daniel J.; Kim, James; Spaunhurst, Katrina; Montoya, Javier; Khodosh, Rita; Chandra, Kalyani; Fu, Teresa; Gilliam, Anita; Molgo, Monserrat; Beachy, Philip A.; Tang, Jean Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-751</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Itraconazole, a US Food and Drug Administration-approved antifungal drug, inhibits the Hedgehog (HH) signaling pathway, a crucial driver of basal cell carcinoma (BCC) tumorigenesis, and reduces BCC growth in mice.  We assessed the effect of itraconazole on the HH pathway and on tumor size in human BCC tumors.  Patients and Methods Patients with ≥ one BCC tumor > 4 mm in diam. were enrolled onto two cohorts to receive oral itraconazole 200 mg twice per day for 1 mo (cohort A) or 100 mg twice per day for an av. of 2.3 mo (cohort B).  The primary end point was change in biomarkers: Ki67 tumor proliferation and HH activity (GLI1 mRNA).  Secondary end points included change in tumor size in a subset of patients with multiple tumors.  Results A total of 29 patients were enrolled, of whom 19 were treated with itraconazole.  Itraconazole treatment was assocd. with two adverse events (grade 2 fatigue and grade 4 congestive heart failure).  Itraconazole reduced cell proliferation by 45% (P = .04), HH pathway activity by 65% (P = .03), and reduced tumor area by 24% (95% CI, 18.2% to 30.0%).  Of eight patients with multiple nonbiopsied tumors, four achieved partial response, and four had stable disease.  Tumors from untreated control patients and from those previously treated with vismodegib showed no significant changes in proliferation or tumor size.  Conclusion Itraconazole has anti-BCC activity in humans.  These results provide the basis for larger trials of longer duration to measure the clin. efficacy of itraconazole, esp. relative to other HH pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5K8INmtn8dbVg90H21EOLACvtfcHk0lg59nq3DB5j8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2itbc%253D&md5=c814893390e5eb07208173c744dda59d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1200%2FJCO.2013.49.9525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2013.49.9525%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSpaunhurst%26aufirst%3DK.%26aulast%3DMontoya%26aufirst%3DJ.%26aulast%3DKhodosh%26aufirst%3DR.%26aulast%3DChandra%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DT.%26aulast%3DGilliam%26aufirst%3DA.%26aulast%3DMolgo%26aufirst%3DM.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26atitle%3DOpen-label%252C%2520exploratory%2520phase%2520ii%2520trial%2520of%2520oral%2520itraconazole%2520for%2520the%2520treatment%2520of%2520basal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26spage%3D745%26epage%3D751%26doi%3D10.1200%2FJCO.2013.49.9525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzillo, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyden, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaGreca, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkalcevic, G. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of pf-04449913, a potent and orally bioavailable inhibitor of smoothened</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1021/ml2002423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2002423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GhsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=106-111&author=M.+J.+Munchhofauthor=Q.+Liauthor=A.+Shavnyaauthor=G.+V.+Borzilloauthor=T.+L.+Boydenauthor=C.+S.+Jonesauthor=S.+D.+LaGrecaauthor=L.+Martinez-Alsinaauthor=N.+Patelauthor=K.+Pelletierauthor=L.+A.+Reiterauthor=M.+D.+Robbinsauthor=G.+T.+Tkalcevic&title=Discovery+of+pf-04449913%2C+a+potent+and+orally+bioavailable+inhibitor+of+smoothened&doi=10.1021%2Fml2002423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened</span></div><div class="casAuthors">Munchhof, Michael J.; Li, Qifang; Shavnya, Andrei; Borzillo, Gary V.; Boyden, Tracey L.; Jones, Christopher S.; LaGreca, Susan D.; Martinez-Alsina, Luis; Patel, Nandini; Pelletier, Kathleen; Reiter, Larry A.; Robbins, Michael D.; Tkalcevic, George T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-111</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hedgehog signaling pathway have generated a great deal of interest in the oncol. area due to the mounting evidence of their potential to provide promising therapeutic options for patients.  Herein, we describe the discovery strategy to overcome the issues inherent in lead structure 1 that resulted in the identification of Smoothened inhibitor 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea (PF-04449913, 26), which has been advanced to human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCSrORZG_pxbVg90H21EOLACvtfcHk0lg59nq3DB5j8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GhsLnO&md5=298ea79230c119359512b1ad07900557</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fml2002423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2002423%26sid%3Dliteratum%253Aachs%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DBorzillo%26aufirst%3DG.%2BV.%26aulast%3DBoyden%26aufirst%3DT.%2BL.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DLaGreca%26aufirst%3DS.%2BD.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPelletier%26aufirst%3DK.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DRobbins%26aufirst%3DM.%2BD.%26aulast%3DTkalcevic%26aufirst%3DG.%2BT.%26atitle%3DDiscovery%2520of%2520pf-04449913%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520smoothened%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D106%26epage%3D111%26doi%3D10.1021%2Fml2002423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotoloni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosovec, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahoor, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makielski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobe, B. A.</span></span> <span> </span><span class="NLM_article-title">Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells</span>. <i>Cancer Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.3109/07357907.2013.820317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3109%2F07357907.2013.820317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23915072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1entrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=480-489&author=A.+H.+Zaidiauthor=Y.+Komatsuauthor=L.+A.+Kellyauthor=U.+Malhotraauthor=C.+Rotoloniauthor=J.+E.+Kosovecauthor=H.+Zahoorauthor=R.+Makielskiauthor=A.+Bhattauthor=T.+Hoppoauthor=B.+A.+Jobe&title=Smoothened+inhibition+leads+to+decreased+proliferation+and+induces+apoptosis+in+esophageal+adenocarcinoma+cells&doi=10.3109%2F07357907.2013.820317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Smoothened Inhibition Leads to Decreased Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells</span></div><div class="casAuthors">Zaidi, Ali H.; Komatsu, Yoshihiro; Kelly, Lori A.; Malhotra, Usha; Rotoloni, Christina; Kosovec, Juliann E.; Zahoor, Haris; Makielski, Rory; Bhatt, Astha; Hoppo, Toshitaka; Jobe, Blair A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-489</span>CODEN:
                <span class="NLM_cas:coden">CINVD7</span>;
        ISSN:<span class="NLM_cas:issn">0735-7907</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway is known to be active in Barrett's carcinogenesis.  Therefore, we evaluated the efficacy and underlying mechanisms of inhibition of cancer cell growth by the smoothened (Smo) antagonist BMS-833923 in esophageal adenocarcinoma (EAC) cell lines.  Cell proliferation and apoptosis were evaluated by flow cytometry, Western blotting, immunofluorescence, and quant. reverse transcription polymerase chain reactions.  Results showed that the Smo antagonist led to reduced Hh pathway activity, resulting in decreased cell proliferation and induction of apoptosis via the intrinsic pathway in the esophageal cancer cells.  In conclusion, the Smo antagonist may have application as an EAC chemotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUABxbxz5YybVg90H21EOLACvtfcHk0lgG8-jwdDY6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1entrbM&md5=34f29c1baab3cdb6cfc02b84dbd2f85b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3109%2F07357907.2013.820317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F07357907.2013.820317%26sid%3Dliteratum%253Aachs%26aulast%3DZaidi%26aufirst%3DA.%2BH.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DL.%2BA.%26aulast%3DMalhotra%26aufirst%3DU.%26aulast%3DRotoloni%26aufirst%3DC.%26aulast%3DKosovec%26aufirst%3DJ.%2BE.%26aulast%3DZahoor%26aufirst%3DH.%26aulast%3DMakielski%26aufirst%3DR.%26aulast%3DBhatt%26aufirst%3DA.%26aulast%3DHoppo%26aufirst%3DT.%26aulast%3DJobe%26aufirst%3DB.%2BA.%26atitle%3DSmoothened%2520inhibition%2520leads%2520to%2520decreased%2520proliferation%2520and%2520induces%2520apoptosis%2520in%2520esophageal%2520adenocarcinoma%2520cells%26jtitle%3DCancer%2520Invest.%26date%3D2013%26volume%3D31%26spage%3D480%26epage%3D489%26doi%3D10.3109%2F07357907.2013.820317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spilker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartkowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Effective targeting of hedgehog signaling in a medulloblastoma model with pf-5274857, a potent and selective smoothened antagonist that penetrates the blood-brain barrier</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1535-7163.MCT-11-0691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22084163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=57-65&author=A.+Rohnerauthor=M.+E.+Spilkerauthor=J.+L.+Lamauthor=B.+Pascualauthor=D.+Bartkowskiauthor=Q.+J.+Liauthor=A.+H.+Yangauthor=G.+Stevensauthor=M.+Xuauthor=P.+A.+Wellsauthor=S.+Plankenauthor=S.+Nairauthor=S.+Sun&title=Effective+targeting+of+hedgehog+signaling+in+a+medulloblastoma+model+with+pf-5274857%2C+a+potent+and+selective+smoothened+antagonist+that+penetrates+the+blood-brain+barrier&doi=10.1158%2F1535-7163.MCT-11-0691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood-Brain Barrier</span></div><div class="casAuthors">Rohner, Allison; Spilker, Mary E.; Lam, Justine L.; Pascual, Bernadette; Bartkowski, Darian; Li, Qing John; Yang, Amy H.; Stevens, Greg; Xu, Meirong; Wells, Peter A.; Planken, Simon; Nair, Sajiv; Sun, Shaoxian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of the Smoothened (Smo) represents a promising therapeutic strategy for treating malignant tumors that are dependent on the Hedgehog (Hh) signaling pathway.  PF-5274857 is a novel Smo antagonist that specifically binds to Smo with a Ki of 4.6 ± 1.1 nmol/L and completely blocks the transcriptional activity of the downstream gene Gli1 with an IC50 of 2.7 ± 1.4 nmol/L in cells.  This Smo antagonist showed robust antitumor activity in a mouse model of medulloblastoma with an in vivo IC50 of 8.9 ± 2.6 nmol/L.  The downregulation of Gli1 is closely linked to the tumor growth inhibition in patched+/- medulloblastoma mice.  Math. anal. of the relationship between the drug's pharmacokinetics and Gli1 pharmacodynamics in patched+/- medulloblastoma tumor models yielded similar tumor and skin Gli1 IC50 values, suggesting that skin can be used as a surrogate tissue for the measurement of tumor Gli1 levels.  In addn., PF-5274857 was found to effectively penetrate the blood-brain barrier and inhibit Smo activity in the brain of primary medulloblastoma mice, resulting in improved animal survival rates.  The brain permeability of PF-5274857 was also confirmed and quantified in nontumor-bearing preclin. species with an intact blood-brain barrier.  PF-5274857 was orally available and metabolically stable in vivo.  These findings suggest that PF-5274857 is a potentially attractive clin. candidate for the treatment of tumor types including brain tumors and brain metastasis driven by an activated Hh pathway.  Mol Cancer Ther; 11(1); 57-65.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3I5j3LKkEULVg90H21EOLACvtfcHk0lgG8-jwdDY6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWmsQ%253D%253D&md5=678bd16cdb1dabcf520cf1d89214ef82</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0691%26sid%3Dliteratum%253Aachs%26aulast%3DRohner%26aufirst%3DA.%26aulast%3DSpilker%26aufirst%3DM.%2BE.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DPascual%26aufirst%3DB.%26aulast%3DBartkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DQ.%2BJ.%26aulast%3DYang%26aufirst%3DA.%2BH.%26aulast%3DStevens%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DEffective%2520targeting%2520of%2520hedgehog%2520signaling%2520in%2520a%2520medulloblastoma%2520model%2520with%2520pf-5274857%252C%2520a%2520potent%2520and%2520selective%2520smoothened%2520antagonist%2520that%2520penetrates%2520the%2520blood-brain%2520barrier%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D57%26epage%3D65%26doi%3D10.1158%2F1535-7163.MCT-11-0691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonamici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of nvp-leq506, a second-generation inhibitor of smoothened</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcmdc.201300217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23821351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVehtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1261-1265&author=S.+Peukertauthor=F.+Heauthor=M.+Daiauthor=R.+Zhangauthor=Y.+Sunauthor=K.+Miller-Moslinauthor=M.+McEwanauthor=B.+Laguauthor=K.+Wangauthor=N.+Yusuffauthor=A.+Bourretauthor=A.+Ramamurthyauthor=W.+Maniaraauthor=A.+Amaralauthor=A.+Vattayauthor=A.+Wangauthor=R.+Guoauthor=J.+Yuanauthor=J.+Greenauthor=J.+Williamsauthor=S.+Buonamiciauthor=J.+F.+Kelleherauthor=M.+Dorsch&title=Discovery+of+nvp-leq506%2C+a+second-generation+inhibitor+of+smoothened&doi=10.1002%2Fcmdc.201300217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened</span></div><div class="casAuthors">Peukert, Stefan; He, Feng; Dai, Miao; Zhang, Rui; Sun, Yingchuan; Miller-Moslin, Karen; McEwan, Michael; Lagu, Bharat; Wang, Kate; Yusuff, Naeem; Bourret, Aaron; Ramamurthy, Arun; Maniara, Wieslawa; Amaral, Adam; Vattay, Anthony; Wang, Anlai; Guo, Ribo; Yuan, Jing; Green, John; Williams, Juliet; Buonamici, Silvia; Kelleher, Joseph F.; Dorsch, Marion</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1261-1265</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of piperazinylpyridazine derivs. was synthesized and evaluated as inhibitors of the Smoothened (Smo) receptor.  NVP-LEQ506 (I) was the most promising deriv. based on soly., hERG activity, and pharmacokinetic properties, and is currently in phase I clin. trials.  Compd. I displays good activity in a rodent model of medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwU3YkMVKfkLVg90H21EOLACvtfcHk0lip2qfXxRjx_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehtLbP&md5=81410b9f6099775b39f97bfe0117f289</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300217%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DMcEwan%26aufirst%3DM.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DBourret%26aufirst%3DA.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DBuonamici%26aufirst%3DS.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520nvp-leq506%252C%2520a%2520second-generation%2520inhibitor%2520of%2520smoothened%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1261%26epage%3D1265%26doi%3D10.1002%2Fcmdc.201300217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human smoothened receptor bound to an antitumour agent</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>497</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/nature12167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature12167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23636324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=338-343&author=C.+Wangauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=W.+Liuauthor=F.+Y.+Siuauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+smoothened+receptor+bound+to+an+antitumour+agent&doi=10.1038%2Fnature12167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human smoothened receptor bound to an antitumour agent</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Liu, Wei; Siu, Fai Yiu; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7449</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis.  It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%.  Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-mol. antagonist LY2940680 at 2.5 Å resoln.  Although the SMO receptor shares the seven-transmembrane helical (7TM) fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulfide bonds.  The ligand binds at the extracellular end of the seven-transmembrane-helix bundle and forms extensive contacts with the loops.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmaIV6OXnzIrVg90H21EOLACvtfcHk0lip2qfXxRjx_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D&md5=fdd96ac77bcf93d5c8da46e5630795b2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature12167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12167%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520smoothened%2520receptor%2520bound%2520to%2520an%2520antitumour%2520agent%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D338%26epage%3D343%26doi%3D10.1038%2Fnature12167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llamas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.,  3rd.</span></span> <span> </span><span class="NLM_article-title">1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3954</span>– <span class="NLM_lpage">3968</span>, <span class="refDoi"> DOI: 10.1021/jm900309j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900309j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVegtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3954-3968&author=K.+Miller-Moslinauthor=S.+Peukertauthor=R.+K.+Jainauthor=M.+A.+McEwanauthor=R.+Karkiauthor=L.+Llamasauthor=N.+Yusuffauthor=F.+Heauthor=Y.+Liauthor=Y.+Sunauthor=M.+Daiauthor=L.+Perezauthor=W.+Michaelauthor=T.+Shengauthor=H.+Leiauthor=R.+Zhangauthor=J.+Williamsauthor=A.+Bourretauthor=A.+Ramamurthyauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=W.+Maniaraauthor=A.+Amaralauthor=M.+Dorschauthor=J.+F.+Kelleher&title=1-amino-4-benzylphthalazines+as+orally+bioavailable+smoothened+antagonists+with+antitumor+activity&doi=10.1021%2Fjm900309j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity</span></div><div class="casAuthors">Miller-Moslin, Karen; Peukert, Stefan; Jain, Rishi K.; McEwan, Michael A.; Karki, Rajesh; Llamas, Luis; Yusuff, Naeem; He, Feng; Li, Yanhong; Sun, Yingchuan; Dai, Miao; Perez, Lawrence; Michael, Walter; Sheng, Tao; Lei, Huangshu; Zhang, Rui; Williams, Juliet; Bourret, Aaron; Ramamurthy, Arun; Yuan, Jing; Guo, Ribo; Matsumoto, Melissa; Vattay, Anthony; Maniara, Wieslawa; Amaral, Adam; Dorsch, Marion; Kelleher, Joseph F., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3954-3968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abnormal activation of the Hedgehog (Hh) signaling pathway has been linked to several types of human cancers, and the development of small-mol. inhibitors of this pathway represents a promising route toward novel anticancer therapeutics.  A cell-based screen performed in our labs. identified a new class of Hh pathway inhibitors, 1-amino-4-benzylphthalazines, e.g. I, that act via antagonism of the Smoothened receptor.  A variety of analogs were synthesized and their structure-activity relationships detd.  This optimization resulted in the discovery of high affinity Smoothened antagonists, one of which was further profiled in vivo.  This compd. displayed a good pharmacokinetic profile and also afforded tumor regression in a genetic mouse model of medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcQwfeb8I_UrVg90H21EOLACvtfcHk0lip2qfXxRjx_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVegtbY%253D&md5=026fa9b87c71751e2af6323402e528c5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm900309j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900309j%26sid%3Dliteratum%253Aachs%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DMcEwan%26aufirst%3DM.%2BA.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DLlamas%26aufirst%3DL.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DBourret%26aufirst%3DA.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26atitle%3D1-amino-4-benzylphthalazines%2520as%2520orally%2520bioavailable%2520smoothened%2520antagonists%2520with%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3954%26epage%3D3968%26doi%3D10.1021%2Fjm900309j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ejmech.2017.06.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28688278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKku77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=384-395&author=X.+Luauthor=Y.+Pengauthor=C.+Wangauthor=J.+Yangauthor=X.+Baoauthor=Q.+Dongauthor=W.+Zhaoauthor=W.+Tanauthor=X.+Dong&title=Design%2C+synthesis%2C+and+biological+evaluation+of+optimized+phthalazine+derivatives+as+hedgehog+signaling+pathway+inhibitors&doi=10.1016%2Fj.ejmech.2017.06.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors</span></div><div class="casAuthors">Lu, Xiuhong; Peng, Yuanqiu; Wang, Chenglin; Yang, Jun; Bao, Xiaolong; Dong, Qian; Zhao, Weili; Tan, Wenfu; Dong, Xiaochun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">384-395</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The authors report herein the design and synthesis of a series of optimized phthalazine compds. as novel hedgehog signaling pathway inhibitors.  The 4-methylamino-piperidine moiety of Taladegib was replaced by different four, five or six-membered azacycle or azaspirocycle building blocks.  The in vitro Gli-luciferase assay results demonstrate that the scaffold hopping in this region afforded significant influences on Hh pathway inhibition.  Pyrrolidin-3-amine moiety is the best linker between pharmacophores phthalazine and fluorine substituted benzoyl group.  Meanwhile the optimization of 1-methyl-1H-pyrazol by different arom. rings was also studied and the SAR was described.  Many new derivs. show potent Hh signaling inhibitory activity with nanomolar IC50 values.  Among these compds., compd. (R)-4-fluoro-N-(1-(4-(4-(hydroxymethyl)phenyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl)benzamide showed the highest inhibitory potency with an IC50 value of 0.17 nM, which was 35-fold more potent than the lead compd. Taladegib and 23-fold more potent than the marketed drug Vismodegib.  The selected compds. (R)-4-fluoro-N-(1-(4-(p-tolyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl) benzamide and (R)-4-fluoro-N-(1-(4-(4-(hydroxymethyl)phenyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl)benzamide also possess potent antitumor activities against medulloblastoma cells proliferation in vitro.  In vivo efficacy of (R)-4-fluoro-N-(1-(4-(4-(hydroxymethyl)phenyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl)benzamide in a ptch+/-p53-/- mouse medulloblastoma allograft model also indicated encouraging results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1P0my-vkiLLVg90H21EOLACvtfcHk0lihdxuc3HW9rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKku77P&md5=23a21140025d3eb8d831355d3b1e8173</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.031%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520optimized%2520phthalazine%2520derivatives%2520as%2520hedgehog%2520signaling%2520pathway%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D384%26epage%3D395%26doi%3D10.1016%2Fj.ejmech.2017.06.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span> <span> </span><span class="NLM_article-title">A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1336</span>, <span class="refDoi"> DOI: 10.1039/C7MD00104E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1039%2FC7MD00104E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30108845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVCgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1332-1336&author=L.+Yeauthor=K.+Dingauthor=F.+Zhaoauthor=X.+Liuauthor=Y.+Wuauthor=Y.+Liuauthor=D.+Xueauthor=F.+Zhouauthor=X.+Zhangauthor=R.+C.+Stevensauthor=F.+Xuauthor=S.+Zhaoauthor=H.+Tao&title=A+structurally+guided+dissection-then-evolution+strategy+for+ligand+optimization+of+smoothened+receptor&doi=10.1039%2FC7MD00104E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor</span></div><div class="casAuthors">Ye, Lintao; Ding, Kang; Zhao, Fei; Liu, Xiaoyan; Wu, Yiran; Liu, Yang; Xue, Dongxiang; Zhou, Fang; Zhang, Xianjun; Stevens, Raymond C.; Xu, Fei; Zhao, Suwen; Tao, Houchao</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1332-1336</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We present herein a novel dissection-then-evolution strategy for ligand optimization.  Using the co-crystal structure of the smoothened receptor (SMO) as a guide, we studied the modular contribution of LY2940680 by systematically "silencing" the specific interaction between the individual residue(s) and the fragment in the ligand.  Following evolution by focusing on the benzoyl part finally yielded an improved ligand 21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofP_6q0s--XLVg90H21EOLACvtfcHk0lj6iNjYZ8XPqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVCgsr8%253D&md5=0268adf9e5db19b26cd11480ee8bf083</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1039%2FC7MD00104E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00104E%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DTao%26aufirst%3DH.%26atitle%3DA%2520structurally%2520guided%2520dissection-then-evolution%2520strategy%2520for%2520ligand%2520optimization%2520of%2520smoothened%2520receptor%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D1332%26epage%3D1336%26doi%3D10.1039%2FC7MD00104E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcmdc.201000011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20229564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFyqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=500-512&author=S.+Peukertauthor=K.+Miller-Moslin&title=Small-molecule+inhibitors+of+the+hedgehog+signaling+pathway+as+cancer+therapeutics&doi=10.1002%2Fcmdc.201000011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics</span></div><div class="casAuthors">Peukert, Stefan; Miller-Moslin, Karen</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">500-512</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the Hedgehog (Hh) mol. signaling pathway have emerged in recent years as a promising new class of potential therapeutics for cancer treatment.  Numerous drug discovery efforts have resulted in the identification of a wide variety of small mols. that target different members of this pathway, including Smoothened (Smo), Sonic hedgehog protein (Shh), and Gli1.  Several Smo inhibitors have now entered human clin. trials, and successful proof-of-concept studies have been carried out in patients with defined genetic mutations in the Hh pathway.  This review provides a general overview of three main topics in this rapidly expanding area: (1) the various types of biol. assays and in vivo models that have been employed for the identification and optimization of Hh pathway inhibitors; (2) Smo inhibitors reported to date, including recent clin. results where available; and (3) efforts toward the identification and characterization of inhibitors of other members of the Hh pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwPNA0A-NVA7Vg90H21EOLACvtfcHk0lj6iNjYZ8XPqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFyqt7o%253D&md5=429705c283818ba2af09f66aceea2ff3</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000011%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520hedgehog%2520signaling%2520pathway%2520as%2520cancer%2520therapeutics%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D500%26epage%3D512%26doi%3D10.1002%2Fcmdc.201000011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span> <span> </span><span class="NLM_article-title">Current trends in hedgehog signaling pathway inhibition by small molecules</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3140</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2018.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30177379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1GlsLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3131-3140&author=F.+Ghirgaauthor=M.+Moriauthor=P.+Infante&title=Current+trends+in+hedgehog+signaling+pathway+inhibition+by+small+molecules&doi=10.1016%2Fj.bmcl.2018.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Current trends in Hedgehog signaling pathway inhibition by small molecules</span></div><div class="casAuthors">Ghirga, Francesca; Mori, Mattia; Infante, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3131-3140</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hedgehog (Hh) signaling pathway is a widely appreciated target for anticancer therapy.  However, drug resistance at the Smoothened receptor (SMO) and Hh activation downstream/independently of SMO seriously limit the clin. use of SMO antagonists.  Here, we address the main strategies that have been recently established to inhibit the Hh pathway and to bypass the above limitations.  Particularly, we review efforts that have been spent to develop novel and potent SMO antagonists able to modulate the drug-resistant forms of SMO, to discover efficient glioma-assocd. oncogene (GLI) antagonists and inhibitors of GLI-mediated transcription, and to establish and assay promising combination of multiple agents with enhanced Hh inhibition at lower individual doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlvJKs68Qsc7Vg90H21EOLACvtfcHk0lhk8T4Fp93HPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1GlsLnF&md5=3e47ec73dcf2865fc5151dafbb4d73d4</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DGhirga%26aufirst%3DF.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DInfante%26aufirst%3DP.%26atitle%3DCurrent%2520trends%2520in%2520hedgehog%2520signaling%2520pathway%2520inhibition%2520by%2520small%2520molecules%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3131%26epage%3D3140%26doi%3D10.1016%2Fj.bmcl.2018.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raleigh, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sever, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elnatan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisignano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Gonzalo, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krup, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, E. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. F.</span></span> <span> </span><span class="NLM_article-title">Cilia-associated oxysterols activate smoothened</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2018.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.molcel.2018.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30340023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKisr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2018&pages=316-327&author=D.+R.+Raleighauthor=N.+Severauthor=P.+K.+Choksiauthor=M.+A.+Siggauthor=K.+M.+Hinesauthor=B.+M.+Thompsonauthor=D.+Elnatanauthor=P.+Jaishankarauthor=P.+Bisignanoauthor=F.+R.+Garcia-Gonzaloauthor=A.+L.+Krupauthor=M.+Eberlauthor=E.+F.+X.+Byrneauthor=C.+Sieboldauthor=S.+Y.+Wongauthor=A.+R.+Rensloauthor=M.+Grabeauthor=J.+G.+McDonaldauthor=L.+Xuauthor=P.+A.+Beachyauthor=J.+F.+Reiter&title=Cilia-associated+oxysterols+activate+smoothened&doi=10.1016%2Fj.molcel.2018.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Cilia-Associated Oxysterols Activate Smoothened</span></div><div class="casAuthors">Raleigh, David R.; Sever, Navdar; Choksi, Pervinder K.; Sigg, Monika Abedin; Hines, Kelly M.; Thompson, Bonne M.; Elnatan, Daniel; Jaishankar, Priyadarshini; Bisignano, Paola; Garcia-Gonzalo, Francesc R.; Krup, Alexis Leigh; Eberl, Markus; Byrne, Eamon F. X.; Siebold, Christian; Wong, Sunny Y.; Renslo, Adam R.; Grabe, Michael; McDonald, Jeffrey G.; Xu, Libin; Beachy, Philip A.; Reiter, Jeremy F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-327.e5</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Primary cilia are required for Smoothened to transduce vertebrate Hedgehog signals, but how Smoothened accumulates in cilia and is activated is incompletely understood.  Here, we identify cilia-assocd. oxysterols that promote Smoothened accumulation in cilia and activate the Hedgehog pathway.  Our data reveal that cilia-assocd. oxysterols bind to two distinct Smoothened domains to modulate Smoothened accumulation in cilia and tune the intensity of Hedgehog pathway activation.  We find that the oxysterol synthase HSD11β2 participates in the prodn. of Smoothened-activating oxysterols and promotes Hedgehog pathway activity.  Inhibiting oxysterol biosynthesis impedes oncogenic Hedgehog pathway activation and attenuates the growth of Hedgehog pathway-assocd. medulloblastoma, suggesting that targeted inhibition of Smoothened-activating oxysterol prodn. may be therapeutically useful for patients with Hedgehog-assocd. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru2l0jZP9ZlLVg90H21EOLACvtfcHk0lhk8T4Fp93HPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKisr%252FP&md5=023a694630c8f42fbdfd30169aa49e55</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2018.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2018.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DRaleigh%26aufirst%3DD.%2BR.%26aulast%3DSever%26aufirst%3DN.%26aulast%3DChoksi%26aufirst%3DP.%2BK.%26aulast%3DSigg%26aufirst%3DM.%2BA.%26aulast%3DHines%26aufirst%3DK.%2BM.%26aulast%3DThompson%26aufirst%3DB.%2BM.%26aulast%3DElnatan%26aufirst%3DD.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DGarcia-Gonzalo%26aufirst%3DF.%2BR.%26aulast%3DKrup%26aufirst%3DA.%2BL.%26aulast%3DEberl%26aufirst%3DM.%26aulast%3DByrne%26aufirst%3DE.%2BF.%2BX.%26aulast%3DSiebold%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%2BY.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DGrabe%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DJ.%2BG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26aulast%3DReiter%26aufirst%3DJ.%2BF.%26atitle%3DCilia-associated%2520oxysterols%2520activate%2520smoothened%26jtitle%3DMol.%2520Cell%26date%3D2018%26volume%3D72%26spage%3D316%26epage%3D327%26doi%3D10.1016%2Fj.molcel.2018.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span> <span> </span><span class="NLM_article-title">Oxysterol binding to the extracellular domain of smoothened in hedgehog signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.1290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23831757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKgs77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=557-564&author=D.+Nedelcuauthor=J.+Liuauthor=Y.+Xuauthor=C.+Jaoauthor=A.+Salic&title=Oxysterol+binding+to+the+extracellular+domain+of+smoothened+in+hedgehog+signaling&doi=10.1038%2Fnchembio.1290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling</span></div><div class="casAuthors">Nedelcu, Daniel; Liu, Jing; Xu, Yangqing; Jao, Cindy; Salic, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">557-564</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oxysterols bind the seven-transmembrane protein Smo and potently activate vertebrate Hedgehog (Hh) signaling, a pathway essential in embryonic development, adult stem cell maintenance and cancer.  It is unknown, however, whether oxysterols are important for normal vertebrate Hh signaling and whether antagonizing oxysterols can inhibit the Hh pathway.  We developed azasterols that block Hh signaling by binding the oxysterol-binding site of Smo.  We show that the binding site for oxysterols and azasterols maps to the extracellular, cysteine-rich domain of Smo and is completely separable from the site bound by other small-mol. modulators, located within the heptahelical bundle of Smo.  Smo mutants in which oxysterol binding is abolished no longer respond to oxysterols and cannot be maximally activated by the Hh ligand.  Our results show that oxysterol binding to vertebrate Smo is required for normal Hh signaling and that targeting the oxysterol-binding site is an effective strategy to inhibit Smo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa3LuWLb8VtrVg90H21EOLACvtfcHk0lhk8T4Fp93HPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKgs77P&md5=865fa3e4bd97ac1c706de40f7fd0c042</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1290%26sid%3Dliteratum%253Aachs%26aulast%3DNedelcu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJao%26aufirst%3DC.%26aulast%3DSalic%26aufirst%3DA.%26atitle%3DOxysterol%2520binding%2520to%2520the%2520extracellular%2520domain%2520of%2520smoothened%2520in%2520hedgehog%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D557%26epage%3D564%26doi%3D10.1038%2Fnchembio.1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rana, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guibao, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the role of the smoothened cysteine-rich domain in hedgehog signalling</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2965</span>, <span class="refDoi"> DOI: 10.1038/ncomms3965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms3965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24351982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslCiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2965&author=R.+Ranaauthor=C.+E.+Carrollauthor=H.+J.+Leeauthor=J.+Baoauthor=S.+Maradaauthor=C.+R.+Graceauthor=C.+D.+Guibaoauthor=S.+K.+Ogdenauthor=J.+J.+Zheng&title=Structural+insights+into+the+role+of+the+smoothened+cysteine-rich+domain+in+hedgehog+signalling&doi=10.1038%2Fncomms3965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signalling</span></div><div class="casAuthors">Rana Rajashree; Zheng Jie J; Carroll Candace E; Lee Ho-Jin; Bao Ju; Grace Christy R R; Guibao Cristina D; Marada Suresh; Ogden Stacey K</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2965</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Smoothened (Smo) is a member of the Frizzled (FzD) class of G-protein-coupled receptors (GPCRs), and functions as the key transducer in the Hedgehog (Hh) signalling pathway.  Smo has an extracellular cysteine-rich domain (CRD), indispensable for its function and downstream Hh signalling.  Despite its essential role, the functional contribution of the CRD to Smo signalling has not been clearly elucidated.  However, given that the FzD CRD binds to the endogenous Wnt ligand, it has been proposed that the Smo CRD may bind its own endogenous ligand.  Here we present the NMR solution structure of the Drosophila Smo CRD, and describe interactions between the glucocorticoid budesonide (Bud) and the Smo CRDs from both Drosophila and human.  Our results highlight a function of the Smo CRD, demonstrating its role in binding to small-molecule modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp62q3xNe7a7QfW6udTcc2ea3HovEms_M7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslCiug%253D%253D&md5=f848a32b83aadb78b339d92be83e8e5f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fncomms3965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3965%26sid%3Dliteratum%253Aachs%26aulast%3DRana%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DC.%2BE.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DBao%26aufirst%3DJ.%26aulast%3DMarada%26aufirst%3DS.%26aulast%3DGrace%26aufirst%3DC.%2BR.%26aulast%3DGuibao%26aufirst%3DC.%2BD.%26aulast%3DOgden%26aufirst%3DS.%2BK.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26atitle%3DStructural%2520insights%2520into%2520the%2520role%2520of%2520the%2520smoothened%2520cysteine-rich%2520domain%2520in%2520hedgehog%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2965%26doi%3D10.1038%2Fncomms3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvanites, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span> <span> </span><span class="NLM_article-title">Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">982</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.chembiol.2012.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22921064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kku7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=972-982&author=Y.+Wangauthor=L.+Davidowauthor=A.+C.+Arvanitesauthor=J.+Blanchardauthor=K.+Lamauthor=K.+Xuauthor=V.+Ozaauthor=J.+W.+Yooauthor=J.+M.+Ngauthor=T.+Curranauthor=L.+L.+Rubinauthor=A.+P.+McMahon&title=Glucocorticoid+compounds+modify+smoothened+localization+and+hedgehog+pathway+activity&doi=10.1016%2Fj.chembiol.2012.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid Compounds Modify Smoothened Localization and Hedgehog Pathway Activity</span></div><div class="casAuthors">Wang, Yu; Davidow, Lance; Arvanites, Anthony C.; Blanchard, Joel; Lam, Kelvin; Xu, Ke; Oza, Vatsal; Yoo, Jin Woo; Ng, Jessica M. Y.; Curran, Tom; Rubin, Lee L.; McMahon, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">972-982</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Hedgehog signaling pathway is linked to a variety of diseases, notably a range of cancers.  The first generation of drug screens identified Smoothened (Smo), a membrane protein essential for signaling, as an attractive drug target.  Smo localizes to the primary cilium upon pathway activation, and this transition is crit. for the response to Hedgehog ligands.  In a high content screen directly monitoring Smo distribution in Hedgehog-responsive cells, the authors identified different glucocorticoids as specific modulators of Smo ciliary accumulation.  One class promoted Smo accumulation, conferring cellular hypersensitivity to Hedgehog stimulation.  In contrast, a second class inhibited Smo ciliary localization and signaling activity by both wild-type Smo, and mutant forms of Smo, SmoM2, and SmoD473H, that are refractory to previously identified Smo antagonists.  These findings point to the potential for developing glucocorticoid-based pharmacol. modulation of Smo signaling to treat mutated drug-resistant forms of Smo, an emerging problem in long-term cancer therapy.  They also raise a concern about potential crosstalk of glucocorticoid drugs in the Hedgehog pathway, if therapeutic administration exceeds levels assocd. with on-target transcriptional mechanisms of glucocorticoid action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlupbrzYeLo7Vg90H21EOLACvtfcHk0lgViU9CVw_LqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kku7zM&md5=295150ec28632cf98b156c4a5ec5857f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDavidow%26aufirst%3DL.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DOza%26aufirst%3DV.%26aulast%3DYoo%26aufirst%3DJ.%2BW.%26aulast%3DNg%26aufirst%3DJ.%2BM.%26aulast%3DCurran%26aufirst%3DT.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26atitle%3DGlucocorticoid%2520compounds%2520modify%2520smoothened%2520localization%2520and%2520hedgehog%2520pathway%2520activity%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D972%26epage%3D982%26doi%3D10.1016%2Fj.chembiol.2012.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span> <span> </span><span class="NLM_article-title">Small molecule antagonists in distinct binding modes inhibit drug-resistant mutant of smoothened</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.chembiol.2011.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21513879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=432-437&author=H.+Taoauthor=Q.+Jinauthor=D.+I.+Kooauthor=X.+Liaoauthor=N.+P.+Englundauthor=Y.+Wangauthor=A.+Ramamurthyauthor=P.+G.+Schultzauthor=M.+Dorschauthor=J.+Kelleherauthor=X.+Wu&title=Small+molecule+antagonists+in+distinct+binding+modes+inhibit+drug-resistant+mutant+of+smoothened&doi=10.1016%2Fj.chembiol.2011.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Antagonists in Distinct Binding Modes Inhibit Drug-Resistant Mutant of Smoothened</span></div><div class="casAuthors">Tao, Haiyan; Jin, Qihui; Koo, Dong-In; Liao, Xuebin; Englund, Nathan P.; Wang, Yan; Ramamurthy, Arun; Schultz, Peter G.; Dorsch, Marion; Kelleher, Joseph; Wu, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-437</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Several small mol. antagonists for Smoothened (Smo) have been developed, and achieved promising preclin. efficacy in cancers that are dependent on Hedgehog (Hh) signaling.  However, in a recent clin. study, a drug-resistant D473H SMO mutant was identified that is thought to be responsible for cancer relapse in a patient with medulloblastoma.  Here, we report two Smo antagonists that bind to distinct sites, as compared to known antagonists and agonists, and inhibit both wild-type and mutant Smo.  These findings provide an insight of the ligand-binding sites of Smo and a basis for the development of potential therapeutics for tumors with drug-resistant Smo mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-DmQdtwuGLVg90H21EOLACvtfcHk0lgViU9CVw_LqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFartrk%253D&md5=d592c4432c438c5644d7bfc8a00dd3f1</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DKoo%26aufirst%3DD.%2BI.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DEnglund%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26atitle%3DSmall%2520molecule%2520antagonists%2520in%2520distinct%2520binding%2520modes%2520inhibit%2520drug-resistant%2520mutant%2520of%2520smoothened%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D432%26epage%3D437%26doi%3D10.1016%2Fj.chembiol.2011.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basset-Seguin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durham, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haverty, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarin, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirix, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migden, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccell.2015.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25759019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFOgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=327-341&author=H.+J.+Sharpeauthor=G.+Pauauthor=G.+J.+Dijkgraafauthor=N.+Basset-Seguinauthor=Z.+Modrusanauthor=T.+Januarioauthor=V.+Tsuiauthor=A.+B.+Durhamauthor=A.+A.+Dlugoszauthor=P.+M.+Havertyauthor=R.+Bourgonauthor=J.+Y.+Tangauthor=K.+Y.+Sarinauthor=L.+Dirixauthor=D.+C.+Fisherauthor=C.+M.+Rudinauthor=H.+Sofenauthor=M.+R.+Migdenauthor=R.+L.+Yauchauthor=F.+J.+de+Sauvage&title=Genomic+analysis+of+smoothened+inhibitor+resistance+in+basal+cell+carcinoma&doi=10.1016%2Fj.ccell.2015.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma</span></div><div class="casAuthors">Sharpe, Hayley J.; Pau, Gregoire; Dijkgraaf, Gerrit J.; Basset-Seguin, Nicole; Modrusan, Zora; Januario, Thomas; Tsui, Vickie; Durham, Alison B.; Dlugosz, Andrzej A.; Haverty, Peter M.; Bourgon, Richard; Tang, Jean Y.; Sarin, Kavita Y.; Dirix, Luc; Fisher, David C.; Rudin, Charles M.; Sofen, Howard; Migden, Michael R.; Yauch, Robert L.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-341</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Smoothened (SMO) inhibitors are under clin. investigation for the treatment of several cancers.  Vismodegib is approved for the treatment of locally advanced and metastatic basal cell carcinoma (BCC).  Most BCC patients experience significant clin. benefit on vismodegib, but some develop resistance.  Genomic anal. of tumor biopsies revealed that vismodegib resistance is assocd. with Hedgehog (Hh) pathway reactivation, predominantly through mutation of the drug target SMO and to a lesser extent through concurrent copy no. changes in SUFU and GLI2.  SMO mutations either directly impaired drug binding or activated SMO to varying levels.  Furthermore, we found evidence for intra-tumor heterogeneity, suggesting that a combination of therapies targeting components at multiple levels of the Hh pathway is required to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIlO1aRWxygbVg90H21EOLACvtfcHk0lhCqQ3mkOar_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFOgtrs%253D&md5=fe0aa6db03295a3250a3e7c3679e08f4</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DSharpe%26aufirst%3DH.%2BJ.%26aulast%3DPau%26aufirst%3DG.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DBasset-Seguin%26aufirst%3DN.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDurham%26aufirst%3DA.%2BB.%26aulast%3DDlugosz%26aufirst%3DA.%2BA.%26aulast%3DHaverty%26aufirst%3DP.%2BM.%26aulast%3DBourgon%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DSarin%26aufirst%3DK.%2BY.%26aulast%3DDirix%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DD.%2BC.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DSofen%26aufirst%3DH.%26aulast%3DMigden%26aufirst%3DM.%2BR.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DGenomic%2520analysis%2520of%2520smoothened%2520inhibitor%2520resistance%2520in%2520basal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26spage%3D327%26epage%3D341%26doi%3D10.1016%2Fj.ccell.2015.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling study on resistance of wt/d473h smo to antagonists lde-225 and leq-506</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2017.11.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.phrs.2017.11.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29175550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFaht73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2018&pages=491-499&author=J.+Tuauthor=J.+J.+Liauthor=L.+T.+Songauthor=H.+L.+Zhaiauthor=J.+Wangauthor=X.+Y.+Zhang&title=Molecular+modeling+study+on+resistance+of+wt%2Fd473h+smo+to+antagonists+lde-225+and+leq-506&doi=10.1016%2Fj.phrs.2017.11.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506</span></div><div class="casAuthors">Tu, Jing; Li, Jiao Jiao; Song, Li Ting; Zhai, Hong Lin; Wang, Juan; Zhang, Xiao Yun</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">491-499</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The smoothened (SMO) receptor, an essential signal transducer in the Hedgehog pathway, was targeted with antagonists to suppress the tumor.  It is interesting that SMO D473H mutation confers resistance on inhibitor LDE-225 rather than LEQ-506.  In this paper, the binding modes of them against the wild type and mutant SMO receptors were identified to gain insights into the resistant and non-resistant factors, based on a comprehensive protocol involving mol. docking, mol. dynamic simulations, free energy calcn. and decompn.  A comparison of resistant LDE-225 and non-resistant LEQ-506 indicates that the vol. of the binding cavity decreases seriously in the mutant complex with resistant LDE-225.  In addn., the D473H mutation disrupts the hydrogen bond network with residues R400 and Q477, which results in the TM6 conformation inward.  Owing to the absence of the hydrogen bond, residues R400 and Q477 make weak contributions to LDE-225.  However, the D473H mutation along with TM6 conformational change has no effect on non-resistant LEQ-506.  Finally, the resistance ascribes to adverse interaction between the greater polarity of mutant residue H473 and the nonpolar phenmethyl of LDE-225.  The elaborate insights into structural and energetic mechanism of drug resistance provide an effective strategy to design rationally non-resistant antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa9BCo-pYySrVg90H21EOLACvtfcHk0lhCqQ3mkOar_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFaht73F&md5=f3d0c235b9788607723724e97159bab0</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2017.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2017.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DSong%26aufirst%3DL.%2BT.%26aulast%3DZhai%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26atitle%3DMolecular%2520modeling%2520study%2520on%2520resistance%2520of%2520wt%252Fd473h%2520smo%2520to%2520antagonists%2520lde-225%2520and%2520leq-506%26jtitle%3DPharmacol.%2520Res.%26date%3D2018%26volume%3D129%26spage%3D491%26epage%3D499%26doi%3D10.1016%2Fj.phrs.2017.11.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, E. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sircar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachtergaele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambo, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, M. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newstead, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohatgi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebold, C.</span></span> <span> </span><span class="NLM_article-title">Structural basis of smoothened regulation by its extracellular domains</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1038/nature18934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature18934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27437577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=517-522&author=E.+F.+X.+Byrneauthor=R.+Sircarauthor=P.+S.+Millerauthor=G.+Hedgerauthor=G.+Luchettiauthor=S.+Nachtergaeleauthor=M.+D.+Tullyauthor=L.+Mydock-McGraneauthor=D.+F.+Coveyauthor=R.+P.+Ramboauthor=M.+S.+P.+Sansomauthor=S.+Newsteadauthor=R.+Rohatgiauthor=C.+Siebold&title=Structural+basis+of+smoothened+regulation+by+its+extracellular+domains&doi=10.1038%2Fnature18934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Smoothened regulation by its extracellular domains</span></div><div class="casAuthors">Byrne, Eamon F. X.; Sircar, Ria; Miller, Paul S.; Hedger, George; Luchetti, Giovanni; Nachtergaele, Sigrid; Tully, Mark D.; Mydock-McGrane, Laurel; Covey, Douglas F.; Rambo, Robert P.; Sansom, Mark S. P.; Newstead, Simon; Rohatgi, Rajat; Siebold, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7613</span>),
    <span class="NLM_cas:pages">517-522</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Developmental signals of the Hedgehog (Hh) and Wnt families are transduced across the membrane by Frizzled-class G-protein-coupled receptors (GPCRs) composed of both a heptahelical transmembrane domain (TMD) and an extracellular cysteine-rich domain (CRD).  How the large extracellular domains of GPCRs regulate signalling by the TMD is unknown.  We present crystal structures of the Hh signal transducer and oncoprotein Smoothened, a GPCR that contains two distinct ligand-binding sites: one in its TMD and one in the CRD.  The CRD is stacked atop the TMD, sepd. by an intervening wedge-like linker domain.  Structure-guided mutations show that the interface between the CRD, linker domain and TMD stabilizes the inactive state of Smoothened.  Unexpectedly, we find a cholesterol mol. bound to Smoothened in the CRD binding site.  Mutations predicted to prevent cholesterol binding impair the ability of Smoothened to transmit native Hh signals.  Binding of a clin. used antagonist, vismodegib, to the TMD induces a conformational change that is propagated to the CRD, resulting in loss of cholesterol from the CRD-linker domain-TMD interface.  Our results clarify the structural mechanism by which the activity of a GPCR is controlled by ligand-regulated interactions between its extracellular and transmembrane domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprpMreLzg7GbVg90H21EOLACvtfcHk0lhIWpLIM7c8eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73O&md5=8ca7a908d602acc663b887a570c1a736</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnature18934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18934%26sid%3Dliteratum%253Aachs%26aulast%3DByrne%26aufirst%3DE.%2BF.%2BX.%26aulast%3DSircar%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DP.%2BS.%26aulast%3DHedger%26aufirst%3DG.%26aulast%3DLuchetti%26aufirst%3DG.%26aulast%3DNachtergaele%26aufirst%3DS.%26aulast%3DTully%26aufirst%3DM.%2BD.%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DCovey%26aufirst%3DD.%2BF.%26aulast%3DRambo%26aufirst%3DR.%2BP.%26aulast%3DSansom%26aufirst%3DM.%2BS.%2BP.%26aulast%3DNewstead%26aufirst%3DS.%26aulast%3DRohatgi%26aufirst%3DR.%26aulast%3DSiebold%26aufirst%3DC.%26atitle%3DStructural%2520basis%2520of%2520smoothened%2520regulation%2520by%2520its%2520extracellular%2520domains%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D517%26epage%3D522%26doi%3D10.1038%2Fnature18934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibition of gdc-0449 refractory smoothened mutants and downstream mechanisms of drug resistance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-2876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-10-2876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21123452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=435-444&author=G.+J.+Dijkgraafauthor=B.+Alickeauthor=L.+Weinmannauthor=T.+Januarioauthor=K.+Westauthor=Z.+Modrusanauthor=D.+Burdickauthor=R.+Goldsmithauthor=K.+Robargeauthor=D.+Sutherlinauthor=S.+J.+Scalesauthor=S.+E.+Gouldauthor=R.+L.+Yauchauthor=F.+J.+de+Sauvage&title=Small+molecule+inhibition+of+gdc-0449+refractory+smoothened+mutants+and+downstream+mechanisms+of+drug+resistance&doi=10.1158%2F0008-5472.CAN-10-2876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance</span></div><div class="casAuthors">Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Weinmann, Lasse; Januario, Thomas; West, Kristina; Modrusan, Zora; Burdick, Dan; Goldsmith, Richard; Robarge, Kirk; Sutherlin, Dan; Scales, Suzie J.; Gould, Stephen E.; Yauch, Robert L.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-444</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inappropriate Hedgehog (Hh) signaling has been directly linked to medulloblastoma (MB), a common malignant brain tumor in children.  GDC-0449 is an Hh pathway inhibitor (HPI) currently under clin. investigation as an anticancer agent.  Treatment of a MB patient with GDC-0449 initially regressed tumors, but this individual ultimately relapsed with a D473H resistance mutation in Smoothened (SMO), the mol. target of GDC-0449.  To explore the role of the mutated aspartic acid residue in SMO function, we substituted D473 with every amino acid and found that all functional mutants were resistant to GDC-0449, with pos. charged residues conferring potential oncogenic properties.  Alanine scan mutagenesis of SMO further identified E518 as a novel prospective mutation site for GDC-0449 resistance.  To overcome this form of acquired resistance, we screened a panel of chem. diverse HPIs and identified several antagonists with potent in vitro activity against these GDC-0449-resistant SMO mutants.  The bis-amide compd. 5 was of particular interest, as it was able to inhibit tumor growth mediated by drug resistant SMO in a murine allograft model of MB.  However, focal amplifications of the Hh pathway transcription factor Gli2 and the Hh target gene cyclin D1 (Ccnd1) were obsd. in two addnl. resistant models, indicating that resistance may also occur downstream of SMO.  Importantly, these HPI resistant MB allografts retained their sensitivity to PI3K inhibition, presenting addnl. opportunities for the treatment of such tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkJl8oB7usSbVg90H21EOLACvtfcHk0lhIWpLIM7c8eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKmtA%253D%253D&md5=d0b110e7c8c22ba9bde5635503565b72</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2876%26sid%3Dliteratum%253Aachs%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DWeinmann%26aufirst%3DL.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibition%2520of%2520gdc-0449%2520refractory%2520smoothened%2520mutants%2520and%2520downstream%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D435%26epage%3D444%26doi%3D10.1158%2F0008-5472.CAN-10-2876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urman, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollmig, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasi, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarin, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span> <span> </span><span class="NLM_article-title">Noncanonical hedgehog pathway activation through srf-mkl1 promotes drug resistance in basal cell carcinomas</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/nm.4476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnm.4476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29400712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=271-281&author=R.+J.+Whitsonauthor=A.+Leeauthor=N.+M.+Urmanauthor=A.+Mirzaauthor=C.+Y.+Yaoauthor=A.+S.+Brownauthor=J.+R.+Liauthor=G.+Shankarauthor=M.+A.+Fryauthor=S.+X.+Atwoodauthor=E.+Y.+Leeauthor=S.+T.+Hollmigauthor=S.+Z.+Aasiauthor=K.+Y.+Sarinauthor=M.+P.+Scottauthor=E.+H.+Epsteinauthor=J.+Y.+Tangauthor=A.+E.+Oro&title=Noncanonical+hedgehog+pathway+activation+through+srf-mkl1+promotes+drug+resistance+in+basal+cell+carcinomas&doi=10.1038%2Fnm.4476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas</span></div><div class="casAuthors">Whitson, Ramon J.; Lee, Alex; Urman, Nicole M.; Mirza, Amar; Yao, Catherine Y.; Brown, Alexander S.; Li, Jiang R.; Shankar, Gautam; Fry, Micah A.; Atwood, Scott X.; Lee, Eunice Y.; Hollmig, S. Tyler; Aasi, Sumaira Z.; Sarin, Kavita Y.; Scott, Matthew P.; Epstein, Ervin H., Jr.; Tang, Jean Y.; Oro, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Hedgehog pathway-dependent cancers can escape Smoothened (SMO) inhibition through mutations in genes encoding canonical hedgehog pathway components; however, around 50% of drug-resistant basal cell carcinomas (BCCs) lack addnl. variants of these genes.  Here we use multidimensional genomics anal. of human and mouse drug-resistant BCCs to identify a noncanonical hedgehog activation pathway driven by the transcription factor serum response factor (SRF).  Active SRF along with its coactivator megakaryoblastic leukemia 1 (MKL1) binds DNA near hedgehog target genes and forms a previously unknown protein complex with the hedgehog transcription factor glioma-assocd. oncogene family zinc finger-1 (GLI1), causing amplification of GLI1 transcriptional activity.  We show that cytoskeletal activation through Rho and the formin family member Diaphanous (mDia) is required for SRF-MKL-driven GLI1 activation and for tumor cell viability.  Remarkably, nuclear MKL1 staining served as a biomarker in tumors from mice and human subjects to predict tumor responsiveness to MKL inhibitors, highlighting the therapeutic potential of targeting this pathway.  Thus, our study illuminates, for the first time, cytoskeletal-activation-driven transcription as a personalized therapeutic target for combating drug-resistant malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gaatPokUjbVg90H21EOLACvtfcHk0lhIWpLIM7c8eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCiu7c%253D&md5=a4391e87dfb08bf311aa8a735fe2cfaf</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fnm.4476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4476%26sid%3Dliteratum%253Aachs%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DUrman%26aufirst%3DN.%2BM.%26aulast%3DMirza%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DC.%2BY.%26aulast%3DBrown%26aufirst%3DA.%2BS.%26aulast%3DLi%26aufirst%3DJ.%2BR.%26aulast%3DShankar%26aufirst%3DG.%26aulast%3DFry%26aufirst%3DM.%2BA.%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DLee%26aufirst%3DE.%2BY.%26aulast%3DHollmig%26aufirst%3DS.%2BT.%26aulast%3DAasi%26aufirst%3DS.%2BZ.%26aulast%3DSarin%26aufirst%3DK.%2BY.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DOro%26aufirst%3DA.%2BE.%26atitle%3DNoncanonical%2520hedgehog%2520pathway%2520activation%2520through%2520srf-mkl1%2520promotes%2520drug%2520resistance%2520in%2520basal%2520cell%2520carcinomas%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D271%26epage%3D281%26doi%3D10.1038%2Fnm.4476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel Bayo-Fina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar Dhanyamraju, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendrich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of gli1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8023</span>, <span class="refDoi"> DOI: 10.1038/ncomms9023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms9023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26310823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8023&author=P.+Schneiderauthor=J.+Miguel+Bayo-Finaauthor=R.+Singhauthor=P.+Kumar+Dhanyamrajuauthor=P.+Holzauthor=A.+Baierauthor=V.+Fendrichauthor=A.+Ramaswamyauthor=S.+Baumeisterauthor=E.+D.+Martinezauthor=M.+Lauth&title=Identification+of+a+novel+actin-dependent+signal+transducing+module+allows+for+the+targeted+degradation+of+gli1&doi=10.1038%2Fncomms9023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1</span></div><div class="casAuthors">Schneider, Philipp; Miguel Bayo-Fina, Juan; Singh, Rajeev; Kumar Dhanyamraju, Pavan; Holz, Philipp; Baier, Aninja; Fendrich, Volker; Ramaswamy, Annette; Baumeister, Stefan; Martinez, Elisabeth D.; Lauth, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8023</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Down syndrome-assocd. DYRK1A kinase has been reported as a stimulator of the developmentally important Hedgehog (Hh) pathway, but cells from Down syndrome patients paradoxically display reduced Hh signalling activity.  Here we find that DYRK1A stimulates GLI transcription factor activity through phosphorylation of general nuclear localization clusters.  In contrast, in vivo and in vitro expts. reveal that DYRK1A kinase can also function as an inhibitor of endogenous Hh signalling by neg. regulating ABLIM proteins, the actin cytoskeleton and the transcriptional co-activator MKL1 (MAL).  As a final effector of the DYRK1A-ABLIM-actin-MKL1 sequence, we identify the MKL1 interactor Jumonji domain demethylase 1A (JMJD1A) as a novel Hh pathway component stabilizing the GLI1 protein in a demethylase-independent manner.  Furthermore, a Jumonji-specific small-mol. antagonist represents a novel and powerful inhibitor of Hh signal transduction by inducing GLI1 protein degrdn. in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0fhhTVI3NPrVg90H21EOLACvtfcHk0lhuHPvDtRXD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P&md5=2d1cd606db85133bde46a1818098711f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms9023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9023%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMiguel%2BBayo-Fina%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DKumar%2BDhanyamraju%26aufirst%3DP.%26aulast%3DHolz%26aufirst%3DP.%26aulast%3DBaier%26aufirst%3DA.%26aulast%3DFendrich%26aufirst%3DV.%26aulast%3DRamaswamy%26aufirst%3DA.%26aulast%3DBaumeister%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26aulast%3DLauth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520actin-dependent%2520signal%2520transducing%2520module%2520allows%2520for%2520the%2520targeted%2520degradation%2520of%2520gli1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8023%26doi%3D10.1038%2Fncomms9023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parigger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cegielkowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span> <span> </span><span class="NLM_article-title">Dyrk1b as therapeutic target in hedgehog/gli-dependent cancer cells with smoothened inhibitor resistance</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">7134</span>– <span class="NLM_lpage">7148</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.6910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26784250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC28nhslSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7134-7148&author=W.+Gruberauthor=M.+Hutzingerauthor=D.+P.+Elmerauthor=T.+Pariggerauthor=C.+Sternbergauthor=L.+Cegielkowskiauthor=M.+Zajaauthor=J.+Lebanauthor=S.+Michelauthor=S.+Hammauthor=D.+Vittauthor=F.+Aberger&title=Dyrk1b+as+therapeutic+target+in+hedgehog%2Fgli-dependent+cancer+cells+with+smoothened+inhibitor+resistance&doi=10.18632%2Foncotarget.6910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance</span></div><div class="casAuthors">Gruber Wolfgang; Hutzinger Martin; Elmer Dominik Patrick; Parigger Thomas; Sternberg Christina; Cegielkowski Lukasz; Aberger Fritz; Zaja Mirko; Michel Susanne; Hamm Svetlana; Vitt Daniel; Leban Johann; Vitt Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7134-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A wide range of human malignancies displays aberrant activation of Hedgehog (HH)/GLI signaling, including cancers of the skin, brain, gastrointestinal tract and hematopoietic system.  Targeting oncogenic HH/GLI signaling with small molecule inhibitors of the essential pathway effector Smoothened (SMO) has shown remarkable therapeutic effects in patients with advanced and metastatic basal cell carcinoma.  However, acquired and de novo resistance to SMO inhibitors poses severe limitations to the use of SMO antagonists and urgently calls for the identification of novel targets and compounds.Here we report on the identification of the Dual-Specificity-Tyrosine-Phosphorylation-Regulated Kinase 1B (DYRK1B) as critical positive regulator of HH/GLI signaling downstream of SMO.  Genetic and chemical inhibition of DYRK1B in human and mouse cancer cells resulted in marked repression of HH signaling and GLI1 expression, respectively.  Importantly, DYRK1B inhibition profoundly impaired GLI1 expression in both SMO-inhibitor sensitive and resistant settings.  We further introduce a novel small molecule DYRK1B inhibitor, DYRKi, with suitable pharmacologic properties to impair SMO-dependent and SMO-independent oncogenic GLI activity.  The results support the use of DYRK1B antagonists for the treatment of HH/GLI-associated cancers where SMO inhibitors fail to demonstrate therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFmF3n8no4EZw7prLlxLOzfW6udTcc2eb9reyShJwG47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nhslSksw%253D%253D&md5=166f2cf11d5cbc8b78bfd91cd5a28b1b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6910%26sid%3Dliteratum%253Aachs%26aulast%3DGruber%26aufirst%3DW.%26aulast%3DHutzinger%26aufirst%3DM.%26aulast%3DElmer%26aufirst%3DD.%2BP.%26aulast%3DParigger%26aufirst%3DT.%26aulast%3DSternberg%26aufirst%3DC.%26aulast%3DCegielkowski%26aufirst%3DL.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DHamm%26aufirst%3DS.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DAberger%26aufirst%3DF.%26atitle%3DDyrk1b%2520as%2520therapeutic%2520target%2520in%2520hedgehog%252Fgli-dependent%2520cancer%2520cells%2520with%2520smoothened%2520inhibitor%2520resistance%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D7134%26epage%3D7148%26doi%3D10.18632%2Foncotarget.6910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanyamraju, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span> <span> </span><span class="NLM_article-title">Dyrk1b blocks canonical and promotes non-canonical hedgehog signaling through activation of the mtor/akt pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.13662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27903983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2sjitFSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=833-845&author=R.+Singhauthor=P.+K.+Dhanyamrajuauthor=M.+Lauth&title=Dyrk1b+blocks+canonical+and+promotes+non-canonical+hedgehog+signaling+through+activation+of+the+mtor%2Fakt+pathway&doi=10.18632%2Foncotarget.13662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway</span></div><div class="casAuthors">Singh Rajeev; Dhanyamraju Pavan Kumar; Lauth Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">833-845</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hedgehog (Hh) signaling plays important roles in embryonic development and in tumor formation.  Apart from the well-established stimulation of the GLI family of transcription factors, Hh ligands promote the phosphorylation and activation of mTOR and AKT kinases, yet the molecular mechanism underlying these processes are unknown.  Here, we identify the DYRK1B kinase as a mediator between Hh signaling and mTOR/AKT activation.  In fibroblasts, Hh signaling induces DYRK1B protein expression, resulting in activation of the mTOR/AKT kinase signaling arm.  Furthermore, DYRK1B exerts positive and negative feedback regulation on the Hh pathway itself: It negatively interferes with SMO-elicited canonical Hh signaling, while at the same time it provides positive feed-forward functions by promoting AKT-mediated GLI stability.  Due to the fact that the mTOR/AKT pathway is itself subject to strong negative feedback regulation, pharmacological inhibition of DYRK1B results in initial upregulation followed by downregulation of AKT phosphorylation and GLI stabilization.  Addressing this issue therapeutically, we show that a pharmacological approach combining a DYRK1B antagonist with an mTOR/AKT inhibitor results in strong GLI1 targeting and in pronounced cytotoxicity in human pancreatic and ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFk21qGRcwucjl5L8hwNX0fW6udTcc2eb9reyShJwG47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjitFSgtA%253D%253D&md5=debb35f2d66e5b639b801fe1f53101f9</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13662%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DDhanyamraju%26aufirst%3DP.%2BK.%26aulast%3DLauth%26aufirst%3DM.%26atitle%3DDyrk1b%2520blocks%2520canonical%2520and%2520promotes%2520non-canonical%2520hedgehog%2520signaling%2520through%2520activation%2520of%2520the%2520mtor%252Fakt%2520pathway%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D833%26epage%3D845%26doi%3D10.18632%2Foncotarget.13662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span> <span> </span><span class="NLM_article-title">Gli activation by atypical protein kinase c iota/lambda regulates the growth of basal cell carcinomas</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>494</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1038/nature11889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature11889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23446420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2013&pages=484-488&author=S.+X.+Atwoodauthor=M.+Liauthor=A.+Leeauthor=J.+Y.+Tangauthor=A.+E.+Oro&title=Gli+activation+by+atypical+protein+kinase+c+iota%2Flambda+regulates+the+growth+of+basal+cell+carcinomas&doi=10.1038%2Fnature11889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas</span></div><div class="casAuthors">Atwood, Scott X.; Li, Mischa; Lee, Alex; Tang, Jean Y.; Oro, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">494</span>
        (<span class="NLM_cas:issue">7438</span>),
    <span class="NLM_cas:pages">484-488</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Growth of basal cell carcinomas (BCCs) requires high levels of hedgehog (HH) signaling through the transcription factor GLI.  Although inhibitors of membrane protein smoothened (SMO) effectively suppress HH signaling, early tumor resistance illustrates the need for addnl. downstream targets for therapy.  Here we identify atypical protein kinase C ι/λ (aPKC-ι/λ) as a novel GLI regulator in mammals. aPKC-ι/λ and its polarity signaling partners colocalize at the centrosome and form a complex with missing-in-metastasis (MIM), a scaffolding protein that potentiates HH signaling.  Genetic or pharmacol. loss of aPKC-ι/λ function blocks HH signaling and proliferation of BCC cells.  Prkci is a HH target gene that forms a pos. feedback loop with GLI and exists at increased levels in BCCs.  Genome-wide transcriptional profiling shows that aPKC-ι/λ and SMO control the expression of similar genes in tumor cells. aPKC-ι/λ functions downstream of SMO to phosphorylate and activate GLI1, resulting in maximal DNA binding and transcriptional activation.  Activated aPKC-ι/λ is upregulated in SMO-inhibitor-resistant tumors and targeting aPKC-ι/λ suppresses signaling and growth of resistant BCC cell lines.  These results demonstrate that aPKC-ι/λ is crit. for HH-dependent processes and implicates aPKC-ι/λ as a new, tumor-selective therapeutic target for the treatment of SMO-inhibitor-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwsCzT5874A7Vg90H21EOLACvtfcHk0liaO2znmzPu0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWiu7o%253D&md5=528b21b31092c6d6e03501c5ed2c2af5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnature11889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11889%26sid%3Dliteratum%253Aachs%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DOro%26aufirst%3DA.%2BE.%26atitle%3DGli%2520activation%2520by%2520atypical%2520protein%2520kinase%2520c%2520iota%252Flambda%2520regulates%2520the%2520growth%2520of%2520basal%2520cell%2520carcinomas%26jtitle%3DNature%26date%3D2013%26volume%3D494%26spage%3D484%26epage%3D488%26doi%3D10.1038%2Fnature11889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayad, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrea, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">A ck1alpha activator penetrates the brain and shows efficacy against drug-resistant metastatic medulloblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1379</span>– <span class="NLM_lpage">1388</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-1319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1078-0432.CCR-18-1319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30487124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BB3crlvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=1379-1388&author=J.+Rodriguez-Blancoauthor=B.+Liauthor=J.+Longauthor=C.+Shenauthor=F.+Yangauthor=D.+Ortonauthor=S.+Collinsauthor=N.+Kasaharaauthor=N.+G.+Ayadauthor=H.+J.+McCreaauthor=M.+F.+Rousselauthor=W.+A.+Weissauthor=A.+J.+Capobiancoauthor=D.+J.+Robbins&title=A+ck1alpha+activator+penetrates+the+brain+and+shows+efficacy+against+drug-resistant+metastatic+medulloblastoma&doi=10.1158%2F1078-0432.CCR-18-1319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma</span></div><div class="casAuthors">Rodriguez-Blanco Jezabel; Li Bin; Long Jun; Shen Chen; Yang Fan; Capobianco Anthony J; Robbins David J; Orton Darren; Collins Sara; Kasahara Noriyuki; Kasahara Noriyuki; Ayad Nagi G; Capobianco Anthony J; Robbins David J; Ayad Nagi G; McCrea Heather J; Roussel Martine F; Weiss William A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1379-1388</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">PURPOSE:  Although most children with medulloblastoma are cured of their disease, Sonic Hedgehog (SHH) subgroup medulloblastoma driven by TRP53 mutations is essentially lethal.  Casein kinase 1α (CK1α) phosphorylates and destabilizes GLI transcription factors, thereby inhibiting the key effectors of SHH signaling.  We therefore tested a second-generation CK1α activator against TRP53-mutant, MYCN-amplified medulloblastoma.  EXPERIMENTAL DESIGN:  The ability of this CK1α activator to block SHH signaling was determined in vitro using GLI reporter cells, granular precursor primary cultures, and PATCHED1 (PTCH1)-mutant sphere cultures.  While in vivo efficacy was tested using 2 different medulloblastoma mouse models: PTCH1 and ND2:SMOA1.  Finally, the clinical relevance of CK1α activators was demonstrated using a TRP53-mutant, MYCN-amplified patient-derived xenograft.  RESULTS:  SSTC3 inhibited SHH activity in vitro, acting downstream of the vismodegib target SMOOTHENED (SMO), and reduced the viability of sphere cultures derived from SHH medulloblastoma.  SSTC3 accumulated in the brain, inhibited growth of SHH medulloblastoma tumors, and blocked metastases in a genetically engineered vismodegib-resistant mouse model of SHH medulloblastoma.  Importantly, SSTC3 attenuated growth and metastasis of orthotopic patient-derived TRP53-mutant, MYCN-amplified, SHH subgroup medulloblastoma xenografts, increasing overall survival.  CONCLUSIONS:  Using a newly described small-molecule, SSTC3, we show that CK1a activators could address a significant unmet clinical need for patients with SMO inhibitor-resistant medulloblastoma, including those harboring mutations in TRP53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8P_DomHDBdjEC-75aqa5AfW6udTcc2eYDrKdqm9SOXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crlvVGnsA%253D%253D&md5=516851f288f08b013570ddf6cbec8bb2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-1319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-1319%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DKasahara%26aufirst%3DN.%26aulast%3DAyad%26aufirst%3DN.%2BG.%26aulast%3DMcCrea%26aufirst%3DH.%2BJ.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DA%2520ck1alpha%2520activator%2520penetrates%2520the%2520brain%2520and%2520shows%2520efficacy%2520against%2520drug-resistant%2520metastatic%2520medulloblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D1379%26epage%3D1388%26doi%3D10.1158%2F1078-0432.CCR-18-1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metcalfe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Pten loss mitigates the response of medulloblastoma to hedgehog pathway inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7034</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-13-1222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24154871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=7034-7042&author=C.+Metcalfeauthor=B.+Alickeauthor=A.+Crowauthor=M.+Lamoureuxauthor=G.+J.+Dijkgraafauthor=F.+Pealeauthor=S.+E.+Gouldauthor=F.+J.+de+Sauvage&title=Pten+loss+mitigates+the+response+of+medulloblastoma+to+hedgehog+pathway+inhibition&doi=10.1158%2F0008-5472.CAN-13-1222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN Loss Mitigates the Response of Medulloblastoma to Hedgehog Pathway Inhibition</span></div><div class="casAuthors">Metcalfe, Ciara; Alicke, Bruno; Crow, Ailey; Lamoureux, Marlea; Dijkgraaf, Gerrit J. P.; Peale, Franklin; Gould, Stephen E.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7034-7042</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Medulloblastoma is a cancer of the cerebellum, for which there is currently no approved targeted therapy.  Recent transcriptomics approaches have demonstrated that medulloblastoma is composed of molecularly distinct subgroups, one of which is characterized by activation of the Hedgehog pathway, which in mouse models is sufficient to drive medulloblastoma development.  There is thus considerable interest in targeting the Hedgehog pathway for therapeutic benefit in medulloblastoma, particularly given the recent approval of the Hedgehog pathway inhibitor vismodegib for metastatic and locally advanced basal cell carcinoma.  Like other molecularly targeted therapies, however, there have been reports of acquired resistance to vismodegib, driven by secondary Hedgehog pathway mutations and potentially by activation of the phosphatidylinositol 3-kinase (PI3K) pathway.  Given that acquired resistance to vismodegib may occur as a result of inappropriate PI3K pathway activation, we asked if loss of the PI3K pathway regulator, phosphatase and tensin homolog (Pten), which has been reported to occur in patients within the Hedgehog subgroup, would constitute a mechanism of innate resistance to vismodegib in Hedgehog-driven medulloblastoma.  We find that Hedgehog pathway inhibition successfully restrains growth of Pten-deficient medulloblastoma in this mouse model, but does not drive tumor regression, as it does in Pten-wild-type medulloblastoma.  Combined inhibition of the Hedgehog and PI3K pathways may lead to superior antitumor activity in Pten-deficient medulloblastoma in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3GdLAnS7UO7Vg90H21EOLACvtfcHk0liaO2znmzPu0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77K&md5=350251756bc5ea2bcf7dbdabcf5be4a1</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1222%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalfe%26aufirst%3DC.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DCrow%26aufirst%3DA.%26aulast%3DLamoureux%26aufirst%3DM.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DPten%2520loss%2520mitigates%2520the%2520response%2520of%2520medulloblastoma%2520to%2520hedgehog%2520pathway%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D7034%26epage%3D7042%26doi%3D10.1158%2F0008-5472.CAN-13-1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponomaryov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornell, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabral, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, R. A.</span></span> <span> </span><span class="NLM_article-title">Ras/mapk activation drives resistance to smo inhibition, metastasis, and tumor evolution in shh pathway-dependent tumors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3623</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2999-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-14-2999-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26130651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWqtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3623-3635&author=X.+Zhaoauthor=T.+Ponomaryovauthor=K.+J.+Ornellauthor=P.+Zhouauthor=S.+K.+Dabralauthor=E.+Pakauthor=W.+Liauthor=S.+X.+Atwoodauthor=R.+J.+Whitsonauthor=A.+L.+Changauthor=J.+Liauthor=A.+E.+Oroauthor=J.+A.+Chanauthor=J.+F.+Kelleherauthor=R.+A.+Segal&title=Ras%2Fmapk+activation+drives+resistance+to+smo+inhibition%2C+metastasis%2C+and+tumor+evolution+in+shh+pathway-dependent+tumors&doi=10.1158%2F0008-5472.CAN-14-2999-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors</span></div><div class="casAuthors">Zhao, Xuesong; Ponomaryov, Tatyana; Ornell, Kimberly J.; Zhou, Pengcheng; Dabral, Sukriti K.; Pak, Ekaterina; Li, Wei; Atwood, Scott X.; Whitson, Ramon J.; Chang, Anne Lynn S.; Li, Jiang; Oro, Anthony E.; Chan, Jennifer A.; Kelleher, Joseph F.; Segal, Rosalind A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3623-3635</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant Shh signaling promotes tumor growth in diverse cancers.  The importance of Shh signaling is particularly evident in medulloblastoma and basal cell carcinoma (BCC), where inhibitors targeting the Shh pathway component Smoothened (Smo) show great therapeutic promise.  However, the emergence of drug resistance limits long-term efficacy, and the mechanisms of resistance remain poorly understood.  Using new medulloblastoma models, we identify two distinct paradigms of resistance to Smo inhibition.  Sufu mutations lead to maintenance of the Shh pathway in the presence of Smo inhibitors.  Alternatively activation of the RAS-MAPK pathway circumvents Shh pathway dependency, drives tumor growth, and enhances metastatic behavior.  Strikingly, in BCC patients treated with Smo inhibitor, squamous cell cancers with RAS/MAPK activation emerged from the antecedent BCC tumors.  Together, these findings reveal a crit. role of the RAS-MAPK pathway in drug resistance and tumor evolution of Shh pathway-dependent tumors.  Cancer Res; 75(17); 3623-35. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzGF7Wk7iVdbVg90H21EOLACvtfcHk0ljer8sSWQEeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWqtLbJ&md5=c905fc4a67db9d7fc70894bdbe1b3b0d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2999-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2999-T%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DPonomaryov%26aufirst%3DT.%26aulast%3DOrnell%26aufirst%3DK.%2BJ.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DDabral%26aufirst%3DS.%2BK.%26aulast%3DPak%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DA.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DRas%252Fmapk%2520activation%2520drives%2520resistance%2520to%2520smo%2520inhibition%252C%2520metastasis%252C%2520and%2520tumor%2520evolution%2520in%2520shh%2520pathway-dependent%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3623%26epage%3D3635%26doi%3D10.1158%2F0008-5472.CAN-14-2999-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tostar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendrich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Dyrk1b-dependent autocrine-to-paracrine shift of hedgehog signaling by mutant ras</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnsmb.1833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20512148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslWmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=718-725&author=M.+Lauthauthor=A.+Bergstromauthor=T.+Shimokawaauthor=U.+Tostarauthor=Q.+Jinauthor=V.+Fendrichauthor=C.+Guerraauthor=M.+Barbacidauthor=R.+Toftgard&title=Dyrk1b-dependent+autocrine-to-paracrine+shift+of+hedgehog+signaling+by+mutant+ras&doi=10.1038%2Fnsmb.1833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS</span></div><div class="casAuthors">Lauth, Matthias; Bergstroem, Aasa; Shimokawa, Takashi; Tostar, Ulrica; Jin, Qianren; Fendrich, Volker; Guerra, Carmen; Barbacid, Mariano; Toftgard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">718-725</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Synergism between the RAS and Hedgehog (HH) pathways has been suggested for carcinogenesis in the pancreas, lung and colon.  We investigated the mol. cross-talk between RAS and HH signaling and found that, although mutant RAS induces or enhances SHH expression and favors paracrine HH signaling, it antagonizes autocrine HH signal transduction.  Activated RAS can be found in primary cilia, the central organelle of HH signal transduction, but functions in a cilium-independent manner and interferes with Gli2 function and Gli3 processing.  In addn., the cell-autonomous neg. regulation of HH signal transduction involves the RAS effector mol. dual specificity tyrosine phosphorylated and regulated kinase 1B (DYRK1B).  In line with a redirection of autocrine toward paracrine HH signaling by a KRAS-DYRK1B network, we find high levels of GLI1 expression restricted to the stromal compartment and not to SHH-expressing tumor cells in human pancreatic adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzELTkuDoSY7Vg90H21EOLACvtfcHk0ljer8sSWQEeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslWmtbk%253D&md5=8f9cde9a4a7540002d8734daa44f0011</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1833%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DShimokawa%26aufirst%3DT.%26aulast%3DTostar%26aufirst%3DU.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DFendrich%26aufirst%3DV.%26aulast%3DGuerra%26aufirst%3DC.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DDyrk1b-dependent%2520autocrine-to-paracrine%2520shift%2520of%2520hedgehog%2520signaling%2520by%2520mutant%2520ras%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D718%26epage%3D725%26doi%3D10.1038%2Fnsmb.1833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biehs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piskol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumahdi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">A cell identity switch allows residual bcc to survive hedgehog pathway inhibition</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0596-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fs41586-018-0596-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30297801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOhtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2018&pages=429-433&author=B.+Biehsauthor=G.+J.+P.+Dijkgraafauthor=R.+Piskolauthor=B.+Alickeauthor=S.+Boumahdiauthor=F.+Pealeauthor=S.+E.+Gouldauthor=F.+J.+de+Sauvage&title=A+cell+identity+switch+allows+residual+bcc+to+survive+hedgehog+pathway+inhibition&doi=10.1038%2Fs41586-018-0596-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition</span></div><div class="casAuthors">Biehs, Brian; Dijkgraaf, Gerrit J. P.; Piskol, Robert; Alicke, Bruno; Boumahdi, Soufiane; Peale, Franklin; Gould, Stephen E.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">7727</span>),
    <span class="NLM_cas:pages">429-433</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite the efficacy of Hedgehog pathway inhibitors in the treatment of basal cell carcinoma (BCC), residual disease persists in some patients and may contribute to relapse when treatment is discontinued.  Here, to study the effect of the Smoothened inhibitor vismodegib on tumor clearance, we have used a Ptch1-Trp53 mouse model of BCC and found that mice treated with vismodegib harbor quiescent residual tumors that regrow upon cessation of treatment.  Profiling expts. revealed that residual BCCs initiate a transcriptional program that closely resembles that of stem cells of the interfollicular epidermis and isthmus, whereas untreated BCCs are more similar to the hair follicle bulge.  This cell identity switch was enabled by a mostly permissive chromatin state accompanied by rapid Wnt pathway activation and reprogramming of super enhancers to drive activation of key transcription factors involved in cellular identity.  Accordingly, treatment of BCC with both vismodegib and a Wnt pathway inhibitor reduced the residual tumor burden and enhanced differentiation.  Our study identifies a resistance mechanism in which tumor cells evade treatment by adopting an alternative identity that does not rely on the original oncogenic driver for survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyok9rqAA9rVg90H21EOLACvtfcHk0ljer8sSWQEeJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOhtrjL&md5=768149d23b6c5b25d0bec65e22108a28</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0596-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0596-y%26sid%3Dliteratum%253Aachs%26aulast%3DBiehs%26aufirst%3DB.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%2BP.%26aulast%3DPiskol%26aufirst%3DR.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DBoumahdi%26aufirst%3DS.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DA%2520cell%2520identity%2520switch%2520allows%2520residual%2520bcc%2520to%2520survive%2520hedgehog%2520pathway%2520inhibition%26jtitle%3DNature%26date%3D2018%26volume%3D562%26spage%3D429%26epage%3D433%26doi%3D10.1038%2Fs41586-018-0596-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelberger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaegen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohm, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span> <span> </span><span class="NLM_article-title">Tumor architecture and notch signaling modulate drug response in basal cell carcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccell.2017.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29395868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=229-243&author=M.+Eberlauthor=D.+Mangelbergerauthor=J.+B.+Swansonauthor=M.+E.+Verhaegenauthor=P.+W.+Harmsauthor=M.+L.+Frohmauthor=A.+A.+Dlugoszauthor=S.+Y.+Wong&title=Tumor+architecture+and+notch+signaling+modulate+drug+response+in+basal+cell+carcinoma&doi=10.1016%2Fj.ccell.2017.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma</span></div><div class="casAuthors">Eberl, Markus; Mangelberger, Doris; Swanson, Jacob B.; Verhaegen, Monique E.; Harms, Paul W.; Frohm, Marcus L.; Dlugosz, Andrzej A.; Wong, Sunny Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-243.e4</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hedgehog (Hh) pathway inhibitors such as vismodegib are highly effective for treating basal cell carcinoma (BCC); however, residual tumor cells frequently persist and regenerate the primary tumor upon drug discontinuation.  Here, we show that BCCs are organized into two molecularly and functionally distinct compartments.  Whereas interior Hh+/Notch+ suprabasal cells undergo apoptosis in response to vismodegib, peripheral Hh+++/Notch- basal cells survive throughout treatment.  Inhibiting Notch specifically promotes tumor persistence without causing drug resistance, while activating Notch is sufficient to regress already established lesions.  Altogether, these findings suggest that the three-dimensional architecture of BCCs establishes a natural hierarchy of drug response in the tumor and that this hierarchy can be overcome, for better or worse, by modulating Notch.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIKCnEtORSl7Vg90H21EOLACvtfcHk0ljAC5RbaTS2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSjur0%253D&md5=c7e02faeb5eae420e42db767c47b8b64</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DM.%26aulast%3DMangelberger%26aufirst%3DD.%26aulast%3DSwanson%26aufirst%3DJ.%2BB.%26aulast%3DVerhaegen%26aufirst%3DM.%2BE.%26aulast%3DHarms%26aufirst%3DP.%2BW.%26aulast%3DFrohm%26aufirst%3DM.%2BL.%26aulast%3DDlugosz%26aufirst%3DA.%2BA.%26aulast%3DWong%26aufirst%3DS.%2BY.%26atitle%3DTumor%2520architecture%2520and%2520notch%2520signaling%2520modulate%2520drug%2520response%2520in%2520basal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D229%26epage%3D243%26doi%3D10.1016%2Fj.ccell.2017.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingallina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Acquarica, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Magno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e2376</span>, <span class="refDoi"> DOI: 10.1038/cddis.2016.195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fcddis.2016.195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27899820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aks77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=e2376&author=P.+Infanteauthor=R.+Alfonsiauthor=C.+Ingallinaauthor=D.+Quaglioauthor=F.+Ghirgaauthor=I.+D%E2%80%99Acquaricaauthor=F.+Bernardiauthor=L.+Di+Magnoauthor=G.+Canettieriauthor=I.+Screpantiauthor=A.+Gulinoauthor=B.+Bottaauthor=M.+Moriauthor=L.+Di+Marcotullio&title=Inhibition+of+hedgehog-dependent+tumors+and+cancer+stem+cells+by+a+newly+identified+naturally+occurring+chemotype&doi=10.1038%2Fcddis.2016.195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype</span></div><div class="casAuthors">Infante, Paola; Alfonsi, Romina; Ingallina, Cinzia; Quaglio, Deborah; Ghirga, Francesca; D'Acquarica, Ilaria; Bernardi, Flavia; Di Magno, Laura; Canettieri, Gianluca; Screpanti, Isabella; Gulino, Alberto; Botta, Bruno; Mori, Mattia; Di Marcotullio, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e2376</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog (Hh) inhibitors have emerged as valid tools in the treatment of a wide range of cancers.  Indeed, aberrant activation of the Hh pathway occurring either by ligand-dependent or -independent mechanisms is a key driver in tumorigenesis.  The smoothened (Smo) receptor is one of the main upstream transducers of the Hh signaling and is a validated target for the development of anticancer compds., as underlined by the FDA-approved Smo antagonist Vismodegib (GDC-0449/Erivedge) for the treatment of basal cell carcinoma.  However, Smo mutations that confer constitutive activity and drug resistance have emerged during treatment with Vismodegib.  For this reason, the development of new effective Hh inhibitors represents a major challenge for cancer therapy.  Natural products have always represented a unique source of lead structures in drug discovery, and in recent years have been used to modulate the Hh pathway at multiple levels.  Here, starting from an in house library of natural compds. and their derivs., we discovered novel chemotypes of Hh inhibitors by mean of virtual screening against the crystallog. structure of Smo.  Hh functional based assay identified the chalcone deriv. 12 as the most effective Hh inhibitor within the test set.  The chalcone 12 binds the Smo receptor and promotes the displacement of Bodipy-Cyclopamine in both Smo WT and drug-resistant Smo mutant.  Our mol. stands as a promising Smo antagonist able to specifically impair the growth of Hh-dependent tumor cells in vitro and in vivo and medulloblastoma stem-like cells and potentially overcome the assocd. drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sXWplTSstbVg90H21EOLACvtfcHk0ljAC5RbaTS2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aks77F&md5=b9cfdba016a885fcc1bb98cac6223b87</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.195%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DIngallina%26aufirst%3DC.%26aulast%3DQuaglio%26aufirst%3DD.%26aulast%3DGhirga%26aufirst%3DF.%26aulast%3DD%25E2%2580%2599Acquarica%26aufirst%3DI.%26aulast%3DBernardi%26aufirst%3DF.%26aulast%3DDi%2BMagno%26aufirst%3DL.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DGulino%26aufirst%3DA.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520hedgehog-dependent%2520tumors%2520and%2520cancer%2520stem%2520cells%2520by%2520a%2520newly%2520identified%2520naturally%2520occurring%2520chemotype%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26spage%3De2376%26doi%3D10.1038%2Fcddis.2016.195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span> <span> </span><span class="NLM_article-title">A novel hedgehog inhibitor for the treatment of hematological malignancies</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1097%2FCAD.0000000000000679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30106753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWqsL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=995-1003&author=P.+Linauthor=Y.+Heauthor=G.+Chenauthor=H.+Maauthor=J.+Zhengauthor=Z.+Zhangauthor=B.+Caoauthor=H.+Zhangauthor=X.+Zhangauthor=X.+Mao&title=A+novel+hedgehog+inhibitor+for+the+treatment+of+hematological+malignancies&doi=10.1097%2FCAD.0000000000000679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A novel hedgehog inhibitor for the treatment of hematological malignancies</span></div><div class="casAuthors">Lin, Peng; He, Yuanming; Chen, Guodong; Ma, Haikuo; Zheng, Jiyue; Zhang, Zubin; Cao, Biyin; Zhang, Hongjian; Zhang, Xiaohu; Mao, Xinliang</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">995-1003</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The hedgehog-smoothened (HH/SMO) pathway has been proposed as a potential therapeutic target for hematol. malignancies.  Our previous studies designed a series of HH inhibitors with novel scaffolds distinctive from vismodegib, the first Food and Drug Administration-approved HH inhibitor for the treatment of basal-cell carcinoma and medulloblastoma.  In the present study, we evaluated these HH inhibitors against blood cancers and found that HH78 displayed potent activity in suppressing the HH signaling pathway.  HH78 competitively bound to SMO and suppressed the transcriptional activity of GLI by the luciferase reporter gene assay and the measurement of HH/SMO-downregulated genes, including cyclin D2, cyclin E, PTCH1, PTCH2, and GLI.  HH78 at low micromolar concns. induced significant cancer cell apoptosis showed by increased caspase-3 activation, annexin V-staining and downregulated prosurvival proteins, including c-Myc, Bcl-2, Mcl-1, and Bcl-xL.  In contrast, vismodegib did not show any effects on these apoptotic events.  HH78 also suppressed the activation of the AKT/mTOR pathway, which cross-talks with the HH/SMO pathway.  Finally, HH78 inhibited the growth of human leukemia K562 in nude mice xenografts with no overt toxicity.  Collectively, the present study identified a novel HH inhibitor with great potential for the treatment of hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTb_9sBXXcGrVg90H21EOLACvtfcHk0ljAC5RbaTS2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWqsL3J&md5=e5ccd0fe3d55027f88fd752d519054cd</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000679%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DX.%26atitle%3DA%2520novel%2520hedgehog%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hematological%2520malignancies%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2018%26volume%3D29%26spage%3D995%26epage%3D1003%26doi%3D10.1097%2FCAD.0000000000000679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roudaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenfelder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihannic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrault, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petricci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taddei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruat, M.</span></span> <span> </span><span class="NLM_article-title">Mrt-92 inhibits hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the smoothened receptor</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1829</span>, <span class="refDoi"> DOI: 10.1096/fj.14-267849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1096%2Ffj.14-267849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25636740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSks7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1817-1829&author=L.+Hochauthor=H.+Faureauthor=H.+Roudautauthor=A.+Schoenfelderauthor=A.+Mannauthor=N.+Girardauthor=L.+Bihannicauthor=O.+Ayraultauthor=E.+Petricciauthor=M.+Taddeiauthor=D.+Rognanauthor=M.+Ruat&title=Mrt-92+inhibits+hedgehog+signaling+by+blocking+overlapping+binding+sites+in+the+transmembrane+domain+of+the+smoothened+receptor&doi=10.1096%2Ffj.14-267849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor</span></div><div class="casAuthors">Hoch, Lucile; Faure, Helene; Roudaut, Hermine; Schoenfelder, Angele; Mann, Andre; Girard, Nicolas; Bihannic, Laure; Ayrault, Olivier; Petricci, Elena; Taddei, Maurizio; Rognan, Didier; Ruat, Martial</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-1829</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The Smoothened (Smo) receptor, a member of class F G protein-coupled receptors, is the main transducer of the Hedgehog (Hh) signaling pathway implicated in a wide range of developmental and adult processes.  Smo is the target of anticancer drugs that bind to a long and narrow cavity in the 7-transmembrane (7TM) domain.  X-ray structures of human Smo (hSmo) bound to several ligands have revealed 2 types of 7TM-directed antagonists: those binding mostly to extracellular loops (site 1, e.g., LY2940680) and those penetrating deeply in the 7TM cavity (site 2, e.g., SANT-1).  Here we report the development of the acylguanidine MRT-92, which displays subnanomolar antagonist activity against Smo in various Hh cell-based assays.  MRT-92 inhibits rodent cerebellar granule cell proliferation induced by Hh pathway activation through pharmacol. (half maximal inhibitory concn. [IC50] = 0.4 nM) or genetic manipulation.  Using [3H]MRT-92 (Kd = 0.3 nM for hSmo), we created a comprehensive framework for the interaction of small mol. modulators with hSmo and for understanding chemoresistance linked to hSmo mutations.  Guided by mol. docking and site-directed mutagenesis data, our work convincingly confirms that MRT-92 simultaneously recognized and occupied both sites 1 and 2.  Our data demonstrate the existence of a third type of Smo antagonists, those entirely filling the Smo binding cavity from the upper extracellular part to the lower cytoplasmic-proximal subpocket.  Our studies should help design novel potent Smo antagonists and more effective therapeutic strategies for treating Hh-linked cancers and assocd. chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4F9p-MCX0k7Vg90H21EOLACvtfcHk0li50m5kZ_Hpeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSks7vF&md5=71050c3e52c8aae6b06d9ea799daf694</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-267849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-267849%26sid%3Dliteratum%253Aachs%26aulast%3DHoch%26aufirst%3DL.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DGirard%26aufirst%3DN.%26aulast%3DBihannic%26aufirst%3DL.%26aulast%3DAyrault%26aufirst%3DO.%26aulast%3DPetricci%26aufirst%3DE.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DMrt-92%2520inhibits%2520hedgehog%2520signaling%2520by%2520blocking%2520overlapping%2520binding%2520sites%2520in%2520the%2520transmembrane%2520domain%2520of%2520the%2520smoothened%2520receptor%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D1817%26epage%3D1829%26doi%3D10.1096%2Ffj.14-267849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition mechanism exploration of investigational drug tak-441 as inhibitor against vismodegib-resistant smoothened mutant</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>723</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ejphar.2013.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24291104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOhsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=723&publication_year=2014&pages=305-313&author=T.+Ishiiauthor=Y.+Shimizuauthor=K.+Nakashimaauthor=S.+Kondoauthor=K.+Ogawaauthor=S.+Sasakiauthor=H.+Matsui&title=Inhibition+mechanism+exploration+of+investigational+drug+tak-441+as+inhibitor+against+vismodegib-resistant+smoothened+mutant&doi=10.1016%2Fj.ejphar.2013.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant</span></div><div class="casAuthors">Ishii, Tsuyoshi; Shimizu, Yuji; Nakashima, Kosuke; Kondo, Shigeru; Ogawa, Kazumasa; Sasaki, Satoshi; Matsui, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">723</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hedgehog signaling is a driving force in medulloblastoma and basal cell carcinoma (BCC), making it an attractive therapeutic target.  Vismodegib recently received FDA approval for the treatment of inoperable BCC, but a drug-resistant Smoothened (Smo) mutant (D473H) was identified in a clin. study.  TAK-441 is a pyrrolo[3,2-c]pyridine-4-one deriv. that potently inhibits Hh signal transduction and is currently under investigation in clin. trials.  We demonstrated that TAK-441 inhibits reporter activity in D473H-transfected cells with an IC50 of 79 nM, while Vismodegib showed an IC50=7100 nM.  In order to investigate the mode of inhibition, we evaluated the Smo inhibitors with three different binding assays, such as [3H]-TAK-441 membrane binding assay, affinity selection-MS detection assay, and bodipy-cylopamine whole cell assay.  In three different assays, Vismodegib and cyclopamine showed lower affinity for the D473H mutant in comparison with wild-type Smo.  On the other hand, TAK-441 showed almost equal binding affinity for the D473H mutant compared with wild-type Smo in the binding assays, although TAK-441 binds to the same binding site as two other well-known inhibitors.  These in vitro findings suggest that TAK-441 has the potential for clin. use in cancers that are dependent on Hedgehog signaling, including wild-type tumors and Vismodegib-resistant D473H mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAe4k2Cv2mbVg90H21EOLACvtfcHk0li50m5kZ_Hpeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOhsbnM&md5=5734463021212b25bfabbb536991889e</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DMatsui%26aufirst%3DH.%26atitle%3DInhibition%2520mechanism%2520exploration%2520of%2520investigational%2520drug%2520tak-441%2520as%2520inhibitor%2520against%2520vismodegib-resistant%2520smoothened%2520mutant%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D723%26spage%3D305%26epage%3D313%26doi%3D10.1016%2Fj.ejphar.2013.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Neuronal delivery of hedgehog directs spatial patterning of taste organ regeneration</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E200</span>– <span class="NLM_lpage">E209</span>, <span class="refDoi"> DOI: 10.1073/pnas.1719109115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1719109115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29279401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVequr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E200-E209&author=W.+J.+Luauthor=R.+K.+Mannauthor=A.+Nguyenauthor=T.+Biauthor=M.+Silversteinauthor=J.+Y.+Tangauthor=X.+Chenauthor=P.+A.+Beachy&title=Neuronal+delivery+of+hedgehog+directs+spatial+patterning+of+taste+organ+regeneration&doi=10.1073%2Fpnas.1719109115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration</span></div><div class="casAuthors">Lu, Wan-Jin; Mann, Randall K.; Nguyen, Allison; Bi, Tingting; Silverstein, Max; Tang, Jean Y.; Chen, Xiaoke; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">E200-E209</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">How organs maintain and restore functional integrity during ordinary tissue turnover or following injury represents a central biol. problem.  The maintenance of taste sensory organs in the tongue was shown 140 years ago to depend on innervation from distant ganglion neurons, but the underlying mechanism has remained unknown.  Here, we show that Sonic hedgehog (Shh), which encodes a secreted protein signal, is expressed in these sensory neurons, and that exptl. ablation of neuronal Shh expression causes loss of taste receptor cells (TRCs).  TRCs are also lost upon pharmacol. blockade of Hedgehog pathway response, accounting for the loss of taste sensation experienced by cancer patients undergoing Hedgehog inhibitor treatment.  We find that TRC regeneration following such pharmacol. ablation requires neuronal expression of Shh and can be substantially enhanced by pharmacol. activation of Hedgehog response.  Such pharmacol. enhancement of Hedgehog response, however, results in addnl. TRC formation at many ectopic sites, unlike the site-restricted regeneration specified by the projection pattern of Shh-expressing neurons.  Stable regeneration of TRCs thus requires neuronal Shh, illustrating the principle that neuronal delivery of cues such as the Shh signal can pattern distant cellular responses to assure functional integrity during tissue maintenance and regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSNWpKLxouKbVg90H21EOLACvtfcHk0lhLBclLDWKolA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVequr7I&md5=37a8060caf59ebe9cd205a7e18276aa4</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1719109115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1719109115%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.%2BJ.%26aulast%3DMann%26aufirst%3DR.%2BK.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DBi%26aufirst%3DT.%26aulast%3DSilverstein%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DNeuronal%2520delivery%2520of%2520hedgehog%2520directs%2520spatial%2520patterning%2520of%2520taste%2520organ%2520regeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE200%26epage%3DE209%26doi%3D10.1073%2Fpnas.1719109115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermilov, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grachtchouk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistretta, C. M.</span></span> <span> </span><span class="NLM_article-title">Recovery of taste organs and sensory function after severe loss from hedgehog/smoothened inhibition with cancer drug sonidegib</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E10369</span>– <span class="NLM_lpage">E10378</span>, <span class="refDoi"> DOI: 10.1073/pnas.1712881114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1712881114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29133390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSisb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E10369-E10378&author=A.+Kumariauthor=A.+N.+Ermilovauthor=M.+Grachtchoukauthor=A.+A.+Dlugoszauthor=B.+L.+Allenauthor=R.+M.+Bradleyauthor=C.+M.+Mistretta&title=Recovery+of+taste+organs+and+sensory+function+after+severe+loss+from+hedgehog%2Fsmoothened+inhibition+with+cancer+drug+sonidegib&doi=10.1073%2Fpnas.1712881114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib</span></div><div class="casAuthors">Kumari, Archana; Ermilov, Alexandre N.; Grachtchouk, Marina; Dlugosz, Andrzej A.; Allen, Benjamin L.; Bradley, Robert M.; Mistretta, Charlotte M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">E10369-E10378</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Striking taste disturbances are reported in cancer patients treated with Hedgehog (HH)-pathway inhibitor drugs, including sonidegib (LDE225), which block the HH pathway effector Smoothened (SMO).  We tested the potential for mol., cellular, and functional recovery in mice from the severe disruption of taste-organ biol. and taste sensation that follows HH/SMO signaling inhibition.  Sonidegib treatment led to rapid loss of taste buds (TB) in both fungiform and circumvallate papillae, including disruption of TB progenitor-cell proliferation and differentiation.  Effects were selective, sparing nontaste papillae.  To confirm that taste-organ effects of sonidegib treatment result from HH/SMO signaling inhibition, we studied mice with conditional global or epithelium-specific Smo deletions and obsd. similar effects.  During sonidegib treatment, chorda tympani nerve responses to lingual chem. stimulation were maintained at 10 d but were eliminated after 16 d, assocd. with nearly complete TB loss.  Notably, responses to tactile or cold stimulus modalities were retained.  Further, innervation, which was maintained in the papilla core throughout treatment, was not sufficient to sustain TB during HH/SMO inhibition.  Importantly, treatment cessation led to rapid and complete restoration of taste responses within 14 d assocd. with morphol. recovery in about 55% of TB.  However, although taste nerve responses were sustained, TB were not restored in all fungiform papillae even with prolonged recovery for several months.  This study establishes a physiol., selective requirement for HH/SMO signaling in taste homeostasis that includes potential for sensory restoration and can explain the temporal recovery after taste dysgeusia in patients treated with HH/SMO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe6ZPbIlxHgrVg90H21EOLACvtfcHk0lhLBclLDWKolA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSisb3O&md5=38494798c3228acb64c257438de967d6</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1712881114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1712881114%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DA.%26aulast%3DErmilov%26aufirst%3DA.%2BN.%26aulast%3DGrachtchouk%26aufirst%3DM.%26aulast%3DDlugosz%26aufirst%3DA.%2BA.%26aulast%3DAllen%26aufirst%3DB.%2BL.%26aulast%3DBradley%26aufirst%3DR.%2BM.%26aulast%3DMistretta%26aufirst%3DC.%2BM.%26atitle%3DRecovery%2520of%2520taste%2520organs%2520and%2520sensory%2520function%2520after%2520severe%2520loss%2520from%2520hedgehog%252Fsmoothened%2520inhibition%2520with%2520cancer%2520drug%2520sonidegib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE10369%26epage%3DE10378%26doi%3D10.1073%2Fpnas.1712881114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span> <span> </span><span class="NLM_article-title">Roles of the hedgehog signaling pathway in epidermal and hair follicle development, homeostasis, and cancer</span>. <i>J. Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.3390/jdb5040012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fjdb5040012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvF2ls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=12&author=Y.+Abeauthor=N.+Tanaka&title=Roles+of+the+hedgehog+signaling+pathway+in+epidermal+and+hair+follicle+development%2C+homeostasis%2C+and+cancer&doi=10.3390%2Fjdb5040012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the hedgehog signaling pathway in epidermal and hair follicle development, homeostasis, and cancer</span></div><div class="casAuthors">Abe, Yoshinori; Tanaka, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Developmental Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">12/1-12/19</span>CODEN:
                <span class="NLM_cas:coden">JDBOAX</span>;
        ISSN:<span class="NLM_cas:issn">2221-3759</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The epidermis is the outermost layer of the skin and provides a protective barrier against environmental insults.  It is a rapidly-renewing tissue undergoing const. regeneration, maintained by several types of stem cells.  The Hedgehog (HH) signaling pathway is one of the fundamental signaling pathways that contributes to epidermal development, homeostasis, and repair, as well as to hair follicle development and follicle bulge stem cell maintenance.  The HH pathway interacts with other signal transduction pathways, including those activated by Wnt, bone morphogenetic protein, platelet-derived growth factor, Notch, and ectodysplasin.  Furthermore, aberrant activation of HH signaling is assocd. with various tumors, including basal cell carcinoma.  Therefore, an understanding of the regulatory mechanisms of the HH signaling pathway is important for elucidating fundamental mechanisms underlying both organogenesis and carcinogenesis.  In this review, we discuss the role of the HH signaling pathway in the development and homeostasis epidermis and hair follicles, and in basal cell carcinoma formation, providing an update of current knowledge in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhGEhB_bmzdrVg90H21EOLACvtfcHk0lhLBclLDWKolA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvF2ls7s%253D&md5=58e8015a6c5c1d07d7b147811c81f6a5</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.3390%2Fjdb5040012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjdb5040012%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DN.%26atitle%3DRoles%2520of%2520the%2520hedgehog%2520signaling%2520pathway%2520in%2520epidermal%2520and%2520hair%2520follicle%2520development%252C%2520homeostasis%252C%2520and%2520cancer%26jtitle%3DJ.%2520Dev.%2520Biol.%26date%3D2017%26volume%3D5%26spage%3D12%26doi%3D10.3390%2Fjdb5040012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span> <span> </span><span class="NLM_article-title">Transient inhibition of the hedgehog pathway in young mice causes permanent defects in bone structure</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2008.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2008.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18328428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVKgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=249-260&author=H.+Kimuraauthor=J.+M.+Ngauthor=T.+Curran&title=Transient+inhibition+of+the+hedgehog+pathway+in+young+mice+causes+permanent+defects+in+bone+structure&doi=10.1016%2Fj.ccr.2008.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure</span></div><div class="casAuthors">Kimura, Hiromichi; Ng, Jessica M. Y.; Curran, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-260</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway plays crit. roles in normal development and in tumorigenesis.  We generated Gli-luciferase transgenic mice to evaluate the Smo inhibitor, HhAntag, by whole animal functional imaging.  HhAntag rapidly reduced systemic luciferase activity in 10- to 14-day-old mice following oral dosing.  Although pathway activity was restored 2 days after drug removal, brief inhibition caused permanent defects in bone growth.  HhAntag inhibited proliferation and promoted differentiation of chondrocytes, leading to dramatic expansion of the hypertrophic zone.  After drug removal, osteoblasts invaded the cartilage plate, mineralization occurred, and there was premature fusion of the growth plate resulting in permanent disruption of bone epiphyses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmLSyJ40mYXbVg90H21EOLACvtfcHk0lhLBclLDWKolA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVKgs70%253D&md5=73765e57376612b3698f8ed54df8ea70</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DJ.%2BM.%26aulast%3DCurran%26aufirst%3DT.%26atitle%3DTransient%2520inhibition%2520of%2520the%2520hedgehog%2520pathway%2520in%2520young%2520mice%2520causes%2520permanent%2520defects%2520in%2520bone%2520structure%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D249%26epage%3D260%26doi%3D10.1016%2Fj.ccr.2008.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aerts, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouffet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechinaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargrave, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalambakas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoerger, B.</span></span> <span> </span><span class="NLM_article-title">Phase i study of oral sonidegib (lde225) in pediatric brain and solid tumors and a phase ii study in children and adults with relapsed medulloblastoma</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1542</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nox109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1093%2Fneuonc%2Fnox109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28605510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2ktbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1542-1552&author=M.+W.+Kieranauthor=J.+Chisholmauthor=M.+Casanovaauthor=A.+A.+Brandesauthor=I.+Aertsauthor=E.+Bouffetauthor=S.+Baileyauthor=S.+Learyauthor=T.+J.+MacDonaldauthor=F.+Mechinaudauthor=K.+J.+Cohenauthor=R.+Riccardiauthor=W.+Masonauthor=D.+Hargraveauthor=S.+Kalambakasauthor=P.+Deshpandeauthor=F.+Taiauthor=E.+Hurhauthor=B.+Geoerger&title=Phase+i+study+of+oral+sonidegib+%28lde225%29+in+pediatric+brain+and+solid+tumors+and+a+phase+ii+study+in+children+and+adults+with+relapsed+medulloblastoma&doi=10.1093%2Fneuonc%2Fnox109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma</span></div><div class="casAuthors">Kieran, Mark W.; Chisholm, Julia; Casanova, Michela; Brandes, Alba A.; Aerts, Isabelle; Bouffet, Eric; Bailey, Simon; Leary, Sarah; MacDonald, Tobey J.; Mechinaud, Francoise; Cohen, Kenneth J.; Riccardi, Riccardo; Mason, Warren; Hargrave, Darren; Kalambakas, Stacey; Deshpande, Priya; Tai, Feng; Hurh, Eunju; Geoerger, Birgit</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1542-1552</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1523-5866</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Sonidegib (LDE225) is a potent, selective hedgehog (Hh) inhibitor of Smoothened.  This study explored the safety and pharmacokinetics of sonidegib in children with relapsed/recurrent tumors followed by a phase II trial in pediatric and adult patients with relapsed medulloblastoma (MB) to assess tumor response.  Pediatric patients aged ≥1 to <18 years were included according to a Bayesian design starting at 372 mg/ m2 of continuous once daily oral sonidegib.  Tumor samples were analyzed for Hh pathway activation using a validated 5-gene Hh signature assay.  In phase II, pediatric patients were treated at the recommended phase II dose (RP2D) while adults received 800 mg daily.  Sixteen adult (16 MB) and 60 pediatric (39 MB, 21 other) patients with an age range of 2-17 years were enrolled.  The RP2D of sonidegib in pediatric patients was established at 680 mg/m2 once daily.  The phase II study was closed prematurely.The 5-gene Hh signature assay showed that the 4 complete responders (2 pediatric and 2 adult) and 1 partial responder (adult) all had Hh-activated tumors, while 5 patients with activated Hh had either stable disease (n = 3) or progressive disease (n = 2).  No patient with an Hh-neg. signature (n = 50) responded.  The safety profile for pediatric patients was generally consistent with the one established for adult patients; however, growth plate changes were obsd. in prepubertal pediatric patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1R9xqXy9sebVg90H21EOLACvtfcHk0ljSwKhGmO68aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2ktbvP&md5=c1ab01d34522dbe851820e3c3a55dd9f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnox109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnox109%26sid%3Dliteratum%253Aachs%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DChisholm%26aufirst%3DJ.%26aulast%3DCasanova%26aufirst%3DM.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DAerts%26aufirst%3DI.%26aulast%3DBouffet%26aufirst%3DE.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DLeary%26aufirst%3DS.%26aulast%3DMacDonald%26aufirst%3DT.%2BJ.%26aulast%3DMechinaud%26aufirst%3DF.%26aulast%3DCohen%26aufirst%3DK.%2BJ.%26aulast%3DRiccardi%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DW.%26aulast%3DHargrave%26aufirst%3DD.%26aulast%3DKalambakas%26aufirst%3DS.%26aulast%3DDeshpande%26aufirst%3DP.%26aulast%3DTai%26aufirst%3DF.%26aulast%3DHurh%26aufirst%3DE.%26aulast%3DGeoerger%26aufirst%3DB.%26atitle%3DPhase%2520i%2520study%2520of%2520oral%2520sonidegib%2520%2528lde225%2529%2520in%2520pediatric%2520brain%2520and%2520solid%2520tumors%2520and%2520a%2520phase%2520ii%2520study%2520in%2520children%2520and%2520adults%2520with%2520relapsed%2520medulloblastoma%26jtitle%3DNeuro%2520Oncol%26date%3D2017%26volume%3D19%26spage%3D1542%26epage%3D1552%26doi%3D10.1093%2Fneuonc%2Fnox109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaste, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chemaitilly, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottardo, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partap, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onar-Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajjar, A.</span></span> <span> </span><span class="NLM_article-title">Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">69295</span>– <span class="NLM_lpage">69302</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.20619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29050204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC1M7isFWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=69295-69302&author=G.+W.+Robinsonauthor=S.+C.+Kasteauthor=W.+Chemaitillyauthor=D.+C.+Bowersauthor=S.+Laughtonauthor=A.+Smithauthor=N.+G.+Gottardoauthor=S.+Partapauthor=A.+Bendelauthor=K.+D.+Wrightauthor=B.+A.+Orrauthor=W.+C.+Warnerauthor=A.+Onar-Thomasauthor=A.+Gajjar&title=Irreversible+growth+plate+fusions+in+children+with+medulloblastoma+treated+with+a+targeted+hedgehog+pathway+inhibitor&doi=10.18632%2Foncotarget.20619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor</span></div><div class="casAuthors">Robinson Giles W; Gajjar Amar; Kaste Sue C; Chemaitilly Wassim; Bowers Daniel C; Laughton Stephen; Smith Amy; Gottardo Nicholas G; Partap Sonia; Bendel Anne; Wright Karen D; Orr Brent A; Warner William C; Onar-Thomas Arzu</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">69295-69302</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The permanent defects in bone growth observed in preclinical studies of hedgehog (Hh) pathway inhibitors were not substantiated in early phase clinical studies of vismodegib in children.  Consequently, vismodegib advanced into pediatric trials for malignancies suspected of being driven by aberrant activation of the Hh pathway.  In one multicenter phase II trial, vismodegib was added to the therapy regimen for newly diagnosed Hh pathway activated medulloblastoma.  Herein, we report on 3 children (2 on trial and one off trial) treated with vismodegib who developed widespread growth plate fusions that persist long after cessation of therapy.  Currently, all 3 patients exhibit profound short stature and disproportionate growth, and 2 subsequently developed precocious puberty.  Notably, the growth plate fusions only developed after a prolonged exposure to the drug (> 140 days).  These findings resulted in a major trial amendment to restrict the agent to skeletally mature patients as well as a product label warning and update.  Moreover, these findings alter the risk-benefit ratio of Hh inhibitors and underscore the importance of careful study of targeted agents in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC7b2by7_iHiEJCPKhJPuqfW6udTcc2eYm4wqbPbYz57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7isFWjtw%253D%253D&md5=1a509da5917b9097f5c2ed2d6ed9d002</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20619%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DG.%2BW.%26aulast%3DKaste%26aufirst%3DS.%2BC.%26aulast%3DChemaitilly%26aufirst%3DW.%26aulast%3DBowers%26aufirst%3DD.%2BC.%26aulast%3DLaughton%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DGottardo%26aufirst%3DN.%2BG.%26aulast%3DPartap%26aufirst%3DS.%26aulast%3DBendel%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DK.%2BD.%26aulast%3DOrr%26aufirst%3DB.%2BA.%26aulast%3DWarner%26aufirst%3DW.%2BC.%26aulast%3DOnar-Thomas%26aufirst%3DA.%26aulast%3DGajjar%26aufirst%3DA.%26atitle%3DIrreversible%2520growth%2520plate%2520fusions%2520in%2520children%2520with%2520medulloblastoma%2520treated%2520with%2520a%2520targeted%2520hedgehog%2520pathway%2520inhibitor%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D69295%26epage%3D69302%26doi%3D10.18632%2Foncotarget.20619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span> <span> </span><span class="NLM_article-title">Reproducibility of academic preclinical translational research: Lessons from the development of hedgehog pathway inhibitors to treat cancer</span>. <i>Open Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">180098</span>, <span class="refDoi"> DOI: 10.1098/rsob.180098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1098%2Frsob.180098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30068568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVamu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=180098&author=T.+Curran&title=Reproducibility+of+academic+preclinical+translational+research%3A+Lessons+from+the+development+of+hedgehog+pathway+inhibitors+to+treat+cancer&doi=10.1098%2Frsob.180098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer</span></div><div class="casAuthors">Curran, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Open Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">180098/1-180098/15</span>CODEN:
                <span class="NLM_cas:coden">OBPICQ</span>;
        ISSN:<span class="NLM_cas:issn">2046-2441</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  Academic translational research is growing at a great pace at a time in which questions have been raised about the reproducibility of preclin. findings.  The development of Hedgehog (HH) pathway inhibitors for the treatment of cancer over the past two decades offers a case study for understanding the root causes of failure to predict clin. outcomes arising from academic pre-clin. translational research.  Although such inhibitors were once hoped to be efficacious in up to 25% of human cancer, clin. studies showed responses only in basal cell carcinoma and the HH subtype of medulloblastoma.  Close examn. of the published studies reveals limitations in the models used, lack of quant. stds., utilization of high drug concns. assocd. with non-specific toxicities and improper use of cell line and mouse models.  In part, these issues arise from scientific complexity, for example, the failure of tumor cell lines to maintain HH pathway activity in vitro, but a greater contributing factor appears to be the influence of unconscious bias.  There was a strong expectation that HH pathway inhibitors would make a profound impact on human cancer and expts. were designed with this assumption in mind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAq_EYETSsKbVg90H21EOLACvtfcHk0ljSwKhGmO68aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVamu74%253D&md5=5e1e67b920a50511f723feb28e116f77</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1098%2Frsob.180098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsob.180098%26sid%3Dliteratum%253Aachs%26aulast%3DCurran%26aufirst%3DT.%26atitle%3DReproducibility%2520of%2520academic%2520preclinical%2520translational%2520research%253A%2520Lessons%2520from%2520the%2520development%2520of%2520hedgehog%2520pathway%2520inhibitors%2520to%2520treat%2520cancer%26jtitle%3DOpen%2520Biol.%26date%3D2018%26volume%3D8%26spage%3D180098%26doi%3D10.1098%2Frsob.180098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balis, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalupski, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, D. M.</span></span> <span> </span><span class="NLM_article-title">Pilot clinical trial of hedgehog pathway inhibitor gdc-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5937</span>– <span class="NLM_lpage">5945</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-1269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1078-0432.CCR-14-1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25278454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGku73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=5937-5945&author=E.+J.+Kimauthor=V.+Sahaiauthor=E.+V.+Abelauthor=K.+A.+Griffithauthor=J.+K.+Greensonauthor=N.+Takebeauthor=G.+N.+Khanauthor=J.+L.+Blauauthor=R.+Craigauthor=U.+G.+Balisauthor=M.+M.+Zalupskiauthor=D.+M.+Simeone&title=Pilot+clinical+trial+of+hedgehog+pathway+inhibitor+gdc-0449+%28vismodegib%29+in+combination+with+gemcitabine+in+patients+with+metastatic+pancreatic+adenocarcinoma&doi=10.1158%2F1078-0432.CCR-14-1269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</span></div><div class="casAuthors">Kim, Edward J.; Sahai, Vaibhav; Abel, Ethan V.; Griffith, Kent A.; Greenson, Joel K.; Takebe, Naoko; Khan, Gazala N.; Blau, John L.; Craig, Ronald; Balis, Ulysses G.; Zalupski, Mark M.; Simeone, Diane M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5937-5945</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hedgehog (HH) signaling pathway is a key regulator in tumorigenesis of pancreatic adenocarcinoma and is upregulated in pancreatic adenocarcinoma cancer stem cells (CSCs).  GDC-0449 is an oral small-mol. inhibitor of the HH pathway.  This study assessed the effect of GDC-0449-mediated HH inhibition in paired biopsies, followed by combined treatment with gemcitabine, in patients with metastatic pancreatic adenocarcinoma.  Twenty-five patients were enrolled of which 23 underwent core biopsies at baseline and following 3 wk of GDC-0449.  On day 29, 23 patients started weekly gemcitabine while continuing GDC-0449.  We evaluated GLI1 and PTCH1 inhibition, change in CSCs, Ki-67, fibrosis, and assessed tumor response, survival and toxicity.  On pretreatment biopsy, 75% of patients had elevated sonic hedgehog (SHH) expression.  On posttreatment biopsy, GLI1 and PTCH1 decreased in 95.6% and 82.6% of 23 patients, fibrosis decreased in 45.4% of 22, and Ki-67 in 52.9% of 17 evaluable patients.  No significant changes were detected in CSCs pre- and postbiopsy.  The median progression-free and overall survival for all treated patients were 2.8 and 5.3 mo.  The response and disease control rate was 21.7% and 65.2%.  No significant correlation was noted between CSCs, fibrosis, SHH, Ki-67, GLI1, PTCH1 (baseline values or relative change on posttreatment biopsy), and survival.  Grade ≥3 adverse events were noted in 56% of patients.  We show that GDC-0449 for 3 wk leads to downmodulation of GLI1 and PTCH1, without significant changes in CSCs compared with baseline.  GDC-0449 and gemcitabine were not superior to gemcitabine alone in the treatment of metastatic pancreatic cancer.  Clin Cancer Res; 20(23); 5937-45. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq5qpSWNo-e7Vg90H21EOLACvtfcHk0ljpAYjzDtgrHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGku73L&md5=c0d47d2a371f9f08e8afb710a176a07c</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-1269%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DSahai%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DE.%2BV.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DGreenson%26aufirst%3DJ.%2BK.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DG.%2BN.%26aulast%3DBlau%26aufirst%3DJ.%2BL.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBalis%26aufirst%3DU.%2BG.%26aulast%3DZalupski%26aufirst%3DM.%2BM.%26aulast%3DSimeone%26aufirst%3DD.%2BM.%26atitle%3DPilot%2520clinical%2520trial%2520of%2520hedgehog%2520pathway%2520inhibitor%2520gdc-0449%2520%2528vismodegib%2529%2520in%2520combination%2520with%2520gemcitabine%2520in%2520patients%2520with%2520metastatic%2520pancreatic%2520adenocarcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D5937%26epage%3D5945%26doi%3D10.1158%2F1078-0432.CCR-14-1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catenacci, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junttila, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiba, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nattam, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozloff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajdev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleckman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, H. L.</span></span> <span> </span><span class="NLM_article-title">Randomized phase ib/ii study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">4284</span>– <span class="NLM_lpage">4292</span>, <span class="refDoi"> DOI: 10.1200/JCO.2015.62.8719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1200%2FJCO.2015.62.8719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26527777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVynsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=4284-4292&author=D.+V.+Catenacciauthor=M.+R.+Junttilaauthor=T.+Karrisonauthor=N.+Baharyauthor=M.+N.+Horibaauthor=S.+R.+Nattamauthor=R.+Marshauthor=J.+Wallaceauthor=M.+Kozloffauthor=L.+Rajdevauthor=D.+Cohenauthor=J.+Wadeauthor=B.+Sleckmanauthor=H.+J.+Lenzauthor=P.+Stiffauthor=P.+Kumarauthor=P.+Xuauthor=L.+Hendersonauthor=N.+Takebeauthor=R.+Salgiaauthor=X.+Wangauthor=W.+M.+Stadlerauthor=F.+J.+de+Sauvageauthor=H.+L.+Kindler&title=Randomized+phase+ib%2Fii+study+of+gemcitabine+plus+placebo+or+vismodegib%2C+a+hedgehog+pathway+inhibitor%2C+in+patients+with+metastatic+pancreatic+cancer&doi=10.1200%2FJCO.2015.62.8719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer</span></div><div class="casAuthors">Catenacci, Daniel V. T.; Junttila, Melissa R.; Karrison, Theodore; Bahary, Nathan; Horiba, Margit N.; Nattam, Sreenivasa R.; Marsh, Robert; Wallace, James; Kozloff, Mark; Rajdev, Lakshmi; Cohen, Deirdre; Wade, James; Sleckman, Bethany; Lenz, Heinz-Josef; Stiff, Patrick; Kumar, Pankaj; Xu, Peng; Henderson, Les; Takebe, Naoko; Salgia, Ravi; Wang, Xi; Stadler, Walter M.; de Sauvage, Frederic J.; Kindler, Hedy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4284-4292</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Sonic hedgehog (SHH), an activating ligand of smoothened (SMO), is overexpressed in > 70% of pancreatic cancers (PCs).  We investigated the impact of vismodegib, an SHH antagonist, plus gemcitabine (GV) or gemcitabine plus placebo (GP) in a multicenter phase Ib/randomized phase II trial and preclin. PC models.  Patients and Methods: Patients with PC not amenable to curative therapy who had received no prior therapy for metastatic disease and had Karnofsky performance score ≥ 80 were enrolled.  Patients were randomly assigned in a one-to-one ratio to GV or GP.  The primary end point was progression-free-survival (PFS).  Exploratory correlative studies included serial SHH serum levels and contrast perfusion computed tomog. imaging.  To further investigate putative biol. mechanisms of SMO inhibition, two autochthonous pancreatic cancer models (KrasG12D; p16/p19fl/fl; Pdx1-Cre and KrasG12D; p53R270H/wt; Pdx1-Cre) were studied.  Results: No safety issues were identified in the phase Ib portion (n = 7), and the phase II study enrolled 106 evaluable patients (n = 53 in each arm).  Median PFS was 4.0 and 2.5 mo for GV and GP arms, resp. (95% CI, 2.5 to 5.3 and 1.9 to 3.8, resp.; adjusted hazard ratio, 0.81; 95% CI, 0.54 to 1.21; P = .30).  Median overall survival (OS) was 6.9 and 6.1 mo for GV and GP arms, resp. (95% CI, 5.8 to 8.0 and 5.0 to 8.0, resp.; adjusted hazard ratio, 1.04; 95% CI, 0.69 to 1.58; P = .84).  Response rates were not significantly different.  There were no significant assocns. between correlative markers and overall response rate, PFS, or OS.  Preclin. trials revealed no significant differences with vismodegib in drug delivery, tumor growth rate, or OS in either model.  Conclusion: The addn. of vismodegib to gemcitabine in an unselected cohort did not improve overall response rate, PFS, or OS in patients with metastatic PC.  Our preclin. and clin. results revealed no statistically significant differences with respect to drug delivery or treatment efficacy using vismodegib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYIFvd4cyQ4bVg90H21EOLACvtfcHk0ljpAYjzDtgrHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVynsbc%253D&md5=3ccbe6276194f6947c9b4e9e894ec3ed</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.62.8719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.62.8719%26sid%3Dliteratum%253Aachs%26aulast%3DCatenacci%26aufirst%3DD.%2BV.%26aulast%3DJunttila%26aufirst%3DM.%2BR.%26aulast%3DKarrison%26aufirst%3DT.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DHoriba%26aufirst%3DM.%2BN.%26aulast%3DNattam%26aufirst%3DS.%2BR.%26aulast%3DMarsh%26aufirst%3DR.%26aulast%3DWallace%26aufirst%3DJ.%26aulast%3DKozloff%26aufirst%3DM.%26aulast%3DRajdev%26aufirst%3DL.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DWade%26aufirst%3DJ.%26aulast%3DSleckman%26aufirst%3DB.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DStiff%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DHenderson%26aufirst%3DL.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DStadler%26aufirst%3DW.%2BM.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26aulast%3DKindler%26aufirst%3DH.%2BL.%26atitle%3DRandomized%2520phase%2520ib%252Fii%2520study%2520of%2520gemcitabine%2520plus%2520placebo%2520or%2520vismodegib%252C%2520a%2520hedgehog%2520pathway%2520inhibitor%252C%2520in%2520patients%2520with%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D33%26spage%3D4284%26epage%3D4292%26doi%3D10.1200%2FJCO.2015.62.8719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallop, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nannini-Pepe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotkow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsters, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">A paracrine requirement for hedgehog signalling in cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1038/nature07275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature07275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18754008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFams7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=406-410&author=R.+L.+Yauchauthor=S.+E.+Gouldauthor=S.+J.+Scalesauthor=T.+Tangauthor=H.+Tianauthor=C.+P.+Ahnauthor=D.+Marshallauthor=L.+Fuauthor=T.+Januarioauthor=D.+Kallopauthor=M.+Nannini-Pepeauthor=K.+Kotkowauthor=J.+C.+Marstersauthor=L.+L.+Rubinauthor=F.+J.+de+Sauvage&title=A+paracrine+requirement+for+hedgehog+signalling+in+cancer&doi=10.1038%2Fnature07275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">A paracrine requirement for hedgehog signalling in cancer</span></div><div class="casAuthors">Yauch, Robert L.; Gould, Stephen E.; Scales, Suzie J.; Tang, Tracy; Tian, Hua; Ahn, Christina P.; Marshall, Derek; Fu, Ling; Januario, Thomas; Kallop, Dara; Nannini-Pepe, Michelle; Kotkow, Karen; Marsters, James C.; Rubin, Lee L.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7211</span>),
    <span class="NLM_cas:pages">406-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ligand-dependent activation of the hedgehog (Hh) signaling pathway has been assocd. with tumorigenesis in a no. of human tissues.  Here it is shown that, although previous reports have described a cell-autonomous role for Hh signaling in these tumors, Hh ligands fail to activate signaling in tumor epithelial cells.  In contrast, these data support ligand-dependent activation of the Hh pathway in the stromal microenvironment.  Specific inhibition of Hh signaling using small mol. inhibitors, a neutralizing anti-Hh antibody or genetic deletion of smoothened (Smo) in the mouse stroma results in growth inhibition in xenograft tumor models.  Taken together, these studies demonstrate a paracrine requirement for Hh ligand signaling in the tumorigenesis of Hh-expressing cancers and have important implications for the development of Hh pathway antagonists in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpJWpPtWaw7Vg90H21EOLACvtfcHk0liKIUljKg4tyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFams7fP&md5=cb96322999aaeee1b41f23e5f080ab23</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnature07275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07275%26sid%3Dliteratum%253Aachs%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DAhn%26aufirst%3DC.%2BP.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DKallop%26aufirst%3DD.%26aulast%3DNannini-Pepe%26aufirst%3DM.%26aulast%3DKotkow%26aufirst%3DK.%26aulast%3DMarsters%26aufirst%3DJ.%2BC.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DA%2520paracrine%2520requirement%2520for%2520hedgehog%2520signalling%2520in%2520cancer%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D406%26epage%3D410%26doi%3D10.1038%2Fnature07275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuPree, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darbonne, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">4254</span>– <span class="NLM_lpage">4259</span>, <span class="refDoi"> DOI: 10.1073/pnas.0813203106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0813203106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19246386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslChu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4254-4259&author=H.+Tianauthor=C.+A.+Callahanauthor=K.+J.+DuPreeauthor=W.+C.+Darbonneauthor=C.+P.+Ahnauthor=S.+J.+Scalesauthor=F.+J.+de+Sauvage&title=Hedgehog+signaling+is+restricted+to+the+stromal+compartment+during+pancreatic+carcinogenesis&doi=10.1073%2Fpnas.0813203106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis</span></div><div class="casAuthors">Tian, Hua; Callahan, Christopher A.; DuPree, Kelly J.; Darbonne, Walter C.; Ahn, Christina P.; Scales, Suzie J.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4254-4259</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway has been implicated in pancreatic cancer but its role remains controversial.  To delineate the cell populations able to respond to Hh ligand stimulation, we expressed an oncogenic allele of Smoothened (SmoM2) to cell autonomously activate Hh signaling in the mouse pancreas.  Surprisingly, we found that expression of SmoM2 in epithelial cells was not able to activate the pathway and had no impact on pancreatic development or neoplasia.  In contrast, activation of Smo in the mesenchyme led to Hh pathway activation, indicating that only the tumor stroma is competent to transduce the Hh signal.  Using a Ptc-LacZ reporter mouse, we show that Hh signaling is active in stromal cells surrounding Hh-expressing tumor epithelium in various mouse pancreatic cancer models.  Activation of the Hh pathway in the tumor stroma of human pancreatic and metastatic cancer specimens was confirmed by quant. RT-PCR of microdissected tissue samples.  These data support a paracrine model of Hh-mediated tumorigenesis, in which tumor cells secrete Hh ligand to induce tumor-promoting Hh target genes in adjacent stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByH4lq_81RbVg90H21EOLACvtfcHk0liKIUljKg4tyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslChu74%253D&md5=f9da3fb447be4e590bc2a8c35744a9e1</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0813203106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0813203106%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DC.%2BA.%26aulast%3DDuPree%26aufirst%3DK.%2BJ.%26aulast%3DDarbonne%26aufirst%3DW.%2BC.%26aulast%3DAhn%26aufirst%3DC.%2BP.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DHedgehog%2520signaling%2520is%2520restricted%2520to%2520the%2520stromal%2520compartment%2520during%2520pancreatic%2520carcinogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D4254%26epage%3D4259%26doi%3D10.1073%2Fpnas.0813203106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan-Stevaux, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truitt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebrok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Zapico, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span> <span> </span><span class="NLM_article-title">Gli1 is regulated through smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates pdac cell survival and transformation</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1101/gad.1753809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1101%2Fgad.1753809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19136624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFWlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=24-36&author=O.+Nolan-Stevauxauthor=J.+Lauauthor=M.+L.+Truittauthor=G.+C.+Chuauthor=M.+Hebrokauthor=M.+E.+Fernandez-Zapicoauthor=D.+Hanahan&title=Gli1+is+regulated+through+smoothened-independent+mechanisms+in+neoplastic+pancreatic+ducts+and+mediates+pdac+cell+survival+and+transformation&doi=10.1101%2Fgad.1753809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">GLI1 is regulated through smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation</span></div><div class="casAuthors">Nolan-Stevaux, Olivier; Lau, Janet; Truitt, Morgan L.; Chu, Gerald C.; Hebrok, Matthias; Fernandez-Zapico, Martin E.; Hanahan, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-36</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is characterized by the deregulation of the hedgehog signaling pathway.  The Sonic Hedgehog ligand (Shh), absent in the normal pancreas, is highly expressed in pancreatic tumors and is sufficient to induce neoplastic precursor lesions in mouse models.  We investigated the mechanism of Shh signaling in PDAC carcinogenesis by genetically ablating the canonical bottleneck of hedgehog signaling, the transmembrane protein Smoothened (Smo), in the pancreatic epithelium of PDAC-susceptible mice.  We report that multistage development of PDAC tumors is not affected by the deletion of Smo in the pancreas, demonstrating that autocrine Shh-Ptch-Smo signaling is not required in pancreatic ductal cells for PDAC progression.  However, the expression of Gli target genes is maintained in Smo-neg. ducts, implicating alternative means of regulating Gli transcription in the neoplastic ductal epithelium.  In PDAC tumor cells, we find that Gli transcription is decoupled from upstream Shh-Ptch-Smo signaling and is regulated by TGF-β and KRAS, and we show that Gli1 is required both for survival and for the KRAS-mediated transformed phenotype of cultured PDAC cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzKdXxhFHpJbVg90H21EOLACvtfcHk0liKIUljKg4tyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFWlsQ%253D%253D&md5=6ef2e938cae3283163a0ff726fb76f48</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1101%2Fgad.1753809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1753809%26sid%3Dliteratum%253Aachs%26aulast%3DNolan-Stevaux%26aufirst%3DO.%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DTruitt%26aufirst%3DM.%2BL.%26aulast%3DChu%26aufirst%3DG.%2BC.%26aulast%3DHebrok%26aufirst%3DM.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DGli1%2520is%2520regulated%2520through%2520smoothened-independent%2520mechanisms%2520in%2520neoplastic%2520pancreatic%2520ducts%2520and%2520mediates%2520pdac%2520cell%2520survival%2520and%2520transformation%26jtitle%3DGenes%2520Dev.%26date%3D2009%26volume%3D23%26spage%3D24%26epage%3D36%26doi%3D10.1101%2Fgad.1753809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberstein, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirek, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastra, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekleva, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becerra, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattersall, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphalen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitajewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Barrena, M.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Zapico, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanger, B. Z.</span></span> <span> </span><span class="NLM_article-title">Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2014.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24856585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslyisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=735-747&author=A.+D.+Rhimauthor=P.+E.+Obersteinauthor=D.+H.+Thomasauthor=E.+T.+Mirekauthor=C.+F.+Palermoauthor=S.+A.+Sastraauthor=E.+N.+Deklevaauthor=T.+Saundersauthor=C.+P.+Becerraauthor=I.+W.+Tattersallauthor=C.+B.+Westphalenauthor=J.+Kitajewskiauthor=M.%0AG.+Fernandez-Barrenaauthor=M.+E.+Fernandez-Zapicoauthor=C.+Iacobuzio-Donahueauthor=K.+P.+Oliveauthor=B.+Z.+Stanger&title=Stromal+elements+act+to+restrain%2C+rather+than+support%2C+pancreatic+ductal+adenocarcinoma&doi=10.1016%2Fj.ccr.2014.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Rhim, Andrew D.; Oberstein, Paul E.; Thomas, Dafydd H.; Mirek, Emily T.; Palermo, Carmine F.; Sastra, Stephen A.; Dekleva, Erin N.; Saunders, Tyler; Becerra, Claudia P.; Tattersall, Ian W.; Westphalen, C. Benedikt; Kitajewski, Jan; Fernandez-Barrena, Maite G.; Fernandez-Zapico, Martin E.; Iacobuzio-Donahue, Christine; Olive, Kenneth P.; Stanger, Ben Z.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">735-747</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Sonic hedgehog (Shh), a sol. ligand overexpressed by neoplastic cells in pancreatic ductal adenocarcinoma (PDAC), drives formation of a fibroblast-rich desmoplastic stroma.  To better understand its role in malignant progression, we deleted Shh in a well-defined mouse model of PDAC.  As predicted, Shh-deficient tumors had reduced stromal content.  Surprisingly, such tumors were more aggressive and exhibited undifferentiated histol., increased vascularity, and heightened proliferation-features that were fully recapitulated in control mice treated with a Smoothened inhibitor.  Furthermore, administration of VEGFR blocking antibody selectively improved survival of Shh-deficient tumors, indicating that Hedgehog-driven stroma suppresses tumor growth in part by restraining tumor angiogenesis.  Together, these data demonstrate that some components of the tumor stroma can act to restrain tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXaMntrm5pkbVg90H21EOLACvtfcHk0li5w82cj5qhJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslyisbc%253D&md5=074369eb89c54fc678b3e5c644d32e29</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DRhim%26aufirst%3DA.%2BD.%26aulast%3DOberstein%26aufirst%3DP.%2BE.%26aulast%3DThomas%26aufirst%3DD.%2BH.%26aulast%3DMirek%26aufirst%3DE.%2BT.%26aulast%3DPalermo%26aufirst%3DC.%2BF.%26aulast%3DSastra%26aufirst%3DS.%2BA.%26aulast%3DDekleva%26aufirst%3DE.%2BN.%26aulast%3DSaunders%26aufirst%3DT.%26aulast%3DBecerra%26aufirst%3DC.%2BP.%26aulast%3DTattersall%26aufirst%3DI.%2BW.%26aulast%3DWestphalen%26aufirst%3DC.%2BB.%26aulast%3DKitajewski%26aufirst%3DJ.%26aulast%3DFernandez-Barrena%26aufirst%3DM.%2BG.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DOlive%26aufirst%3DK.%2BP.%26aulast%3DStanger%26aufirst%3DB.%2BZ.%26atitle%3DStromal%2520elements%2520act%2520to%2520restrain%252C%2520rather%2520than%2520support%252C%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D735%26epage%3D747%26doi%3D10.1016%2Fj.ccr.2014.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozdemir, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentcheva-Hoang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstens, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laklai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novitskiy, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jesus-Acosta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBleu, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalluri, R.</span></span> <span> </span><span class="NLM_article-title">Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2014.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24856586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2hsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=719-734&author=B.+C.+Ozdemirauthor=T.+Pentcheva-Hoangauthor=J.+L.+Carstensauthor=X.+Zhengauthor=C.+C.+Wuauthor=T.+R.+Simpsonauthor=H.+Laklaiauthor=H.+Sugimotoauthor=C.+Kahlertauthor=S.+V.+Novitskiyauthor=A.+De+Jesus-Acostaauthor=P.+Sharmaauthor=P.+Heidariauthor=U.+Mahmoodauthor=L.+Chinauthor=H.+L.+Mosesauthor=V.+M.+Weaverauthor=A.+Maitraauthor=J.+P.+Allisonauthor=V.+S.+LeBleuauthor=R.+Kalluri&title=Depletion+of+carcinoma-associated+fibroblasts+and+fibrosis+induces+immunosuppression+and+accelerates+pancreas+cancer+with+reduced+survival&doi=10.1016%2Fj.ccr.2014.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival</span></div><div class="casAuthors">Ozdemir, Berna C.; Pentcheva-Hoang, Tsvetelina; Carstens, Julienne L.; Zheng, Xiaofeng; Wu, Chia-Chin; Simpson, Tyler R.; Laklai, Hanane; Sugimoto, Hikaru; Kahlert, Christoph; Novitskiy, Sergey V.; De Jesus-Acosta, Ana; Sharma, Padmanee; Heidari, Pedram; Mahmood, Umar; Chin, Lynda; Moses, Harold L.; Weaver, Valerie M.; Maitra, Anirban; Allison, James P.; LeBleu, Valerie S.; Kalluri, Raghu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-734</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is assocd. with marked fibrosis and stromal myofibroblasts, but their functional contribution remains unknown.  Transgenic mice with the ability to delete αSMA+ myofibroblasts in pancreatic cancer were generated.  Depletion starting at either noninvasive precursor (pancreatic intraepithelial neoplasia) or the PDAC stage led to invasive, undifferentiated tumors with enhanced hypoxia, epithelial-to-mesenchymal transition, and cancer stem cells, with diminished animal survival.  In PDAC patients, fewer myofibroblasts in their tumors also correlated with reduced survival.  Suppressed immune surveillance with increased CD4+Foxp3+ Tregs was obsd. in myofibroblast-depleted mouse tumors.  Although myofibroblast-depleted tumors did not respond to gemcitabine, anti-CTLA4 immunotherapy reversed disease acceleration and prolonged animal survival.  This study underscores the need for caution in targeting carcinoma-assocd. fibroblasts in PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfEmS1FleEo7Vg90H21EOLACvtfcHk0li5w82cj5qhJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2hsr0%253D&md5=682e316bd29cdd7a4d5a71bb6b0649b5</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DOzdemir%26aufirst%3DB.%2BC.%26aulast%3DPentcheva-Hoang%26aufirst%3DT.%26aulast%3DCarstens%26aufirst%3DJ.%2BL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DC.%2BC.%26aulast%3DSimpson%26aufirst%3DT.%2BR.%26aulast%3DLaklai%26aufirst%3DH.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DKahlert%26aufirst%3DC.%26aulast%3DNovitskiy%26aufirst%3DS.%2BV.%26aulast%3DDe%2BJesus-Acosta%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DHeidari%26aufirst%3DP.%26aulast%3DMahmood%26aufirst%3DU.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DMoses%26aufirst%3DH.%2BL.%26aulast%3DWeaver%26aufirst%3DV.%2BM.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26aulast%3DLeBleu%26aufirst%3DV.%2BS.%26aulast%3DKalluri%26aufirst%3DR.%26atitle%3DDepletion%2520of%2520carcinoma-associated%2520fibroblasts%2520and%2520fibrosis%2520induces%2520immunosuppression%2520and%2520accelerates%2520pancreas%2520cancer%2520with%2520reduced%2520survival%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D719%26epage%3D734%26doi%3D10.1016%2Fj.ccr.2014.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neesse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gress, T. M.</span></span> <span> </span><span class="NLM_article-title">Stromal biology and therapy in pancreatic cancer: Ready for clinical translation?</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2018-316451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1136%2Fgutjnl-2018-316451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30177543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKls7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2019&pages=159-171&author=A.+Neesseauthor=C.+A.+Bauerauthor=D.+Ohlundauthor=M.+Lauthauthor=M.+Buchholzauthor=P.+Michlauthor=D.+A.+Tuvesonauthor=T.+M.+Gress&title=Stromal+biology+and+therapy+in+pancreatic+cancer%3A+Ready+for+clinical+translation%3F&doi=10.1136%2Fgutjnl-2018-316451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal biology and therapy in pancreatic cancer: ready for clinical translation?</span></div><div class="casAuthors">Neesse, Albrecht; Bauer, Christian Alexander; Oehlund, Daniel; Lauth, Matthias; Buchholz, Malte; Michl, Patrick; Tuveson, David A.; Gress, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-171</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic ductal adenocarcinoma (PDA) is notoriously aggressive and hard to treat.  The tumor microenvironment (TME) in PDA is highly dynamic and has been found to promote tumor progression, metastasis niche formation and therapeutic resistance.  Intensive research of recent years has revealed an incredible heterogeneity and complexity of the different components of the TME, including cancer-assocd. fibroblasts, immune cells, extracellular matrix components, tumor vessels and nerves.  It has been hypothesised that paracrine interactions between neoplastic epithelial cells and TME compartments may result in either tumor-promoting or tumor-restraining consequences.  A better preclin. understanding of such complex and dynamic network systems is required to develop more powerful treatment strategies for patients.  Scientific activity and the no. of compelling findings has virtually exploded during recent years.  Here, we provide an update of the most recent findings in this area and discuss their translational and clin. implications for basic scientists and clinicians alike.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV8HJgV9Ti1LVg90H21EOLACvtfcHk0li5w82cj5qhJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKls7jL&md5=0f03d36f9e3abffe7a09adce20614a5e</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2018-316451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2018-316451%26sid%3Dliteratum%253Aachs%26aulast%3DNeesse%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DC.%2BA.%26aulast%3DOhlund%26aufirst%3DD.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DMichl%26aufirst%3DP.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DGress%26aufirst%3DT.%2BM.%26atitle%3DStromal%2520biology%2520and%2520therapy%2520in%2520pancreatic%2520cancer%253A%2520Ready%2520for%2520clinical%2520translation%253F%26jtitle%3DGut%26date%3D2019%26volume%3D68%26spage%3D159%26epage%3D171%26doi%3D10.1136%2Fgutjnl-2018-316451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buller, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frings, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wielenga, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhl, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Brink, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Stromal hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12321</span>, <span class="refDoi"> DOI: 10.1038/ncomms12321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms12321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27492255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlalsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12321&author=M.+Gerlingauthor=N.+V.+Bullerauthor=L.+M.+Kirnauthor=S.+Joostauthor=O.+Fringsauthor=B.+Englertauthor=A.+Bergstromauthor=R.+V.+Kuiperauthor=L.+Blaasauthor=M.+C.+Wielengaauthor=S.+Almerauthor=A.+A.+Kuhlauthor=E.+Fredlundauthor=G.+R.+van+den+Brinkauthor=R.+Toftgard&title=Stromal+hedgehog+signalling+is+downregulated+in+colon+cancer+and+its+restoration+restrains+tumour+growth&doi=10.1038%2Fncomms12321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth</span></div><div class="casAuthors">Gerling, Marco; Buller, Nike V. J. A.; Kirn, Leonard M.; Joost, Simon; Frings, Oliver; Englert, Benjamin; Bergstroem, Aasa; Kuiper, Raoul V.; Blaas, Leander; Wielenga, Mattheus C. B.; Almer, Sven; Kuhl, Anja A.; Fredlund, Erik; van den Brink, Gijs R.; Toftgaard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12321</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A role for Hedgehog (Hh) signalling in the development of colorectal cancer (CRC) has been proposed.  In CRC and other solid tumors, Hh ligands are upregulated; however, a specific Hh antagonist provided no benefit in a clin. trial.  Here we use Hh reporter mice to show that downstream Hh activity is unexpectedly diminished in a mouse model of colitis-assocd. colon cancer, and that downstream Hh signalling is restricted to the stroma.  Functionally, stroma-specific Hh activation in mice markedly reduces the tumor load and blocks progression of advanced neoplasms, partly via the modulation of BMP signalling and restriction of the colonic stem cell signature.  By contrast, attenuated Hh signalling accelerates colonic tumorigenesis.  In human CRC, downstream Hh activity is similarly reduced and canonical Hh signalling remains predominantly paracrine.  Our results suggest that diminished downstream Hh signalling enhances CRC development, and that stromal Hh activation can act as a colonic tumor suppressor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Q_8DHVrSWrVg90H21EOLACvtfcHk0lj5YFIKxcZU_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlalsbvE&md5=2a3004c26c67398117eb30c4036826cf</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fncomms12321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12321%26sid%3Dliteratum%253Aachs%26aulast%3DGerling%26aufirst%3DM.%26aulast%3DBuller%26aufirst%3DN.%2BV.%26aulast%3DKirn%26aufirst%3DL.%2BM.%26aulast%3DJoost%26aufirst%3DS.%26aulast%3DFrings%26aufirst%3DO.%26aulast%3DEnglert%26aufirst%3DB.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DKuiper%26aufirst%3DR.%2BV.%26aulast%3DBlaas%26aufirst%3DL.%26aulast%3DWielenga%26aufirst%3DM.%2BC.%26aulast%3DAlmer%26aufirst%3DS.%26aulast%3DKuhl%26aufirst%3DA.%2BA.%26aulast%3DFredlund%26aufirst%3DE.%26aulast%3Dvan%2Bden%2BBrink%26aufirst%3DG.%2BR.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DStromal%2520hedgehog%2520signalling%2520is%2520downregulated%2520in%2520colon%2520cancer%2520and%2520its%2520restoration%2520restrains%2520tumour%2520growth%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12321%26doi%3D10.1038%2Fncomms12321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruzas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamin, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geles, K. G.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated fibroblasts suppress sox2-induced dysplasia in a lung squamous cancer coculture</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E11671</span>– <span class="NLM_lpage">E11680</span>, <span class="refDoi"> DOI: 10.1073/pnas.1803718115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1803718115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30487219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E11671-E11680&author=S.+Chenauthor=A.+Giannakouauthor=S.+Wymanauthor=J.+Gruzasauthor=J.+Golasauthor=W.+Zhongauthor=C.+Lorethauthor=L.+Sridharanauthor=T.+T.+Yaminauthor=M.+Damelinauthor=K.+G.+Geles&title=Cancer-associated+fibroblasts+suppress+sox2-induced+dysplasia+in+a+lung+squamous+cancer+coculture&doi=10.1073%2Fpnas.1803718115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture</span></div><div class="casAuthors">Chen, Shuang; Giannakou, Andreas; Wyman, Sarah; Gruzas, Janet; Golas, Jonathon; Zhong, Wenyan; Loreth, Christine; Sridharan, Latha; Yamin, Ting-Ting; Damelin, Marc; Geles, Kenneth G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">E11671-E11680</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumorigenesis depends on intricate interactions between genetically altered tumor cells and their surrounding microenvironment.  While oncogenic drivers in lung squamous carcinoma (LUSC) have been described, the role of stroma in modulating tissue architecture, particularly cell polarity, remains unclear.  Here, we report the establishment of a 3D coculture system of LUSC epithelial cells with cancer-assocd. fibroblasts (CAFs) and extracellular matrix that together capture key components of the tumor microenvironment (TME).  Single LUSC epithelial cells develop into acinar-like structures with 0.02% efficiency, and addn. of CAFs provides proper tumor-stromal interactions within an appropriate 3D architectural context.  Using this model, we recapitulate key pathol. changes during tumorigenesis, from hyperplasia to dysplasia and eventually invasion, in malignant LUSC spheroids that undergo phenotypic switching in response to cell intrinsic and extrinsic changes.  Overexpression of SOX2 is sufficient to mediate the transition from hyperplasia to dysplasia in LUSC spheroids, while the presence of CAFs makes them invasive.  Unexpectedly, CAFs suppress the activity of high SOX2 levels, restore hyperplasia, and enhance the formation of acinar-like structures.  Taken together, these observations suggest that stromal factors can override cell intrinsic oncogenic changes in detg. the disease phenotype, thus providing fundamental evidence for the existence of dynamic reciprocity between the nucleus and the TME of LUSC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGD17vpA5T7Vg90H21EOLACvtfcHk0lj5YFIKxcZU_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhu7jI&md5=b64aff031db9e3ec681b9fc140524129</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1803718115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1803718115%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGiannakou%26aufirst%3DA.%26aulast%3DWyman%26aufirst%3DS.%26aulast%3DGruzas%26aufirst%3DJ.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DLoreth%26aufirst%3DC.%26aulast%3DSridharan%26aufirst%3DL.%26aulast%3DYamin%26aufirst%3DT.%2BT.%26aulast%3DDamelin%26aufirst%3DM.%26aulast%3DGeles%26aufirst%3DK.%2BG.%26atitle%3DCancer-associated%2520fibroblasts%2520suppress%2520sox2-induced%2520dysplasia%2520in%2520a%2520lung%2520squamous%2520cancer%2520coculture%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE11671%26epage%3DE11680%26doi%3D10.1073%2Fpnas.1803718115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, A. L.</span></span> <span> </span><span class="NLM_article-title">Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1242/dmm.027417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1242%2Fdmm.027417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27935821" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=39-52&author=Z.+Yangauthor=Y.+C.+Pengauthor=A.+Gopalanauthor=D.+Gaoauthor=Y.+Chenauthor=A.+L.+Joyner&title=Stromal+hedgehog+signaling+maintains+smooth+muscle+and+hampers+micro-invasive+prostate+cancer&doi=10.1242%2Fdmm.027417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1242%2Fdmm.027417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.027417%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DY.%2BC.%26aulast%3DGopalan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoyner%26aufirst%3DA.%2BL.%26atitle%3DStromal%2520hedgehog%2520signaling%2520maintains%2520smooth%2520muscle%2520and%2520hampers%2520micro-invasive%2520prostate%2520cancer%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2017%26volume%3D10%26spage%3D39%26epage%3D52%26doi%3D10.1242%2Fdmm.027417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selway, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herath, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harwood, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirzado, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelsell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neill, G. W.</span></span> <span> </span><span class="NLM_article-title">A novel mechanism for activation of gli1 by nuclear smo that escapes anti-smo inhibitors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2577</span>– <span class="NLM_lpage">2588</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-17-2897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-17-2897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29463581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=2577-2588&author=M.+M.+Rahmanauthor=A.+Hazanauthor=J.+L.+Selwayauthor=D.+S.+Herathauthor=C.+A.+Harwoodauthor=M.+S.+Pirzadoauthor=R.+Atkarauthor=D.+P.+Kelsellauthor=K.+J.+Lintonauthor=M.+P.+Philpottauthor=G.+W.+Neill&title=A+novel+mechanism+for+activation+of+gli1+by+nuclear+smo+that+escapes+anti-smo+inhibitors&doi=10.1158%2F0008-5472.CAN-17-2897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors</span></div><div class="casAuthors">Rahman, Muhammad M.; Hazan, Allon; Selway, Joanne L.; Herath, Dimalee S.; Harwood, Catherine A.; Pirzado, Muhammad S.; Atkar, Ravinder; Kelsell, David P.; Linton, Kenneth J.; Philpott, Mike P.; Neill, Graham W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2577-2588</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of the Hedgehog (HH) pathway receptor Smoothened (SMO) have been effective in treating some patients with basal cell carcinoma (BCC), where the HH pathway is often activated, but many patients respond poorly.  In this study, we report the results of investigations on PTCH1 signaling in the HH pathway that suggest why most patients with BCC respond poorly to SMO inhibitors.  In immortalized human keratinocytes, PTCH1 silencing led to the generation of a compact, holoclone-like morphol. with increased expression of SMO and the downstream HH pathway transcription factor GLI1.  Notably, although siRNA silencing of SMO in PTCH1-silenced cells was sufficient to suppress GLI1 activity, this effect was not phenocopied by pharmacol. inhibition of SMO, suggesting the presence of a second undefined pathway through which SMO can induce GLI1.  Consistent with this possibility, we obsd. increased nuclear localization of SMO in PTCH1-silenced cells as mediated by a putative SMO nuclear/nucleolar localization signal [N(o)LS].  Mutational inactivation of the N(o)LS ablated this increase and suppressed GLI1 induction.  Immunohistol. anal. of human and mouse BCC confirmed evidence of nuclear SMO, although the pattern was heterogeneous between tumors.  In PTCH1-silenced cells, >80% of the genes found to be differentially expressed were unaffected by SMO inhibitors, including the putative BCC driver gene CXCL11.  Our results demonstrate how PTCH1 loss results in aberrant regulation of SMO-independent mechanisms important for BCC biol. and highlights a novel nuclear mechanism of SMO-GLI1 signaling that is unresponsive to SMO inhibitors.  Significance: This study describes novel noncanonical Hedgehog signaling, where SMO enters the nucleus to activate GLI1, a mode that is unaffected by SMO inhibitors, thus prompting re-evaluation of current BCC treatment as well as new potential therapies targeting nuclear SMO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCCN7UfZggqrVg90H21EOLACvtfcHk0lhdfd_oOKQ_cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsbvN&md5=27156c409b90adbc7b16d137de98aa29</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-2897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-2897%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DM.%2BM.%26aulast%3DHazan%26aufirst%3DA.%26aulast%3DSelway%26aufirst%3DJ.%2BL.%26aulast%3DHerath%26aufirst%3DD.%2BS.%26aulast%3DHarwood%26aufirst%3DC.%2BA.%26aulast%3DPirzado%26aufirst%3DM.%2BS.%26aulast%3DAtkar%26aufirst%3DR.%26aulast%3DKelsell%26aufirst%3DD.%2BP.%26aulast%3DLinton%26aufirst%3DK.%2BJ.%26aulast%3DPhilpott%26aufirst%3DM.%2BP.%26aulast%3DNeill%26aufirst%3DG.%2BW.%26atitle%3DA%2520novel%2520mechanism%2520for%2520activation%2520of%2520gli1%2520by%2520nuclear%2520smo%2520that%2520escapes%2520anti-smo%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2018%26volume%3D78%26spage%3D2577%26epage%3D2588%26doi%3D10.1158%2F0008-5472.CAN-17-2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">The hedgehog pathway effector smoothened exhibits signaling competency in the absence of ciliary accumulation</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1680</span>– <span class="NLM_lpage">1689</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.chembiol.2014.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25484239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKnu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1680-1689&author=C.+W.+Fanauthor=B.+Chenauthor=I.+Francoauthor=J.+Luauthor=H.+Shiauthor=S.+Weiauthor=C.+Wangauthor=X.+Wuauthor=W.+Tangauthor=M.+G.+Rothauthor=N.+S.+Williamsauthor=E.+Hirschauthor=C.+Chenauthor=L.+Lum&title=The+hedgehog+pathway+effector+smoothened+exhibits+signaling+competency+in+the+absence+of+ciliary+accumulation&doi=10.1016%2Fj.chembiol.2014.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation</span></div><div class="casAuthors">Fan, Chih-Wei; Chen, Baozhi; Franco, Irene; Lu, Jianming; Shi, Heping; Wei, Shuguang; Wang, Changguang; Wu, Xiaofeng; Tang, Wei; Roth, Michael G.; Williams, Noelle S.; Hirsch, Emilio; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1680-1689</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Misactivation of the seven-transmembrane protein Smoothened (Smo) is frequently assocd. with basal cell carcinoma and medulloblastoma.  Cellular exposure to secreted Hedgehog (Hh) protein or oncogenic mutations in Hh pathway components induces Smo accumulation in the primary cilium, an antenna-like organelle with mostly unknown cellular functions.  Despite the data supporting an indispensable role of the primary cilium in Smo activation, the mechanistic underpinnings of this dependency remain unclear.  Using a cell-membrane-impermeable Smo antagonist (IHR-1), we demonstrate that Smo supplied with a synthetic agonist or activated with oncogenic mutations can signal without ciliary accumulation.  Similarly, cells with compromised ciliary Smo trafficking due to loss of the phosphatidylinositol-4-phosphate 3-kinase (PI3K)-C2α retain transcriptional response to an exogenously supplied Smo agonist.  These observations suggest that assembly of a Smo-signaling complex in the primary cilium is not a prerequisite for Hh pathway activation driven by Smo agonists or oncogenic Smo mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqowN-Z1_-MwbVg90H21EOLACvtfcHk0lhdfd_oOKQ_cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKnu7vK&md5=65aee97b46821125bb9dce3015bd7f86</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%2BW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DFranco%26aufirst%3DI.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DThe%2520hedgehog%2520pathway%2520effector%2520smoothened%2520exhibits%2520signaling%2520competency%2520in%2520the%2520absence%2520of%2520ciliary%2520accumulation%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1680%26epage%3D1689%26doi%3D10.1016%2Fj.chembiol.2014.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cupido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rack, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocasio, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. K.</span></span> <span> </span><span class="NLM_article-title">The imidazopyridine derivative jk184 reveals dual roles for microtubules in hedgehog signaling</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2321</span>– <span class="NLM_lpage">2324</span>, <span class="refDoi"> DOI: 10.1002/anie.200805666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fanie.200805666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1yqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2321-2324&author=T.+Cupidoauthor=P.+G.+Rackauthor=A.+J.+Firestoneauthor=J.+M.+Hymanauthor=K.+Hanauthor=S.+Sinhaauthor=C.+A.+Ocasioauthor=J.+K.+Chen&title=The+imidazopyridine+derivative+jk184+reveals+dual+roles+for+microtubules+in+hedgehog+signaling&doi=10.1002%2Fanie.200805666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The imidazopyridine derivative JK184 reveals dual roles for microtubules in hedgehog signaling</span></div><div class="casAuthors">Cupido, Tommaso; Rack, Paul G.; Firestone, Ari J.; Hyman, Joel M.; Han, Kyuho; Sinha, Surajit; Ocasio, Cory A.; Chen, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2321-2324</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Eradicating hedgehogs: The title mol. has been previously identified as a potent inhibitor of the Hedgehog signaling pathway, which gives embryonic cells information needed to develop properly.  This mol. is shown to modulate Hedgehog target gene expression by depolymg. microtubules, thus revealing dual roles of the cytoskeleton in pathway regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqryhyQ-Ii6i7Vg90H21EOLACvtfcHk0ljrep0zfmhkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1yqtLY%253D&md5=114978ea115db78ef98599d8ff6eeb09</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805666%26sid%3Dliteratum%253Aachs%26aulast%3DCupido%26aufirst%3DT.%26aulast%3DRack%26aufirst%3DP.%2BG.%26aulast%3DFirestone%26aufirst%3DA.%2BJ.%26aulast%3DHyman%26aufirst%3DJ.%2BM.%26aulast%3DHan%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DOcasio%26aufirst%3DC.%2BA.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26atitle%3DThe%2520imidazopyridine%2520derivative%2520jk184%2520reveals%2520dual%2520roles%2520for%2520microtubules%2520in%2520hedgehog%2520signaling%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D2321%26epage%3D2324%26doi%3D10.1002%2Fanie.200805666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span> <span> </span><span class="NLM_article-title">Biodegradable polymeric micelles encapsulated jk184 suppress tumor growth through inhibiting hedgehog signaling pathway</span>. <i>Nanoscale</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2609</span>– <span class="NLM_lpage">2624</span>, <span class="refDoi"> DOI: 10.1039/C4NR06300G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1039%2FC4NR06300G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25581613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFehtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2609-2624&author=N.+Zhangauthor=S.+Liuauthor=N.+Wangauthor=S.+Dengauthor=L.+Songauthor=Q.+Wuauthor=L.+Liuauthor=W.+Suauthor=Y.+Weiauthor=Y.+Xieauthor=C.+Gong&title=Biodegradable+polymeric+micelles+encapsulated+jk184+suppress+tumor+growth+through+inhibiting+hedgehog+signaling+pathway&doi=10.1039%2FC4NR06300G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway</span></div><div class="casAuthors">Zhang, Nannan; Liu, Shichang; Wang, Ning; Deng, Senyi; Song, Linjiang; Wu, Qinjie; Liu, Lei; Su, Weijun; Wei, Yuquan; Xie, Yongmei; Gong, Changyang</div><div class="citationInfo"><span class="NLM_cas:title">Nanoscale</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2609-2624</span>CODEN:
                <span class="NLM_cas:coden">NANOHL</span>;
        ISSN:<span class="NLM_cas:issn">2040-3372</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">JK184 can specially inhibit Gli in the Hedgehog (Hh) pathway, which showed great promise for cancer therapeutics.  For developing aq. formulation and improving anti-tumor activity of JK184, we prepd. JK184 encapsulated MPEG-PCL micelles by the solid dispersion method without using surfactants or toxic org. solvents.  The cytotoxicity and cellular uptake of JK184 micelles were both increased compared with the free drug.  JK184 micelles induced more apoptosis and blocked proliferation of Panc-1 and BxPC-3 tumor cells.  In addn., JK184 micelles exerted a sustained in vitro release behavior and had a stronger inhibitory effect on proliferation, migration and invasion of HUVECs than free JK184.  Furthermore, JK184 micelles had stronger tumor growth inhibiting effects in s.c. Panc-1 and BxPC-3 tumor models.  Histol. anal. showed that JK184 micelles improved anti-tumor activity by inducing more apoptosis, decreasing microvessel d. and reducing expression of CD31, Ki67, and VEGF in tumor tissues.  JK184 micelles showed a stronger inhibition of Gli expression in Hh signaling, which played an important role in pancreatic carcinoma.  Furthermore, circulation time of JK184 in blood was prolonged after entrapment in polymeric micelles.  Our results suggested that JK184 micelles are a promising drug candidate for treating pancreatic tumors with a highly inhibitory effect on Hh activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zoGFYMcRbVg90H21EOLACvtfcHk0ljrep0zfmhkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFehtbbO&md5=a98434bbaf545da17c6f3d0c09d8582a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1039%2FC4NR06300G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NR06300G%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DC.%26atitle%3DBiodegradable%2520polymeric%2520micelles%2520encapsulated%2520jk184%2520suppress%2520tumor%2520growth%2520through%2520inhibiting%2520hedgehog%2520signaling%2520pathway%26jtitle%3DNanoscale%26date%3D2015%26volume%3D7%26spage%3D2609%26epage%3D2624%26doi%3D10.1039%2FC4NR06300G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca di
Magliano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebrok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of the hedgehog signaling pathway</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1916</span>– <span class="NLM_lpage">1919</span>, <span class="refDoi"> DOI: 10.1002/cbic.200700403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcbic.200700403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17886323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGhu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1916-1919&author=J.+Leeauthor=X.+Wuauthor=M.+Pasca+di%0AMaglianoauthor=E.+C.+Petersauthor=Y.+Wangauthor=J.+Hongauthor=M.+Hebrokauthor=S.+Dingauthor=C.+Y.+Choauthor=P.+G.+Schultz&title=A+small-molecule+antagonist+of+the+hedgehog+signaling+pathway&doi=10.1002%2Fcbic.200700403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule antagonist of the Hedgehog signaling pathway</span></div><div class="casAuthors">Lee, Jongkook; Wu, Xu; Pasca di Magliano, Marina; Peters, Eric C.; Wang, Yan; Hong, Jiyong; Hebrok, Metthias; Ding, Sheng; Cho, Charles Y.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1916-1919</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Shadow the Hedgehog.  JK184 (illustrated in the scheme) was identified as an antagonist of Hedgehog signaling through a cell-based screen of chem. libraries.  Results from biochem. and cellular expts. suggest that JK184 functions by inhibiting ge.  This mol. should serve as a useful tool for studying Hedgehog signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkCXV2p07S-bVg90H21EOLACvtfcHk0lh8tY0uwVDwCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGhu7jL&md5=f533c8964ab8984b1d27a3c74255e1f1</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700403%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DPasca%2Bdi%2BMagliano%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DHebrok%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DC.%2BY.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520the%2520hedgehog%2520signaling%2520pathway%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1916%26epage%3D1919%26doi%3D10.1002%2Fcbic.200700403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. F.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of smoothened ciliary localization and ciliogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">13644</span>– <span class="NLM_lpage">13649</span>, <span class="refDoi"> DOI: 10.1073/pnas.1207170109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1207170109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22864913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsValu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=13644-13649&author=V.+M.+Wuauthor=S.+C.+Chenauthor=M.+R.+Arkinauthor=J.+F.+Reiter&title=Small+molecule+inhibitors+of+smoothened+ciliary+localization+and+ciliogenesis&doi=10.1073%2Fpnas.1207170109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of Smoothened ciliary localization and ciliogenesis</span></div><div class="casAuthors">Wu, Victoria M.; Chen, Steven C.; Arkin, Michelle R.; Reiter, Jeremy F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">13644-13649, S13644/1-S13644/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Vertebrate Hedgehog (Hh) signals involved in development and some forms of cancer, such as basal cell carcinoma, are transduced by the primary cilium, a microtubular projection found on many cells.  A crit. step in vertebrate Hh signal transduction is the regulated movement of Smoothened (Smo), a seven-transmembrane protein, to the primary cilium.  To identify small mols. that interfere with either the ciliary localization of Smo or ciliogenesis, we undertook a high-throughput, microscopy-based screen for compds. that alter the ciliary localization of YFP-tagged Smo.  This screen identified 10 compds. that inhibit Hh pathway activity.  Nine of these Smo antagonists (SA1-9) bind Smo, and one (SA10) does not.  We also identified two compds. (CA1 and CA2) that inhibit ciliary biogenesis, which block microtubule polymn. or alter centrosome compn.  Differential labeling of cell surface and intracellular Smo pools indicates that SA1-7 and 10 specifically inhibit trafficking of intracellular Smo to cilia.  In contrast, SA8 and 9 recruit endogenous Smo to the cilium in some cell types.  Despite these different mechanisms of action, all of the SAs inhibit activation of the Hh pathway by an oncogenic form of Smo, and abrogate the proliferation of basal cell carcinoma-like cancer cells.  The SA compds. may provide alternative means of inhibiting pathogenic Hh signaling, and our study reveals that different pools of Smo move into cilia through distinct mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbOvOftfa6m7Vg90H21EOLACvtfcHk0lh8tY0uwVDwCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsValu7nF&md5=6d8697afe4176df55ef7d643b875bf98</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1207170109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1207170109%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DV.%2BM.%26aulast%3DChen%26aufirst%3DS.%2BC.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DReiter%26aufirst%3DJ.%2BF.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520smoothened%2520ciliary%2520localization%2520and%2520ciliogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D13644%26epage%3D13649%26doi%3D10.1073%2Fpnas.1207170109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messias, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerlof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanker, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasenoder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lickert, H.</span></span> <span> </span><span class="NLM_article-title">Novel small molecules targeting ciliary transport of smoothened and oncogenic hedgehog pathway activation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22540</span>, <span class="refDoi"> DOI: 10.1038/srep22540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fsrep22540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26931153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22540&author=B.+Jungauthor=A.+C.+Messiasauthor=K.+Schorppauthor=A.+Geerlofauthor=G.+Schneiderauthor=D.+Saurauthor=K.+Hadianauthor=M.+Sattlerauthor=E.+E.+Wankerauthor=S.+Hasenoderauthor=H.+Lickert&title=Novel+small+molecules+targeting+ciliary+transport+of+smoothened+and+oncogenic+hedgehog+pathway+activation&doi=10.1038%2Fsrep22540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecules targeting ciliary transport of Smoothened and oncogenic Hedgehog pathway activation</span></div><div class="casAuthors">Jung, Bomi; Messias, Ana C.; Schorpp, Kenji; Geerlof, Arie; Schneider, Guenter; Saur, Dieter; Hadian, Kamyar; Sattler, Michael; Wanker, Erich E.; Hasenoeder, Stefan; Lickert, Heiko</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22540</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Trafficking of the G protein-coupled receptor (GPCR) Smoothened (Smo) to the primary cilium (PC) is a potential target to inhibit oncogenic Hh pathway activation in a large no. of tumors.  One drawback is the appearance of Smo mutations that resist drug treatment, which is a common reason for cancer treatment failure.  Here, we undertook a high content screen with compds. in preclin. or clin. development and identified ten small mols. that prevent constitutive active mutant SmoM2 transport into PC for subsequent Hh pathway activation.  Eight of the ten small mols. act through direct interference with the G protein-coupled receptor assocd. sorting protein 2 (Gprasp2)-SmoM2 ciliary targeting complex, whereas one antagonist of ionotropic receptors prevents intracellular trafficking of Smo to the PC.  Together, these findings identify several compds. with the potential to treat drug-resistant SmoM2-driven cancer forms, but also reveal off-target effects of established drugs in the clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqqz3QlxrJgbVg90H21EOLACvtfcHk0lh8tY0uwVDwCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFektLY%253D&md5=d78ca8f49e97fa1b4e7e804876cb474f</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fsrep22540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22540%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DB.%26aulast%3DMessias%26aufirst%3DA.%2BC.%26aulast%3DSchorpp%26aufirst%3DK.%26aulast%3DGeerlof%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DSaur%26aufirst%3DD.%26aulast%3DHadian%26aufirst%3DK.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26aulast%3DHasenoder%26aufirst%3DS.%26aulast%3DLickert%26aufirst%3DH.%26atitle%3DNovel%2520small%2520molecules%2520targeting%2520ciliary%2520transport%2520of%2520smoothened%2520and%2520oncogenic%2520hedgehog%2520pathway%2520activation%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22540%26doi%3D10.1038%2Fsrep22540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wassif, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krakowiak, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">A defective response to hedgehog signaling in disorders of cholesterol biosynthesis</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/ng1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fng1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12652302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVGit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=508-513&author=M.+K.+Cooperauthor=C.+A.+Wassifauthor=P.+A.+Krakowiakauthor=J.+Taipaleauthor=R.+Gongauthor=R.+I.+Kelleyauthor=F.+D.+Porterauthor=P.+A.+Beachy&title=A+defective+response+to+hedgehog+signaling+in+disorders+of+cholesterol+biosynthesis&doi=10.1038%2Fng1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis</span></div><div class="casAuthors">Cooper, Michael K.; Wassif, Christopher A.; Krakowiak, Patrycja A.; Taipale, Jussi; Gong, Ruoyu; Kelley, Richard I.; Porter, Forbes D.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Smith-Lemli-Opitz syndrome (SLOS), desmosterolosis and lathosterolosis are human syndromes caused by defects in the final stages of cholesterol biosynthesis.  Many of the developmental malformations in these syndromes occur in tissues and structures whose embryonic patterning depends on signaling by the Hedgehog (Hh) family of secreted proteins.  Here the authors report that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacol. depleted of sterols.  We show that decreasing levels of cellular sterols correlate with diminishing responsiveness to the Hh signal.  This diminished response occurs at sterol levels sufficient for normal autoprocessing of Hh protein, which requires cholesterol as cofactor and covalent adduct.  We further find that sterol depletion affects the activity of Smoothened (Smo), an essential component of the Hh signal transduction app.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfwsX7RQrc4LVg90H21EOLACvtfcHk0lhX-83mzO2c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVGit7s%253D&md5=c0d15c9ce938c5ef8c6288afc823e62a</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fng1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1134%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DWassif%26aufirst%3DC.%2BA.%26aulast%3DKrakowiak%26aufirst%3DP.%2BA.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DR.%2BI.%26aulast%3DPorter%26aufirst%3DF.%2BD.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DA%2520defective%2520response%2520to%2520hedgehog%2520signaling%2520in%2520disorders%2520of%2520cholesterol%2520biosynthesis%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D33%26spage%3D508%26epage%3D513%26doi%3D10.1038%2Fng1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohnalter, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooshesh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1124/mol.110.066431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1124%2Fmol.110.066431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20558592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFersbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=486-496&author=M.+Lauthauthor=V.+Rohnalterauthor=A.+Bergstromauthor=M.+Koosheshauthor=P.+Svenningssonauthor=R.+Toftgard&title=Antipsychotic+drugs+regulate+hedgehog+signaling+by+modulation+of+7-dehydrocholesterol+reductase+levels&doi=10.1124%2Fmol.110.066431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotic drugs regulate Hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels</span></div><div class="casAuthors">Lauth, Matthias; Rohnalter, Verena; Bergstroem, Asa; Kooshesh, Mahsa; Svenningsson, Per; Toftgard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recently we identified GANT61, a small-mol. antagonist of Gli transcription factors, which are the final effectors of the mammalian Hedgehog (HH) signaling pathway.  Here we describe a diamine substructure of GANT61 that carries the biol. activity and show that this part of the mol. is structurally related to trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride (AY9944), an inhibitor of the enzymic activity and transcriptional inducer of 7-dehydrocholesterol-reductase (Dhcr7, EC 1.3.1.21).  Treatment of cells with the GANT61 diamine, AY9944, or overexpression of DHCR7 results in the attenuation of Smoothened-dependent and -independent HH signaling.  Whereas GANT61 function is independent of Dhcr7, AY9944 does require up-regulation of endogenous Dhcr7.  In line with these findings, Dhcr7-modulating antipsychotic (clozapine, chlorpromazine, haloperidol) and antidepressant (imipramine) drugs regulate HH signaling in vitro and in vivo.  Modulation of HH signaling may represent a hitherto undiscovered biol. (side) effect of therapeutics used to treat schizophrenia and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGWX8qOdvW6LVg90H21EOLACvtfcHk0lhX-83mzO2c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFersbjN&md5=feba8aad93b1ab05ab92e7e694054eb0</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.066431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.066431%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DRohnalter%26aufirst%3DV.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DKooshesh%26aufirst%3DM.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DAntipsychotic%2520drugs%2520regulate%2520hedgehog%2520signaling%2520by%2520modulation%2520of%25207-dehydrocholesterol%2520reductase%2520levels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D486%26epage%3D496%26doi%3D10.1124%2Fmol.110.066431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Incardona, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelink, H.</span></span> <span> </span><span class="NLM_article-title">The role of cholesterol in shh signaling and teratogen-induced holoprosencephaly</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1719</span>, <span class="refDoi"> DOI: 10.1007/PL00000653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1007%2FPL00000653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=11130177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=1709-1719&author=J.+P.+Incardonaauthor=H.+Roelink&title=The+role+of+cholesterol+in+shh+signaling+and+teratogen-induced+holoprosencephaly&doi=10.1007%2FPL00000653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly</span></div><div class="casAuthors">Incardona, J. P.; Roelink, H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1709-1719</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review with 72 refs.  Holoprosencephaly, or an undivided forebrain, is a complex brain malformation assocd. with Sonic hedgehog (Shh) mutations.  Other causes of holoprosencephaly have converged upon the Shh signaling pathway: genetic and pharmacol. impairment of cholesterol synthesis, and the action of the steroidal alkaloid cyclopamine.  This review focuses on recent studies aimed at detg. how Shh signaling is affected by these causes of holoprosencephaly, whether they involve a common mechanism and the role played by cholesterol.  Cholesterol is potentially important for both biogenesis of Shh and in signal transduction in Shh-responsive cells.  Teratogens that induce holoprosencephaly appear to affect Shh signal transduction rather than Shh biogenesis.  Anal. of these agents and other compds. that affect various aspects of cellular cholesterol distribution indicates that the role of cholesterol in Shh signal transduction is novel and complicated.  The similarity of the Shh receptor, Patched (Ptc), to the Niemann-Pick C1 protein, which is involved in the vesicular trafficking of cholesterol, provides insight into the role of cholesterol and the action of compds. like cyclopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpczZFtT5WI2bVg90H21EOLACvtfcHk0lhX-83mzO2c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsg%253D%253D&md5=2e38e504511cff8e4b0350ffde3159a8</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1007%2FPL00000653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00000653%26sid%3Dliteratum%253Aachs%26aulast%3DIncardona%26aufirst%3DJ.%2BP.%26aulast%3DRoelink%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520cholesterol%2520in%2520shh%2520signaling%2520and%2520teratogen-induced%2520holoprosencephaly%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2000%26volume%3D57%26spage%3D1709%26epage%3D1719%26doi%3D10.1007%2FPL00000653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbadawy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamawaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takenouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunedomi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1098</span>, <span class="refDoi"> DOI: 10.3390/ijms19041098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fijms19041098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOqt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1098&author=T.+Usuiauthor=M.+Sakuraiauthor=K.+Umataauthor=M.+Elbadawyauthor=T.+Ohamaauthor=H.+Yamawakiauthor=S.+Hazamaauthor=H.+Takenouchiauthor=M.+Nakajimaauthor=R.+Tsunedomiauthor=N.+Suzukiauthor=H.+Naganoauthor=K.+Satoauthor=M.+Kanedaauthor=K.+Sasaki&title=Hedgehog+signals+mediate+anti-cancer+drug+resistance+in+three-dimensional+primary+colorectal+cancer+organoid+culture&doi=10.3390%2Fijms19041098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture</span></div><div class="casAuthors">Usui, Tatsuya; Sakurai, Masashi; Umata, Koji; Elbadawy, Mohamed; Ohama, Takashi; Yamawaki, Heyuki; Hazama, Shoichi; Takenouchi, Hiroko; Nakajima, Masao; Tsunedomi, Ryouichi; Suzuki, Nobuaki; Nagano, Hiroaki; Sato, Koichi; Kaneda, Masahiro; Sasaki, Kazuaki</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1098/1-1098/12</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Colorectal cancer is one of the most common causes of cancer death worldwide.  In patients with metastatic colorectal cancer, combination treatment with several anti-cancer drugs is employed and improves overall survival in some patients.  Nevertheless, most patients with metastatic disease are not cured owing to the drug resistance.  Cancer stem cells are known to regulate resistance to chemotherapy.  In the previous study, we established a novel three-dimensional organoid culture model from tumor colorectal tissues of human patients using an air-liq. interface (ALI) method, which contained numerous cancer stem cells and showed resistance to 5-fluorouracil (5-FU) and Irinotecan.  Here, we investigate which inhibitor for stem cell-related signal improves the sensitivity for anti-cancer drug treatment in tumor ALI organoids.  Treatment with Hedgehog signal inhibitors (AY9944, GANT61) decreases the cell viability of organoids compared with Notch (YO-01027, DAPT) and Wnt (WAV939, Wnt-C59) signal inhibitors.  Combination treatment of AY9944 or GANT61 with 5-FU, Irinotecan or Oxaliplatin decreases the cell viability of tumor organoids compared with each anti-cancer drug alone treatment.  Treatment with AY9944 or GANT61 inhibits expression of stem cell markers c-Myc, CD44 and Nanog, likely through the decrease of their transcription factor, GLI-1 expression.  Combination treatment of AY9944 or GANT61 with 5-FU or Irinotecan also prevents colony formation of colorectal cancer cell lines HCT116 and SW480.  These findings suggest that Hedgehog signals mediate anti-cancer drug resistance in colorectal tumor patient-derived ALI organoids and that the inhibitors are useful as a combinational therapeutic strategy against colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCFW-7FRWCibVg90H21EOLACvtfcHk0lhX-83mzO2c8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOqt7nM&md5=6abc885638a6a82baf7c6ea8c0d5c4aa</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.3390%2Fijms19041098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19041098%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DUmata%26aufirst%3DK.%26aulast%3DElbadawy%26aufirst%3DM.%26aulast%3DOhama%26aufirst%3DT.%26aulast%3DYamawaki%26aufirst%3DH.%26aulast%3DHazama%26aufirst%3DS.%26aulast%3DTakenouchi%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DTsunedomi%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DNagano%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKaneda%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DK.%26atitle%3DHedgehog%2520signals%2520mediate%2520anti-cancer%2520drug%2520resistance%2520in%2520three-dimensional%2520primary%2520colorectal%2520cancer%2520organoid%2520culture%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1098%26doi%3D10.3390%2Fijms19041098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol modification of hedgehog signaling proteins in animal development</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1126/science.274.5285.255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.274.5285.255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=8824192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK28XmtlWltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=255-259&author=J.+A.+Porterauthor=K.+E.+Youngauthor=P.+A.+Beachy&title=Cholesterol+modification+of+hedgehog+signaling+proteins+in+animal+development&doi=10.1126%2Fscience.274.5285.255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol modification of hedgehog signaling proteins in animal development</span></div><div class="casAuthors">Porter, Jeffery A.; Young, Keith E.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5285</span>),
    <span class="NLM_cas:pages">255-259</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Hedgehog (Hh) proteins comprise a family of secreted signaling mols. essential for patterning a variety of structures in animal embryogenesis.  During biosynthesis, Hh undergoes an autocleavage reaction, mediated by its carboxyl-terminal domain, that produces a lipid-modified amino-terminal fragment responsible for all known Hh signaling activity.  Here it is reported that cholesterol is the lipophilic moiety covalently attached to the amino-terminal signaling domain during autoprocessing and that the carboxyl-terminal domain acts as an intramol. cholesterol transferase.  This use of cholesterol to modify embryonic signaling proteins may account for some of the effects of perturbed cholesterol biosynthesis on animal development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx4g4_YaDbCLVg90H21EOLACvtfcHk0lg-v4loEwyjvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlWltrk%253D&md5=36a58f66eeed32e4739905576c9e67ae</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5285.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5285.255%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DYoung%26aufirst%3DK.%2BE.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DCholesterol%2520modification%2520of%2520hedgehog%2520signaling%2520proteins%2520in%2520animal%2520development%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D255%26epage%3D259%26doi%3D10.1126%2Fscience.274.5285.255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egleston, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astsaturov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. J.</span></span> <span> </span><span class="NLM_article-title">Statins synergize with hedgehog pathway inhibitors for treatment of medulloblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1375</span>– <span class="NLM_lpage">1388</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-17-2923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1078-0432.CCR-17-2923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29437795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1ymur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1375-1388&author=R.+E.+Gordonauthor=L.+Zhangauthor=S.+Periauthor=Y.+M.+Kuoauthor=F.+Duauthor=B.+L.+Eglestonauthor=J.+M.+Y.+Ngauthor=A.+J.+Andrewsauthor=I.+Astsaturovauthor=T.+Curranauthor=Z.+J.+Yang&title=Statins+synergize+with+hedgehog+pathway+inhibitors+for+treatment+of+medulloblastoma&doi=10.1158%2F1078-0432.CCR-17-2923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma</span></div><div class="casAuthors">Gordon, Renata E.; Zhang, Li; Peri, Suraj; Kuo, Yin-Ming; Du, Fang; Egleston, Brian L.; Ng, Jessica M. Y.; Andrews, Andrew J.; Astsaturov, Igor; Curran, Tom; Yang, Zeng-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1375-1388</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The role of cholesterol biosynthesis in hedgehog pathway activity and progression of hedgehog pathway medulloblastoma (Hh-MB) were examd. in vivo.  Statins, commonly used cholesterol-lowering agents, were utilized to validate cholesterol biosynthesis as a therapeutic target for Hh-MB.  Exptl. Design: Bioinformatic anal. was performed to evaluate the assocn. between cholesterol biosynthesis with hedgehog group medulloblastoma in human biospecimens.  Alterations in hedgehog signaling were evaluated in medulloblastoma cells after inhibition of cholesterol biosynthesis.  The progression of endogenous medulloblastoma in mice was examd. after genetic blockage of cholesterol biosynthesis in tumor cells.  Statins alone, or in combination with vismodegib (an FDA-approved Smoothened antagonist), were utilized to inhibit medulloblastoma growth in vivo.  Results: Cholesterol biosynthesis was markedly enhanced in Hh-MB from both humans and mice.  Inhibition of cholesterol biosynthesis dramatically decreased Hh pathway activity and reduced proliferation of medulloblastoma cells.  Statins effectively inhibited medulloblastoma growth in vivo and functioned synergistically in combination with vismodegib.  Conclusions: Cholesterol biosynthesis is required for Smoothened activity in the hedgehog pathway, and it is indispensable for the growth of Hh-MB.  Targeting cholesterol biosynthesis represents a promising strategy for treatment of Hh-MB.  Clin Cancer Res; 24(6); 1375-88. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqOxdI9RiIIbVg90H21EOLACvtfcHk0lg-v4loEwyjvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1ymur4%253D&md5=3c439dba49a62d1411ec03299e14d02f</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-2923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-2923%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DR.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeri%26aufirst%3DS.%26aulast%3DKuo%26aufirst%3DY.%2BM.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DEgleston%26aufirst%3DB.%2BL.%26aulast%3DNg%26aufirst%3DJ.%2BM.%2BY.%26aulast%3DAndrews%26aufirst%3DA.%2BJ.%26aulast%3DAstsaturov%26aufirst%3DI.%26aulast%3DCurran%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BJ.%26atitle%3DStatins%2520synergize%2520with%2520hedgehog%2520pathway%2520inhibitors%2520for%2520treatment%2520of%2520medulloblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D24%26spage%3D1375%26epage%3D1388%26doi%3D10.1158%2F1078-0432.CCR-17-2923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gipp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushman, W.</span></span> <span> </span><span class="NLM_article-title">Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2006.10.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.juro.2006.10.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17296441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtF2hs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2007&pages=1179-1185&author=J.+Zhangauthor=R.+Lipinskiauthor=A.+Shawauthor=J.+Gippauthor=W.+Bushman&title=Lack+of+demonstrable+autocrine+hedgehog+signaling+in+human+prostate+cancer+cell+lines&doi=10.1016%2Fj.juro.2006.10.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines</span></div><div class="casAuthors">Zhang, Jingxian; Lipinski, Robert; Shaw, Aubie; Gipp, Jerry; Bushman, Wade</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1185</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several recent reports highlighted the role of hedgehog signaling in prostate cancer.  However, the relative contributions of autocrine and paracrine hedgehog signaling to tumor growth and progression are unclear.  Efforts to model autocrine signaling for drug development have been hampered by conflicting reports of the presence or absence of autocrine signaling in established human prostate cancer cell lines.  We comprehensively characterized the expression of hedgehog pathway genes in the 3 prostate cancer cell lines LNCaP, PC3 and 22RV1 (American Type Culture Collection, Manassas, Virginia).  We also examd. their response to Shh ligand and to the hedgehog pathway inhibitor cyclopamine (Toronto Research Chems., Toronto, Ontario, Canada).  Expression of hedgehog ligand, patched and Gli1 in all 3 cell lines was lower than the expression level in normal human prostate tissue.  All 3 cell lines showed hedgehog target gene activation when transfected with an activated form of Gli2 but none showed a detectable transcriptional response to hedgehog ligand or to transfection with an activated form of smoothened.  Furthermore, treatment with the hedgehog pathway inhibitor cyclopamine did not inhibit hedgehog target gene expression in any of the 3 prostate cancer cell lines, although cyclopamine inhibited proliferation in culture.  LNCaP, PC3 and 22RV1 show no evidence of autocrine signaling by ligand dependent mechanisms and cyclopamine mediated inhibition of growth in culture occurs without of any discernible effect on canonical hedgehog pathway activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSkWEZ4WjnmrVg90H21EOLACvtfcHk0liyBiX5pVkf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtF2hs7o%253D&md5=6476c0b80a5398a8cee4ab57c3b9df95</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.10.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.10.032%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLipinski%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DGipp%26aufirst%3DJ.%26aulast%3DBushman%26aufirst%3DW.%26atitle%3DLack%2520of%2520demonstrable%2520autocrine%2520hedgehog%2520signaling%2520in%2520human%2520prostate%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Urol.%26date%3D2007%26volume%3D177%26spage%3D1179%26epage%3D1185%26doi%3D10.1016%2Fj.juro.2006.10.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basten, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willekers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermaat, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaats, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voest, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Diest, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, R. H.</span></span> <span> </span><span class="NLM_article-title">Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue</span>. <i>Cilia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2</span>, <span class="refDoi"> DOI: 10.1186/2046-2530-2-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1186%2F2046-2530-2-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23369289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC3szktlGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=2&author=S.+G.+Bastenauthor=S.+Willekersauthor=J.+S.+Vermaatauthor=G.+G.+Slaatsauthor=E.+E.+Voestauthor=P.+J.+van+Diestauthor=R.+H.+Giles&title=Reduced+cilia+frequencies+in+human+renal+cell+carcinomas+versus+neighboring+parenchymal+tissue&doi=10.1186%2F2046-2530-2-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue</span></div><div class="casAuthors">Basten Sander G; Willekers Sven; Vermaat Joost Sp; Slaats Gisela Gg; Voest Emile E; van Diest Paul J; Giles Rachel H</div><div class="citationInfo"><span class="NLM_cas:title">Cilia</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn">2046-2530</span>.
    </div><div class="casAbstract">UNLABELLED:  BACKGROUND:  Cilia are essential organelles in multiple organ systems, including the kidney where they serve as important regulators of renal homeostasis.  Renal nephron cilia emanate from the apical membrane of epithelia, extending into the lumen where they function in flow-sensing and ligand-dependent signaling cascades.  Ciliary dysfunction underlies renal cyst formation that is in part caused by deregulation of planar cell polarity and canonical Wnt signaling.  Renal cancer pathologies occur sporadically or in heritable syndromes caused by germline mutations in tumor suppressor genes including VHL.  Importantly, Von Hippel-Lindau (VHL) patients frequently develop complex renal cysts that can be considered a premalignant stage.  One of the well-characterized molecular functions of VHL is its requirement for the maintenance of cilia.  In this study, tissue from 110 renal cancer patients who underwent nephrectomy was analyzed to determine if lower ciliary frequency is a common hallmark of renal tumorigenesis by comparing cilia frequencies in both tumor and adjacent parenchymal tissue biopsies from the same kidney.  METHODS:  We stained sections of human renal material using markers for cilia.  Preliminary staining was performed using an immunofluorescent approach and a combination of acetylated-α-tubulin and pericentrin antibodies and DAPI.  After validation of an alternative, higher throughput approach using acetylated-α-tubulin immunohistochemistry, we continued to manually quantify cilia in all tissues.  Nuclei were separately counted in an automated fashion in order to determine ciliary frequencies.  Similar staining and scoring for Ki67 positive cells was performed to exclude that proliferation obscures cilia formation potential.  RESULTS:  Samples from renal cell carcinoma patients deposited in our hospital tissue bank were previously used to compose a tissue microarray containing three cores of both tumor and parenchymal tissue per patient.  Cilia frequencies in a total of eighty-nine clear cell, eight papillary, five chromophobe renal cell carcinomas, two sarcomatoid renal tumors and six oncocytomas were determined.  A marked decrease of primary cilia across renal cell carcinoma subtypes was observed compared to adjacent nontumorigenic tissue.  CONCLUSIONS:  Our study shows that cilia are predominantly lost in renal cell carcinomas compared to tissue of the tumor parenchyma.  These results suggest that ciliary loss is common in renal tumorigenesis, possibly participating in the sequence of cellular events leading to malignant tumor development.  Future therapies aimed at restoring or circumventing cilia signaling might therefore aid in current treatment efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB8nxRBba5AJVVjGoY74BafW6udTcc2ebH4tfYZMg41bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szktlGhtg%253D%253D&md5=57a4a398210688cc6980c595e8bba1df</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1186%2F2046-2530-2-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2046-2530-2-2%26sid%3Dliteratum%253Aachs%26aulast%3DBasten%26aufirst%3DS.%2BG.%26aulast%3DWillekers%26aufirst%3DS.%26aulast%3DVermaat%26aufirst%3DJ.%2BS.%26aulast%3DSlaats%26aufirst%3DG.%2BG.%26aulast%3DVoest%26aufirst%3DE.%2BE.%26aulast%3Dvan%2BDiest%26aufirst%3DP.%2BJ.%26aulast%3DGiles%26aufirst%3DR.%2BH.%26atitle%3DReduced%2520cilia%2520frequencies%2520in%2520human%2520renal%2520cell%2520carcinomas%2520versus%2520neighboring%2520parenchymal%2520tissue%26jtitle%3DCilia%26date%3D2013%26volume%3D2%26spage%3D2%26doi%3D10.1186%2F2046-2530-2-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carriere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetze, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longnecker, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korc, M.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-1290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-08-1290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19147554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=422-430&author=E.+S.+Seeleyauthor=C.+Carriereauthor=T.+Goetzeauthor=D.+S.+Longneckerauthor=M.+Korc&title=Pancreatic+cancer+and+precursor+pancreatic+intraepithelial+neoplasia+lesions+are+devoid+of+primary+cilia&doi=10.1158%2F0008-5472.CAN-08-1290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia</span></div><div class="casAuthors">Seeley, E. Scott; Carriere, Catherine; Goetze, Tobias; Longnecker, Daniel S.; Korc, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-430</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Primary cilia have been proposed to participate in the modulation of growth factor signaling pathways.  In this study, we detd. that ciliogenesis is suppressed in both pancreatic cancer cells and pancreatic intraepithelial neoplasia (PanIN) lesions in human pancreatic ductal adenocarcinoma (PDAC).  Primary cilia were absent in these cells even when not actively proliferating.  Cilia were also absent from mouse PanIN cells in three different mouse models of PDAC driven by an endogenous oncogenic Kras allele.  Inhibition of Kras effector pathways restored ciliogenesis in a mouse pancreatic cancer cell line, raising the possibility that ciliogenesis may be actively repressed by oncogenic Kras.  By contrast, normal duct, islet, and centroacinar cells retained primary cilia in both human and mouse pancreata.  Thus, arrested ciliogenesis is a cardinal feature of PDAC and its precursor PanIN lesions, does not require ongoing proliferation, and could potentially be targeted pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJxFFRTBbHbVg90H21EOLACvtfcHk0liyBiX5pVkf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSjtA%253D%253D&md5=ae4d4a97239d7ff38611f09d0f1a3643</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1290%26sid%3Dliteratum%253Aachs%26aulast%3DSeeley%26aufirst%3DE.%2BS.%26aulast%3DCarriere%26aufirst%3DC.%26aulast%3DGoetze%26aufirst%3DT.%26aulast%3DLongnecker%26aufirst%3DD.%2BS.%26aulast%3DKorc%26aufirst%3DM.%26atitle%3DPancreatic%2520cancer%2520and%2520precursor%2520pancreatic%2520intraepithelial%2520neoplasia%2520lesions%2520are%2520devoid%2520of%2520primary%2520cilia%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D422%26epage%3D430%26doi%3D10.1158%2F0008-5472.CAN-08-1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frolova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steg, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, A. R.</span></span> <span> </span><span class="NLM_article-title">Primary cilia are decreased in breast cancer: Analysis of a collection of human breast cancer cell lines and tissues</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1369/jhc.2010.955856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1369%2Fjhc.2010.955856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20530462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WgtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=857-870&author=K.+Yuanauthor=N.+Frolovaauthor=Y.+Xieauthor=D.+Wangauthor=L.+Cookauthor=Y.+J.+Kwonauthor=A.+D.+Stegauthor=R.+Serraauthor=A.+R.+Frost&title=Primary+cilia+are+decreased+in+breast+cancer%3A+Analysis+of+a+collection+of+human+breast+cancer+cell+lines+and+tissues&doi=10.1369%2Fjhc.2010.955856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues</span></div><div class="casAuthors">Yuan, Kun; Frolova, Natalya; Xie, Yi; Wang, Dezhi; Cook, Leah; Kwon, Yeon-Jin; Steg, Adam D.; Serra, Rosa; Frost, Andra R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">857-870</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Primary cilia (PC) are solitary, sensory organelles that are crit. for several signaling pathways.  PC were detected by immunofluorescence of cultured cells and breast tissues.  After growth for 7 days in vitro, PC were detected in ∼70% of breast fibroblasts and in 7-19% of epithelial cells derived from benign breast (184A1 and MCF10A).  In 11 breast cancer cell lines, PC were present at a low frequency in four (from 0.3% to 4% of cells), but were absent in the remainder.  The cancer cell lines with PC were all of the basal B subtype, which is analogous to the clin. triple-neg. breast cancer subtype.  Furthermore, the frequency of PC decreased with increasing degree of transformation/progression in the MCF10 and MDA-MB-435/LCC6 isogenic models of cancer progression.  In histol. normal breast tissues, PC were frequent in fibroblasts and myoepithelial cells and less common in luminal epithelial cells.  Of 26 breast cancers examd., rare PC were identified in cancer epithelial cells of only one cancer, which was of the triple-neg. subtype.  These data indicate a decrease or loss of PC in breast cancer and an assocn. of PC with the basal B subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDDk7vCW6B5bVg90H21EOLACvtfcHk0lh3fVYSrARM9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WgtL%252FI&md5=e7fdf938c7cf6a341e841c1476682302</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1369%2Fjhc.2010.955856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.2010.955856%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DK.%26aulast%3DFrolova%26aufirst%3DN.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DL.%26aulast%3DKwon%26aufirst%3DY.%2BJ.%26aulast%3DSteg%26aufirst%3DA.%2BD.%26aulast%3DSerra%26aufirst%3DR.%26aulast%3DFrost%26aufirst%3DA.%2BR.%26atitle%3DPrimary%2520cilia%2520are%2520decreased%2520in%2520breast%2520cancer%253A%2520Analysis%2520of%2520a%2520collection%2520of%2520human%2520breast%2520cancer%2520cell%2520lines%2520and%2520tissues%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2010%26volume%3D58%26spage%3D857%26epage%3D870%26doi%3D10.1369%2Fjhc.2010.955856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassounah, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalkin, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, K. M.</span></span> <span> </span><span class="NLM_article-title">Primary cilia are lost in preinvasive and invasive prostate cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e68521</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0068521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1371%2Fjournal.pone.0068521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23844214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68521&author=N.+B.+Hassounahauthor=R.+Nagleauthor=K.+Sabodaauthor=D.+J.+Roeauthor=B.+L.+Dalkinauthor=K.+M.+McDermott&title=Primary+cilia+are+lost+in+preinvasive+and+invasive+prostate+cancer&doi=10.1371%2Fjournal.pone.0068521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Primary cilia are lost in preinvasive and invasive prostate cancer</span></div><div class="casAuthors">Hassounah, Nadia B.; Nagle, Ray; Saboda, Kathylynn; Roe, Denise J.; Dalkin, Bruce L.; McDermott, Kimberly M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68521</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Prostate cancer is the second most commonly diagnosed cancer in men worldwide.  Little is known about the role of primary cilia in preinvasive and invasive prostate cancer.  However, reduced cilia expression has been obsd. in human cancers including pancreatic cancer, renal cell carcinoma, breast cancer, cholangiocarcinoma, and melanoma.  The aim of this study was to characterize primary cilia expression in preinvasive and invasive human prostate cancer, and to investigate the correlation between primary cilia and the Wnt signaling pathway.  Human prostate tissues representative of stages of prostate cancer formation (normal prostate, prostatic intraepithelial neoplasia (PIN), and invasive prostate cancer (including perineural invasion)) were stained for ciliary proteins.  The frequency of primary cilia was detd.  A decrease in the percentage of ciliated cells in PIN, invasive cancer and perineural invasion lesions was obsd. when compared to normal.  Cilia lengths were also measured to indirectly test functionality.  Cilia were shorter in PIN, cancer, and perineural invasion lesions, suggesting dysfunction.  Primary cilia have been shown to suppress the Wnt pathway.  Increased Wnt signaling has been implicated in prostate cancer.  Therefore, we investigated a correlation between loss of primary cilia and increased Wnt signaling in normal prostate and in preinvasive and invasive prostate cancer.  To investigate Wnt signaling in our cohort, serial tissue sections were stained for β-catenin as a measure of Wnt signaling.  Nuclear β-catenin was analyzed and Wnt signaling was found to be higher in un-ciliated cells in the normal prostate, PIN, a subset of invasive cancers, and perineural invasion.  Our results suggest that cilia normally function to suppress the Wnt signaling pathway in epithelial cells and that cilia loss may play a role in increased Wnt signaling in some prostate cancers.  These results suggest that cilia are dysfunctional in human prostate cancer, and increase Wnt signaling occurs in a subset of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZkBN10hxE5LVg90H21EOLACvtfcHk0lh3fVYSrARM9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGqsr%252FL&md5=72bab002cffeb2aa565950ed89c654d1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068521%26sid%3Dliteratum%253Aachs%26aulast%3DHassounah%26aufirst%3DN.%2BB.%26aulast%3DNagle%26aufirst%3DR.%26aulast%3DSaboda%26aufirst%3DK.%26aulast%3DRoe%26aufirst%3DD.%2BJ.%26aulast%3DDalkin%26aufirst%3DB.%2BL.%26aulast%3DMcDermott%26aufirst%3DK.%2BM.%26atitle%3DPrimary%2520cilia%2520are%2520lost%2520in%2520preinvasive%2520and%2520invasive%2520prostate%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68521%26doi%3D10.1371%2Fjournal.pone.0068521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stecca, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbinden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piguet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz i Altaba, A.</span></span> <span> </span><span class="NLM_article-title">Melanomas require hedgehog-gli signaling regulated by interactions between gli1 and the ras-mek/akt pathways</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">5895</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1073/pnas.0700776104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0700776104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17392427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1CqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=5895-5900&author=B.+Steccaauthor=C.+Masauthor=V.+Clementauthor=M.+Zbindenauthor=R.+Correaauthor=V.+Piguetauthor=F.+Beermannauthor=A.+Ruiz+i+Altaba&title=Melanomas+require+hedgehog-gli+signaling+regulated+by+interactions+between+gli1+and+the+ras-mek%2Fakt+pathways&doi=10.1073%2Fpnas.0700776104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways</span></div><div class="casAuthors">Stecca, Barbara; Mas, Christophe; Clement, Virginie; Zbinden, Marie; Correa, Rafael; Piguet, Vincent; Beermann, Friedrich; Ruiz i Altaba, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5895-5900</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Melanoma is one of the most aggressive cancers, and its incidence is increasing.  These tumors derive from the melanocyte lineage and remain incurable after metastasis.  Here we report that SONIC HEDGEHOG (SHH)-GLI signaling is active in the matrix of human hair follicles, and that it is required for the normal proliferation of human melanocytes in culture.  SHH-GLI signaling also regulates the proliferation and survival of human melanomas: the growth, recurrence, and metastasis of melanoma xenografts in mice are prevented by local or systemic interference of HH-GLI function.  Moreover, we show that oncogenic RAS-induced melanomas in transgenic mice express GLI1 and require Hh-Gli signaling in vitro and in vivo.  Finally, we provide evidence that endogenous RAS-MEK and AKT signaling regulate the nuclear localization and transcriptional activity of GLI1 in melanoma and other cancer cells.  Our data uncover an unsuspected role of HH-GLI signaling in melanocytes and melanomas, demonstrate a role for this pathway in RAS-induced tumors, suggest a general integration of the RAS/AKT and HH-GLI pathways, and open a therapeutic approach for human melanomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEymXBlCsjNrVg90H21EOLACvtfcHk0liZ_HR97S2ydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1CqtLg%253D&md5=73c79615db235dbb9b873ad27f7b22bb</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0700776104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0700776104%26sid%3Dliteratum%253Aachs%26aulast%3DStecca%26aufirst%3DB.%26aulast%3DMas%26aufirst%3DC.%26aulast%3DClement%26aufirst%3DV.%26aulast%3DZbinden%26aufirst%3DM.%26aulast%3DCorrea%26aufirst%3DR.%26aulast%3DPiguet%26aufirst%3DV.%26aulast%3DBeermann%26aufirst%3DF.%26aulast%3DRuiz%2Bi%2BAltaba%26aufirst%3DA.%26atitle%3DMelanomas%2520require%2520hedgehog-gli%2520signaling%2520regulated%2520by%2520interactions%2520between%2520gli1%2520and%2520the%2520ras-mek%252Fakt%2520pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D5895%26epage%3D5900%26doi%3D10.1073%2Fpnas.0700776104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of gli-mediated transcription and tumor cell growth by small-molecule antagonists</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">8455</span>– <span class="NLM_lpage">8460</span>, <span class="refDoi"> DOI: 10.1073/pnas.0609699104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0609699104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17494766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=8455-8460&author=M.+Lauthauthor=A.+Bergstromauthor=T.+Shimokawaauthor=R.+Toftgard&title=Inhibition+of+gli-mediated+transcription+and+tumor+cell+growth+by+small-molecule+antagonists&doi=10.1073%2Fpnas.0609699104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists</span></div><div class="casAuthors">Lauth, Matthias; Bergstroem, Asa; Shimokawa, Takashi; Toftgard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8455-8460</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The developmentally important Hedgehog (Hh) signaling pathway has recently been implicated in several forms of solid cancer.  Current drug development programs focus on targeting the protooncogene Smoothened, a key transmembrane pathway member.  These drug candidates, albeit promising, do not address the scenario in which pathway activation occurs downstream of Smoothened, as obsd. in cases of medulloblastoma, glioma, pericytoma, breast cancer, and prostate cancer.  A cellular screen for small-mol. antagonists of GLI-mediated transcription, which constitutes the final step in the Hh pathway, revealed two mols. that are able to selectively inhibit GLI-mediated gene transactivation.  We provide genetic evidence of downstream pathway blockade by these compds. and demonstrate the ineffectiveness of upstream antagonists such as cyclopamine in such situations.  Mechanistically, both inhibitors act in the nucleus to block GLI function, and one of them interferes with GLI1 DNA binding in living cells.  Importantly, the discovered compds. efficiently inhibited in vitro tumor cell proliferation in a GLI-dependent manner and successfully blocked cell growth in an in vivo xenograft model using human prostate cancer cells harboring downstream activation of the Hh pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnlBrXj0X1ELVg90H21EOLACvtfcHk0liZ_HR97S2ydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVChtbw%253D&md5=c579b952f8c878fa3058b21d41e16f07</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0609699104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0609699104%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DShimokawa%26aufirst%3DT.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520gli-mediated%2520transcription%2520and%2520tumor%2520cell%2520growth%2520by%2520small-molecule%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D8455%26epage%3D8460%26doi%3D10.1073%2Fpnas.0609699104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moshai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wemeau-Stervinou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cigna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somme, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailleux, A. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2013-0154OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1165%2Frcmb.2013-0154OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24450438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFegtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2014&pages=11-25&author=E.+F.+Moshaiauthor=L.+Wemeau-Stervinouauthor=N.+Cignaauthor=S.+Brayerauthor=J.+M.+Sommeauthor=B.+Crestaniauthor=A.+A.+Mailleux&title=Targeting+the+hedgehog-glioma-associated+oncogene+homolog+pathway+inhibits+bleomycin-induced+lung+fibrosis+in+mice&doi=10.1165%2Frcmb.2013-0154OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Hedgehog-Glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice</span></div><div class="casAuthors">Moshai, Elika Farrokhi; Wemeau-Stervinou, Lidwine; Cigna, Natacha; Brayer, Stephanie; Marchal Somme, Joelle; Crestani, Bruno; Mailleux, Arnaud A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-25, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis has been assocd. with the reactivation of developmental pathways, notably the Hedgehog-Glioma-assocd. oncogene homolog (GLI) pathway.  In this study, we detd. whether the Hedgehog pathway was activated in bleomycin-induced lung injury in mice and whether targeting the Hedgehog-Gli pathway could decrease bleomycin-induced lung fibrosis.  After intratracheal injection of bleomycin on Day 0, C57Bl6 mice received GDC-0449 (an inhibitor of Smoothened, the transducer of the pathway), or 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl] bis (methylene)] bis [N,N dimethylbenzenamine (GANT61; an inhibitor of GLI transcription factors in the nucleus)], from Day 7 to Day 13.  At Day 14, whole-lung homogenates were obtained for morphol. anal., assessment of cell apoptosis and proliferation, collagen quantification and evaluation of profibrotic (transforming growth factor-β, connective tissue growth factor, plasminogen activator inhibitor 1, vascular endothelial growth factor-A) and proinflammatory mediators (IL-1β) expression.  We showed that the Hedgehog pathway was activated in bleomycin-induced lung fibrosis on Day 14 after injury, with an increased lung expression of the ligand, Sonic Hedgehog and with increased mRNA expression and nuclear localization of GLI1 and GLI2.  Inhibition of Smoothened with GDC-0449 did not influence the development of bleomycin-induced lung fibrosis.  By contrast, the inhibition of GLI activity with GANT61 decreased lung fibrosis and lung collagen accumulation and promoted an antifibrotic and anti-inflammatory environment.  Our results identify the Hedgehog-Gli pathway as a profibrotic pathway in exptl. fibrosis.  Inhibition of the Hedgehog-Gli pathway at the level of GLI transcriptional activity could be a therapeutic option in fibrotic lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6mloCraMx77Vg90H21EOLACvtfcHk0li9MmLNgnKQ8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFegtLbI&md5=d08a8d915e6f88a8b6d8233d80c2baa2</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2013-0154OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2013-0154OC%26sid%3Dliteratum%253Aachs%26aulast%3DMoshai%26aufirst%3DE.%2BF.%26aulast%3DWemeau-Stervinou%26aufirst%3DL.%26aulast%3DCigna%26aufirst%3DN.%26aulast%3DBrayer%26aufirst%3DS.%26aulast%3DSomme%26aufirst%3DJ.%2BM.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DMailleux%26aufirst%3DA.%2BA.%26atitle%3DTargeting%2520the%2520hedgehog-glioma-associated%2520oncogene%2520homolog%2520pathway%2520inhibits%2520bleomycin-induced%2520lung%2520fibrosis%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2014%26volume%3D51%26spage%3D11%26epage%3D25%26doi%3D10.1165%2Frcmb.2013-0154OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agyeman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazumdar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, J. A.</span></span> <span> </span><span class="NLM_article-title">Mode and specificity of binding of the small molecule gant61 to gli determines inhibition of gli-DNA binding</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4492</span>– <span class="NLM_lpage">4503</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.2046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24962990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2cfmtlGgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4492-4503&author=A.+Agyemanauthor=B.+K.+Jhaauthor=T.+Mazumdarauthor=J.+A.+Houghton&title=Mode+and+specificity+of+binding+of+the+small+molecule+gant61+to+gli+determines+inhibition+of+gli-DNA+binding&doi=10.18632%2Foncotarget.2046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding</span></div><div class="casAuthors">Agyeman Akwasi; Houghton Janet A; Jha Babal K; Mazumdar Tapati</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4492-503</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The GLI genes, GLI1 and GLI2, are transcription factors that regulate target genes at the distal end of the canonical Hedgehog (HH) signaling pathway (SHH->PTCH->SMO->GLI), tightly regulated in embryonic development, tissue patterning and differentiation.  Both GLI1 and GLI2 are oncogenes, constitutively activated in many types of human cancers.  In colon cancer cells oncogenic KRAS-GLI signaling circumvents the HH-SMO-GLI axis to channel through and activate GLI in the transcriptional regulation of target genes.  We have observed extensive cell death in a panel of 7 human colon carcinoma cell lines using the small molecule GLI inhibitor GANT61.  Using computational docking and experimental confirmation by Surface Plasmon Resonance, GANT61 binds to the 5-zinc finger GLI1 protein between zinc fingers 2 and 3 at sites E119 and E167, independent of the GLI-DNA binding region, and conserved between GLI1 and GLI2.  GANT61 does not bind to other zinc finger transcription factors (KLF4, TFIIβ).  Mutating the predicted GANT61 binding sites in GLI1 significantly inhibits GANT61-GLI binding and GLI-luciferase activity.  Data establish the specificity of GANT61 for targeting GLI, and substantiate the critical role of GLI in cancer cell survival.  Thus, targeting GLI in cancer therapeutics may be of high impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHnxetXWD6STAEfvC7EH1LfW6udTcc2eZQV2LAjcm3Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfmtlGgug%253D%253D&md5=c3c16d3abd686bcc736af4a3ac1f7327</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2046%26sid%3Dliteratum%253Aachs%26aulast%3DAgyeman%26aufirst%3DA.%26aulast%3DJha%26aufirst%3DB.%2BK.%26aulast%3DMazumdar%26aufirst%3DT.%26aulast%3DHoughton%26aufirst%3DJ.%2BA.%26atitle%3DMode%2520and%2520specificity%2520of%2520binding%2520of%2520the%2520small%2520molecule%2520gant61%2520to%2520gli%2520determines%2520inhibition%2520of%2520gli-DNA%2520binding%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D4492%26epage%3D4503%26doi%3D10.18632%2Foncotarget.2046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calcaterra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iovine, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Acquarica, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciogli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iazzetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lospinoso Severini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span> <span> </span><span class="NLM_article-title">Chemical, computational and functional insights into the chemical stability of the hedgehog pathway inhibitor gant61</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1080/14756366.2017.1419221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1080%2F14756366.2017.1419221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29338454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVajt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=349-358&author=A.+Calcaterraauthor=V.+Iovineauthor=B.+Bottaauthor=D.+Quaglioauthor=I.+D%E2%80%99Acquaricaauthor=A.+Ciogliauthor=A.+Iazzettiauthor=R.+Alfonsiauthor=L.+Lospinoso+Severiniauthor=P.+Infanteauthor=L.+Di+Marcotullioauthor=M.+Moriauthor=F.+Ghirga&title=Chemical%2C+computational+and+functional+insights+into+the+chemical+stability+of+the+hedgehog+pathway+inhibitor+gant61&doi=10.1080%2F14756366.2017.1419221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61</span></div><div class="casAuthors">Calcaterra, Andrea; Iovine, Valentina; Botta, Bruno; Quaglio, Deborah; D'Acquarica, Ilaria; Ciogli, Alessia; Iazzetti, Antonia; Alfonsi, Romina; Lospinoso Severini, Ludovica; Infante, Paola; Di Marcotullio, Lucia; Mori, Mattia; Ghirga, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">349-358</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">This work aims at elucidating the mechanism and kinetics of hydrolysis of GANT61, the first and most-widely used inhibitor of the Hedgehog (Hh) signaling pathway that targets Glioma-assocd. oncogene homolog (Gli) proteins, and at confirming the chem. nature of its bioactive form.  GANT61 is poorly stable under physiol. conditions and rapidly hydrolyzes into an aldehyde species (GANT61-A), which is devoid of the biol. activity against Hh signaling, and a diamine deriv. (GANT61-D), which has shown inhibition of Gli-mediated transcription.  Here, the authors combined chem. synthesis, NMR spectroscopy, anal. studies, mol. modeling and functional cell assays to characterize the GANT61 hydrolysis pathway.  The authors' results show that GANT61-D is the bioactive form of GANT61 in NIH3T3 Shh-Light II cells and SuFu-/- mouse embryonic fibroblasts, and clarify the structural requirements for GANT61-D binding to Gli1.  This study paves the way to the design of GANT61 derivs. with improved potency and chem. stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNtq0nozn517Vg90H21EOLACvtfcHk0lizIu0xBiEsbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVajt7s%253D&md5=050642aa38026bd31449c13fd5ded885</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1080%2F14756366.2017.1419221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2017.1419221%26sid%3Dliteratum%253Aachs%26aulast%3DCalcaterra%26aufirst%3DA.%26aulast%3DIovine%26aufirst%3DV.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DQuaglio%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Acquarica%26aufirst%3DI.%26aulast%3DCiogli%26aufirst%3DA.%26aulast%3DIazzetti%26aufirst%3DA.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DLospinoso%2BSeverini%26aufirst%3DL.%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DGhirga%26aufirst%3DF.%26atitle%3DChemical%252C%2520computational%2520and%2520functional%2520insights%2520into%2520the%2520chemical%2520stability%2520of%2520the%2520hedgehog%2520pathway%2520inhibitor%2520gant61%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D349%26epage%3D358%26doi%3D10.1080%2F14756366.2017.1419221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingallina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Po, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello Barretta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span> <span> </span><span class="NLM_article-title">Gli1/DNA interaction is a druggable target for hedgehog-dependent tumors</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.15252/embj.201489213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.15252%2Fembj.201489213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25476449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislSitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=200-217&author=P.+Infanteauthor=M.+Moriauthor=R.+Alfonsiauthor=F.+Ghirgaauthor=F.+Aielloauthor=S.+Toscanoauthor=C.+Ingallinaauthor=M.+Silerauthor=D.+Cucchiauthor=A.+Poauthor=E.+Mieleauthor=D.+D%E2%80%99Amicoauthor=G.+Canettieriauthor=E.+De+Smaeleauthor=E.+Ferrettiauthor=I.+Screpantiauthor=G.+Uccello+Barrettaauthor=M.+Bottaauthor=B.+Bottaauthor=A.+Gulinoauthor=L.+Di+Marcotullio&title=Gli1%2FDNA+interaction+is+a+druggable+target+for+hedgehog-dependent+tumors&doi=10.15252%2Fembj.201489213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors</span></div><div class="casAuthors">Infante, Paola; Mori, Mattia; Alfonsi, Romina; Ghirga, Francesca; Aiello, Federica; Toscano, Sara; Ingallina, Cinzia; Siler, Mariangela; Cucchi, Danilo; Po, Agnese; Miele, Evelina; D'Amico, Davide; Canettieri, Gianluca; De Smaele, Enrico; Ferretti, Elisabetta; Screpanti, Isabella; Barretta, Gloria Uccello; Botta, Maurizio; Botta, Bruno; Gulino, Alberto; Di Marcotullio, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-217</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Hedgehog signaling is essential for tissue development and stemness, and its deregulation has been obsd. in many tumors.  Aberrant activation of Hedgehog signaling is the result of genetic mutations of pathway components or other Smo-dependent or independent mechanisms, all triggering the downstream effector Gli1.  For this reason, understanding the poorly elucidated mechanism of Gli1-mediated transcription allows to identify novel mols. blocking the pathway at a downstream level, representing a crit. goal in tumor biol.  Here, we clarify the structural requirements of the pathway effector Gli1 for binding to DNA and identify Glabrescione B as the first small mol. binding to Gli1 zinc finger and impairing Gli1 activity by interfering with its interaction with DNA.  Remarkably, as a consequence of its robust inhibitory effect on Gli1 activity, Glabrescione B inhibited the growth of Hedgehog-dependent tumor cells in vitro and in vivo as well as the self-renewal ability and clonogenicity of tumor-derived stem cells.  The identification of the structural requirements of Gli1/DNA interaction highlights their relevance for pharmacol. interference of Gli signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2YShhrICegbVg90H21EOLACvtfcHk0lizIu0xBiEsbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislSitLY%253D&md5=9aae45acbf9e3a723bf85bf52a474ec1</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.15252%2Fembj.201489213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201489213%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DGhirga%26aufirst%3DF.%26aulast%3DAiello%26aufirst%3DF.%26aulast%3DToscano%26aufirst%3DS.%26aulast%3DIngallina%26aufirst%3DC.%26aulast%3DSiler%26aufirst%3DM.%26aulast%3DCucchi%26aufirst%3DD.%26aulast%3DPo%26aufirst%3DA.%26aulast%3DMiele%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DD.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DDe%2BSmaele%26aufirst%3DE.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DUccello%2BBarretta%26aufirst%3DG.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DGulino%26aufirst%3DA.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26atitle%3DGli1%252FDNA%2520interaction%2520is%2520a%2520druggable%2520target%2520for%2520hedgehog-dependent%2520tumors%26jtitle%3DEMBO%2520J.%26date%3D2015%26volume%3D34%26spage%3D200%26epage%3D217%26doi%3D10.15252%2Fembj.201489213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slusarz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenouda, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakla, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenkhahn, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narula, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besch-Williford, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubahn, D. B.</span></span> <span> </span><span class="NLM_article-title">Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3390</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-09-3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20395211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslSgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3382-3390&author=A.+Slusarzauthor=N.+S.+Shenoudaauthor=M.+S.+Saklaauthor=S.+K.+Drenkhahnauthor=A.+S.+Narulaauthor=R.+S.+MacDonaldauthor=C.+L.+Besch-Willifordauthor=D.+B.+Lubahn&title=Common+botanical+compounds+inhibit+the+hedgehog+signaling+pathway+in+prostate+cancer&doi=10.1158%2F0008-5472.CAN-09-3012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer</span></div><div class="casAuthors">Slusarz, Anna; Shenouda, Nader S.; Sakla, Mary S.; Drenkhahn, Sara K.; Narula, Acharan S.; MacDonald, Ruth S.; Besch-Williford, Cynthia L.; Lubahn, Dennis B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3390</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Many botanical compds. have been proposed to prevent cancer.  We investigated the cancer treatment and prevention abilities of apigenin, baicalein, curcumin, epigallocatechin 3-gallate (EGCG), genistein, quercetin, and resveratrol both in vivo in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice as well as in vitro in prostate cancer cell lines.  In our expts., these seven compds. act similarly to the Hedgehog antagonist cyclopamine, a teratogenic plant alkaloid, which had been previously shown to "cure" prostate cancer in a mouse xenograft model.  With IC50 values ranging from <1 to 25 μmol/L, these compds. can inhibit Gli1 mRNA concn. by up to 95% and downregulate Gli reporter activity by 80%.  We show that four compds., genistein, curcumin, EGCG, and resveratrol, inhibit Hedgehog signaling as monitored by real-time reverse transcription-PCR anal. of Gli1 mRNA concn. or by Gli reporter activity.  Three compds., apigenin, baicalein, and quercetin, decreased Gli1 mRNA concn. but not Gli reporter activity.  Our results show that these compds. are also able to reduce or delay prostate cancer in vivo in TRAMP mice.  All seven compds., when fed in combination as pure compds. or as crude plant exts., inhibit well-differentiated carcinoma of the prostate by 58% and 81%, resp.  In vitro, we show that all seven compds. also inhibit growth in human and mouse prostate cancer cell lines.  Mechanistically, we propose the Hedgehog signaling pathway to be a direct or indirect target of these compds.  These botanicals at pharmacol. concns. are potentially safer and less expensive alternatives to cyclopamine and its pharmaceutical analogs for cancer therapy.  Cancer Res; 70(8); 3382-90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmU2Nuo81_QbVg90H21EOLACvtfcHk0lh55KpdMK8XZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslSgsrY%253D&md5=2f50f1f660c52fe4cce666579216b763</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3012%26sid%3Dliteratum%253Aachs%26aulast%3DSlusarz%26aufirst%3DA.%26aulast%3DShenouda%26aufirst%3DN.%2BS.%26aulast%3DSakla%26aufirst%3DM.%2BS.%26aulast%3DDrenkhahn%26aufirst%3DS.%2BK.%26aulast%3DNarula%26aufirst%3DA.%2BS.%26aulast%3DMacDonald%26aufirst%3DR.%2BS.%26aulast%3DBesch-Williford%26aufirst%3DC.%2BL.%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26atitle%3DCommon%2520botanical%2520compounds%2520inhibit%2520the%2520hedgehog%2520signaling%2520pathway%2520in%2520prostate%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3382%26epage%3D3390%26doi%3D10.1158%2F0008-5472.CAN-09-3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namgung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">Daidzein suppresses tumor necrosis factor-alpha induced migration and invasion by inhibiting hedgehog/gli1 signaling in human breast cancer cells</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3759</span>– <span class="NLM_lpage">3767</span>, <span class="refDoi"> DOI: 10.1021/jf500231t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf500231t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVWhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=3759-3767&author=C.+Baoauthor=H.+Namgungauthor=J.+Leeauthor=H.+C.+Parkauthor=J.+Koauthor=H.+Moonauthor=H.+W.+Koauthor=H.+J.+Lee&title=Daidzein+suppresses+tumor+necrosis+factor-alpha+induced+migration+and+invasion+by+inhibiting+hedgehog%2Fgli1+signaling+in+human+breast+cancer+cells&doi=10.1021%2Fjf500231t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Daidzein Suppresses Tumor Necrosis Factor-α Induced Migration and Invasion by Inhibiting Hedgehog/Gli1 Signaling in Human Breast Cancer Cells</span></div><div class="casAuthors">Bao, Cheng; Namgung, Hyeju; Lee, Jaehoo; Park, Hyun-Chang; Ko, Jiwon; Moon, Heejung; Ko, Hyuk Wan; Lee, Hong Jin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3759-3767</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In breast cancer, the cytokine tumor necrosis factor-α (TNF-α) induces cell invasion, although the mol. basis of it has not been clearly elucidated.  In this study, we investigated the role of daidzein in regulating TNF-α induced cell invasion and the underlying mol. mechanisms.  Daidzein inhibited TNF-α induced cellular migration and invasion in estrogen receptor (ER) neg. MCF10DCIS.com human breast cancer cells.  TNF-α activated Hedgehog (Hh) signaling by enhancing Gli1 nuclear translocation and transcriptional activity, which resulted in increased invasiveness; these effects were blocked by daidzein and the Hh signaling inhibitors, cyclopamine and vismodegib.  Moreover, these compds. suppressed TNF-α induced matrix metalloproteinase (MMP)-9 mRNA expression and activity.  Taken together, mammary tumor cell invasiveness was stimulated by TNF-α induced activation of Hh signaling; these effects were abrogated by daidzein, which suppressed Gli1 activation, thereby inhibiting migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtJ0_E32sKf7Vg90H21EOLACvtfcHk0lh55KpdMK8XZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVWhur0%253D&md5=18061ec361aa566c6f63e55432c586ec</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjf500231t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf500231t%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DC.%26aulast%3DNamgung%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%2BC.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DMoon%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DDaidzein%2520suppresses%2520tumor%2520necrosis%2520factor-alpha%2520induced%2520migration%2520and%2520invasion%2520by%2520inhibiting%2520hedgehog%252Fgli1%2520signaling%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2014%26volume%3D62%26spage%3D3759%26epage%3D3767%26doi%3D10.1021%2Fjf500231t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berardozzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingallina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Paolis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caimano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span> <span> </span><span class="NLM_article-title">Synergistic inhibition of the hedgehog pathway by newly designed smo and gli antagonists bearing the isoflavone scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ejmech.2018.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30025349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCmsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=554-562&author=S.+Berardozziauthor=F.+Bernardiauthor=P.+Infanteauthor=C.+Ingallinaauthor=S.+Toscanoauthor=E.+De+Paolisauthor=R.+Alfonsiauthor=M.+Caimanoauthor=B.+Bottaauthor=M.+Moriauthor=L.+Di+Marcotullioauthor=F.+Ghirga&title=Synergistic+inhibition+of+the+hedgehog+pathway+by+newly+designed+smo+and+gli+antagonists+bearing+the+isoflavone+scaffold&doi=10.1016%2Fj.ejmech.2018.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold</span></div><div class="casAuthors">Berardozzi, Simone; Bernardi, Flavia; Infante, Paola; Ingallina, Cinzia; Toscano, Sara; De Paolis, Elisa; Alfonsi, Romina; Caimano, Miriam; Botta, Bruno; Mori, Mattia; Di Marcotullio, Lucia; Ghirga, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">554-562</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Aberrant activation of the Hedgehog (Hh) pathway is responsible for the onset and progression of several malignancies.  Small mols. able to block the pathway at the upstream receptor Smoothened (Smo) or the downstream effector Gli1 have thus emerged recently as valuable anticancer agents.  Here, we have designed, synthesized, and tested new Hh inhibitors taking advantage by the highly versatile and privileged isoflavone scaffold.  The introduction of specific substitutions on the isoflavone's ring B allowed the identification of mols. targeting preferentially Smo or Gli1.  Biol. assays coupled with mol. modeling corroborated the design strategy, and provided new insights into the mechanism of action of these mols.  The combined administration of two different isoflavones behaving as Smo and Gli antagonists, resp., in primary medulloblastoma (MB) cells highlighted the synergistic effects of these agents, thus paving the way to further and innovative strategies for the pharmacol. inhibition of Hh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRYMtkDfh-Z7Vg90H21EOLACvtfcHk0lhf8HVh8bpCoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCmsLfF&md5=6b7f4e1d1fef4dae2d4a56ff1fb0f8e1</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DBerardozzi%26aufirst%3DS.%26aulast%3DBernardi%26aufirst%3DF.%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DIngallina%26aufirst%3DC.%26aulast%3DToscano%26aufirst%3DS.%26aulast%3DDe%2BPaolis%26aufirst%3DE.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DCaimano%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DGhirga%26aufirst%3DF.%26atitle%3DSynergistic%2520inhibition%2520of%2520the%2520hedgehog%2520pathway%2520by%2520newly%2520designed%2520smo%2520and%2520gli%2520antagonists%2520bearing%2520the%2520isoflavone%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D554%26epage%3D562%26doi%3D10.1016%2Fj.ejmech.2018.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocasio, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rack, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solow-Cordero, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowitch, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors reveal multiple strategies for hedgehog pathway blockade</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">14132</span>– <span class="NLM_lpage">14137</span>, <span class="refDoi"> DOI: 10.1073/pnas.0907134106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0907134106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19666565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=14132-14137&author=J.+M.+Hymanauthor=A.+J.+Firestoneauthor=V.+M.+Heineauthor=Y.+Zhaoauthor=C.+A.+Ocasioauthor=K.+Hanauthor=M.+Sunauthor=P.+G.+Rackauthor=S.+Sinhaauthor=J.+J.+Wuauthor=D.+E.+Solow-Corderoauthor=J.+Jiangauthor=D.+H.+Rowitchauthor=J.+K.+Chen&title=Small-molecule+inhibitors+reveal+multiple+strategies+for+hedgehog+pathway+blockade&doi=10.1073%2Fpnas.0907134106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors reveal multiple strategies for hedgehog pathway blockade</span></div><div class="casAuthors">Hyman, Joel M.; Firestone, Ari J.; Heine, Vivi M.; Zhao, Yun; Ocasio, Cory A.; Han, Kyuho; Sun, Mark; Rack, Paul G.; Sinha, Surajit; Wu, Jason J.; Solow-Cordero, David E.; Jiang, Jin; Rowitch, David H.; Chen, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">14132-14137, S14132/1-S14132/21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inappropriate activation of the Hedgehog (Hh) signaling pathway has been implicated in a diverse spectrum of cancers, and its pharmacol. blockade has emerged as an anti-tumor strategy.  While nearly all known Hh pathway antagonists target the trans-membrane protein Smoothened (Smo), small mols. that suppress downstream effectors could more comprehensively remediate Hh pathway-dependent tumors.  The authors report here four Hh pathway antagonists that are epistatic to the nucleocytoplasmic regulator Suppressor of Fused [Su(fu)], including two that can inhibit Hh target gene expression induced by overexpression of the Gli transcription factors.  Each inhibitor has a unique mechanism of action, and their phenotypes reveal that Gli processing, Gli activation, and primary cilia formation are pharmacol. targetable.  The authors further establish the ability of certain compds. to block the proliferation of cerebellar granule neuron precursors expressing an oncogenic form of Smo, and the authors demonstrate that Hh pathway inhibitors can have tissue-specific activities.  These antagonists therefore constitute a valuable set of chem. tools for interrogating downstream Hh signaling mechanisms and for developing chemotherapies against Hh pathway-related cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZXrIN2SzvLVg90H21EOLACvtfcHk0lhf8HVh8bpCoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrF&md5=2c0e1c6017b5a86a138c1a192667af0a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907134106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907134106%26sid%3Dliteratum%253Aachs%26aulast%3DHyman%26aufirst%3DJ.%2BM.%26aulast%3DFirestone%26aufirst%3DA.%2BJ.%26aulast%3DHeine%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DOcasio%26aufirst%3DC.%2BA.%26aulast%3DHan%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DRack%26aufirst%3DP.%2BG.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26aulast%3DSolow-Cordero%26aufirst%3DD.%2BE.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DRowitch%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26atitle%3DSmall-molecule%2520inhibitors%2520reveal%2520multiple%2520strategies%2520for%2520hedgehog%2520pathway%2520blockade%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D14132%26epage%3D14137%26doi%3D10.1073%2Fpnas.0907134106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Naturally occurring small-molecule inhibitors of hedgehog/gli-mediated transcription</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1002/cbic.200700511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcbic.200700511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18357592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVWiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1082-1092&author=T.+Hosoyaauthor=M.+A.+Araiauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=M.+Ishibashi&title=Naturally+occurring+small-molecule+inhibitors+of+hedgehog%2Fgli-mediated+transcription&doi=10.1002%2Fcbic.200700511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription</span></div><div class="casAuthors">Hosoya, Takahiro; Arai, Midori A.; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1082-1092</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors.  To search for Hh/GLI inhibitors, we screened for naturally occurring inhibitors of the transcriptional activator GLI1 by using a cell-based assay.  We identified zerumbone (1), zerumbone epoxide (2), staurosporinone (9), 6-hydroxystaurosporinone (10), arcyriaflavin C (11) and 5,6-dihydroxyarcyriaflavin A (12) as inhibitors of GLI-mediated transcription.  In addn., we isolated physalins F (17) and B (18) from Physalis min., which are also potent inhibitors.  These compds. also inhibited GLI2-mediated transactivation.  Semi-quant. RT-PCR and Western blotting anal. further revealed that 1, 9, 17, and 18 decreased Hh-related component expressions.  We also show that inhibitors of GLI-mediated transactivation reduce the level of the anti-apoptosis Bcl2 expression.  Finally, these identified compds. were cytotoxic to PANC1 pancreatic cancer cells, which express Hh/GLI components.  These results strongly suggest that the cytotoxicity of the compds. to PANC1 cells correlates with their inhibition of GLI-mediated transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdnhvedOW82bVg90H21EOLACvtfcHk0lhD6XZzTKAD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVWiur4%253D&md5=35ca60bee419aa5b14f45b04082dad9a</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700511%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DNaturally%2520occurring%2520small-molecule%2520inhibitors%2520of%2520hedgehog%252Fgli-mediated%2520transcription%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D1082%26epage%3D1092%26doi%3D10.1002%2Fcbic.200700511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of the right-side structure of type b physalins</span>. <i>Isr. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1002/ijch.201600110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fijch.201600110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28659646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGjt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=309-318&author=M.+Moritaauthor=S.+Kojimaauthor=M.+Ohkuboauthor=H.+Koshinoauthor=D.+Hashizumeauthor=G.+Hiraiauthor=K.+Maruokaauthor=M.+Sodeoka&title=Synthesis+of+the+right-side+structure+of+type+b+physalins&doi=10.1002%2Fijch.201600110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the Right-Side Structure of Type B Physalins</span></div><div class="casAuthors">Morita, Masaki; Kojima, Shuntaro; Ohkubo, Megumi; Koshino, Hiroyuki; Hashizume, Daisuke; Hirai, Go; Maruoka, Keiji; Sodeoka, Mikiko</div><div class="citationInfo"><span class="NLM_cas:title">Israel Journal of Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">309-318</span>CODEN:
                <span class="NLM_cas:coden">ISJCAT</span>;
        ISSN:<span class="NLM_cas:issn">0021-2148</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A full account of our synthetic studies on the racemic DEFGH-ring moiety of physalins, featuring domino ring transformation of a tricyclic key intermediate was presented.  The results of a detailed mechanistic examn. of the domino ring transformation, as well as a reoptimization of the 2,3-Wittig rearrangement and methylation steps was also reported.  Furthermore, a method for the prepn. of an optically active synthetic intermediate by enzymic kinetic resoln was newly established.  This work provided access to both natural and nonnatural right-side physalin structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4HlzoYaXBsrVg90H21EOLACvtfcHk0lhD6XZzTKAD8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGjt77L&md5=56f1941393750397a703fb4d9ff58391</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1002%2Fijch.201600110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijch.201600110%26sid%3Dliteratum%253Aachs%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DKojima%26aufirst%3DS.%26aulast%3DOhkubo%26aufirst%3DM.%26aulast%3DKoshino%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DD.%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DMaruoka%26aufirst%3DK.%26aulast%3DSodeoka%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520the%2520right-side%2520structure%2520of%2520type%2520b%2520physalins%26jtitle%3DIsr.%2520J.%2520Chem.%26date%3D2017%26volume%3D57%26spage%3D309%26epage%3D318%26doi%3D10.1002%2Fijch.201600110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Hedgehog/gli-mediated transcriptional inhibitors from zizyphus cambodiana</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">9420</span>– <span class="NLM_lpage">9424</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmc.2008.09.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18842418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KltrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9420-9424&author=M.+A.+Araiauthor=C.+Tatenoauthor=T.+Hosoyaauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=M.+Ishibashi&title=Hedgehog%2Fgli-mediated+transcriptional+inhibitors+from+zizyphus+cambodiana&doi=10.1016%2Fj.bmc.2008.09.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana</span></div><div class="casAuthors">Arai, Midori A.; Tateno, Chikashi; Hosoya, Takahiro; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9420-9424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors.  By screening tropical plant exts. by using our screening system, Zizyphus cambodiana was found to include Hh/GLI signaling inhibitors.  Bioassay-guided fractionation of this plant ext. led to the isolation of three active pentacyclic triterpenes, colubrinic acid (1), betulinic acid (2) and alphitolic acid (3), as potent inhibitors.  The inhibition of GLI-related protein expression with 1 or 2 was obsd. in HaCaT cells with exogenous GLI1, or human pancreatic cancer cells (PANC1), which express Hh/GLI components aberrantly.  The expressions of GLI-related proteins PTCH and BCL2 were clearly inhibited by 1 or 2.  We also examd. the cytotoxicity of these active compds. against PANC1, human prostate cancer cells (DU145) and mouse embryo fibroblast cells (C3H10T1/2).  The cytotoxicity against cancer cells (PANC1 and DU145) by 1 or 2 would be caused by inhibition of the expression of the anti-apoptosis protein BCL2.  These pentacyclic triterpene inhibitors showed an important relationship between Hh/GLI signaling inhibition, the decrease of BCL2, and cytotoxicity against cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIWCUSB2F5SrVg90H21EOLACvtfcHk0liMT35YOh8spg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KltrnO&md5=2253f7234ec1aee0e631cb5a972fc837</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DHedgehog%252Fgli-mediated%2520transcriptional%2520inhibitors%2520from%2520zizyphus%2520cambodiana%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D9420%26epage%3D9424%26doi%3D10.1016%2Fj.bmc.2008.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rifai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhu, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">New hedgehog/gli signaling inhibitors from excoecaria agallocha</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2010.11.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21190854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=718-722&author=Y.+Rifaiauthor=M.+A.+Araiauthor=S.+K.+Sadhuauthor=F.+Ahmedauthor=M.+Ishibashi&title=New+hedgehog%2Fgli+signaling+inhibitors+from+excoecaria+agallocha&doi=10.1016%2Fj.bmcl.2010.11.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha</span></div><div class="casAuthors">Rifai, Yusnita; Arai, Midori A.; Sadhu, Samir K.; Ahmed, Firoj; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">718-722</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The inhibition of the Hedgehog (Hh) signaling pathway has emerged as an anti-cancer strategy.  Three flavonoid glycosides, including 2 new compds. (1-2), were isolated from Excoecaria agallocha as Hedgehog/GLI1-mediated transcriptional inhibitors and exhibited cytotoxicity against human pancreatic (PANC1) and prostate (DU145) cancer cells.  The data revealed that compd. 1 clearly inhibited the expression of GLI-related proteins (PTCH and BCL-2) and blocked the translocation of GLI1 transcription factors into the nucleus in PANC1.  Deleting the Smoothened (Smo) function in PANC1 treated with compd. 1 led to downregulation of the mRNA expression of Ptch.  This study describes the first Hh signaling inhibitor which blocks GLI1 movement into the nucleus without interfering with Smo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpioNJrbW8TcbVg90H21EOLACvtfcHk0liMT35YOh8spg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOjsQ%253D%253D&md5=cc5028e73f195856a5dd14d18d95eea1</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.126%26sid%3Dliteratum%253Aachs%26aulast%3DRifai%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DSadhu%26aufirst%3DS.%2BK.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DNew%2520hedgehog%252Fgli%2520signaling%2520inhibitors%2520from%2520excoecaria%2520agallocha%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D718%26epage%3D722%26doi%3D10.1016%2Fj.bmcl.2010.11.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">New hedgehog/gli-signaling inhibitors from adenium obesum</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1139</span>, <span class="refDoi"> DOI: 10.1039/C0OB00677G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1039%2FC0OB00677G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21170436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1133-1139&author=M.+A.+Araiauthor=C.+Tatenoauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=S.+Kawabeauthor=M.+Ishibashi&title=New+hedgehog%2Fgli-signaling+inhibitors+from+adenium+obesum&doi=10.1039%2FC0OB00677G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">New hedgehog/GLI-signaling inhibitors from Adenium obesum</span></div><div class="casAuthors">Arai, Midori A.; Tateno, Chikashi; Koyano, Takashi; Kowithayakorn, Thaworn; Kawabe, Seiichiro; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1133-1139</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors.  We recently constructed a cell-based screening system to search for Hh/GLI signaling inhibitors from natural resources.  Using our screening system, Adenium obesum was found to include Hh/GLI signaling inhibitors from our tropical plant ext. libraries.  Bioassay-guided fractionation of this plant ext. led to the isolation of 17 cardiac glycosides, including 3 new compds.  These compds. showed strong inhibitory activities, e.g., IC50 of 0.11 μM.  The inhibition of GLI-related protein expression with some compds. was obsd. in human pancreatic cancer cells (PANC1), which express Hh/GLI components aberrantly.  The expressions of GLI-related proteins PTCH and BCL2 were clearly inhibited.  These compds. also showed selective cytotoxicity against two cancer cell lines, with less effect against normal cells (C3H10T1/2).  RT-PCT examns. showed that Ptch mRNA expression was inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow1yfIaOz9OrVg90H21EOLACvtfcHk0liMT35YOh8spg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCjtL0%253D&md5=37745174dbc52e54c0e7074d5cbb3ff5</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC0OB00677G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0OB00677G%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DS.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DNew%2520hedgehog%252Fgli-signaling%2520inhibitors%2520from%2520adenium%2520obesum%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D1133%26epage%3D1139%26doi%3D10.1039%2FC0OB00677G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suganami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhu, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Gli1 inhibitors identified by target protein oriented natural products isolation (tpo-napi) with hedgehog inhibition</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2559</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00492</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00492" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Witb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2551-2559&author=M.+A.+Araiauthor=F.+Ochiauthor=Y.+Makitaauthor=T.+Chibaauthor=K.+Higashiauthor=A.+Suganamiauthor=Y.+Tamuraauthor=T.+Toidaauthor=A.+Iwamaauthor=S.+K.+Sadhuauthor=F.+Ahmedauthor=M.+Ishibashi&title=Gli1+inhibitors+identified+by+target+protein+oriented+natural+products+isolation+%28tpo-napi%29+with+hedgehog+inhibition&doi=10.1021%2Facschembio.8b00492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition</span></div><div class="casAuthors">Arai, Midori A.; Ochi, Fumie; Makita, Yoshinori; Chiba, Tetsuhiro; Higashi, Kyohei; Suganami, Akiko; Tamura, Yutaka; Toida, Toshihiko; Iwama, Atsushi; Sadhu, Samir K.; Ahmed, Firoj; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2551-2559</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes the development of a target-protein-oriented natural-products-isolation (TPO-NAPI) method for Hedgehog inhibitors and the direct GLI1 inhibitor, 5'-O-methyl-3-hydroxyflemingin A , which inhibited hedgehog (Hh) signal transduction and diminished characteristics of cancer stem cells.  Eight natural products (including three newly described products) that directly bind to GLI1 were rapidly obtained via the TPO-NAPI method developed using GLI1 protein-immobilized beads.  5'-O-Methyl-3-hydroxyflemingin A inhibited Hh signaling (IC50 7.3 μM), leading to decreasing prodn. of the Hh target proteins BCL2, PTCH1, and BMI1.  5'-O-Methyl-3-hydroxyflemingin A was cytotoxic to Hh-related cancer cells.  CD expts. revealed that 5'-O-methyl-3-hydroxyflemingin A directly bound GLI1 (Kd = 7.7 μM).  Moreover, 5'-O-methyl-3-hydroxyflemingin A diminished cancer stem cell characters of Huh7 such as sphere formation and prodn. of the cancer stem cell marker EpCAM.  These results suggest that Hh inhibitors can efficiently suppress the activity of cancer stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppt1O3xio1XLVg90H21EOLACvtfcHk0lhk31N06kA_1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Witb%252FP&md5=1f0605e92e3aaff4616c13d7fd3ede66</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00492%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DOchi%26aufirst%3DF.%26aulast%3DMakita%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DHigashi%26aufirst%3DK.%26aulast%3DSuganami%26aufirst%3DA.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DToida%26aufirst%3DT.%26aulast%3DIwama%26aufirst%3DA.%26aulast%3DSadhu%26aufirst%3DS.%2BK.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DGli1%2520inhibitors%2520identified%2520by%2520target%2520protein%2520oriented%2520natural%2520products%2520isolation%2520%2528tpo-napi%2529%2520with%2520hedgehog%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D2551%26epage%3D2559%26doi%3D10.1021%2Facschembio.8b00492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span> <span> </span><span class="NLM_article-title">Solasonine, a natural glycoalkaloid compound, inhibits gli-mediated transcriptional activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1364</span>, <span class="refDoi"> DOI: 10.3390/molecules21101364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fmolecules21101364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1364&author=J.+Yangauthor=W.+Huangauthor=W.+Tan&title=Solasonine%2C+a+natural+glycoalkaloid+compound%2C+inhibits+gli-mediated+transcriptional+activity&doi=10.3390%2Fmolecules21101364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Solasonine, a natural glycoalkaloid compound, inhibits Gli-mediated transcriptional activity</span></div><div class="casAuthors">Yang, Jun; Huang, Wenjing; Tan, Wenfu</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1364/1-1364/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The major obstacle limiting the efficacy of current Smoothened (Smo) inhibitors is the primary and acquired resistance mainly caused by Smo mutations and Gli amplification.  In this context, developing Hh inhibitors targeting Gli, the final effector of this signaling pathway, may combat the resistance.  In this study we found that solasonine, a natural glycoalkaloid compd., significantly inhibited the hedgehog (Hh) pathway activity.  Meanwhile, solasonine may obviously inhibit the alk. phosphatase (ALP) activity in C3H10T1/2 cells, concomitantly with redns. of the mRNA expression of Gli1 and Ptch1.  However, we found that solasonine exhibited no effect on the transcriptional factors activities provoked by TNF-α and PGE2, thus suggesting its selectivity against Hh pathway activity.  Furthermore, we identified that solasonine inhibited the Hh pathway activity by acting on its transcriptional factor Gli using a series of complementary data.  We also obsd. that solasonine obviously inhibited the Gli-luciferase activity provoked by ectopic expression of Smo mutants which may cause the resistance to the current Smo inhibitors.  Our study suggests that solasonine may significantly inhibit the Hh pathway activity by acting on Gli, therefore indicating the possibility to use solasonine as a lead compd. to develop anticancer drugs for combating the resistance of current Smo inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEmcclfDKCLVg90H21EOLACvtfcHk0lhk31N06kA_1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSqurc%253D&md5=a3ba5ced46c9fce513b722721a86889c</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21101364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21101364%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DW.%26atitle%3DSolasonine%252C%2520a%2520natural%2520glycoalkaloid%2520compound%252C%2520inhibits%2520gli-mediated%2520transcriptional%2520activity%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D1364%26doi%3D10.3390%2Fmolecules21101364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayank</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaitak, V.</span></span> <span> </span><span class="NLM_article-title">Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy</span>. <i>Comput. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.compbiolchem.2015.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.compbiolchem.2015.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26278973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCrtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=145-154&author=+Mayankauthor=V.+Jaitak&title=Molecular+docking+study+of+natural+alkaloids+as+multi-targeted+hedgehog+pathway+inhibitors+in+cancer+stem+cell+therapy&doi=10.1016%2Fj.compbiolchem.2015.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy</span></div><div class="casAuthors">Mayank; Jaitak, Vikas</div><div class="citationInfo"><span class="NLM_cas:title">Computational Biology and Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-154</span>CODEN:
                <span class="NLM_cas:coden">CBCOCH</span>;
        ISSN:<span class="NLM_cas:issn">1476-9271</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer is responsible for millions of deaths throughout the world every year.  Increased understanding as well as advancements in the therapeutic aspect seems suboptimal to restrict the huge deaths assocd. with cancer.  The major cause responsible for this is high resistance as well as relapse rate assocd. with cancers.  Several evidences indicated that cancer stem cells (CSC) are mainly responsible for the resistance and relapses assocd. with cancer.  Furthermore, agents targeting a single protein seem to have higher chances of resistance than multitargeting drugs.  According to the concept of network model, partial inhibition of multiple targets is more productive than single hit agents.  Thus, by fusing both the premises that CSC and single hit anticancer drugs, both are responsible for cancer related resistances and screened alkaloids for the search of leads having CSC targeting ability as well as the capability to modulating multiple target proteins.  The in silico exptl. data indicated that emetine and cortistatin have the ability to modulate hedgehog (Hh) pathway by binding to sonic hedgehog (Hh), smoothened (Smo) and Gli protein, involved in maintenance CSCs.  Furthermore, solamargine, solasonine and tylophorine are also seems to be good lead mols. targeting towards CSCs by modulating Hh pathway.  Except solamargine and solasonine, other best lead mols. also showed acceptable in silico ADME profile.  The predicted lead mols. can be suitably modified to get multitargeting CSC targeting agent to get rid of assoc. resistances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPPPzg7_ziIrVg90H21EOLACvtfcHk0lhk31N06kA_1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCrtbvP&md5=ece6a2ab494621b64cda1fe1d5500cdc</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiolchem.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiolchem.2015.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DMayank%26aulast%3DJaitak%26aufirst%3DV.%26atitle%3DMolecular%2520docking%2520study%2520of%2520natural%2520alkaloids%2520as%2520multi-targeted%2520hedgehog%2520pathway%2520inhibitors%2520in%2520cancer%2520stem%2520cell%2520therapy%26jtitle%3DComput.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D62%26spage%3D145%26epage%3D154%26doi%3D10.1016%2Fj.compbiolchem.2015.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. P.</span></span> <span> </span><span class="NLM_article-title">Cynanbungeigenin c and d, a pair of novel epimers from cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of gli</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>420</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.canlet.2018.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29425683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFalt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2018&pages=195-207&author=X.+Y.+Liauthor=L.+F.+Zhouauthor=L.+J.+Gaoauthor=Y.+Weiauthor=S.+F.+Xuauthor=F.+Y.+Chenauthor=W.+J.+Huangauthor=W.+F.+Tanauthor=Y.+P.+Ye&title=Cynanbungeigenin+c+and+d%2C+a+pair+of+novel+epimers+from+cynanchum+bungei%2C+suppress+hedgehog+pathway-dependent+medulloblastoma+by+blocking+signaling+at+the+level+of+gli&doi=10.1016%2Fj.canlet.2018.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Cynanbungeigenin C and D, a pair of novel epimers from Cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of Gli</span></div><div class="casAuthors">Li, Xiao-Yu; Zhou, Li-Fei; Gao, Li-Juan; Wei, Yang; Xu, Shi-Fang; Chen, Feng-Yang; Huang, Wen-Jing; Tan, Wen-Fu; Ye, Yi-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Uncontrolled excessive activation of Hedgehog (Hh) signaling pathway is linked to a no. of human malignant tumorigenesis.  To obtain valuable Hh pathway inhibitors from natural product, in present study, a pair of novel epimers, Cynanbungeigenin C (CBC) and D (CBD) from the plant Cynanchum bungei Decne were chem. characterized by multiple spectroscopic data and chem. derivatization, and evaluated for their inhibition on Hh pathway.  Mechanistically, CBC and CBD block Hh pathway signaling not through targeting Smo and Sufu, but at the level of Gli.  In addn., both eipmers significantly suppress Hh pathway-dependent Ptch+/-; p53-/- medulloblastoma in vitro and in vivo.  Furthermore, both CBC and CBD inhibited two Smo mutants induced Hh pathway activation, which suggested that they are potential compds. for the treatment of medulloblastoma with primary or acquired resistance to current Smo inhibitors.  These results highlight the potential of CBC and CBD as effective lead compds. in the treatment of medulloblastoma and other Hh-dependent malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_aSZZQU9cS7Vg90H21EOLACvtfcHk0li2pAO83PKbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFalt7w%253D&md5=4320747c048909c3c2fcb85dd295ece9</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DZhou%26aufirst%3DL.%2BF.%26aulast%3DGao%26aufirst%3DL.%2BJ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DF.%2BY.%26aulast%3DHuang%26aufirst%3DW.%2BJ.%26aulast%3DTan%26aufirst%3DW.%2BF.%26aulast%3DYe%26aufirst%3DY.%2BP.%26atitle%3DCynanbungeigenin%2520c%2520and%2520d%252C%2520a%2520pair%2520of%2520novel%2520epimers%2520from%2520cynanchum%2520bungei%252C%2520suppress%2520hedgehog%2520pathway-dependent%2520medulloblastoma%2520by%2520blocking%2520signaling%2520at%2520the%2520level%2520of%2520gli%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D420%26spage%3D195%26epage%3D207%26doi%3D10.1016%2Fj.canlet.2018.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rifai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Terpenoids and a flavonoid glycoside from acacia pennata leaves as hedgehog/gli-mediated transcriptional inhibitors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1021/np1000818</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np1000818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=995-997&author=Y.+Rifaiauthor=M.+A.+Araiauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=M.+Ishibashi&title=Terpenoids+and+a+flavonoid+glycoside+from+acacia+pennata+leaves+as+hedgehog%2Fgli-mediated+transcriptional+inhibitors&doi=10.1021%2Fnp1000818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenoids and a Flavonoid Glycoside from Acacia pennata Leaves as Hedgehog/GLI-Mediated Transcriptional Inhibitors</span></div><div class="casAuthors">Rifai, Yusnita; Arai, Midori A.; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">995-997</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Overexpression of glioma-assocd. oncogene 1 (GLI1), which has been characterized as a terminal effector and a target gene of the Hedgehog (Hh) signaling pathway, is assocd. with the development of cancer.  A cellular screen was applied utilizing of a GLI-dependent luciferase reporter in human keratinocyte cells (HaCaT) and identified two terpenoids (1 and 2) and a flavonoid glycoside (5) from Acacia pennata as Hh/GLI inhibitors.  Compds. 1, 2, and 5 exhibited selective cytotoxicity against human pancreatic (PANC1) and prostate (DU145) cancer cells with no toxic effect on normal cells.  This result was consistent with a dose-dependent redn. of the protein levels of antiapoptotic BCL-2 and the tumor suppressor patched 1 protein (PTCH).  Addnl., treatment of 1 downregulated mRNA expression of Ptch in PANC1, suggesting that the compd. has an inhibitory effect on the transcription of Hh/GLI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwdWjuBo6oLVg90H21EOLACvtfcHk0li2pAO83PKbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslehu70%253D&md5=8cc75a560b2d9825a1af1b16e7e1fed5</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fnp1000818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp1000818%26sid%3Dliteratum%253Aachs%26aulast%3DRifai%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DTerpenoids%2520and%2520a%2520flavonoid%2520glycoside%2520from%2520acacia%2520pennata%2520leaves%2520as%2520hedgehog%252Fgli-mediated%2520transcriptional%2520inhibitors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D995%26epage%3D997%26doi%3D10.1021%2Fnp1000818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span> <span> </span><span class="NLM_article-title">Three new alkaloids from veratrum grandiflorum loes with inhibition activities on hedgehog pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4735</span>– <span class="NLM_lpage">4738</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2016.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27567371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVaksbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4735-4738&author=L.+Gaoauthor=F.+Chenauthor=X.+Liauthor=S.+Xuauthor=W.+Huangauthor=Y.+Ye&title=Three+new+alkaloids+from+veratrum+grandiflorum+loes+with+inhibition+activities+on+hedgehog+pathway&doi=10.1016%2Fj.bmcl.2016.08.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Three new alkaloids from Veratrum grandiflorum Loes with inhibition activities on Hedgehog pathway</span></div><div class="casAuthors">Gao, Lijuan; Chen, Fengyang; Li, Xiaoyu; Xu, Shifang; Huang, Wenhai; Ye, Yiping</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4735-4738</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three new steroidal alkaloids 1-3, together with four known compds. 4-7, were isolated from the ethanol ext. of Veratrum grandiflorum Loes.  Their structures were elucidated by NMR (1D and 2D NMR) and MS spectroscopic data.  The inhibition activities on Hedgehog (Hh) pathway were evaluated using a cell-based bioassay system (Shh-LIGHT 2 cells).  The results showed that compds. 1-3 and 5 displayed inhibitory activities obviously with the IC50 values of 0.63-3.11 μM.  Among them, compd. 5 showed the most prominent inhibition activity (IC50 = 0.63 ± 0.02 μM).  Thus, these active alkaloids may be potent natural compds. as Hh pathway inhibitors for the treatment of various cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGputceyD7hQELVg90H21EOLACvtfcHk0li2pAO83PKbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVaksbfO&md5=ba913c39e62a7c88da88c32f3e12969d</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DY.%26atitle%3DThree%2520new%2520alkaloids%2520from%2520veratrum%2520grandiflorum%2520loes%2520with%2520inhibition%2520activities%2520on%2520hedgehog%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4735%26epage%3D4738%26doi%3D10.1016%2Fj.bmcl.2016.08.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span> <span> </span><span class="NLM_article-title">Steroidal aglycones from stems of Marsdenia tenacissima that inhibited the hedgehog signaling pathway</span>. <i>Nat. Prod. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1177/1934578X1400900204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1177%2F1934578X1400900204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24689277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1arsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=155-156&author=L.+Zhangauthor=F.+Y.+Chenauthor=S.+F.+Xuauthor=Y.+P.+Yeauthor=X.+Y.+Li&title=Steroidal+aglycones+from+stems+of+Marsdenia+tenacissima+that+inhibited+the+hedgehog+signaling+pathway&doi=10.1177%2F1934578X1400900204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Steroidal aglycones from stems of Marsdenia tenacissima that inhibited the hedgehog signaling pathway</span></div><div class="casAuthors">Zhang, Lin; Chen, Feng-yang; Xu, Shi-fang; Ye, Yi-ping; Li, Xiao-yu</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-156</span>CODEN:
                <span class="NLM_cas:coden">NPCACO</span>;
        ISSN:<span class="NLM_cas:issn">1934-578X</span>.
    
            (<span class="NLM_cas:orgname">Natural Product Inc.</span>)
        </div><div class="casAbstract">Two novel steroidal aglycons, together with four known ones, were isolated from the hydrolysis ext. of the CHCl3 sol. ext. of the stems of Marsdenia tenacissima.  Their structures were detd. on the basis of chem. evidence and extensive spectroscopic methods, including 1D and 2D NMR spectroscopy.  These compds. displayed inhibition of the Hedgehog signaling pathway in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppt5G82BLxIrVg90H21EOLACvtfcHk0ljr3icJZa-pvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1arsr0%253D&md5=8c7cf085055ce5e133d0368037928c3b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1177%2F1934578X1400900204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1934578X1400900204%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DF.%2BY.%26aulast%3DXu%26aufirst%3DS.%2BF.%26aulast%3DYe%26aufirst%3DY.%2BP.%26aulast%3DLi%26aufirst%3DX.%2BY.%26atitle%3DSteroidal%2520aglycones%2520from%2520stems%2520of%2520Marsdenia%2520tenacissima%2520that%2520inhibited%2520the%2520hedgehog%2520signaling%2520pathway%26jtitle%3DNat.%2520Prod.%2520Commun.%26date%3D2014%26volume%3D9%26spage%3D155%26epage%3D156%26doi%3D10.1177%2F1934578X1400900204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Y.</span></span> <span> </span><span class="NLM_article-title">The loss of a sugar chain at c(3) position enhances stemucronatoside k-induced apoptosis, cell cycle arrest, and hedgehog pathway inhibition in ht-29 cells</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1484</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201600054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcbdv.201600054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27449706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1eisr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=1484-1492&author=X.+Zhouauthor=L.+F.+Zhouauthor=B.+Yangauthor=H.+J.+Zhaoauthor=Y.+Q.+Wangauthor=X.+Y.+Liauthor=Y.+P.+Yeauthor=F.+Y.+Chen&title=The+loss+of+a+sugar+chain+at+c%283%29+position+enhances+stemucronatoside+k-induced+apoptosis%2C+cell+cycle+arrest%2C+and+hedgehog+pathway+inhibition+in+ht-29+cells&doi=10.1002%2Fcbdv.201600054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The loss of a sugar chain at C(3) position enhances stemucronatoside K-induced apoptosis, cell cycle arrest, and Hedgehog pathway inhibition in HT-29 cells</span></div><div class="casAuthors">Zhou, Xia; Zhou, Li-Fei; Yang, Bo; Zhao, Hua-Jun; Wang, Yi-Qi; Li, Xiao-Yu; Ye, Yi-Ping; Chen, Feng-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1484-1492</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Stemucronatoside K (SMK) and its aglycon stephanthraniline A (STA) are the most representative of a series of novel C21 steriodal compds. that we have previously isolated from Asclepiadaceae plants.  The objectives of this study were to investigate the antitumor activity of SMK and STA, and clarify the effect of the sugar chain at the C(3) position.  Our results showed that both SMK and STA decreased the growth of HT-29 cells in a dose- and time-dependent manner.  Meanwhile, STA showed much stronger inhibitory effect than SMK.  Treatment of HT-29 cells with STA increased the apoptotic cell nos. and the protein expression of cleaved caspase 3 and cleaved-PARP.  G1 phase cell cycle arrest and decreased expression of cyclin D1 and cyclin-dependent kinases 4 were also obsd. after STA treatment.  Furthermore, STA reduced the mRNA levels of four Hedgehog pathway components (GLI1, GLI2, GLI3, and PTCH1) and suppressed Shh-induced Hedgehog pathway activation in a concn.-dependent manner.  These results indicated that SMK and STA could inhibit the growth of HT-29 cells by inducing apoptosis, cell cycle arrest, and hedgehog pathway inhibition.  The loss of sugar chain at C(3) position could enhance SMK's activity.  This study is beneficial to understand the use of natural C21 steroids as antitumor lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2a7zKGqCPrVg90H21EOLACvtfcHk0ljr3icJZa-pvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1eisr3L&md5=30e02977af1966fb22574fdddb247eb3</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201600054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201600054%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DL.%2BF.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BQ.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DYe%26aufirst%3DY.%2BP.%26aulast%3DChen%26aufirst%3DF.%2BY.%26atitle%3DThe%2520loss%2520of%2520a%2520sugar%2520chain%2520at%2520c%25283%2529%2520position%2520enhances%2520stemucronatoside%2520k-induced%2520apoptosis%252C%2520cell%2520cycle%2520arrest%252C%2520and%2520hedgehog%2520pathway%2520inhibition%2520in%2520ht-29%2520cells%26jtitle%3DChem.%2520Biodiversity%26date%3D2016%26volume%3D13%26spage%3D1484%26epage%3D1492%26doi%3D10.1002%2Fcbdv.201600054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrosanti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinkuhler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitagliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulino, A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase and cullin3-ren(kctd11) ubiquitin ligase interplay regulates hedgehog signalling through gli acetylation</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1038/ncb2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncb2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20081843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=132-142&author=G.+Canettieriauthor=L.+Di+Marcotullioauthor=A.+Grecoauthor=S.+Coniauthor=L.+Antonucciauthor=P.+Infanteauthor=L.+Pietrosantiauthor=E.+De+Smaeleauthor=E.+Ferrettiauthor=E.+Mieleauthor=M.+Pelloniauthor=G.+De+Simoneauthor=E.+M.+Pedoneauthor=P.+Gallinariauthor=A.+Giorgiauthor=C.+Steinkuhlerauthor=L.+Vitaglianoauthor=C.+Pedoneauthor=M.+E.+Schininauthor=I.+Screpantiauthor=A.+Gulino&title=Histone+deacetylase+and+cullin3-ren%28kctd11%29+ubiquitin+ligase+interplay+regulates+hedgehog+signalling+through+gli+acetylation&doi=10.1038%2Fncb2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation</span></div><div class="casAuthors">Canettieri, Gianluca; Di Marcotullio, Lucia; Greco, Azzura; Coni, Sonia; Antonucci, Laura; Infante, Paola; Pietrosanti, Laura; De Smaele, Enrico; Ferretti, Elisabetta; Miele, Evelina; Pelloni, Marianna; De Simone, Giuseppina; Pedone, Emilia Maria; Gallinari, Paola; Giorgi, Alessandra; Steinkuehler, Christian; Vitagliano, Luigi; Pedone, Carlo; Schinin, M. Eugenia; Screpanti, Isabella; Gulino, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog signalling is crucial for development and is deregulated in several tumors, including medulloblastoma.  Regulation of the transcriptional activity of Gli (glioma-assocd. oncogene) proteins, effectors of the Hedgehog pathway, is poorly understood.  We show here that Gli1 and Gli2 are acetylated proteins and that their HDAC-mediated deacetylation promotes transcriptional activation and sustains a pos. autoregulatory loop through Hedgehog-induced upregulation of HDAC1.  This mechanism is turned off by HDAC1 degrdn. through an E3 ubiquitin ligase complex formed by Cullin3 and REN, a Gli antagonist lost in human medulloblastoma.  Whereas high HDAC1 and low REN expression in neural progenitors and medulloblastomas correlates with active Hedgehog signalling, loss of HDAC activity suppresses Hedgehog-dependent growth of neural progenitors and tumor cells.  Consistent with this, abrogation of Gli1 acetylation enhances cellular proliferation and transformation.  These data identify an integrated HDAC- and ubiquitin-mediated circuitry, where acetylation of Gli proteins functions as an unexpected key transcriptional checkpoint of Hedgehog signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxrrIzZx1MebVg90H21EOLACvtfcHk0ljr3icJZa-pvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbw%253D&md5=03f90e14b156c34af5e19858d8463623</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2Fncb2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2013%26sid%3Dliteratum%253Aachs%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DGreco%26aufirst%3DA.%26aulast%3DConi%26aufirst%3DS.%26aulast%3DAntonucci%26aufirst%3DL.%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DPietrosanti%26aufirst%3DL.%26aulast%3DDe%2BSmaele%26aufirst%3DE.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DMiele%26aufirst%3DE.%26aulast%3DPelloni%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DPedone%26aufirst%3DE.%2BM.%26aulast%3DGallinari%26aufirst%3DP.%26aulast%3DGiorgi%26aufirst%3DA.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DVitagliano%26aufirst%3DL.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DSchinin%26aufirst%3DM.%2BE.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DGulino%26aufirst%3DA.%26atitle%3DHistone%2520deacetylase%2520and%2520cullin3-ren%2528kctd11%2529%2520ubiquitin%2520ligase%2520interplay%2520regulates%2520hedgehog%2520signalling%2520through%2520gli%2520acetylation%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D132%26epage%3D142%26doi%3D10.1038%2Fncb2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhans, S. A.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e71455</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0071455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1371%2Fjournal.pone.0071455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23951168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlams7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e71455&author=S.+J.+Leeauthor=S.+Lindseyauthor=B.+Gravesauthor=S.+Yooauthor=J.+M.+Olsonauthor=S.+A.+Langhans&title=Sonic+hedgehog-induced+histone+deacetylase+activation+is+required+for+cerebellar+granule+precursor+hyperplasia+in+medulloblastoma&doi=10.1371%2Fjournal.pone.0071455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma</span></div><div class="casAuthors">Lee, Seung Joon; Lindsey, Stephan; Graves, Bruce; Yoo, Soonmoon; Olson, James M.; Langhans, Sigrid A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e71455</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Medulloblastoma, the most common pediatric brain tumor, is thought to arise from deregulated proliferation of cerebellar granule precursor (CGP) cells.  Sonic hedgehog (Shh) is the primary mitogen that regulates proliferation of CGP cells during the early stages of postnatal cerebellum development.  Aberrant activation of Shh signaling during this time has been assocd. with hyperplasia of CGP cells and eventually may lead to the development of medulloblastoma.  The mol. targets of Shh signaling involved in medulloblastoma formation are still not well-understood.  Here, we show that Shh regulates sustained activation of histone deacetylases (HDACs) and that this activity is required for continued proliferation of CGP cells.  Suppression of HDAC activity not only blocked the Shh-induced CGP proliferation in primary cell cultures, but also ameliorated aberrant CGP proliferation at the external germinal layer (EGL) in a medulloblastoma mouse model.  Increased levels of mRNA and protein of several HDAC family members were found in medulloblastoma compared to wild type cerebellum suggesting that HDAC activity is required for the survival/progression of tumor cells.  The identification of a role of HDACs in the early steps of medulloblastoma formation suggests there may be a therapeutic potential for HDAC inhibitors in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6reSdRZ2TsrVg90H21EOLACvtfcHk0li4r6zAt5oYjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlams7rE&md5=8ad5c8bc973ffba643a0c98e0da19171</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0071455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0071455%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DLindsey%26aufirst%3DS.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DS.%26aulast%3DOlson%26aufirst%3DJ.%2BM.%26aulast%3DLanghans%26aufirst%3DS.%2BA.%26atitle%3DSonic%2520hedgehog-induced%2520histone%2520deacetylase%2520activation%2520is%2520required%2520for%2520cerebellar%2520granule%2520precursor%2520hyperplasia%2520in%2520medulloblastoma%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De71455%26doi%3D10.1371%2Fjournal.pone.0071455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKellar, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urman, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollmig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasi, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span> <span> </span><span class="NLM_article-title">Lap2 proteins chaperone gli1 movement between the lamina and chromatin to regulate transcription</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2018.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30503211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlOktb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=198-212&author=A.+N.+Mirzaauthor=S.+A.+McKellarauthor=N.+M.+Urmanauthor=A.+S.+Brownauthor=T.+Hollmigauthor=S.+Z.+Aasiauthor=A.+E.+Oro&title=Lap2+proteins+chaperone+gli1+movement+between+the+lamina+and+chromatin+to+regulate+transcription&doi=10.1016%2Fj.cell.2018.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">LAP2 Proteins Chaperone GLI1 Movement between the Lamina and Chromatin to Regulate Transcription</span></div><div class="casAuthors">Mirza, Amar N.; McKellar, Siegen A.; Urman, Nicole M.; Brown, Alexander S.; Hollmig, Tyler; Aasi, Sumaira Z.; Oro, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">198-212.e15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Understanding transcription factor navigation through the nucleus remains crit. for developing targeted therapeutics.  The GLI1 transcription factor must maintain maximal Hedgehog pathway output in basal cell carcinomas (BCCs), and we have previously shown that resistant BCCs increase GLI1 deacetylation through atypical protein kinase Cι/λ (aPKC) and HDAC1.  Here we identify a lamina-assocd. polypeptide 2 (LAP2) isoform-dependent nuclear chaperoning system that regulates GLI1 movement between the nuclear lamina and nucleoplasm to achieve maximal activation.  LAP2β forms a two-site interaction with the GLI1 zinc-finger domain and acetylation site, stabilizing an acetylation-dependent reserve on the inner nuclear membrane (INM).  By contrast, the nucleoplasmic LAP2α competes with LAP2β for GLI1 while scaffolding HDAC1 to deacetylate the secondary binding site. aPKC functions to promote GLI1 assocn. with LAP2α, promoting egress off the INM.  GLI1 intranuclear trafficking by LAP2 isoforms represents a powerful signal amplifier in BCCs with implications for zinc finger-based signal transduction and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6fzq2atvYurVg90H21EOLACvtfcHk0li4r6zAt5oYjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlOktb3K&md5=a281eb2bc4cb7a2cc3d41e5eee1b0a63</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DMirza%26aufirst%3DA.%2BN.%26aulast%3DMcKellar%26aufirst%3DS.%2BA.%26aulast%3DUrman%26aufirst%3DN.%2BM.%26aulast%3DBrown%26aufirst%3DA.%2BS.%26aulast%3DHollmig%26aufirst%3DT.%26aulast%3DAasi%26aufirst%3DS.%2BZ.%26aulast%3DOro%26aufirst%3DA.%2BE.%26atitle%3DLap2%2520proteins%2520chaperone%2520gli1%2520movement%2520between%2520the%2520lamina%2520and%2520chromatin%2520to%2520regulate%2520transcription%26jtitle%3DCell%26date%3D2019%26volume%3D176%26spage%3D198%26epage%3D212%26doi%3D10.1016%2Fj.cell.2018.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Burgo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neureiter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span> <span> </span><span class="NLM_article-title">Targeting class i histone deacetylases by the novel small molecule inhibitor 4sc-202 blocks oncogenic hedgehog-gli signaling and overcomes smoothened inhibitor resistance</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1002/ijc.31117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fijc.31117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29055107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2018&pages=968-975&author=W.+Gruberauthor=E.+Peerauthor=D.+P.+Elmerauthor=C.+Sternbergauthor=S.+Tesanovicauthor=P.+Del+Burgoauthor=S.+Coniauthor=G.+Canettieriauthor=D.+Neureiterauthor=R.+Bartzauthor=H.+Kohlhofauthor=D.+Vittauthor=F.+Aberger&title=Targeting+class+i+histone+deacetylases+by+the+novel+small+molecule+inhibitor+4sc-202+blocks+oncogenic+hedgehog-gli+signaling+and+overcomes+smoothened+inhibitor+resistance&doi=10.1002%2Fijc.31117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance</span></div><div class="casAuthors">Gruber, Wolfgang; Peer, Elisabeth; Elmer, Dominik P.; Sternberg, Christina; Tesanovic, Suzana; del Burgo, Pedro; Coni, Sonia; Canettieri, Gianluca; Neureiter, Daniel; Bartz, Rene; Kohlhof, Hella; Vitt, Daniel; Aberger, Fritz</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-975</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Aberrant activation of Hedgehog (HH)/GLI signaling is causally involved in numerous human malignancies, including basal cell carcinoma (BCC) and medulloblastoma.  HH pathway antagonists targeting smoothened (SMO), an essential effector of canonical HH/GLI signaling, show significant clin. success in BCC patients and have recently been approved for the treatment of advanced and metastatic BCC.  However, rapid and frequent development of drug resistance to SMO inhibitors (SMOi) together with severe side effects caused by prolonged SMOi treatment call for alternative treatment strategies targeting HH/GLI signaling downstream of SMO.  In this study, we report that 4SC-202, a novel clin. validated inhibitor of class I histone deacetylases (HDACs), efficiently blocks HH/GLI signaling.  Notably, 4SC-202 treatment abrogates GLI activation and HH target gene expression in both SMOi-sensitive and -resistant cells.  Mechanistically, we propose that the inhibition of HDACs 1/2/3 is crucial for targeting oncogenic HH/GLI signaling, and that class I HDAC inhibitors either in combination with SMOi or as second-line therapy may improve the treatment options for HH-assocd. malignancies with SMOi resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCfqA0SMfaXLVg90H21EOLACvtfcHk0lg2nkW2P97JUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jI&md5=9783d863f1c0991e0f0d8c03c6eb064a</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1002%2Fijc.31117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31117%26sid%3Dliteratum%253Aachs%26aulast%3DGruber%26aufirst%3DW.%26aulast%3DPeer%26aufirst%3DE.%26aulast%3DElmer%26aufirst%3DD.%2BP.%26aulast%3DSternberg%26aufirst%3DC.%26aulast%3DTesanovic%26aufirst%3DS.%26aulast%3DDel%2BBurgo%26aufirst%3DP.%26aulast%3DConi%26aufirst%3DS.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DNeureiter%26aufirst%3DD.%26aulast%3DBartz%26aufirst%3DR.%26aulast%3DKohlhof%26aufirst%3DH.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DAberger%26aufirst%3DF.%26atitle%3DTargeting%2520class%2520i%2520histone%2520deacetylases%2520by%2520the%2520novel%2520small%2520molecule%2520inhibitor%25204sc-202%2520blocks%2520oncogenic%2520hedgehog-gli%2520signaling%2520and%2520overcomes%2520smoothened%2520inhibitor%2520resistance%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2018%26volume%3D142%26spage%3D968%26epage%3D975%26doi%3D10.1002%2Fijc.31117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Magno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sdruscia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiombi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bufalieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusio-Kobialka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capalbo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewiadomski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span> <span> </span><span class="NLM_article-title">Selective targeting of hdac1/2 elicits anticancer effects through gli1 acetylation in preclinical models of shh medulloblastoma</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">44079</span>, <span class="refDoi"> DOI: 10.1038/srep44079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fsrep44079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28276480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC1czksFShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=44079&author=S.+Coniauthor=A.+B.+Mancusoauthor=L.+Di+Magnoauthor=G.+Sdrusciaauthor=S.+Manniauthor=S.+M.+Serraoauthor=D.+Rotiliauthor=E.+Spiombiauthor=F.+Bufalieriauthor=M.+Petroniauthor=M.+Kusio-Kobialkaauthor=E.+De+Smaeleauthor=E.+Ferrettiauthor=C.+Capalboauthor=A.+Maiauthor=P.+Niewiadomskiauthor=I.+Screpantiauthor=L.+Di+Marcotullioauthor=G.+Canettieri&title=Selective+targeting+of+hdac1%2F2+elicits+anticancer+effects+through+gli1+acetylation+in+preclinical+models+of+shh+medulloblastoma&doi=10.1038%2Fsrep44079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma</span></div><div class="casAuthors">Coni Sonia; Mancuso Anna Barbara; Manni Simona; Serrao Silvia Maria; Spiombi Eleonora; Capalbo Carlo; Screpanti Isabella; Di Marcotullio Lucia; Canettieri Gianluca; Di Magno Laura; Sdruscia Giulia; Bufalieri Francesca; Petroni Marialaura; Rotili Dante; Mai Antonello; Kusio-Kobialka Monika; Niewiadomski Pawel; De Smaele Enrico; Ferretti Elisabetta; Ferretti Elisabetta; Mai Antonello; Di Marcotullio Lucia; Canettieri Gianluca</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44079</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SHH Medulloblastoma (SHH-MB) is a pediatric brain tumor characterized by an inappropriate activation of the developmental Hedgehog (Hh) signaling.  SHH-MB patients treated with the FDA-approved vismodegib, an Hh inhibitor that targets the transmembrane activator Smoothened (Smo), have shown the rapid development of drug resistance and tumor relapse due to novel Smo mutations.  Moreover, a subset of patients did not respond to vismodegib because mutations were localized downstream of Smo.  Thus, targeting downstream Hh components is now considered a preferable approach.  We show here that selective inhibition of the downstream Hh effectors HDAC1 and HDAC2 robustly counteracts SHH-MB growth in mouse models.  These two deacetylases are upregulated in tumor and their knockdown inhibits Hh signaling and decreases tumor growth.  We demonstrate that mocetinostat (MGCD0103), a selective HDAC1/HDAC2 inhibitor, is a potent Hh inhibitor and that its effect is linked to Gli1 acetylation at K518.  Of note, we demonstrate that administration of mocetinostat to mouse models of SHH-MB drastically reduces tumor growth, by reducing proliferation and increasing apoptosis of tumor cells and prolongs mouse survival rate.  Collectively, these data demonstrate the preclinical efficacy of targeting the downstream HDAC1/2-Gli1 acetylation in the treatment of SHH-MB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzPPj8gFbG6FWTCLT8lX9SfW6udTcc2ebBb0aQsX9Yd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czksFShuw%253D%253D&md5=094368d17cf31727cb69622ee498830b</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fsrep44079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep44079%26sid%3Dliteratum%253Aachs%26aulast%3DConi%26aufirst%3DS.%26aulast%3DMancuso%26aufirst%3DA.%2BB.%26aulast%3DDi%2BMagno%26aufirst%3DL.%26aulast%3DSdruscia%26aufirst%3DG.%26aulast%3DManni%26aufirst%3DS.%26aulast%3DSerrao%26aufirst%3DS.%2BM.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DSpiombi%26aufirst%3DE.%26aulast%3DBufalieri%26aufirst%3DF.%26aulast%3DPetroni%26aufirst%3DM.%26aulast%3DKusio-Kobialka%26aufirst%3DM.%26aulast%3DDe%2BSmaele%26aufirst%3DE.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DCapalbo%26aufirst%3DC.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DNiewiadomski%26aufirst%3DP.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DCanettieri%26aufirst%3DG.%26atitle%3DSelective%2520targeting%2520of%2520hdac1%252F2%2520elicits%2520anticancer%2520effects%2520through%2520gli1%2520acetylation%2520in%2520preclinical%2520models%2520of%2520shh%2520medulloblastoma%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D44079%26doi%3D10.1038%2Fsrep44079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gholamin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandopadhayay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergthold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masoud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balansay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnuswami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monje, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheshier, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wechsler-Reya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. J.</span></span> <span> </span><span class="NLM_article-title">Epigenetic targeting of hedgehog pathway transcriptional output through bet bromodomain inhibition</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">740</span>, <span class="refDoi"> DOI: 10.1038/nm.3613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnm.3613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24973920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKlsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=732-740&author=Y.+Tangauthor=S.+Gholaminauthor=S.+Schubertauthor=M.+I.+Willardsonauthor=A.+Leeauthor=P.+Bandopadhayayauthor=G.+Bergtholdauthor=S.+Masoudauthor=B.+Nguyenauthor=N.+Vueauthor=B.+Balansayauthor=F.+Yuauthor=S.+Ohauthor=P.+Wooauthor=S.+Chenauthor=A.+Ponnuswamiauthor=M.+Monjeauthor=S.+X.+Atwoodauthor=R.+J.+Whitsonauthor=S.+Mitraauthor=S.+H.+Cheshierauthor=J.+Qiauthor=R.+Beroukhimauthor=J.+Y.+Tangauthor=R.+Wechsler-Reyaauthor=A.+E.+Oroauthor=B.+A.+Linkauthor=J.+E.+Bradnerauthor=Y.+J.+Cho&title=Epigenetic+targeting+of+hedgehog+pathway+transcriptional+output+through+bet+bromodomain+inhibition&doi=10.1038%2Fnm.3613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition</span></div><div class="casAuthors">Tang, Yujie; Gholamin, Sharareh; Schubert, Simone; Willardson, Minde I.; Lee, Alex; Bandopadhayay, Pratiti; Bergthold, Guillame; Masoud, Sabran; Nguyen, Brian; Vue, Nujsaubnusi; Balansay, Brianna; Yu, Furong; Oh, Sekyung; Woo, Pamelyn; Chen, Spenser; Ponnuswami, Anitha; Monje, Michelle; Atwood, Scott X.; Whitson, Ramon J.; Mitra, Siddhartha; Cheshier, Samuel H.; Qi, Jun; Beroukhim, Rameen; Tang, Jean Y.; Wechsler-Reya, Rob; Oro, Anthony E.; Link, Brian A.; Bradner, James E.; Cho, Yoon-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">732-740</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog signaling drives oncogenesis in several cancers, and strategies targeting this pathway have been developed, most notably through inhibition of Smoothened (SMO).  However, resistance to Smoothened inhibitors occurs by genetic changes of Smoothened or other downstream Hedgehog components.  Here we overcome these resistance mechanisms by modulating GLI transcription through inhibition of bromo and extra C-terminal (BET) bromodomain proteins.  We show that BRD4 and other BET bromodomain proteins regulate GLI transcription downstream of SMO and suppressor of fused (SUFU), and chromatin immunopptn. studies reveal that BRD4 directly occupies GLI1 and GLI2 promoters, with a substantial decrease in engagement of these sites after treatment with JQ1, a small-mol. inhibitor targeting BRD4.  Globally, genes assocd. with medulloblastoma-specific GLI1 binding sites are downregulated in response to JQ1 treatment, supporting direct regulation of GLI activity by BRD4.  Notably, patient- and GEMM (genetically engineered mouse model)-derived Hedgehog-driven tumors (basal cell carcinoma, medulloblastoma and atypical teratoid rhabdoid tumor) respond to JQ1 even when harboring genetic lesions rendering them resistant to Smoothened antagonists.  Altogether, our results reveal BET proteins as crit. regulators of Hedgehog pathway transcriptional output and nominate BET bromodomain inhibitors as a strategy for treating Hedgehog-driven tumors with emerged or a priori resistance to Smoothened antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7oydLPh9X7Vg90H21EOLACvtfcHk0lg3yRSDhRyoaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKlsrfJ&md5=2d976901600f4a1bba99cea25f099f28</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fnm.3613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3613%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DGholamin%26aufirst%3DS.%26aulast%3DSchubert%26aufirst%3DS.%26aulast%3DWillardson%26aufirst%3DM.%2BI.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DBandopadhayay%26aufirst%3DP.%26aulast%3DBergthold%26aufirst%3DG.%26aulast%3DMasoud%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DVue%26aufirst%3DN.%26aulast%3DBalansay%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DWoo%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DPonnuswami%26aufirst%3DA.%26aulast%3DMonje%26aufirst%3DM.%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DCheshier%26aufirst%3DS.%2BH.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DWechsler-Reya%26aufirst%3DR.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DLink%26aufirst%3DB.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26atitle%3DEpigenetic%2520targeting%2520of%2520hedgehog%2520pathway%2520transcriptional%2520output%2520through%2520bet%2520bromodomain%2520inhibition%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D732%26epage%3D740%26doi%3D10.1038%2Fnm.3613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijichi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokudo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span> <span> </span><span class="NLM_article-title">Stromal remodeling by the bet bromodomain inhibitor jq1 suppresses the progression of human pancreatic cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">61469</span>– <span class="NLM_lpage">61484</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.11129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.11129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27528027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2szgvFyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=61469-61484&author=K.+Yamamotoauthor=K.+Tateishiauthor=Y.+Kudoauthor=M.+Hoshikawaauthor=M.+Tanakaauthor=T.+Nakatsukaauthor=H.+Fujiwaraauthor=K.+Miyabayashiauthor=R.+Takahashiauthor=Y.+Tanakaauthor=H.+Ijichiauthor=Y.+Nakaiauthor=H.+Isayamaauthor=Y.+Morishitaauthor=T.+Aokiauthor=Y.+Sakamotoauthor=K.+Hasegawaauthor=N.+Kokudoauthor=M.+Fukayamaauthor=K.+Koike&title=Stromal+remodeling+by+the+bet+bromodomain+inhibitor+jq1+suppresses+the+progression+of+human+pancreatic+cancer&doi=10.18632%2Foncotarget.11129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer</span></div><div class="casAuthors">Yamamoto Keisuke; Tateishi Keisuke; Kudo Yotaro; Nakatsuka Takuma; Fujiwara Hiroaki; Miyabayashi Koji; Takahashi Ryota; Tanaka Yasuo; Ijichi Hideaki; Nakai Yousuke; Isayama Hiroyuki; Koike Kazuhiko; Hoshikawa Mayumi; Aoki Taku; Sakamoto Yoshihiro; Hasegawa Kiyoshi; Kokudo Norihiro; Tanaka Mariko; Morishita Yasuyuki; Fukayama Masashi; Morishita Yasuyuki; Aoki Taku</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">61469-61484</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibitors of bromodomain and extraterminal domain (BET) proteins, a family of chromatin reader proteins, have therapeutic efficacy against various malignancies.  However, the detailed mechanisms underlying the anti-tumor effects in distinct tumor types remain elusive.  Here, we show a novel antitumor mechanism of BET inhibition in pancreatic ductal adenocarcinoma (PDAC).  We found that JQ1, a BET inhibitor, decreased desmoplastic stroma, a hallmark of PDAC, and suppressed the growth of patient-derived tumor xenografts (PDX) of PDACs.  In vivo antitumor effects of JQ1 were not always associated with the JQ1 sensitivity of respective PDAC cells, and were rather dependent on the suppression of tumor-promoting activity in cancer-associated fibroblasts (CAFs).  JQ1 inhibited Hedgehog and TGF-β pathways as potent regulators of CAF activation and suppressed the expression of α-SMA, extracellular matrix, cytokines, and growth factors in human primary CAFs.  Consistently, conditioned media (CM) from CAFs promoted the proliferation of PDAC cells along with the activation of ERK, AKT, and STAT3 pathways, though these effects were suppressed when CM from JQ1-treated CAFs was used.  Mechanistically, chromatin immunoprecipitation experiments revealed that JQ1 reduced TGF-β-dependent gene expression by disrupting the recruitment of the transcriptional machinery containing BET proteins.  Finally, combination therapy with gemcitabine plus JQ1 showed greater efficacy than gemcitabine monotherapy against PDAC in vivo.  Thus, our results reveal BET proteins as the critical regulators of CAF-activation and also provide evidence that stromal remodeling by epigenetic modulators can be a novel therapeutic option for PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRROnImGd4gmQvupmecNw_lfW6udTcc2ea-9U5dAfTjQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szgvFyrtA%253D%253D&md5=bcee0a19bc8383b79d6797ce2fc8007a</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.11129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.11129%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DTateishi%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DHoshikawa%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakatsuka%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DMiyabayashi%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DIjichi%26aufirst%3DH.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DIsayama%26aufirst%3DH.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKokudo%26aufirst%3DN.%26aulast%3DFukayama%26aufirst%3DM.%26aulast%3DKoike%26aufirst%3DK.%26atitle%3DStromal%2520remodeling%2520by%2520the%2520bet%2520bromodomain%2520inhibitor%2520jq1%2520suppresses%2520the%2520progression%2520of%2520human%2520pancreatic%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D61469%26epage%3D61484%26doi%3D10.18632%2Foncotarget.11129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Llopis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babinski, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, E. D.</span></span> <span> </span><span class="NLM_article-title">A small molecule modulates jumonji histone demethylase activity and selectively inhibits cancer growth</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2035</span>, <span class="refDoi"> DOI: 10.1038/ncomms3035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms3035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23792809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC3sjksV2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2035&author=L.+Wangauthor=J.+Changauthor=D.+Vargheseauthor=M.+Dellingerauthor=S.+Kumarauthor=A.+M.+Bestauthor=J.+Ruizauthor=R.+Bruickauthor=S.+Pena-Llopisauthor=J.+Xuauthor=D.+J.+Babinskiauthor=D.+E.+Frantzauthor=R.+A.+Brekkenauthor=A.+M.+Quinnauthor=A.+Simeonovauthor=J.+Easmonauthor=E.+D.+Martinez&title=A+small+molecule+modulates+jumonji+histone+demethylase+activity+and+selectively+inhibits+cancer+growth&doi=10.1038%2Fncomms3035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth</span></div><div class="casAuthors">Wang Lei; Chang Jianjun; Varghese Diana; Dellinger Michael; Kumar Subodh; Best Anne M; Ruiz Julio; Bruick Richard; Pena-Llopis Samuel; Xu Junjie; Babinski David J; Frantz Doug E; Brekken Rolf A; Quinn Amy M; Simeonov Anton; Easmon Johnny; Martinez Elisabeth D</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2035</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmacological inhibition of general transcriptional regulators has the potential to block growth through targeting multiple tumorigenic signalling pathways simultaneously.  Here, using an innovative cell-based screen, we identify a structurally unique small molecule (named JIB-04) that specifically inhibits the activity of the Jumonji family of histone demethylases in vitro, in cancer cells, and in tumours in vivo.  Unlike known inhibitors, JIB-04 is not a competitive inhibitor of α-ketoglutarate.  In cancer, but not in patient-matched normal cells, JIB-04 alters a subset of transcriptional pathways and blocks viability.  In mice, JIB-04 reduces tumour burden and prolongs survival.  Importantly, we find that patients with breast tumours that overexpress Jumonji demethylases have significantly lower survival.  Thus, JIB-04, a novel inhibitor of Jumonji demethylases in vitro and in vivo, constitutes a unique potential therapeutic and research tool against cancer, and validates the use of unbiased cellular screens to discover chemical modulators with disease relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5QxHbn8WTZg20zIbnCCI3fW6udTcc2eas9AI1Q0MJibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjksV2iug%253D%253D&md5=37aa303d173d027fd711bc4ef7fd841b</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fncomms3035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DVarghese%26aufirst%3DD.%26aulast%3DDellinger%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBest%26aufirst%3DA.%2BM.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBruick%26aufirst%3DR.%26aulast%3DPena-Llopis%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DBabinski%26aufirst%3DD.%2BJ.%26aulast%3DFrantz%26aufirst%3DD.%2BE.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DQuinn%26aufirst%3DA.%2BM.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DEasmon%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26atitle%3DA%2520small%2520molecule%2520modulates%2520jumonji%2520histone%2520demethylase%2520activity%2520and%2520selectively%2520inhibits%2520cancer%2520growth%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2035%26doi%3D10.1038%2Fncomms3035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brockmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deubzer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rycak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thway, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roels, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of aurora-a induce proteasomal degradation of n-myc in childhood neuroblastoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2013.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23792191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=75-89&author=M.+Brockmannauthor=E.+Poonauthor=T.+Berryauthor=A.+Carstensenauthor=H.+E.+Deubzerauthor=L.+Rycakauthor=Y.+Jaminauthor=K.+Thwayauthor=S.+P.+Robinsonauthor=F.+Roelsauthor=O.+Wittauthor=M.+Fischerauthor=L.+Cheslerauthor=M.+Eilers&title=Small+molecule+inhibitors+of+aurora-a+induce+proteasomal+degradation+of+n-myc+in+childhood+neuroblastoma&doi=10.1016%2Fj.ccr.2013.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma</span></div><div class="casAuthors">Brockmann, Markus; Poon, Evon; Berry, Teeara; Carstensen, Anne; Deubzer, Hedwig E.; Rycak, Lukas; Jamin, Yann; Thway, Khin; Robinson, Simon P.; Roels, Frederik; Witt, Olaf; Fischer, Matthias; Chesler, Louis; Eilers, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-89</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Amplification of MYCN is a driver mutation in a subset of human neuroendocrine tumors, including neuroblastoma.  No small mols. that target N-Myc, the protein encoded by MYCN, are clin. available.  N-Myc forms a complex with the Aurora-A kinase, which protects N-Myc from proteasomal degrdn.  Although stabilization of N-Myc does not require the catalytic activity of Aurora-A, we show here that 2 Aurora-A inhibitors, MLN8054 and MLN8237, disrupt the Aurora-A/N-Myc complex and promote degrdn. of N-Myc mediated by the Fbxw7 ubiquitin ligase.  Disruption of the Aurora-A/N-Myc complex inhibits N-Myc-dependent transcription, correlating with tumor regression and prolonged survival in a mouse model of MYCN-driven neuroblastoma.  We conclude that Aurora-A is an accessible target that makes destabilization of N-Myc a viable therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09vD68WUraLVg90H21EOLACvtfcHk0ljCWAk18_rUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymurY%253D&md5=0b53df3d2aaaad8c9a46c07e06227b2c</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBrockmann%26aufirst%3DM.%26aulast%3DPoon%26aufirst%3DE.%26aulast%3DBerry%26aufirst%3DT.%26aulast%3DCarstensen%26aufirst%3DA.%26aulast%3DDeubzer%26aufirst%3DH.%2BE.%26aulast%3DRycak%26aufirst%3DL.%26aulast%3DJamin%26aufirst%3DY.%26aulast%3DThway%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DS.%2BP.%26aulast%3DRoels%26aufirst%3DF.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DChesler%26aufirst%3DL.%26aulast%3DEilers%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520aurora-a%2520induce%2520proteasomal%2520degradation%2520of%2520n-myc%2520in%2520childhood%2520neuroblastoma%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26spage%3D75%26epage%3D89%26doi%3D10.1016%2Fj.ccr.2013.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span> <span> </span><span class="NLM_article-title">Structural basis of n-myc binding by aurora-a and its destabilization by kinase inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">13726</span>– <span class="NLM_lpage">13731</span>, <span class="refDoi"> DOI: 10.1073/pnas.1610626113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1610626113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27837025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCiur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=13726-13731&author=M.+W.+Richardsauthor=S.+G.+Burgessauthor=E.+Poonauthor=A.+Carstensenauthor=M.+Eilersauthor=L.+Cheslerauthor=R.+Bayliss&title=Structural+basis+of+n-myc+binding+by+aurora-a+and+its+destabilization+by+kinase+inhibitors&doi=10.1073%2Fpnas.1610626113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors</span></div><div class="casAuthors">Richards, Mark W.; Burgess, Selena G.; Poon, Evon; Carstensen, Anne; Eilers, Martin; Chesler, Louis; Bayliss, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">13726-13731</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Myc family proteins promote cancer by inducing widespread changes in gene expression.  Their rapid turnover by the ubiquitin-proteasome pathway is regulated through phosphorylation of Myc Box I and ubiquitination by E3 ubiquitin ligase SCFFbxW7.  However, N-Myc protein (the product of the MYCN oncogene) is stabilized in neuroblastoma by the protein kinase Aurora-A in a manner that is sensitive to certain Aurora-A-selective inhibitors.  Here, the authors identified a direct interaction between the catalytic domain of Aurora-A kinase and a site flanking Myc Box I that also binds SCFFbxW7.  The authors detd. the crystal structure of the complex between Aurora-A kinase and this region of N-Myc to 1.72-Å resoln.  The structure indicated that the conformation of Aurora-A induced by compds. such as alisertib and CD532 was not compatible with the binding of N-Myc, explaining the activity of these compds. in neuroblastoma cells and providing a rational basis for the design of cancer therapeutics optimized for destabilization of the complex.  The authors also proposed a model for the stabilization mechanism in which binding to Aurora-A alters how N-Myc interacts with SCFFbxW7 to disfavor the generation of Lys-48-linked polyubiquitin chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAK31pqP6M4bVg90H21EOLACvtfcHk0ljCWAk18_rUPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCiur7I&md5=0aa2b960303f040d9685fb16fb8ea980</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1610626113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1610626113%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BW.%26aulast%3DBurgess%26aufirst%3DS.%2BG.%26aulast%3DPoon%26aufirst%3DE.%26aulast%3DCarstensen%26aufirst%3DA.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DChesler%26aufirst%3DL.%26aulast%3DBayliss%26aufirst%3DR.%26atitle%3DStructural%2520basis%2520of%2520n-myc%2520binding%2520by%2520aurora-a%2520and%2520its%2520destabilization%2520by%2520kinase%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D13726%26epage%3D13731%26doi%3D10.1073%2Fpnas.1610626113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerowitz, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nekritz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonds, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthay, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertz, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span> <span> </span><span class="NLM_article-title">Drugging mycn through an allosteric transition in aurora kinase a</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2014.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25175806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKmsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=414-427&author=W.+C.+Gustafsonauthor=J.+G.+Meyerowitzauthor=E.+A.+Nekritzauthor=J.+Chenauthor=C.+Benesauthor=E.+Charronauthor=E.+F.+Simondsauthor=R.+Seegerauthor=K.+K.+Matthayauthor=N.+T.+Hertzauthor=M.+Eilersauthor=K.+M.+Shokatauthor=W.+A.+Weiss&title=Drugging+mycn+through+an+allosteric+transition+in+aurora+kinase+a&doi=10.1016%2Fj.ccr.2014.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging MYCN through an Allosteric Transition in Aurora Kinase A</span></div><div class="casAuthors">Gustafson, William Clay; Meyerowitz, Justin Gabriel; Nekritz, Erin A.; Chen, Justin; Benes, Cyril; Charron, Elise; Simonds, Erin F.; Seeger, Robert; Matthay, Katherine K.; Hertz, Nicholas T.; Eilers, Martin; Shokat, Kevan M.; Weiss, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-427</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">MYC proteins are major drivers of cancer, yet are considered undruggable because their DNA binding domains are composed of two extended alpha helixes with no apparent surfaces for small-mol. binding.  Proteolytic degrdn. of MYCN protein is regulated in part by a kinase-independent function of Aurora A.  We describe a class of inhibitors that disrupts the native conformation of Aurora A and drives the degrdn. of MYCN protein across MYCN-driven cancers.  Comparison of cocrystal structures with structure-activity relationships across multiple inhibitors and chemotypes, coupled with mechanistic studies and biochem. assays, delineates an Aurora A conformation-specific effect on proteolytic degrdn. of MYCN, rather than simple nanomolar-level inhibition of Aurora A kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8At2LNPE-ubVg90H21EOLACvtfcHk0ljykJxO3U_-2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKmsLnJ&md5=20944894851fe5466422c149a0a0b266</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DMeyerowitz%26aufirst%3DJ.%2BG.%26aulast%3DNekritz%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DCharron%26aufirst%3DE.%26aulast%3DSimonds%26aufirst%3DE.%2BF.%26aulast%3DSeeger%26aufirst%3DR.%26aulast%3DMatthay%26aufirst%3DK.%2BK.%26aulast%3DHertz%26aufirst%3DN.%2BT.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DDrugging%2520mycn%2520through%2520an%2520allosteric%2520transition%2520in%2520aurora%2520kinase%2520a%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D26%26spage%3D414%26epage%3D427%26doi%3D10.1016%2Fj.ccr.2014.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulut, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajwan, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peaceman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozdemirli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toretsky, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uren, A.</span></span> <span> </span><span class="NLM_article-title">Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking hedgehog/gli pathway</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1172/JCI42874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1172%2FJCI42874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21183792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1yntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=148-160&author=E.+M.+Beauchampauthor=L.+Ringerauthor=G.+Bulutauthor=K.+P.+Sajwanauthor=M.+D.+Hallauthor=Y.+C.+Leeauthor=D.+Peacemanauthor=M.+Ozdemirliauthor=O.+Rodriguezauthor=T.+J.+Macdonaldauthor=C.+Albaneseauthor=J.+A.+Toretskyauthor=A.+Uren&title=Arsenic+trioxide+inhibits+human+cancer+cell+growth+and+tumor+development+in+mice+by+blocking+hedgehog%2Fgli+pathway&doi=10.1172%2FJCI42874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway</span></div><div class="casAuthors">Beauchamp, Elspeth M.; Ringer, Lymor; Bulut, Gulay; Sajwan, Kamal P.; Hall, Michael D.; Lee, Yi-Chien; Peaceman, Daniel; Ozdemirli, Metin; Rodriguez, Olga; MacDonald, Tobey J.; Albanese, Chris; Toretsky, Jeffrey A.; Uren, Aykut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">148-160</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway is activated in some human cancers, including medulloblastoma.  The glioma-assocd. oncogene homolog (GLI) transcription factors are crit. mediators of the activated Hh pathway, and their expression may be elevated in some tumors independent of upstream Hh signaling.  Thus, therapies targeting GLI transcription factors may benefit a wide spectrum of patients with mutations at different nodal points of the Hh pathway.  In this study, we present evidence that arsenic trioxide (ATO) suppresses human cancer cell growth and tumor development in mice by inhibiting GLI1.  Mechanistically, ATO directly bound to GLI1 protein, inhibited its transcriptional activity, and decreased expression of endogenous GLI target genes.  Consistent with this, ATO inhibited the growth of human cancer cell lines that depended on upregulated GLI expression in vitro and in vivo in a xenograft model of Ewing sarcoma.  Furthermore, ATO improved survival of a clin. relevant spontaneous mouse model of medulloblastoma with activated Hh pathway signaling.  Our results establish ATO as a Hh pathway inhibitor acting at the level of GLI1 both in vitro and in vivo.  These results warrant the clin. investigation of ATO for tumors with activated Hh/GLI signaling, in particular patients who develop resistance to current therapies targeting the Hh pathway upstream of GLI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5klZh1rqPQLVg90H21EOLACvtfcHk0ljykJxO3U_-2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1yntQ%253D%253D&md5=1c9ec64353bc73b01a0843c8e4a94f95</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1172%2FJCI42874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI42874%26sid%3Dliteratum%253Aachs%26aulast%3DBeauchamp%26aufirst%3DE.%2BM.%26aulast%3DRinger%26aufirst%3DL.%26aulast%3DBulut%26aufirst%3DG.%26aulast%3DSajwan%26aufirst%3DK.%2BP.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DPeaceman%26aufirst%3DD.%26aulast%3DOzdemirli%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DO.%26aulast%3DMacdonald%26aufirst%3DT.%2BJ.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DToretsky%26aufirst%3DJ.%2BA.%26aulast%3DUren%26aufirst%3DA.%26atitle%3DArsenic%2520trioxide%2520inhibits%2520human%2520cancer%2520cell%2520growth%2520and%2520tumor%2520development%2520in%2520mice%2520by%2520blocking%2520hedgehog%252Fgli%2520pathway%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D148%26epage%3D160%26doi%3D10.1172%2FJCI42874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Arsenic antagonizes the hedgehog pathway by preventing ciliary accumulation and reducing stability of the gli2 transcriptional effector</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">13432</span>– <span class="NLM_lpage">13437</span>, <span class="refDoi"> DOI: 10.1073/pnas.1006822107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1006822107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20624968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GrurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13432-13437&author=J.+Kimauthor=J.+J.+Leeauthor=J.+Kimauthor=D.+Gardnerauthor=P.+A.+Beachy&title=Arsenic+antagonizes+the+hedgehog+pathway+by+preventing+ciliary+accumulation+and+reducing+stability+of+the+gli2+transcriptional+effector&doi=10.1073%2Fpnas.1006822107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector</span></div><div class="casAuthors">Kim, Jynho; Lee, John J.; Kim, James; Gardner, Dale; Beachya, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">13432-13437, S13432/1-S13432/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant Hedgehog (Hh) pathway activation has been implicated in cancers of diverse tissues and organs, and the tumor growth-inhibiting effects of pathway antagonists in animal models have stimulated efforts to develop pathway antagonists for human therapeutic purposes.  These efforts have focused largely on cyclopamine derivs. or other compds. that mimic cyclopamine action in binding to and antagonizing Smoothened, a membrane transductory component.  We report here that arsenicals, in contrast, antagonize the Hh pathway by targeting Gli transcriptional effectors; in the short term, arsenic blocks Hh-induced ciliary accumulation of Gli2, the primary activator of Hh-dependent transcription, and with prolonged incubation arsenic reduces steady-state levels of Gli2.  Arsenicals active in Hh pathway antagonism include arsenic trioxide (ATO), a curative agent in clin. use for acute promyelocytic leukemia (APL); in our studies, ATO inhibited growth of Hh pathway-driven medulloblastoma allografts derived from Ptch+/-p53-/- mice within a range of serum levels comparable to those achieved in treatment of human APL.  Arsenic thus could be tested rapidly as a therapeutic agent in malignant diseases assocd. with Hh pathway activation and could be particularly useful in such diseases that are inherently resistant or have acquired resistance to cyclopamine mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyuJxKjzbqxLVg90H21EOLACvtfcHk0ljykJxO3U_-2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GrurbO&md5=08445246bd4e58e5d87522ac3b752646</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1006822107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1006822107%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DD.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DArsenic%2520antagonizes%2520the%2520hedgehog%2520pathway%2520by%2520preventing%2520ciliary%2520accumulation%2520and%2520reducing%2520stability%2520of%2520the%2520gli2%2520transcriptional%2520effector%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D13432%26epage%3D13437%26doi%3D10.1073%2Fpnas.1006822107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aftab, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borodovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span> <span> </span><span class="NLM_article-title">Itraconazole and arsenic trioxide inhibit hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2012.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23291299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvV2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=23-34&author=J.+Kimauthor=B.+T.+Aftabauthor=J.+Y.+Tangauthor=D.+Kimauthor=A.+H.+Leeauthor=M.+Rezaeeauthor=J.+Kimauthor=B.+Chenauthor=E.+M.+Kingauthor=A.+Borodovskyauthor=G.+J.+Rigginsauthor=E.+H.+Epsteinauthor=P.+A.+Beachyauthor=C.+M.+Rudin&title=Itraconazole+and+arsenic+trioxide+inhibit+hedgehog+pathway+activation+and+tumor+growth+associated+with+acquired+resistance+to+smoothened+antagonists&doi=10.1016%2Fj.ccr.2012.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists</span></div><div class="casAuthors">Kim, James; Aftab, Blake T.; Tang, Jean Y.; Kim, Daniel; Lee, Alex H.; Rezaee, Melika; Kim, Jynho; Chen, Baozhi; King, Emily M.; Borodovsky, Alexandra; Riggins, Gregory J.; Epstein, Ervin H.; Beachy, Philip A.; Rudin, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Recognition of the multiple roles of Hedgehog signaling in cancer has prompted intensive efforts to develop targeted pathway inhibitors.  Leading inhibitors in clin. development act by binding to a common site within Smoothened, a crit. pathway component.  Acquired Smoothened mutations, including SMOD477G, confer resistance to these inhibitors.  Here, we report that itraconazole and arsenic trioxide, two agents in clin. use that inhibit Hedgehog signaling by mechanisms distinct from that of current Smoothened antagonists, retain inhibitory activity in vitro in the context of all reported resistance-conferring Smoothened mutants and GLI2 overexpression.  Itraconazole and arsenic trioxide, alone or in combination, inhibit the growth of medulloblastoma and basal cell carcinoma in vivo, and prolong survival of mice with intracranial drug-resistant SMOD477G medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJIF4ZyQQOh7Vg90H21EOLACvtfcHk0lgHh3Pa8NOG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvV2iuw%253D%253D&md5=ea44c59e02099478f5cb351bcaedecd9</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAftab%26aufirst%3DB.%2BT.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DA.%2BH.%26aulast%3DRezaee%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DKing%26aufirst%3DE.%2BM.%26aulast%3DBorodovsky%26aufirst%3DA.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26atitle%3DItraconazole%2520and%2520arsenic%2520trioxide%2520inhibit%2520hedgehog%2520pathway%2520activation%2520and%2520tumor%2520growth%2520associated%2520with%2520acquired%2520resistance%2520to%2520smoothened%2520antagonists%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D23%26spage%3D23%26epage%3D34%26doi%3D10.1016%2Fj.ccr.2012.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozul, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosse, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Activation of hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1981</span>– <span class="NLM_lpage">1988</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-09-2898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20179202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1981-1988&author=D.+L.+Feiauthor=H.+Liauthor=C.+D.+Kozulauthor=K.+E.+Blackauthor=S.+Singhauthor=J.+A.+Gosseauthor=J.+DiRenzoauthor=K.+A.+Martinauthor=B.+Wangauthor=J.+W.+Hamiltonauthor=M.+R.+Karagasauthor=D.+J.+Robbins&title=Activation+of+hedgehog+signaling+by+the+environmental+toxicant+arsenic+may+contribute+to+the+etiology+of+arsenic-induced+tumors&doi=10.1158%2F0008-5472.CAN-09-2898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Hedgehog Signaling by the Environmental Toxicant Arsenic May Contribute to the Etiology of Arsenic-Induced Tumors</span></div><div class="casAuthors">Fei, Dennis Liang; Li, Hua; Kozul, Courtney D.; Black, Kendall E.; Singh, Samer; Gosse, Julie A.; Di Renzo, James; Martin, Kathleen A.; Wang, Baolin; Hamilton, Joshua W.; Karagas, Margaret R.; Robbins, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1981-1988</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Exposure to the environmental toxicant arsenic, through both contaminated water and food, contributes to significant health problems worldwide.  In particular, arsenic exposure is thought to function as a carcinogen for lung, skin, and bladder cancer via mechanisms that remain largely unknown.  More recently, the Hedgehog signaling pathway has also been implicated in the progression and maintenance of these same cancers.  Based on these similarities, we tested the hypothesis that arsenic may act in part through activating Hedgehog signaling.  Here, we show that arsenic is able to activate Hedgehog signaling in several primary and established tissue culture cells as well as in vivo.  Arsenic activates Hedgehog signaling by decreasing the stability of the repressor form of GLI3, one of the transcription factors that ultimately regulate Hedgehog activity.  We also show, using tumor samples from a cohort of bladder cancer patients, that high levels of arsenic exposure are assocd. with high levels of Hedgehog activity.  Given the important role Hedgehog signaling plays in the maintenance and progression of a variety of tumors, including bladder cancer, these results suggest that arsenic exposure may in part promote cancer through the activation of Hedgehog signaling.  Thus, we provide an important insight into the etiol. of arsenic-induced human carcinogenesis, which may be relevant to millions of people exposed to high levels of arsenic worldwide.  Cancer Res; 70(5); 1981-8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1bMwqxGWi9bVg90H21EOLACvtfcHk0lgHh3Pa8NOG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWisrs%253D&md5=dada08bf0777cca2ea4592479767f4ca</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2898%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKozul%26aufirst%3DC.%2BD.%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DGosse%26aufirst%3DJ.%2BA.%26aulast%3DDiRenzo%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHamilton%26aufirst%3DJ.%2BW.%26aulast%3DKaragas%26aufirst%3DM.%2BR.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DActivation%2520of%2520hedgehog%2520signaling%2520by%2520the%2520environmental%2520toxicant%2520arsenic%2520may%2520contribute%2520to%2520the%2520etiology%2520of%2520arsenic-induced%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1981%26epage%3D1988%26doi%3D10.1158%2F0008-5472.CAN-09-2898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giambelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterbottom, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbarayan, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardalan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Arsenic attenuates gli signaling, increasing or decreasing its transcriptional program in a context-dependent manner</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1124/mol.115.100867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1124%2Fmol.115.100867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26573582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVOjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=226-232&author=B.+Liauthor=C.+Giambelliauthor=B.+Tangauthor=E.+Winterbottomauthor=J.+Longauthor=K.+Jinauthor=Z.+Wangauthor=D.+L.+Feiauthor=D.+M.+Nguyenauthor=M.+Atharauthor=B.+Wangauthor=P.+R.+Subbarayanauthor=L.+Wangauthor=P.+Raiauthor=B.+Ardalanauthor=A.+J.+Capobiancoauthor=D.+J.+Robbins&title=Arsenic+attenuates+gli+signaling%2C+increasing+or+decreasing+its+transcriptional+program+in+a+context-dependent+manner&doi=10.1124%2Fmol.115.100867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic attenuates GLI signaling, increasing or decreasing its transcriptional program in a context-dependent manner</span></div><div class="casAuthors">Li, Bin; Giambelli, Camilla; Tang, Bo; Winterbottom, Emily; Long, Jun; Jin, Ke; Wang, Zhiqiang; Fei, Dennis Liang; Nguyen, Dao M.; Athar, Mohammad; Wang, Baolin; Subbarayan, Pochi R.; Wang, Lily; Rai, Priyamvada; Ardalan, Bach; Capobianco, Anthony J.; Robbins, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-232</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metalloid arsenic is a worldwide environmental toxicant, exposure to which is assocd. with many adverse outcomes.  Arsenic is also an effective therapeutic agent in certain disease settings.  Arsenic was recently shown to regulate the activity of the Hedgehog (HH) signal transduction pathway, and this regulation of HH signaling was proposed to be responsible for a subset of arsenic's biol. effects.  Surprisingly, these sep. reports proposed contradictory activities for arsenic, as either an agonist or antagonist of HH signaling.  Here we provide in vitro and in vivo evidence that arsenic acts as a modulator of the activity of the HH effector protein glioma-assocd. oncogene family zinc finger (GLI), activating or inhibiting GLI activity in a context-dependent manner.  This arsenic-induced modulation of HH signaling is obsd. in cultured cells, patients with colorectal cancer who have received arsenic-based therapy, and a mouse colorectal cancer xenograft model.  Our results show that arsenic activates GLI signaling when the intrinsic GLI activity is low but inhibits signaling in the presence of high-level GLI activity.  Furthermore, we show that this modulation occurs downstream of primary cilia, evidenced by expts. in suppressor of fused homolog (SUFU) deficient cells.  Combining our findings with previous reports, we present an inclusive model in which arsenic plays dual roles in GLI signaling modulation: when GLIs are primarily in their repressor form, arsenic antagonizes their repression capacity, leading to low-level GLI activation, but when GLIs are primarily in their activator form, arsenic attenuates their activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqPL8AUeY24bVg90H21EOLACvtfcHk0liBJNRudJwvgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVOjtb0%253D&md5=bf444d2e5a1d7856522d9217f57a6542</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100867%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DGiambelli%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DWinterbottom%26aufirst%3DE.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DAthar%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DSubbarayan%26aufirst%3DP.%2BR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRai%26aufirst%3DP.%26aulast%3DArdalan%26aufirst%3DB.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DArsenic%2520attenuates%2520gli%2520signaling%252C%2520increasing%2520or%2520decreasing%2520its%2520transcriptional%2520program%2520in%2520a%2520context-dependent%2520manner%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D89%26spage%3D226%26epage%3D232%26doi%3D10.1124%2Fmol.115.100867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaveny, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahmane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baubet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Pyrvinium attenuates hedgehog signaling downstream of smoothened</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">4811</span>– <span class="NLM_lpage">4821</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-14-0317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24994715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOisbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=4811-4821&author=B.+Liauthor=D.+L.+Feiauthor=C.+A.+Flavenyauthor=N.+Dahmaneauthor=V.+Baubetauthor=Z.+Wangauthor=F.+Baiauthor=X.+H.+Peiauthor=J.+Rodriguez-Blancoauthor=B.+Hangauthor=D.+Ortonauthor=L.+Hanauthor=B.+Wangauthor=A.+J.+Capobiancoauthor=E.+Leeauthor=D.+J.+Robbins&title=Pyrvinium+attenuates+hedgehog+signaling+downstream+of+smoothened&doi=10.1158%2F0008-5472.CAN-14-0317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened</span></div><div class="casAuthors">Li, Bin; Fei, Dennis Liang; Flaveny, Colin A.; Dahmane, Nadia; Baubet, Valerie; Wang, Zhiqiang; Bai, Feng; Pei, Xin-Hai; Rodriguez-Blanco, Jezabel; Hang, Brian; Orton, Darren; Han, Lu; Wang, Baolin; Capobianco, Anthony J.; Lee, Ethan; Robbins, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4811-4821</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Hedgehog (HH) signaling pathway represents an important class of emerging developmental signaling pathways that play crit. roles in the genesis of a large no. of human cancers.  The pharmaceutical industry is currently focused on developing small mols. targeting Smoothened (Smo)1 a key signaling effector of the HH pathway that regulates the levels and activity of the Gli family of transcription factors.  Although one of these compds., vismodegib, is now FDA-approved for patients with advanced basal cell carcinoma, acquired mutations in Smo can result in rapid relapse.  Furthermore, many cancers also exhibit a Smo-independent activation of Gli proteins, an observation that may underlie the limited efficacy of Smo inhibitors in clin. trials against other types of cancer.  Thus, there remains a crit. need for HH inhibitors with different mechanisms of action, particularly those that act downstream of Smo.  Recently, we identified the FDA-approved anti-pinworm compd. pyrvinium as a novel, potent (IC50, 10 nmol/L) casein kinase-α (CK1α) agonist.  We show here that pyrvinium is a potent inhibitor of HH signaling, which acts by reducing the stability of the Gli family of transcription factors.  Consistent with CK1α agonists acting on these most distal components of the HH signaling pathway, pyrvinium is able to inhibit the activity of a clin. relevant, vismodegib -resistant Smo mutant, as well as the Gli activity resulting from loss of the neg. regulator suppressor of fused.  We go on to demonstrate the utility of this small mol. in vivo, against the HH-dependent cancer medulloblastoma, attenuating its growth and reducing the expression of HH biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1CUJVX_j4NrVg90H21EOLACvtfcHk0liBJNRudJwvgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOisbzE&md5=7d7699bb877ac6499496230a15df2f65</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0317%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DFlaveny%26aufirst%3DC.%2BA.%26aulast%3DDahmane%26aufirst%3DN.%26aulast%3DBaubet%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DPei%26aufirst%3DX.%2BH.%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DHang%26aufirst%3DB.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DPyrvinium%2520attenuates%2520hedgehog%2520signaling%2520downstream%2520of%2520smoothened%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D4811%26epage%3D4821%26doi%3D10.1158%2F0008-5472.CAN-14-0317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahinci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cselenyi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidu, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of wnt signaling through activation of casein kinase 1alpha</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20890287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=829-836&author=C.+A.+Thorneauthor=A.+J.+Hansonauthor=J.+Schneiderauthor=E.+Tahinciauthor=D.+Ortonauthor=C.+S.+Cselenyiauthor=K.+K.+Jerniganauthor=K.+C.+Meyersauthor=B.+I.+Hangauthor=A.+G.+Watersonauthor=K.+Kimauthor=B.+Melanconauthor=V.+P.+Ghiduauthor=G.+A.+Sulikowskiauthor=B.+LaFleurauthor=A.+Salicauthor=L.+A.+Leeauthor=D.+M.+Millerauthor=E.+Lee&title=Small-molecule+inhibition+of+wnt+signaling+through+activation+of+casein+kinase+1alpha&doi=10.1038%2Fnchembio.453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α</span></div><div class="casAuthors">Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M.; Lee, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease.  Using Xenopus laevis egg ext. to screen for compds. that both stabilize Axin and promote β-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC50 of ∼ 10 nM).  We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concns. and pyrvinium selectively potentiates casein kinase 1α (CK1α) kinase activity.  CK1α knockdown abrogates the effects of pyrvinium on the Wnt pathway.  In addn. to its effects on Axin and β-catenin levels, pyrvinium promotes degrdn. of Pygopus, a Wnt transcriptional component.  Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation.  Our findings reveal allosteric activation of CK1α as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7QzU0tiGpLVg90H21EOLACvtfcHk0liBJNRudJwvgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO&md5=1412b6b25b26689f9191145151e91608</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.453%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DHanson%26aufirst%3DA.%2BJ.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DTahinci%26aufirst%3DE.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCselenyi%26aufirst%3DC.%2BS.%26aulast%3DJernigan%26aufirst%3DK.%2BK.%26aulast%3DMeyers%26aufirst%3DK.%2BC.%26aulast%3DHang%26aufirst%3DB.%2BI.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DMelancon%26aufirst%3DB.%26aulast%3DGhidu%26aufirst%3DV.%2BP.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DLaFleur%26aufirst%3DB.%26aulast%3DSalic%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DE.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520wnt%2520signaling%2520through%2520activation%2520of%2520casein%2520kinase%25201alpha%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D829%26epage%3D836%26doi%3D10.1038%2Fnchembio.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cigna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrokhi Moshai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchal-Somme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wemeau-Stervinou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leseche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehoux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailleux, A. A.</span></span> <span> </span><span class="NLM_article-title">The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: Involvement in idiopathic pulmonary fibrosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2137</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ajpath.2012.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23031257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFShsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2012&pages=2126-2137&author=N.+Cignaauthor=E.+Farrokhi+Moshaiauthor=S.+Brayerauthor=J.+Marchal-Sommeauthor=L.+Wemeau-Stervinouauthor=A.+Fabreauthor=H.+Malauthor=G.+Lesecheauthor=M.+Dehouxauthor=P.+Solerauthor=B.+Crestaniauthor=A.+A.+Mailleux&title=The+hedgehog+system+machinery+controls+transforming+growth+factor-beta-dependent+myofibroblastic+differentiation+in+humans%3A+Involvement+in+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.ajpath.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Cigna, Natacha; Moshai, Elika Farrokhi; Brayer, Stephanie; Marchal-Somme, Joelle; Wemeau-Stervinou, Lidwine; Fabre, Aurelie; Mal, Herve; Leseche, Guy; Dehoux, Monique; Soler, Paul; Crestani, Bruno; Mailleux, Arnaud A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2126-2137</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown cause.  Key signaling developmental pathways are aberrantly expressed in IPF.  The hedgehog pathway plays a key role during fetal lung development and may be involved in lung fibrogenesis.  We detd. the expression pattern of several Sonic hedgehog (SHH) pathway members in normal and IPF human lung biopsies and primary fibroblasts.  The effect of hedgehog pathway inhibition was assayed by lung fibroblast proliferation and differentiation with and without transforming growth factor (TGF)-β1.  We showed that the hedgehog pathway was reactivated in the IPF lung.  Importantly, we deciphered the cross talk between the hedgehog and TGF-β pathway in human lung fibroblasts.  TGF-β1 modulated the expression of key components of the hedgehog pathway independent of Smoothened, the obligatory signal transducer of the pathway.  Smoothened was required for TGF-β1-induced myofibroblastic differentiation of control fibroblasts, but differentiation of IPF fibroblasts was partially resistant to Smoothened inhibition.  Furthermore, functional hedgehog pathway machinery from the primary cilium, as well as GLI-dependent transcription in the nucleus, was required for the TGF-β1 effects on normal and IPF fibroblasts during myofibroblastic differentiation.  These data identify the GLI transcription factors as potential therapeutic targets in lung fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY8yHz01sZs7Vg90H21EOLACvtfcHk0linrw_lqkwlFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFShsL%252FL&md5=defc9548531066303f933fb4deb38031</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DCigna%26aufirst%3DN.%26aulast%3DFarrokhi%2BMoshai%26aufirst%3DE.%26aulast%3DBrayer%26aufirst%3DS.%26aulast%3DMarchal-Somme%26aufirst%3DJ.%26aulast%3DWemeau-Stervinou%26aufirst%3DL.%26aulast%3DFabre%26aufirst%3DA.%26aulast%3DMal%26aufirst%3DH.%26aulast%3DLeseche%26aufirst%3DG.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DSoler%26aufirst%3DP.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DMailleux%26aufirst%3DA.%2BA.%26atitle%3DThe%2520hedgehog%2520system%2520machinery%2520controls%2520transforming%2520growth%2520factor-beta-dependent%2520myofibroblastic%2520differentiation%2520in%2520humans%253A%2520Involvement%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D181%26spage%3D2126%26epage%3D2137%26doi%3D10.1016%2Fj.ajpath.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didiasova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwapiszewska, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wujak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wygrecka, M.</span></span> <span> </span><span class="NLM_article-title">Pirfenidone exerts antifibrotic effects through inhibition of gli transcription factors</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1916</span>– <span class="NLM_lpage">1928</span>, <span class="refDoi"> DOI: 10.1096/fj.201600892RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1096%2Ffj.201600892RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28148565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1916-1928&author=M.+Didiasovaauthor=R.+Singhauthor=J.+Wilhelmauthor=G.+Kwapiszewskaauthor=L.+Wujakauthor=D.+Zakrzewiczauthor=L.+Schaeferauthor=P.+Markartauthor=W.+Seegerauthor=M.+Lauthauthor=M.+Wygrecka&title=Pirfenidone+exerts+antifibrotic+effects+through+inhibition+of+gli+transcription+factors&doi=10.1096%2Ffj.201600892RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors</span></div><div class="casAuthors">Didiasova, Miroslava; Singh, Rajeev; Wilhelm, Jochen; Kwapiszewska, Grazyna; Wujak, Lukasz; Zakrzewicz, Dariusz; Schaefer, Liliana; Markart, Philipp; Seeger, Werner; Lauth, Matthias; Wygrecka, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1916-1928</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Pirfenidone is an antifibrotic drug, recently approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF).  Although pirfenidone exhibits anti-inflammatory, antioxidant, and antifibrotic properties, the mol. mechanism underlying its protective effects remains unknown.  Here, we link pirfenidone action with the regulation of the profibrotic hedgehog (Hh) signaling pathway.  We demonstrate that pirfenidone selectively destabilizes the glioma-assocd. oncogene homolog (GLI)2 protein, the primary activator of Hh-mediated gene transcription.  Consequently, pirfenidone decreases overall Hh pathway activity in patients with IPF and in patient-derived primary lung fibroblasts and leads to diminished levels of Hh target genes, such as GLI1, Hh receptor Patched-1, α-smooth muscle actin, and fibronectin, and to reduced cell migration and proliferation.  Interestingly, Hh-triggered TGF-β1 expression potentiated Hh responsiveness of primary lung fibroblasts by elevating the available pool of glioma-assocd. oncogene homolog (GLI)1/GLI2, thus creating a vicious cycle of amplifying fibrotic processes.  Because GLI transcription factors are not only crucial for Hh-mediated changes but are also required as mediators of TGF-β signaling, our findings suggest that pirfenidone exerts its clin. beneficial effects through dual Hh/TGF-β inhibition by targeting the GLI2 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcpe0tW-jZxrVg90H21EOLACvtfcHk0linrw_lqkwlFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7%252FE&md5=d136b619b3e8974002ec4c017b6903d9</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1096%2Ffj.201600892RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201600892RR%26sid%3Dliteratum%253Aachs%26aulast%3DDidiasova%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DWilhelm%26aufirst%3DJ.%26aulast%3DKwapiszewska%26aufirst%3DG.%26aulast%3DWujak%26aufirst%3DL.%26aulast%3DZakrzewicz%26aufirst%3DD.%26aulast%3DSchaefer%26aufirst%3DL.%26aulast%3DMarkart%26aufirst%3DP.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DWygrecka%26aufirst%3DM.%26atitle%3DPirfenidone%2520exerts%2520antifibrotic%2520effects%2520through%2520inhibition%2520of%2520gli%2520transcription%2520factors%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D1916%26epage%3D1928%26doi%3D10.1096%2Ffj.201600892RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">UyenPhuong Tran, Grace C. Zhang, Ryan Eom, Kelvin L. Billingsley, <span class="NLM_string-name hlFld-ContribAuthor">Alison E. Ondrus</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Intervention in a Protein Kinase C–Gli Transcription Factor Axis. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 1321-1327. <a href="https://doi.org/10.1021/acschembio.0c00355" title="DOI URL">https://doi.org/10.1021/acschembio.0c00355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00355%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSmall%252BMolecule%252BIntervention%252Bin%252Ba%252BProtein%252BKinase%252BC%2525E2%252580%252593Gli%252BTranscription%252BFactor%252BAxis%26aulast%3DTran%26aufirst%3DUyenPhuong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06052020%26date%3D01062020%26date%3D08062020%26date%3D01062020%26volume%3D15%26issue%3D6%26spage%3D1321%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiyu  Sun</span>, <span class="hlFld-ContribAuthor ">Dajun  Zhang</span>, <span class="hlFld-ContribAuthor ">Tian  Luan</span>, <span class="hlFld-ContribAuthor ">Youbing  Wang</span>, <span class="hlFld-ContribAuthor ">Wenhu  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  Lin</span>, <span class="hlFld-ContribAuthor ">Meihua  Jiang</span>, <span class="hlFld-ContribAuthor ">Ziqian  Hao</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-methoxybenzamide derivatives and evaluation of their hedgehog signaling pathway inhibition. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (37)
                                     , 22820-22825. <a href="https://doi.org/10.1039/D1RA00732G" title="DOI URL">https://doi.org/10.1039/D1RA00732G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA00732G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA00732G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252B2-methoxybenzamide%252Bderivatives%252Band%252Bevaluation%252Bof%252Btheir%252Bhedgehog%252Bsignaling%252Bpathway%252Binhibition%26aulast%3DSun%26aufirst%3DChiyu%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D37%26spage%3D22820%26epage%3D22825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Hupfer</span>, <span class="hlFld-ContribAuthor ">Anna  Brichkina</span>, <span class="hlFld-ContribAuthor ">Till  Adhikary</span>, <span class="hlFld-ContribAuthor ">Matthias  Lauth</span>. </span><span class="cited-content_cbyCitation_article-title">The mammalian Hedgehog pathway is modulated by ANP32 proteins. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2021,</strong> <em>553 </em>, 78-84. <a href="https://doi.org/10.1016/j.bbrc.2021.03.027" title="DOI URL">https://doi.org/10.1016/j.bbrc.2021.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2021.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2021.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DThe%252Bmammalian%252BHedgehog%252Bpathway%252Bis%252Bmodulated%252Bby%252BANP32%252Bproteins%26aulast%3DHupfer%26aufirst%3DAnna%26date%3D2021%26volume%3D553%26spage%3D78%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anke  Koeniger</span>, <span class="hlFld-ContribAuthor ">Anna  Brichkina</span>, <span class="hlFld-ContribAuthor ">Iris  Nee</span>, <span class="hlFld-ContribAuthor ">Lukas  Dempwolff</span>, <span class="hlFld-ContribAuthor ">Anna  Hupfer</span>, <span class="hlFld-ContribAuthor ">Ilya  Galperin</span>, <span class="hlFld-ContribAuthor ">Florian  Finkernagel</span>, <span class="hlFld-ContribAuthor ">Andrea  Nist</span>, <span class="hlFld-ContribAuthor ">Thorsten  Stiewe</span>, <span class="hlFld-ContribAuthor ">Till  Adhikary</span>, <span class="hlFld-ContribAuthor ">Wibke  Diederich</span>, <span class="hlFld-ContribAuthor ">Matthias  Lauth</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (8)
                                     , 1908. <a href="https://doi.org/10.3390/cancers13081908" title="DOI URL">https://doi.org/10.3390/cancers13081908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13081908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13081908%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DActivation%252Bof%252BCilia-Independent%252BHedgehog%25252FGLI1%252BSignaling%252Bas%252Ba%252BNovel%252BConcept%252Bfor%252BNeuroblastoma%252BTherapy%26aulast%3DKoeniger%26aufirst%3DAnke%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D8%26spage%3D1908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiyu  Sun</span>, <span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Han  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengxu  Yin</span>, <span class="hlFld-ContribAuthor ">Lingqiong  Wu</span>, <span class="hlFld-ContribAuthor ">Yanmiao  Huang</span>, <span class="hlFld-ContribAuthor ">Wenhu  Zhang</span>, <span class="hlFld-ContribAuthor ">Youbing  Wang</span>, <span class="hlFld-ContribAuthor ">Qibo  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and biological evaluation of phenyl imidazole analogs as hedgehog signaling pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 546-552. <a href="https://doi.org/10.1111/cbdd.13799" title="DOI URL">https://doi.org/10.1111/cbdd.13799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13799%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%252Band%252Bbiological%252Bevaluation%252Bof%252Bphenyl%252Bimidazole%252Banalogs%252Bas%252Bhedgehog%252Bsignaling%252Bpathway%252Binhibitors%26aulast%3DSun%26aufirst%3DChiyu%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D546%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuo-Shyang  Jeng</span>, <span class="hlFld-ContribAuthor ">I-Shyan  Sheen</span>, <span class="hlFld-ContribAuthor ">Chuen-Miin  Leu</span>, <span class="hlFld-ContribAuthor ">Ping-Hui  Tseng</span>, <span class="hlFld-ContribAuthor ">Chiung-Fang  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Smoothened in Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (18)
                                     , 6863. <a href="https://doi.org/10.3390/ijms21186863" title="DOI URL">https://doi.org/10.3390/ijms21186863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21186863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21186863%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BRole%252Bof%252BSmoothened%252Bin%252BCancer%26aulast%3DJeng%26aufirst%3DKuo-Shyang%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D18%26spage%3D6863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel N.  Pitsinos</span>, <span class="hlFld-ContribAuthor ">Ioannis  Mavridis</span>, <span class="hlFld-ContribAuthor ">Eirini  Tzouma</span>, <span class="hlFld-ContribAuthor ">Veroniki P.  Vidali</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of Cassane-Type Furanoditerpenoids: Total Synthesis of Sucutiniranes C and D. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (30)
                                     , 4730-4742. <a href="https://doi.org/10.1002/ejoc.202000724" title="DOI URL">https://doi.org/10.1002/ejoc.202000724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000724%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BCassane-Type%252BFuranoditerpenoids%25253A%252BTotal%252BSynthesis%252Bof%252BSucutiniranes%252BC%252Band%252BD%26aulast%3DPitsinos%26aufirst%3DEmmanuel%2BN.%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D30%26spage%3D4730%26epage%3D4742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taikangxiang  Yun</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Wenjing  Huang</span>, <span class="hlFld-ContribAuthor ">Luhua  Lai</span>, <span class="hlFld-ContribAuthor ">Wenfu  Tan</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Small Molecule Inhibitors Targeting the Sonic Hedgehog. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.00498" title="DOI URL">https://doi.org/10.3389/fchem.2020.00498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.00498%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSmall%252BMolecule%252BInhibitors%252BTargeting%252Bthe%252BSonic%252BHedgehog%26aulast%3DYun%26aufirst%3DTaikangxiang%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanna K.L.  Johansson</span>, <span class="hlFld-ContribAuthor ">Terje  Svingen</span>. </span><span class="cited-content_cbyCitation_article-title">Hedgehog signal disruption, gonadal dysgenesis and reproductive disorders: Is there a link to endocrine disrupting chemicals?. </span><span class="cited-content_cbyCitation_journal-name">Current Research in Toxicology</span><span> <strong>2020,</strong> <em>1 </em>, 116-123. <a href="https://doi.org/10.1016/j.crtox.2020.10.001" title="DOI URL">https://doi.org/10.1016/j.crtox.2020.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.crtox.2020.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.crtox.2020.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Research%2520in%2520Toxicology%26atitle%3DHedgehog%252Bsignal%252Bdisruption%25252C%252Bgonadal%252Bdysgenesis%252Band%252Breproductive%252Bdisorders%25253A%252BIs%252Bthere%252Ba%252Blink%252Bto%252Bendocrine%252Bdisrupting%252Bchemicals%25253F%26aulast%3DJohansson%26aufirst%3DHanna%2BK.L.%26date%3D2020%26volume%3D1%26spage%3D116%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen‐feng  Xiao</span>, <span class="hlFld-ContribAuthor ">Yu‐sheng  Li</span>, <span class="hlFld-ContribAuthor ">Ang  Deng</span>, <span class="hlFld-ContribAuthor ">Yun‐tao  Yang</span>, <span class="hlFld-ContribAuthor ">Miao  He</span>. </span><span class="cited-content_cbyCitation_article-title">Functional role of hedgehog pathway in osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Cell Biochemistry and Function</span><span> <strong>2020,</strong> <em>38 </em>
                                    (2)
                                     , 122-129. <a href="https://doi.org/10.1002/cbf.3448" title="DOI URL">https://doi.org/10.1002/cbf.3448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbf.3448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbf.3448%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Biochemistry%2520and%2520Function%26atitle%3DFunctional%252Brole%252Bof%252Bhedgehog%252Bpathway%252Bin%252Bosteoarthritis%26aulast%3DXiao%26aufirst%3DWen%25E2%2580%2590feng%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D2%26spage%3D122%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dezhong  Ji</span>, <span class="hlFld-ContribAuthor ">Wanwan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (6)
                                     , 115354. <a href="https://doi.org/10.1016/j.bmc.2020.115354" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115354%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Banthranilamide%252Bderivatives%252Bas%252Bpotent%252BSMO%252Binhibitors%26aulast%3DJi%26aufirst%3DDezhong%26date%3D2020%26volume%3D28%26issue%3D6%26spage%3D115354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of canonical Hh signaling in mammalian cells. Please refer to the main text for details.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural representation of compounds <b>1</b> (robotnikinin), <b>2</b> (RU-SKI43), and <b>3</b> (RU-SKI201) antagonizing Hh ligand function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of SMO antagonists <b>4</b> (cyclopamine) and <b>5</b> (saridegib).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystallographically determined binding mode of <b>4</b> (cyclopamine) to Smo (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R">4O9R</a>) according to ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and visualized in PyMOL 0.99 (<contrib-group><span class="NLM_string-name">DeLano, W. L.</span></contrib-group> (<span class="NLM_year">2002</span>)   <cite><i>The PyMOL Molecular Graphics System</i></cite>; DeLano Scientific: San Carlos, CA, U.S.). For clarity of presentation some residues of the 7-TM have been omitted. The protein backbone is shown as cartoon (wheat), the ligand as well as important amino acids in stick representation, color coded by atom type. For the ligand: carbon, green; nitrogen, blue; oxygen, red. For the protein: carbon, wheat; nitrogen, blue; oxygen, red. Potential hydrogen bonds are indicated by black dashes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of selected SMO antagonists <b>6</b> (vismodegib), <b>7</b> (sonidegib), <b>8</b> (itraconazole), <b>9</b> (BMS-833923), <b>10</b> (glasdegib), <b>11</b> (PF-5274857).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Optimization of the screening hit <b>12</b> leading to <b>15</b> (NVP-LEQ506).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Further structural optimization of <b>16</b> resulting in compounds <b>17</b> and <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structures of CRD-binding SMO modulators <b>19</b>, <b>20</b>, <b>21</b>, and <b>22</b>. All compounds except <b>19</b> function as antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Crystallographically determined binding mode of <b>6</b> (vismodegib) in Smo (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L7I">5L7I</a>) according to ref <a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> and visualized in PyMOL 0.99 (<contrib-group><span class="NLM_string-name">DeLano, W. L.</span></contrib-group> (<span class="NLM_year">2002</span>)   <cite><i>The PyMOL Molecular Graphics System</i></cite>; DeLano Scientific: San Carlos, CA, U.S.). For clarity of presentation some residues of the 7-TM have been omitted. The protein backbone is shown as cartoon (wheat), the ligand as well as important amino acids in stick representation, color coded by atom type. For the ligand: carbon, orange; nitrogen, blue; oxygen, red; chlorine, green; sulfur, yellow. For the protein: carbon, wheat; nitrogen, blue; oxygen, red. Potential hydrogen bonds are indicated by black dashes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of SMO inhibitors reported to retain activity against vismodegib-resistant SMO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Examples of compounds indirectly affecting Hh signaling by interference with microtubules, primary cilia formation, and/or SMO transport.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Compounds inhibiting Hh signaling at the level of the GLI transcription factors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Clinically approved drugs with GLI-inhibitory ability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/medium/jm-2019-001883_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Schematic outline of an active Hh pathway and the points at which known small molecule inhibitors interfere with signal transduction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-18/acs.jmedchem.9b00188/20190920/images/large/jm-2019-001883_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00188&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 170 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbottom, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pownall, M. E.</span></span> <span> </span><span class="NLM_article-title">Regulation of hedgehog signalling inside and outside the cell</span>. <i>J. Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.3390/jdb4030023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fjdb4030023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27547735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=23&author=S.+A.+Ramsbottomauthor=M.+E.+Pownall&title=Regulation+of+hedgehog+signalling+inside+and+outside+the+cell&doi=10.3390%2Fjdb4030023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of hedgehog signalling inside and outside the cell</span></div><div class="casAuthors">Ramsbottom, Simon A.; Pownall, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Developmental Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">23/1-23/20</span>CODEN:
                <span class="NLM_cas:coden">JDBOAX</span>;
        ISSN:<span class="NLM_cas:issn">2221-3759</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The hedgehog (Hh) signalling pathway is conserved throughout metazoans and plays an important regulatory role in both embryonic development and adult homeostasis.  Many levels of regulation exist that control the release, reception, and interpretation of the hedgehog signal.  The fatty nature of the Shh ligand means that it tends to assoc. tightly with the cell membrane, and yet it is known to act as a morphogen that diffuses to elicit pattern formation.  Heparan sulfate proteoglycans (HSPGs) play a major role in the regulation of Hh distribution outside the cell.  Inside the cell, the primary cilium provides an important hub for processing the Hh signal in vertebrates.  This review will summarise the current understanding of how the Hh pathway is regulated from ligand prodn., release, and diffusion, through to signal reception and intracellular transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5hYUdRByfuLVg90H21EOLACvtfcHk0lgQ9-Hr1nynEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsV2gsLk%253D&md5=5b3b26639d6c0bc1707f49b9ea26efcb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fjdb4030023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjdb4030023%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbottom%26aufirst%3DS.%2BA.%26aulast%3DPownall%26aufirst%3DM.%2BE.%26atitle%3DRegulation%2520of%2520hedgehog%2520signalling%2520inside%2520and%2520outside%2520the%2520cell%26jtitle%3DJ.%2520Dev.%2520Biol.%26date%3D2016%26volume%3D4%26spage%3D23%26doi%3D10.3390%2Fjdb4030023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, R. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signal transduction: Key players, oncogenic drivers, and cancer therapy</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2016.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.devcel.2016.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27554855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWlu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2016&pages=333-344&author=E.+Pakauthor=R.+A.+Segal&title=Hedgehog+signal+transduction%3A+Key+players%2C+oncogenic+drivers%2C+and+cancer+therapy&doi=10.1016%2Fj.devcel.2016.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy</span></div><div class="casAuthors">Pak, Ekaterina; Segal, Rosalind A.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">333-344</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) signaling pathway governs complex developmental processes, including proliferation and patterning within diverse tissues.  These activities rely on a tightly regulated transduction system that converts graded Hh input signals into specific levels of pathway activity.  Uncontrolled activation of Hh signaling drives tumor initiation and maintenance.  However, recent entry of pathway-specific inhibitors into the clinic reveals mixed patient responses and thus prompts further exploration of pathway activation and inhibition.  In this review, we share emerging insights into regulated and oncogenic Hh signaling, supplemented with updates on the development and use of Hh pathway-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Ps2jrlOu37Vg90H21EOLACvtfcHk0lgQ9-Hr1nynEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWlu7bI&md5=297d0d71e402c66eac0b9233a0a575ef</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2016.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2016.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DPak%26aufirst%3DE.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DHedgehog%2520signal%2520transduction%253A%2520Key%2520players%252C%2520oncogenic%2520drivers%252C%2520and%2520cancer%2520therapy%26jtitle%3DDev.%2520Cell%26date%3D2016%26volume%3D38%26spage%3D333%26epage%3D344%26doi%3D10.1016%2Fj.devcel.2016.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roessler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruszka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullikin, J. C.</span></span>; <span class="NLM_contrib-group">NISC Comparative Sequencing Program</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhuber, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richieri-Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro-Bicudo, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muenke, M.</span></span> <span> </span><span class="NLM_article-title">Common genetic causes of holoprosencephaly are limited to a small set of evolutionarily conserved driver genes of midline development coordinated by tgf-beta, hedgehog, and fgf signaling</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">1427</span>, <span class="refDoi"> DOI: 10.1002/humu.23590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fhumu.23590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29992659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=1416-1427&author=E.+Roesslerauthor=P.+Huauthor=J.+Marinoauthor=S.+Hongauthor=R.+Hartauthor=S.+Bergerauthor=A.+Martinezauthor=Y.+Abeauthor=P.+Kruszkaauthor=J.+W.+Thomasauthor=J.+C.+Mullikinauthor=NISC+Comparative+Sequencing+Programauthor=Y.+Wangauthor=W.+S.+W.+Wongauthor=J.+E.+Niederhuberauthor=B.+D.+Solomonauthor=A.+Richieri-Costaauthor=L.+A.+Ribeiro-Bicudoauthor=M.+Muenke&title=Common+genetic+causes+of+holoprosencephaly+are+limited+to+a+small+set+of+evolutionarily+conserved+driver+genes+of+midline+development+coordinated+by+tgf-beta%2C+hedgehog%2C+and+fgf+signaling&doi=10.1002%2Fhumu.23590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Common genetic causes of holoprosencephaly are limited to a small set of evolutionarily conserved driver genes of midline development coordinated by TGF-β, hedgehog, and FGF signaling</span></div><div class="casAuthors">Roessler, Erich; Hu, Ping; Marino, Juliana; Hong, Sungkook; Hart, Rachel; Berger, Seth; Martinez, Ariel; Abe, Yu; Kruszka, Paul; Thomas, James W.; Mullikin, James C.; Wang, Yupeng; Wong, Wendy S. W.; Niederhuber, John E.; Solomon, Benjamin D.; Richieri-Costa, Antonio; Ribeiro-Bicudo, L. A.; Muenke, Maximilian</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1416-1427</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Here, we applied targeted capture to examine 153 genes representative of all the major vertebrate developmental pathways among 333 probands to rank their relative significance as causes for holoprosencephaly (HPE).  We now show that comparisons of variant transmission vs. nontransmission among 136 HPE Trios indicates some reported genes now lack confirmation, while novel genes are implicated.  Furthermore, we demonstrate that variation of modest intrinsic effect can synergize with these driver mutations as gene modifiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpxRzeYOTWNbVg90H21EOLACvtfcHk0lgQ9-Hr1nynEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnsrvJ&md5=f9c09f1f95446b9fcaf0bf5001b7c31a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fhumu.23590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.23590%26sid%3Dliteratum%253Aachs%26aulast%3DRoessler%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DMarino%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DHart%26aufirst%3DR.%26aulast%3DBerger%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKruszka%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DJ.%2BW.%26aulast%3DMullikin%26aufirst%3DJ.%2BC.%26aulast%3D%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DW.%2BS.%2BW.%26aulast%3DNiederhuber%26aufirst%3DJ.%2BE.%26aulast%3DSolomon%26aufirst%3DB.%2BD.%26aulast%3DRichieri-Costa%26aufirst%3DA.%26aulast%3DRibeiro-Bicudo%26aufirst%3DL.%2BA.%26aulast%3DMuenke%26aufirst%3DM.%26atitle%3DCommon%2520genetic%2520causes%2520of%2520holoprosencephaly%2520are%2520limited%2520to%2520a%2520small%2520set%2520of%2520evolutionarily%2520conserved%2520driver%2520genes%2520of%2520midline%2520development%2520coordinated%2520by%2520tgf-beta%252C%2520hedgehog%252C%2520and%2520fgf%2520signaling%26jtitle%3DHum.%2520Mutat.%26date%3D2018%26volume%3D39%26spage%3D1416%26epage%3D1427%26doi%3D10.1002%2Fhumu.23590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Patched acts catalytically to suppress the activity of smoothened</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>418</i></span>,  <span class="NLM_fpage">892</span>– <span class="NLM_lpage">897</span>, <span class="refDoi"> DOI: 10.1038/nature00989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature00989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12192414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlWltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2002&pages=892-897&author=J.+Taipaleauthor=M.+K.+Cooperauthor=T.+Maitiauthor=P.+A.+Beachy&title=Patched+acts+catalytically+to+suppress+the+activity+of+smoothened&doi=10.1038%2Fnature00989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Patched acts catalytically to suppress the activity of Smoothened</span></div><div class="casAuthors">Taipale, J.; Cooper, M. K.; Maiti, T.; Beachy, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">6900</span>),
    <span class="NLM_cas:pages">892-896</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations affecting the transmembrane proteins Patched (Ptc) or Smoothened (Smo) that trigger ligand-independent activity of the Hedgehog (Hh) signaling pathway are assocd. with human tumors such as basal cell carcinoma (BCC) and medulloblastoma.  Despite extensive genetic studies demonstrating the importance of these receptor components in embryonic patterning and cancer, the mechanism by which Ptc regulates Smo is not understood.  Here we report that Ptc and Smo are not significantly assocd. within Hh-responsive cells.  Furthermore, we show that free Ptc (unbound by Hh) acts sub-stoichiometrically to suppress Smo activity and thus is crit. in specifying the level of pathway activity.  Patched is a twelve-transmembrane protein with homol. to bacterial proton-driven transmembrane mol. transporters; we demonstrate that the function of Ptc is impaired by alterations of residues that are conserved in and required for function of these bacterial transporters.  These results suggest that the Ptc tumor suppressor functions normally as a transmembrane mol. transporter, which acts indirectly to inhibit Smo activity, possibly through changes in distribution or concn. of a small mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc5RyHcisDXrVg90H21EOLACvtfcHk0ljUGmAqSw39Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlWltb0%253D&md5=61ba9ffee2e91889b09d900910ac3af5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature00989%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DMaiti%26aufirst%3DT.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DPatched%2520acts%2520catalytically%2520to%2520suppress%2520the%2520activity%2520of%2520smoothened%26jtitle%3DNature%26date%3D2002%26volume%3D418%26spage%3D892%26epage%3D897%26doi%3D10.1038%2Fnature00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulkley, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asarnow, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Structural basis for cholesterol transport-like activity of the hedgehog receptor patched</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1352</span>– <span class="NLM_lpage">1364</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2018.10.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30415841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=1352-1364&author=Y.+Zhangauthor=D.+P.+Bulkleyauthor=Y.+Xinauthor=K.+J.+Robertsauthor=D.+E.+Asarnowauthor=A.+Sharmaauthor=B.+R.+Myersauthor=W.+Choauthor=Y.+Chengauthor=P.+A.+Beachy&title=Structural+basis+for+cholesterol+transport-like+activity+of+the+hedgehog+receptor+patched&doi=10.1016%2Fj.cell.2018.10.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Cholesterol Transport-like Activity of the Hedgehog Receptor Patched</span></div><div class="casAuthors">Zhang, Yunxiao; Bulkley, David P.; Xin, Yao; Roberts, Kelsey J.; Asarnow, Daniel E.; Sharma, Ashutosh; Myers, Benjamin R.; Cho, Wonhwa; Cheng, Yifan; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1352-1364.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hedgehog protein signals mediate tissue patterning and maintenance by binding to and inactivating their common receptor Patched, a 12-transmembrane protein that otherwise would suppress the activity of the 7-transmembrane protein Smoothened (SMO).  Loss of Patched function, the most common cause of basal cell carcinoma, permits unregulated activation of Smoothened and of the Hedgehog pathway.  A cryo-EM structure of the Patched protein reveals striking transmembrane domain similarities to prokaryotic RND transporters.  A central hydrophobic conduit with cholesterol-like contents courses through the extracellular domain and resembles that used by other RND proteins to transport substrates, suggesting Patched activity in cholesterol transport.  Cholesterol activity in the inner leaflet of the plasma membrane is reduced by Patched1 (PTCH1) expression but rapidly restored by Hedgehog stimulation, suggesting that PTCH1 regulates Smoothened by controlling cholesterol availability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiSFavoTDQI7Vg90H21EOLACvtfcHk0ljUGmAqSw39Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCgsbzO&md5=1543ef948bd093d4b3e716faad9538e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBulkley%26aufirst%3DD.%2BP.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRoberts%26aufirst%3DK.%2BJ.%26aulast%3DAsarnow%26aufirst%3DD.%2BE.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DMyers%26aufirst%3DB.%2BR.%26aulast%3DCho%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DStructural%2520basis%2520for%2520cholesterol%2520transport-like%2520activity%2520of%2520the%2520hedgehog%2520receptor%2520patched%26jtitle%3DCell%26date%3D2018%26volume%3D175%26spage%3D1352%26epage%3D1364%26doi%3D10.1016%2Fj.cell.2018.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog-regulated processing of gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80678-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2FS0092-8674%2800%2980678-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10693759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVOltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=423-434&author=B.+Wangauthor=J.+F.+Fallonauthor=P.+A.+Beachy&title=Hedgehog-regulated+processing+of+gli3+produces+an+anterior%2Fposterior+repressor+gradient+in+the+developing+vertebrate+limb&doi=10.1016%2FS0092-8674%2800%2980678-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb</span></div><div class="casAuthors">Wang, Baolin; Fallon, John F.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">423-434</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ci/Gli zinc finger proteins mediate the transcriptional effects of Hedgehog protein signals.  In Drosophila, Ci action as transcriptional repressor or activator is contingent upon Hedgehog-regulated, PKA-dependent proteolytic processing.  We demonstrate that PKA-dependent processing of vertebrate Gli3 in developing limb similarly generates a potent repressor in a manner antagonized by apparent long-range signaling from posteriorly localized Sonic hedgehog protein.  The resulting anterior/posterior Gli3 repressor gradient can be perturbed by mutations of Gli3 in human genetic syndromes or by misregulation of Gli3 processing in the chicken mutant talpid2, producing a range of limb patterning malformations.  The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for neg. Hedgehog pathway regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9O-Nv76-hO7Vg90H21EOLACvtfcHk0ljUGmAqSw39Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVOltbc%253D&md5=cb4f06af63a1572e9eafaf29d0aceff2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980678-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980678-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DFallon%26aufirst%3DJ.%2BF.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DHedgehog-regulated%2520processing%2520of%2520gli3%2520produces%2520an%2520anterior%252Fposterior%2520repressor%2520gradient%2520in%2520the%2520developing%2520vertebrate%2520limb%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D423%26epage%3D434%26doi%3D10.1016%2FS0092-8674%2800%2980678-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog signaling regulates gli2 transcriptional activity by suppressing its processing and degradation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3365</span>– <span class="NLM_lpage">3377</span>, <span class="refDoi"> DOI: 10.1128/MCB.26.9.3365-3377.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1128%2FMCB.26.9.3365-3377.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16611981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVKks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=3365-3377&author=Y.+Panauthor=C.+B.+Baiauthor=A.+L.+Joynerauthor=B.+Wang&title=Sonic+hedgehog+signaling+regulates+gli2+transcriptional+activity+by+suppressing+its+processing+and+degradation&doi=10.1128%2FMCB.26.9.3365-3377.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation</span></div><div class="casAuthors">Pan, Yong; Bai, Chunyang Brian; Joyner, Alexandra L.; Wang, Baolin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3365-3377</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Gli2 and Gli3 are the primary transcription factors that mediate Sonic hedgehog (Shh) signals in the mouse.  Gli3 mainly acts as a transcriptional repressor, because the majority of full-length Gli3 protein is proteolytically processed.  Gli2 is mostly regarded as a transcriptional activator, even though it is also suggested to have a weak repressing activity.  What the mol. basis for its possible dual function is and how its activity is regulated by Shh signaling are largely unknown.  Here we demonstrate that unlike the results seen with Gli3 and Cubitus Interruptus, the fly homolog of Gli, only a minor fraction of Gli2 is proteolytically processed to form a transcriptional repressor in vivo and that in addn. to being processed, Gli2 full-length protein is readily degraded.  The degrdn. of Gli2 requires the phosphorylation of a cluster of numerous serine residues in its carboxyl terminus by protein kinase A and subsequently by casein kinase 1 and glycogen synthase kinase 3.  The phosphorylated Gli2 interacts directly with βTrCP in the SCF ubiquitin-ligase complex through two binding sites, which results in Gli2 ubiquitination and subsequent degrdn. by the proteasome.  Both processing and degrdn. of Gli2 are suppressed by Shh signaling in vivo.  Our findings provide the first demonstration of a mol. mechanism by which the Gli2 transcriptional activity is regulated by Shh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXmdqHoGF1H7Vg90H21EOLACvtfcHk0ljlKMCrC3eO0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVKks70%253D&md5=7e6039db518abf4a62154f11b2d29884</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.9.3365-3377.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.9.3365-3377.2006%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%26aulast%3DBai%26aufirst%3DC.%2BB.%26aulast%3DJoyner%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DSonic%2520hedgehog%2520signaling%2520regulates%2520gli2%2520transcriptional%2520activity%2520by%2520suppressing%2520its%2520processing%2520and%2520degradation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D3365%26epage%3D3377%26doi%3D10.1128%2FMCB.26.9.3365-3377.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainprize, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agatep, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiappa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowrance, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavrou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dura, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squire, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutka, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, D.</span></span> <span> </span><span class="NLM_article-title">Mutations in sufu predispose to medulloblastoma</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1038/ng916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fng916" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12068298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2002&pages=306-310&author=M.+D.+Taylorauthor=L.+Liuauthor=C.+Raffelauthor=C.+C.+Huiauthor=T.+G.+Mainprizeauthor=X.+Zhangauthor=R.+Agatepauthor=S.+Chiappaauthor=L.+Gaoauthor=A.+Lowranceauthor=A.+Haoauthor=A.+M.+Goldsteinauthor=T.+Stavrouauthor=S.+W.+Schererauthor=W.+T.+Duraauthor=B.+Wainwrightauthor=J.+A.+Squireauthor=J.+T.+Rutkaauthor=D.+Hogg&title=Mutations+in+sufu+predispose+to+medulloblastoma&doi=10.1038%2Fng916"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in SUFU predispose to medulloblastoma</span></div><div class="casAuthors">Taylor, Michael D.; Liu, Ling; Raffel, Corey; Hui, Chi-chung; Mainprize, Todd G.; Zhang, Xiaoyun; Agatep, Ron; Chiappa, Sharon; Gao, Luzhang; Lowrance, Anja; Hao, Aihau; Goldstein, Alisa M.; Stavrou, Theodora; Scherer, Stephen W.; Dura, Wieslaw T.; Wainwright, Brandon; Squire, Jeremy A.; Rutka, James T.; Hogg, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-310</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse organisms and is disrupted in a variety of malignancies.  Pathway activation is triggered by binding of hedgehog proteins to the multipass Patched-1 (PTCH) receptor, which in the absence of hedgehog suppresses the activity of the seven-pass membrane protein Smoothened (SMOH).  De-repression of SMOH culminates in the activation of one or more of the GLI transcription factors that regulate the transcription of downstream targets.  Individuals with germline mutations of the SHH receptor gene PTCH are at high risk of developmental anomalies and of basal-cell carcinomas, medulloblastomas and other cancers (a pattern consistent with nevoid basal-cell carcinoma syndrome, NBCCS).  In keeping with the role of PTCH as a tumor-suppressor gene, somatic mutations of this gene occur in sporadic basal-cell carcinomas and medulloblastomas.  We report here that a subset of children with medulloblastoma carry germline and somatic mutations in SUFU (encoding the human suppressor of fused) of the SHH pathway, accompanied by loss of heterozygosity of the wildtype allele.  Several of these mutations encode truncated proteins that are unable to export the GLI transcription factor from nucleus to cytoplasm, resulting in the activation of SHH signaling.  SUFU is a newly identified tumor-suppressor gene that predisposes individuals to medulloblastoma by modulating the SHH signaling pathway through a newly identified mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohQT7TDk1-EbVg90H21EOLACvtfcHk0ljlKMCrC3eO0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVGmtLY%253D&md5=cc8df5599e8e37a0b8c992a31ecc3cca</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng916%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRaffel%26aufirst%3DC.%26aulast%3DHui%26aufirst%3DC.%2BC.%26aulast%3DMainprize%26aufirst%3DT.%2BG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAgatep%26aufirst%3DR.%26aulast%3DChiappa%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DLowrance%26aufirst%3DA.%26aulast%3DHao%26aufirst%3DA.%26aulast%3DGoldstein%26aufirst%3DA.%2BM.%26aulast%3DStavrou%26aufirst%3DT.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DDura%26aufirst%3DW.%2BT.%26aulast%3DWainwright%26aufirst%3DB.%26aulast%3DSquire%26aufirst%3DJ.%2BA.%26aulast%3DRutka%26aufirst%3DJ.%2BT.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DMutations%2520in%2520sufu%2520predispose%2520to%2520medulloblastoma%26jtitle%3DNat.%2520Genet.%26date%3D2002%26volume%3D31%26spage%3D306%26epage%3D310%26doi%3D10.1038%2Fng916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heby Henricson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson-Lek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teglund, S.</span></span> <span> </span><span class="NLM_article-title">Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian hedgehog signaling pathway</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2005.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.devcel.2005.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16459298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BD28%252Fnt1GgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=187-197&author=J.+Svardauthor=K.+Heby+Henricsonauthor=M.+Persson-Lekauthor=B.+Rozellauthor=M.+Lauthauthor=A.+Bergstromauthor=J.+Ericsonauthor=R.+Toftgardauthor=S.+Teglund&title=Genetic+elimination+of+suppressor+of+fused+reveals+an+essential+repressor+function+in+the+mammalian+hedgehog+signaling+pathway&doi=10.1016%2Fj.devcel.2005.12.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic elimination of Suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway</span></div><div class="casAuthors">Svard Jessica; Heby-Henricson Karin; Henricson Karin Heby; Persson-Lek Madelen; Rozell Bjorn; Lauth Matthias; Bergstrom Asa; Ericson Johan; Toftgard Rune; Teglund Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Developmental cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-97</span>
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    </div><div class="casAbstract">The Hedgehog (Hh) pathway plays important roles during embryogenesis and carcinogenesis.  Here, we show that ablation of the mouse Suppressor of fused (Sufu), an intracellular pathway component, leads to embryonic lethality at approximately E9.5 with cephalic and neural tube defects.  Fibroblasts derived from Sufu(-/-) embryos showed high Gli-mediated Hh pathway activity that could not be modulated at the level of Smoothened and could only partially be blocked by PKA activation.  Despite the robust constitutive pathway activation in the Sufu(-/-) fibroblasts, the GLI1 steady-state localization remained largely cytoplasmic, implying the presence of an effective nuclear export mechanism.  Sufu(+/-) mice develop a skin phenotype with basaloid changes and jaw keratocysts, characteristic features of Gorlin syndrome, a human genetic disease linked to enhanced Hh signaling.  Our data demonstrate that, in striking contrast to Drosophila, in mammals, Sufu has a central role, and its loss of function leads to potent ligand-independent activation of the Hh pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTZ5qTpwY0ADY3yKPtYViAGfW6udTcc2eaKJjNH9xQIK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252Fnt1GgtQ%253D%253D&md5=29ca37c5c29c080311a1b9a4386bff2e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2005.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2005.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DSvard%26aufirst%3DJ.%26aulast%3DHeby%2BHenricson%26aufirst%3DK.%26aulast%3DPersson-Lek%26aufirst%3DM.%26aulast%3DRozell%26aufirst%3DB.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DEricson%26aufirst%3DJ.%26aulast%3DToftgard%26aufirst%3DR.%26aulast%3DTeglund%26aufirst%3DS.%26atitle%3DGenetic%2520elimination%2520of%2520suppressor%2520of%2520fused%2520reveals%2520an%2520essential%2520repressor%2520function%2520in%2520the%2520mammalian%2520hedgehog%2520signaling%2520pathway%26jtitle%3DDev.%2520Cell%26date%3D2006%26volume%3D10%26spage%3D187%26epage%3D197%26doi%3D10.1016%2Fj.devcel.2005.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loktev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. K.</span></span> <span> </span><span class="NLM_article-title">The ciliary g-protein-coupled receptor gpr161 negatively regulates the sonic hedgehog pathway via camp signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2012.12.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23332756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Olurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2013&pages=210-223&author=S.+Mukhopadhyayauthor=X.+Wenauthor=N.+Rattiauthor=A.+Loktevauthor=L.+Rangellauthor=S.+J.+Scalesauthor=P.+K.+Jackson&title=The+ciliary+g-protein-coupled+receptor+gpr161+negatively+regulates+the+sonic+hedgehog+pathway+via+camp+signaling&doi=10.1016%2Fj.cell.2012.12.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Ciliary G-Protein-Coupled Receptor Gpr161 Negatively Regulates the Sonic Hedgehog Pathway via cAMP Signaling</span></div><div class="casAuthors">Mukhopadhyay, Saikat; Wen, Xiaohui; Ratti, Navneet; Loktev, Alexander; Rangell, Linda; Scales, Suzie J.; Jackson, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">210-223</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The primary cilium is required for Sonic hedgehog (Shh) signaling in vertebrates.  In contrast to mutants affecting ciliary assembly, mutations in the intraflagellar transport complex A (IFT-A) paradoxically cause increased Shh signaling.  We previously showed that the IFT-A complex, in addn. to its canonical role in retrograde IFT, binds to the tubby-like protein, Tulp3, and recruits it to cilia.  Here, we describe a conserved vertebrate G-protein-coupled receptor, Gpr161, which localizes to primary cilia in a Tulp3/IFT-A-dependent manner.  Complete loss of Gpr161 in mouse causes midgestation lethality and increased Shh signaling in the neural tube, phenocopying Tulp3/IFT-A mutants.  Constitutive Gpr161 activity increases cAMP levels and represses Shh signaling by detg. the processing of Gli3 to its repressor form.  Conversely, Shh signaling directs Gpr161 to be internalized from cilia, preventing its activity.  Thus, Gpr161 defines a morphogenetic pathway coupling protein kinase A activation to Shh signaling during neural tube development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsxiCVAB3Iq7Vg90H21EOLACvtfcHk0ljSPZ67K1yYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Olurs%253D&md5=07b27a576840f6259d38f4fa907a4db4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DRatti%26aufirst%3DN.%26aulast%3DLoktev%26aufirst%3DA.%26aulast%3DRangell%26aufirst%3DL.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26atitle%3DThe%2520ciliary%2520g-protein-coupled%2520receptor%2520gpr161%2520negatively%2520regulates%2520the%2520sonic%2520hedgehog%2520pathway%2520via%2520camp%2520signaling%26jtitle%3DCell%26date%3D2013%26volume%3D152%26spage%3D210%26epage%3D223%26doi%3D10.1016%2Fj.cell.2012.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hempel, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frist, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, C. C.</span></span> <span> </span><span class="NLM_article-title">An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.celrep.2015.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25818300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=43-50&author=C.+H.+Williamsauthor=J.+E.+Hempelauthor=J.+Haoauthor=A.+Y.+Fristauthor=M.+M.+Williamsauthor=J.+T.+Flemingauthor=G.+A.+Sulikowskiauthor=M.+K.+Cooperauthor=C.+Chiangauthor=C.+C.+Hong&title=An+in+vivo+chemical+genetic+screen+identifies+phosphodiesterase+4+as+a+pharmacological+target+for+hedgehog+signaling+inhibition&doi=10.1016%2Fj.celrep.2015.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">An In Vivo Chemical Genetic Screen Identifies Phosphodiesterase 4 as a Pharmacological Target for Hedgehog Signaling Inhibition</span></div><div class="casAuthors">Williams, Charles H.; Hempel, Jonathan E.; Hao, Jijun; Frist, Audrey Y.; Williams, Michelle M.; Fleming, Jonathan T.; Sulikowski, Gary A.; Cooper, Michael K.; Chiang, Chin; Hong, Charles C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hedgehog (Hh) signaling plays an integral role in vertebrate development, and its dysregulation has been accepted widely as a driver of numerous malignancies.  While a variety of small mols. target Smoothened (Smo) as a strategy for Hh inhibition, Smo gain-of-function mutations have limited their clin. implementation.  Modulation of targets downstream of Smo could define a paradigm for treatment of Hh-dependent cancers.  Here, we describe eggmanone, a small mol. identified from a chem. genetic zebrafish screen, which induced an Hh-null phenotype.  Eggmanone exerts its Hh-inhibitory effects through selective antagonism of phosphodiesterase 4 (PDE4), leading to protein kinase A activation and subsequent Hh blockade.  Our study implicates PDE4 as a target for Hh inhibition, suggests an improved strategy for Hh-dependent cancer therapy, and identifies a unique probe of downstream-of-Smo Hh modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohObViSNfnH7Vg90H21EOLACvtfcHk0ljSPZ67K1yYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOis7g%253D&md5=54fdb4541c7911021467cea8d00cbd64</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DC.%2BH.%26aulast%3DHempel%26aufirst%3DJ.%2BE.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DFrist%26aufirst%3DA.%2BY.%26aulast%3DWilliams%26aufirst%3DM.%2BM.%26aulast%3DFleming%26aufirst%3DJ.%2BT.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DChiang%26aufirst%3DC.%26aulast%3DHong%26aufirst%3DC.%2BC.%26atitle%3DAn%2520in%2520vivo%2520chemical%2520genetic%2520screen%2520identifies%2520phosphodiesterase%25204%2520as%2520a%2520pharmacological%2520target%2520for%2520hedgehog%2520signaling%2520inhibition%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D11%26spage%3D43%26epage%3D50%26doi%3D10.1016%2Fj.celrep.2015.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Non-canonical activation of gli transcription factors: Implications for targeted anti-cancer therapy</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2458</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.4161/cc.6.20.4808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.4161%2Fcc.6.20.4808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17726373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVahtr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=2458-2463&author=M.+Lauthauthor=R.+Toftgard&title=Non-canonical+activation+of+gli+transcription+factors%3A+Implications+for+targeted+anti-cancer+therapy&doi=10.4161%2Fcc.6.20.4808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical activation of GLI transcription factors: Implications for targeted anti-cancer therapy</span></div><div class="casAuthors">Lauth, Matthias; Toftgaard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2458-2463</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  GLI transcription factors constitute the final effectors of the Hedgehog (HH) signaling pathway.  In many tumors, such as those of the pancreas, prostate, skin or lung, ectopic activation of GLI proteins has been linked to tumorigenesis.  In several of these cases, HH ligand- or receptor-induced signaling (canonical HH signaling) was found to be the cause underlying GLI activation.  Recent evidence points towards addnl., non-canonical, mechanisms of GLI activation.  Here we review findings on the crosstalk of two HH-unrelated signaling pathways (RAS and Transforming growth factor β) to the HH pathway downstream of the signaling component Smoothened.  Both pathways stimulate and/or induce GLI1 and GLI2 activity independent of the presence of HH ligands.  We also discuss the putative roles of these crosstalk mechanisms for tumor cell metastasis.  The emerging picture of GLI transcription factors as an integrative platform of numerous signaling inputs has important implications for the understanding of tumor development and argues for inclusion of targets acting downstream of the receptor level in the design of current drug development programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot0x1m1SK_irVg90H21EOLACvtfcHk0ljSPZ67K1yYZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVahtr7J&md5=fa6f9f21f43ef6e463981ce0d87b7488</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4161%2Fcc.6.20.4808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.6.20.4808%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DNon-canonical%2520activation%2520of%2520gli%2520transcription%2520factors%253A%2520Implications%2520for%2520targeted%2520anti-cancer%2520therapy%26jtitle%3DCell%2520Cycle%26date%3D2007%26volume%3D6%26spage%3D2458%26epage%3D2463%26doi%3D10.4161%2Fcc.6.20.4808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, D.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signalling: Emerging evidence for non-canonical pathways</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2009.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cellsig.2009.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19399989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFelu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=1023-1034&author=D.+Jenkins&title=Hedgehog+signalling%3A+Emerging+evidence+for+non-canonical+pathways&doi=10.1016%2Fj.cellsig.2009.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signalling: Emerging evidence for non-canonical pathways</span></div><div class="casAuthors">Jenkins, Dagan</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1023-1034</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hedgehog (HH) signalling is involved in the development of numerous embryonic tissues.  In humans, germline mutations in hedgehog pathway components cause congenital malformations and somatic mutations are assocd. with cancers.  The basic framework of the HH pathway was elucidated in the fruit fly, Drosophila melanogaster, and this pathway is largely conserved in vertebrates, although some important differences have been noted.  The current paradigm of the 'canonical' pathway views HH signalling as a series of repressive interactions which culminates in GLI-mediated transcriptional regulation of a variety of cellular processes.  Definitions of 'non-canonical' signalling stem from examples where the response to HH morphogen deviates from this paradigm and, according to current reports, three general scenarios of non-canonical HH signalling can be defined: (1) Signalling that involves HH pathway components but which is independent of GLI-mediated transcription; (2) Direct interaction of HH signalling components with components of other mol. pathways; and (3) 'Non-contiguous' or 'atypical' interaction of core HH pathway components with one another.  Currently, the evidence supporting non-canonical HH signalling is not conclusive.  However, Sonic hedgehog (SHH) has been shown to regulate cell migration and axon guidance in several contexts, and some of these processes are independent of downstream components of the HH pathway, and presumably the transcriptional response to morphogen.  Furthermore, biochem. studies have shown that the HH receptor, PTCH1, can directly interact both with Cyclin B1 and caspases, to inhibit cell proliferation and to promote apoptosis, resp., and that these functions are inhibited in the presence of morphogen.  Genetic anal. of orthologues of the HH pathway in nematode worms further supports the notion that PTCH1-related mols. can function independently of other components of the canonical HH pathway, and the phenotypes of mice with point mutations in the Ptch1 gene offer clues as to the processes that non-canonical HH signalling might regulate.  While none of these evidences are conclusive, collectively they point to the existence of added complexity in the HH pathway in the form of non-canonical pathways.  A major difficulty in studying this problem is that canonical and non-canonical pathways are likely to act in parallel, and so in many situations it will not be possible to implicate non-canonical responses in certain cellular processes simply by excluding a role for the canonical pathway-directed analyses of non-canonical HH signalling are therefore necessary.  The aim of this review is to present the cumulative evidence supporting non-canonical HH signalling, with the hope of promoting further enquiry into this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWDRKosNHurVg90H21EOLACvtfcHk0lgOlr5c0LC9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFelu7g%253D&md5=9e81fa8b39143ccef27f6e5204be82c2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2009.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2009.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DJenkins%26aufirst%3DD.%26atitle%3DHedgehog%2520signalling%253A%2520Emerging%2520evidence%2520for%2520non-canonical%2520pathways%26jtitle%3DCell.%2520Signalling%26date%3D2009%26volume%3D21%26spage%3D1023%26epage%3D1034%26doi%3D10.1016%2Fj.cellsig.2009.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bijlsma, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damhofer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelink, H.</span></span> <span> </span><span class="NLM_article-title">Hedgehog-stimulated chemotaxis is mediated by smoothened located outside the primary cilium</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">ra60</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2002798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscisignal.2002798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22912493" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=ra60&author=M.+F.+Bijlsmaauthor=H.+Damhoferauthor=H.+Roelink&title=Hedgehog-stimulated+chemotaxis+is+mediated+by+smoothened+located+outside+the+primary+cilium&doi=10.1126%2Fscisignal.2002798"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002798%26sid%3Dliteratum%253Aachs%26aulast%3DBijlsma%26aufirst%3DM.%2BF.%26aulast%3DDamhofer%26aufirst%3DH.%26aulast%3DRoelink%26aufirst%3DH.%26atitle%3DHedgehog-stimulated%2520chemotaxis%2520is%2520mediated%2520by%2520smoothened%2520located%2520outside%2520the%2520primary%2520cilium%26jtitle%3DSci.%2520Signaling%26date%3D2012%26volume%3D5%26spage%3Dra60%26doi%3D10.1126%2Fscisignal.2002798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinchilla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazanietz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.4161/cc.9.3.10591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.4161%2Fcc.9.3.10591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20081366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1Cgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=570-579&author=P.+Chinchillaauthor=L.+Xiaoauthor=M.+G.+Kazanietzauthor=N.+A.+Riobo&title=Hedgehog+proteins+activate+pro-angiogenic+responses+in+endothelial+cells+through+non-canonical+signaling+pathways&doi=10.4161%2Fcc.9.3.10591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways</span></div><div class="casAuthors">Chinchilla, Pilar; Xiao, Liqing; Kazanietz, Marcelo G.; Riobo, Natalia A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">570-579</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway orchestrates developmental and homeostatic angiogenesis.  The three Hh isoforms-Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh)-signal through Patched-1 (PTCH1) and Smoothened (SMO), to activate the Gli transcription factors with a characteristic rank of potency (Shh >> Ihh > Dhh).  To dissect the mechanisms through which Hh proteins promote angiogenesis, we analyzed processes inherent to vessel formation in endothelial cells.  We found that none of the Hh ligands were able to induce Gli-target genes in human umbilical vein (HUVEC) or human cardiac microvascular endothelial cells (HMVEC), suggesting that endothelial cells do not respond to Hh through the canonical pathway.  However, our results show that the three Hh proteins promote endothelial cell tubulogenesis in 3D cultures in a SMO- and Gi protein-dependent manner.  Consistent with the required cytoskeletal rearrangement for tubulogenesis, Shh, Ihh and Dhh all stimulated the small GTPase RhoA and the formation of actin stress fibers.  This effect, which was mediated by SMO, Gi proteins and Rac1, defines a new non-canonical Hh pathway.  In addn. to regulating the actin cytoskeleton, the Hh ligands promoted survival through inhibition of the pro-apoptotic effect of PTCH1 in a SMO-independent manner.  Altogether, our results support the existence of Gli-independent Hh responses in endothelial cells that regulate tubulogenesis and apoptosis.  The identification of novel non-canonical responses elicited by Hh proteins in endothelial cells highlights the complexity of the Hh signaling pathway and reveals striking differences in ligand strength for transcriptional and non-transcriptional responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR_GJfExrnl7Vg90H21EOLACvtfcHk0lgOlr5c0LC9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1Cgs7g%253D&md5=2c6761de5117c5313355a029634143fd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4161%2Fcc.9.3.10591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.9.3.10591%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DP.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DKazanietz%26aufirst%3DM.%2BG.%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26atitle%3DHedgehog%2520proteins%2520activate%2520pro-angiogenic%2520responses%2520in%2520endothelial%2520cells%2520through%2520non-canonical%2520signaling%2520pathways%26jtitle%3DCell%2520Cycle%26date%3D2010%26volume%3D9%26spage%3D570%26epage%3D579%26doi%3D10.4161%2Fcc.9.3.10591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yam, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, F.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog guides axons through a noncanonical, src-family-kinase-dependent signaling pathway</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2009.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.neuron.2009.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19447091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2009&pages=349-362&author=P.+T.+Yamauthor=S.+D.+Langloisauthor=S.+Morinauthor=F.+Charron&title=Sonic+hedgehog+guides+axons+through+a+noncanonical%2C+src-family-kinase-dependent+signaling+pathway&doi=10.1016%2Fj.neuron.2009.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sonic hedgehog guides axons through a noncanonical, Src-family-kinase-dependent signaling pathway</span></div><div class="casAuthors">Yam, Patricia T.; Langlois, Sebastien D.; Morin, Steves; Charron, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-362</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Sonic hedgehog (Shh) plays essential roles in developmental events such as cell fate specification and axon guidance.  Shh induces cell fate specification through canonical Shh signaling, mediated by transcription.  However, the mechanism by which Shh guides axons is unknown.  To study this, we developed an in vitro assay for axon guidance, in which neurons can be imaged while responding to a defined gradient of a chem. cue.  Axons of dissocd. commissural neurons placed in a Shh gradient turned rapidly toward increasing concns. of Shh.  Consistent with this rapid response, we showed that attraction by Shh does not require transcription.  Instead, Shh stimulates the activity of Src family kinase (SFK) members in a Smoothened-dependent manner.  Moreover, SFK activity is required for Shh-mediated guidance of commissural axons, but not for induction of Gli transcriptional reporter activity.  Together, these results indicate that Shh acts via a rapidly acting, noncanonical signaling pathway to guide axons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxhsXx7pQxQbVg90H21EOLACvtfcHk0lgOlr5c0LC9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWjtL4%253D&md5=9c19e9dcff31e1a5cef0cd2c7baedeca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2009.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2009.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DYam%26aufirst%3DP.%2BT.%26aulast%3DLanglois%26aufirst%3DS.%2BD.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DCharron%26aufirst%3DF.%26atitle%3DSonic%2520hedgehog%2520guides%2520axons%2520through%2520a%2520noncanonical%252C%2520src-family-kinase-dependent%2520signaling%2520pathway%26jtitle%3DNeuron%26date%3D2009%26volume%3D62%26spage%3D349%26epage%3D362%26doi%3D10.1016%2Fj.neuron.2009.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
la Roche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angus, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earnshaw, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, G. M.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signaling controls t cell killing at the immunological synapse</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1126/science.1244689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.1244689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24311692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1247-1250&author=M.+de%0Ala+Rocheauthor=A.+T.+Ritterauthor=K.+L.+Angusauthor=C.+Dinsmoreauthor=C.+H.+Earnshawauthor=J.+F.+Reiterauthor=G.+M.+Griffiths&title=Hedgehog+signaling+controls+t+cell+killing+at+the+immunological+synapse&doi=10.1126%2Fscience.1244689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signaling controls T cell killing at the immunological synapse</span></div><div class="casAuthors">De la Roche, Maike; Ritter, Alex T.; Angus, Karen L.; Dinsmore, Colin; Earnshaw, Charles H.; Reiter, Jeremy F.; Griffiths, Gillian M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6163</span>),
    <span class="NLM_cas:pages">1247-1250</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The centrosome is essential for cytotoxic T lymphocyte (CTL) function, contacting the plasma membrane and directing cytotoxic granules for secretion at the immunol. synapse.  Centrosome docking at the plasma membrane also occurs during cilia formation.  The primary cilium, formed in nonhematopoietic cells, is essential for vertebrate Hedgehog (Hh) signaling.  Lymphocytes do not form primary cilia, but we found and describe here that Hh signaling played an important role in CTL killing.  T cell receptor activation, which "prearms" CTLs with cytotoxic granules, also initiated Hh signaling.  Hh pathway activation occurred intracellularly and triggered Rac1 synthesis.  These events "prearmed" CTLs for action by promoting the actin remodeling required for centrosome polarization and granule release.  Thus, Hh signaling plays a role in CTL function, and the immunol. synapse may represent a modified cilium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3-gydGTacyrVg90H21EOLACvtfcHk0liY3UiMvxuisw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhtLjI&md5=769f3e31cacdae3f0375196f86b983f6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1244689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1244689%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BRoche%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DA.%2BT.%26aulast%3DAngus%26aufirst%3DK.%2BL.%26aulast%3DDinsmore%26aufirst%3DC.%26aulast%3DEarnshaw%26aufirst%3DC.%2BH.%26aulast%3DReiter%26aufirst%3DJ.%2BF.%26aulast%3DGriffiths%26aufirst%3DG.%2BM.%26atitle%3DHedgehog%2520signaling%2520controls%2520t%2520cell%2520killing%2520at%2520the%2520immunological%2520synapse%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1247%26epage%3D1250%26doi%3D10.1126%2Fscience.1244689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dennler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexaki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnaldo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ten Dijke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrecchia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauviel, A.</span></span> <span> </span><span class="NLM_article-title">Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of gli2 and gli1 expression in vitro and in vivo</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6981</span>– <span class="NLM_lpage">6986</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-0491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-07-0491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17638910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6981-6986&author=S.+Dennlerauthor=J.+Andreauthor=I.+Alexakiauthor=A.+Liauthor=T.+Magnaldoauthor=P.+ten+Dijkeauthor=X.+J.+Wangauthor=F.+Verrecchiaauthor=A.+Mauviel&title=Induction+of+sonic+hedgehog+mediators+by+transforming+growth+factor-beta%3A+Smad3-dependent+activation+of+gli2+and+gli1+expression+in+vitro+and+in+vivo&doi=10.1158%2F0008-5472.CAN-07-0491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of Sonic Hedgehog Mediators by Transforming Growth Factor-β: Smad3-Dependent Activation of Gli2 and Gli1 Expression In vitro and In vivo</span></div><div class="casAuthors">Dennler, Sylviane; Andre, Jocelyne; Alexaki, Ismini; Li, Allen; Magnaldo, Thierry; ten Dijke, Peter; Wang, Xiao-Jing; Verrecchia, Franck; Mauviel, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6981-6986</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hedgehog (Hh) and transforming growth factor-β (TGF-β) family members are involved in numerous overlapping processes during embryonic development, hair cycle, and cancer.  Herein, we show that TGF-β induces the expression of the Hh signaling mols. Gli1 and Gli2 in various human cell types, including normal fibroblasts and keratinocytes, as well as various cancer cell lines.  Gli2 induction by TGF-β is rapid, independent from Hh receptor signaling, and requires a functional Smad pathway.  Gli1 expression is subsequently activated in a Gli2-dependent manner.  In transgenic mice overexpressing TGF-β1 in the skin, Gli1 and Gli2 expression is also elevated and depends on Smad3.  In pancreatic adenocarcinoma cell lines resistant to Hh inhibition, pharmacol. blockade of TGF-β signaling leads to repression of cell proliferation accompanied with a redn. in Gli2 expression.  We thus identify TGF-β as a potent transcriptional inducer of Gli transcription factors.  Targeting the cooperation of Hh and TGF-β signaling may provide new therapeutic opportunities for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt2lbvXxU-zLVg90H21EOLACvtfcHk0liY3UiMvxuisw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOit7c%253D&md5=99c473dff43c00b5ef20d6937fa69cf6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0491%26sid%3Dliteratum%253Aachs%26aulast%3DDennler%26aufirst%3DS.%26aulast%3DAndre%26aufirst%3DJ.%26aulast%3DAlexaki%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DMagnaldo%26aufirst%3DT.%26aulast%3Dten%2BDijke%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DVerrecchia%26aufirst%3DF.%26aulast%3DMauviel%26aufirst%3DA.%26atitle%3DInduction%2520of%2520sonic%2520hedgehog%2520mediators%2520by%2520transforming%2520growth%2520factor-beta%253A%2520Smad3-dependent%2520activation%2520of%2520gli2%2520and%2520gli1%2520expression%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6981%26epage%3D6986%26doi%3D10.1158%2F0008-5472.CAN-07-0491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teperino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loipetzberger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kammerer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgaard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaraj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee-Young, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Febbraio, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pospisilik, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esterbauer, H.</span></span> <span> </span><span class="NLM_article-title">Hedgehog partial agonism drives warburg-like metabolism in muscle and brown fat</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2012.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23063129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2qurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2012&pages=414-426&author=R.+Teperinoauthor=S.+Amannauthor=M.+Bayerauthor=S.+L.+McGeeauthor=A.+Loipetzbergerauthor=T.+Connorauthor=C.+Jaegerauthor=B.+Kammererauthor=L.+Winterauthor=G.+Wicheauthor=K.+Dalgaardauthor=M.+Selvarajauthor=M.+Gasterauthor=R.+S.+Lee-Youngauthor=M.+A.+Febbraioauthor=C.+Knaufauthor=P.+D.+Caniauthor=F.+Abergerauthor=J.+M.+Penningerauthor=J.+A.+Pospisilikauthor=H.+Esterbauer&title=Hedgehog+partial+agonism+drives+warburg-like+metabolism+in+muscle+and+brown+fat&doi=10.1016%2Fj.cell.2012.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat</span></div><div class="casAuthors">Teperino, Raffaele; Amann, Sabine; Bayer, Martina; McGee, Sean L.; Loipetzberger, Andrea; Connor, Timothy; Jaeger, Carsten; Kammerer, Bernd; Winter, Lilli; Wiche, Gerhard; Dalgaard, Kevin; Selvaraj, Madhan; Gaster, Michael; Lee-Young, Robert S.; Febbraio, Mark A.; Knauf, Claude; Cani, Patrice D.; Aberger, Fritz; Penninger, Josef M.; Pospisilik, J. Andrew; Esterbauer, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">414-426</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diabetes, obesity, and cancer affect upward of 15% of the world's population.  Interestingly, all three diseases juxtapose dysregulated intracellular signaling with altered metabolic state.  Exactly which genetic factors define stable metabolic set points in vivo remains poorly understood.  Here, we show that hedgehog signaling rewires cellular metab.  We identify a cilium-dependent Smo-Ca2+-Ampk axis that triggers rapid Warburg-like metabolic reprogramming within minutes of activation and is required for proper metabolic selectivity and flexibility.  We show that Smo modulators can uncouple the Smo-Ampk axis from canonical signaling and identify cyclopamine as one of a new class of "selective partial agonists," capable of concomitant inhibition of canonical and activation of noncanonical hedgehog signaling.  Intriguingly, activation of the Smo-Ampk axis in vivo drives robust insulin-independent glucose uptake in muscle and brown adipose tissue.  These data identify multiple noncanonical endpoints that are pivotal for rational design of hedgehog modulators and provide a new therapeutic avenue for obesity and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzbRse8OoQE7Vg90H21EOLACvtfcHk0liY3UiMvxuisw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2qurbE&md5=e37290b31326d087be98372541060d40</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DTeperino%26aufirst%3DR.%26aulast%3DAmann%26aufirst%3DS.%26aulast%3DBayer%26aufirst%3DM.%26aulast%3DMcGee%26aufirst%3DS.%2BL.%26aulast%3DLoipetzberger%26aufirst%3DA.%26aulast%3DConnor%26aufirst%3DT.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DKammerer%26aufirst%3DB.%26aulast%3DWinter%26aufirst%3DL.%26aulast%3DWiche%26aufirst%3DG.%26aulast%3DDalgaard%26aufirst%3DK.%26aulast%3DSelvaraj%26aufirst%3DM.%26aulast%3DGaster%26aufirst%3DM.%26aulast%3DLee-Young%26aufirst%3DR.%2BS.%26aulast%3DFebbraio%26aufirst%3DM.%2BA.%26aulast%3DKnauf%26aufirst%3DC.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DAberger%26aufirst%3DF.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DPospisilik%26aufirst%3DJ.%2BA.%26aulast%3DEsterbauer%26aufirst%3DH.%26atitle%3DHedgehog%2520partial%2520agonism%2520drives%2520warburg-like%2520metabolism%2520in%2520muscle%2520and%2520brown%2520fat%26jtitle%3DCell%26date%3D2012%26volume%3D151%26spage%3D414%26epage%3D426%26doi%3D10.1016%2Fj.cell.2012.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almada, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Zapico, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, D. R.</span></span> <span> </span><span class="NLM_article-title">The alpha subunit of the g protein g13 regulates activity of one or more gli transcription factors independently of smoothened</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">30714</span>– <span class="NLM_lpage">30722</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.219279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1074%2Fjbc.M111.219279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21757753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOktL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=30714-30722&author=A.+E.+Douglasauthor=J.+A.+Heimauthor=F.+Shenauthor=L.+L.+Almadaauthor=N.+A.+Rioboauthor=M.+E.+Fernandez-Zapicoauthor=D.+R.+Manning&title=The+alpha+subunit+of+the+g+protein+g13+regulates+activity+of+one+or+more+gli+transcription+factors+independently+of+smoothened&doi=10.1074%2Fjbc.M111.219279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The α subunit of the G protein G13 regulates activity of one or more Gli transcription factors independently of smoothened</span></div><div class="casAuthors">Douglas, Andrew E.; Heim, Jennifer A.; Shen, Feng; Almada, Luciana L.; Riobo, Natalia A.; Fernandez-Zapico, Martin E.; Manning, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30714-30722, S30714/1-S30714/3</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Smoothened (Smo) is a seven-transmembrane (7-TM) receptor that is essential to most actions of the Hedgehog family of morphogens.  We found previously that Smo couples to members of the Gi family of heterotrimeric G proteins, which in some cases are integral although alone insufficient in the activation of Gli transcription factors through Hedgehog signaling.  In response to a report that the G12/13 family is relevant to Hedgehog signaling as well, we re-evaluated the coupling of Smo to one member of this family, G13, and investigated the capacity of this and other G proteins to activate one or more of forms of Gli.  We found no evidence that Smo couples directly to G13.  We found nonetheless that Gα13 and to some extent Gαq and Gα12 are able to effect activation of Gli(s).  This capacity is realized in some cells, e.g. C3H10T1/2, MC3T3, and pancreatic cancer cells, but not all cells.  The mechanism employed is distinct from that achieved through canonical Hedgehog signaling, as the activation does not involve autocrine signaling or in any other way require active Smo and does not necessarily involve enhanced transcription of Gli1.  The activation by Gα13 can be replicated through a Gq/G12/13-coupled receptor, CCKA, and is attenuated by inhibitors of p38 mitogen-activated protein kinase and Tec tyrosine kinases.  We posit that G proteins, and perhaps G13 in particular, provide access to Gli that is independent of Smo and that they thus establish a basis for control of at least some forms of Gli-mediated transcription apart from Hedgehogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6MYsbdhzO37Vg90H21EOLACvtfcHk0liGx4ZUjYzxPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOktL%252FJ&md5=6321aff87babb03854f252e1faeec15e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.219279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.219279%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DA.%2BE.%26aulast%3DHeim%26aufirst%3DJ.%2BA.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DAlmada%26aufirst%3DL.%2BL.%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DManning%26aufirst%3DD.%2BR.%26atitle%3DThe%2520alpha%2520subunit%2520of%2520the%2520g%2520protein%2520g13%2520regulates%2520activity%2520of%2520one%2520or%2520more%2520gli%2520transcription%2520factors%2520independently%2520of%2520smoothened%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D30714%26epage%3D30722%26doi%3D10.1074%2Fjbc.M111.219279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saucy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilizio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, D. R.</span></span> <span> </span><span class="NLM_article-title">Activation of heterotrimeric g proteins by smoothened</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">12607</span>– <span class="NLM_lpage">12612</span>, <span class="refDoi"> DOI: 10.1073/pnas.0600880103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0600880103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16885213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD28XoslSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=12607-12612&author=N.+A.+Rioboauthor=B.+Saucyauthor=C.+Dilizioauthor=D.+R.+Manning&title=Activation+of+heterotrimeric+g+proteins+by+smoothened&doi=10.1073%2Fpnas.0600880103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of heterotrimeric G proteins by Smoothened</span></div><div class="casAuthors">Riobo, Natalia A.; Saucy, Berangere; DiLizio, Cherisse; Manning, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12607-12612</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mechanisms by which the activation of Smoothened (Smo), a protein essential to the actions of the Hedgehog family of secreted proteins, is translated into signals that converge on the Gli transcription factors are not fully understood.  The seven-transmembrane structure of SMO has long implied the utilization of heterotrimeric GTP-binding regulatory proteins (G proteins); however, evidence in this regard has been indirect and contradictory.  In the current study we evaluated the capacity of mammalian Smo to couple to G proteins directly.  We found that Smo, by virtue of what appears to be constitutive activity, activates all members of the Gi family but does not activate members of the Gs, Gq, and G12 families.  The activation is suppressed by cyclopamine and other inhibitors of Hedgehog (Hh) signaling and is enhanced by the Smo agonist purmorphamine.  Activation of Gi by Smo is essential in the activation of Gli in fibroblasts, because disruption of coupling to Gi with pertussis toxin inhibits the activation of Gli by Sonic hedgehog and a constitutively active form of Smo (SmoM2).  However, Gi does not provide a sufficient signal because a truncated form of Smo, although capable of activating Gi, does not effect activation of Gli.  Rescue of pertussis toxin-inhibited activation of Gli by Sonic hedgehog can be achieved with a constitutively active Gαi-subunit.  The data suggest that Smo is in fact the source of two signals relevant to the activation of Gli: one involving Gi and the other involving events at Smo's C-tail independent of Gi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSUAJeGdwtrrVg90H21EOLACvtfcHk0liGx4ZUjYzxPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XoslSnsrY%253D&md5=63b4035a1249181b2ab089237df284d0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600880103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600880103%26sid%3Dliteratum%253Aachs%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26aulast%3DSaucy%26aufirst%3DB.%26aulast%3DDilizio%26aufirst%3DC.%26aulast%3DManning%26aufirst%3DD.%2BR.%26atitle%3DActivation%2520of%2520heterotrimeric%2520g%2520proteins%2520by%2520smoothened%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D12607%26epage%3D12612%26doi%3D10.1073%2Fpnas.0600880103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polizio, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinchilla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N. A.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog activates the gtpases rac1 and rhoa in a gli-independent manner through coupling of smoothened to gi proteins</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">pt7</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2002396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscisignal.2002396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22114142" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=pt7&author=A.+H.+Polizioauthor=P.+Chinchillaauthor=X.+Chenauthor=D.+R.+Manningauthor=N.+A.+Riobo&title=Sonic+hedgehog+activates+the+gtpases+rac1+and+rhoa+in+a+gli-independent+manner+through+coupling+of+smoothened+to+gi+proteins&doi=10.1126%2Fscisignal.2002396"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002396%26sid%3Dliteratum%253Aachs%26aulast%3DPolizio%26aufirst%3DA.%2BH.%26aulast%3DChinchilla%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DManning%26aufirst%3DD.%2BR.%26aulast%3DRiobo%26aufirst%3DN.%2BA.%26atitle%3DSonic%2520hedgehog%2520activates%2520the%2520gtpases%2520rac1%2520and%2520rhoa%2520in%2520a%2520gli-independent%2520manner%2520through%2520coupling%2520of%2520smoothened%2520to%2520gi%2520proteins%26jtitle%3DSci.%2520Signaling%26date%3D2011%26volume%3D4%26spage%3Dpt7%26doi%3D10.1126%2Fscisignal.2002396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teperino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esterbauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riobo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pospisilik, J. A.</span></span> <span> </span><span class="NLM_article-title">Canonical and non-canonical hedgehog signalling and the control of metabolism</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2014.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.semcdb.2014.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24862854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSrurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=81-92&author=R.+Teperinoauthor=F.+Abergerauthor=H.+Esterbauerauthor=N.+Rioboauthor=J.+A.+Pospisilik&title=Canonical+and+non-canonical+hedgehog+signalling+and+the+control+of+metabolism&doi=10.1016%2Fj.semcdb.2014.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Canonical and non-canonical Hedgehog signalling and the control of metabolism</span></div><div class="casAuthors">Teperino, Raffaele; Aberger, Fritz; Esterbauer, Harald; Riobo, Natalia; Pospisilik, John Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Obesity and diabetes represent key healthcare challenges of our day, affecting upwards of one billion people worldwide.  These individuals are at higher risk for cancer, stroke, blindness, heart and cardiovascular disease, and to date, have no effective long-term treatment options available.  Recent and accumulating evidence has implicated the developmental morphogen Hedgehog and its downstream signalling in metabolic control.  Generally thought to be quiescent in adults, Hedgehog is assocd. with several human cancers, and as such, has already emerged as a therapeutic target in oncol.  Here, we attempt to give a comprehensive overview of the key signalling events assocd. with both canonical and non-canonical Hedgehog signalling, and highlight the increasingly complex regulatory modalities that appear to link Hedgehog and control metab.  We highlight these key findings and discuss their impact for therapeutic development, cancer and metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLpgXFCdjDgrVg90H21EOLACvtfcHk0lj3ddk52ylPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSrurbI&md5=29c8fbfb6780e73da155f4fb8800a5c9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2014.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2014.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DTeperino%26aufirst%3DR.%26aulast%3DAberger%26aufirst%3DF.%26aulast%3DEsterbauer%26aufirst%3DH.%26aulast%3DRiobo%26aufirst%3DN.%26aulast%3DPospisilik%26aufirst%3DJ.%2BA.%26atitle%3DCanonical%2520and%2520non-canonical%2520hedgehog%2520signalling%2520and%2520the%2520control%2520of%2520metabolism%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2014%26volume%3D33%26spage%3D81%26epage%3D92%26doi%3D10.1016%2Fj.semcdb.2014.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fombonne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guix, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corset, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span> <span> </span><span class="NLM_article-title">The patched dependence receptor triggers apoptosis through a dral-caspase-9 complex</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1038/ncb1880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncb1880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19465923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1als70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=739-746&author=F.+Milleauthor=C.+Thibertauthor=J.+Fombonneauthor=N.+Ramaauthor=C.+Guixauthor=H.+Hayashiauthor=V.+Corsetauthor=J.+C.+Reedauthor=P.+Mehlen&title=The+patched+dependence+receptor+triggers+apoptosis+through+a+dral-caspase-9+complex&doi=10.1038%2Fncb1880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex</span></div><div class="casAuthors">Mille, Frederic; Thibert, Chantal; Fombonne, Joanna; Rama, Nicolas; Guix, Catherine; Hayashi, Hideki; Corset, Veronique; Reed, John C.; Mehlen, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">739-746</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sonic hedgehog (Shh) and its main receptor, Patched (Ptc), are implicated in both neural development and tumorigenesis.  Besides its classic morphogenic activity, Shh is also a survival factor.  Along this line, Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh.  Here we show that, in the absence of its ligand, Ptc interacts with the adaptor protein DRAL (downregulated in rhabdomyosarcoma LIM-domain protein; also known as FHL2).  DRAL is required for the pro-apoptotic activity of Ptc both in immortalized cells and during neural tube development in chick embryos.  We demonstrate that, in the absence of Shh, Ptc recruits a protein complex that includes DRAL, one of the caspase recruitment (CARD)-domain contg. proteins TUCAN (family member, 8) or NALP1 (NLR family, pyrin domain contg. 1) and apical caspase-9.  Ptc triggers caspase-9 activation and enhances cell death through a caspase-9-dependent mechanism.  Thus, we propose that in the absence of its ligand Shh the dependence receptor Ptc serves as the anchor for a caspase-activating complex that includes DRAL, and caspase-9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT8nEmIBVT_7Vg90H21EOLACvtfcHk0lj3ddk52ylPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1als70%253D&md5=31135731b7f12a87c47d3525ce0e828a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncb1880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1880%26sid%3Dliteratum%253Aachs%26aulast%3DMille%26aufirst%3DF.%26aulast%3DThibert%26aufirst%3DC.%26aulast%3DFombonne%26aufirst%3DJ.%26aulast%3DRama%26aufirst%3DN.%26aulast%3DGuix%26aufirst%3DC.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DCorset%26aufirst%3DV.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DMehlen%26aufirst%3DP.%26atitle%3DThe%2520patched%2520dependence%2520receptor%2520triggers%2520apoptosis%2520through%2520a%2520dral-caspase-9%2520complex%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2009%26volume%3D11%26spage%3D739%26epage%3D746%26doi%3D10.1038%2Fncb1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thibert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teillet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazelin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Douarin, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehlen, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>301</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1126/science.1085405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.1085405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12907805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=843-846&author=C.+Thibertauthor=M.+A.+Teilletauthor=F.+Lapointeauthor=L.+Mazelinauthor=N.+M.+Le+Douarinauthor=P.+Mehlen&title=Inhibition+of+neuroepithelial+patched-induced+apoptosis+by+sonic+hedgehog&doi=10.1126%2Fscience.1085405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of neuroepithelial Patched-induced apoptosis by Sonic hedgehog</span></div><div class="casAuthors">Thibert, Chantal; Teillet, Marie-Aimee; Lapointe, Francoise; Mazelin, Laetitia; Le Douarin, Nicole M.; Mehlen, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">5634</span>),
    <span class="NLM_cas:pages">843-846</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">During early development in vertebrates, Sonic hedgehog (Shh) is produced by the notochord and the floor plate.  A ventrodorsal gradient of Shh directs ventrodorsal patterning of the neural tube.  However, Shh is also required for the survival of neuroepithelial cells.  We show that Patched (Ptc) induces apoptotic cell death unless its ligand Shh is present to block the signal.  Moreover, the blockade of Ptc-induced cell death partly rescues the chick spinal cord defect provoked by Shh deprivation.  Thus, the proapoptotic activity of unbound Ptc and the pos. effect of Shh-bound Ptc on cell differentiation probably cooperate to achieve the appropriate spinal cord development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcQYG2X3MPV7Vg90H21EOLACvtfcHk0lj3ddk52ylPYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVGqsL4%253D&md5=0d87a08ac670f8e912fa0ad46374ff20</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1085405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1085405%26sid%3Dliteratum%253Aachs%26aulast%3DThibert%26aufirst%3DC.%26aulast%3DTeillet%26aufirst%3DM.%2BA.%26aulast%3DLapointe%26aufirst%3DF.%26aulast%3DMazelin%26aufirst%3DL.%26aulast%3DLe%2BDouarin%26aufirst%3DN.%2BM.%26aulast%3DMehlen%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520neuroepithelial%2520patched-induced%2520apoptosis%2520by%2520sonic%2520hedgehog%26jtitle%3DScience%26date%3D2003%26volume%3D301%26spage%3D843%26epage%3D846%26doi%3D10.1126%2Fscience.1085405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buonamici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrissey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ospina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fordjour, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monahan, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maira, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Echeverria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span> <span> </span><span class="NLM_article-title">Interfering with resistance to smoothened antagonists by inhibition of the pi3k pathway in medulloblastoma</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">51ra70</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscitranslmed.3001599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20881279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmtFensQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=51ra70&author=S.+Buonamiciauthor=J.+Williamsauthor=M.+Morrisseyauthor=A.+Wangauthor=R.+Guoauthor=A.+Vattayauthor=K.+Hsiaoauthor=J.+Yuanauthor=J.+Greenauthor=B.+Ospinaauthor=Q.+Yuauthor=L.+Ostromauthor=P.+Fordjourauthor=D.+L.+Andersonauthor=J.+E.+Monahanauthor=J.+F.+Kelleherauthor=S.+Peukertauthor=S.+Panauthor=X.+Wuauthor=S.+M.+Mairaauthor=C.+Garcia-Echeverriaauthor=K.+J.+Briggsauthor=D.+N.+Watkinsauthor=Y.+M.+Yaoauthor=C.+Lengauerauthor=M.+Warmuthauthor=W.+R.+Sellersauthor=M.+Dorsch&title=Interfering+with+resistance+to+smoothened+antagonists+by+inhibition+of+the+pi3k+pathway+in+medulloblastoma&doi=10.1126%2Fscitranslmed.3001599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma</span></div><div class="casAuthors">Buonamici Silvia; Williams Juliet; Morrissey Michael; Wang Anlai; Guo Ribo; Vattay Anthony; Hsiao Kathy; Yuan Jing; Green John; Ospina Beatriz; Yu Qunyan; Ostrom Lance; Fordjour Paul; Anderson Dustin L; Monahan John E; Kelleher Joseph F; Peukert Stefan; Pan Shifeng; Wu Xu; Maira Sauveur-Michel; Garcia-Echeverria Carlos; Briggs Kimberly J; Watkins D Neil; Yao Yung-mae; Lengauer Christoph; Warmuth Markus; Sellers William R; Dorsch Marion</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">51ra70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The malignant brain cancer medulloblastoma is characterized by mutations in Hedgehog (Hh) signaling pathway genes, which lead to constitutive activation of the G protein (heterotrimeric guanosine triphosphate-binding protein)-coupled receptor Smoothened (Smo).  The Smo antagonist NVP-LDE225 inhibits Hh signaling and induces tumor regression in animal models of medulloblastoma.  However, evidence of resistance was observed during the course of treatment.  Molecular analysis of resistant tumors revealed several resistance mechanisms.  We noted chromosomal amplification of Gli2, a downstream effector of Hh signaling, and, more rarely, point mutations in Smo that led to reactivated Hh signaling and restored tumor growth.  Analysis of pathway gene expression signatures also, unexpectedly, identified up-regulation of phosphatidylinositol 3-kinase (PI3K) signaling in resistant tumors as another potential mechanism of resistance.  Probing the relevance of increased PI3K signaling, we demonstrated that addition of the PI3K inhibitor NVP-BKM120 or the dual PI3K-mTOR (mammalian target of rapamycin) inhibitor NVP-BEZ235 to the initial treatment with the Smo antagonist markedly delayed the development of resistance.  Our findings may be useful in informing treatment strategies for medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFGV5VGgi31Q5nADWVYHg1fW6udTcc2eaPOICB4zMWcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmtFensQ%253D%253D&md5=54560688e5f56b311350ed46837935de</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001599%26sid%3Dliteratum%253Aachs%26aulast%3DBuonamici%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DMorrissey%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DOspina%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DOstrom%26aufirst%3DL.%26aulast%3DFordjour%26aufirst%3DP.%26aulast%3DAnderson%26aufirst%3DD.%2BL.%26aulast%3DMonahan%26aufirst%3DJ.%2BE.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DMaira%26aufirst%3DS.%2BM.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DBriggs%26aufirst%3DK.%2BJ.%26aulast%3DWatkins%26aufirst%3DD.%2BN.%26aulast%3DYao%26aufirst%3DY.%2BM.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DInterfering%2520with%2520resistance%2520to%2520smoothened%2520antagonists%2520by%2520inhibition%2520of%2520the%2520pi3k%2520pathway%2520in%2520medulloblastoma%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D51ra70%26doi%3D10.1126%2Fscitranslmed.3001599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holcomb, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshagiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>326</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1126/science.1179386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.1179386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19726788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ymsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2009&pages=572-574&author=R.+L.+Yauchauthor=G.+J.+Dijkgraafauthor=B.+Alickeauthor=T.+Januarioauthor=C.+P.+Ahnauthor=T.+Holcombauthor=K.+Pujaraauthor=J.+Stinsonauthor=C.+A.+Callahanauthor=T.+Tangauthor=J.+F.+Bazanauthor=Z.+Kanauthor=S.+Seshagiriauthor=C.+L.+Hannauthor=S.+E.+Gouldauthor=J.+A.+Lowauthor=C.+M.+Rudinauthor=F.+J.+de+Sauvage&title=Smoothened+mutation+confers+resistance+to+a+hedgehog+pathway+inhibitor+in+medulloblastoma&doi=10.1126%2Fscience.1179386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma</span></div><div class="casAuthors">Yauch, Robert L.; Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Januario, Thomas; Ahn, Christina P.; Holcomb, Thomas; Pujara, Kanan; Stinson, Jeremy; Callahan, Christopher A.; Tang, Tracy; Bazan, J. Fernando; Kan, Zhengyan; Seshagiri, Somasekar; Hann, Christine L.; Gould, Stephen E.; Low, Jennifer A.; Rudin, Charles M.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">5952</span>),
    <span class="NLM_cas:pages">572-574</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) signaling pathway is inappropriately activated in certain human cancers, including medulloblastoma, an aggressive brain tumor.  GDC-0449, a drug that inhibits Hh signaling by targeting the serpentine receptor Smoothened (SMO), has produced promising anti-tumor responses in early clin. studies of cancers driven by mutations in this pathway.  To evaluate the mechanism of resistance in a medulloblastoma patient who had relapsed after an initial response to GDC-0449, we detd. the mutational status of Hh signaling genes in the tumor after disease progression.  We identified an amino acid substitution at a conserved aspartic acid residue of SMO that had no effect on Hh signaling but disrupted the ability of GDC-0449 to bind SMO and suppress this pathway.  A mutation altering the same amino acid also arose in a GDC-0449-resistant mouse model of medulloblastoma.  These findings show that acquired mutations in a serpentine receptor with features of a G protein-coupled receptor can serve as a mechanism of drug resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMTHlVjB62IbVg90H21EOLACvtfcHk0lhDZjq_CXM8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ymsrbM&md5=5e19833f47e248ad0a6d43bd4684bade</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.1179386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1179386%26sid%3Dliteratum%253Aachs%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DAhn%26aufirst%3DC.%2BP.%26aulast%3DHolcomb%26aufirst%3DT.%26aulast%3DPujara%26aufirst%3DK.%26aulast%3DStinson%26aufirst%3DJ.%26aulast%3DCallahan%26aufirst%3DC.%2BA.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DKan%26aufirst%3DZ.%26aulast%3DSeshagiri%26aufirst%3DS.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DSmoothened%2520mutation%2520confers%2520resistance%2520to%2520a%2520hedgehog%2520pathway%2520inhibitor%2520in%2520medulloblastoma%26jtitle%3DScience%26date%3D2009%26volume%3D326%26spage%3D572%26epage%3D574%26doi%3D10.1126%2Fscience.1179386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarin, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ally, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span> <span> </span><span class="NLM_article-title">Smoothened variants explain the majority of drug resistance in basal cell carcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">342</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccell.2015.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25759020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFOgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=342-353&author=S.+X.+Atwoodauthor=K.+Y.+Sarinauthor=R.+J.+Whitsonauthor=J.+R.+Liauthor=G.+Kimauthor=M.+Rezaeeauthor=M.+S.+Allyauthor=J.+Kimauthor=C.+Yaoauthor=A.+L.+Changauthor=A.+E.+Oroauthor=J.+Y.+Tang&title=Smoothened+variants+explain+the+majority+of+drug+resistance+in+basal+cell+carcinoma&doi=10.1016%2Fj.ccell.2015.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma</span></div><div class="casAuthors">Atwood, Scott X.; Sarin, Kavita Y.; Whitson, Ramon J.; Li, Jiang R.; Kim, Geurim; Rezaee, Melika; Ally, Mina S.; Kim, Jinah; Yao, Catherine; Chang, Anne Lynn S.; Oro, Anthony E.; Tang, Jean Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-353</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms.  Here we identify SMO mutations in 50% (22 of 44) of resistant BCCs and show that these mutations maintain Hedgehog signaling in the presence of SMO inhibitors.  Alterations include four ligand binding pocket mutations defining sites of inhibitor binding and four variants conferring constitutive activity and inhibitor resistance, illuminating pivotal residues that ensure receptor autoinhibition.  In the presence of a SMO inhibitor, tumor cells contg. either class of SMO mutants effectively outcompete cells contg. the wild-type SMO.  Finally, we show that both classes of SMO variants respond to aPKC-ι/λ or GLI2 inhibitors that operate downstream of SMO, setting the stage for the clin. use of GLI antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLWuAsc6vYLVg90H21EOLACvtfcHk0lhDZjq_CXM8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFOgt70%253D&md5=550299c250d49e0b1df749cbf279e017</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DSarin%26aufirst%3DK.%2BY.%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DG.%26aulast%3DRezaee%26aufirst%3DM.%26aulast%3DAlly%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DC.%26aulast%3DChang%26aufirst%3DA.%2BL.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26atitle%3DSmoothened%2520variants%2520explain%2520the%2520majority%2520of%2520drug%2520resistance%2520in%2520basal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26spage%3D342%26epage%3D353%26doi%3D10.1016%2Fj.ccell.2015.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloof, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffner, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveras, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandinova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">A small molecule that binds hedgehog and blocks its signaling in human cells</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1038/nchembio.142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19151731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFGrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=154-156&author=B.+Z.+Stantonauthor=L.+F.+Pengauthor=N.+Maloofauthor=K.+Nakaiauthor=X.+Wangauthor=J.+L.+Duffnerauthor=K.+M.+Taverasauthor=J.+M.+Hymanauthor=S.+W.+Leeauthor=A.+N.+Koehlerauthor=J.+K.+Chenauthor=J.+L.+Foxauthor=A.+Mandinovaauthor=S.+L.+Schreiber&title=A+small+molecule+that+binds+hedgehog+and+blocks+its+signaling+in+human+cells&doi=10.1038%2Fnchembio.142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule that binds Hedgehog and blocks its signaling in human cells</span></div><div class="casAuthors">Stanton, Benjamin Z.; Peng, Lee F.; Maloof, Nicole; Nakai, Kazuo; Wang, Xiang; Duffner, Jay L.; Taveras, Kennedy M.; Hyman, Joel M.; Lee, Sam W.; Koehler, Angela N.; Chen, James K.; Fox, Julia L.; Mandinova, Anna; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">154-156</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. inhibition of extracellular proteins that activate membrane receptors has proven to be extremely challenging.  Diversity-oriented synthesis and small-mol. microarrays enabled the discovery of robotnikinin, a small mol. that binds the extracellular Sonic hedgehog (Shh) protein and blocks Shh signaling in cell lines, human primary keratinocytes and a synthetic model of human skin.  Shh pathway activity is rescued by small-mol. agonists of Smoothened, which functions immediately downstream of the Shh receptor Patched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonRF64xivBNLVg90H21EOLACvtfcHk0lhABU_LYkvfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFGrtw%253D%253D&md5=a94abdb674167ae2bc3feb719b30a683</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.142%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DB.%2BZ.%26aulast%3DPeng%26aufirst%3DL.%2BF.%26aulast%3DMaloof%26aufirst%3DN.%26aulast%3DNakai%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDuffner%26aufirst%3DJ.%2BL.%26aulast%3DTaveras%26aufirst%3DK.%2BM.%26aulast%3DHyman%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DKoehler%26aufirst%3DA.%2BN.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26aulast%3DFox%26aufirst%3DJ.%2BL.%26aulast%3DMandinova%26aufirst%3DA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DA%2520small%2520molecule%2520that%2520binds%2520hedgehog%2520and%2520blocks%2520its%2520signaling%2520in%2520human%2520cells%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D154%26epage%3D156%26doi%3D10.1038%2Fnchembio.142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodakh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konitsiotis, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterisation of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine inhibitors of hedgehog acyltransferase</span>. <i>Data Brief</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1016/j.dib.2016.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.dib.2016.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27077078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC28fpvFyitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=257-281&author=T.+Lanyon-Hoggauthor=N.+Masumotoauthor=G.+Bodakhauthor=A.+D.+Konitsiotisauthor=E.+Thinonauthor=U.+R.+Rodgersauthor=R.+J.+Owensauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Synthesis+and+characterisation+of+5-acyl-6%2C7-dihydrothieno%5B3%2C2-c%5Dpyridine+inhibitors+of+hedgehog+acyltransferase&doi=10.1016%2Fj.dib.2016.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterisation of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine inhibitors of Hedgehog acyltransferase</span></div><div class="casAuthors">Lanyon-Hogg Thomas; Masumoto Naoko; Bodakh George; Thinon Emmanuelle; Tate Edward W; Konitsiotis Antonio D; Rodgers Ursula R; Magee Anthony I; Owens Raymond J</div><div class="citationInfo"><span class="NLM_cas:title">Data in brief</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-81</span>
        ISSN:<span class="NLM_cas:issn">2352-3409</span>.
    </div><div class="casAbstract">In this data article we describe synthetic and characterisation data for four members of the 5-acyl-6,7-dihydrothieno[3,2-c]pyridine (termed "RU-SKI") class of inhibitors of Hedgehog acyltransferase, including associated NMR spectra for final compounds.  RU-SKI compounds were selected for synthesis based on their published high potencies against the enzyme target.  RU-SKI 41 (9a), RU-SKI 43 (9b), RU-SKI 101 (9c), and RU-SKI 201 (9d) were profiled for activity in the related article "Click chemistry armed enzyme linked immunosorbent assay to measure palmitoylation by Hedgehog acyltransferase" (Lanyon-Hogg et al., 2015) [1]. (1)H NMR spectral data indicate different amide conformational ratios between the RU-SKI inhibitors, as has been observed in other 5-acyl-6,7-dihydrothieno[3,2-c]pyridines.  The synthetic and characterisation data supplied in the current article provide validated access to the class of RU-SKI inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdUsQUE1cAM-xsqfvU0ziafW6udTcc2eagAJC--OMy97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fpvFyitw%253D%253D&md5=2bf25f879ec935325c29c250ea256102</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.dib.2016.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dib.2016.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DBodakh%26aufirst%3DG.%26aulast%3DKonitsiotis%26aufirst%3DA.%2BD.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DRodgers%26aufirst%3DU.%2BR.%26aulast%3DOwens%26aufirst%3DR.%2BJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520and%2520characterisation%2520of%25205-acyl-6%252C7-dihydrothieno%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520hedgehog%2520acyltransferase%26jtitle%3DData%2520Brief%26date%3D2016%26volume%3D7%26spage%3D257%26epage%3D281%26doi%3D10.1016%2Fj.dib.2016.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodakh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konitsiotis, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Click chemistry armed enzyme-linked immunosorbent assay to measure palmitoylation by hedgehog acyltransferase</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2015.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ab.2015.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26334609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFeit77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2015&pages=66-72&author=T.+Lanyon-Hoggauthor=N.+Masumotoauthor=G.+Bodakhauthor=A.+D.+Konitsiotisauthor=E.+Thinonauthor=U.+R.+Rodgersauthor=R.+J.+Owensauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Click+chemistry+armed+enzyme-linked+immunosorbent+assay+to+measure+palmitoylation+by+hedgehog+acyltransferase&doi=10.1016%2Fj.ab.2015.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry armed enzyme-linked immunosorbent assay to measure palmitoylation by hedgehog acyltransferase</span></div><div class="casAuthors">Lanyon-Hogg, Thomas; Masumoto, Naoko; Bodakh, George; Konitsiotis, Antonio D.; Thinon, Emmanuelle; Rodgers, Ursula R.; Owens, Raymond J.; Magee, Anthony I.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">66-72</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hedgehog signaling is crit. for correct embryogenesis and tissue development.  However, on maturation, signaling is also found to be aberrantly activated in many cancers.  Palmitoylation of the secreted signaling protein sonic hedgehog (Shh) by the enzyme hedgehog acyltransferase (Hhat) is required for functional signaling.  To quantify this important posttranslational modification, many in vitro Shh palmitoylation assays employ radiolabeled fatty acids, which have limitations in terms of cost and safety.  Here we present a click chem. armed ELISA (click-ELISA) for assessment of Hhat activity through acylation of biotinylated Shh peptide with an alkyne-tagged palmitoyl-CoA analog.  Click chem. functionalization of the alkyne tag with azido-FLAG peptide allows anal. through an ELISA protocol and colorimetric readout.  This assay format identified the detergent n-dodecyl β-D-maltopyranoside as an improved solubilizing agent for Hhat activity.  Quantification of the potency of RU-SKI small mol. Hhat inhibitors by click-ELISA indicated IC50 values in the low- or sub-micromolar range.  A stopped assay format was also employed that allows measurement of Hhat kinetic parameters where satg. substrate concns. exceed the binding capacity of the streptavidin-coated plate.  Therefore, click-ELISA represents a nonradioactive method for assessing protein palmitoylation in vitro that is readily expandable to other classes of protein lipidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3LQxDvK4jGLVg90H21EOLACvtfcHk0lhABU_LYkvfXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFeit77E&md5=d52dcffd605d5b7010c24013c01df184</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2015.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2015.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DBodakh%26aufirst%3DG.%26aulast%3DKonitsiotis%26aufirst%3DA.%2BD.%26aulast%3DThinon%26aufirst%3DE.%26aulast%3DRodgers%26aufirst%3DU.%2BR.%26aulast%3DOwens%26aufirst%3DR.%2BJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DClick%2520chemistry%2520armed%2520enzyme-linked%2520immunosorbent%2520assay%2520to%2520measure%2520palmitoylation%2520by%2520hedgehog%2520acyltransferase%26jtitle%3DAnal.%2520Biochem.%26date%3D2015%26volume%3D490%26spage%3D66%26epage%3D72%26doi%3D10.1016%2Fj.ab.2015.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rzepa, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Modulation of amide bond rotamers in 5-acyl-6,7-dihydrothieno[3,2-c]pyridines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">4370</span>– <span class="NLM_lpage">4377</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.5b00205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b00205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtlSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=4370-4377&author=T.+Lanyon-Hoggauthor=M.+Ritzefeldauthor=N.+Masumotoauthor=A.+I.+Mageeauthor=H.+S.+Rzepaauthor=E.+W.+Tate&title=Modulation+of+amide+bond+rotamers+in+5-acyl-6%2C7-dihydrothieno%5B3%2C2-c%5Dpyridines&doi=10.1021%2Facs.joc.5b00205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Amide Bond Rotamers in 5-Acyl-6,7-dihydrothieno[3,2-c]pyridines</span></div><div class="casAuthors">Lanyon-Hogg, Thomas; Ritzefeld, Markus; Masumoto, Naoko; Magee, Anthony I.; Rzepa, Henry S.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4370-4377</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Substituted N-acyl-piperidine is a widespread and important structural motif, found in approx. 500 currently available structures, and present in nearly 30 pharmaceutically active compds.  Restricted rotation of the acyl substituent in such mols. can give rise to two distinct chem. environments.  Here we demonstrate, using NMR studies and d. functional theory modeling of the lowest energy structures of 5-acyl-6,7-dihydrothieno[3,2-c]pyridine derivs., that the amide E:Z equil. is affected by non-covalent interactions between the amide oxygen and adjacent arom. protons.  Structural predictions were used to design mols. that promote either the E- or Z-amide conformation, enabling prepn. of compds. with a tailored conformational ratio, as proven by NMR studies.  Anal. of the available X-ray data of a variety of published N-acyl-piperidine-contg. compds. further indicates that these mols. are also clustered in the two obsd. conformations.  This finding emphasizes that directed conformational isomerism has significant implications for the design of both small mols. and larger amide-contg. mol. architectures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnBdTZoqyDS7Vg90H21EOLACvtfcHk0li3Y38Zf2Yk2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtlSms7Y%253D&md5=595a2080f90ebc8ed201d5e0b5d3e6a5</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b00205%26sid%3Dliteratum%253Aachs%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DRzepa%26aufirst%3DH.%2BS.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DModulation%2520of%2520amide%2520bond%2520rotamers%2520in%25205-acyl-6%252C7-dihydrothieno%255B3%252C2-c%255Dpyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26spage%3D4370%26epage%3D4377%26doi%3D10.1021%2Facs.joc.5b00205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matevossian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resh, M. D.</span></span> <span> </span><span class="NLM_article-title">Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1038/onc.2013.575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fonc.2013.575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24469057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1yks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=263-268&author=E.+Petrovaauthor=A.+Matevossianauthor=M.+D.+Resh&title=Hedgehog+acyltransferase+as+a+target+in+pancreatic+ductal+adenocarcinoma&doi=10.1038%2Fonc.2013.575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma</span></div><div class="casAuthors">Petrova, E.; Matevossian, A.; Resh, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-268</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sonic Hedgehog (Shh) is abnormally expressed in pancreatic cancer and is assocd. with disease onset and progression.  Inhibition of Shh signaling is thus an attractive clin. target for therapeutic intervention.  Most efforts to block Shh signaling have focused on inhibitors of Smoothened, which target the canonical Shh signaling pathway.  These approaches have met with limited success, in part due to development of resistance-conferring mutations and contributions from non-canonical signaling pathways.  Here, we show that Hedgehog acyltransferase (Hhat), the enzyme responsible for the attachment of palmitate onto Shh, is a novel target for inhibition of Shh signaling in pancreatic cancer cells.  Depletion of Hhat with lentivirally delivered small hairpin RNA decreased both anchorage-dependent and independent proliferation of human pancreatic cancer cells.  In vivo, Hhat knockdown led to redn. of tumor growth in a mouse xenograft model of pancreatic cancer.  RU-SKI 43, a small mol. inhibitor of Hhat recently developed by our group, reduced pancreatic cancer cell proliferation and Gli-1 activation through Smoothened-independent non-canonical signaling.  In addn., RU-SKI 43 treatment inhibited two key proliferative pathways regulated by Akt and mTOR.  This work demonstrates that Hhat has a crit. role in pancreatic cancer and that a small mol. inhibitor of Hhat can successfully block pancreatic cancer cell proliferation.  It also highlights the importance of developing optimized Hhat inhibitors to be used as therapeutics in pancreatic cancer, as well as in other malignancies characterized by Shh overexpression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6IOPXTpklJbVg90H21EOLACvtfcHk0li3Y38Zf2Yk2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1yks7c%253D&md5=b54973ce86f9e5aa5f59f0b01955e056</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.575%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DE.%26aulast%3DMatevossian%26aufirst%3DA.%26aulast%3DResh%26aufirst%3DM.%2BD.%26atitle%3DHedgehog%2520acyltransferase%2520as%2520a%2520target%2520in%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D263%26epage%3D268%26doi%3D10.1038%2Fonc.2013.575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rios-Esteves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouerfelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resh, M. D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of hedgehog acyltransferase block sonic hedgehog signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23416332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=247-249&author=E.+Petrovaauthor=J.+Rios-Estevesauthor=O.+Ouerfelliauthor=J.+F.+Glickmanauthor=M.+D.+Resh&title=Inhibitors+of+hedgehog+acyltransferase+block+sonic+hedgehog+signaling&doi=10.1038%2Fnchembio.1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling</span></div><div class="casAuthors">Petrova, Elissaveta; Rios-Esteves, Jessica; Ouerfelli, Ouathek; Glickman, J. Fraser; Resh, Marilyn D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-249</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of Sonic hedgehog (Shh) signaling is of great clin. interest.  Here we exploit Hedgehog acyltransferase (Hhat)-mediated Shh palmitoylation, a modification crit. for Shh signaling, as a new target for Shh pathway inhibition.  A target-oriented high-throughput screen was used to identify small-mol. inhibitors of Hhat.  In cells, these Hhat inhibitors specifically block Shh palmitoylation and inhibit autocrine and paracrine Shh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF48ZjslUQFbVg90H21EOLACvtfcHk0li3Y38Zf2Yk2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1ahtLw%253D&md5=38dd997bbbf7f29d6d38e727d48fa797</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1184%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DE.%26aulast%3DRios-Esteves%26aufirst%3DJ.%26aulast%3DOuerfelli%26aufirst%3DO.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DResh%26aufirst%3DM.%2BD.%26atitle%3DInhibitors%2520of%2520hedgehog%2520acyltransferase%2520block%2520sonic%2520hedgehog%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D247%26epage%3D249%26doi%3D10.1038%2Fnchembio.1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanyon-Hogg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzefeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magee, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span> <span> </span><span class="NLM_article-title">Characterization of hedgehog acyltransferase inhibitors identifies a small molecule probe for hedgehog signaling by cancer cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3256</span>– <span class="NLM_lpage">3262</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00896</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWhurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3256-3262&author=U.+R.+Rodgersauthor=T.+Lanyon-Hoggauthor=N.+Masumotoauthor=M.+Ritzefeldauthor=R.+Burkeauthor=J.+Blaggauthor=A.+I.+Mageeauthor=E.+W.+Tate&title=Characterization+of+hedgehog+acyltransferase+inhibitors+identifies+a+small+molecule+probe+for+hedgehog+signaling+by+cancer+cells&doi=10.1021%2Facschembio.6b00896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Hedgehog Acyltransferase Inhibitors Identifies a Small Molecule Probe for Hedgehog Signaling by Cancer Cells</span></div><div class="casAuthors">Rodgers, Ursula R.; Lanyon-Hogg, Thomas; Masumoto, Naoko; Ritzefeld, Markus; Burke, Rosemary; Blagg, Julian; Magee, Anthony I.; Tate, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3256-3262</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Sonic Hedgehog (Shh) signaling pathway plays a crit. role during embryonic development and cancer progression.  N-terminal palmitoylation of Shh by Hedgehog acyltransferase (Hhat) is essential for efficient signaling, raising interest in Hhat as a novel drug target.  A recently identified series of dihydrothienopyridines has been proposed to function via this mode of action; however, the lead compd. in this series (RUSKI-43) was subsequently shown to possess cytotoxic activity unrelated to canonical Shh signaling.  To identify a selective chem. probe for cellular studies, we profiled three RUSKI compds. in orthogonal cell-based assays.  We found that RUSKI-43 exhibits off-target cytotoxicity, masking its effect on Hhat-dependent signaling, hence results obtained with this compd. in cells should be treated with caution.  In contrast, RUSKI-201 showed no off-target cytotoxicity, and quant. whole-proteome palmitoylation profiling with a bioorthogonal alkyne-palmitate reporter demonstrated specific inhibition of Hhat in cells.  RUSKI-201 is the first selective Hhat chem. probe in cells and should be used in future studies of Hhat catalytic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3CiPlcZE8rVg90H21EOLACvtfcHk0lhlxkYe8Iz9vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWhurnK&md5=aa2a9668bf0f3cc06751ac39f34e061f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00896%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DU.%2BR.%26aulast%3DLanyon-Hogg%26aufirst%3DT.%26aulast%3DMasumoto%26aufirst%3DN.%26aulast%3DRitzefeld%26aufirst%3DM.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DMagee%26aufirst%3DA.%2BI.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DCharacterization%2520of%2520hedgehog%2520acyltransferase%2520inhibitors%2520identifies%2520a%2520small%2520molecule%2520probe%2520for%2520hedgehog%2520signaling%2520by%2520cancer%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D3256%26epage%3D3262%26doi%3D10.1021%2Facschembio.6b00896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokhunts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giambelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang Fei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galimberti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejarano, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glassberg, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockwood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmitrovsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">The hedgehog processing pathway is required for nsclc growth and survival</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2335</span>– <span class="NLM_lpage">2345</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fonc.2012.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22733134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVKlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2335-2345&author=J.+Rodriguez-Blancoauthor=N.+S.+Schillingauthor=R.+Tokhuntsauthor=C.+Giambelliauthor=J.+Longauthor=D.+Liang+Feiauthor=S.+Singhauthor=K.+E.+Blackauthor=Z.+Wangauthor=F.+Galimbertiauthor=P.+A.+Bejaranoauthor=S.+Elliotauthor=M.+K.+Glassbergauthor=D.+M.+Nguyenauthor=W.+W.+Lockwoodauthor=W.+L.+Lamauthor=E.+Dmitrovskyauthor=A.+J.+Capobiancoauthor=D.+J.+Robbins&title=The+hedgehog+processing+pathway+is+required+for+nsclc+growth+and+survival&doi=10.1038%2Fonc.2012.243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The hedgehog processing pathway is required for NSCLC growth and survival</span></div><div class="casAuthors">Rodriguez-Blanco, J.; Schilling, N. S.; Tokhunts, R.; Giambelli, C.; Long, J.; Fei, D. Liang; Singh, S.; Black, K. E.; Wang, Z.; Galimberti, F.; Bejarano, P. A.; Elliot, S.; Glassberg, M. K.; Nguyen, D. M.; Lockwood, W. W.; Lam, W. L.; Dmitrovsky, E.; Capobianco, A. J.; Robbins, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2335-2345</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Considerable interest has been generated from the results of recent clin. trials using smoothened (SMO) antagonists to inhibit the growth of hedgehog (HH) signaling-dependent tumors.  This interest is tempered by the discovery of SMO mutations mediating resistance, underscoring the rationale for developing therapeutic strategies that interrupt HH signaling at levels distinct from those inhibiting SMO function.  Here, we demonstrate that HH-dependent non-small cell lung carcinoma (NSCLC) growth is sensitive to blockade of the HH pathway upstream of SMO, at the level of HH ligand processing.  Individually, the use of different lentivirally delivered shRNA constructs targeting two functionally distinct HH-processing proteins, skinny hedgehog (SKN) or dispatched-1 (DISP-1), in NSCLC cell lines produced similar decreases in cell proliferation and increased cell death.  Further, providing either an exogenous source of processed HH or a SMO agonist reverses these effects.  The attenuation of HH processing, by knocking down either of these gene products, also abrogated tumor growth in mouse xenografts.  Finally, we extended these findings to primary clin. specimens, showing that SKN is frequently overexpressed in NSCLC and that higher DISP-1 expression is assocd. with an unfavorable clin. outcome.  Our results show a crit. role for HH processing in HH-dependent tumors, identifies two potential druggable targets in the HH pathway, and suggest that similar therapeutic strategies could be explored to treat patients harboring HH ligand-dependent cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyuEIV9duCo7Vg90H21EOLACvtfcHk0lhlxkYe8Iz9vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVKlsbw%253D&md5=deee60126b2bb9266b44fba6b7f55a48</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.243%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DSchilling%26aufirst%3DN.%2BS.%26aulast%3DTokhunts%26aufirst%3DR.%26aulast%3DGiambelli%26aufirst%3DC.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DLiang%2BFei%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGalimberti%26aufirst%3DF.%26aulast%3DBejarano%26aufirst%3DP.%2BA.%26aulast%3DElliot%26aufirst%3DS.%26aulast%3DGlassberg%26aufirst%3DM.%2BK.%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DLockwood%26aufirst%3DW.%2BW.%26aulast%3DLam%26aufirst%3DW.%2BL.%26aulast%3DDmitrovsky%26aufirst%3DE.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520hedgehog%2520processing%2520pathway%2520is%2520required%2520for%2520nsclc%2520growth%2520and%2520survival%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D2335%26epage%3D2345%26doi%3D10.1038%2Fonc.2012.243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicking, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaphiropoulos, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gailani, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidambaram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vorechovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unden, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pressman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenevix-Trench, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bale, A. E.</span></span> <span> </span><span class="NLM_article-title">Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">841</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81268-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2FS0092-8674%2800%2981268-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=8681379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK28XjslSku74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=841-851&author=H.+Hahnauthor=C.+Wickingauthor=P.+G.+Zaphiropoulosauthor=M.+R.+Gailaniauthor=S.+Shanleyauthor=A.+Chidambaramauthor=I.+Vorechovskyauthor=E.+Holmbergauthor=A.+B.+Undenauthor=S.+Gilliesauthor=K.+Negusauthor=I.+Smythauthor=C.+Pressmanauthor=D.+J.+Leffellauthor=B.+Gerrardauthor=A.+M.+Goldsteinauthor=M.+Deanauthor=R.+Toftgardauthor=G.+Chenevix-Trenchauthor=B.+Wainwrightauthor=A.+E.+Bale&title=Mutations+of+the+human+homolog+of+drosophila+patched+in+the+nevoid+basal+cell+carcinoma+syndrome&doi=10.1016%2FS0092-8674%2800%2981268-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome</span></div><div class="casAuthors">Hahn, Heidi; Wicking, Carol; Zaphiropoulos, Peter G.; Gailani, Mae R.; Shanley, Susan; Chidambaram, Abirami; Vorechovsky, Igor; Holmberg, Erika; Unden, Anne Birgitte; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">841-851</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by multiple basal cell carcinomas (BCCs), pits of the palms and soles, jaw keratocysts, a variety of other tumors, and developmental abnormalities.  NBCCS maps to chromosome 9q22.3.  Familial and sporadic BCCs display loss of heterozygosity in this region, consistent with the gene being a tumor suppressor.  A human sequence (PTC) with strong homol. to the Drosophila segment polarity gene, patched, was isolated from a YAC and cosmid contig of the NBCCS region.  Mutation anal. revealed alterations of PTC in NBCCS patients and in related tumors.  The authors propose that a redn. in expression of the patched gene can lead to the developmental abnormalities obsd. in the syndrome and that complete loss of patched function contributes to transformation of certain cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJn67md4sIDbVg90H21EOLACvtfcHk0lhlxkYe8Iz9vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjslSku74%253D&md5=5e27d796adffc4374b08347bb972c083</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981268-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981268-4%26sid%3Dliteratum%253Aachs%26aulast%3DHahn%26aufirst%3DH.%26aulast%3DWicking%26aufirst%3DC.%26aulast%3DZaphiropoulos%26aufirst%3DP.%2BG.%26aulast%3DGailani%26aufirst%3DM.%2BR.%26aulast%3DShanley%26aufirst%3DS.%26aulast%3DChidambaram%26aufirst%3DA.%26aulast%3DVorechovsky%26aufirst%3DI.%26aulast%3DHolmberg%26aufirst%3DE.%26aulast%3DUnden%26aufirst%3DA.%2BB.%26aulast%3DGillies%26aufirst%3DS.%26aulast%3DNegus%26aufirst%3DK.%26aulast%3DSmyth%26aufirst%3DI.%26aulast%3DPressman%26aufirst%3DC.%26aulast%3DLeffell%26aufirst%3DD.%2BJ.%26aulast%3DGerrard%26aufirst%3DB.%26aulast%3DGoldstein%26aufirst%3DA.%2BM.%26aulast%3DDean%26aufirst%3DM.%26aulast%3DToftgard%26aufirst%3DR.%26aulast%3DChenevix-Trench%26aufirst%3DG.%26aulast%3DWainwright%26aufirst%3DB.%26aulast%3DBale%26aufirst%3DA.%2BE.%26atitle%3DMutations%2520of%2520the%2520human%2520homolog%2520of%2520drosophila%2520patched%2520in%2520the%2520nevoid%2520basal%2520cell%2520carcinoma%2520syndrome%26jtitle%3DCell%26date%3D1996%26volume%3D85%26spage%3D841%26epage%3D851%26doi%3D10.1016%2FS0092-8674%2800%2981268-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrich, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bare, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. P.</span></span> <span> </span><span class="NLM_article-title">Human homolog of patched, a candidate gene for the basal cell nevus syndrome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1671</span>, <span class="refDoi"> DOI: 10.1126/science.272.5268.1668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.272.5268.1668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=8658145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1eju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1996&pages=1668-1671&author=R.+L.+Johnsonauthor=A.+L.+Rothmanauthor=J.+Xieauthor=L.+V.+Goodrichauthor=J.+W.+Bareauthor=J.+M.+Bonifasauthor=A.+G.+Quinnauthor=R.+M.+Myersauthor=D.+R.+Coxauthor=E.+H.+Epsteinauthor=M.+P.+Scott&title=Human+homolog+of+patched%2C+a+candidate+gene+for+the+basal+cell+nevus+syndrome&doi=10.1126%2Fscience.272.5268.1668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Human homolog of patched, a candidate gene for the basal cell nevus syndrome</span></div><div class="casAuthors">Johnson, Ronald L.; Rothman, Alana L.; Xie, Jingwu; Goodrich, Lisa V.; Bare, John W.; Bonifas, Jeannette M.; Quinn, Anthony G.; Myers, Richard M.; Cox, David R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5268</span>),
    <span class="NLM_cas:pages">1668-1671</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The basal cell nevus syndrome (BCNS) is characterized by developmental abnormalities and by the postnatal occurrence of cancers, esp. basal cell carcinomas (BCCs), the most common human cancer.  Heritable mutations in BCNS patients and a somatic mutation in a sporadic BCC were identified in a human homolog of the Drosophila patched (ptc) gene.  The ptc gene encodes a transmembrane protein that in Drosophila acts in opposition to the Hedgehog signaling protein, controlling cell fates, patterning, and growth in numerous tissues.  The human PTC gene appears to be crucial for proper embryonic development and for tumor suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-dJmVRHdewbVg90H21EOLACvtfcHk0ljI5MquficqJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1eju78%253D&md5=818093d8a7cf966e1c8e98810b47628f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.272.5268.1668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.272.5268.1668%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DRothman%26aufirst%3DA.%2BL.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGoodrich%26aufirst%3DL.%2BV.%26aulast%3DBare%26aufirst%3DJ.%2BW.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DQuinn%26aufirst%3DA.%2BG.%26aulast%3DMyers%26aufirst%3DR.%2BM.%26aulast%3DCox%26aufirst%3DD.%2BR.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DScott%26aufirst%3DM.%2BP.%26atitle%3DHuman%2520homolog%2520of%2520patched%252C%2520a%2520candidate%2520gene%2520for%2520the%2520basal%2520cell%2520nevus%2520syndrome%26jtitle%3DScience%26date%3D1996%26volume%3D272%26spage%3D1668%26epage%3D1671%26doi%3D10.1126%2Fscience.272.5268.1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weeraratne, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeranz
Krummel, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auclair, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochicchio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cibulskis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlich, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greulich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennon, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russ, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shefler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivachenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogoloff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teider, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northcott, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kautzman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. J.</span></span> <span> </span><span class="NLM_article-title">Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1038/nature11329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature11329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22820256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=106-110&author=T.+J.+Pughauthor=S.+D.+Weeraratneauthor=T.+C.+Archerauthor=D.+A.+Pomeranz%0AKrummelauthor=D.+Auclairauthor=J.+Bochicchioauthor=M.+O.+Carneiroauthor=S.+L.+Carterauthor=K.+Cibulskisauthor=R.+L.+Erlichauthor=H.+Greulichauthor=M.+S.+Lawrenceauthor=N.+J.+Lennonauthor=A.+McKennaauthor=J.+Meldrimauthor=A.+H.+Ramosauthor=M.+G.+Rossauthor=C.+Russauthor=E.+Sheflerauthor=A.+Sivachenkoauthor=B.+Sogoloffauthor=P.+Stojanovauthor=P.+Tamayoauthor=J.+P.+Mesirovauthor=V.+Amaniauthor=N.+Teiderauthor=S.+Senguptaauthor=J.+P.+Francoisauthor=P.+A.+Northcottauthor=M.+D.+Taylorauthor=F.+Yuauthor=G.+R.+Crabtreeauthor=A.+G.+Kautzmanauthor=S.+B.+Gabrielauthor=G.+Getzauthor=N.+Jagerauthor=D.+T.+Jonesauthor=P.+Lichterauthor=S.+M.+Pfisterauthor=T.+M.+Robertsauthor=M.+Meyersonauthor=S.+L.+Pomeroyauthor=Y.+J.+Cho&title=Medulloblastoma+exome+sequencing+uncovers+subtype-specific+somatic+mutations&doi=10.1038%2Fnature11329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations</span></div><div class="casAuthors">Pugh, Trevor J.; Weeraratne, Shyamal Dilhan; Archer, Tenley C.; Pomeranz Krummel, Daniel A.; Auclair, Daniel; Bochicchio, James; Carneiro, Mauricio O.; Carter, Scott L.; Cibulskis, Kristian; Erlich, Rachel L.; Greulich, Heidi; Lawrence, Michael S.; Lennon, Niall J.; McKenna, Aaron; Meldrim, James; Ramos, Alex H.; Ross, Michael G.; Russ, Carsten; Shefler, Erica; Sivachenko, Andrey; Sogoloff, Brian; Stojanov, Petar; Tamayo, Pablo; Mesirov, Jill P.; Amani, Vladimir; Teider, Natalia; Sengupta, Soma; Francois, Jessica Pierre; Northcott, Paul A.; Taylor, Michael D.; Yu, Furong; Crabtree, Gerald R.; Kautzman, Amanda G.; Gabriel, Stacey B.; Getz, Gad; Jaeger, Natalie; Jones, David T. W.; Lichter, Peter; Pfister, Stefan M.; Roberts, Thomas M.; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">106-110</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Medulloblastomas are the most common malignant brain tumors in children.  Identifying and understanding the genetic events that drive these tumors is crit. for the development of more effective diagnostic, prognostic and therapeutic strategies.  Recently, our group and others described distinct mol. subtypes of medulloblastoma on the basis of transcriptional and copy no. profiles.  Here we use whole-exome hybrid capture and deep sequencing to identify somatic mutations across the coding regions of 92 primary medulloblastoma/normal pairs.  Overall, medulloblastomas have low mutation rates consistent with other pediatric tumors, with a median of 0.35 non-silent mutations per megabase.  We identified twelve genes mutated at statistically significant frequencies, including previously known mutated genes in medulloblastoma such as CTNNB1, PTCH1, MLL2, SMARCA4 and TP53.  Recurrent somatic mutations were newly identified in an RNA helicase gene, DDX3X, often concurrent with CTNNB1 mutations, and in the nuclear co-repressor (N-CoR) complex genes GPS2, BCOR and LDB1.  We show that mutant DDX3X potentiates transactivation of a TCF promoter and enhances cell viability in combination with mutant, but not wild-type, β-catenin.  Together, our study reveals the alteration of WNT, hedgehog, histone methyltransferase and now N-CoR pathways across medulloblastomas and within specific subtypes of this disease, and nominates the RNA helicase DDX3X as a component of pathogenic β-catenin signaling in medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocg21WjMOyX7Vg90H21EOLACvtfcHk0ljI5MquficqJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmsrvJ&md5=d5ed22d294da53187713b060ac587fe2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnature11329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11329%26sid%3Dliteratum%253Aachs%26aulast%3DPugh%26aufirst%3DT.%2BJ.%26aulast%3DWeeraratne%26aufirst%3DS.%2BD.%26aulast%3DArcher%26aufirst%3DT.%2BC.%26aulast%3DPomeranz%2BKrummel%26aufirst%3DD.%2BA.%26aulast%3DAuclair%26aufirst%3DD.%26aulast%3DBochicchio%26aufirst%3DJ.%26aulast%3DCarneiro%26aufirst%3DM.%2BO.%26aulast%3DCarter%26aufirst%3DS.%2BL.%26aulast%3DCibulskis%26aufirst%3DK.%26aulast%3DErlich%26aufirst%3DR.%2BL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DLennon%26aufirst%3DN.%2BJ.%26aulast%3DMcKenna%26aufirst%3DA.%26aulast%3DMeldrim%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DA.%2BH.%26aulast%3DRoss%26aufirst%3DM.%2BG.%26aulast%3DRuss%26aufirst%3DC.%26aulast%3DShefler%26aufirst%3DE.%26aulast%3DSivachenko%26aufirst%3DA.%26aulast%3DSogoloff%26aufirst%3DB.%26aulast%3DStojanov%26aufirst%3DP.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26aulast%3DAmani%26aufirst%3DV.%26aulast%3DTeider%26aufirst%3DN.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DFrancois%26aufirst%3DJ.%2BP.%26aulast%3DNorthcott%26aufirst%3DP.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BD.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DCrabtree%26aufirst%3DG.%2BR.%26aulast%3DKautzman%26aufirst%3DA.%2BG.%26aulast%3DGabriel%26aufirst%3DS.%2BB.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DJager%26aufirst%3DN.%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DLichter%26aufirst%3DP.%26aulast%3DPfister%26aufirst%3DS.%2BM.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26atitle%3DMedulloblastoma%2520exome%2520sequencing%2520uncovers%2520subtype-specific%2520somatic%2520mutations%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D106%26epage%3D110%26doi%3D10.1038%2Fnature11329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Z. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B. L.</span></span> <span> </span><span class="NLM_article-title">Cholesterol modification of smoothened is required for hedgehog signaling</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2017.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.molcel.2017.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28344083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFWqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=154-162&author=X.+Xiaoauthor=J.+J.+Tangauthor=C.+Pengauthor=Y.+Wangauthor=L.+Fuauthor=Z.+P.+Qiuauthor=Y.+Xiongauthor=L.+F.+Yangauthor=H.+W.+Cuiauthor=X.+L.+Heauthor=L.+Yinauthor=W.+Qiauthor=C.+C.+Wongauthor=Y.+Zhaoauthor=B.+L.+Liauthor=W.+W.+Qiuauthor=B.+L.+Song&title=Cholesterol+modification+of+smoothened+is+required+for+hedgehog+signaling&doi=10.1016%2Fj.molcel.2017.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling</span></div><div class="casAuthors">Xiao, Xu; Tang, Jing-Jie; Peng, Chao; Wang, Yan; Fu, Lin; Qiu, Zhi-Ping; Xiong, Yue; Yang, Lian-Fang; Cui, Hai-Wei; He, Xiao-Long; Yin, Lei; Qi, Wei; Wong, Catherine C. L.; Zhao, Yun; Li, Bo-Liang; Qiu, Wen-Wei; Song, Bao-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-162.e10</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hedgehog (Hh) has been known as the only cholesterol-modified morphogen playing pivotal roles in development and tumorigenesis.  A major unsolved question is how Hh signaling regulates the activity of Smoothened (SMO).  Here, we performed an unbiased biochem. screen and identified that SMO was covalently modified by cholesterol on the Asp95 (D95) residue through an ester bond.  This modification was inhibited by Patched-1 (Ptch1) but enhanced by Hh.  The SMO(D95N) mutation, which could not be cholesterol modified, was refractory to Hh-stimulated ciliary localization and failed to activate downstream signaling.  Furthermore, homozygous SmoD99N/D99N (the equiv. residue in mouse) knockin mice were embryonic lethal with severe cardiac defects, phenocopying the Smo-/- mice.  Together, the results of our study suggest that Hh signaling transduces to SMO through modulating its cholesterylation and provides a therapeutic opportunity to treat Hh-pathway-related cancers by targeting SMO cholesterylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0HDMdKzJbybVg90H21EOLACvtfcHk0lhNNeO5BA43LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFWqtb0%253D&md5=fb6d980d86b459c066a7e75e7e1da6e4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2017.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2017.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DJ.%2BJ.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DZ.%2BP.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%2BF.%26aulast%3DCui%26aufirst%3DH.%2BW.%26aulast%3DHe%26aufirst%3DX.%2BL.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DC.%2BC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%2BL.%26aulast%3DQiu%26aufirst%3DW.%2BW.%26aulast%3DSong%26aufirst%3DB.%2BL.%26atitle%3DCholesterol%2520modification%2520of%2520smoothened%2520is%2520required%2520for%2520hedgehog%2520signaling%26jtitle%3DMol.%2520Cell%26date%3D2017%26volume%3D66%26spage%3D154%26epage%3D162%26doi%3D10.1016%2Fj.molcel.2017.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span> <span> </span><span class="NLM_article-title">Cellular cholesterol directly activates smoothened in hedgehog signaling</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">1176</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2016.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27545348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlyjtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2016&pages=1176-1187&author=P.+Huangauthor=D.+Nedelcuauthor=M.+Watanabeauthor=C.+Jaoauthor=Y.+Kimauthor=J.+Liuauthor=A.+Salic&title=Cellular+cholesterol+directly+activates+smoothened+in+hedgehog+signaling&doi=10.1016%2Fj.cell.2016.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling</span></div><div class="casAuthors">Huang, Pengxiang; Nedelcu, Daniel; Watanabe, Miyako; Jao, Cindy; Kim, Youngchang; Liu, Jing; Salic, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1176-1187.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In vertebrates, sterols are necessary for Hedgehog signaling, a pathway crit. in embryogenesis and cancer.  Sterols activate the membrane protein Smoothened by binding its extracellular, cysteine-rich domain (CRD).  Major unanswered questions concern the nature of the endogenous, activating sterol and the mechanism by which it regulates Smoothened.  We report crystal structures of CRD complexed with sterols and alone, revealing that sterols induce a dramatic conformational change of the binding site, which is sufficient for Smoothened activation and is unique among CRD-contg. receptors.  We demonstrate that Hedgehog signaling requires sterol binding to Smoothened and define key residues for sterol recognition and activity.  We also show that cholesterol itself binds and activates Smoothened.  Furthermore, the effect of oxysterols is abolished in Smoothened mutants that retain activation by cholesterol and Hedgehog.  We propose that the endogenous Smoothened activator is cholesterol, not oxysterols, and that vertebrate Hedgehog signaling controls Smoothened by regulating its access to cholesterol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNyYx88XIFgrVg90H21EOLACvtfcHk0lhNNeO5BA43LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlyjtbzK&md5=ddcbbf7fc8ac442cbd3d43d6aa885217</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DNedelcu%26aufirst%3DD.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DJao%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSalic%26aufirst%3DA.%26atitle%3DCellular%2520cholesterol%2520directly%2520activates%2520smoothened%2520in%2520hedgehog%2520signaling%26jtitle%3DCell%26date%3D2016%26volume%3D166%26spage%3D1176%26epage%3D1187%26doi%3D10.1016%2Fj.cell.2016.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. P.</span></span> <span> </span><span class="NLM_article-title">Oxysterols stimulate sonic hedgehog signal transduction and proliferation of medulloblastoma cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8408</span>– <span class="NLM_lpage">8413</span>, <span class="refDoi"> DOI: 10.1073/pnas.0602852103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0602852103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=16707575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=8408-8413&author=R.+B.+Corcoranauthor=M.+P.+Scott&title=Oxysterols+stimulate+sonic+hedgehog+signal+transduction+and+proliferation+of+medulloblastoma+cells&doi=10.1073%2Fpnas.0602852103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterols stimulate sonic hedgehog signal transduction and proliferation of medulloblastoma cells</span></div><div class="casAuthors">Corcoran, Ryan B.; Scott, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8408-8413</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sterol synthesis is required for Sonic hedgehog (Shh) signal transduction.  Errors in Shh signal transduction play important roles in the formation of human tumors, including medulloblastoma (MB).  It is not clear which products of sterol synthesis are necessary for Shh signal transduction or how they act.  Here we show that cholesterol or specific oxysterols are the crit. products of sterol synthesis required for Shh pathway signal transduction in MB cells.  In MB cells, sterol synthesis inhibitors reduce Shh target gene transcription and block Shh pathway-dependent proliferation.  These effects of sterol synthesis inhibitors can be reversed by exogenous cholesterol or specific oxysterols.  We also show that certain oxysterols can maximally activate Shh target gene transcription through the Smoothened (Smo) protein as effectively as the known Smo full agonist, SAG.  Thus, sterols are required and sufficient for Shh pathway activation.  These results suggest that oxysterols may be crit. regulators of Smo, and thereby Shh signal transduction.  Inhibition of Shh signaling by sterol synthesis inhibitors may offer a novel approach to the treatment of MB and other Shh pathway-dependent human tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8vnFl_Fs9wrVg90H21EOLACvtfcHk0lhNNeO5BA43LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFCht7o%253D&md5=5cecabdc971028ebd3f5c450c1963a7a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0602852103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0602852103%26sid%3Dliteratum%253Aachs%26aulast%3DCorcoran%26aufirst%3DR.%2BB.%26aulast%3DScott%26aufirst%3DM.%2BP.%26atitle%3DOxysterols%2520stimulate%2520sonic%2520hedgehog%2520signal%2520transduction%2520and%2520proliferation%2520of%2520medulloblastoma%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D8408%26epage%3D8413%26doi%3D10.1073%2Fpnas.0602852103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nachtergaele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rammohan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlesinger, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohatgi, R.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are allosteric activators of the oncoprotein smoothened</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nchembio.765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22231273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsF2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=211-220&author=S.+Nachtergaeleauthor=L.+K.+Mydockauthor=K.+Krishnanauthor=J.+Rammohanauthor=P.+H.+Schlesingerauthor=D.+F.+Coveyauthor=R.+Rohatgi&title=Oxysterols+are+allosteric+activators+of+the+oncoprotein+smoothened&doi=10.1038%2Fnchembio.765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterols are allosteric activators of the oncoprotein Smoothened</span></div><div class="casAuthors">Nachtergaele, Sigrid; Mydock, Laurel K.; Krishnan, Kathiresan; Rammohan, Jayan; Schlesinger, Paul H.; Covey, Douglas F.; Rohatgi, Rajat</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-220</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oxysterols are a class of endogenous signaling mols. that can activate the Hedgehog pathway, which has crit. roles in development, regeneration and cancer.  However, it has been unclear how oxysterols influence Hedgehog signaling, including whether their effects are mediated through a protein target or indirectly through effects on membrane properties.  To answer this question, we synthesized the enantiomer and an epimer of the most potent oxysterol, 20(S)-hydroxycholesterol.  Using these mols., we show that the effects of oxysterols on Hedgehog signaling are exquisitely stereoselective, consistent with the hypothesis that they function through a specific protein target.  We present several lines of evidence that this protein target is the seven-pass transmembrane protein Smoothened (Smo), a major drug target in oncol.  Our work suggests that these enigmatic sterols, which have multiple effects on cell physiol., may act as ligands for signaling receptors and provides a generally applicable framework for probing sterol signaling mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8G-Fryjj6ebVg90H21EOLACvtfcHk0lgBTIZYH5gcuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsF2mtg%253D%253D&md5=c4aef9019e715a2df6c5ae6567007198</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.765%26sid%3Dliteratum%253Aachs%26aulast%3DNachtergaele%26aufirst%3DS.%26aulast%3DMydock%26aufirst%3DL.%2BK.%26aulast%3DKrishnan%26aufirst%3DK.%26aulast%3DRammohan%26aufirst%3DJ.%26aulast%3DSchlesinger%26aufirst%3DP.%2BH.%26aulast%3DCovey%26aufirst%3DD.%2BF.%26aulast%3DRohatgi%26aufirst%3DR.%26atitle%3DOxysterols%2520are%2520allosteric%2520activators%2520of%2520the%2520oncoprotein%2520smoothened%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D211%26epage%3D220%26doi%3D10.1038%2Fnchembio.765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myers, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sever, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belani, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rychnovsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2013.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.devcel.2013.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23954590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ylt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=346-357&author=B.+R.+Myersauthor=N.+Severauthor=Y.+C.+Chongauthor=J.+Kimauthor=J.+D.+Belaniauthor=S.+Rychnovskyauthor=J.+F.+Bazanauthor=P.+A.+Beachy&title=Hedgehog+pathway+modulation+by+multiple+lipid+binding+sites+on+the+smoothened+effector+of+signal+response&doi=10.1016%2Fj.devcel.2013.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog Pathway Modulation by Multiple Lipid Binding Sites on the Smoothened Effector of Signal Response</span></div><div class="casAuthors">Myers, Benjamin R.; Sever, Navdar; Chong, Yong Chun; Kim, James; Belani, Jitendra D.; Rychnovsky, Scott; Bazan, J. Fernando; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">346-357</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hedgehog (Hh) signaling during development and in postembryonic tissues requires activation of the 7TM oncoprotein Smoothened (Smo) by mechanisms that may involve endogenous lipidic modulators.  Exogenous Smo ligands previously identified include the plant sterol cyclopamine (and its therapeutically useful synthetic mimics) and hydroxylated cholesterol derivs. (oxysterols); Smo is also highly sensitive to cellular sterol levels.  The relationships between these effects are unclear because the relevant Smo structural determinants are unknown.  We identify the conserved extracellular cysteine-rich domain (CRD) as the site of action for oxysterols on Smo, involving residues structurally analogous to those contacting the Wnt lipid adduct in the homologous Frizzled CRD; this modulatory effect is distinct from that of cyclopamine mimics, from Hh-mediated regulation, and from the permissive action of cellular sterol pools.  These results imply that Hh pathway activity is sensitive to lipid binding at several Smo sites, suggesting mechanisms for tuning by multiple physiol. inputs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHl687XdSYgLVg90H21EOLACvtfcHk0lgBTIZYH5gcuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ylt73M&md5=63900d9ed6d0a1291da7f39edfe3f13d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2013.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2013.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DB.%2BR.%26aulast%3DSever%26aufirst%3DN.%26aulast%3DChong%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DBelani%26aufirst%3DJ.%2BD.%26aulast%3DRychnovsky%26aufirst%3DS.%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DHedgehog%2520pathway%2520modulation%2520by%2520multiple%2520lipid%2520binding%2520sites%2520on%2520the%2520smoothened%2520effector%2520of%2520signal%2520response%26jtitle%3DDev.%2520Cell%26date%3D2013%26volume%3D26%26spage%3D346%26epage%3D357%26doi%3D10.1016%2Fj.devcel.2013.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Incardona, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaffield, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelink, H.</span></span> <span> </span><span class="NLM_article-title">The teratogenic veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">3553</span>– <span class="NLM_lpage">3562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=9716521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK1cXmslKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1998&pages=3553-3562&author=J.+P.+Incardonaauthor=W.+Gaffieldauthor=R.+P.+Kapurauthor=H.+Roelink&title=The+teratogenic+veratrum+alkaloid+cyclopamine+inhibits+sonic+hedgehog+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction</span></div><div class="casAuthors">Incardona, John P.; Gaffield, William; Kapur, Raj P.; Roelink, Henk</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3553-3562</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The steroidal alkaloid cyclopamine produces cyclopia and holoprosencephaly when administered to gastrulation-stage amniote embryos.  Cyclopamine-induced malformations in chick embryos are assocd. with interruption of Sonic hedgehog (Shh)-mediated dorsoventral patterning of the neural tube and somites.  Cell types normally induced in the ventral neural tube by Shh are either absent or appear aberrantly at the ventral midline after cyclopamine treatment, while dorsal cell types normally repressed by Shh appear ventrally.  Somites in cyclopamine-treated embryos show Pax7 expression throughout, indicating failure of sclerotome induction.  Cyclopamine at concns. of 20-100 nM blocks the response of neural plate explants to recombinant Shh-N in a dose-dependent manner.  Similar concns. have no effect on the post-translational modification of Shh by cholesterol in transfected COS-1 cells.  Comparison of the effects of cyclopamine to those of the holoprosencephaly-inducing cholesterol synthesis inhibitor AY-9944 shows that cyclopamine does not induce malformations by interfering with cholesterol metab.  Although AY-9944 does not interrupt Shh signaling in ovo, it blocks the response to Shh-N in explants cultured without an exogenous cholesterol source.  As predicted by current models of the regulation of cholesterol metab., the response to Shh-N in AY-9944-treated explants is restored by providing exogenous cholesterol.  However, exogenous cholesterol does not restore Shh signaling in cyclopamine-treated explants.  These findings suggest that cyclopamine-induced teratogenesis is due to a more direct antagonism of Shh signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcBtoDosJpI7Vg90H21EOLACvtfcHk0lgBTIZYH5gcuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslKmtbk%253D&md5=ee8613c71aa3a2b556b3653d74b6e9f3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIncardona%26aufirst%3DJ.%2BP.%26aulast%3DGaffield%26aufirst%3DW.%26aulast%3DKapur%26aufirst%3DR.%2BP.%26aulast%3DRoelink%26aufirst%3DH.%26atitle%3DThe%2520teratogenic%2520veratrum%2520alkaloid%2520cyclopamine%2520inhibits%2520sonic%2520hedgehog%2520signal%2520transduction%26jtitle%3DDevelopment%26date%3D1998%26volume%3D125%26spage%3D3553%26epage%3D3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Teratogen-mediated inhibition of target tissue response to shh signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">1603</span>– <span class="NLM_lpage">1607</span>, <span class="refDoi"> DOI: 10.1126/science.280.5369.1603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.280.5369.1603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=9616123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=1603-1607&author=M.+K.+Cooperauthor=J.+A.+Porterauthor=K.+E.+Youngauthor=P.+A.+Beachy&title=Teratogen-mediated+inhibition+of+target+tissue+response+to+shh+signaling&doi=10.1126%2Fscience.280.5369.1603"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Teratogen-mediated inhibition of target tissue response to Shh signaling</span></div><div class="casAuthors">Cooper, Michael K.; Porter, Jeffery A.; Young, Keith E.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">5369</span>),
    <span class="NLM_cas:pages">1603-1607</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Veratrum alkaloids and distal inhibitors of cholesterol biosynthesis have been studied for more than 30 yr as potent teratogens capable of inducing cyclopia and other birth defects.  Here, it is shown that these compds. specifically block the Sonic hedgehog (Shh) signaling pathway.  These teratogens did not prevent the sterol modification of Shh during autoprocessing but rather inhibited the response of target tissues to Shh, possibly acting through the sterol sensing domain within the Patched protein regulator of Shh response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPwaA3YwN2S7Vg90H21EOLACvtfcHk0lgEis2z6uwGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFKjurY%253D&md5=9428d88e53a145d6924fcdee4b4e3621</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.280.5369.1603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.280.5369.1603%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DYoung%26aufirst%3DK.%2BE.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DTeratogen-mediated%2520inhibition%2520of%2520target%2520tissue%2520response%2520to%2520shh%2520signaling%26jtitle%3DScience%26date%3D1998%26volume%3D280%26spage%3D1603%26epage%3D1607%26doi%3D10.1126%2Fscience.280.5369.1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescarbeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grogan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austad, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Diez, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and orally active hedgehog pathway antagonist (ipi-926)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4400</span>– <span class="NLM_lpage">4418</span>, <span class="refDoi"> DOI: 10.1021/jm900305z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900305z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4400-4418&author=M.+R.+Tremblayauthor=A.+Lescarbeauauthor=M.+J.+Groganauthor=E.+Tanauthor=G.+Linauthor=B.+C.+Austadauthor=L.+C.+Yuauthor=M.+L.+Behnkeauthor=S.+J.+Nairauthor=M.+Hagelauthor=K.+Whiteauthor=J.+Conleyauthor=J.+D.+Mannaauthor=T.+M.+Alvarez-Diezauthor=J.+Hoytauthor=C.+N.+Woodwardauthor=J.+R.+Sydorauthor=M.+Pinkauthor=J.+MacDougallauthor=M.+J.+Campbellauthor=J.+Cushingauthor=J.+Fergusonauthor=M.+S.+Curtisauthor=K.+McGovernauthor=M.+A.+Readauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=A.+C.+Castro&title=Discovery+of+a+potent+and+orally+active+hedgehog+pathway+antagonist+%28ipi-926%29&doi=10.1021%2Fjm900305z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)</span></div><div class="casAuthors">Tremblay, Martin R.; Lescarbeau, Andre; Grogan, Michael J.; Tan, Eddy; Lin, Grace; Austad, Brian C.; Yu, Lin-Chen; Behnke, Mark L.; Nair, Somarajan J.; Hagel, Margit; White, Kerry; Conley, James; Manna, Joseph D.; Alvarez-Diez, Teresa M.; Hoyt, Jennifer; Woodward, Caroline N.; Sydor, Jens R.; Pink, Melissa; MacDougall, John; Campbell, Matthew J.; Cushing, Jill; Ferguson, Jeanne; Curtis, Michael S.; McGovern, Karen; Read, Margaret A.; Palombella, Vito J.; Adams, Julian; Castro, Alfredo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4400-4418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent evidence suggests that blocking aberrant hedgehog pathway signaling may be a promising therapeutic strategy for the treatment of several types of cancer.  Cyclopamine, a plant Veratrum alkaloid, is a natural product antagonist of the hedgehog pathway.  In a previous report, a seven-membered D-ring semisynthetic analog of cyclopamine, IPI-269609 (2), was shown to have greater acid stability and better aq. soly. compared to cyclopamine.  Further modifications of the A-ring system generated three series of analogs with improved potency and/or soly.  Lead compds. from each series were characterized in vitro and evaluated in vivo for biol. activity and pharmacokinetic properties.  These studies led to the discovery of IPI-926 (compd. 28), a novel semisynthetic cyclopamine analog with substantially improved pharmaceutical properties and potency and a favorable pharmacokinetic profile relative to cyclopamine and compd. 2.  As a result, complete tumor regression was obsd. in a Hh-dependent medulloblastoma allograft model after daily oral administration of 40 mg/kg of compd. 28.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-f15bWq7kM7Vg90H21EOLACvtfcHk0lgEis2z6uwGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D&md5=9455ee5eadb8293fdb3bd5cdec0e5d67</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900305z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900305z%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DLescarbeau%26aufirst%3DA.%26aulast%3DGrogan%26aufirst%3DM.%2BJ.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DAustad%26aufirst%3DB.%2BC.%26aulast%3DYu%26aufirst%3DL.%2BC.%26aulast%3DBehnke%26aufirst%3DM.%2BL.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DConley%26aufirst%3DJ.%26aulast%3DManna%26aufirst%3DJ.%2BD.%26aulast%3DAlvarez-Diez%26aufirst%3DT.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%2BN.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DMacDougall%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DM.%2BJ.%26aulast%3DCushing%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DM.%2BS.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520orally%2520active%2520hedgehog%2520pathway%2520antagonist%2520%2528ipi-926%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4400%26epage%3D4418%26doi%3D10.1021%2Fjm900305z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevalainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faia, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sydor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span> <span> </span><span class="NLM_article-title">Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6646</span>– <span class="NLM_lpage">6649</span>, <span class="refDoi"> DOI: 10.1021/jm8008508</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8008508" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ahs7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6646-6649&author=M.+R.+Tremblayauthor=M.+Nevalainenauthor=S.+J.+Nairauthor=J.+R.+Porterauthor=A.+C.+Castroauthor=M.+L.+Behnkeauthor=L.+C.+Yuauthor=M.+Hagelauthor=K.+Whiteauthor=K.+Faiaauthor=L.+Grenierauthor=M.+J.+Campbellauthor=J.+Cushingauthor=C.+N.+Woodwardauthor=J.+Hoytauthor=M.+A.+Foleyauthor=M.+A.+Readauthor=J.+R.+Sydorauthor=J.+K.+Tongauthor=V.+J.+Palombellaauthor=K.+McGovernauthor=J.+Adams&title=Semisynthetic+cyclopamine+analogues+as+potent+and+orally+bioavailable+hedgehog+pathway+antagonists&doi=10.1021%2Fjm8008508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Semisynthetic Cyclopamine Analogues as Potent and Orally Bioavailable Hedgehog Pathway Antagonists</span></div><div class="casAuthors">Tremblay, Martin R.; Nevalainen, Marta; Nair, Somarajan J.; Porter, James R.; Castro, Alfredo C.; Behnke, Mark L.; Yu, Lin-Chen; Hagel, Margit; White, Kerry; Faia, Kerrie; Grenier, Louis; Campbell, Matthew J.; Cushing, Jill; Woodward, Caroline N.; Hoyt, Jennifer; Foley, Michael A.; Read, Margaret A.; Sydor, Jens R.; Tong, Jeffrey K.; Palombella, Vito J.; McGovern, Karen; Adams, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6646-6649</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein is reported the synthesis of a novel class of hedgehog antagonists derived from cyclopamine.  The acid sensitive D-ring of cyclopamine was homologated utilizing a sequence of chemoselective cyclopropanation and stereoselective acid-catalyzed rearrangement.  Further modification of the A/B-ring homoallylic alc. to the conjugated ketone led to the discovery of new cyclopamine analogs, e.g. I, with improved pharmaceutical properties and in vitro potency (EC50) ranging from 10 to 1000 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquaq3irKGMhrVg90H21EOLACvtfcHk0lgEis2z6uwGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ahs7jM&md5=e1bf29e85ba30baa517d587739ea0297</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm8008508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008508%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DNevalainen%26aufirst%3DM.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26aulast%3DBehnke%26aufirst%3DM.%2BL.%26aulast%3DYu%26aufirst%3DL.%2BC.%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DFaia%26aufirst%3DK.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DM.%2BJ.%26aulast%3DCushing%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%2BN.%26aulast%3DHoyt%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DM.%2BA.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DSemisynthetic%2520cyclopamine%2520analogues%2520as%2520potent%2520and%2520orally%2520bioavailable%2520hedgehog%2520pathway%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6646%26epage%3D6649%26doi%3D10.1021%2Fjm8008508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villavicencio, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditzler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tunkey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBlanc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph-Habecker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoblaugh, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainwright, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGovern, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. M.</span></span> <span> </span><span class="NLM_article-title">Hedgehog pathway inhibitor saridegib (ipi-926) increases lifespan in a mouse medulloblastoma model</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">7859</span>– <span class="NLM_lpage">7864</span>, <span class="refDoi"> DOI: 10.1073/pnas.1114718109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1114718109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22550175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1Knt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=7859-7864&author=M.+J.+Leeauthor=B.+A.+Hattonauthor=E.+H.+Villavicencioauthor=P.+C.+Khannaauthor=S.+D.+Friedmanauthor=S.+Ditzlerauthor=B.+Pullarauthor=K.+Robisonauthor=K.+F.+Whiteauthor=C.+Tunkeyauthor=M.+LeBlancauthor=J.+Randolph-Habeckerauthor=S.+E.+Knoblaughauthor=S.+Hansenauthor=A.+Richardsauthor=B.+J.+Wainwrightauthor=K.+McGovernauthor=J.+M.+Olson&title=Hedgehog+pathway+inhibitor+saridegib+%28ipi-926%29+increases+lifespan+in+a+mouse+medulloblastoma+model&doi=10.1073%2Fpnas.1114718109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model</span></div><div class="casAuthors">Lee, Michelle J.; Hatton, Beryl A.; Villavicencio, Elisabeth H.; Khanna, Paritosh C.; Friedman, Seth D.; Ditzler, Sally; Pullar, Barbara; Robison, Keith; White, Kerry F.; Tunkey, Chris; LeBlanc, Michael; Randolph-Habecker, Julie; Knoblaugh, Sue E.; Hansen, Stacey; Richards, Andrew; Wainwright, Brandon J.; McGovern, Karen; Olson, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7859-7864, S7859/1-S7859/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Sonic Hedgehog (Shh) pathway drives a subset of medulloblastomas, a malignant neuroectodermal brain cancer, and other cancers.  Small-mol. Shh pathway inhibitors have induced tumor regression in mice and patients with medulloblastoma; however, drug resistance rapidly emerges, in some cases via de novo mutation of the drug target.  Here we assess the response and resistance mechanisms to the natural product deriv. saridegib in an aggressive Shh-driven mouse medulloblastoma model.  In this model, saridegib treatment induced tumor redn. and significantly prolonged survival.  Furthermore, the effect of saridegib on tumor-initiating capacity was demonstrated by reduced tumor in- cidence, slower growth, and spontaneous tumor regression that occurred in allografts generated from previously treated autochthonous medulloblastomas compared with those from untreated donors.  Saridegib, a known P-glycoprotein (Pgp) substrate, induced Pgp activity in treated tumors, which likely contributed to emergence of drug resistance.  Unlike other Smoothened (Smo) inhibitors, the drug resistance was neither mutation-dependent nor Gli2 amplification-dependent, and saridegib was found to be active in cells with the D473H point mutation that rendered them resistant to another Smo inhibitor, GDC-0449.  The fivefold increase in lifespan in mice treated with saridegib as a single agent compares favorably with both targeted and cytotoxic therapies.  The absence of genetic mutations that confer resistance distinguishes saridegib from other Smo inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEe1PqkK6YPbVg90H21EOLACvtfcHk0lgw-fKXk434Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1Knt7Y%253D&md5=29d439813c9bae6c6b355b4161c7e268</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1114718109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1114718109%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DHatton%26aufirst%3DB.%2BA.%26aulast%3DVillavicencio%26aufirst%3DE.%2BH.%26aulast%3DKhanna%26aufirst%3DP.%2BC.%26aulast%3DFriedman%26aufirst%3DS.%2BD.%26aulast%3DDitzler%26aufirst%3DS.%26aulast%3DPullar%26aufirst%3DB.%26aulast%3DRobison%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DK.%2BF.%26aulast%3DTunkey%26aufirst%3DC.%26aulast%3DLeBlanc%26aufirst%3DM.%26aulast%3DRandolph-Habecker%26aufirst%3DJ.%26aulast%3DKnoblaugh%26aufirst%3DS.%2BE.%26aulast%3DHansen%26aufirst%3DS.%26aulast%3DRichards%26aufirst%3DA.%26aulast%3DWainwright%26aufirst%3DB.%2BJ.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DOlson%26aufirst%3DJ.%2BM.%26atitle%3DHedgehog%2520pathway%2520inhibitor%2520saridegib%2520%2528ipi-926%2529%2520increases%2520lifespan%2520in%2520a%2520mouse%2520medulloblastoma%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D7859%26epage%3D7864%26doi%3D10.1073%2Fpnas.1114718109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weierstall, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spence, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce Doak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromme, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotjohann, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koglin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvin Seibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoeman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirian, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyerlein, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span> <span> </span><span class="NLM_article-title">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3309</span>, <span class="refDoi"> DOI: 10.1038/ncomms4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24525480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3309&author=U.+Weierstallauthor=D.+Jamesauthor=C.+Wangauthor=T.+A.+Whiteauthor=D.+Wangauthor=W.+Liuauthor=J.+C.+Spenceauthor=R.+Bruce+Doakauthor=G.+Nelsonauthor=P.+Frommeauthor=R.+Frommeauthor=I.+Grotjohannauthor=C.+Kupitzauthor=N.+A.+Zatsepinauthor=H.+Liuauthor=S.+Basuauthor=D.+Wackerauthor=G.+W.+Hanauthor=V.+Katritchauthor=S.+Boutetauthor=M.+Messerschmidtauthor=G.+J.+Williamsauthor=J.+E.+Koglinauthor=M.+Marvin+Seibertauthor=M.+Klinkerauthor=C.+Gatiauthor=R.+L.+Shoemanauthor=A.+Bartyauthor=H.+N.+Chapmanauthor=R.+A.+Kirianauthor=K.+R.+Beyerleinauthor=R.+C.+Stevensauthor=D.+Liauthor=S.+T.+Shahauthor=N.+Howeauthor=M.+Caffreyauthor=V.+Cherezov&title=Lipidic+cubic+phase+injector+facilitates+membrane+protein+serial+femtosecond+crystallography&doi=10.1038%2Fncomms4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography</span></div><div class="casAuthors">Weierstall Uwe; James Daniel; Wang Dingjie; Spence John C H; Bruce Doak R; Nelson Garrett; Zatsepin Nadia A; Liu Haiguang; Wang Chong; Liu Wei; Wacker Daniel; Han Gye Won; Katritch Vsevolod; Stevens Raymond C; Cherezov Vadim; White Thomas A; Gati Cornelius; Barty Anton; Beyerlein Kenneth R; Fromme Petra; Fromme Raimund; Grotjohann Ingo; Kupitz Christopher; Basu Shibom; Boutet Sebastien; Messerschmidt Marc; Williams Garth J; Koglin Jason E; Marvin Seibert M; Klinker Markus; Shoeman Robert L; Chapman Henry N; Kirian Richard A; Li Dianfan; Shah Syed T A; Howe Nicole; Caffrey Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3309</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lipidic cubic phase (LCP) crystallization has proven successful for high-resolution structure determination of challenging membrane proteins.  Here we present a technique for extruding gel-like LCP with embedded membrane protein microcrystals, providing a continuously renewed source of material for serial femtosecond crystallography.  Data collected from sub-10-μm-sized crystals produced with less than 0.5 mg of purified protein yield structural insights regarding cyclopamine binding to the Smoothened receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQDUg0uqQckxOWhZTslLrfffW6udTcc2eb5kjtpEKi-b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvltVeqsA%253D%253D&md5=ce335fa0a5bfeb8990c836e7f425e2d2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fncomms4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4309%26sid%3Dliteratum%253Aachs%26aulast%3DWeierstall%26aufirst%3DU.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DT.%2BA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSpence%26aufirst%3DJ.%2BC.%26aulast%3DBruce%2BDoak%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DG.%26aulast%3DFromme%26aufirst%3DP.%26aulast%3DFromme%26aufirst%3DR.%26aulast%3DGrotjohann%26aufirst%3DI.%26aulast%3DKupitz%26aufirst%3DC.%26aulast%3DZatsepin%26aufirst%3DN.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DBoutet%26aufirst%3DS.%26aulast%3DMesserschmidt%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DKoglin%26aufirst%3DJ.%2BE.%26aulast%3DMarvin%2BSeibert%26aufirst%3DM.%26aulast%3DKlinker%26aufirst%3DM.%26aulast%3DGati%26aufirst%3DC.%26aulast%3DShoeman%26aufirst%3DR.%2BL.%26aulast%3DBarty%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DH.%2BN.%26aulast%3DKirian%26aufirst%3DR.%2BA.%26aulast%3DBeyerlein%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DS.%2BT.%26aulast%3DHowe%26aufirst%3DN.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DCherezov%26aufirst%3DV.%26atitle%3DLipidic%2520cubic%2520phase%2520injector%2520facilitates%2520membrane%2520protein%2520serial%2520femtosecond%2520crystallography%26jtitle%3DNat.%2520Commun.%26date%3D2014%26volume%3D5%26spage%3D3309%26doi%3D10.1038%2Fncomms4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunton, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dina, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichert, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunzner, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotkow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsters, J. C.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stibbard, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubhayaker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.</span></span> <span> </span><span class="NLM_article-title">Gdc-0449-a potent inhibitor of the hedgehog pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5576</span>– <span class="NLM_lpage">5581</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2009.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19716296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5576-5581&author=K.+D.+Robargeauthor=S.+A.+Bruntonauthor=G.+M.+Castanedoauthor=Y.+Cuiauthor=M.+S.+Dinaauthor=R.+Goldsmithauthor=S.+E.+Gouldauthor=O.+Guichertauthor=J.+L.+Gunznerauthor=J.+Halladayauthor=W.+Jiaauthor=C.+Khojastehauthor=M.+F.+Koehlerauthor=K.+Kotkowauthor=H.+Laauthor=R.+L.+Lalondeauthor=K.+Lauauthor=L.+Leeauthor=D.+Marshallauthor=J.+C.+Marstersauthor=L.+J.+Murrayauthor=C.+Qianauthor=L.+L.+Rubinauthor=L.+Salphatiauthor=M.+S.+Stanleyauthor=J.+H.+Stibbardauthor=D.+P.+Sutherlinauthor=S.+Ubhayakerauthor=S.+Wangauthor=S.+Wongauthor=M.+Xie&title=Gdc-0449-a+potent+inhibitor+of+the+hedgehog+pathway&doi=10.1016%2Fj.bmcl.2009.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">GDC-0449-A potent inhibitor of the hedgehog pathway</span></div><div class="casAuthors">Robarge, Kirk D.; Brunton, Shirley A.; Castanedo, Georgette M.; Cui, Yong; Dina, Michael S.; Goldsmith, Richard; Gould, Stephen E.; Guichert, Oivin; Gunzner, Janet L.; Halladay, Jason; Jia, Wei; Khojasteh, Cyrus; Koehler, Michael F. T.; Kotkow, Karen; La, Hank; La Londe, Rebecca L.; Lau, Kevin; Lee, Leslie; Marshall, Derek; Marsters, James C.; Murray, Lesley J.; Qian, Changgeng; Rubin, Lee L.; Salphati, Laurent; Stanley, Mark S.; Stibbard, John H. A.; Sutherlin, Daniel P.; Ubhayaker, Savita; Wang, Shumei; Wong, Susan; Xie, Minli</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5576-5581</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SAR for a wide variety of heterocyclic replacements for a benzimidazole led to the discovery of functionalized 2-pyridyl amides as novel inhibitors of the hedgehog pathway.  The 2-pyridyl amides were optimized for potency, PK, and drug-like properties by modifications to the amide portion of the mol. resulting in I (GDC-0449).  Amide I produced complete tumor regression at doses as low as 12.5 mg/kg BID in a medulloblastoma allograft mouse model that is wholly dependent on the Hh pathway for growth and is currently in human clin. trials, where it is initially being evaluated for the treatment of BCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZfOHMTd5tXbVg90H21EOLACvtfcHk0lixYoe7AG_PJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur7O&md5=cb8fb6e6b99bd85abd9359b04de33898</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DRobarge%26aufirst%3DK.%2BD.%26aulast%3DBrunton%26aufirst%3DS.%2BA.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DDina%26aufirst%3DM.%2BS.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DGuichert%26aufirst%3DO.%26aulast%3DGunzner%26aufirst%3DJ.%2BL.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DKhojasteh%26aufirst%3DC.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DKotkow%26aufirst%3DK.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLalonde%26aufirst%3DR.%2BL.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DMarsters%26aufirst%3DJ.%2BC.%26aulast%3DMurray%26aufirst%3DL.%2BJ.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DStanley%26aufirst%3DM.%2BS.%26aulast%3DStibbard%26aufirst%3DJ.%2BH.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DUbhayaker%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DM.%26atitle%3DGdc-0449-a%2520potent%2520inhibitor%2520of%2520the%2520hedgehog%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5576%26epage%3D5581%26doi%3D10.1016%2Fj.bmcl.2009.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pferdekamper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of nvp-lde225, a potent and selective smoothened antagonist</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1021/ml1000307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=130-134&author=S.+Panauthor=X.+Wuauthor=J.+Jiangauthor=W.+Gaoauthor=Y.+Wanauthor=D.+Chengauthor=D.+Hanauthor=J.+Liuauthor=N.+P.+Englundauthor=Y.+Wangauthor=S.+Peukertauthor=K.+Miller-Moslinauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=Y.+Jiangauthor=J.+Tsaoauthor=F.+Sunauthor=A.+C.+Pferdekamperauthor=S.+Doddauthor=T.+Tuntlandauthor=W.+Maniaraauthor=J.+F.+Kelleherauthor=Y.+M.+Yaoauthor=M.+Warmuthauthor=J.+Williamsauthor=M.+Dorsch&title=Discovery+of+nvp-lde225%2C+a+potent+and+selective+smoothened+antagonist&doi=10.1021%2Fml1000307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist</span></div><div class="casAuthors">Pan, Shifeng; Wu, Xu; Jiang, Jiqing; Gao, Wenqi; Wan, Yongqin; Cheng, Dai; Han, Dong; Liu, Jun; Englund, Nathan P.; Wang, Yan; Peukert, Stefan; Miller-Moslin, Karen; Yuan, Jing; Guo, Ribo; Matsumoto, Melissa; Vattay, Anthony; Jiang, Yun; Tsao, Jeffrey; Sun, Fangxian; Pferdekamper, AnneMarie C.; Dodd, Stephanie; Tuntland, Tove; Maniara, Wieslawa; Kelleher, Joseph F., III; Yao, Yung-mae; Warmuth, Markus; Williams, Juliet; Dorsch, Marion</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-134</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The blockade of aberrant hedgehog (Hh) signaling has shown promise for therapeutic intervention in cancer.  A cell-based phenotypic high-throughput screen was performed, and the lead structure (1) was identified as an inhibitor of the Hh pathway via antagonism of the Smoothened receptor (Smo).  Structure-activity relation studies led to the discovery of a potent and specific Smoothened antagonist N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide (5m, NVP-LDE225), which is currently in clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkXrdZB74WfbVg90H21EOLACvtfcHk0lixYoe7AG_PJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1Cqt7c%253D&md5=c4d1348e8d47ed9561151ce59305531e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fml1000307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000307%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEnglund%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DTsao%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DPferdekamper%26aufirst%3DA.%2BC.%26aulast%3DDodd%26aufirst%3DS.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DYao%26aufirst%3DY.%2BM.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520nvp-lde225%252C%2520a%2520potent%2520and%2520selective%2520smoothened%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D130%26epage%3D134%26doi%3D10.1021%2Fml1000307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekulic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migden, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirix, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainsworth, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arron, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedlander, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmur, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackey, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauschild, A.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of vismodegib in advanced basal-cell carcinoma</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">2171</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1113713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1056%2FNEJMoa1113713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22670903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=2171-2179&author=A.+Sekulicauthor=M.+R.+Migdenauthor=A.+E.+Oroauthor=L.+Dirixauthor=K.+D.+Lewisauthor=J.+D.+Hainsworthauthor=J.+A.+Solomonauthor=S.+Yooauthor=S.+T.+Arronauthor=P.+A.+Friedlanderauthor=E.+Marmurauthor=C.+M.+Rudinauthor=A.+L.+Changauthor=J.+A.+Lowauthor=H.+M.+Mackeyauthor=R.+L.+Yauchauthor=R.+A.+Grahamauthor=J.+C.+Reddyauthor=A.+Hauschild&title=Efficacy+and+safety+of+vismodegib+in+advanced+basal-cell+carcinoma&doi=10.1056%2FNEJMoa1113713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of vismodegib in advanced basal-cell carcinoma</span></div><div class="casAuthors">Sekulic, Aleksandar; Migden, Michael R.; Oro, Anthony E.; Dirix, Luc; Lewis, Karl D.; Hainsworth, John D.; Solomon, James A.; Yoo, Simon; Arron, Sarah T.; Friedlander, Philip A.; Marmur, Ellen; Rudin, Charles M.; Chang, Anne Lynn S.; Low, Jennifer A.; Mackey, Howard M.; Yauch, Robert L.; Graham, Richard A.; Reddy, Josina C.; Hauschild, Axel</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2171-2179</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Alterations in hedgehog signaling are implicated in the pathogenesis of basal-cell carcinoma.  Although most basal-cell carcinomas are treated surgically, no effective therapy exists for locally advanced or metastatic basal-cell carcinoma.  A phase 1 study of vismodegib (GDC-0449), a 1st-in-class, small-mol. inhibitor of the hedgehog pathway, showed a 58% response rate among patients with advanced basal-cell carcinoma.  In this multicenter, international, 2-cohort, nonrandomized study, we enrolled patients with metastatic basal-cell carcinoma and those with locally advanced basal-cell carcinoma who had inoperable disease or for whom surgery was inappropriate (because of multiple recurrences and a low likelihood of surgical cure, or substantial anticipated disfigurement).  All patients received 150 mg of oral vismodegib daily.  The primary end point was the independently assessed objective response rate; the primary hypotheses were that the response rate would be greater than 20% for patients with locally advanced basal-cell carcinoma and greater than 10% for those with metastatic basal-cell carcinoma.  In 33 patients with metastatic basal-cell carcinoma, the independently assessed response rate was 30% (95% confidence interval [CI], 16 to 48; P = 0.001).  In 63 patients with locally advanced basal-cell carcinoma, the independently assessed response rate was 43% (95% CI, 31 to 56; P < 0.001), with complete responses in 13 patients (21%/).  The median duration of response was 7.6 mo in both cohorts.  Adverse events occurring in more than 30% of patients were muscle spasms, alopecia, dysgeusia (taste disturbance), wt. loss, and fatigue.  Serious adverse events were reported in 25% of patients; 7 deaths due to adverse events were noted.  Vismodegib is assocd. with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDSfP7MPfQNbVg90H21EOLACvtfcHk0lieDaRz2C2mIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVehsb8%253D&md5=e4bb30e44c79f77841fa63b15f88ce6e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1113713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1113713%26sid%3Dliteratum%253Aachs%26aulast%3DSekulic%26aufirst%3DA.%26aulast%3DMigden%26aufirst%3DM.%2BR.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DDirix%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DK.%2BD.%26aulast%3DHainsworth%26aufirst%3DJ.%2BD.%26aulast%3DSolomon%26aufirst%3DJ.%2BA.%26aulast%3DYoo%26aufirst%3DS.%26aulast%3DArron%26aufirst%3DS.%2BT.%26aulast%3DFriedlander%26aufirst%3DP.%2BA.%26aulast%3DMarmur%26aufirst%3DE.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DChang%26aufirst%3DA.%2BL.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26aulast%3DMackey%26aufirst%3DH.%2BM.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DGraham%26aufirst%3DR.%2BA.%26aulast%3DReddy%26aufirst%3DJ.%2BC.%26aulast%3DHauschild%26aufirst%3DA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520vismodegib%2520in%2520advanced%2520basal-cell%2520carcinoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D2171%26epage%3D2179%26doi%3D10.1056%2FNEJMoa1113713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancois, P.</span></span> <span> </span><span class="NLM_article-title">Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2018.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.jaad.2018.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30003981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFyns7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2018&pages=1089-1100&author=P.+Xieauthor=P.+Lefrancois&title=Efficacy%2C+safety%2C+and+comparison+of+sonic+hedgehog+inhibitors+in+basal+cell+carcinomas%3A+A+systematic+review+and+meta-analysis&doi=10.1016%2Fj.jaad.2018.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis</span></div><div class="casAuthors">Xie, Pingxing; Lefrancois, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1089-1100.e17</span>CODEN:
                <span class="NLM_cas:coden">JAADDB</span>;
        ISSN:<span class="NLM_cas:issn">0190-9622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Sonic hedgehog inhibitors (SHHis) provide an addnl. treatment option for basal cell carcinomas (BCCs), esp. for metastatic or locally advanced BCC.  However, studies have been heterogeneous and lacked direct comparisons between mols.  To det. the efficacy and safety of the class of mols. SHHi for treating BCC and to compare them individually.  We performed a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-compliant systematic review of studies followed by a meta-anal.  Eighteen articles were included in our meta-anal.; 16 articles were combined for efficacy and 16 for safety.  In locally advanced BCC, overall response rates (ORRs) were similar for vismodegib and sonidegib (69% vs 57%, resp.) but not complete response rates (31% vs 3%, resp.).  In metastatic disease, the ORR of vismodegib was 2.7-fold higher than the ORR of sonidegib (39% vs 15%, resp.).  For side effects affecting a majority of patients, prevalences for muscle spasms (67.1%), dysgeusia (54.1%), and alopecia (57.7%) were in similar proportions for sonidegib and vismodegib.  Patients receiving sonidegib experienced more upper gastrointestinal distress than patients receiving vismodegib.  SHHis induce a partial response to locally advanced BCC disease.  Side effects are common, similar across mols., assocd. with high discontinuation rates, and warrant discussion beforehand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrac1BL82VL5rVg90H21EOLACvtfcHk0lieDaRz2C2mIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFyns7zO&md5=d5daa7c6b08ad5231aed6a729cd78c85</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2018.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DP.%26aulast%3DLefrancois%26aufirst%3DP.%26atitle%3DEfficacy%252C%2520safety%252C%2520and%2520comparison%2520of%2520sonic%2520hedgehog%2520inhibitors%2520in%2520basal%2520cell%2520carcinomas%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2018%26volume%3D79%26spage%3D1089%26epage%3D1100%26doi%3D10.1016%2Fj.jaad.2018.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cazet, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsworth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skhinas, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johan, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Borrego, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigo, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezares, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caballero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Toole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swarbrick, A.</span></span> <span> </span><span class="NLM_article-title">Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2897</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05220-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fs41467-018-05220-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30042390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BB3c7hsF2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=2897&author=A.+S.+Cazetauthor=M.+N.+Huiauthor=B.+L.+Elsworthauthor=S.+Z.+Wuauthor=D.+Rodenauthor=C.+L.+Chanauthor=J.+N.+Skhinasauthor=R.+Collotauthor=J.+Yangauthor=K.+Harveyauthor=M.+Z.+Johanauthor=C.+Cooperauthor=R.+Nairauthor=D.+Herrmannauthor=A.+McFarlandauthor=N.+Dengauthor=M.+Ruiz-Borregoauthor=F.+Rojoauthor=J.+M.+Trigoauthor=S.+Bezaresauthor=R.+Caballeroauthor=E.+Limauthor=P.+Timpsonauthor=S.+O%E2%80%99Tooleauthor=D.+N.+Watkinsauthor=T.+R.+Coxauthor=M.+S.+Samuelauthor=M.+Martinauthor=A.+Swarbrick&title=Targeting+stromal+remodeling+and+cancer+stem+cell+plasticity+overcomes+chemoresistance+in+triple+negative+breast+cancer&doi=10.1038%2Fs41467-018-05220-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer</span></div><div class="casAuthors">Cazet Aurelie S; Hui Mun N; Wu Sunny Z; Roden Daniel; Chan Chia-Ling; Skhinas Joanna N; Collot Raphael; Yang Jessica; Harvey Kate; Herrmann David; McFarland Andrea; Deng Niantao; Lim Elgene; Timpson Paul; O'Toole Sandra; Watkins D Neil; Cox Thomas R; Swarbrick Alexander; Cazet Aurelie S; Hui Mun N; Wu Sunny Z; Roden Daniel; Chan Chia-Ling; Skhinas Joanna N; Collot Raphael; Yang Jessica; Harvey Kate; Herrmann David; McFarland Andrea; Deng Niantao; Lim Elgene; Timpson Paul; O'Toole Sandra; Watkins D Neil; Cox Thomas R; Swarbrick Alexander; Cazet Aurelie S; Wu Sunny Z; Roden Daniel; Herrmann David; Deng Niantao; Lim Elgene; Timpson Paul; Watkins D Neil; Cox Thomas R; Swarbrick Alexander; Hui Mun N; Hui Mun N; O'Toole Sandra; Elsworth Benjamin L; Johan M Zahied; Samuel Michael S; Johan M Zahied; Samuel Michael S; Cooper Caroline; Nair Radhika; Ruiz-Borrego Manuel; Rojo Federico; Trigo Jose M; Bezares Susana; Caballero Rosalia; Lim Elgene; Watkins D Neil; Martin Miguel</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2897</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies.  In mouse models of triple negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms cancer-associated fibroblasts (CAFs) to provide a supportive niche for the acquisition of a chemo-resistant, cancer stem cell (CSC) phenotype via FGF5 expression and production of fibrillar collagen.  Stromal treatment of patient-derived xenografts with smoothened inhibitors (SMOi) downregulates CSC markers expression and sensitizes tumors to docetaxel, leading to markedly improved survival and reduced metastatic burden.  In the phase I clinical trial EDALINE, 3 of 12 patients with metastatic TNBC derived clinical benefit from combination therapy with the SMOi Sonidegib and docetaxel chemotherapy, with one patient experiencing a complete response.  These studies identify Hedgehog signaling to CAFs as a novel mediator of CSC plasticity and an exciting new therapeutic target in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRFrTPyJmXj_5NiNltV31zlfW6udTcc2ebD5yDUXDE0M7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7hsF2lsA%253D%253D&md5=4b7d1416c3872d1b72e261b75ca614e5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05220-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05220-6%26sid%3Dliteratum%253Aachs%26aulast%3DCazet%26aufirst%3DA.%2BS.%26aulast%3DHui%26aufirst%3DM.%2BN.%26aulast%3DElsworth%26aufirst%3DB.%2BL.%26aulast%3DWu%26aufirst%3DS.%2BZ.%26aulast%3DRoden%26aufirst%3DD.%26aulast%3DChan%26aufirst%3DC.%2BL.%26aulast%3DSkhinas%26aufirst%3DJ.%2BN.%26aulast%3DCollot%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DJohan%26aufirst%3DM.%2BZ.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DNair%26aufirst%3DR.%26aulast%3DHerrmann%26aufirst%3DD.%26aulast%3DMcFarland%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DRuiz-Borrego%26aufirst%3DM.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DTrigo%26aufirst%3DJ.%2BM.%26aulast%3DBezares%26aufirst%3DS.%26aulast%3DCaballero%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DE.%26aulast%3DTimpson%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Toole%26aufirst%3DS.%26aulast%3DWatkins%26aufirst%3DD.%2BN.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DSamuel%26aufirst%3DM.%2BS.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DSwarbrick%26aufirst%3DA.%26atitle%3DTargeting%2520stromal%2520remodeling%2520and%2520cancer%2520stem%2520cell%2520plasticity%2520overcomes%2520chemoresistance%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D2897%26doi%3D10.1038%2Fs41467-018-05220-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fereshteh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.02.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2010.02.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20385363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsF2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=388-399&author=J.+Kimauthor=J.+Y.+Tangauthor=R.+Gongauthor=J.+Kimauthor=J.+J.+Leeauthor=K.+V.+Clemonsauthor=C.+R.+Chongauthor=K.+S.+Changauthor=M.+Fereshtehauthor=D.+Gardnerauthor=T.+Reyaauthor=J.+O.+Liuauthor=E.+H.+Epsteinauthor=D.+A.+Stevensauthor=P.+A.+Beachy&title=Itraconazole%2C+a+commonly+used+antifungal+that+inhibits+hedgehog+pathway+activity+and+cancer+growth&doi=10.1016%2Fj.ccr.2010.02.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth</span></div><div class="casAuthors">Kim, James; Tang, Jean Y.; Gong, Ruoyu; Kim, Jynho; Lee, John J.; Clemons, Karl V.; Chong, Curtis R.; Chang, Kris S.; Fereshteh, Mark; Gardner, Dale; Reya, Tannishtha; Liu, Jun O.; Epstein, Ervin H.; Stevens, David A.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">388-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In a screen of drugs previously tested in humans we identified itraconazole, a systemic antifungal, as a potent antagonist of the Hedgehog (Hh) signaling pathway that acts by a mechanism distinct from its inhibitory effect on fungal sterol biosynthesis.  Systemically administered itraconazole, like other Hh pathway antagonists, can suppress Hh pathway activity and the growth of medulloblastoma in a mouse allograft model and does so at serum levels comparable to those in patients undergoing antifungal therapy.  Mechanistically, itraconazole appears to act on the essential Hh pathway component Smoothened (SMO) by a mechanism distinct from that of cyclopamine and other known SMO antagonists, and prevents the ciliary accumulation of SMO normally caused by Hh stimulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXBQNwOfKF77Vg90H21EOLACvtfcHk0lg2hmsMfkMbTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsF2msb4%253D&md5=2c69fff20561231b43dfd020c588534f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.02.027%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DGong%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DClemons%26aufirst%3DK.%2BV.%26aulast%3DChong%26aufirst%3DC.%2BR.%26aulast%3DChang%26aufirst%3DK.%2BS.%26aulast%3DFereshteh%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DD.%26aulast%3DReya%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DStevens%26aufirst%3DD.%2BA.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DItraconazole%252C%2520a%2520commonly%2520used%2520antifungal%2520that%2520inhibits%2520hedgehog%2520pathway%2520activity%2520and%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D388%26epage%3D399%26doi%3D10.1016%2Fj.ccr.2010.02.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaunhurst, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodosh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molgo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span> <span> </span><span class="NLM_article-title">Open-label, exploratory phase ii trial of oral itraconazole for the treatment of basal cell carcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1200/JCO.2013.49.9525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1200%2FJCO.2013.49.9525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24493717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2itbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=745-751&author=D.+J.+Kimauthor=J.+Kimauthor=K.+Spaunhurstauthor=J.+Montoyaauthor=R.+Khodoshauthor=K.+Chandraauthor=T.+Fuauthor=A.+Gilliamauthor=M.+Molgoauthor=P.+A.+Beachyauthor=J.+Y.+Tang&title=Open-label%2C+exploratory+phase+ii+trial+of+oral+itraconazole+for+the+treatment+of+basal+cell+carcinoma&doi=10.1200%2FJCO.2013.49.9525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma</span></div><div class="casAuthors">Kim, Daniel J.; Kim, James; Spaunhurst, Katrina; Montoya, Javier; Khodosh, Rita; Chandra, Kalyani; Fu, Teresa; Gilliam, Anita; Molgo, Monserrat; Beachy, Philip A.; Tang, Jean Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-751</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Itraconazole, a US Food and Drug Administration-approved antifungal drug, inhibits the Hedgehog (HH) signaling pathway, a crucial driver of basal cell carcinoma (BCC) tumorigenesis, and reduces BCC growth in mice.  We assessed the effect of itraconazole on the HH pathway and on tumor size in human BCC tumors.  Patients and Methods Patients with ≥ one BCC tumor > 4 mm in diam. were enrolled onto two cohorts to receive oral itraconazole 200 mg twice per day for 1 mo (cohort A) or 100 mg twice per day for an av. of 2.3 mo (cohort B).  The primary end point was change in biomarkers: Ki67 tumor proliferation and HH activity (GLI1 mRNA).  Secondary end points included change in tumor size in a subset of patients with multiple tumors.  Results A total of 29 patients were enrolled, of whom 19 were treated with itraconazole.  Itraconazole treatment was assocd. with two adverse events (grade 2 fatigue and grade 4 congestive heart failure).  Itraconazole reduced cell proliferation by 45% (P = .04), HH pathway activity by 65% (P = .03), and reduced tumor area by 24% (95% CI, 18.2% to 30.0%).  Of eight patients with multiple nonbiopsied tumors, four achieved partial response, and four had stable disease.  Tumors from untreated control patients and from those previously treated with vismodegib showed no significant changes in proliferation or tumor size.  Conclusion Itraconazole has anti-BCC activity in humans.  These results provide the basis for larger trials of longer duration to measure the clin. efficacy of itraconazole, esp. relative to other HH pathway inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5K8INmtn8dbVg90H21EOLACvtfcHk0lg2hmsMfkMbTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2itbc%253D&md5=c814893390e5eb07208173c744dda59d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1200%2FJCO.2013.49.9525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2013.49.9525%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSpaunhurst%26aufirst%3DK.%26aulast%3DMontoya%26aufirst%3DJ.%26aulast%3DKhodosh%26aufirst%3DR.%26aulast%3DChandra%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DT.%26aulast%3DGilliam%26aufirst%3DA.%26aulast%3DMolgo%26aufirst%3DM.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26atitle%3DOpen-label%252C%2520exploratory%2520phase%2520ii%2520trial%2520of%2520oral%2520itraconazole%2520for%2520the%2520treatment%2520of%2520basal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2014%26volume%3D32%26spage%3D745%26epage%3D751%26doi%3D10.1200%2FJCO.2013.49.9525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzillo, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyden, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaGreca, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkalcevic, G. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of pf-04449913, a potent and orally bioavailable inhibitor of smoothened</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1021/ml2002423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2002423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GhsLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=106-111&author=M.+J.+Munchhofauthor=Q.+Liauthor=A.+Shavnyaauthor=G.+V.+Borzilloauthor=T.+L.+Boydenauthor=C.+S.+Jonesauthor=S.+D.+LaGrecaauthor=L.+Martinez-Alsinaauthor=N.+Patelauthor=K.+Pelletierauthor=L.+A.+Reiterauthor=M.+D.+Robbinsauthor=G.+T.+Tkalcevic&title=Discovery+of+pf-04449913%2C+a+potent+and+orally+bioavailable+inhibitor+of+smoothened&doi=10.1021%2Fml2002423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened</span></div><div class="casAuthors">Munchhof, Michael J.; Li, Qifang; Shavnya, Andrei; Borzillo, Gary V.; Boyden, Tracey L.; Jones, Christopher S.; LaGreca, Susan D.; Martinez-Alsina, Luis; Patel, Nandini; Pelletier, Kathleen; Reiter, Larry A.; Robbins, Michael D.; Tkalcevic, George T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-111</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hedgehog signaling pathway have generated a great deal of interest in the oncol. area due to the mounting evidence of their potential to provide promising therapeutic options for patients.  Herein, we describe the discovery strategy to overcome the issues inherent in lead structure 1 that resulted in the identification of Smoothened inhibitor 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea (PF-04449913, 26), which has been advanced to human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCSrORZG_pxbVg90H21EOLACvtfcHk0lg2hmsMfkMbTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GhsLnO&md5=298ea79230c119359512b1ad07900557</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fml2002423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2002423%26sid%3Dliteratum%253Aachs%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DBorzillo%26aufirst%3DG.%2BV.%26aulast%3DBoyden%26aufirst%3DT.%2BL.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DLaGreca%26aufirst%3DS.%2BD.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPelletier%26aufirst%3DK.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DRobbins%26aufirst%3DM.%2BD.%26aulast%3DTkalcevic%26aufirst%3DG.%2BT.%26atitle%3DDiscovery%2520of%2520pf-04449913%252C%2520a%2520potent%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520smoothened%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D106%26epage%3D111%26doi%3D10.1021%2Fml2002423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotoloni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosovec, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahoor, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makielski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobe, B. A.</span></span> <span> </span><span class="NLM_article-title">Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells</span>. <i>Cancer Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.3109/07357907.2013.820317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3109%2F07357907.2013.820317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23915072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1entrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=480-489&author=A.+H.+Zaidiauthor=Y.+Komatsuauthor=L.+A.+Kellyauthor=U.+Malhotraauthor=C.+Rotoloniauthor=J.+E.+Kosovecauthor=H.+Zahoorauthor=R.+Makielskiauthor=A.+Bhattauthor=T.+Hoppoauthor=B.+A.+Jobe&title=Smoothened+inhibition+leads+to+decreased+proliferation+and+induces+apoptosis+in+esophageal+adenocarcinoma+cells&doi=10.3109%2F07357907.2013.820317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Smoothened Inhibition Leads to Decreased Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells</span></div><div class="casAuthors">Zaidi, Ali H.; Komatsu, Yoshihiro; Kelly, Lori A.; Malhotra, Usha; Rotoloni, Christina; Kosovec, Juliann E.; Zahoor, Haris; Makielski, Rory; Bhatt, Astha; Hoppo, Toshitaka; Jobe, Blair A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-489</span>CODEN:
                <span class="NLM_cas:coden">CINVD7</span>;
        ISSN:<span class="NLM_cas:issn">0735-7907</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway is known to be active in Barrett's carcinogenesis.  Therefore, we evaluated the efficacy and underlying mechanisms of inhibition of cancer cell growth by the smoothened (Smo) antagonist BMS-833923 in esophageal adenocarcinoma (EAC) cell lines.  Cell proliferation and apoptosis were evaluated by flow cytometry, Western blotting, immunofluorescence, and quant. reverse transcription polymerase chain reactions.  Results showed that the Smo antagonist led to reduced Hh pathway activity, resulting in decreased cell proliferation and induction of apoptosis via the intrinsic pathway in the esophageal cancer cells.  In conclusion, the Smo antagonist may have application as an EAC chemotherapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUABxbxz5YybVg90H21EOLACvtfcHk0lgt3JJ7Ttiggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1entrbM&md5=34f29c1baab3cdb6cfc02b84dbd2f85b</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3109%2F07357907.2013.820317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F07357907.2013.820317%26sid%3Dliteratum%253Aachs%26aulast%3DZaidi%26aufirst%3DA.%2BH.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DL.%2BA.%26aulast%3DMalhotra%26aufirst%3DU.%26aulast%3DRotoloni%26aufirst%3DC.%26aulast%3DKosovec%26aufirst%3DJ.%2BE.%26aulast%3DZahoor%26aufirst%3DH.%26aulast%3DMakielski%26aufirst%3DR.%26aulast%3DBhatt%26aufirst%3DA.%26aulast%3DHoppo%26aufirst%3DT.%26aulast%3DJobe%26aufirst%3DB.%2BA.%26atitle%3DSmoothened%2520inhibition%2520leads%2520to%2520decreased%2520proliferation%2520and%2520induces%2520apoptosis%2520in%2520esophageal%2520adenocarcinoma%2520cells%26jtitle%3DCancer%2520Invest.%26date%3D2013%26volume%3D31%26spage%3D480%26epage%3D489%26doi%3D10.3109%2F07357907.2013.820317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spilker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartkowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Effective targeting of hedgehog signaling in a medulloblastoma model with pf-5274857, a potent and selective smoothened antagonist that penetrates the blood-brain barrier</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1535-7163.MCT-11-0691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22084163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=57-65&author=A.+Rohnerauthor=M.+E.+Spilkerauthor=J.+L.+Lamauthor=B.+Pascualauthor=D.+Bartkowskiauthor=Q.+J.+Liauthor=A.+H.+Yangauthor=G.+Stevensauthor=M.+Xuauthor=P.+A.+Wellsauthor=S.+Plankenauthor=S.+Nairauthor=S.+Sun&title=Effective+targeting+of+hedgehog+signaling+in+a+medulloblastoma+model+with+pf-5274857%2C+a+potent+and+selective+smoothened+antagonist+that+penetrates+the+blood-brain+barrier&doi=10.1158%2F1535-7163.MCT-11-0691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood-Brain Barrier</span></div><div class="casAuthors">Rohner, Allison; Spilker, Mary E.; Lam, Justine L.; Pascual, Bernadette; Bartkowski, Darian; Li, Qing John; Yang, Amy H.; Stevens, Greg; Xu, Meirong; Wells, Peter A.; Planken, Simon; Nair, Sajiv; Sun, Shaoxian</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of the Smoothened (Smo) represents a promising therapeutic strategy for treating malignant tumors that are dependent on the Hedgehog (Hh) signaling pathway.  PF-5274857 is a novel Smo antagonist that specifically binds to Smo with a Ki of 4.6 ± 1.1 nmol/L and completely blocks the transcriptional activity of the downstream gene Gli1 with an IC50 of 2.7 ± 1.4 nmol/L in cells.  This Smo antagonist showed robust antitumor activity in a mouse model of medulloblastoma with an in vivo IC50 of 8.9 ± 2.6 nmol/L.  The downregulation of Gli1 is closely linked to the tumor growth inhibition in patched+/- medulloblastoma mice.  Math. anal. of the relationship between the drug's pharmacokinetics and Gli1 pharmacodynamics in patched+/- medulloblastoma tumor models yielded similar tumor and skin Gli1 IC50 values, suggesting that skin can be used as a surrogate tissue for the measurement of tumor Gli1 levels.  In addn., PF-5274857 was found to effectively penetrate the blood-brain barrier and inhibit Smo activity in the brain of primary medulloblastoma mice, resulting in improved animal survival rates.  The brain permeability of PF-5274857 was also confirmed and quantified in nontumor-bearing preclin. species with an intact blood-brain barrier.  PF-5274857 was orally available and metabolically stable in vivo.  These findings suggest that PF-5274857 is a potentially attractive clin. candidate for the treatment of tumor types including brain tumors and brain metastasis driven by an activated Hh pathway.  Mol Cancer Ther; 11(1); 57-65.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3I5j3LKkEULVg90H21EOLACvtfcHk0lgt3JJ7Ttiggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWmsQ%253D%253D&md5=678bd16cdb1dabcf520cf1d89214ef82</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0691%26sid%3Dliteratum%253Aachs%26aulast%3DRohner%26aufirst%3DA.%26aulast%3DSpilker%26aufirst%3DM.%2BE.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DPascual%26aufirst%3DB.%26aulast%3DBartkowski%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DQ.%2BJ.%26aulast%3DYang%26aufirst%3DA.%2BH.%26aulast%3DStevens%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DEffective%2520targeting%2520of%2520hedgehog%2520signaling%2520in%2520a%2520medulloblastoma%2520model%2520with%2520pf-5274857%252C%2520a%2520potent%2520and%2520selective%2520smoothened%2520antagonist%2520that%2520penetrates%2520the%2520blood-brain%2520barrier%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D57%26epage%3D65%26doi%3D10.1158%2F1535-7163.MCT-11-0691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonamici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of nvp-leq506, a second-generation inhibitor of smoothened</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1261</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcmdc.201300217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23821351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVehtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1261-1265&author=S.+Peukertauthor=F.+Heauthor=M.+Daiauthor=R.+Zhangauthor=Y.+Sunauthor=K.+Miller-Moslinauthor=M.+McEwanauthor=B.+Laguauthor=K.+Wangauthor=N.+Yusuffauthor=A.+Bourretauthor=A.+Ramamurthyauthor=W.+Maniaraauthor=A.+Amaralauthor=A.+Vattayauthor=A.+Wangauthor=R.+Guoauthor=J.+Yuanauthor=J.+Greenauthor=J.+Williamsauthor=S.+Buonamiciauthor=J.+F.+Kelleherauthor=M.+Dorsch&title=Discovery+of+nvp-leq506%2C+a+second-generation+inhibitor+of+smoothened&doi=10.1002%2Fcmdc.201300217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened</span></div><div class="casAuthors">Peukert, Stefan; He, Feng; Dai, Miao; Zhang, Rui; Sun, Yingchuan; Miller-Moslin, Karen; McEwan, Michael; Lagu, Bharat; Wang, Kate; Yusuff, Naeem; Bourret, Aaron; Ramamurthy, Arun; Maniara, Wieslawa; Amaral, Adam; Vattay, Anthony; Wang, Anlai; Guo, Ribo; Yuan, Jing; Green, John; Williams, Juliet; Buonamici, Silvia; Kelleher, Joseph F.; Dorsch, Marion</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1261-1265</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of piperazinylpyridazine derivs. was synthesized and evaluated as inhibitors of the Smoothened (Smo) receptor.  NVP-LEQ506 (I) was the most promising deriv. based on soly., hERG activity, and pharmacokinetic properties, and is currently in phase I clin. trials.  Compd. I displays good activity in a rodent model of medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwU3YkMVKfkLVg90H21EOLACvtfcHk0lgt3JJ7Ttiggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVehtLbP&md5=81410b9f6099775b39f97bfe0117f289</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300217%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DMcEwan%26aufirst%3DM.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DBourret%26aufirst%3DA.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DBuonamici%26aufirst%3DS.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DDorsch%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520nvp-leq506%252C%2520a%2520second-generation%2520inhibitor%2520of%2520smoothened%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1261%26epage%3D1265%26doi%3D10.1002%2Fcmdc.201300217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the human smoothened receptor bound to an antitumour agent</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>497</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1038/nature12167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature12167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23636324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=338-343&author=C.+Wangauthor=H.+Wuauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.+P.+Huangauthor=W.+Liuauthor=F.+Y.+Siuauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+human+smoothened+receptor+bound+to+an+antitumour+agent&doi=10.1038%2Fnature12167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the human smoothened receptor bound to an antitumour agent</span></div><div class="casAuthors">Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Liu, Wei; Siu, Fai Yiu; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7449</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis.  It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%.  Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-mol. antagonist LY2940680 at 2.5 Å resoln.  Although the SMO receptor shares the seven-transmembrane helical (7TM) fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulfide bonds.  The ligand binds at the extracellular end of the seven-transmembrane-helix bundle and forms extensive contacts with the loops.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmaIV6OXnzIrVg90H21EOLACvtfcHk0lggRGCLx05_jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFylsb0%253D&md5=fdd96ac77bcf93d5c8da46e5630795b2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnature12167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12167%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520human%2520smoothened%2520receptor%2520bound%2520to%2520an%2520antitumour%2520agent%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D338%26epage%3D343%26doi%3D10.1038%2Fnature12167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llamas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuff, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniara, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.,  3rd.</span></span> <span> </span><span class="NLM_article-title">1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3954</span>– <span class="NLM_lpage">3968</span>, <span class="refDoi"> DOI: 10.1021/jm900309j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900309j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVegtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3954-3968&author=K.+Miller-Moslinauthor=S.+Peukertauthor=R.+K.+Jainauthor=M.+A.+McEwanauthor=R.+Karkiauthor=L.+Llamasauthor=N.+Yusuffauthor=F.+Heauthor=Y.+Liauthor=Y.+Sunauthor=M.+Daiauthor=L.+Perezauthor=W.+Michaelauthor=T.+Shengauthor=H.+Leiauthor=R.+Zhangauthor=J.+Williamsauthor=A.+Bourretauthor=A.+Ramamurthyauthor=J.+Yuanauthor=R.+Guoauthor=M.+Matsumotoauthor=A.+Vattayauthor=W.+Maniaraauthor=A.+Amaralauthor=M.+Dorschauthor=J.+F.+Kelleher&title=1-amino-4-benzylphthalazines+as+orally+bioavailable+smoothened+antagonists+with+antitumor+activity&doi=10.1021%2Fjm900309j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity</span></div><div class="casAuthors">Miller-Moslin, Karen; Peukert, Stefan; Jain, Rishi K.; McEwan, Michael A.; Karki, Rajesh; Llamas, Luis; Yusuff, Naeem; He, Feng; Li, Yanhong; Sun, Yingchuan; Dai, Miao; Perez, Lawrence; Michael, Walter; Sheng, Tao; Lei, Huangshu; Zhang, Rui; Williams, Juliet; Bourret, Aaron; Ramamurthy, Arun; Yuan, Jing; Guo, Ribo; Matsumoto, Melissa; Vattay, Anthony; Maniara, Wieslawa; Amaral, Adam; Dorsch, Marion; Kelleher, Joseph F., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3954-3968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abnormal activation of the Hedgehog (Hh) signaling pathway has been linked to several types of human cancers, and the development of small-mol. inhibitors of this pathway represents a promising route toward novel anticancer therapeutics.  A cell-based screen performed in our labs. identified a new class of Hh pathway inhibitors, 1-amino-4-benzylphthalazines, e.g. I, that act via antagonism of the Smoothened receptor.  A variety of analogs were synthesized and their structure-activity relationships detd.  This optimization resulted in the discovery of high affinity Smoothened antagonists, one of which was further profiled in vivo.  This compd. displayed a good pharmacokinetic profile and also afforded tumor regression in a genetic mouse model of medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcQwfeb8I_UrVg90H21EOLACvtfcHk0lggRGCLx05_jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVegtbY%253D&md5=026fa9b87c71751e2af6323402e528c5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm900309j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900309j%26sid%3Dliteratum%253Aachs%26aulast%3DMiller-Moslin%26aufirst%3DK.%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DMcEwan%26aufirst%3DM.%2BA.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DLlamas%26aufirst%3DL.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DBourret%26aufirst%3DA.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DVattay%26aufirst%3DA.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26atitle%3D1-amino-4-benzylphthalazines%2520as%2520orally%2520bioavailable%2520smoothened%2520antagonists%2520with%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3954%26epage%3D3968%26doi%3D10.1021%2Fjm900309j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">384</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ejmech.2017.06.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28688278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKku77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=384-395&author=X.+Luauthor=Y.+Pengauthor=C.+Wangauthor=J.+Yangauthor=X.+Baoauthor=Q.+Dongauthor=W.+Zhaoauthor=W.+Tanauthor=X.+Dong&title=Design%2C+synthesis%2C+and+biological+evaluation+of+optimized+phthalazine+derivatives+as+hedgehog+signaling+pathway+inhibitors&doi=10.1016%2Fj.ejmech.2017.06.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors</span></div><div class="casAuthors">Lu, Xiuhong; Peng, Yuanqiu; Wang, Chenglin; Yang, Jun; Bao, Xiaolong; Dong, Qian; Zhao, Weili; Tan, Wenfu; Dong, Xiaochun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">384-395</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The authors report herein the design and synthesis of a series of optimized phthalazine compds. as novel hedgehog signaling pathway inhibitors.  The 4-methylamino-piperidine moiety of Taladegib was replaced by different four, five or six-membered azacycle or azaspirocycle building blocks.  The in vitro Gli-luciferase assay results demonstrate that the scaffold hopping in this region afforded significant influences on Hh pathway inhibition.  Pyrrolidin-3-amine moiety is the best linker between pharmacophores phthalazine and fluorine substituted benzoyl group.  Meanwhile the optimization of 1-methyl-1H-pyrazol by different arom. rings was also studied and the SAR was described.  Many new derivs. show potent Hh signaling inhibitory activity with nanomolar IC50 values.  Among these compds., compd. (R)-4-fluoro-N-(1-(4-(4-(hydroxymethyl)phenyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl)benzamide showed the highest inhibitory potency with an IC50 value of 0.17 nM, which was 35-fold more potent than the lead compd. Taladegib and 23-fold more potent than the marketed drug Vismodegib.  The selected compds. (R)-4-fluoro-N-(1-(4-(p-tolyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl) benzamide and (R)-4-fluoro-N-(1-(4-(4-(hydroxymethyl)phenyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl)benzamide also possess potent antitumor activities against medulloblastoma cells proliferation in vitro.  In vivo efficacy of (R)-4-fluoro-N-(1-(4-(4-(hydroxymethyl)phenyl)phthalazin-1-yl)pyrrolidin-3-yl)-2-(trifluoromethyl)benzamide in a ptch+/-p53-/- mouse medulloblastoma allograft model also indicated encouraging results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1P0my-vkiLLVg90H21EOLACvtfcHk0lizqRtdqRyaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKku77P&md5=23a21140025d3eb8d831355d3b1e8173</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.031%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DBao%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520optimized%2520phthalazine%2520derivatives%2520as%2520hedgehog%2520signaling%2520pathway%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D384%26epage%3D395%26doi%3D10.1016%2Fj.ejmech.2017.06.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span> <span> </span><span class="NLM_article-title">A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1336</span>, <span class="refDoi"> DOI: 10.1039/C7MD00104E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1039%2FC7MD00104E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30108845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVCgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1332-1336&author=L.+Yeauthor=K.+Dingauthor=F.+Zhaoauthor=X.+Liuauthor=Y.+Wuauthor=Y.+Liuauthor=D.+Xueauthor=F.+Zhouauthor=X.+Zhangauthor=R.+C.+Stevensauthor=F.+Xuauthor=S.+Zhaoauthor=H.+Tao&title=A+structurally+guided+dissection-then-evolution+strategy+for+ligand+optimization+of+smoothened+receptor&doi=10.1039%2FC7MD00104E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor</span></div><div class="casAuthors">Ye, Lintao; Ding, Kang; Zhao, Fei; Liu, Xiaoyan; Wu, Yiran; Liu, Yang; Xue, Dongxiang; Zhou, Fang; Zhang, Xianjun; Stevens, Raymond C.; Xu, Fei; Zhao, Suwen; Tao, Houchao</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1332-1336</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We present herein a novel dissection-then-evolution strategy for ligand optimization.  Using the co-crystal structure of the smoothened receptor (SMO) as a guide, we studied the modular contribution of LY2940680 by systematically "silencing" the specific interaction between the individual residue(s) and the fragment in the ligand.  Following evolution by focusing on the benzoyl part finally yielded an improved ligand 21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofP_6q0s--XLVg90H21EOLACvtfcHk0lizqRtdqRyaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVCgsr8%253D&md5=0268adf9e5db19b26cd11480ee8bf083</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1039%2FC7MD00104E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00104E%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DTao%26aufirst%3DH.%26atitle%3DA%2520structurally%2520guided%2520dissection-then-evolution%2520strategy%2520for%2520ligand%2520optimization%2520of%2520smoothened%2520receptor%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D1332%26epage%3D1336%26doi%3D10.1039%2FC7MD00104E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peukert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller-Moslin, K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201000011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcmdc.201000011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20229564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFyqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=500-512&author=S.+Peukertauthor=K.+Miller-Moslin&title=Small-molecule+inhibitors+of+the+hedgehog+signaling+pathway+as+cancer+therapeutics&doi=10.1002%2Fcmdc.201000011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics</span></div><div class="casAuthors">Peukert, Stefan; Miller-Moslin, Karen</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">500-512</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the Hedgehog (Hh) mol. signaling pathway have emerged in recent years as a promising new class of potential therapeutics for cancer treatment.  Numerous drug discovery efforts have resulted in the identification of a wide variety of small mols. that target different members of this pathway, including Smoothened (Smo), Sonic hedgehog protein (Shh), and Gli1.  Several Smo inhibitors have now entered human clin. trials, and successful proof-of-concept studies have been carried out in patients with defined genetic mutations in the Hh pathway.  This review provides a general overview of three main topics in this rapidly expanding area: (1) the various types of biol. assays and in vivo models that have been employed for the identification and optimization of Hh pathway inhibitors; (2) Smo inhibitors reported to date, including recent clin. results where available; and (3) efforts toward the identification and characterization of inhibitors of other members of the Hh pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwPNA0A-NVA7Vg90H21EOLACvtfcHk0lizqRtdqRyaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFyqt7o%253D&md5=429705c283818ba2af09f66aceea2ff3</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000011%26sid%3Dliteratum%253Aachs%26aulast%3DPeukert%26aufirst%3DS.%26aulast%3DMiller-Moslin%26aufirst%3DK.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520hedgehog%2520signaling%2520pathway%2520as%2520cancer%2520therapeutics%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D500%26epage%3D512%26doi%3D10.1002%2Fcmdc.201000011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span> <span> </span><span class="NLM_article-title">Current trends in hedgehog signaling pathway inhibition by small molecules</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3140</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2018.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30177379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1GlsLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3131-3140&author=F.+Ghirgaauthor=M.+Moriauthor=P.+Infante&title=Current+trends+in+hedgehog+signaling+pathway+inhibition+by+small+molecules&doi=10.1016%2Fj.bmcl.2018.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Current trends in Hedgehog signaling pathway inhibition by small molecules</span></div><div class="casAuthors">Ghirga, Francesca; Mori, Mattia; Infante, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3131-3140</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hedgehog (Hh) signaling pathway is a widely appreciated target for anticancer therapy.  However, drug resistance at the Smoothened receptor (SMO) and Hh activation downstream/independently of SMO seriously limit the clin. use of SMO antagonists.  Here, we address the main strategies that have been recently established to inhibit the Hh pathway and to bypass the above limitations.  Particularly, we review efforts that have been spent to develop novel and potent SMO antagonists able to modulate the drug-resistant forms of SMO, to discover efficient glioma-assocd. oncogene (GLI) antagonists and inhibitors of GLI-mediated transcription, and to establish and assay promising combination of multiple agents with enhanced Hh inhibition at lower individual doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlvJKs68Qsc7Vg90H21EOLACvtfcHk0lhwFLVMguie9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1GlsLnF&md5=3e47ec73dcf2865fc5151dafbb4d73d4</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DGhirga%26aufirst%3DF.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DInfante%26aufirst%3DP.%26atitle%3DCurrent%2520trends%2520in%2520hedgehog%2520signaling%2520pathway%2520inhibition%2520by%2520small%2520molecules%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3131%26epage%3D3140%26doi%3D10.1016%2Fj.bmcl.2018.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raleigh, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sever, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elnatan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisignano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Gonzalo, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krup, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, E. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebold, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. F.</span></span> <span> </span><span class="NLM_article-title">Cilia-associated oxysterols activate smoothened</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2018.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.molcel.2018.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30340023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKisr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2018&pages=316-327&author=D.+R.+Raleighauthor=N.+Severauthor=P.+K.+Choksiauthor=M.+A.+Siggauthor=K.+M.+Hinesauthor=B.+M.+Thompsonauthor=D.+Elnatanauthor=P.+Jaishankarauthor=P.+Bisignanoauthor=F.+R.+Garcia-Gonzaloauthor=A.+L.+Krupauthor=M.+Eberlauthor=E.+F.+X.+Byrneauthor=C.+Sieboldauthor=S.+Y.+Wongauthor=A.+R.+Rensloauthor=M.+Grabeauthor=J.+G.+McDonaldauthor=L.+Xuauthor=P.+A.+Beachyauthor=J.+F.+Reiter&title=Cilia-associated+oxysterols+activate+smoothened&doi=10.1016%2Fj.molcel.2018.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Cilia-Associated Oxysterols Activate Smoothened</span></div><div class="casAuthors">Raleigh, David R.; Sever, Navdar; Choksi, Pervinder K.; Sigg, Monika Abedin; Hines, Kelly M.; Thompson, Bonne M.; Elnatan, Daniel; Jaishankar, Priyadarshini; Bisignano, Paola; Garcia-Gonzalo, Francesc R.; Krup, Alexis Leigh; Eberl, Markus; Byrne, Eamon F. X.; Siebold, Christian; Wong, Sunny Y.; Renslo, Adam R.; Grabe, Michael; McDonald, Jeffrey G.; Xu, Libin; Beachy, Philip A.; Reiter, Jeremy F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-327.e5</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Primary cilia are required for Smoothened to transduce vertebrate Hedgehog signals, but how Smoothened accumulates in cilia and is activated is incompletely understood.  Here, we identify cilia-assocd. oxysterols that promote Smoothened accumulation in cilia and activate the Hedgehog pathway.  Our data reveal that cilia-assocd. oxysterols bind to two distinct Smoothened domains to modulate Smoothened accumulation in cilia and tune the intensity of Hedgehog pathway activation.  We find that the oxysterol synthase HSD11β2 participates in the prodn. of Smoothened-activating oxysterols and promotes Hedgehog pathway activity.  Inhibiting oxysterol biosynthesis impedes oncogenic Hedgehog pathway activation and attenuates the growth of Hedgehog pathway-assocd. medulloblastoma, suggesting that targeted inhibition of Smoothened-activating oxysterol prodn. may be therapeutically useful for patients with Hedgehog-assocd. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru2l0jZP9ZlLVg90H21EOLACvtfcHk0lhwFLVMguie9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKisr%252FP&md5=023a694630c8f42fbdfd30169aa49e55</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2018.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2018.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DRaleigh%26aufirst%3DD.%2BR.%26aulast%3DSever%26aufirst%3DN.%26aulast%3DChoksi%26aufirst%3DP.%2BK.%26aulast%3DSigg%26aufirst%3DM.%2BA.%26aulast%3DHines%26aufirst%3DK.%2BM.%26aulast%3DThompson%26aufirst%3DB.%2BM.%26aulast%3DElnatan%26aufirst%3DD.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DGarcia-Gonzalo%26aufirst%3DF.%2BR.%26aulast%3DKrup%26aufirst%3DA.%2BL.%26aulast%3DEberl%26aufirst%3DM.%26aulast%3DByrne%26aufirst%3DE.%2BF.%2BX.%26aulast%3DSiebold%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%2BY.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DGrabe%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DJ.%2BG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26aulast%3DReiter%26aufirst%3DJ.%2BF.%26atitle%3DCilia-associated%2520oxysterols%2520activate%2520smoothened%26jtitle%3DMol.%2520Cell%26date%3D2018%26volume%3D72%26spage%3D316%26epage%3D327%26doi%3D10.1016%2Fj.molcel.2018.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nedelcu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span> <span> </span><span class="NLM_article-title">Oxysterol binding to the extracellular domain of smoothened in hedgehog signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.1290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23831757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKgs77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=557-564&author=D.+Nedelcuauthor=J.+Liuauthor=Y.+Xuauthor=C.+Jaoauthor=A.+Salic&title=Oxysterol+binding+to+the+extracellular+domain+of+smoothened+in+hedgehog+signaling&doi=10.1038%2Fnchembio.1290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling</span></div><div class="casAuthors">Nedelcu, Daniel; Liu, Jing; Xu, Yangqing; Jao, Cindy; Salic, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">557-564</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oxysterols bind the seven-transmembrane protein Smo and potently activate vertebrate Hedgehog (Hh) signaling, a pathway essential in embryonic development, adult stem cell maintenance and cancer.  It is unknown, however, whether oxysterols are important for normal vertebrate Hh signaling and whether antagonizing oxysterols can inhibit the Hh pathway.  We developed azasterols that block Hh signaling by binding the oxysterol-binding site of Smo.  We show that the binding site for oxysterols and azasterols maps to the extracellular, cysteine-rich domain of Smo and is completely separable from the site bound by other small-mol. modulators, located within the heptahelical bundle of Smo.  Smo mutants in which oxysterol binding is abolished no longer respond to oxysterols and cannot be maximally activated by the Hh ligand.  Our results show that oxysterol binding to vertebrate Smo is required for normal Hh signaling and that targeting the oxysterol-binding site is an effective strategy to inhibit Smo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa3LuWLb8VtrVg90H21EOLACvtfcHk0lhwFLVMguie9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKgs77P&md5=865fa3e4bd97ac1c706de40f7fd0c042</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1290%26sid%3Dliteratum%253Aachs%26aulast%3DNedelcu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJao%26aufirst%3DC.%26aulast%3DSalic%26aufirst%3DA.%26atitle%3DOxysterol%2520binding%2520to%2520the%2520extracellular%2520domain%2520of%2520smoothened%2520in%2520hedgehog%2520signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D557%26epage%3D564%26doi%3D10.1038%2Fnchembio.1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rana, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grace, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guibao, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the role of the smoothened cysteine-rich domain in hedgehog signalling</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2965</span>, <span class="refDoi"> DOI: 10.1038/ncomms3965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms3965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24351982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslCiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2965&author=R.+Ranaauthor=C.+E.+Carrollauthor=H.+J.+Leeauthor=J.+Baoauthor=S.+Maradaauthor=C.+R.+Graceauthor=C.+D.+Guibaoauthor=S.+K.+Ogdenauthor=J.+J.+Zheng&title=Structural+insights+into+the+role+of+the+smoothened+cysteine-rich+domain+in+hedgehog+signalling&doi=10.1038%2Fncomms3965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signalling</span></div><div class="casAuthors">Rana Rajashree; Zheng Jie J; Carroll Candace E; Lee Ho-Jin; Bao Ju; Grace Christy R R; Guibao Cristina D; Marada Suresh; Ogden Stacey K</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2965</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Smoothened (Smo) is a member of the Frizzled (FzD) class of G-protein-coupled receptors (GPCRs), and functions as the key transducer in the Hedgehog (Hh) signalling pathway.  Smo has an extracellular cysteine-rich domain (CRD), indispensable for its function and downstream Hh signalling.  Despite its essential role, the functional contribution of the CRD to Smo signalling has not been clearly elucidated.  However, given that the FzD CRD binds to the endogenous Wnt ligand, it has been proposed that the Smo CRD may bind its own endogenous ligand.  Here we present the NMR solution structure of the Drosophila Smo CRD, and describe interactions between the glucocorticoid budesonide (Bud) and the Smo CRDs from both Drosophila and human.  Our results highlight a function of the Smo CRD, demonstrating its role in binding to small-molecule modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp62q3xNe7a7QfW6udTcc2eYr3Jqp0qwcFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslCiug%253D%253D&md5=f848a32b83aadb78b339d92be83e8e5f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fncomms3965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3965%26sid%3Dliteratum%253Aachs%26aulast%3DRana%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DC.%2BE.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DBao%26aufirst%3DJ.%26aulast%3DMarada%26aufirst%3DS.%26aulast%3DGrace%26aufirst%3DC.%2BR.%26aulast%3DGuibao%26aufirst%3DC.%2BD.%26aulast%3DOgden%26aufirst%3DS.%2BK.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26atitle%3DStructural%2520insights%2520into%2520the%2520role%2520of%2520the%2520smoothened%2520cysteine-rich%2520domain%2520in%2520hedgehog%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2965%26doi%3D10.1038%2Fncomms3965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidow, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arvanites, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, A. P.</span></span> <span> </span><span class="NLM_article-title">Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">982</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.chembiol.2012.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22921064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kku7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=972-982&author=Y.+Wangauthor=L.+Davidowauthor=A.+C.+Arvanitesauthor=J.+Blanchardauthor=K.+Lamauthor=K.+Xuauthor=V.+Ozaauthor=J.+W.+Yooauthor=J.+M.+Ngauthor=T.+Curranauthor=L.+L.+Rubinauthor=A.+P.+McMahon&title=Glucocorticoid+compounds+modify+smoothened+localization+and+hedgehog+pathway+activity&doi=10.1016%2Fj.chembiol.2012.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Glucocorticoid Compounds Modify Smoothened Localization and Hedgehog Pathway Activity</span></div><div class="casAuthors">Wang, Yu; Davidow, Lance; Arvanites, Anthony C.; Blanchard, Joel; Lam, Kelvin; Xu, Ke; Oza, Vatsal; Yoo, Jin Woo; Ng, Jessica M. Y.; Curran, Tom; Rubin, Lee L.; McMahon, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">972-982</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Hedgehog signaling pathway is linked to a variety of diseases, notably a range of cancers.  The first generation of drug screens identified Smoothened (Smo), a membrane protein essential for signaling, as an attractive drug target.  Smo localizes to the primary cilium upon pathway activation, and this transition is crit. for the response to Hedgehog ligands.  In a high content screen directly monitoring Smo distribution in Hedgehog-responsive cells, the authors identified different glucocorticoids as specific modulators of Smo ciliary accumulation.  One class promoted Smo accumulation, conferring cellular hypersensitivity to Hedgehog stimulation.  In contrast, a second class inhibited Smo ciliary localization and signaling activity by both wild-type Smo, and mutant forms of Smo, SmoM2, and SmoD473H, that are refractory to previously identified Smo antagonists.  These findings point to the potential for developing glucocorticoid-based pharmacol. modulation of Smo signaling to treat mutated drug-resistant forms of Smo, an emerging problem in long-term cancer therapy.  They also raise a concern about potential crosstalk of glucocorticoid drugs in the Hedgehog pathway, if therapeutic administration exceeds levels assocd. with on-target transcriptional mechanisms of glucocorticoid action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlupbrzYeLo7Vg90H21EOLACvtfcHk0lgKApUvCRCBnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kku7zM&md5=295150ec28632cf98b156c4a5ec5857f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDavidow%26aufirst%3DL.%26aulast%3DArvanites%26aufirst%3DA.%2BC.%26aulast%3DBlanchard%26aufirst%3DJ.%26aulast%3DLam%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DOza%26aufirst%3DV.%26aulast%3DYoo%26aufirst%3DJ.%2BW.%26aulast%3DNg%26aufirst%3DJ.%2BM.%26aulast%3DCurran%26aufirst%3DT.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DMcMahon%26aufirst%3DA.%2BP.%26atitle%3DGlucocorticoid%2520compounds%2520modify%2520smoothened%2520localization%2520and%2520hedgehog%2520pathway%2520activity%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D972%26epage%3D982%26doi%3D10.1016%2Fj.chembiol.2012.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englund, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span> <span> </span><span class="NLM_article-title">Small molecule antagonists in distinct binding modes inhibit drug-resistant mutant of smoothened</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.chembiol.2011.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21513879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=432-437&author=H.+Taoauthor=Q.+Jinauthor=D.+I.+Kooauthor=X.+Liaoauthor=N.+P.+Englundauthor=Y.+Wangauthor=A.+Ramamurthyauthor=P.+G.+Schultzauthor=M.+Dorschauthor=J.+Kelleherauthor=X.+Wu&title=Small+molecule+antagonists+in+distinct+binding+modes+inhibit+drug-resistant+mutant+of+smoothened&doi=10.1016%2Fj.chembiol.2011.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Antagonists in Distinct Binding Modes Inhibit Drug-Resistant Mutant of Smoothened</span></div><div class="casAuthors">Tao, Haiyan; Jin, Qihui; Koo, Dong-In; Liao, Xuebin; Englund, Nathan P.; Wang, Yan; Ramamurthy, Arun; Schultz, Peter G.; Dorsch, Marion; Kelleher, Joseph; Wu, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-437</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Several small mol. antagonists for Smoothened (Smo) have been developed, and achieved promising preclin. efficacy in cancers that are dependent on Hedgehog (Hh) signaling.  However, in a recent clin. study, a drug-resistant D473H SMO mutant was identified that is thought to be responsible for cancer relapse in a patient with medulloblastoma.  Here, we report two Smo antagonists that bind to distinct sites, as compared to known antagonists and agonists, and inhibit both wild-type and mutant Smo.  These findings provide an insight of the ligand-binding sites of Smo and a basis for the development of potential therapeutics for tumors with drug-resistant Smo mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-DmQdtwuGLVg90H21EOLACvtfcHk0lgKApUvCRCBnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFartrk%253D&md5=d592c4432c438c5644d7bfc8a00dd3f1</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DKoo%26aufirst%3DD.%2BI.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DEnglund%26aufirst%3DN.%2BP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRamamurthy%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DDorsch%26aufirst%3DM.%26aulast%3DKelleher%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26atitle%3DSmall%2520molecule%2520antagonists%2520in%2520distinct%2520binding%2520modes%2520inhibit%2520drug-resistant%2520mutant%2520of%2520smoothened%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D432%26epage%3D437%26doi%3D10.1016%2Fj.chembiol.2011.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basset-Seguin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durham, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haverty, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarin, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirix, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migden, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2015.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccell.2015.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25759019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFOgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=327-341&author=H.+J.+Sharpeauthor=G.+Pauauthor=G.+J.+Dijkgraafauthor=N.+Basset-Seguinauthor=Z.+Modrusanauthor=T.+Januarioauthor=V.+Tsuiauthor=A.+B.+Durhamauthor=A.+A.+Dlugoszauthor=P.+M.+Havertyauthor=R.+Bourgonauthor=J.+Y.+Tangauthor=K.+Y.+Sarinauthor=L.+Dirixauthor=D.+C.+Fisherauthor=C.+M.+Rudinauthor=H.+Sofenauthor=M.+R.+Migdenauthor=R.+L.+Yauchauthor=F.+J.+de+Sauvage&title=Genomic+analysis+of+smoothened+inhibitor+resistance+in+basal+cell+carcinoma&doi=10.1016%2Fj.ccell.2015.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma</span></div><div class="casAuthors">Sharpe, Hayley J.; Pau, Gregoire; Dijkgraaf, Gerrit J.; Basset-Seguin, Nicole; Modrusan, Zora; Januario, Thomas; Tsui, Vickie; Durham, Alison B.; Dlugosz, Andrzej A.; Haverty, Peter M.; Bourgon, Richard; Tang, Jean Y.; Sarin, Kavita Y.; Dirix, Luc; Fisher, David C.; Rudin, Charles M.; Sofen, Howard; Migden, Michael R.; Yauch, Robert L.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-341</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Smoothened (SMO) inhibitors are under clin. investigation for the treatment of several cancers.  Vismodegib is approved for the treatment of locally advanced and metastatic basal cell carcinoma (BCC).  Most BCC patients experience significant clin. benefit on vismodegib, but some develop resistance.  Genomic anal. of tumor biopsies revealed that vismodegib resistance is assocd. with Hedgehog (Hh) pathway reactivation, predominantly through mutation of the drug target SMO and to a lesser extent through concurrent copy no. changes in SUFU and GLI2.  SMO mutations either directly impaired drug binding or activated SMO to varying levels.  Furthermore, we found evidence for intra-tumor heterogeneity, suggesting that a combination of therapies targeting components at multiple levels of the Hh pathway is required to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIlO1aRWxygbVg90H21EOLACvtfcHk0livGQf67DQvoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFOgtrs%253D&md5=fe0aa6db03295a3250a3e7c3679e08f4</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DSharpe%26aufirst%3DH.%2BJ.%26aulast%3DPau%26aufirst%3DG.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DBasset-Seguin%26aufirst%3DN.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDurham%26aufirst%3DA.%2BB.%26aulast%3DDlugosz%26aufirst%3DA.%2BA.%26aulast%3DHaverty%26aufirst%3DP.%2BM.%26aulast%3DBourgon%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DSarin%26aufirst%3DK.%2BY.%26aulast%3DDirix%26aufirst%3DL.%26aulast%3DFisher%26aufirst%3DD.%2BC.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DSofen%26aufirst%3DH.%26aulast%3DMigden%26aufirst%3DM.%2BR.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DGenomic%2520analysis%2520of%2520smoothened%2520inhibitor%2520resistance%2520in%2520basal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26spage%3D327%26epage%3D341%26doi%3D10.1016%2Fj.ccell.2015.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling study on resistance of wt/d473h smo to antagonists lde-225 and leq-506</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2017.11.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.phrs.2017.11.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29175550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFaht73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2018&pages=491-499&author=J.+Tuauthor=J.+J.+Liauthor=L.+T.+Songauthor=H.+L.+Zhaiauthor=J.+Wangauthor=X.+Y.+Zhang&title=Molecular+modeling+study+on+resistance+of+wt%2Fd473h+smo+to+antagonists+lde-225+and+leq-506&doi=10.1016%2Fj.phrs.2017.11.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506</span></div><div class="casAuthors">Tu, Jing; Li, Jiao Jiao; Song, Li Ting; Zhai, Hong Lin; Wang, Juan; Zhang, Xiao Yun</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">491-499</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The smoothened (SMO) receptor, an essential signal transducer in the Hedgehog pathway, was targeted with antagonists to suppress the tumor.  It is interesting that SMO D473H mutation confers resistance on inhibitor LDE-225 rather than LEQ-506.  In this paper, the binding modes of them against the wild type and mutant SMO receptors were identified to gain insights into the resistant and non-resistant factors, based on a comprehensive protocol involving mol. docking, mol. dynamic simulations, free energy calcn. and decompn.  A comparison of resistant LDE-225 and non-resistant LEQ-506 indicates that the vol. of the binding cavity decreases seriously in the mutant complex with resistant LDE-225.  In addn., the D473H mutation disrupts the hydrogen bond network with residues R400 and Q477, which results in the TM6 conformation inward.  Owing to the absence of the hydrogen bond, residues R400 and Q477 make weak contributions to LDE-225.  However, the D473H mutation along with TM6 conformational change has no effect on non-resistant LEQ-506.  Finally, the resistance ascribes to adverse interaction between the greater polarity of mutant residue H473 and the nonpolar phenmethyl of LDE-225.  The elaborate insights into structural and energetic mechanism of drug resistance provide an effective strategy to design rationally non-resistant antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa9BCo-pYySrVg90H21EOLACvtfcHk0livGQf67DQvoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFaht73F&md5=f3d0c235b9788607723724e97159bab0</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2017.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2017.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DSong%26aufirst%3DL.%2BT.%26aulast%3DZhai%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26atitle%3DMolecular%2520modeling%2520study%2520on%2520resistance%2520of%2520wt%252Fd473h%2520smo%2520to%2520antagonists%2520lde-225%2520and%2520leq-506%26jtitle%3DPharmacol.%2520Res.%26date%3D2018%26volume%3D129%26spage%3D491%26epage%3D499%26doi%3D10.1016%2Fj.phrs.2017.11.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, E. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sircar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachtergaele, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydock-McGrane, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambo, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, M. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newstead, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohatgi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siebold, C.</span></span> <span> </span><span class="NLM_article-title">Structural basis of smoothened regulation by its extracellular domains</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1038/nature18934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature18934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27437577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=517-522&author=E.+F.+X.+Byrneauthor=R.+Sircarauthor=P.+S.+Millerauthor=G.+Hedgerauthor=G.+Luchettiauthor=S.+Nachtergaeleauthor=M.+D.+Tullyauthor=L.+Mydock-McGraneauthor=D.+F.+Coveyauthor=R.+P.+Ramboauthor=M.+S.+P.+Sansomauthor=S.+Newsteadauthor=R.+Rohatgiauthor=C.+Siebold&title=Structural+basis+of+smoothened+regulation+by+its+extracellular+domains&doi=10.1038%2Fnature18934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Smoothened regulation by its extracellular domains</span></div><div class="casAuthors">Byrne, Eamon F. X.; Sircar, Ria; Miller, Paul S.; Hedger, George; Luchetti, Giovanni; Nachtergaele, Sigrid; Tully, Mark D.; Mydock-McGrane, Laurel; Covey, Douglas F.; Rambo, Robert P.; Sansom, Mark S. P.; Newstead, Simon; Rohatgi, Rajat; Siebold, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7613</span>),
    <span class="NLM_cas:pages">517-522</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Developmental signals of the Hedgehog (Hh) and Wnt families are transduced across the membrane by Frizzled-class G-protein-coupled receptors (GPCRs) composed of both a heptahelical transmembrane domain (TMD) and an extracellular cysteine-rich domain (CRD).  How the large extracellular domains of GPCRs regulate signalling by the TMD is unknown.  We present crystal structures of the Hh signal transducer and oncoprotein Smoothened, a GPCR that contains two distinct ligand-binding sites: one in its TMD and one in the CRD.  The CRD is stacked atop the TMD, sepd. by an intervening wedge-like linker domain.  Structure-guided mutations show that the interface between the CRD, linker domain and TMD stabilizes the inactive state of Smoothened.  Unexpectedly, we find a cholesterol mol. bound to Smoothened in the CRD binding site.  Mutations predicted to prevent cholesterol binding impair the ability of Smoothened to transmit native Hh signals.  Binding of a clin. used antagonist, vismodegib, to the TMD induces a conformational change that is propagated to the CRD, resulting in loss of cholesterol from the CRD-linker domain-TMD interface.  Our results clarify the structural mechanism by which the activity of a GPCR is controlled by ligand-regulated interactions between its extracellular and transmembrane domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprpMreLzg7GbVg90H21EOLACvtfcHk0livGQf67DQvoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ont73O&md5=8ca7a908d602acc663b887a570c1a736</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnature18934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18934%26sid%3Dliteratum%253Aachs%26aulast%3DByrne%26aufirst%3DE.%2BF.%2BX.%26aulast%3DSircar%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DP.%2BS.%26aulast%3DHedger%26aufirst%3DG.%26aulast%3DLuchetti%26aufirst%3DG.%26aulast%3DNachtergaele%26aufirst%3DS.%26aulast%3DTully%26aufirst%3DM.%2BD.%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DCovey%26aufirst%3DD.%2BF.%26aulast%3DRambo%26aufirst%3DR.%2BP.%26aulast%3DSansom%26aufirst%3DM.%2BS.%2BP.%26aulast%3DNewstead%26aufirst%3DS.%26aulast%3DRohatgi%26aufirst%3DR.%26aulast%3DSiebold%26aufirst%3DC.%26atitle%3DStructural%2520basis%2520of%2520smoothened%2520regulation%2520by%2520its%2520extracellular%2520domains%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D517%26epage%3D522%26doi%3D10.1038%2Fnature18934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibition of gdc-0449 refractory smoothened mutants and downstream mechanisms of drug resistance</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-2876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-10-2876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21123452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFKmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=435-444&author=G.+J.+Dijkgraafauthor=B.+Alickeauthor=L.+Weinmannauthor=T.+Januarioauthor=K.+Westauthor=Z.+Modrusanauthor=D.+Burdickauthor=R.+Goldsmithauthor=K.+Robargeauthor=D.+Sutherlinauthor=S.+J.+Scalesauthor=S.+E.+Gouldauthor=R.+L.+Yauchauthor=F.+J.+de+Sauvage&title=Small+molecule+inhibition+of+gdc-0449+refractory+smoothened+mutants+and+downstream+mechanisms+of+drug+resistance&doi=10.1158%2F0008-5472.CAN-10-2876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance</span></div><div class="casAuthors">Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Weinmann, Lasse; Januario, Thomas; West, Kristina; Modrusan, Zora; Burdick, Dan; Goldsmith, Richard; Robarge, Kirk; Sutherlin, Dan; Scales, Suzie J.; Gould, Stephen E.; Yauch, Robert L.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-444</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inappropriate Hedgehog (Hh) signaling has been directly linked to medulloblastoma (MB), a common malignant brain tumor in children.  GDC-0449 is an Hh pathway inhibitor (HPI) currently under clin. investigation as an anticancer agent.  Treatment of a MB patient with GDC-0449 initially regressed tumors, but this individual ultimately relapsed with a D473H resistance mutation in Smoothened (SMO), the mol. target of GDC-0449.  To explore the role of the mutated aspartic acid residue in SMO function, we substituted D473 with every amino acid and found that all functional mutants were resistant to GDC-0449, with pos. charged residues conferring potential oncogenic properties.  Alanine scan mutagenesis of SMO further identified E518 as a novel prospective mutation site for GDC-0449 resistance.  To overcome this form of acquired resistance, we screened a panel of chem. diverse HPIs and identified several antagonists with potent in vitro activity against these GDC-0449-resistant SMO mutants.  The bis-amide compd. 5 was of particular interest, as it was able to inhibit tumor growth mediated by drug resistant SMO in a murine allograft model of MB.  However, focal amplifications of the Hh pathway transcription factor Gli2 and the Hh target gene cyclin D1 (Ccnd1) were obsd. in two addnl. resistant models, indicating that resistance may also occur downstream of SMO.  Importantly, these HPI resistant MB allografts retained their sensitivity to PI3K inhibition, presenting addnl. opportunities for the treatment of such tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkJl8oB7usSbVg90H21EOLACvtfcHk0lgcOM5sLgn5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFKmtA%253D%253D&md5=d0b110e7c8c22ba9bde5635503565b72</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2876%26sid%3Dliteratum%253Aachs%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DWeinmann%26aufirst%3DL.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DBurdick%26aufirst%3DD.%26aulast%3DGoldsmith%26aufirst%3DR.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DSutherlin%26aufirst%3DD.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DSmall%2520molecule%2520inhibition%2520of%2520gdc-0449%2520refractory%2520smoothened%2520mutants%2520and%2520downstream%2520mechanisms%2520of%2520drug%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D435%26epage%3D444%26doi%3D10.1158%2F0008-5472.CAN-10-2876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urman, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollmig, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasi, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarin, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span> <span> </span><span class="NLM_article-title">Noncanonical hedgehog pathway activation through srf-mkl1 promotes drug resistance in basal cell carcinomas</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/nm.4476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnm.4476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29400712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=271-281&author=R.+J.+Whitsonauthor=A.+Leeauthor=N.+M.+Urmanauthor=A.+Mirzaauthor=C.+Y.+Yaoauthor=A.+S.+Brownauthor=J.+R.+Liauthor=G.+Shankarauthor=M.+A.+Fryauthor=S.+X.+Atwoodauthor=E.+Y.+Leeauthor=S.+T.+Hollmigauthor=S.+Z.+Aasiauthor=K.+Y.+Sarinauthor=M.+P.+Scottauthor=E.+H.+Epsteinauthor=J.+Y.+Tangauthor=A.+E.+Oro&title=Noncanonical+hedgehog+pathway+activation+through+srf-mkl1+promotes+drug+resistance+in+basal+cell+carcinomas&doi=10.1038%2Fnm.4476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas</span></div><div class="casAuthors">Whitson, Ramon J.; Lee, Alex; Urman, Nicole M.; Mirza, Amar; Yao, Catherine Y.; Brown, Alexander S.; Li, Jiang R.; Shankar, Gautam; Fry, Micah A.; Atwood, Scott X.; Lee, Eunice Y.; Hollmig, S. Tyler; Aasi, Sumaira Z.; Sarin, Kavita Y.; Scott, Matthew P.; Epstein, Ervin H., Jr.; Tang, Jean Y.; Oro, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Hedgehog pathway-dependent cancers can escape Smoothened (SMO) inhibition through mutations in genes encoding canonical hedgehog pathway components; however, around 50% of drug-resistant basal cell carcinomas (BCCs) lack addnl. variants of these genes.  Here we use multidimensional genomics anal. of human and mouse drug-resistant BCCs to identify a noncanonical hedgehog activation pathway driven by the transcription factor serum response factor (SRF).  Active SRF along with its coactivator megakaryoblastic leukemia 1 (MKL1) binds DNA near hedgehog target genes and forms a previously unknown protein complex with the hedgehog transcription factor glioma-assocd. oncogene family zinc finger-1 (GLI1), causing amplification of GLI1 transcriptional activity.  We show that cytoskeletal activation through Rho and the formin family member Diaphanous (mDia) is required for SRF-MKL-driven GLI1 activation and for tumor cell viability.  Remarkably, nuclear MKL1 staining served as a biomarker in tumors from mice and human subjects to predict tumor responsiveness to MKL inhibitors, highlighting the therapeutic potential of targeting this pathway.  Thus, our study illuminates, for the first time, cytoskeletal-activation-driven transcription as a personalized therapeutic target for combating drug-resistant malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3gaatPokUjbVg90H21EOLACvtfcHk0lgcOM5sLgn5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCiu7c%253D&md5=a4391e87dfb08bf311aa8a735fe2cfaf</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fnm.4476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4476%26sid%3Dliteratum%253Aachs%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DUrman%26aufirst%3DN.%2BM.%26aulast%3DMirza%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DC.%2BY.%26aulast%3DBrown%26aufirst%3DA.%2BS.%26aulast%3DLi%26aufirst%3DJ.%2BR.%26aulast%3DShankar%26aufirst%3DG.%26aulast%3DFry%26aufirst%3DM.%2BA.%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DLee%26aufirst%3DE.%2BY.%26aulast%3DHollmig%26aufirst%3DS.%2BT.%26aulast%3DAasi%26aufirst%3DS.%2BZ.%26aulast%3DSarin%26aufirst%3DK.%2BY.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DOro%26aufirst%3DA.%2BE.%26atitle%3DNoncanonical%2520hedgehog%2520pathway%2520activation%2520through%2520srf-mkl1%2520promotes%2520drug%2520resistance%2520in%2520basal%2520cell%2520carcinomas%26jtitle%3DNat.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D271%26epage%3D281%26doi%3D10.1038%2Fnm.4476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel Bayo-Fina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar Dhanyamraju, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendrich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaswamy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumeister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of gli1</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8023</span>, <span class="refDoi"> DOI: 10.1038/ncomms9023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms9023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26310823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8023&author=P.+Schneiderauthor=J.+Miguel+Bayo-Finaauthor=R.+Singhauthor=P.+Kumar+Dhanyamrajuauthor=P.+Holzauthor=A.+Baierauthor=V.+Fendrichauthor=A.+Ramaswamyauthor=S.+Baumeisterauthor=E.+D.+Martinezauthor=M.+Lauth&title=Identification+of+a+novel+actin-dependent+signal+transducing+module+allows+for+the+targeted+degradation+of+gli1&doi=10.1038%2Fncomms9023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1</span></div><div class="casAuthors">Schneider, Philipp; Miguel Bayo-Fina, Juan; Singh, Rajeev; Kumar Dhanyamraju, Pavan; Holz, Philipp; Baier, Aninja; Fendrich, Volker; Ramaswamy, Annette; Baumeister, Stefan; Martinez, Elisabeth D.; Lauth, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8023</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Down syndrome-assocd. DYRK1A kinase has been reported as a stimulator of the developmentally important Hedgehog (Hh) pathway, but cells from Down syndrome patients paradoxically display reduced Hh signalling activity.  Here we find that DYRK1A stimulates GLI transcription factor activity through phosphorylation of general nuclear localization clusters.  In contrast, in vivo and in vitro expts. reveal that DYRK1A kinase can also function as an inhibitor of endogenous Hh signalling by neg. regulating ABLIM proteins, the actin cytoskeleton and the transcriptional co-activator MKL1 (MAL).  As a final effector of the DYRK1A-ABLIM-actin-MKL1 sequence, we identify the MKL1 interactor Jumonji domain demethylase 1A (JMJD1A) as a novel Hh pathway component stabilizing the GLI1 protein in a demethylase-independent manner.  Furthermore, a Jumonji-specific small-mol. antagonist represents a novel and powerful inhibitor of Hh signal transduction by inducing GLI1 protein degrdn. in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0fhhTVI3NPrVg90H21EOLACvtfcHk0lgcOM5sLgn5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhu77P&md5=2d1cd606db85133bde46a1818098711f</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms9023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9023%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DMiguel%2BBayo-Fina%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DKumar%2BDhanyamraju%26aufirst%3DP.%26aulast%3DHolz%26aufirst%3DP.%26aulast%3DBaier%26aufirst%3DA.%26aulast%3DFendrich%26aufirst%3DV.%26aulast%3DRamaswamy%26aufirst%3DA.%26aulast%3DBaumeister%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26aulast%3DLauth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520novel%2520actin-dependent%2520signal%2520transducing%2520module%2520allows%2520for%2520the%2520targeted%2520degradation%2520of%2520gli1%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8023%26doi%3D10.1038%2Fncomms9023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutzinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parigger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cegielkowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span> <span> </span><span class="NLM_article-title">Dyrk1b as therapeutic target in hedgehog/gli-dependent cancer cells with smoothened inhibitor resistance</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">7134</span>– <span class="NLM_lpage">7148</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.6910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.6910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26784250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC28nhslSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7134-7148&author=W.+Gruberauthor=M.+Hutzingerauthor=D.+P.+Elmerauthor=T.+Pariggerauthor=C.+Sternbergauthor=L.+Cegielkowskiauthor=M.+Zajaauthor=J.+Lebanauthor=S.+Michelauthor=S.+Hammauthor=D.+Vittauthor=F.+Aberger&title=Dyrk1b+as+therapeutic+target+in+hedgehog%2Fgli-dependent+cancer+cells+with+smoothened+inhibitor+resistance&doi=10.18632%2Foncotarget.6910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance</span></div><div class="casAuthors">Gruber Wolfgang; Hutzinger Martin; Elmer Dominik Patrick; Parigger Thomas; Sternberg Christina; Cegielkowski Lukasz; Aberger Fritz; Zaja Mirko; Michel Susanne; Hamm Svetlana; Vitt Daniel; Leban Johann; Vitt Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">7134-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A wide range of human malignancies displays aberrant activation of Hedgehog (HH)/GLI signaling, including cancers of the skin, brain, gastrointestinal tract and hematopoietic system.  Targeting oncogenic HH/GLI signaling with small molecule inhibitors of the essential pathway effector Smoothened (SMO) has shown remarkable therapeutic effects in patients with advanced and metastatic basal cell carcinoma.  However, acquired and de novo resistance to SMO inhibitors poses severe limitations to the use of SMO antagonists and urgently calls for the identification of novel targets and compounds.Here we report on the identification of the Dual-Specificity-Tyrosine-Phosphorylation-Regulated Kinase 1B (DYRK1B) as critical positive regulator of HH/GLI signaling downstream of SMO.  Genetic and chemical inhibition of DYRK1B in human and mouse cancer cells resulted in marked repression of HH signaling and GLI1 expression, respectively.  Importantly, DYRK1B inhibition profoundly impaired GLI1 expression in both SMO-inhibitor sensitive and resistant settings.  We further introduce a novel small molecule DYRK1B inhibitor, DYRKi, with suitable pharmacologic properties to impair SMO-dependent and SMO-independent oncogenic GLI activity.  The results support the use of DYRK1B antagonists for the treatment of HH/GLI-associated cancers where SMO inhibitors fail to demonstrate therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFmF3n8no4EZw7prLlxLOzfW6udTcc2eZjsiud0UCxrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nhslSksw%253D%253D&md5=166f2cf11d5cbc8b78bfd91cd5a28b1b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6910%26sid%3Dliteratum%253Aachs%26aulast%3DGruber%26aufirst%3DW.%26aulast%3DHutzinger%26aufirst%3DM.%26aulast%3DElmer%26aufirst%3DD.%2BP.%26aulast%3DParigger%26aufirst%3DT.%26aulast%3DSternberg%26aufirst%3DC.%26aulast%3DCegielkowski%26aufirst%3DL.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DLeban%26aufirst%3DJ.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DHamm%26aufirst%3DS.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DAberger%26aufirst%3DF.%26atitle%3DDyrk1b%2520as%2520therapeutic%2520target%2520in%2520hedgehog%252Fgli-dependent%2520cancer%2520cells%2520with%2520smoothened%2520inhibitor%2520resistance%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D7134%26epage%3D7148%26doi%3D10.18632%2Foncotarget.6910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanyamraju, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span> <span> </span><span class="NLM_article-title">Dyrk1b blocks canonical and promotes non-canonical hedgehog signaling through activation of the mtor/akt pathway</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.13662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27903983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2sjitFSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=833-845&author=R.+Singhauthor=P.+K.+Dhanyamrajuauthor=M.+Lauth&title=Dyrk1b+blocks+canonical+and+promotes+non-canonical+hedgehog+signaling+through+activation+of+the+mtor%2Fakt+pathway&doi=10.18632%2Foncotarget.13662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway</span></div><div class="casAuthors">Singh Rajeev; Dhanyamraju Pavan Kumar; Lauth Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">833-845</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hedgehog (Hh) signaling plays important roles in embryonic development and in tumor formation.  Apart from the well-established stimulation of the GLI family of transcription factors, Hh ligands promote the phosphorylation and activation of mTOR and AKT kinases, yet the molecular mechanism underlying these processes are unknown.  Here, we identify the DYRK1B kinase as a mediator between Hh signaling and mTOR/AKT activation.  In fibroblasts, Hh signaling induces DYRK1B protein expression, resulting in activation of the mTOR/AKT kinase signaling arm.  Furthermore, DYRK1B exerts positive and negative feedback regulation on the Hh pathway itself: It negatively interferes with SMO-elicited canonical Hh signaling, while at the same time it provides positive feed-forward functions by promoting AKT-mediated GLI stability.  Due to the fact that the mTOR/AKT pathway is itself subject to strong negative feedback regulation, pharmacological inhibition of DYRK1B results in initial upregulation followed by downregulation of AKT phosphorylation and GLI stabilization.  Addressing this issue therapeutically, we show that a pharmacological approach combining a DYRK1B antagonist with an mTOR/AKT inhibitor results in strong GLI1 targeting and in pronounced cytotoxicity in human pancreatic and ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFk21qGRcwucjl5L8hwNX0fW6udTcc2eZjsiud0UCxrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjitFSgtA%253D%253D&md5=debb35f2d66e5b639b801fe1f53101f9</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13662%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DDhanyamraju%26aufirst%3DP.%2BK.%26aulast%3DLauth%26aufirst%3DM.%26atitle%3DDyrk1b%2520blocks%2520canonical%2520and%2520promotes%2520non-canonical%2520hedgehog%2520signaling%2520through%2520activation%2520of%2520the%2520mtor%252Fakt%2520pathway%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D833%26epage%3D845%26doi%3D10.18632%2Foncotarget.13662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span> <span> </span><span class="NLM_article-title">Gli activation by atypical protein kinase c iota/lambda regulates the growth of basal cell carcinomas</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>494</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">488</span>, <span class="refDoi"> DOI: 10.1038/nature11889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature11889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23446420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2013&pages=484-488&author=S.+X.+Atwoodauthor=M.+Liauthor=A.+Leeauthor=J.+Y.+Tangauthor=A.+E.+Oro&title=Gli+activation+by+atypical+protein+kinase+c+iota%2Flambda+regulates+the+growth+of+basal+cell+carcinomas&doi=10.1038%2Fnature11889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas</span></div><div class="casAuthors">Atwood, Scott X.; Li, Mischa; Lee, Alex; Tang, Jean Y.; Oro, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">494</span>
        (<span class="NLM_cas:issue">7438</span>),
    <span class="NLM_cas:pages">484-488</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Growth of basal cell carcinomas (BCCs) requires high levels of hedgehog (HH) signaling through the transcription factor GLI.  Although inhibitors of membrane protein smoothened (SMO) effectively suppress HH signaling, early tumor resistance illustrates the need for addnl. downstream targets for therapy.  Here we identify atypical protein kinase C ι/λ (aPKC-ι/λ) as a novel GLI regulator in mammals. aPKC-ι/λ and its polarity signaling partners colocalize at the centrosome and form a complex with missing-in-metastasis (MIM), a scaffolding protein that potentiates HH signaling.  Genetic or pharmacol. loss of aPKC-ι/λ function blocks HH signaling and proliferation of BCC cells.  Prkci is a HH target gene that forms a pos. feedback loop with GLI and exists at increased levels in BCCs.  Genome-wide transcriptional profiling shows that aPKC-ι/λ and SMO control the expression of similar genes in tumor cells. aPKC-ι/λ functions downstream of SMO to phosphorylate and activate GLI1, resulting in maximal DNA binding and transcriptional activation.  Activated aPKC-ι/λ is upregulated in SMO-inhibitor-resistant tumors and targeting aPKC-ι/λ suppresses signaling and growth of resistant BCC cell lines.  These results demonstrate that aPKC-ι/λ is crit. for HH-dependent processes and implicates aPKC-ι/λ as a new, tumor-selective therapeutic target for the treatment of SMO-inhibitor-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwsCzT5874A7Vg90H21EOLACvtfcHk0liTuW_l7tcVHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWiu7o%253D&md5=528b21b31092c6d6e03501c5ed2c2af5</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fnature11889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11889%26sid%3Dliteratum%253Aachs%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DOro%26aufirst%3DA.%2BE.%26atitle%3DGli%2520activation%2520by%2520atypical%2520protein%2520kinase%2520c%2520iota%252Flambda%2520regulates%2520the%2520growth%2520of%2520basal%2520cell%2520carcinomas%26jtitle%3DNature%26date%3D2013%26volume%3D494%26spage%3D484%26epage%3D488%26doi%3D10.1038%2Fnature11889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayad, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrea, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">A ck1alpha activator penetrates the brain and shows efficacy against drug-resistant metastatic medulloblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1379</span>– <span class="NLM_lpage">1388</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-18-1319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1078-0432.CCR-18-1319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30487124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BB3crlvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=1379-1388&author=J.+Rodriguez-Blancoauthor=B.+Liauthor=J.+Longauthor=C.+Shenauthor=F.+Yangauthor=D.+Ortonauthor=S.+Collinsauthor=N.+Kasaharaauthor=N.+G.+Ayadauthor=H.+J.+McCreaauthor=M.+F.+Rousselauthor=W.+A.+Weissauthor=A.+J.+Capobiancoauthor=D.+J.+Robbins&title=A+ck1alpha+activator+penetrates+the+brain+and+shows+efficacy+against+drug-resistant+metastatic+medulloblastoma&doi=10.1158%2F1078-0432.CCR-18-1319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma</span></div><div class="casAuthors">Rodriguez-Blanco Jezabel; Li Bin; Long Jun; Shen Chen; Yang Fan; Capobianco Anthony J; Robbins David J; Orton Darren; Collins Sara; Kasahara Noriyuki; Kasahara Noriyuki; Ayad Nagi G; Capobianco Anthony J; Robbins David J; Ayad Nagi G; McCrea Heather J; Roussel Martine F; Weiss William A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1379-1388</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">PURPOSE:  Although most children with medulloblastoma are cured of their disease, Sonic Hedgehog (SHH) subgroup medulloblastoma driven by TRP53 mutations is essentially lethal.  Casein kinase 1α (CK1α) phosphorylates and destabilizes GLI transcription factors, thereby inhibiting the key effectors of SHH signaling.  We therefore tested a second-generation CK1α activator against TRP53-mutant, MYCN-amplified medulloblastoma.  EXPERIMENTAL DESIGN:  The ability of this CK1α activator to block SHH signaling was determined in vitro using GLI reporter cells, granular precursor primary cultures, and PATCHED1 (PTCH1)-mutant sphere cultures.  While in vivo efficacy was tested using 2 different medulloblastoma mouse models: PTCH1 and ND2:SMOA1.  Finally, the clinical relevance of CK1α activators was demonstrated using a TRP53-mutant, MYCN-amplified patient-derived xenograft.  RESULTS:  SSTC3 inhibited SHH activity in vitro, acting downstream of the vismodegib target SMOOTHENED (SMO), and reduced the viability of sphere cultures derived from SHH medulloblastoma.  SSTC3 accumulated in the brain, inhibited growth of SHH medulloblastoma tumors, and blocked metastases in a genetically engineered vismodegib-resistant mouse model of SHH medulloblastoma.  Importantly, SSTC3 attenuated growth and metastasis of orthotopic patient-derived TRP53-mutant, MYCN-amplified, SHH subgroup medulloblastoma xenografts, increasing overall survival.  CONCLUSIONS:  Using a newly described small-molecule, SSTC3, we show that CK1a activators could address a significant unmet clinical need for patients with SMO inhibitor-resistant medulloblastoma, including those harboring mutations in TRP53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8P_DomHDBdjEC-75aqa5AfW6udTcc2eaXJfIEifIgYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crlvVGnsA%253D%253D&md5=516851f288f08b013570ddf6cbec8bb2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-18-1319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-18-1319%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DKasahara%26aufirst%3DN.%26aulast%3DAyad%26aufirst%3DN.%2BG.%26aulast%3DMcCrea%26aufirst%3DH.%2BJ.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DA%2520ck1alpha%2520activator%2520penetrates%2520the%2520brain%2520and%2520shows%2520efficacy%2520against%2520drug-resistant%2520metastatic%2520medulloblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D25%26spage%3D1379%26epage%3D1388%26doi%3D10.1158%2F1078-0432.CCR-18-1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metcalfe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Pten loss mitigates the response of medulloblastoma to hedgehog pathway inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7034</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-13-1222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24154871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=7034-7042&author=C.+Metcalfeauthor=B.+Alickeauthor=A.+Crowauthor=M.+Lamoureuxauthor=G.+J.+Dijkgraafauthor=F.+Pealeauthor=S.+E.+Gouldauthor=F.+J.+de+Sauvage&title=Pten+loss+mitigates+the+response+of+medulloblastoma+to+hedgehog+pathway+inhibition&doi=10.1158%2F0008-5472.CAN-13-1222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN Loss Mitigates the Response of Medulloblastoma to Hedgehog Pathway Inhibition</span></div><div class="casAuthors">Metcalfe, Ciara; Alicke, Bruno; Crow, Ailey; Lamoureux, Marlea; Dijkgraaf, Gerrit J. P.; Peale, Franklin; Gould, Stephen E.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7034-7042</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Medulloblastoma is a cancer of the cerebellum, for which there is currently no approved targeted therapy.  Recent transcriptomics approaches have demonstrated that medulloblastoma is composed of molecularly distinct subgroups, one of which is characterized by activation of the Hedgehog pathway, which in mouse models is sufficient to drive medulloblastoma development.  There is thus considerable interest in targeting the Hedgehog pathway for therapeutic benefit in medulloblastoma, particularly given the recent approval of the Hedgehog pathway inhibitor vismodegib for metastatic and locally advanced basal cell carcinoma.  Like other molecularly targeted therapies, however, there have been reports of acquired resistance to vismodegib, driven by secondary Hedgehog pathway mutations and potentially by activation of the phosphatidylinositol 3-kinase (PI3K) pathway.  Given that acquired resistance to vismodegib may occur as a result of inappropriate PI3K pathway activation, we asked if loss of the PI3K pathway regulator, phosphatase and tensin homolog (Pten), which has been reported to occur in patients within the Hedgehog subgroup, would constitute a mechanism of innate resistance to vismodegib in Hedgehog-driven medulloblastoma.  We find that Hedgehog pathway inhibition successfully restrains growth of Pten-deficient medulloblastoma in this mouse model, but does not drive tumor regression, as it does in Pten-wild-type medulloblastoma.  Combined inhibition of the Hedgehog and PI3K pathways may lead to superior antitumor activity in Pten-deficient medulloblastoma in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3GdLAnS7UO7Vg90H21EOLACvtfcHk0lj69oJ8I28uqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77K&md5=350251756bc5ea2bcf7dbdabcf5be4a1</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1222%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalfe%26aufirst%3DC.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DCrow%26aufirst%3DA.%26aulast%3DLamoureux%26aufirst%3DM.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DPten%2520loss%2520mitigates%2520the%2520response%2520of%2520medulloblastoma%2520to%2520hedgehog%2520pathway%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D7034%26epage%3D7042%26doi%3D10.1158%2F0008-5472.CAN-13-1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponomaryov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornell, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabral, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, R. A.</span></span> <span> </span><span class="NLM_article-title">Ras/mapk activation drives resistance to smo inhibition, metastasis, and tumor evolution in shh pathway-dependent tumors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">3623</span>– <span class="NLM_lpage">3635</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-2999-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-14-2999-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26130651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWqtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3623-3635&author=X.+Zhaoauthor=T.+Ponomaryovauthor=K.+J.+Ornellauthor=P.+Zhouauthor=S.+K.+Dabralauthor=E.+Pakauthor=W.+Liauthor=S.+X.+Atwoodauthor=R.+J.+Whitsonauthor=A.+L.+Changauthor=J.+Liauthor=A.+E.+Oroauthor=J.+A.+Chanauthor=J.+F.+Kelleherauthor=R.+A.+Segal&title=Ras%2Fmapk+activation+drives+resistance+to+smo+inhibition%2C+metastasis%2C+and+tumor+evolution+in+shh+pathway-dependent+tumors&doi=10.1158%2F0008-5472.CAN-14-2999-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors</span></div><div class="casAuthors">Zhao, Xuesong; Ponomaryov, Tatyana; Ornell, Kimberly J.; Zhou, Pengcheng; Dabral, Sukriti K.; Pak, Ekaterina; Li, Wei; Atwood, Scott X.; Whitson, Ramon J.; Chang, Anne Lynn S.; Li, Jiang; Oro, Anthony E.; Chan, Jennifer A.; Kelleher, Joseph F.; Segal, Rosalind A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3623-3635</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aberrant Shh signaling promotes tumor growth in diverse cancers.  The importance of Shh signaling is particularly evident in medulloblastoma and basal cell carcinoma (BCC), where inhibitors targeting the Shh pathway component Smoothened (Smo) show great therapeutic promise.  However, the emergence of drug resistance limits long-term efficacy, and the mechanisms of resistance remain poorly understood.  Using new medulloblastoma models, we identify two distinct paradigms of resistance to Smo inhibition.  Sufu mutations lead to maintenance of the Shh pathway in the presence of Smo inhibitors.  Alternatively activation of the RAS-MAPK pathway circumvents Shh pathway dependency, drives tumor growth, and enhances metastatic behavior.  Strikingly, in BCC patients treated with Smo inhibitor, squamous cell cancers with RAS/MAPK activation emerged from the antecedent BCC tumors.  Together, these findings reveal a crit. role of the RAS-MAPK pathway in drug resistance and tumor evolution of Shh pathway-dependent tumors.  Cancer Res; 75(17); 3623-35. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzGF7Wk7iVdbVg90H21EOLACvtfcHk0lj69oJ8I28uqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWqtLbJ&md5=c905fc4a67db9d7fc70894bdbe1b3b0d</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-2999-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-2999-T%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DPonomaryov%26aufirst%3DT.%26aulast%3DOrnell%26aufirst%3DK.%2BJ.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DDabral%26aufirst%3DS.%2BK.%26aulast%3DPak%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DA.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DKelleher%26aufirst%3DJ.%2BF.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DRas%252Fmapk%2520activation%2520drives%2520resistance%2520to%2520smo%2520inhibition%252C%2520metastasis%252C%2520and%2520tumor%2520evolution%2520in%2520shh%2520pathway-dependent%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3623%26epage%3D3635%26doi%3D10.1158%2F0008-5472.CAN-14-2999-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tostar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fendrich, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Dyrk1b-dependent autocrine-to-paracrine shift of hedgehog signaling by mutant ras</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1038/nsmb.1833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnsmb.1833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20512148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslWmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=718-725&author=M.+Lauthauthor=A.+Bergstromauthor=T.+Shimokawaauthor=U.+Tostarauthor=Q.+Jinauthor=V.+Fendrichauthor=C.+Guerraauthor=M.+Barbacidauthor=R.+Toftgard&title=Dyrk1b-dependent+autocrine-to-paracrine+shift+of+hedgehog+signaling+by+mutant+ras&doi=10.1038%2Fnsmb.1833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS</span></div><div class="casAuthors">Lauth, Matthias; Bergstroem, Aasa; Shimokawa, Takashi; Tostar, Ulrica; Jin, Qianren; Fendrich, Volker; Guerra, Carmen; Barbacid, Mariano; Toftgard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">718-725</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Synergism between the RAS and Hedgehog (HH) pathways has been suggested for carcinogenesis in the pancreas, lung and colon.  We investigated the mol. cross-talk between RAS and HH signaling and found that, although mutant RAS induces or enhances SHH expression and favors paracrine HH signaling, it antagonizes autocrine HH signal transduction.  Activated RAS can be found in primary cilia, the central organelle of HH signal transduction, but functions in a cilium-independent manner and interferes with Gli2 function and Gli3 processing.  In addn., the cell-autonomous neg. regulation of HH signal transduction involves the RAS effector mol. dual specificity tyrosine phosphorylated and regulated kinase 1B (DYRK1B).  In line with a redirection of autocrine toward paracrine HH signaling by a KRAS-DYRK1B network, we find high levels of GLI1 expression restricted to the stromal compartment and not to SHH-expressing tumor cells in human pancreatic adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzELTkuDoSY7Vg90H21EOLACvtfcHk0lhYyyBIdYc4Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslWmtbk%253D&md5=8f9cde9a4a7540002d8734daa44f0011</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1833%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DShimokawa%26aufirst%3DT.%26aulast%3DTostar%26aufirst%3DU.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DFendrich%26aufirst%3DV.%26aulast%3DGuerra%26aufirst%3DC.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DDyrk1b-dependent%2520autocrine-to-paracrine%2520shift%2520of%2520hedgehog%2520signaling%2520by%2520mutant%2520ras%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D718%26epage%3D725%26doi%3D10.1038%2Fnsmb.1833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biehs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkgraaf, G. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piskol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alicke, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boumahdi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">A cell identity switch allows residual bcc to survive hedgehog pathway inhibition</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0596-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fs41586-018-0596-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30297801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOhtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2018&pages=429-433&author=B.+Biehsauthor=G.+J.+P.+Dijkgraafauthor=R.+Piskolauthor=B.+Alickeauthor=S.+Boumahdiauthor=F.+Pealeauthor=S.+E.+Gouldauthor=F.+J.+de+Sauvage&title=A+cell+identity+switch+allows+residual+bcc+to+survive+hedgehog+pathway+inhibition&doi=10.1038%2Fs41586-018-0596-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition</span></div><div class="casAuthors">Biehs, Brian; Dijkgraaf, Gerrit J. P.; Piskol, Robert; Alicke, Bruno; Boumahdi, Soufiane; Peale, Franklin; Gould, Stephen E.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">7727</span>),
    <span class="NLM_cas:pages">429-433</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Despite the efficacy of Hedgehog pathway inhibitors in the treatment of basal cell carcinoma (BCC), residual disease persists in some patients and may contribute to relapse when treatment is discontinued.  Here, to study the effect of the Smoothened inhibitor vismodegib on tumor clearance, we have used a Ptch1-Trp53 mouse model of BCC and found that mice treated with vismodegib harbor quiescent residual tumors that regrow upon cessation of treatment.  Profiling expts. revealed that residual BCCs initiate a transcriptional program that closely resembles that of stem cells of the interfollicular epidermis and isthmus, whereas untreated BCCs are more similar to the hair follicle bulge.  This cell identity switch was enabled by a mostly permissive chromatin state accompanied by rapid Wnt pathway activation and reprogramming of super enhancers to drive activation of key transcription factors involved in cellular identity.  Accordingly, treatment of BCC with both vismodegib and a Wnt pathway inhibitor reduced the residual tumor burden and enhanced differentiation.  Our study identifies a resistance mechanism in which tumor cells evade treatment by adopting an alternative identity that does not rely on the original oncogenic driver for survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyok9rqAA9rVg90H21EOLACvtfcHk0lhYyyBIdYc4Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOhtrjL&md5=768149d23b6c5b25d0bec65e22108a28</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0596-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0596-y%26sid%3Dliteratum%253Aachs%26aulast%3DBiehs%26aufirst%3DB.%26aulast%3DDijkgraaf%26aufirst%3DG.%2BJ.%2BP.%26aulast%3DPiskol%26aufirst%3DR.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DBoumahdi%26aufirst%3DS.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DA%2520cell%2520identity%2520switch%2520allows%2520residual%2520bcc%2520to%2520survive%2520hedgehog%2520pathway%2520inhibition%26jtitle%3DNature%26date%3D2018%26volume%3D562%26spage%3D429%26epage%3D433%26doi%3D10.1038%2Fs41586-018-0596-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangelberger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaegen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohm, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. Y.</span></span> <span> </span><span class="NLM_article-title">Tumor architecture and notch signaling modulate drug response in basal cell carcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccell.2017.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29395868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=229-243&author=M.+Eberlauthor=D.+Mangelbergerauthor=J.+B.+Swansonauthor=M.+E.+Verhaegenauthor=P.+W.+Harmsauthor=M.+L.+Frohmauthor=A.+A.+Dlugoszauthor=S.+Y.+Wong&title=Tumor+architecture+and+notch+signaling+modulate+drug+response+in+basal+cell+carcinoma&doi=10.1016%2Fj.ccell.2017.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma</span></div><div class="casAuthors">Eberl, Markus; Mangelberger, Doris; Swanson, Jacob B.; Verhaegen, Monique E.; Harms, Paul W.; Frohm, Marcus L.; Dlugosz, Andrzej A.; Wong, Sunny Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-243.e4</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Hedgehog (Hh) pathway inhibitors such as vismodegib are highly effective for treating basal cell carcinoma (BCC); however, residual tumor cells frequently persist and regenerate the primary tumor upon drug discontinuation.  Here, we show that BCCs are organized into two molecularly and functionally distinct compartments.  Whereas interior Hh+/Notch+ suprabasal cells undergo apoptosis in response to vismodegib, peripheral Hh+++/Notch- basal cells survive throughout treatment.  Inhibiting Notch specifically promotes tumor persistence without causing drug resistance, while activating Notch is sufficient to regress already established lesions.  Altogether, these findings suggest that the three-dimensional architecture of BCCs establishes a natural hierarchy of drug response in the tumor and that this hierarchy can be overcome, for better or worse, by modulating Notch.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIKCnEtORSl7Vg90H21EOLACvtfcHk0lhYyyBIdYc4Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSjur0%253D&md5=c7e02faeb5eae420e42db767c47b8b64</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DM.%26aulast%3DMangelberger%26aufirst%3DD.%26aulast%3DSwanson%26aufirst%3DJ.%2BB.%26aulast%3DVerhaegen%26aufirst%3DM.%2BE.%26aulast%3DHarms%26aufirst%3DP.%2BW.%26aulast%3DFrohm%26aufirst%3DM.%2BL.%26aulast%3DDlugosz%26aufirst%3DA.%2BA.%26aulast%3DWong%26aufirst%3DS.%2BY.%26atitle%3DTumor%2520architecture%2520and%2520notch%2520signaling%2520modulate%2520drug%2520response%2520in%2520basal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D33%26spage%3D229%26epage%3D243%26doi%3D10.1016%2Fj.ccell.2017.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingallina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Acquarica, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Magno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e2376</span>, <span class="refDoi"> DOI: 10.1038/cddis.2016.195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fcddis.2016.195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27899820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aks77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=e2376&author=P.+Infanteauthor=R.+Alfonsiauthor=C.+Ingallinaauthor=D.+Quaglioauthor=F.+Ghirgaauthor=I.+D%E2%80%99Acquaricaauthor=F.+Bernardiauthor=L.+Di+Magnoauthor=G.+Canettieriauthor=I.+Screpantiauthor=A.+Gulinoauthor=B.+Bottaauthor=M.+Moriauthor=L.+Di+Marcotullio&title=Inhibition+of+hedgehog-dependent+tumors+and+cancer+stem+cells+by+a+newly+identified+naturally+occurring+chemotype&doi=10.1038%2Fcddis.2016.195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype</span></div><div class="casAuthors">Infante, Paola; Alfonsi, Romina; Ingallina, Cinzia; Quaglio, Deborah; Ghirga, Francesca; D'Acquarica, Ilaria; Bernardi, Flavia; Di Magno, Laura; Canettieri, Gianluca; Screpanti, Isabella; Gulino, Alberto; Botta, Bruno; Mori, Mattia; Di Marcotullio, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e2376</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog (Hh) inhibitors have emerged as valid tools in the treatment of a wide range of cancers.  Indeed, aberrant activation of the Hh pathway occurring either by ligand-dependent or -independent mechanisms is a key driver in tumorigenesis.  The smoothened (Smo) receptor is one of the main upstream transducers of the Hh signaling and is a validated target for the development of anticancer compds., as underlined by the FDA-approved Smo antagonist Vismodegib (GDC-0449/Erivedge) for the treatment of basal cell carcinoma.  However, Smo mutations that confer constitutive activity and drug resistance have emerged during treatment with Vismodegib.  For this reason, the development of new effective Hh inhibitors represents a major challenge for cancer therapy.  Natural products have always represented a unique source of lead structures in drug discovery, and in recent years have been used to modulate the Hh pathway at multiple levels.  Here, starting from an in house library of natural compds. and their derivs., we discovered novel chemotypes of Hh inhibitors by mean of virtual screening against the crystallog. structure of Smo.  Hh functional based assay identified the chalcone deriv. 12 as the most effective Hh inhibitor within the test set.  The chalcone 12 binds the Smo receptor and promotes the displacement of Bodipy-Cyclopamine in both Smo WT and drug-resistant Smo mutant.  Our mol. stands as a promising Smo antagonist able to specifically impair the growth of Hh-dependent tumor cells in vitro and in vivo and medulloblastoma stem-like cells and potentially overcome the assocd. drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sXWplTSstbVg90H21EOLACvtfcHk0ljXiSlQuZQ6zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aks77F&md5=b9cfdba016a885fcc1bb98cac6223b87</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2016.195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2016.195%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DIngallina%26aufirst%3DC.%26aulast%3DQuaglio%26aufirst%3DD.%26aulast%3DGhirga%26aufirst%3DF.%26aulast%3DD%25E2%2580%2599Acquarica%26aufirst%3DI.%26aulast%3DBernardi%26aufirst%3DF.%26aulast%3DDi%2BMagno%26aufirst%3DL.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DGulino%26aufirst%3DA.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520hedgehog-dependent%2520tumors%2520and%2520cancer%2520stem%2520cells%2520by%2520a%2520newly%2520identified%2520naturally%2520occurring%2520chemotype%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2016%26volume%3D7%26spage%3De2376%26doi%3D10.1038%2Fcddis.2016.195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span> <span> </span><span class="NLM_article-title">A novel hedgehog inhibitor for the treatment of hematological malignancies</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1097/CAD.0000000000000679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1097%2FCAD.0000000000000679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30106753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWqsL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=995-1003&author=P.+Linauthor=Y.+Heauthor=G.+Chenauthor=H.+Maauthor=J.+Zhengauthor=Z.+Zhangauthor=B.+Caoauthor=H.+Zhangauthor=X.+Zhangauthor=X.+Mao&title=A+novel+hedgehog+inhibitor+for+the+treatment+of+hematological+malignancies&doi=10.1097%2FCAD.0000000000000679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">A novel hedgehog inhibitor for the treatment of hematological malignancies</span></div><div class="casAuthors">Lin, Peng; He, Yuanming; Chen, Guodong; Ma, Haikuo; Zheng, Jiyue; Zhang, Zubin; Cao, Biyin; Zhang, Hongjian; Zhang, Xiaohu; Mao, Xinliang</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">995-1003</span>CODEN:
                <span class="NLM_cas:coden">ANTDEV</span>;
        ISSN:<span class="NLM_cas:issn">0959-4973</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The hedgehog-smoothened (HH/SMO) pathway has been proposed as a potential therapeutic target for hematol. malignancies.  Our previous studies designed a series of HH inhibitors with novel scaffolds distinctive from vismodegib, the first Food and Drug Administration-approved HH inhibitor for the treatment of basal-cell carcinoma and medulloblastoma.  In the present study, we evaluated these HH inhibitors against blood cancers and found that HH78 displayed potent activity in suppressing the HH signaling pathway.  HH78 competitively bound to SMO and suppressed the transcriptional activity of GLI by the luciferase reporter gene assay and the measurement of HH/SMO-downregulated genes, including cyclin D2, cyclin E, PTCH1, PTCH2, and GLI.  HH78 at low micromolar concns. induced significant cancer cell apoptosis showed by increased caspase-3 activation, annexin V-staining and downregulated prosurvival proteins, including c-Myc, Bcl-2, Mcl-1, and Bcl-xL.  In contrast, vismodegib did not show any effects on these apoptotic events.  HH78 also suppressed the activation of the AKT/mTOR pathway, which cross-talks with the HH/SMO pathway.  Finally, HH78 inhibited the growth of human leukemia K562 in nude mice xenografts with no overt toxicity.  Collectively, the present study identified a novel HH inhibitor with great potential for the treatment of hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTb_9sBXXcGrVg90H21EOLACvtfcHk0ljXiSlQuZQ6zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWqsL3J&md5=e5ccd0fe3d55027f88fd752d519054cd</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1097%2FCAD.0000000000000679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCAD.0000000000000679%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DX.%26atitle%3DA%2520novel%2520hedgehog%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hematological%2520malignancies%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D2018%26volume%3D29%26spage%3D995%26epage%3D1003%26doi%3D10.1097%2FCAD.0000000000000679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faure, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roudaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenfelder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihannic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayrault, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petricci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taddei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruat, M.</span></span> <span> </span><span class="NLM_article-title">Mrt-92 inhibits hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the smoothened receptor</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1829</span>, <span class="refDoi"> DOI: 10.1096/fj.14-267849</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1096%2Ffj.14-267849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25636740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSks7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=1817-1829&author=L.+Hochauthor=H.+Faureauthor=H.+Roudautauthor=A.+Schoenfelderauthor=A.+Mannauthor=N.+Girardauthor=L.+Bihannicauthor=O.+Ayraultauthor=E.+Petricciauthor=M.+Taddeiauthor=D.+Rognanauthor=M.+Ruat&title=Mrt-92+inhibits+hedgehog+signaling+by+blocking+overlapping+binding+sites+in+the+transmembrane+domain+of+the+smoothened+receptor&doi=10.1096%2Ffj.14-267849"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor</span></div><div class="casAuthors">Hoch, Lucile; Faure, Helene; Roudaut, Hermine; Schoenfelder, Angele; Mann, Andre; Girard, Nicolas; Bihannic, Laure; Ayrault, Olivier; Petricci, Elena; Taddei, Maurizio; Rognan, Didier; Ruat, Martial</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-1829</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The Smoothened (Smo) receptor, a member of class F G protein-coupled receptors, is the main transducer of the Hedgehog (Hh) signaling pathway implicated in a wide range of developmental and adult processes.  Smo is the target of anticancer drugs that bind to a long and narrow cavity in the 7-transmembrane (7TM) domain.  X-ray structures of human Smo (hSmo) bound to several ligands have revealed 2 types of 7TM-directed antagonists: those binding mostly to extracellular loops (site 1, e.g., LY2940680) and those penetrating deeply in the 7TM cavity (site 2, e.g., SANT-1).  Here we report the development of the acylguanidine MRT-92, which displays subnanomolar antagonist activity against Smo in various Hh cell-based assays.  MRT-92 inhibits rodent cerebellar granule cell proliferation induced by Hh pathway activation through pharmacol. (half maximal inhibitory concn. [IC50] = 0.4 nM) or genetic manipulation.  Using [3H]MRT-92 (Kd = 0.3 nM for hSmo), we created a comprehensive framework for the interaction of small mol. modulators with hSmo and for understanding chemoresistance linked to hSmo mutations.  Guided by mol. docking and site-directed mutagenesis data, our work convincingly confirms that MRT-92 simultaneously recognized and occupied both sites 1 and 2.  Our data demonstrate the existence of a third type of Smo antagonists, those entirely filling the Smo binding cavity from the upper extracellular part to the lower cytoplasmic-proximal subpocket.  Our studies should help design novel potent Smo antagonists and more effective therapeutic strategies for treating Hh-linked cancers and assocd. chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4F9p-MCX0k7Vg90H21EOLACvtfcHk0ljXiSlQuZQ6zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSks7vF&md5=71050c3e52c8aae6b06d9ea799daf694</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-267849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-267849%26sid%3Dliteratum%253Aachs%26aulast%3DHoch%26aufirst%3DL.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoudaut%26aufirst%3DH.%26aulast%3DSchoenfelder%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DA.%26aulast%3DGirard%26aufirst%3DN.%26aulast%3DBihannic%26aufirst%3DL.%26aulast%3DAyrault%26aufirst%3DO.%26aulast%3DPetricci%26aufirst%3DE.%26aulast%3DTaddei%26aufirst%3DM.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DMrt-92%2520inhibits%2520hedgehog%2520signaling%2520by%2520blocking%2520overlapping%2520binding%2520sites%2520in%2520the%2520transmembrane%2520domain%2520of%2520the%2520smoothened%2520receptor%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D1817%26epage%3D1829%26doi%3D10.1096%2Ffj.14-267849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span> <span> </span><span class="NLM_article-title">Inhibition mechanism exploration of investigational drug tak-441 as inhibitor against vismodegib-resistant smoothened mutant</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>723</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2013.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ejphar.2013.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24291104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOhsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=723&publication_year=2014&pages=305-313&author=T.+Ishiiauthor=Y.+Shimizuauthor=K.+Nakashimaauthor=S.+Kondoauthor=K.+Ogawaauthor=S.+Sasakiauthor=H.+Matsui&title=Inhibition+mechanism+exploration+of+investigational+drug+tak-441+as+inhibitor+against+vismodegib-resistant+smoothened+mutant&doi=10.1016%2Fj.ejphar.2013.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant</span></div><div class="casAuthors">Ishii, Tsuyoshi; Shimizu, Yuji; Nakashima, Kosuke; Kondo, Shigeru; Ogawa, Kazumasa; Sasaki, Satoshi; Matsui, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">723</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hedgehog signaling is a driving force in medulloblastoma and basal cell carcinoma (BCC), making it an attractive therapeutic target.  Vismodegib recently received FDA approval for the treatment of inoperable BCC, but a drug-resistant Smoothened (Smo) mutant (D473H) was identified in a clin. study.  TAK-441 is a pyrrolo[3,2-c]pyridine-4-one deriv. that potently inhibits Hh signal transduction and is currently under investigation in clin. trials.  We demonstrated that TAK-441 inhibits reporter activity in D473H-transfected cells with an IC50 of 79 nM, while Vismodegib showed an IC50=7100 nM.  In order to investigate the mode of inhibition, we evaluated the Smo inhibitors with three different binding assays, such as [3H]-TAK-441 membrane binding assay, affinity selection-MS detection assay, and bodipy-cylopamine whole cell assay.  In three different assays, Vismodegib and cyclopamine showed lower affinity for the D473H mutant in comparison with wild-type Smo.  On the other hand, TAK-441 showed almost equal binding affinity for the D473H mutant compared with wild-type Smo in the binding assays, although TAK-441 binds to the same binding site as two other well-known inhibitors.  These in vitro findings suggest that TAK-441 has the potential for clin. use in cancers that are dependent on Hedgehog signaling, including wild-type tumors and Vismodegib-resistant D473H mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAe4k2Cv2mbVg90H21EOLACvtfcHk0limGoIe_l2Fjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOhsbnM&md5=5734463021212b25bfabbb536991889e</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DMatsui%26aufirst%3DH.%26atitle%3DInhibition%2520mechanism%2520exploration%2520of%2520investigational%2520drug%2520tak-441%2520as%2520inhibitor%2520against%2520vismodegib-resistant%2520smoothened%2520mutant%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D723%26spage%3D305%26epage%3D313%26doi%3D10.1016%2Fj.ejphar.2013.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Neuronal delivery of hedgehog directs spatial patterning of taste organ regeneration</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E200</span>– <span class="NLM_lpage">E209</span>, <span class="refDoi"> DOI: 10.1073/pnas.1719109115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1719109115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29279401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVequr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E200-E209&author=W.+J.+Luauthor=R.+K.+Mannauthor=A.+Nguyenauthor=T.+Biauthor=M.+Silversteinauthor=J.+Y.+Tangauthor=X.+Chenauthor=P.+A.+Beachy&title=Neuronal+delivery+of+hedgehog+directs+spatial+patterning+of+taste+organ+regeneration&doi=10.1073%2Fpnas.1719109115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration</span></div><div class="casAuthors">Lu, Wan-Jin; Mann, Randall K.; Nguyen, Allison; Bi, Tingting; Silverstein, Max; Tang, Jean Y.; Chen, Xiaoke; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">E200-E209</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">How organs maintain and restore functional integrity during ordinary tissue turnover or following injury represents a central biol. problem.  The maintenance of taste sensory organs in the tongue was shown 140 years ago to depend on innervation from distant ganglion neurons, but the underlying mechanism has remained unknown.  Here, we show that Sonic hedgehog (Shh), which encodes a secreted protein signal, is expressed in these sensory neurons, and that exptl. ablation of neuronal Shh expression causes loss of taste receptor cells (TRCs).  TRCs are also lost upon pharmacol. blockade of Hedgehog pathway response, accounting for the loss of taste sensation experienced by cancer patients undergoing Hedgehog inhibitor treatment.  We find that TRC regeneration following such pharmacol. ablation requires neuronal expression of Shh and can be substantially enhanced by pharmacol. activation of Hedgehog response.  Such pharmacol. enhancement of Hedgehog response, however, results in addnl. TRC formation at many ectopic sites, unlike the site-restricted regeneration specified by the projection pattern of Shh-expressing neurons.  Stable regeneration of TRCs thus requires neuronal Shh, illustrating the principle that neuronal delivery of cues such as the Shh signal can pattern distant cellular responses to assure functional integrity during tissue maintenance and regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSNWpKLxouKbVg90H21EOLACvtfcHk0limGoIe_l2Fjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVequr7I&md5=37a8060caf59ebe9cd205a7e18276aa4</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1719109115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1719109115%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DW.%2BJ.%26aulast%3DMann%26aufirst%3DR.%2BK.%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DBi%26aufirst%3DT.%26aulast%3DSilverstein%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DNeuronal%2520delivery%2520of%2520hedgehog%2520directs%2520spatial%2520patterning%2520of%2520taste%2520organ%2520regeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE200%26epage%3DE209%26doi%3D10.1073%2Fpnas.1719109115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermilov, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grachtchouk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistretta, C. M.</span></span> <span> </span><span class="NLM_article-title">Recovery of taste organs and sensory function after severe loss from hedgehog/smoothened inhibition with cancer drug sonidegib</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E10369</span>– <span class="NLM_lpage">E10378</span>, <span class="refDoi"> DOI: 10.1073/pnas.1712881114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1712881114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29133390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSisb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E10369-E10378&author=A.+Kumariauthor=A.+N.+Ermilovauthor=M.+Grachtchoukauthor=A.+A.+Dlugoszauthor=B.+L.+Allenauthor=R.+M.+Bradleyauthor=C.+M.+Mistretta&title=Recovery+of+taste+organs+and+sensory+function+after+severe+loss+from+hedgehog%2Fsmoothened+inhibition+with+cancer+drug+sonidegib&doi=10.1073%2Fpnas.1712881114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Recovery of taste organs and sensory function after severe loss from Hedgehog/Smoothened inhibition with cancer drug sonidegib</span></div><div class="casAuthors">Kumari, Archana; Ermilov, Alexandre N.; Grachtchouk, Marina; Dlugosz, Andrzej A.; Allen, Benjamin L.; Bradley, Robert M.; Mistretta, Charlotte M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">E10369-E10378</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Striking taste disturbances are reported in cancer patients treated with Hedgehog (HH)-pathway inhibitor drugs, including sonidegib (LDE225), which block the HH pathway effector Smoothened (SMO).  We tested the potential for mol., cellular, and functional recovery in mice from the severe disruption of taste-organ biol. and taste sensation that follows HH/SMO signaling inhibition.  Sonidegib treatment led to rapid loss of taste buds (TB) in both fungiform and circumvallate papillae, including disruption of TB progenitor-cell proliferation and differentiation.  Effects were selective, sparing nontaste papillae.  To confirm that taste-organ effects of sonidegib treatment result from HH/SMO signaling inhibition, we studied mice with conditional global or epithelium-specific Smo deletions and obsd. similar effects.  During sonidegib treatment, chorda tympani nerve responses to lingual chem. stimulation were maintained at 10 d but were eliminated after 16 d, assocd. with nearly complete TB loss.  Notably, responses to tactile or cold stimulus modalities were retained.  Further, innervation, which was maintained in the papilla core throughout treatment, was not sufficient to sustain TB during HH/SMO inhibition.  Importantly, treatment cessation led to rapid and complete restoration of taste responses within 14 d assocd. with morphol. recovery in about 55% of TB.  However, although taste nerve responses were sustained, TB were not restored in all fungiform papillae even with prolonged recovery for several months.  This study establishes a physiol., selective requirement for HH/SMO signaling in taste homeostasis that includes potential for sensory restoration and can explain the temporal recovery after taste dysgeusia in patients treated with HH/SMO inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe6ZPbIlxHgrVg90H21EOLACvtfcHk0limGoIe_l2Fjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSisb3O&md5=38494798c3228acb64c257438de967d6</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1712881114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1712881114%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DA.%26aulast%3DErmilov%26aufirst%3DA.%2BN.%26aulast%3DGrachtchouk%26aufirst%3DM.%26aulast%3DDlugosz%26aufirst%3DA.%2BA.%26aulast%3DAllen%26aufirst%3DB.%2BL.%26aulast%3DBradley%26aufirst%3DR.%2BM.%26aulast%3DMistretta%26aufirst%3DC.%2BM.%26atitle%3DRecovery%2520of%2520taste%2520organs%2520and%2520sensory%2520function%2520after%2520severe%2520loss%2520from%2520hedgehog%252Fsmoothened%2520inhibition%2520with%2520cancer%2520drug%2520sonidegib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE10369%26epage%3DE10378%26doi%3D10.1073%2Fpnas.1712881114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, N.</span></span> <span> </span><span class="NLM_article-title">Roles of the hedgehog signaling pathway in epidermal and hair follicle development, homeostasis, and cancer</span>. <i>J. Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.3390/jdb5040012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fjdb5040012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvF2ls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=12&author=Y.+Abeauthor=N.+Tanaka&title=Roles+of+the+hedgehog+signaling+pathway+in+epidermal+and+hair+follicle+development%2C+homeostasis%2C+and+cancer&doi=10.3390%2Fjdb5040012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of the hedgehog signaling pathway in epidermal and hair follicle development, homeostasis, and cancer</span></div><div class="casAuthors">Abe, Yoshinori; Tanaka, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Developmental Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">12/1-12/19</span>CODEN:
                <span class="NLM_cas:coden">JDBOAX</span>;
        ISSN:<span class="NLM_cas:issn">2221-3759</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The epidermis is the outermost layer of the skin and provides a protective barrier against environmental insults.  It is a rapidly-renewing tissue undergoing const. regeneration, maintained by several types of stem cells.  The Hedgehog (HH) signaling pathway is one of the fundamental signaling pathways that contributes to epidermal development, homeostasis, and repair, as well as to hair follicle development and follicle bulge stem cell maintenance.  The HH pathway interacts with other signal transduction pathways, including those activated by Wnt, bone morphogenetic protein, platelet-derived growth factor, Notch, and ectodysplasin.  Furthermore, aberrant activation of HH signaling is assocd. with various tumors, including basal cell carcinoma.  Therefore, an understanding of the regulatory mechanisms of the HH signaling pathway is important for elucidating fundamental mechanisms underlying both organogenesis and carcinogenesis.  In this review, we discuss the role of the HH signaling pathway in the development and homeostasis epidermis and hair follicles, and in basal cell carcinoma formation, providing an update of current knowledge in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhGEhB_bmzdrVg90H21EOLACvtfcHk0lgQhchAe8Z4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvF2ls7s%253D&md5=58e8015a6c5c1d07d7b147811c81f6a5</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.3390%2Fjdb5040012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjdb5040012%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DN.%26atitle%3DRoles%2520of%2520the%2520hedgehog%2520signaling%2520pathway%2520in%2520epidermal%2520and%2520hair%2520follicle%2520development%252C%2520homeostasis%252C%2520and%2520cancer%26jtitle%3DJ.%2520Dev.%2520Biol.%26date%3D2017%26volume%3D5%26spage%3D12%26doi%3D10.3390%2Fjdb5040012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span> <span> </span><span class="NLM_article-title">Transient inhibition of the hedgehog pathway in young mice causes permanent defects in bone structure</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2008.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2008.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18328428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVKgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=249-260&author=H.+Kimuraauthor=J.+M.+Ngauthor=T.+Curran&title=Transient+inhibition+of+the+hedgehog+pathway+in+young+mice+causes+permanent+defects+in+bone+structure&doi=10.1016%2Fj.ccr.2008.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure</span></div><div class="casAuthors">Kimura, Hiromichi; Ng, Jessica M. Y.; Curran, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-260</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway plays crit. roles in normal development and in tumorigenesis.  We generated Gli-luciferase transgenic mice to evaluate the Smo inhibitor, HhAntag, by whole animal functional imaging.  HhAntag rapidly reduced systemic luciferase activity in 10- to 14-day-old mice following oral dosing.  Although pathway activity was restored 2 days after drug removal, brief inhibition caused permanent defects in bone growth.  HhAntag inhibited proliferation and promoted differentiation of chondrocytes, leading to dramatic expansion of the hypertrophic zone.  After drug removal, osteoblasts invaded the cartilage plate, mineralization occurred, and there was premature fusion of the growth plate resulting in permanent disruption of bone epiphyses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmLSyJ40mYXbVg90H21EOLACvtfcHk0lgQhchAe8Z4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVKgs70%253D&md5=73765e57376612b3698f8ed54df8ea70</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DJ.%2BM.%26aulast%3DCurran%26aufirst%3DT.%26atitle%3DTransient%2520inhibition%2520of%2520the%2520hedgehog%2520pathway%2520in%2520young%2520mice%2520causes%2520permanent%2520defects%2520in%2520bone%2520structure%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D249%26epage%3D260%26doi%3D10.1016%2Fj.ccr.2008.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieran, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aerts, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouffet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechinaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargrave, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalambakas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshpande, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoerger, B.</span></span> <span> </span><span class="NLM_article-title">Phase i study of oral sonidegib (lde225) in pediatric brain and solid tumors and a phase ii study in children and adults with relapsed medulloblastoma</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1542</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nox109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1093%2Fneuonc%2Fnox109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28605510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2ktbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1542-1552&author=M.+W.+Kieranauthor=J.+Chisholmauthor=M.+Casanovaauthor=A.+A.+Brandesauthor=I.+Aertsauthor=E.+Bouffetauthor=S.+Baileyauthor=S.+Learyauthor=T.+J.+MacDonaldauthor=F.+Mechinaudauthor=K.+J.+Cohenauthor=R.+Riccardiauthor=W.+Masonauthor=D.+Hargraveauthor=S.+Kalambakasauthor=P.+Deshpandeauthor=F.+Taiauthor=E.+Hurhauthor=B.+Geoerger&title=Phase+i+study+of+oral+sonidegib+%28lde225%29+in+pediatric+brain+and+solid+tumors+and+a+phase+ii+study+in+children+and+adults+with+relapsed+medulloblastoma&doi=10.1093%2Fneuonc%2Fnox109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma</span></div><div class="casAuthors">Kieran, Mark W.; Chisholm, Julia; Casanova, Michela; Brandes, Alba A.; Aerts, Isabelle; Bouffet, Eric; Bailey, Simon; Leary, Sarah; MacDonald, Tobey J.; Mechinaud, Francoise; Cohen, Kenneth J.; Riccardi, Riccardo; Mason, Warren; Hargrave, Darren; Kalambakas, Stacey; Deshpande, Priya; Tai, Feng; Hurh, Eunju; Geoerger, Birgit</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1542-1552</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1523-5866</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Sonidegib (LDE225) is a potent, selective hedgehog (Hh) inhibitor of Smoothened.  This study explored the safety and pharmacokinetics of sonidegib in children with relapsed/recurrent tumors followed by a phase II trial in pediatric and adult patients with relapsed medulloblastoma (MB) to assess tumor response.  Pediatric patients aged ≥1 to <18 years were included according to a Bayesian design starting at 372 mg/ m2 of continuous once daily oral sonidegib.  Tumor samples were analyzed for Hh pathway activation using a validated 5-gene Hh signature assay.  In phase II, pediatric patients were treated at the recommended phase II dose (RP2D) while adults received 800 mg daily.  Sixteen adult (16 MB) and 60 pediatric (39 MB, 21 other) patients with an age range of 2-17 years were enrolled.  The RP2D of sonidegib in pediatric patients was established at 680 mg/m2 once daily.  The phase II study was closed prematurely.The 5-gene Hh signature assay showed that the 4 complete responders (2 pediatric and 2 adult) and 1 partial responder (adult) all had Hh-activated tumors, while 5 patients with activated Hh had either stable disease (n = 3) or progressive disease (n = 2).  No patient with an Hh-neg. signature (n = 50) responded.  The safety profile for pediatric patients was generally consistent with the one established for adult patients; however, growth plate changes were obsd. in prepubertal pediatric patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1R9xqXy9sebVg90H21EOLACvtfcHk0lgQhchAe8Z4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2ktbvP&md5=c1ab01d34522dbe851820e3c3a55dd9f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnox109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnox109%26sid%3Dliteratum%253Aachs%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DChisholm%26aufirst%3DJ.%26aulast%3DCasanova%26aufirst%3DM.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DAerts%26aufirst%3DI.%26aulast%3DBouffet%26aufirst%3DE.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DLeary%26aufirst%3DS.%26aulast%3DMacDonald%26aufirst%3DT.%2BJ.%26aulast%3DMechinaud%26aufirst%3DF.%26aulast%3DCohen%26aufirst%3DK.%2BJ.%26aulast%3DRiccardi%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DW.%26aulast%3DHargrave%26aufirst%3DD.%26aulast%3DKalambakas%26aufirst%3DS.%26aulast%3DDeshpande%26aufirst%3DP.%26aulast%3DTai%26aufirst%3DF.%26aulast%3DHurh%26aufirst%3DE.%26aulast%3DGeoerger%26aufirst%3DB.%26atitle%3DPhase%2520i%2520study%2520of%2520oral%2520sonidegib%2520%2528lde225%2529%2520in%2520pediatric%2520brain%2520and%2520solid%2520tumors%2520and%2520a%2520phase%2520ii%2520study%2520in%2520children%2520and%2520adults%2520with%2520relapsed%2520medulloblastoma%26jtitle%3DNeuro%2520Oncol%26date%3D2017%26volume%3D19%26spage%3D1542%26epage%3D1552%26doi%3D10.1093%2Fneuonc%2Fnox109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaste, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chemaitilly, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottardo, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partap, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onar-Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajjar, A.</span></span> <span> </span><span class="NLM_article-title">Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">69295</span>– <span class="NLM_lpage">69302</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.20619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29050204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC1M7isFWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=69295-69302&author=G.+W.+Robinsonauthor=S.+C.+Kasteauthor=W.+Chemaitillyauthor=D.+C.+Bowersauthor=S.+Laughtonauthor=A.+Smithauthor=N.+G.+Gottardoauthor=S.+Partapauthor=A.+Bendelauthor=K.+D.+Wrightauthor=B.+A.+Orrauthor=W.+C.+Warnerauthor=A.+Onar-Thomasauthor=A.+Gajjar&title=Irreversible+growth+plate+fusions+in+children+with+medulloblastoma+treated+with+a+targeted+hedgehog+pathway+inhibitor&doi=10.18632%2Foncotarget.20619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor</span></div><div class="casAuthors">Robinson Giles W; Gajjar Amar; Kaste Sue C; Chemaitilly Wassim; Bowers Daniel C; Laughton Stephen; Smith Amy; Gottardo Nicholas G; Partap Sonia; Bendel Anne; Wright Karen D; Orr Brent A; Warner William C; Onar-Thomas Arzu</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">69295-69302</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The permanent defects in bone growth observed in preclinical studies of hedgehog (Hh) pathway inhibitors were not substantiated in early phase clinical studies of vismodegib in children.  Consequently, vismodegib advanced into pediatric trials for malignancies suspected of being driven by aberrant activation of the Hh pathway.  In one multicenter phase II trial, vismodegib was added to the therapy regimen for newly diagnosed Hh pathway activated medulloblastoma.  Herein, we report on 3 children (2 on trial and one off trial) treated with vismodegib who developed widespread growth plate fusions that persist long after cessation of therapy.  Currently, all 3 patients exhibit profound short stature and disproportionate growth, and 2 subsequently developed precocious puberty.  Notably, the growth plate fusions only developed after a prolonged exposure to the drug (> 140 days).  These findings resulted in a major trial amendment to restrict the agent to skeletally mature patients as well as a product label warning and update.  Moreover, these findings alter the risk-benefit ratio of Hh inhibitors and underscore the importance of careful study of targeted agents in children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTC7b2by7_iHiEJCPKhJPuqfW6udTcc2ebDzSBT-nhjV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7isFWjtw%253D%253D&md5=1a509da5917b9097f5c2ed2d6ed9d002</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20619%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DG.%2BW.%26aulast%3DKaste%26aufirst%3DS.%2BC.%26aulast%3DChemaitilly%26aufirst%3DW.%26aulast%3DBowers%26aufirst%3DD.%2BC.%26aulast%3DLaughton%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DGottardo%26aufirst%3DN.%2BG.%26aulast%3DPartap%26aufirst%3DS.%26aulast%3DBendel%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DK.%2BD.%26aulast%3DOrr%26aufirst%3DB.%2BA.%26aulast%3DWarner%26aufirst%3DW.%2BC.%26aulast%3DOnar-Thomas%26aufirst%3DA.%26aulast%3DGajjar%26aufirst%3DA.%26atitle%3DIrreversible%2520growth%2520plate%2520fusions%2520in%2520children%2520with%2520medulloblastoma%2520treated%2520with%2520a%2520targeted%2520hedgehog%2520pathway%2520inhibitor%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D69295%26epage%3D69302%26doi%3D10.18632%2Foncotarget.20619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span> <span> </span><span class="NLM_article-title">Reproducibility of academic preclinical translational research: Lessons from the development of hedgehog pathway inhibitors to treat cancer</span>. <i>Open Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">180098</span>, <span class="refDoi"> DOI: 10.1098/rsob.180098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1098%2Frsob.180098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30068568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVamu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=180098&author=T.+Curran&title=Reproducibility+of+academic+preclinical+translational+research%3A+Lessons+from+the+development+of+hedgehog+pathway+inhibitors+to+treat+cancer&doi=10.1098%2Frsob.180098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer</span></div><div class="casAuthors">Curran, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Open Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">180098/1-180098/15</span>CODEN:
                <span class="NLM_cas:coden">OBPICQ</span>;
        ISSN:<span class="NLM_cas:issn">2046-2441</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  Academic translational research is growing at a great pace at a time in which questions have been raised about the reproducibility of preclin. findings.  The development of Hedgehog (HH) pathway inhibitors for the treatment of cancer over the past two decades offers a case study for understanding the root causes of failure to predict clin. outcomes arising from academic pre-clin. translational research.  Although such inhibitors were once hoped to be efficacious in up to 25% of human cancer, clin. studies showed responses only in basal cell carcinoma and the HH subtype of medulloblastoma.  Close examn. of the published studies reveals limitations in the models used, lack of quant. stds., utilization of high drug concns. assocd. with non-specific toxicities and improper use of cell line and mouse models.  In part, these issues arise from scientific complexity, for example, the failure of tumor cell lines to maintain HH pathway activity in vitro, but a greater contributing factor appears to be the influence of unconscious bias.  There was a strong expectation that HH pathway inhibitors would make a profound impact on human cancer and expts. were designed with this assumption in mind.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAq_EYETSsKbVg90H21EOLACvtfcHk0lgl0xYTphhZug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVamu74%253D&md5=5e1e67b920a50511f723feb28e116f77</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1098%2Frsob.180098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsob.180098%26sid%3Dliteratum%253Aachs%26aulast%3DCurran%26aufirst%3DT.%26atitle%3DReproducibility%2520of%2520academic%2520preclinical%2520translational%2520research%253A%2520Lessons%2520from%2520the%2520development%2520of%2520hedgehog%2520pathway%2520inhibitors%2520to%2520treat%2520cancer%26jtitle%3DOpen%2520Biol.%26date%3D2018%26volume%3D8%26spage%3D180098%26doi%3D10.1098%2Frsob.180098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blau, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balis, U. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalupski, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, D. M.</span></span> <span> </span><span class="NLM_article-title">Pilot clinical trial of hedgehog pathway inhibitor gdc-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5937</span>– <span class="NLM_lpage">5945</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-1269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1078-0432.CCR-14-1269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25278454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGku73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=5937-5945&author=E.+J.+Kimauthor=V.+Sahaiauthor=E.+V.+Abelauthor=K.+A.+Griffithauthor=J.+K.+Greensonauthor=N.+Takebeauthor=G.+N.+Khanauthor=J.+L.+Blauauthor=R.+Craigauthor=U.+G.+Balisauthor=M.+M.+Zalupskiauthor=D.+M.+Simeone&title=Pilot+clinical+trial+of+hedgehog+pathway+inhibitor+gdc-0449+%28vismodegib%29+in+combination+with+gemcitabine+in+patients+with+metastatic+pancreatic+adenocarcinoma&doi=10.1158%2F1078-0432.CCR-14-1269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma</span></div><div class="casAuthors">Kim, Edward J.; Sahai, Vaibhav; Abel, Ethan V.; Griffith, Kent A.; Greenson, Joel K.; Takebe, Naoko; Khan, Gazala N.; Blau, John L.; Craig, Ronald; Balis, Ulysses G.; Zalupski, Mark M.; Simeone, Diane M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5937-5945</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hedgehog (HH) signaling pathway is a key regulator in tumorigenesis of pancreatic adenocarcinoma and is upregulated in pancreatic adenocarcinoma cancer stem cells (CSCs).  GDC-0449 is an oral small-mol. inhibitor of the HH pathway.  This study assessed the effect of GDC-0449-mediated HH inhibition in paired biopsies, followed by combined treatment with gemcitabine, in patients with metastatic pancreatic adenocarcinoma.  Twenty-five patients were enrolled of which 23 underwent core biopsies at baseline and following 3 wk of GDC-0449.  On day 29, 23 patients started weekly gemcitabine while continuing GDC-0449.  We evaluated GLI1 and PTCH1 inhibition, change in CSCs, Ki-67, fibrosis, and assessed tumor response, survival and toxicity.  On pretreatment biopsy, 75% of patients had elevated sonic hedgehog (SHH) expression.  On posttreatment biopsy, GLI1 and PTCH1 decreased in 95.6% and 82.6% of 23 patients, fibrosis decreased in 45.4% of 22, and Ki-67 in 52.9% of 17 evaluable patients.  No significant changes were detected in CSCs pre- and postbiopsy.  The median progression-free and overall survival for all treated patients were 2.8 and 5.3 mo.  The response and disease control rate was 21.7% and 65.2%.  No significant correlation was noted between CSCs, fibrosis, SHH, Ki-67, GLI1, PTCH1 (baseline values or relative change on posttreatment biopsy), and survival.  Grade ≥3 adverse events were noted in 56% of patients.  We show that GDC-0449 for 3 wk leads to downmodulation of GLI1 and PTCH1, without significant changes in CSCs compared with baseline.  GDC-0449 and gemcitabine were not superior to gemcitabine alone in the treatment of metastatic pancreatic cancer.  Clin Cancer Res; 20(23); 5937-45. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq5qpSWNo-e7Vg90H21EOLACvtfcHk0lgl0xYTphhZug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGku73L&md5=c0d47d2a371f9f08e8afb710a176a07c</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-1269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-1269%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DSahai%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DE.%2BV.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DGreenson%26aufirst%3DJ.%2BK.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DG.%2BN.%26aulast%3DBlau%26aufirst%3DJ.%2BL.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBalis%26aufirst%3DU.%2BG.%26aulast%3DZalupski%26aufirst%3DM.%2BM.%26aulast%3DSimeone%26aufirst%3DD.%2BM.%26atitle%3DPilot%2520clinical%2520trial%2520of%2520hedgehog%2520pathway%2520inhibitor%2520gdc-0449%2520%2528vismodegib%2529%2520in%2520combination%2520with%2520gemcitabine%2520in%2520patients%2520with%2520metastatic%2520pancreatic%2520adenocarcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D5937%26epage%3D5945%26doi%3D10.1158%2F1078-0432.CCR-14-1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catenacci, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junttila, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahary, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiba, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nattam, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozloff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajdev, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleckman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takebe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, H. L.</span></span> <span> </span><span class="NLM_article-title">Randomized phase ib/ii study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">4284</span>– <span class="NLM_lpage">4292</span>, <span class="refDoi"> DOI: 10.1200/JCO.2015.62.8719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1200%2FJCO.2015.62.8719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26527777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVynsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=4284-4292&author=D.+V.+Catenacciauthor=M.+R.+Junttilaauthor=T.+Karrisonauthor=N.+Baharyauthor=M.+N.+Horibaauthor=S.+R.+Nattamauthor=R.+Marshauthor=J.+Wallaceauthor=M.+Kozloffauthor=L.+Rajdevauthor=D.+Cohenauthor=J.+Wadeauthor=B.+Sleckmanauthor=H.+J.+Lenzauthor=P.+Stiffauthor=P.+Kumarauthor=P.+Xuauthor=L.+Hendersonauthor=N.+Takebeauthor=R.+Salgiaauthor=X.+Wangauthor=W.+M.+Stadlerauthor=F.+J.+de+Sauvageauthor=H.+L.+Kindler&title=Randomized+phase+ib%2Fii+study+of+gemcitabine+plus+placebo+or+vismodegib%2C+a+hedgehog+pathway+inhibitor%2C+in+patients+with+metastatic+pancreatic+cancer&doi=10.1200%2FJCO.2015.62.8719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer</span></div><div class="casAuthors">Catenacci, Daniel V. T.; Junttila, Melissa R.; Karrison, Theodore; Bahary, Nathan; Horiba, Margit N.; Nattam, Sreenivasa R.; Marsh, Robert; Wallace, James; Kozloff, Mark; Rajdev, Lakshmi; Cohen, Deirdre; Wade, James; Sleckman, Bethany; Lenz, Heinz-Josef; Stiff, Patrick; Kumar, Pankaj; Xu, Peng; Henderson, Les; Takebe, Naoko; Salgia, Ravi; Wang, Xi; Stadler, Walter M.; de Sauvage, Frederic J.; Kindler, Hedy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4284-4292</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Sonic hedgehog (SHH), an activating ligand of smoothened (SMO), is overexpressed in > 70% of pancreatic cancers (PCs).  We investigated the impact of vismodegib, an SHH antagonist, plus gemcitabine (GV) or gemcitabine plus placebo (GP) in a multicenter phase Ib/randomized phase II trial and preclin. PC models.  Patients and Methods: Patients with PC not amenable to curative therapy who had received no prior therapy for metastatic disease and had Karnofsky performance score ≥ 80 were enrolled.  Patients were randomly assigned in a one-to-one ratio to GV or GP.  The primary end point was progression-free-survival (PFS).  Exploratory correlative studies included serial SHH serum levels and contrast perfusion computed tomog. imaging.  To further investigate putative biol. mechanisms of SMO inhibition, two autochthonous pancreatic cancer models (KrasG12D; p16/p19fl/fl; Pdx1-Cre and KrasG12D; p53R270H/wt; Pdx1-Cre) were studied.  Results: No safety issues were identified in the phase Ib portion (n = 7), and the phase II study enrolled 106 evaluable patients (n = 53 in each arm).  Median PFS was 4.0 and 2.5 mo for GV and GP arms, resp. (95% CI, 2.5 to 5.3 and 1.9 to 3.8, resp.; adjusted hazard ratio, 0.81; 95% CI, 0.54 to 1.21; P = .30).  Median overall survival (OS) was 6.9 and 6.1 mo for GV and GP arms, resp. (95% CI, 5.8 to 8.0 and 5.0 to 8.0, resp.; adjusted hazard ratio, 1.04; 95% CI, 0.69 to 1.58; P = .84).  Response rates were not significantly different.  There were no significant assocns. between correlative markers and overall response rate, PFS, or OS.  Preclin. trials revealed no significant differences with vismodegib in drug delivery, tumor growth rate, or OS in either model.  Conclusion: The addn. of vismodegib to gemcitabine in an unselected cohort did not improve overall response rate, PFS, or OS in patients with metastatic PC.  Our preclin. and clin. results revealed no statistically significant differences with respect to drug delivery or treatment efficacy using vismodegib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYIFvd4cyQ4bVg90H21EOLACvtfcHk0lgItI-BeqSmag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVynsbc%253D&md5=3ccbe6276194f6947c9b4e9e894ec3ed</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.62.8719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.62.8719%26sid%3Dliteratum%253Aachs%26aulast%3DCatenacci%26aufirst%3DD.%2BV.%26aulast%3DJunttila%26aufirst%3DM.%2BR.%26aulast%3DKarrison%26aufirst%3DT.%26aulast%3DBahary%26aufirst%3DN.%26aulast%3DHoriba%26aufirst%3DM.%2BN.%26aulast%3DNattam%26aufirst%3DS.%2BR.%26aulast%3DMarsh%26aufirst%3DR.%26aulast%3DWallace%26aufirst%3DJ.%26aulast%3DKozloff%26aufirst%3DM.%26aulast%3DRajdev%26aufirst%3DL.%26aulast%3DCohen%26aufirst%3DD.%26aulast%3DWade%26aufirst%3DJ.%26aulast%3DSleckman%26aufirst%3DB.%26aulast%3DLenz%26aufirst%3DH.%2BJ.%26aulast%3DStiff%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DHenderson%26aufirst%3DL.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DSalgia%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DStadler%26aufirst%3DW.%2BM.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26aulast%3DKindler%26aufirst%3DH.%2BL.%26atitle%3DRandomized%2520phase%2520ib%252Fii%2520study%2520of%2520gemcitabine%2520plus%2520placebo%2520or%2520vismodegib%252C%2520a%2520hedgehog%2520pathway%2520inhibitor%252C%2520in%2520patients%2520with%2520metastatic%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D33%26spage%3D4284%26epage%3D4292%26doi%3D10.1200%2FJCO.2015.62.8719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yauch, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Januario, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallop, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nannini-Pepe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotkow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsters, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">A paracrine requirement for hedgehog signalling in cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">406</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1038/nature07275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnature07275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18754008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFams7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=406-410&author=R.+L.+Yauchauthor=S.+E.+Gouldauthor=S.+J.+Scalesauthor=T.+Tangauthor=H.+Tianauthor=C.+P.+Ahnauthor=D.+Marshallauthor=L.+Fuauthor=T.+Januarioauthor=D.+Kallopauthor=M.+Nannini-Pepeauthor=K.+Kotkowauthor=J.+C.+Marstersauthor=L.+L.+Rubinauthor=F.+J.+de+Sauvage&title=A+paracrine+requirement+for+hedgehog+signalling+in+cancer&doi=10.1038%2Fnature07275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">A paracrine requirement for hedgehog signalling in cancer</span></div><div class="casAuthors">Yauch, Robert L.; Gould, Stephen E.; Scales, Suzie J.; Tang, Tracy; Tian, Hua; Ahn, Christina P.; Marshall, Derek; Fu, Ling; Januario, Thomas; Kallop, Dara; Nannini-Pepe, Michelle; Kotkow, Karen; Marsters, James C.; Rubin, Lee L.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">7211</span>),
    <span class="NLM_cas:pages">406-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ligand-dependent activation of the hedgehog (Hh) signaling pathway has been assocd. with tumorigenesis in a no. of human tissues.  Here it is shown that, although previous reports have described a cell-autonomous role for Hh signaling in these tumors, Hh ligands fail to activate signaling in tumor epithelial cells.  In contrast, these data support ligand-dependent activation of the Hh pathway in the stromal microenvironment.  Specific inhibition of Hh signaling using small mol. inhibitors, a neutralizing anti-Hh antibody or genetic deletion of smoothened (Smo) in the mouse stroma results in growth inhibition in xenograft tumor models.  Taken together, these studies demonstrate a paracrine requirement for Hh ligand signaling in the tumorigenesis of Hh-expressing cancers and have important implications for the development of Hh pathway antagonists in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpJWpPtWaw7Vg90H21EOLACvtfcHk0lgItI-BeqSmag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFams7fP&md5=cb96322999aaeee1b41f23e5f080ab23</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1038%2Fnature07275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07275%26sid%3Dliteratum%253Aachs%26aulast%3DYauch%26aufirst%3DR.%2BL.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DAhn%26aufirst%3DC.%2BP.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DJanuario%26aufirst%3DT.%26aulast%3DKallop%26aufirst%3DD.%26aulast%3DNannini-Pepe%26aufirst%3DM.%26aulast%3DKotkow%26aufirst%3DK.%26aulast%3DMarsters%26aufirst%3DJ.%2BC.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DA%2520paracrine%2520requirement%2520for%2520hedgehog%2520signalling%2520in%2520cancer%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D406%26epage%3D410%26doi%3D10.1038%2Fnature07275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuPree, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darbonne, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Sauvage, F. J.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">4254</span>– <span class="NLM_lpage">4259</span>, <span class="refDoi"> DOI: 10.1073/pnas.0813203106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0813203106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19246386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslChu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=4254-4259&author=H.+Tianauthor=C.+A.+Callahanauthor=K.+J.+DuPreeauthor=W.+C.+Darbonneauthor=C.+P.+Ahnauthor=S.+J.+Scalesauthor=F.+J.+de+Sauvage&title=Hedgehog+signaling+is+restricted+to+the+stromal+compartment+during+pancreatic+carcinogenesis&doi=10.1073%2Fpnas.0813203106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis</span></div><div class="casAuthors">Tian, Hua; Callahan, Christopher A.; DuPree, Kelly J.; Darbonne, Walter C.; Ahn, Christina P.; Scales, Suzie J.; de Sauvage, Frederic J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4254-4259</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway has been implicated in pancreatic cancer but its role remains controversial.  To delineate the cell populations able to respond to Hh ligand stimulation, we expressed an oncogenic allele of Smoothened (SmoM2) to cell autonomously activate Hh signaling in the mouse pancreas.  Surprisingly, we found that expression of SmoM2 in epithelial cells was not able to activate the pathway and had no impact on pancreatic development or neoplasia.  In contrast, activation of Smo in the mesenchyme led to Hh pathway activation, indicating that only the tumor stroma is competent to transduce the Hh signal.  Using a Ptc-LacZ reporter mouse, we show that Hh signaling is active in stromal cells surrounding Hh-expressing tumor epithelium in various mouse pancreatic cancer models.  Activation of the Hh pathway in the tumor stroma of human pancreatic and metastatic cancer specimens was confirmed by quant. RT-PCR of microdissected tissue samples.  These data support a paracrine model of Hh-mediated tumorigenesis, in which tumor cells secrete Hh ligand to induce tumor-promoting Hh target genes in adjacent stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByH4lq_81RbVg90H21EOLACvtfcHk0lgItI-BeqSmag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslChu74%253D&md5=f9da3fb447be4e590bc2a8c35744a9e1</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0813203106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0813203106%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DH.%26aulast%3DCallahan%26aufirst%3DC.%2BA.%26aulast%3DDuPree%26aufirst%3DK.%2BJ.%26aulast%3DDarbonne%26aufirst%3DW.%2BC.%26aulast%3DAhn%26aufirst%3DC.%2BP.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BSauvage%26aufirst%3DF.%2BJ.%26atitle%3DHedgehog%2520signaling%2520is%2520restricted%2520to%2520the%2520stromal%2520compartment%2520during%2520pancreatic%2520carcinogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D4254%26epage%3D4259%26doi%3D10.1073%2Fpnas.0813203106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan-Stevaux, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truitt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebrok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Zapico, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span> <span> </span><span class="NLM_article-title">Gli1 is regulated through smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates pdac cell survival and transformation</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1101/gad.1753809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1101%2Fgad.1753809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19136624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptFWlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=24-36&author=O.+Nolan-Stevauxauthor=J.+Lauauthor=M.+L.+Truittauthor=G.+C.+Chuauthor=M.+Hebrokauthor=M.+E.+Fernandez-Zapicoauthor=D.+Hanahan&title=Gli1+is+regulated+through+smoothened-independent+mechanisms+in+neoplastic+pancreatic+ducts+and+mediates+pdac+cell+survival+and+transformation&doi=10.1101%2Fgad.1753809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">GLI1 is regulated through smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation</span></div><div class="casAuthors">Nolan-Stevaux, Olivier; Lau, Janet; Truitt, Morgan L.; Chu, Gerald C.; Hebrok, Matthias; Fernandez-Zapico, Martin E.; Hanahan, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-36</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is characterized by the deregulation of the hedgehog signaling pathway.  The Sonic Hedgehog ligand (Shh), absent in the normal pancreas, is highly expressed in pancreatic tumors and is sufficient to induce neoplastic precursor lesions in mouse models.  We investigated the mechanism of Shh signaling in PDAC carcinogenesis by genetically ablating the canonical bottleneck of hedgehog signaling, the transmembrane protein Smoothened (Smo), in the pancreatic epithelium of PDAC-susceptible mice.  We report that multistage development of PDAC tumors is not affected by the deletion of Smo in the pancreas, demonstrating that autocrine Shh-Ptch-Smo signaling is not required in pancreatic ductal cells for PDAC progression.  However, the expression of Gli target genes is maintained in Smo-neg. ducts, implicating alternative means of regulating Gli transcription in the neoplastic ductal epithelium.  In PDAC tumor cells, we find that Gli transcription is decoupled from upstream Shh-Ptch-Smo signaling and is regulated by TGF-β and KRAS, and we show that Gli1 is required both for survival and for the KRAS-mediated transformed phenotype of cultured PDAC cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzKdXxhFHpJbVg90H21EOLACvtfcHk0lh66ZT4bWOsdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptFWlsQ%253D%253D&md5=6ef2e938cae3283163a0ff726fb76f48</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1101%2Fgad.1753809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1753809%26sid%3Dliteratum%253Aachs%26aulast%3DNolan-Stevaux%26aufirst%3DO.%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DTruitt%26aufirst%3DM.%2BL.%26aulast%3DChu%26aufirst%3DG.%2BC.%26aulast%3DHebrok%26aufirst%3DM.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DGli1%2520is%2520regulated%2520through%2520smoothened-independent%2520mechanisms%2520in%2520neoplastic%2520pancreatic%2520ducts%2520and%2520mediates%2520pdac%2520cell%2520survival%2520and%2520transformation%26jtitle%3DGenes%2520Dev.%26date%3D2009%26volume%3D23%26spage%3D24%26epage%3D36%26doi%3D10.1101%2Fgad.1753809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberstein, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirek, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastra, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekleva, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becerra, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattersall, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westphalen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitajewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Barrena, M.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Zapico, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanger, B. Z.</span></span> <span> </span><span class="NLM_article-title">Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2014.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24856585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslyisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=735-747&author=A.+D.+Rhimauthor=P.+E.+Obersteinauthor=D.+H.+Thomasauthor=E.+T.+Mirekauthor=C.+F.+Palermoauthor=S.+A.+Sastraauthor=E.+N.+Deklevaauthor=T.+Saundersauthor=C.+P.+Becerraauthor=I.+W.+Tattersallauthor=C.+B.+Westphalenauthor=J.+Kitajewskiauthor=M.%0AG.+Fernandez-Barrenaauthor=M.+E.+Fernandez-Zapicoauthor=C.+Iacobuzio-Donahueauthor=K.+P.+Oliveauthor=B.+Z.+Stanger&title=Stromal+elements+act+to+restrain%2C+rather+than+support%2C+pancreatic+ductal+adenocarcinoma&doi=10.1016%2Fj.ccr.2014.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Rhim, Andrew D.; Oberstein, Paul E.; Thomas, Dafydd H.; Mirek, Emily T.; Palermo, Carmine F.; Sastra, Stephen A.; Dekleva, Erin N.; Saunders, Tyler; Becerra, Claudia P.; Tattersall, Ian W.; Westphalen, C. Benedikt; Kitajewski, Jan; Fernandez-Barrena, Maite G.; Fernandez-Zapico, Martin E.; Iacobuzio-Donahue, Christine; Olive, Kenneth P.; Stanger, Ben Z.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">735-747</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Sonic hedgehog (Shh), a sol. ligand overexpressed by neoplastic cells in pancreatic ductal adenocarcinoma (PDAC), drives formation of a fibroblast-rich desmoplastic stroma.  To better understand its role in malignant progression, we deleted Shh in a well-defined mouse model of PDAC.  As predicted, Shh-deficient tumors had reduced stromal content.  Surprisingly, such tumors were more aggressive and exhibited undifferentiated histol., increased vascularity, and heightened proliferation-features that were fully recapitulated in control mice treated with a Smoothened inhibitor.  Furthermore, administration of VEGFR blocking antibody selectively improved survival of Shh-deficient tumors, indicating that Hedgehog-driven stroma suppresses tumor growth in part by restraining tumor angiogenesis.  Together, these data demonstrate that some components of the tumor stroma can act to restrain tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXaMntrm5pkbVg90H21EOLACvtfcHk0lh66ZT4bWOsdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslyisbc%253D&md5=074369eb89c54fc678b3e5c644d32e29</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DRhim%26aufirst%3DA.%2BD.%26aulast%3DOberstein%26aufirst%3DP.%2BE.%26aulast%3DThomas%26aufirst%3DD.%2BH.%26aulast%3DMirek%26aufirst%3DE.%2BT.%26aulast%3DPalermo%26aufirst%3DC.%2BF.%26aulast%3DSastra%26aufirst%3DS.%2BA.%26aulast%3DDekleva%26aufirst%3DE.%2BN.%26aulast%3DSaunders%26aufirst%3DT.%26aulast%3DBecerra%26aufirst%3DC.%2BP.%26aulast%3DTattersall%26aufirst%3DI.%2BW.%26aulast%3DWestphalen%26aufirst%3DC.%2BB.%26aulast%3DKitajewski%26aufirst%3DJ.%26aulast%3DFernandez-Barrena%26aufirst%3DM.%2BG.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DOlive%26aufirst%3DK.%2BP.%26aulast%3DStanger%26aufirst%3DB.%2BZ.%26atitle%3DStromal%2520elements%2520act%2520to%2520restrain%252C%2520rather%2520than%2520support%252C%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D735%26epage%3D747%26doi%3D10.1016%2Fj.ccr.2014.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozdemir, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentcheva-Hoang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstens, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laklai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novitskiy, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jesus-Acosta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBleu, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalluri, R.</span></span> <span> </span><span class="NLM_article-title">Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2014.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24856586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2hsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=719-734&author=B.+C.+Ozdemirauthor=T.+Pentcheva-Hoangauthor=J.+L.+Carstensauthor=X.+Zhengauthor=C.+C.+Wuauthor=T.+R.+Simpsonauthor=H.+Laklaiauthor=H.+Sugimotoauthor=C.+Kahlertauthor=S.+V.+Novitskiyauthor=A.+De+Jesus-Acostaauthor=P.+Sharmaauthor=P.+Heidariauthor=U.+Mahmoodauthor=L.+Chinauthor=H.+L.+Mosesauthor=V.+M.+Weaverauthor=A.+Maitraauthor=J.+P.+Allisonauthor=V.+S.+LeBleuauthor=R.+Kalluri&title=Depletion+of+carcinoma-associated+fibroblasts+and+fibrosis+induces+immunosuppression+and+accelerates+pancreas+cancer+with+reduced+survival&doi=10.1016%2Fj.ccr.2014.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival</span></div><div class="casAuthors">Ozdemir, Berna C.; Pentcheva-Hoang, Tsvetelina; Carstens, Julienne L.; Zheng, Xiaofeng; Wu, Chia-Chin; Simpson, Tyler R.; Laklai, Hanane; Sugimoto, Hikaru; Kahlert, Christoph; Novitskiy, Sergey V.; De Jesus-Acosta, Ana; Sharma, Padmanee; Heidari, Pedram; Mahmood, Umar; Chin, Lynda; Moses, Harold L.; Weaver, Valerie M.; Maitra, Anirban; Allison, James P.; LeBleu, Valerie S.; Kalluri, Raghu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-734</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is assocd. with marked fibrosis and stromal myofibroblasts, but their functional contribution remains unknown.  Transgenic mice with the ability to delete αSMA+ myofibroblasts in pancreatic cancer were generated.  Depletion starting at either noninvasive precursor (pancreatic intraepithelial neoplasia) or the PDAC stage led to invasive, undifferentiated tumors with enhanced hypoxia, epithelial-to-mesenchymal transition, and cancer stem cells, with diminished animal survival.  In PDAC patients, fewer myofibroblasts in their tumors also correlated with reduced survival.  Suppressed immune surveillance with increased CD4+Foxp3+ Tregs was obsd. in myofibroblast-depleted mouse tumors.  Although myofibroblast-depleted tumors did not respond to gemcitabine, anti-CTLA4 immunotherapy reversed disease acceleration and prolonged animal survival.  This study underscores the need for caution in targeting carcinoma-assocd. fibroblasts in PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfEmS1FleEo7Vg90H21EOLACvtfcHk0lh66ZT4bWOsdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2hsr0%253D&md5=682e316bd29cdd7a4d5a71bb6b0649b5</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DOzdemir%26aufirst%3DB.%2BC.%26aulast%3DPentcheva-Hoang%26aufirst%3DT.%26aulast%3DCarstens%26aufirst%3DJ.%2BL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DC.%2BC.%26aulast%3DSimpson%26aufirst%3DT.%2BR.%26aulast%3DLaklai%26aufirst%3DH.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DKahlert%26aufirst%3DC.%26aulast%3DNovitskiy%26aufirst%3DS.%2BV.%26aulast%3DDe%2BJesus-Acosta%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DHeidari%26aufirst%3DP.%26aulast%3DMahmood%26aufirst%3DU.%26aulast%3DChin%26aufirst%3DL.%26aulast%3DMoses%26aufirst%3DH.%2BL.%26aulast%3DWeaver%26aufirst%3DV.%2BM.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26aulast%3DLeBleu%26aufirst%3DV.%2BS.%26aulast%3DKalluri%26aufirst%3DR.%26atitle%3DDepletion%2520of%2520carcinoma-associated%2520fibroblasts%2520and%2520fibrosis%2520induces%2520immunosuppression%2520and%2520accelerates%2520pancreas%2520cancer%2520with%2520reduced%2520survival%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D719%26epage%3D734%26doi%3D10.1016%2Fj.ccr.2014.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neesse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gress, T. M.</span></span> <span> </span><span class="NLM_article-title">Stromal biology and therapy in pancreatic cancer: Ready for clinical translation?</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2018-316451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1136%2Fgutjnl-2018-316451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30177543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKls7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2019&pages=159-171&author=A.+Neesseauthor=C.+A.+Bauerauthor=D.+Ohlundauthor=M.+Lauthauthor=M.+Buchholzauthor=P.+Michlauthor=D.+A.+Tuvesonauthor=T.+M.+Gress&title=Stromal+biology+and+therapy+in+pancreatic+cancer%3A+Ready+for+clinical+translation%3F&doi=10.1136%2Fgutjnl-2018-316451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal biology and therapy in pancreatic cancer: ready for clinical translation?</span></div><div class="casAuthors">Neesse, Albrecht; Bauer, Christian Alexander; Oehlund, Daniel; Lauth, Matthias; Buchholz, Malte; Michl, Patrick; Tuveson, David A.; Gress, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-171</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic ductal adenocarcinoma (PDA) is notoriously aggressive and hard to treat.  The tumor microenvironment (TME) in PDA is highly dynamic and has been found to promote tumor progression, metastasis niche formation and therapeutic resistance.  Intensive research of recent years has revealed an incredible heterogeneity and complexity of the different components of the TME, including cancer-assocd. fibroblasts, immune cells, extracellular matrix components, tumor vessels and nerves.  It has been hypothesised that paracrine interactions between neoplastic epithelial cells and TME compartments may result in either tumor-promoting or tumor-restraining consequences.  A better preclin. understanding of such complex and dynamic network systems is required to develop more powerful treatment strategies for patients.  Scientific activity and the no. of compelling findings has virtually exploded during recent years.  Here, we provide an update of the most recent findings in this area and discuss their translational and clin. implications for basic scientists and clinicians alike.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV8HJgV9Ti1LVg90H21EOLACvtfcHk0lgDtYONZ4Mpcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKls7jL&md5=0f03d36f9e3abffe7a09adce20614a5e</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2018-316451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2018-316451%26sid%3Dliteratum%253Aachs%26aulast%3DNeesse%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DC.%2BA.%26aulast%3DOhlund%26aufirst%3DD.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DMichl%26aufirst%3DP.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DGress%26aufirst%3DT.%2BM.%26atitle%3DStromal%2520biology%2520and%2520therapy%2520in%2520pancreatic%2520cancer%253A%2520Ready%2520for%2520clinical%2520translation%253F%26jtitle%3DGut%26date%3D2019%26volume%3D68%26spage%3D159%26epage%3D171%26doi%3D10.1136%2Fgutjnl-2018-316451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buller, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joost, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frings, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wielenga, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhl, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Brink, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Stromal hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12321</span>, <span class="refDoi"> DOI: 10.1038/ncomms12321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms12321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27492255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlalsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12321&author=M.+Gerlingauthor=N.+V.+Bullerauthor=L.+M.+Kirnauthor=S.+Joostauthor=O.+Fringsauthor=B.+Englertauthor=A.+Bergstromauthor=R.+V.+Kuiperauthor=L.+Blaasauthor=M.+C.+Wielengaauthor=S.+Almerauthor=A.+A.+Kuhlauthor=E.+Fredlundauthor=G.+R.+van+den+Brinkauthor=R.+Toftgard&title=Stromal+hedgehog+signalling+is+downregulated+in+colon+cancer+and+its+restoration+restrains+tumour+growth&doi=10.1038%2Fncomms12321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth</span></div><div class="casAuthors">Gerling, Marco; Buller, Nike V. J. A.; Kirn, Leonard M.; Joost, Simon; Frings, Oliver; Englert, Benjamin; Bergstroem, Aasa; Kuiper, Raoul V.; Blaas, Leander; Wielenga, Mattheus C. B.; Almer, Sven; Kuhl, Anja A.; Fredlund, Erik; van den Brink, Gijs R.; Toftgaard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12321</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A role for Hedgehog (Hh) signalling in the development of colorectal cancer (CRC) has been proposed.  In CRC and other solid tumors, Hh ligands are upregulated; however, a specific Hh antagonist provided no benefit in a clin. trial.  Here we use Hh reporter mice to show that downstream Hh activity is unexpectedly diminished in a mouse model of colitis-assocd. colon cancer, and that downstream Hh signalling is restricted to the stroma.  Functionally, stroma-specific Hh activation in mice markedly reduces the tumor load and blocks progression of advanced neoplasms, partly via the modulation of BMP signalling and restriction of the colonic stem cell signature.  By contrast, attenuated Hh signalling accelerates colonic tumorigenesis.  In human CRC, downstream Hh activity is similarly reduced and canonical Hh signalling remains predominantly paracrine.  Our results suggest that diminished downstream Hh signalling enhances CRC development, and that stromal Hh activation can act as a colonic tumor suppressor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Q_8DHVrSWrVg90H21EOLACvtfcHk0lgDtYONZ4Mpcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlalsbvE&md5=2a3004c26c67398117eb30c4036826cf</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fncomms12321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12321%26sid%3Dliteratum%253Aachs%26aulast%3DGerling%26aufirst%3DM.%26aulast%3DBuller%26aufirst%3DN.%2BV.%26aulast%3DKirn%26aufirst%3DL.%2BM.%26aulast%3DJoost%26aufirst%3DS.%26aulast%3DFrings%26aufirst%3DO.%26aulast%3DEnglert%26aufirst%3DB.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DKuiper%26aufirst%3DR.%2BV.%26aulast%3DBlaas%26aufirst%3DL.%26aulast%3DWielenga%26aufirst%3DM.%2BC.%26aulast%3DAlmer%26aufirst%3DS.%26aulast%3DKuhl%26aufirst%3DA.%2BA.%26aulast%3DFredlund%26aufirst%3DE.%26aulast%3Dvan%2Bden%2BBrink%26aufirst%3DG.%2BR.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DStromal%2520hedgehog%2520signalling%2520is%2520downregulated%2520in%2520colon%2520cancer%2520and%2520its%2520restoration%2520restrains%2520tumour%2520growth%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12321%26doi%3D10.1038%2Fncomms12321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruzas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamin, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geles, K. G.</span></span> <span> </span><span class="NLM_article-title">Cancer-associated fibroblasts suppress sox2-induced dysplasia in a lung squamous cancer coculture</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E11671</span>– <span class="NLM_lpage">E11680</span>, <span class="refDoi"> DOI: 10.1073/pnas.1803718115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1803718115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30487219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E11671-E11680&author=S.+Chenauthor=A.+Giannakouauthor=S.+Wymanauthor=J.+Gruzasauthor=J.+Golasauthor=W.+Zhongauthor=C.+Lorethauthor=L.+Sridharanauthor=T.+T.+Yaminauthor=M.+Damelinauthor=K.+G.+Geles&title=Cancer-associated+fibroblasts+suppress+sox2-induced+dysplasia+in+a+lung+squamous+cancer+coculture&doi=10.1073%2Fpnas.1803718115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture</span></div><div class="casAuthors">Chen, Shuang; Giannakou, Andreas; Wyman, Sarah; Gruzas, Janet; Golas, Jonathon; Zhong, Wenyan; Loreth, Christine; Sridharan, Latha; Yamin, Ting-Ting; Damelin, Marc; Geles, Kenneth G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">E11671-E11680</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumorigenesis depends on intricate interactions between genetically altered tumor cells and their surrounding microenvironment.  While oncogenic drivers in lung squamous carcinoma (LUSC) have been described, the role of stroma in modulating tissue architecture, particularly cell polarity, remains unclear.  Here, we report the establishment of a 3D coculture system of LUSC epithelial cells with cancer-assocd. fibroblasts (CAFs) and extracellular matrix that together capture key components of the tumor microenvironment (TME).  Single LUSC epithelial cells develop into acinar-like structures with 0.02% efficiency, and addn. of CAFs provides proper tumor-stromal interactions within an appropriate 3D architectural context.  Using this model, we recapitulate key pathol. changes during tumorigenesis, from hyperplasia to dysplasia and eventually invasion, in malignant LUSC spheroids that undergo phenotypic switching in response to cell intrinsic and extrinsic changes.  Overexpression of SOX2 is sufficient to mediate the transition from hyperplasia to dysplasia in LUSC spheroids, while the presence of CAFs makes them invasive.  Unexpectedly, CAFs suppress the activity of high SOX2 levels, restore hyperplasia, and enhance the formation of acinar-like structures.  Taken together, these observations suggest that stromal factors can override cell intrinsic oncogenic changes in detg. the disease phenotype, thus providing fundamental evidence for the existence of dynamic reciprocity between the nucleus and the TME of LUSC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGD17vpA5T7Vg90H21EOLACvtfcHk0lj7fITywU2mow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhu7jI&md5=b64aff031db9e3ec681b9fc140524129</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1803718115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1803718115%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DGiannakou%26aufirst%3DA.%26aulast%3DWyman%26aufirst%3DS.%26aulast%3DGruzas%26aufirst%3DJ.%26aulast%3DGolas%26aufirst%3DJ.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DLoreth%26aufirst%3DC.%26aulast%3DSridharan%26aufirst%3DL.%26aulast%3DYamin%26aufirst%3DT.%2BT.%26aulast%3DDamelin%26aufirst%3DM.%26aulast%3DGeles%26aufirst%3DK.%2BG.%26atitle%3DCancer-associated%2520fibroblasts%2520suppress%2520sox2-induced%2520dysplasia%2520in%2520a%2520lung%2520squamous%2520cancer%2520coculture%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE11671%26epage%3DE11680%26doi%3D10.1073%2Fpnas.1803718115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyner, A. L.</span></span> <span> </span><span class="NLM_article-title">Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1242/dmm.027417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1242%2Fdmm.027417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27935821" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=39-52&author=Z.+Yangauthor=Y.+C.+Pengauthor=A.+Gopalanauthor=D.+Gaoauthor=Y.+Chenauthor=A.+L.+Joyner&title=Stromal+hedgehog+signaling+maintains+smooth+muscle+and+hampers+micro-invasive+prostate+cancer&doi=10.1242%2Fdmm.027417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1242%2Fdmm.027417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.027417%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DY.%2BC.%26aulast%3DGopalan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoyner%26aufirst%3DA.%2BL.%26atitle%3DStromal%2520hedgehog%2520signaling%2520maintains%2520smooth%2520muscle%2520and%2520hampers%2520micro-invasive%2520prostate%2520cancer%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2017%26volume%3D10%26spage%3D39%26epage%3D52%26doi%3D10.1242%2Fdmm.027417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selway, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herath, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harwood, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pirzado, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelsell, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neill, G. W.</span></span> <span> </span><span class="NLM_article-title">A novel mechanism for activation of gli1 by nuclear smo that escapes anti-smo inhibitors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2577</span>– <span class="NLM_lpage">2588</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-17-2897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-17-2897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29463581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=2577-2588&author=M.+M.+Rahmanauthor=A.+Hazanauthor=J.+L.+Selwayauthor=D.+S.+Herathauthor=C.+A.+Harwoodauthor=M.+S.+Pirzadoauthor=R.+Atkarauthor=D.+P.+Kelsellauthor=K.+J.+Lintonauthor=M.+P.+Philpottauthor=G.+W.+Neill&title=A+novel+mechanism+for+activation+of+gli1+by+nuclear+smo+that+escapes+anti-smo+inhibitors&doi=10.1158%2F0008-5472.CAN-17-2897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors</span></div><div class="casAuthors">Rahman, Muhammad M.; Hazan, Allon; Selway, Joanne L.; Herath, Dimalee S.; Harwood, Catherine A.; Pirzado, Muhammad S.; Atkar, Ravinder; Kelsell, David P.; Linton, Kenneth J.; Philpott, Mike P.; Neill, Graham W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2577-2588</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of the Hedgehog (HH) pathway receptor Smoothened (SMO) have been effective in treating some patients with basal cell carcinoma (BCC), where the HH pathway is often activated, but many patients respond poorly.  In this study, we report the results of investigations on PTCH1 signaling in the HH pathway that suggest why most patients with BCC respond poorly to SMO inhibitors.  In immortalized human keratinocytes, PTCH1 silencing led to the generation of a compact, holoclone-like morphol. with increased expression of SMO and the downstream HH pathway transcription factor GLI1.  Notably, although siRNA silencing of SMO in PTCH1-silenced cells was sufficient to suppress GLI1 activity, this effect was not phenocopied by pharmacol. inhibition of SMO, suggesting the presence of a second undefined pathway through which SMO can induce GLI1.  Consistent with this possibility, we obsd. increased nuclear localization of SMO in PTCH1-silenced cells as mediated by a putative SMO nuclear/nucleolar localization signal [N(o)LS].  Mutational inactivation of the N(o)LS ablated this increase and suppressed GLI1 induction.  Immunohistol. anal. of human and mouse BCC confirmed evidence of nuclear SMO, although the pattern was heterogeneous between tumors.  In PTCH1-silenced cells, >80% of the genes found to be differentially expressed were unaffected by SMO inhibitors, including the putative BCC driver gene CXCL11.  Our results demonstrate how PTCH1 loss results in aberrant regulation of SMO-independent mechanisms important for BCC biol. and highlights a novel nuclear mechanism of SMO-GLI1 signaling that is unresponsive to SMO inhibitors.  Significance: This study describes novel noncanonical Hedgehog signaling, where SMO enters the nucleus to activate GLI1, a mode that is unaffected by SMO inhibitors, thus prompting re-evaluation of current BCC treatment as well as new potential therapies targeting nuclear SMO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCCN7UfZggqrVg90H21EOLACvtfcHk0lj7fITywU2mow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKjsbvN&md5=27156c409b90adbc7b16d137de98aa29</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-17-2897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-17-2897%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DM.%2BM.%26aulast%3DHazan%26aufirst%3DA.%26aulast%3DSelway%26aufirst%3DJ.%2BL.%26aulast%3DHerath%26aufirst%3DD.%2BS.%26aulast%3DHarwood%26aufirst%3DC.%2BA.%26aulast%3DPirzado%26aufirst%3DM.%2BS.%26aulast%3DAtkar%26aufirst%3DR.%26aulast%3DKelsell%26aufirst%3DD.%2BP.%26aulast%3DLinton%26aufirst%3DK.%2BJ.%26aulast%3DPhilpott%26aufirst%3DM.%2BP.%26aulast%3DNeill%26aufirst%3DG.%2BW.%26atitle%3DA%2520novel%2520mechanism%2520for%2520activation%2520of%2520gli1%2520by%2520nuclear%2520smo%2520that%2520escapes%2520anti-smo%2520inhibitors%26jtitle%3DCancer%2520Res.%26date%3D2018%26volume%3D78%26spage%3D2577%26epage%3D2588%26doi%3D10.1158%2F0008-5472.CAN-17-2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">The hedgehog pathway effector smoothened exhibits signaling competency in the absence of ciliary accumulation</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1680</span>– <span class="NLM_lpage">1689</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.chembiol.2014.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25484239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKnu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1680-1689&author=C.+W.+Fanauthor=B.+Chenauthor=I.+Francoauthor=J.+Luauthor=H.+Shiauthor=S.+Weiauthor=C.+Wangauthor=X.+Wuauthor=W.+Tangauthor=M.+G.+Rothauthor=N.+S.+Williamsauthor=E.+Hirschauthor=C.+Chenauthor=L.+Lum&title=The+hedgehog+pathway+effector+smoothened+exhibits+signaling+competency+in+the+absence+of+ciliary+accumulation&doi=10.1016%2Fj.chembiol.2014.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation</span></div><div class="casAuthors">Fan, Chih-Wei; Chen, Baozhi; Franco, Irene; Lu, Jianming; Shi, Heping; Wei, Shuguang; Wang, Changguang; Wu, Xiaofeng; Tang, Wei; Roth, Michael G.; Williams, Noelle S.; Hirsch, Emilio; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1680-1689</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Misactivation of the seven-transmembrane protein Smoothened (Smo) is frequently assocd. with basal cell carcinoma and medulloblastoma.  Cellular exposure to secreted Hedgehog (Hh) protein or oncogenic mutations in Hh pathway components induces Smo accumulation in the primary cilium, an antenna-like organelle with mostly unknown cellular functions.  Despite the data supporting an indispensable role of the primary cilium in Smo activation, the mechanistic underpinnings of this dependency remain unclear.  Using a cell-membrane-impermeable Smo antagonist (IHR-1), we demonstrate that Smo supplied with a synthetic agonist or activated with oncogenic mutations can signal without ciliary accumulation.  Similarly, cells with compromised ciliary Smo trafficking due to loss of the phosphatidylinositol-4-phosphate 3-kinase (PI3K)-C2α retain transcriptional response to an exogenously supplied Smo agonist.  These observations suggest that assembly of a Smo-signaling complex in the primary cilium is not a prerequisite for Hh pathway activation driven by Smo agonists or oncogenic Smo mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqowN-Z1_-MwbVg90H21EOLACvtfcHk0lj7fITywU2mow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKnu7vK&md5=65aee97b46821125bb9dce3015bd7f86</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%2BW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DFranco%26aufirst%3DI.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DThe%2520hedgehog%2520pathway%2520effector%2520smoothened%2520exhibits%2520signaling%2520competency%2520in%2520the%2520absence%2520of%2520ciliary%2520accumulation%26jtitle%3DChem.%2520Biol.%26date%3D2014%26volume%3D21%26spage%3D1680%26epage%3D1689%26doi%3D10.1016%2Fj.chembiol.2014.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cupido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rack, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocasio, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. K.</span></span> <span> </span><span class="NLM_article-title">The imidazopyridine derivative jk184 reveals dual roles for microtubules in hedgehog signaling</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2321</span>– <span class="NLM_lpage">2324</span>, <span class="refDoi"> DOI: 10.1002/anie.200805666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fanie.200805666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1yqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2321-2324&author=T.+Cupidoauthor=P.+G.+Rackauthor=A.+J.+Firestoneauthor=J.+M.+Hymanauthor=K.+Hanauthor=S.+Sinhaauthor=C.+A.+Ocasioauthor=J.+K.+Chen&title=The+imidazopyridine+derivative+jk184+reveals+dual+roles+for+microtubules+in+hedgehog+signaling&doi=10.1002%2Fanie.200805666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The imidazopyridine derivative JK184 reveals dual roles for microtubules in hedgehog signaling</span></div><div class="casAuthors">Cupido, Tommaso; Rack, Paul G.; Firestone, Ari J.; Hyman, Joel M.; Han, Kyuho; Sinha, Surajit; Ocasio, Cory A.; Chen, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2321-2324</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Eradicating hedgehogs: The title mol. has been previously identified as a potent inhibitor of the Hedgehog signaling pathway, which gives embryonic cells information needed to develop properly.  This mol. is shown to modulate Hedgehog target gene expression by depolymg. microtubules, thus revealing dual roles of the cytoskeleton in pathway regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqryhyQ-Ii6i7Vg90H21EOLACvtfcHk0li_TwercvlO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1yqtLY%253D&md5=114978ea115db78ef98599d8ff6eeb09</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805666%26sid%3Dliteratum%253Aachs%26aulast%3DCupido%26aufirst%3DT.%26aulast%3DRack%26aufirst%3DP.%2BG.%26aulast%3DFirestone%26aufirst%3DA.%2BJ.%26aulast%3DHyman%26aufirst%3DJ.%2BM.%26aulast%3DHan%26aufirst%3DK.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DOcasio%26aufirst%3DC.%2BA.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26atitle%3DThe%2520imidazopyridine%2520derivative%2520jk184%2520reveals%2520dual%2520roles%2520for%2520microtubules%2520in%2520hedgehog%2520signaling%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D2321%26epage%3D2324%26doi%3D10.1002%2Fanie.200805666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span> <span> </span><span class="NLM_article-title">Biodegradable polymeric micelles encapsulated jk184 suppress tumor growth through inhibiting hedgehog signaling pathway</span>. <i>Nanoscale</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2609</span>– <span class="NLM_lpage">2624</span>, <span class="refDoi"> DOI: 10.1039/C4NR06300G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1039%2FC4NR06300G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25581613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFehtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2609-2624&author=N.+Zhangauthor=S.+Liuauthor=N.+Wangauthor=S.+Dengauthor=L.+Songauthor=Q.+Wuauthor=L.+Liuauthor=W.+Suauthor=Y.+Weiauthor=Y.+Xieauthor=C.+Gong&title=Biodegradable+polymeric+micelles+encapsulated+jk184+suppress+tumor+growth+through+inhibiting+hedgehog+signaling+pathway&doi=10.1039%2FC4NR06300G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway</span></div><div class="casAuthors">Zhang, Nannan; Liu, Shichang; Wang, Ning; Deng, Senyi; Song, Linjiang; Wu, Qinjie; Liu, Lei; Su, Weijun; Wei, Yuquan; Xie, Yongmei; Gong, Changyang</div><div class="citationInfo"><span class="NLM_cas:title">Nanoscale</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2609-2624</span>CODEN:
                <span class="NLM_cas:coden">NANOHL</span>;
        ISSN:<span class="NLM_cas:issn">2040-3372</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">JK184 can specially inhibit Gli in the Hedgehog (Hh) pathway, which showed great promise for cancer therapeutics.  For developing aq. formulation and improving anti-tumor activity of JK184, we prepd. JK184 encapsulated MPEG-PCL micelles by the solid dispersion method without using surfactants or toxic org. solvents.  The cytotoxicity and cellular uptake of JK184 micelles were both increased compared with the free drug.  JK184 micelles induced more apoptosis and blocked proliferation of Panc-1 and BxPC-3 tumor cells.  In addn., JK184 micelles exerted a sustained in vitro release behavior and had a stronger inhibitory effect on proliferation, migration and invasion of HUVECs than free JK184.  Furthermore, JK184 micelles had stronger tumor growth inhibiting effects in s.c. Panc-1 and BxPC-3 tumor models.  Histol. anal. showed that JK184 micelles improved anti-tumor activity by inducing more apoptosis, decreasing microvessel d. and reducing expression of CD31, Ki67, and VEGF in tumor tissues.  JK184 micelles showed a stronger inhibition of Gli expression in Hh signaling, which played an important role in pancreatic carcinoma.  Furthermore, circulation time of JK184 in blood was prolonged after entrapment in polymeric micelles.  Our results suggested that JK184 micelles are a promising drug candidate for treating pancreatic tumors with a highly inhibitory effect on Hh activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zoGFYMcRbVg90H21EOLACvtfcHk0li_TwercvlO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFehtbbO&md5=a98434bbaf545da17c6f3d0c09d8582a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1039%2FC4NR06300G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NR06300G%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DGong%26aufirst%3DC.%26atitle%3DBiodegradable%2520polymeric%2520micelles%2520encapsulated%2520jk184%2520suppress%2520tumor%2520growth%2520through%2520inhibiting%2520hedgehog%2520signaling%2520pathway%26jtitle%3DNanoscale%26date%3D2015%26volume%3D7%26spage%3D2609%26epage%3D2624%26doi%3D10.1039%2FC4NR06300G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasca di
Magliano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebrok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of the hedgehog signaling pathway</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1916</span>– <span class="NLM_lpage">1919</span>, <span class="refDoi"> DOI: 10.1002/cbic.200700403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcbic.200700403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17886323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGhu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1916-1919&author=J.+Leeauthor=X.+Wuauthor=M.+Pasca+di%0AMaglianoauthor=E.+C.+Petersauthor=Y.+Wangauthor=J.+Hongauthor=M.+Hebrokauthor=S.+Dingauthor=C.+Y.+Choauthor=P.+G.+Schultz&title=A+small-molecule+antagonist+of+the+hedgehog+signaling+pathway&doi=10.1002%2Fcbic.200700403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule antagonist of the Hedgehog signaling pathway</span></div><div class="casAuthors">Lee, Jongkook; Wu, Xu; Pasca di Magliano, Marina; Peters, Eric C.; Wang, Yan; Hong, Jiyong; Hebrok, Metthias; Ding, Sheng; Cho, Charles Y.; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1916-1919</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Shadow the Hedgehog.  JK184 (illustrated in the scheme) was identified as an antagonist of Hedgehog signaling through a cell-based screen of chem. libraries.  Results from biochem. and cellular expts. suggest that JK184 functions by inhibiting ge.  This mol. should serve as a useful tool for studying Hedgehog signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkCXV2p07S-bVg90H21EOLACvtfcHk0lgdloLYnuCu5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGhu7jL&md5=f533c8964ab8984b1d27a3c74255e1f1</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700403%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DPasca%2Bdi%2BMagliano%26aufirst%3DM.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DHebrok%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DC.%2BY.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520the%2520hedgehog%2520signaling%2520pathway%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1916%26epage%3D1919%26doi%3D10.1002%2Fcbic.200700403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, J. F.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of smoothened ciliary localization and ciliogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">13644</span>– <span class="NLM_lpage">13649</span>, <span class="refDoi"> DOI: 10.1073/pnas.1207170109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1207170109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=22864913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsValu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=13644-13649&author=V.+M.+Wuauthor=S.+C.+Chenauthor=M.+R.+Arkinauthor=J.+F.+Reiter&title=Small+molecule+inhibitors+of+smoothened+ciliary+localization+and+ciliogenesis&doi=10.1073%2Fpnas.1207170109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of Smoothened ciliary localization and ciliogenesis</span></div><div class="casAuthors">Wu, Victoria M.; Chen, Steven C.; Arkin, Michelle R.; Reiter, Jeremy F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">13644-13649, S13644/1-S13644/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Vertebrate Hedgehog (Hh) signals involved in development and some forms of cancer, such as basal cell carcinoma, are transduced by the primary cilium, a microtubular projection found on many cells.  A crit. step in vertebrate Hh signal transduction is the regulated movement of Smoothened (Smo), a seven-transmembrane protein, to the primary cilium.  To identify small mols. that interfere with either the ciliary localization of Smo or ciliogenesis, we undertook a high-throughput, microscopy-based screen for compds. that alter the ciliary localization of YFP-tagged Smo.  This screen identified 10 compds. that inhibit Hh pathway activity.  Nine of these Smo antagonists (SA1-9) bind Smo, and one (SA10) does not.  We also identified two compds. (CA1 and CA2) that inhibit ciliary biogenesis, which block microtubule polymn. or alter centrosome compn.  Differential labeling of cell surface and intracellular Smo pools indicates that SA1-7 and 10 specifically inhibit trafficking of intracellular Smo to cilia.  In contrast, SA8 and 9 recruit endogenous Smo to the cilium in some cell types.  Despite these different mechanisms of action, all of the SAs inhibit activation of the Hh pathway by an oncogenic form of Smo, and abrogate the proliferation of basal cell carcinoma-like cancer cells.  The SA compds. may provide alternative means of inhibiting pathogenic Hh signaling, and our study reveals that different pools of Smo move into cilia through distinct mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbOvOftfa6m7Vg90H21EOLACvtfcHk0lgdloLYnuCu5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsValu7nF&md5=6d8697afe4176df55ef7d643b875bf98</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1207170109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1207170109%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DV.%2BM.%26aulast%3DChen%26aufirst%3DS.%2BC.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DReiter%26aufirst%3DJ.%2BF.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520smoothened%2520ciliary%2520localization%2520and%2520ciliogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D13644%26epage%3D13649%26doi%3D10.1073%2Fpnas.1207170109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messias, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorpp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerlof, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanker, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasenoder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lickert, H.</span></span> <span> </span><span class="NLM_article-title">Novel small molecules targeting ciliary transport of smoothened and oncogenic hedgehog pathway activation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22540</span>, <span class="refDoi"> DOI: 10.1038/srep22540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fsrep22540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26931153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFektLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22540&author=B.+Jungauthor=A.+C.+Messiasauthor=K.+Schorppauthor=A.+Geerlofauthor=G.+Schneiderauthor=D.+Saurauthor=K.+Hadianauthor=M.+Sattlerauthor=E.+E.+Wankerauthor=S.+Hasenoderauthor=H.+Lickert&title=Novel+small+molecules+targeting+ciliary+transport+of+smoothened+and+oncogenic+hedgehog+pathway+activation&doi=10.1038%2Fsrep22540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecules targeting ciliary transport of Smoothened and oncogenic Hedgehog pathway activation</span></div><div class="casAuthors">Jung, Bomi; Messias, Ana C.; Schorpp, Kenji; Geerlof, Arie; Schneider, Guenter; Saur, Dieter; Hadian, Kamyar; Sattler, Michael; Wanker, Erich E.; Hasenoeder, Stefan; Lickert, Heiko</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22540</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Trafficking of the G protein-coupled receptor (GPCR) Smoothened (Smo) to the primary cilium (PC) is a potential target to inhibit oncogenic Hh pathway activation in a large no. of tumors.  One drawback is the appearance of Smo mutations that resist drug treatment, which is a common reason for cancer treatment failure.  Here, we undertook a high content screen with compds. in preclin. or clin. development and identified ten small mols. that prevent constitutive active mutant SmoM2 transport into PC for subsequent Hh pathway activation.  Eight of the ten small mols. act through direct interference with the G protein-coupled receptor assocd. sorting protein 2 (Gprasp2)-SmoM2 ciliary targeting complex, whereas one antagonist of ionotropic receptors prevents intracellular trafficking of Smo to the PC.  Together, these findings identify several compds. with the potential to treat drug-resistant SmoM2-driven cancer forms, but also reveal off-target effects of established drugs in the clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqqz3QlxrJgbVg90H21EOLACvtfcHk0lgdloLYnuCu5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFektLY%253D&md5=d78ca8f49e97fa1b4e7e804876cb474f</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fsrep22540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22540%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DB.%26aulast%3DMessias%26aufirst%3DA.%2BC.%26aulast%3DSchorpp%26aufirst%3DK.%26aulast%3DGeerlof%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DSaur%26aufirst%3DD.%26aulast%3DHadian%26aufirst%3DK.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DWanker%26aufirst%3DE.%2BE.%26aulast%3DHasenoder%26aufirst%3DS.%26aulast%3DLickert%26aufirst%3DH.%26atitle%3DNovel%2520small%2520molecules%2520targeting%2520ciliary%2520transport%2520of%2520smoothened%2520and%2520oncogenic%2520hedgehog%2520pathway%2520activation%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22540%26doi%3D10.1038%2Fsrep22540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wassif, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krakowiak, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">A defective response to hedgehog signaling in disorders of cholesterol biosynthesis</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/ng1134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fng1134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=12652302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVGit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=508-513&author=M.+K.+Cooperauthor=C.+A.+Wassifauthor=P.+A.+Krakowiakauthor=J.+Taipaleauthor=R.+Gongauthor=R.+I.+Kelleyauthor=F.+D.+Porterauthor=P.+A.+Beachy&title=A+defective+response+to+hedgehog+signaling+in+disorders+of+cholesterol+biosynthesis&doi=10.1038%2Fng1134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis</span></div><div class="casAuthors">Cooper, Michael K.; Wassif, Christopher A.; Krakowiak, Patrycja A.; Taipale, Jussi; Gong, Ruoyu; Kelley, Richard I.; Porter, Forbes D.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Smith-Lemli-Opitz syndrome (SLOS), desmosterolosis and lathosterolosis are human syndromes caused by defects in the final stages of cholesterol biosynthesis.  Many of the developmental malformations in these syndromes occur in tissues and structures whose embryonic patterning depends on signaling by the Hedgehog (Hh) family of secreted proteins.  Here the authors report that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacol. depleted of sterols.  We show that decreasing levels of cellular sterols correlate with diminishing responsiveness to the Hh signal.  This diminished response occurs at sterol levels sufficient for normal autoprocessing of Hh protein, which requires cholesterol as cofactor and covalent adduct.  We further find that sterol depletion affects the activity of Smoothened (Smo), an essential component of the Hh signal transduction app.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfwsX7RQrc4LVg90H21EOLACvtfcHk0lhRUOYuKwQ8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVGit7s%253D&md5=c0d15c9ce938c5ef8c6288afc823e62a</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fng1134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1134%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DM.%2BK.%26aulast%3DWassif%26aufirst%3DC.%2BA.%26aulast%3DKrakowiak%26aufirst%3DP.%2BA.%26aulast%3DTaipale%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DR.%26aulast%3DKelley%26aufirst%3DR.%2BI.%26aulast%3DPorter%26aufirst%3DF.%2BD.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DA%2520defective%2520response%2520to%2520hedgehog%2520signaling%2520in%2520disorders%2520of%2520cholesterol%2520biosynthesis%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D33%26spage%3D508%26epage%3D513%26doi%3D10.1038%2Fng1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohnalter, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooshesh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Antipsychotic drugs regulate hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1124/mol.110.066431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1124%2Fmol.110.066431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20558592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFersbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=486-496&author=M.+Lauthauthor=V.+Rohnalterauthor=A.+Bergstromauthor=M.+Koosheshauthor=P.+Svenningssonauthor=R.+Toftgard&title=Antipsychotic+drugs+regulate+hedgehog+signaling+by+modulation+of+7-dehydrocholesterol+reductase+levels&doi=10.1124%2Fmol.110.066431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotic drugs regulate Hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels</span></div><div class="casAuthors">Lauth, Matthias; Rohnalter, Verena; Bergstroem, Asa; Kooshesh, Mahsa; Svenningsson, Per; Toftgard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recently we identified GANT61, a small-mol. antagonist of Gli transcription factors, which are the final effectors of the mammalian Hedgehog (HH) signaling pathway.  Here we describe a diamine substructure of GANT61 that carries the biol. activity and show that this part of the mol. is structurally related to trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride (AY9944), an inhibitor of the enzymic activity and transcriptional inducer of 7-dehydrocholesterol-reductase (Dhcr7, EC 1.3.1.21).  Treatment of cells with the GANT61 diamine, AY9944, or overexpression of DHCR7 results in the attenuation of Smoothened-dependent and -independent HH signaling.  Whereas GANT61 function is independent of Dhcr7, AY9944 does require up-regulation of endogenous Dhcr7.  In line with these findings, Dhcr7-modulating antipsychotic (clozapine, chlorpromazine, haloperidol) and antidepressant (imipramine) drugs regulate HH signaling in vitro and in vivo.  Modulation of HH signaling may represent a hitherto undiscovered biol. (side) effect of therapeutics used to treat schizophrenia and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGWX8qOdvW6LVg90H21EOLACvtfcHk0lhRUOYuKwQ8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFersbjN&md5=feba8aad93b1ab05ab92e7e694054eb0</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.066431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.066431%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DRohnalter%26aufirst%3DV.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DKooshesh%26aufirst%3DM.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DAntipsychotic%2520drugs%2520regulate%2520hedgehog%2520signaling%2520by%2520modulation%2520of%25207-dehydrocholesterol%2520reductase%2520levels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D486%26epage%3D496%26doi%3D10.1124%2Fmol.110.066431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Incardona, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelink, H.</span></span> <span> </span><span class="NLM_article-title">The role of cholesterol in shh signaling and teratogen-induced holoprosencephaly</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1719</span>, <span class="refDoi"> DOI: 10.1007/PL00000653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1007%2FPL00000653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=11130177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=1709-1719&author=J.+P.+Incardonaauthor=H.+Roelink&title=The+role+of+cholesterol+in+shh+signaling+and+teratogen-induced+holoprosencephaly&doi=10.1007%2FPL00000653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly</span></div><div class="casAuthors">Incardona, J. P.; Roelink, H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1709-1719</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review with 72 refs.  Holoprosencephaly, or an undivided forebrain, is a complex brain malformation assocd. with Sonic hedgehog (Shh) mutations.  Other causes of holoprosencephaly have converged upon the Shh signaling pathway: genetic and pharmacol. impairment of cholesterol synthesis, and the action of the steroidal alkaloid cyclopamine.  This review focuses on recent studies aimed at detg. how Shh signaling is affected by these causes of holoprosencephaly, whether they involve a common mechanism and the role played by cholesterol.  Cholesterol is potentially important for both biogenesis of Shh and in signal transduction in Shh-responsive cells.  Teratogens that induce holoprosencephaly appear to affect Shh signal transduction rather than Shh biogenesis.  Anal. of these agents and other compds. that affect various aspects of cellular cholesterol distribution indicates that the role of cholesterol in Shh signal transduction is novel and complicated.  The similarity of the Shh receptor, Patched (Ptc), to the Niemann-Pick C1 protein, which is involved in the vesicular trafficking of cholesterol, provides insight into the role of cholesterol and the action of compds. like cyclopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpczZFtT5WI2bVg90H21EOLACvtfcHk0lhRUOYuKwQ8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFKgsg%253D%253D&md5=2e38e504511cff8e4b0350ffde3159a8</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1007%2FPL00000653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00000653%26sid%3Dliteratum%253Aachs%26aulast%3DIncardona%26aufirst%3DJ.%2BP.%26aulast%3DRoelink%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520cholesterol%2520in%2520shh%2520signaling%2520and%2520teratogen-induced%2520holoprosencephaly%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2000%26volume%3D57%26spage%3D1709%26epage%3D1719%26doi%3D10.1007%2FPL00000653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbadawy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamawaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takenouchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunedomi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span> <span> </span><span class="NLM_article-title">Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1098</span>, <span class="refDoi"> DOI: 10.3390/ijms19041098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fijms19041098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOqt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1098&author=T.+Usuiauthor=M.+Sakuraiauthor=K.+Umataauthor=M.+Elbadawyauthor=T.+Ohamaauthor=H.+Yamawakiauthor=S.+Hazamaauthor=H.+Takenouchiauthor=M.+Nakajimaauthor=R.+Tsunedomiauthor=N.+Suzukiauthor=H.+Naganoauthor=K.+Satoauthor=M.+Kanedaauthor=K.+Sasaki&title=Hedgehog+signals+mediate+anti-cancer+drug+resistance+in+three-dimensional+primary+colorectal+cancer+organoid+culture&doi=10.3390%2Fijms19041098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture</span></div><div class="casAuthors">Usui, Tatsuya; Sakurai, Masashi; Umata, Koji; Elbadawy, Mohamed; Ohama, Takashi; Yamawaki, Heyuki; Hazama, Shoichi; Takenouchi, Hiroko; Nakajima, Masao; Tsunedomi, Ryouichi; Suzuki, Nobuaki; Nagano, Hiroaki; Sato, Koichi; Kaneda, Masahiro; Sasaki, Kazuaki</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1098/1-1098/12</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Colorectal cancer is one of the most common causes of cancer death worldwide.  In patients with metastatic colorectal cancer, combination treatment with several anti-cancer drugs is employed and improves overall survival in some patients.  Nevertheless, most patients with metastatic disease are not cured owing to the drug resistance.  Cancer stem cells are known to regulate resistance to chemotherapy.  In the previous study, we established a novel three-dimensional organoid culture model from tumor colorectal tissues of human patients using an air-liq. interface (ALI) method, which contained numerous cancer stem cells and showed resistance to 5-fluorouracil (5-FU) and Irinotecan.  Here, we investigate which inhibitor for stem cell-related signal improves the sensitivity for anti-cancer drug treatment in tumor ALI organoids.  Treatment with Hedgehog signal inhibitors (AY9944, GANT61) decreases the cell viability of organoids compared with Notch (YO-01027, DAPT) and Wnt (WAV939, Wnt-C59) signal inhibitors.  Combination treatment of AY9944 or GANT61 with 5-FU, Irinotecan or Oxaliplatin decreases the cell viability of tumor organoids compared with each anti-cancer drug alone treatment.  Treatment with AY9944 or GANT61 inhibits expression of stem cell markers c-Myc, CD44 and Nanog, likely through the decrease of their transcription factor, GLI-1 expression.  Combination treatment of AY9944 or GANT61 with 5-FU or Irinotecan also prevents colony formation of colorectal cancer cell lines HCT116 and SW480.  These findings suggest that Hedgehog signals mediate anti-cancer drug resistance in colorectal tumor patient-derived ALI organoids and that the inhibitors are useful as a combinational therapeutic strategy against colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCFW-7FRWCibVg90H21EOLACvtfcHk0lgzPLVhwLxQ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOqt7nM&md5=6abc885638a6a82baf7c6ea8c0d5c4aa</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.3390%2Fijms19041098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19041098%26sid%3Dliteratum%253Aachs%26aulast%3DUsui%26aufirst%3DT.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DUmata%26aufirst%3DK.%26aulast%3DElbadawy%26aufirst%3DM.%26aulast%3DOhama%26aufirst%3DT.%26aulast%3DYamawaki%26aufirst%3DH.%26aulast%3DHazama%26aufirst%3DS.%26aulast%3DTakenouchi%26aufirst%3DH.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DTsunedomi%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DNagano%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKaneda%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DK.%26atitle%3DHedgehog%2520signals%2520mediate%2520anti-cancer%2520drug%2520resistance%2520in%2520three-dimensional%2520primary%2520colorectal%2520cancer%2520organoid%2520culture%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1098%26doi%3D10.3390%2Fijms19041098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Cholesterol modification of hedgehog signaling proteins in animal development</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1126/science.274.5285.255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1126%2Fscience.274.5285.255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=8824192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADyaK28XmtlWltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=255-259&author=J.+A.+Porterauthor=K.+E.+Youngauthor=P.+A.+Beachy&title=Cholesterol+modification+of+hedgehog+signaling+proteins+in+animal+development&doi=10.1126%2Fscience.274.5285.255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Cholesterol modification of hedgehog signaling proteins in animal development</span></div><div class="casAuthors">Porter, Jeffery A.; Young, Keith E.; Beachy, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5285</span>),
    <span class="NLM_cas:pages">255-259</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Hedgehog (Hh) proteins comprise a family of secreted signaling mols. essential for patterning a variety of structures in animal embryogenesis.  During biosynthesis, Hh undergoes an autocleavage reaction, mediated by its carboxyl-terminal domain, that produces a lipid-modified amino-terminal fragment responsible for all known Hh signaling activity.  Here it is reported that cholesterol is the lipophilic moiety covalently attached to the amino-terminal signaling domain during autoprocessing and that the carboxyl-terminal domain acts as an intramol. cholesterol transferase.  This use of cholesterol to modify embryonic signaling proteins may account for some of the effects of perturbed cholesterol biosynthesis on animal development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx4g4_YaDbCLVg90H21EOLACvtfcHk0lgzPLVhwLxQ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlWltrk%253D&md5=36a58f66eeed32e4739905576c9e67ae</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5285.255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5285.255%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DYoung%26aufirst%3DK.%2BE.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DCholesterol%2520modification%2520of%2520hedgehog%2520signaling%2520proteins%2520in%2520animal%2520development%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D255%26epage%3D259%26doi%3D10.1126%2Fscience.274.5285.255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egleston, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astsaturov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. J.</span></span> <span> </span><span class="NLM_article-title">Statins synergize with hedgehog pathway inhibitors for treatment of medulloblastoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1375</span>– <span class="NLM_lpage">1388</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-17-2923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F1078-0432.CCR-17-2923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29437795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1ymur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1375-1388&author=R.+E.+Gordonauthor=L.+Zhangauthor=S.+Periauthor=Y.+M.+Kuoauthor=F.+Duauthor=B.+L.+Eglestonauthor=J.+M.+Y.+Ngauthor=A.+J.+Andrewsauthor=I.+Astsaturovauthor=T.+Curranauthor=Z.+J.+Yang&title=Statins+synergize+with+hedgehog+pathway+inhibitors+for+treatment+of+medulloblastoma&doi=10.1158%2F1078-0432.CCR-17-2923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma</span></div><div class="casAuthors">Gordon, Renata E.; Zhang, Li; Peri, Suraj; Kuo, Yin-Ming; Du, Fang; Egleston, Brian L.; Ng, Jessica M. Y.; Andrews, Andrew J.; Astsaturov, Igor; Curran, Tom; Yang, Zeng-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1375-1388</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The role of cholesterol biosynthesis in hedgehog pathway activity and progression of hedgehog pathway medulloblastoma (Hh-MB) were examd. in vivo.  Statins, commonly used cholesterol-lowering agents, were utilized to validate cholesterol biosynthesis as a therapeutic target for Hh-MB.  Exptl. Design: Bioinformatic anal. was performed to evaluate the assocn. between cholesterol biosynthesis with hedgehog group medulloblastoma in human biospecimens.  Alterations in hedgehog signaling were evaluated in medulloblastoma cells after inhibition of cholesterol biosynthesis.  The progression of endogenous medulloblastoma in mice was examd. after genetic blockage of cholesterol biosynthesis in tumor cells.  Statins alone, or in combination with vismodegib (an FDA-approved Smoothened antagonist), were utilized to inhibit medulloblastoma growth in vivo.  Results: Cholesterol biosynthesis was markedly enhanced in Hh-MB from both humans and mice.  Inhibition of cholesterol biosynthesis dramatically decreased Hh pathway activity and reduced proliferation of medulloblastoma cells.  Statins effectively inhibited medulloblastoma growth in vivo and functioned synergistically in combination with vismodegib.  Conclusions: Cholesterol biosynthesis is required for Smoothened activity in the hedgehog pathway, and it is indispensable for the growth of Hh-MB.  Targeting cholesterol biosynthesis represents a promising strategy for treatment of Hh-MB.  Clin Cancer Res; 24(6); 1375-88. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqOxdI9RiIIbVg90H21EOLACvtfcHk0lgzPLVhwLxQ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1ymur4%253D&md5=3c439dba49a62d1411ec03299e14d02f</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-2923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-2923%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DR.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeri%26aufirst%3DS.%26aulast%3DKuo%26aufirst%3DY.%2BM.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DEgleston%26aufirst%3DB.%2BL.%26aulast%3DNg%26aufirst%3DJ.%2BM.%2BY.%26aulast%3DAndrews%26aufirst%3DA.%2BJ.%26aulast%3DAstsaturov%26aufirst%3DI.%26aulast%3DCurran%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DZ.%2BJ.%26atitle%3DStatins%2520synergize%2520with%2520hedgehog%2520pathway%2520inhibitors%2520for%2520treatment%2520of%2520medulloblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D24%26spage%3D1375%26epage%3D1388%26doi%3D10.1158%2F1078-0432.CCR-17-2923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gipp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushman, W.</span></span> <span> </span><span class="NLM_article-title">Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2006.10.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.juro.2006.10.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17296441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtF2hs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2007&pages=1179-1185&author=J.+Zhangauthor=R.+Lipinskiauthor=A.+Shawauthor=J.+Gippauthor=W.+Bushman&title=Lack+of+demonstrable+autocrine+hedgehog+signaling+in+human+prostate+cancer+cell+lines&doi=10.1016%2Fj.juro.2006.10.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines</span></div><div class="casAuthors">Zhang, Jingxian; Lipinski, Robert; Shaw, Aubie; Gipp, Jerry; Bushman, Wade</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1185</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several recent reports highlighted the role of hedgehog signaling in prostate cancer.  However, the relative contributions of autocrine and paracrine hedgehog signaling to tumor growth and progression are unclear.  Efforts to model autocrine signaling for drug development have been hampered by conflicting reports of the presence or absence of autocrine signaling in established human prostate cancer cell lines.  We comprehensively characterized the expression of hedgehog pathway genes in the 3 prostate cancer cell lines LNCaP, PC3 and 22RV1 (American Type Culture Collection, Manassas, Virginia).  We also examd. their response to Shh ligand and to the hedgehog pathway inhibitor cyclopamine (Toronto Research Chems., Toronto, Ontario, Canada).  Expression of hedgehog ligand, patched and Gli1 in all 3 cell lines was lower than the expression level in normal human prostate tissue.  All 3 cell lines showed hedgehog target gene activation when transfected with an activated form of Gli2 but none showed a detectable transcriptional response to hedgehog ligand or to transfection with an activated form of smoothened.  Furthermore, treatment with the hedgehog pathway inhibitor cyclopamine did not inhibit hedgehog target gene expression in any of the 3 prostate cancer cell lines, although cyclopamine inhibited proliferation in culture.  LNCaP, PC3 and 22RV1 show no evidence of autocrine signaling by ligand dependent mechanisms and cyclopamine mediated inhibition of growth in culture occurs without of any discernible effect on canonical hedgehog pathway activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSkWEZ4WjnmrVg90H21EOLACvtfcHk0liy3lAPYvfwxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtF2hs7o%253D&md5=6476c0b80a5398a8cee4ab57c3b9df95</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.10.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.10.032%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLipinski%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DA.%26aulast%3DGipp%26aufirst%3DJ.%26aulast%3DBushman%26aufirst%3DW.%26atitle%3DLack%2520of%2520demonstrable%2520autocrine%2520hedgehog%2520signaling%2520in%2520human%2520prostate%2520cancer%2520cell%2520lines%26jtitle%3DJ.%2520Urol.%26date%3D2007%26volume%3D177%26spage%3D1179%26epage%3D1185%26doi%3D10.1016%2Fj.juro.2006.10.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basten, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willekers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermaat, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaats, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voest, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Diest, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giles, R. H.</span></span> <span> </span><span class="NLM_article-title">Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue</span>. <i>Cilia</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2</span>, <span class="refDoi"> DOI: 10.1186/2046-2530-2-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1186%2F2046-2530-2-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23369289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC3szktlGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=2&author=S.+G.+Bastenauthor=S.+Willekersauthor=J.+S.+Vermaatauthor=G.+G.+Slaatsauthor=E.+E.+Voestauthor=P.+J.+van+Diestauthor=R.+H.+Giles&title=Reduced+cilia+frequencies+in+human+renal+cell+carcinomas+versus+neighboring+parenchymal+tissue&doi=10.1186%2F2046-2530-2-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue</span></div><div class="casAuthors">Basten Sander G; Willekers Sven; Vermaat Joost Sp; Slaats Gisela Gg; Voest Emile E; van Diest Paul J; Giles Rachel H</div><div class="citationInfo"><span class="NLM_cas:title">Cilia</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn">2046-2530</span>.
    </div><div class="casAbstract">UNLABELLED:  BACKGROUND:  Cilia are essential organelles in multiple organ systems, including the kidney where they serve as important regulators of renal homeostasis.  Renal nephron cilia emanate from the apical membrane of epithelia, extending into the lumen where they function in flow-sensing and ligand-dependent signaling cascades.  Ciliary dysfunction underlies renal cyst formation that is in part caused by deregulation of planar cell polarity and canonical Wnt signaling.  Renal cancer pathologies occur sporadically or in heritable syndromes caused by germline mutations in tumor suppressor genes including VHL.  Importantly, Von Hippel-Lindau (VHL) patients frequently develop complex renal cysts that can be considered a premalignant stage.  One of the well-characterized molecular functions of VHL is its requirement for the maintenance of cilia.  In this study, tissue from 110 renal cancer patients who underwent nephrectomy was analyzed to determine if lower ciliary frequency is a common hallmark of renal tumorigenesis by comparing cilia frequencies in both tumor and adjacent parenchymal tissue biopsies from the same kidney.  METHODS:  We stained sections of human renal material using markers for cilia.  Preliminary staining was performed using an immunofluorescent approach and a combination of acetylated-α-tubulin and pericentrin antibodies and DAPI.  After validation of an alternative, higher throughput approach using acetylated-α-tubulin immunohistochemistry, we continued to manually quantify cilia in all tissues.  Nuclei were separately counted in an automated fashion in order to determine ciliary frequencies.  Similar staining and scoring for Ki67 positive cells was performed to exclude that proliferation obscures cilia formation potential.  RESULTS:  Samples from renal cell carcinoma patients deposited in our hospital tissue bank were previously used to compose a tissue microarray containing three cores of both tumor and parenchymal tissue per patient.  Cilia frequencies in a total of eighty-nine clear cell, eight papillary, five chromophobe renal cell carcinomas, two sarcomatoid renal tumors and six oncocytomas were determined.  A marked decrease of primary cilia across renal cell carcinoma subtypes was observed compared to adjacent nontumorigenic tissue.  CONCLUSIONS:  Our study shows that cilia are predominantly lost in renal cell carcinomas compared to tissue of the tumor parenchyma.  These results suggest that ciliary loss is common in renal tumorigenesis, possibly participating in the sequence of cellular events leading to malignant tumor development.  Future therapies aimed at restoring or circumventing cilia signaling might therefore aid in current treatment efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB8nxRBba5AJVVjGoY74BafW6udTcc2ebUkuwF28OUgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szktlGhtg%253D%253D&md5=57a4a398210688cc6980c595e8bba1df</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1186%2F2046-2530-2-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2046-2530-2-2%26sid%3Dliteratum%253Aachs%26aulast%3DBasten%26aufirst%3DS.%2BG.%26aulast%3DWillekers%26aufirst%3DS.%26aulast%3DVermaat%26aufirst%3DJ.%2BS.%26aulast%3DSlaats%26aufirst%3DG.%2BG.%26aulast%3DVoest%26aufirst%3DE.%2BE.%26aulast%3Dvan%2BDiest%26aufirst%3DP.%2BJ.%26aulast%3DGiles%26aufirst%3DR.%2BH.%26atitle%3DReduced%2520cilia%2520frequencies%2520in%2520human%2520renal%2520cell%2520carcinomas%2520versus%2520neighboring%2520parenchymal%2520tissue%26jtitle%3DCilia%26date%3D2013%26volume%3D2%26spage%3D2%26doi%3D10.1186%2F2046-2530-2-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carriere, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetze, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longnecker, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korc, M.</span></span> <span> </span><span class="NLM_article-title">Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-1290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-08-1290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19147554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=422-430&author=E.+S.+Seeleyauthor=C.+Carriereauthor=T.+Goetzeauthor=D.+S.+Longneckerauthor=M.+Korc&title=Pancreatic+cancer+and+precursor+pancreatic+intraepithelial+neoplasia+lesions+are+devoid+of+primary+cilia&doi=10.1158%2F0008-5472.CAN-08-1290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia</span></div><div class="casAuthors">Seeley, E. Scott; Carriere, Catherine; Goetze, Tobias; Longnecker, Daniel S.; Korc, Murray</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-430</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Primary cilia have been proposed to participate in the modulation of growth factor signaling pathways.  In this study, we detd. that ciliogenesis is suppressed in both pancreatic cancer cells and pancreatic intraepithelial neoplasia (PanIN) lesions in human pancreatic ductal adenocarcinoma (PDAC).  Primary cilia were absent in these cells even when not actively proliferating.  Cilia were also absent from mouse PanIN cells in three different mouse models of PDAC driven by an endogenous oncogenic Kras allele.  Inhibition of Kras effector pathways restored ciliogenesis in a mouse pancreatic cancer cell line, raising the possibility that ciliogenesis may be actively repressed by oncogenic Kras.  By contrast, normal duct, islet, and centroacinar cells retained primary cilia in both human and mouse pancreata.  Thus, arrested ciliogenesis is a cardinal feature of PDAC and its precursor PanIN lesions, does not require ongoing proliferation, and could potentially be targeted pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJxFFRTBbHbVg90H21EOLACvtfcHk0liy3lAPYvfwxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSjtA%253D%253D&md5=ae4d4a97239d7ff38611f09d0f1a3643</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-1290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-1290%26sid%3Dliteratum%253Aachs%26aulast%3DSeeley%26aufirst%3DE.%2BS.%26aulast%3DCarriere%26aufirst%3DC.%26aulast%3DGoetze%26aufirst%3DT.%26aulast%3DLongnecker%26aufirst%3DD.%2BS.%26aulast%3DKorc%26aufirst%3DM.%26atitle%3DPancreatic%2520cancer%2520and%2520precursor%2520pancreatic%2520intraepithelial%2520neoplasia%2520lesions%2520are%2520devoid%2520of%2520primary%2520cilia%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D422%26epage%3D430%26doi%3D10.1158%2F0008-5472.CAN-08-1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frolova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steg, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, A. R.</span></span> <span> </span><span class="NLM_article-title">Primary cilia are decreased in breast cancer: Analysis of a collection of human breast cancer cell lines and tissues</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1369/jhc.2010.955856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1369%2Fjhc.2010.955856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20530462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WgtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=857-870&author=K.+Yuanauthor=N.+Frolovaauthor=Y.+Xieauthor=D.+Wangauthor=L.+Cookauthor=Y.+J.+Kwonauthor=A.+D.+Stegauthor=R.+Serraauthor=A.+R.+Frost&title=Primary+cilia+are+decreased+in+breast+cancer%3A+Analysis+of+a+collection+of+human+breast+cancer+cell+lines+and+tissues&doi=10.1369%2Fjhc.2010.955856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues</span></div><div class="casAuthors">Yuan, Kun; Frolova, Natalya; Xie, Yi; Wang, Dezhi; Cook, Leah; Kwon, Yeon-Jin; Steg, Adam D.; Serra, Rosa; Frost, Andra R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">857-870</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Primary cilia (PC) are solitary, sensory organelles that are crit. for several signaling pathways.  PC were detected by immunofluorescence of cultured cells and breast tissues.  After growth for 7 days in vitro, PC were detected in ∼70% of breast fibroblasts and in 7-19% of epithelial cells derived from benign breast (184A1 and MCF10A).  In 11 breast cancer cell lines, PC were present at a low frequency in four (from 0.3% to 4% of cells), but were absent in the remainder.  The cancer cell lines with PC were all of the basal B subtype, which is analogous to the clin. triple-neg. breast cancer subtype.  Furthermore, the frequency of PC decreased with increasing degree of transformation/progression in the MCF10 and MDA-MB-435/LCC6 isogenic models of cancer progression.  In histol. normal breast tissues, PC were frequent in fibroblasts and myoepithelial cells and less common in luminal epithelial cells.  Of 26 breast cancers examd., rare PC were identified in cancer epithelial cells of only one cancer, which was of the triple-neg. subtype.  These data indicate a decrease or loss of PC in breast cancer and an assocn. of PC with the basal B subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDDk7vCW6B5bVg90H21EOLACvtfcHk0liycRxVuNtXHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WgtL%252FI&md5=e7fdf938c7cf6a341e841c1476682302</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1369%2Fjhc.2010.955856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.2010.955856%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DK.%26aulast%3DFrolova%26aufirst%3DN.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DL.%26aulast%3DKwon%26aufirst%3DY.%2BJ.%26aulast%3DSteg%26aufirst%3DA.%2BD.%26aulast%3DSerra%26aufirst%3DR.%26aulast%3DFrost%26aufirst%3DA.%2BR.%26atitle%3DPrimary%2520cilia%2520are%2520decreased%2520in%2520breast%2520cancer%253A%2520Analysis%2520of%2520a%2520collection%2520of%2520human%2520breast%2520cancer%2520cell%2520lines%2520and%2520tissues%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2010%26volume%3D58%26spage%3D857%26epage%3D870%26doi%3D10.1369%2Fjhc.2010.955856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassounah, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalkin, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, K. M.</span></span> <span> </span><span class="NLM_article-title">Primary cilia are lost in preinvasive and invasive prostate cancer</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e68521</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0068521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1371%2Fjournal.pone.0068521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23844214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFGqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68521&author=N.+B.+Hassounahauthor=R.+Nagleauthor=K.+Sabodaauthor=D.+J.+Roeauthor=B.+L.+Dalkinauthor=K.+M.+McDermott&title=Primary+cilia+are+lost+in+preinvasive+and+invasive+prostate+cancer&doi=10.1371%2Fjournal.pone.0068521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Primary cilia are lost in preinvasive and invasive prostate cancer</span></div><div class="casAuthors">Hassounah, Nadia B.; Nagle, Ray; Saboda, Kathylynn; Roe, Denise J.; Dalkin, Bruce L.; McDermott, Kimberly M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68521</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Prostate cancer is the second most commonly diagnosed cancer in men worldwide.  Little is known about the role of primary cilia in preinvasive and invasive prostate cancer.  However, reduced cilia expression has been obsd. in human cancers including pancreatic cancer, renal cell carcinoma, breast cancer, cholangiocarcinoma, and melanoma.  The aim of this study was to characterize primary cilia expression in preinvasive and invasive human prostate cancer, and to investigate the correlation between primary cilia and the Wnt signaling pathway.  Human prostate tissues representative of stages of prostate cancer formation (normal prostate, prostatic intraepithelial neoplasia (PIN), and invasive prostate cancer (including perineural invasion)) were stained for ciliary proteins.  The frequency of primary cilia was detd.  A decrease in the percentage of ciliated cells in PIN, invasive cancer and perineural invasion lesions was obsd. when compared to normal.  Cilia lengths were also measured to indirectly test functionality.  Cilia were shorter in PIN, cancer, and perineural invasion lesions, suggesting dysfunction.  Primary cilia have been shown to suppress the Wnt pathway.  Increased Wnt signaling has been implicated in prostate cancer.  Therefore, we investigated a correlation between loss of primary cilia and increased Wnt signaling in normal prostate and in preinvasive and invasive prostate cancer.  To investigate Wnt signaling in our cohort, serial tissue sections were stained for β-catenin as a measure of Wnt signaling.  Nuclear β-catenin was analyzed and Wnt signaling was found to be higher in un-ciliated cells in the normal prostate, PIN, a subset of invasive cancers, and perineural invasion.  Our results suggest that cilia normally function to suppress the Wnt signaling pathway in epithelial cells and that cilia loss may play a role in increased Wnt signaling in some prostate cancers.  These results suggest that cilia are dysfunctional in human prostate cancer, and increase Wnt signaling occurs in a subset of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZkBN10hxE5LVg90H21EOLACvtfcHk0liycRxVuNtXHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFGqsr%252FL&md5=72bab002cffeb2aa565950ed89c654d1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068521%26sid%3Dliteratum%253Aachs%26aulast%3DHassounah%26aufirst%3DN.%2BB.%26aulast%3DNagle%26aufirst%3DR.%26aulast%3DSaboda%26aufirst%3DK.%26aulast%3DRoe%26aufirst%3DD.%2BJ.%26aulast%3DDalkin%26aufirst%3DB.%2BL.%26aulast%3DMcDermott%26aufirst%3DK.%2BM.%26atitle%3DPrimary%2520cilia%2520are%2520lost%2520in%2520preinvasive%2520and%2520invasive%2520prostate%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68521%26doi%3D10.1371%2Fjournal.pone.0068521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stecca, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbinden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piguet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz i Altaba, A.</span></span> <span> </span><span class="NLM_article-title">Melanomas require hedgehog-gli signaling regulated by interactions between gli1 and the ras-mek/akt pathways</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">5895</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1073/pnas.0700776104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0700776104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17392427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1CqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=5895-5900&author=B.+Steccaauthor=C.+Masauthor=V.+Clementauthor=M.+Zbindenauthor=R.+Correaauthor=V.+Piguetauthor=F.+Beermannauthor=A.+Ruiz+i+Altaba&title=Melanomas+require+hedgehog-gli+signaling+regulated+by+interactions+between+gli1+and+the+ras-mek%2Fakt+pathways&doi=10.1073%2Fpnas.0700776104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways</span></div><div class="casAuthors">Stecca, Barbara; Mas, Christophe; Clement, Virginie; Zbinden, Marie; Correa, Rafael; Piguet, Vincent; Beermann, Friedrich; Ruiz i Altaba, Ariel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5895-5900</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Melanoma is one of the most aggressive cancers, and its incidence is increasing.  These tumors derive from the melanocyte lineage and remain incurable after metastasis.  Here we report that SONIC HEDGEHOG (SHH)-GLI signaling is active in the matrix of human hair follicles, and that it is required for the normal proliferation of human melanocytes in culture.  SHH-GLI signaling also regulates the proliferation and survival of human melanomas: the growth, recurrence, and metastasis of melanoma xenografts in mice are prevented by local or systemic interference of HH-GLI function.  Moreover, we show that oncogenic RAS-induced melanomas in transgenic mice express GLI1 and require Hh-Gli signaling in vitro and in vivo.  Finally, we provide evidence that endogenous RAS-MEK and AKT signaling regulate the nuclear localization and transcriptional activity of GLI1 in melanoma and other cancer cells.  Our data uncover an unsuspected role of HH-GLI signaling in melanocytes and melanomas, demonstrate a role for this pathway in RAS-induced tumors, suggest a general integration of the RAS/AKT and HH-GLI pathways, and open a therapeutic approach for human melanomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEymXBlCsjNrVg90H21EOLACvtfcHk0liycRxVuNtXHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1CqtLg%253D&md5=73c79615db235dbb9b873ad27f7b22bb</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0700776104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0700776104%26sid%3Dliteratum%253Aachs%26aulast%3DStecca%26aufirst%3DB.%26aulast%3DMas%26aufirst%3DC.%26aulast%3DClement%26aufirst%3DV.%26aulast%3DZbinden%26aufirst%3DM.%26aulast%3DCorrea%26aufirst%3DR.%26aulast%3DPiguet%26aufirst%3DV.%26aulast%3DBeermann%26aufirst%3DF.%26aulast%3DRuiz%2Bi%2BAltaba%26aufirst%3DA.%26atitle%3DMelanomas%2520require%2520hedgehog-gli%2520signaling%2520regulated%2520by%2520interactions%2520between%2520gli1%2520and%2520the%2520ras-mek%252Fakt%2520pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D5895%26epage%3D5900%26doi%3D10.1073%2Fpnas.0700776104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toftgard, R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of gli-mediated transcription and tumor cell growth by small-molecule antagonists</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">8455</span>– <span class="NLM_lpage">8460</span>, <span class="refDoi"> DOI: 10.1073/pnas.0609699104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0609699104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=17494766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=8455-8460&author=M.+Lauthauthor=A.+Bergstromauthor=T.+Shimokawaauthor=R.+Toftgard&title=Inhibition+of+gli-mediated+transcription+and+tumor+cell+growth+by+small-molecule+antagonists&doi=10.1073%2Fpnas.0609699104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists</span></div><div class="casAuthors">Lauth, Matthias; Bergstroem, Asa; Shimokawa, Takashi; Toftgard, Rune</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8455-8460</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The developmentally important Hedgehog (Hh) signaling pathway has recently been implicated in several forms of solid cancer.  Current drug development programs focus on targeting the protooncogene Smoothened, a key transmembrane pathway member.  These drug candidates, albeit promising, do not address the scenario in which pathway activation occurs downstream of Smoothened, as obsd. in cases of medulloblastoma, glioma, pericytoma, breast cancer, and prostate cancer.  A cellular screen for small-mol. antagonists of GLI-mediated transcription, which constitutes the final step in the Hh pathway, revealed two mols. that are able to selectively inhibit GLI-mediated gene transactivation.  We provide genetic evidence of downstream pathway blockade by these compds. and demonstrate the ineffectiveness of upstream antagonists such as cyclopamine in such situations.  Mechanistically, both inhibitors act in the nucleus to block GLI function, and one of them interferes with GLI1 DNA binding in living cells.  Importantly, the discovered compds. efficiently inhibited in vitro tumor cell proliferation in a GLI-dependent manner and successfully blocked cell growth in an in vivo xenograft model using human prostate cancer cells harboring downstream activation of the Hh pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnlBrXj0X1ELVg90H21EOLACvtfcHk0liycRxVuNtXHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVChtbw%253D&md5=c579b952f8c878fa3058b21d41e16f07</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0609699104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0609699104%26sid%3Dliteratum%253Aachs%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DA.%26aulast%3DShimokawa%26aufirst%3DT.%26aulast%3DToftgard%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520gli-mediated%2520transcription%2520and%2520tumor%2520cell%2520growth%2520by%2520small-molecule%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D8455%26epage%3D8460%26doi%3D10.1073%2Fpnas.0609699104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moshai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wemeau-Stervinou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cigna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somme, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailleux, A. A.</span></span> <span> </span><span class="NLM_article-title">Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2013-0154OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1165%2Frcmb.2013-0154OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24450438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFegtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2014&pages=11-25&author=E.+F.+Moshaiauthor=L.+Wemeau-Stervinouauthor=N.+Cignaauthor=S.+Brayerauthor=J.+M.+Sommeauthor=B.+Crestaniauthor=A.+A.+Mailleux&title=Targeting+the+hedgehog-glioma-associated+oncogene+homolog+pathway+inhibits+bleomycin-induced+lung+fibrosis+in+mice&doi=10.1165%2Frcmb.2013-0154OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Hedgehog-Glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice</span></div><div class="casAuthors">Moshai, Elika Farrokhi; Wemeau-Stervinou, Lidwine; Cigna, Natacha; Brayer, Stephanie; Marchal Somme, Joelle; Crestani, Bruno; Mailleux, Arnaud A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-25, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis has been assocd. with the reactivation of developmental pathways, notably the Hedgehog-Glioma-assocd. oncogene homolog (GLI) pathway.  In this study, we detd. whether the Hedgehog pathway was activated in bleomycin-induced lung injury in mice and whether targeting the Hedgehog-Gli pathway could decrease bleomycin-induced lung fibrosis.  After intratracheal injection of bleomycin on Day 0, C57Bl6 mice received GDC-0449 (an inhibitor of Smoothened, the transducer of the pathway), or 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl] bis (methylene)] bis [N,N dimethylbenzenamine (GANT61; an inhibitor of GLI transcription factors in the nucleus)], from Day 7 to Day 13.  At Day 14, whole-lung homogenates were obtained for morphol. anal., assessment of cell apoptosis and proliferation, collagen quantification and evaluation of profibrotic (transforming growth factor-β, connective tissue growth factor, plasminogen activator inhibitor 1, vascular endothelial growth factor-A) and proinflammatory mediators (IL-1β) expression.  We showed that the Hedgehog pathway was activated in bleomycin-induced lung fibrosis on Day 14 after injury, with an increased lung expression of the ligand, Sonic Hedgehog and with increased mRNA expression and nuclear localization of GLI1 and GLI2.  Inhibition of Smoothened with GDC-0449 did not influence the development of bleomycin-induced lung fibrosis.  By contrast, the inhibition of GLI activity with GANT61 decreased lung fibrosis and lung collagen accumulation and promoted an antifibrotic and anti-inflammatory environment.  Our results identify the Hedgehog-Gli pathway as a profibrotic pathway in exptl. fibrosis.  Inhibition of the Hedgehog-Gli pathway at the level of GLI transcriptional activity could be a therapeutic option in fibrotic lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6mloCraMx77Vg90H21EOLACvtfcHk0lilTbTyje6YQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFegtLbI&md5=d08a8d915e6f88a8b6d8233d80c2baa2</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2013-0154OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2013-0154OC%26sid%3Dliteratum%253Aachs%26aulast%3DMoshai%26aufirst%3DE.%2BF.%26aulast%3DWemeau-Stervinou%26aufirst%3DL.%26aulast%3DCigna%26aufirst%3DN.%26aulast%3DBrayer%26aufirst%3DS.%26aulast%3DSomme%26aufirst%3DJ.%2BM.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DMailleux%26aufirst%3DA.%2BA.%26atitle%3DTargeting%2520the%2520hedgehog-glioma-associated%2520oncogene%2520homolog%2520pathway%2520inhibits%2520bleomycin-induced%2520lung%2520fibrosis%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2014%26volume%3D51%26spage%3D11%26epage%3D25%26doi%3D10.1165%2Frcmb.2013-0154OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agyeman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazumdar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, J. A.</span></span> <span> </span><span class="NLM_article-title">Mode and specificity of binding of the small molecule gant61 to gli determines inhibition of gli-DNA binding</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4492</span>– <span class="NLM_lpage">4503</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.2046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24962990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2cfmtlGgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4492-4503&author=A.+Agyemanauthor=B.+K.+Jhaauthor=T.+Mazumdarauthor=J.+A.+Houghton&title=Mode+and+specificity+of+binding+of+the+small+molecule+gant61+to+gli+determines+inhibition+of+gli-DNA+binding&doi=10.18632%2Foncotarget.2046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding</span></div><div class="casAuthors">Agyeman Akwasi; Houghton Janet A; Jha Babal K; Mazumdar Tapati</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4492-503</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The GLI genes, GLI1 and GLI2, are transcription factors that regulate target genes at the distal end of the canonical Hedgehog (HH) signaling pathway (SHH->PTCH->SMO->GLI), tightly regulated in embryonic development, tissue patterning and differentiation.  Both GLI1 and GLI2 are oncogenes, constitutively activated in many types of human cancers.  In colon cancer cells oncogenic KRAS-GLI signaling circumvents the HH-SMO-GLI axis to channel through and activate GLI in the transcriptional regulation of target genes.  We have observed extensive cell death in a panel of 7 human colon carcinoma cell lines using the small molecule GLI inhibitor GANT61.  Using computational docking and experimental confirmation by Surface Plasmon Resonance, GANT61 binds to the 5-zinc finger GLI1 protein between zinc fingers 2 and 3 at sites E119 and E167, independent of the GLI-DNA binding region, and conserved between GLI1 and GLI2.  GANT61 does not bind to other zinc finger transcription factors (KLF4, TFIIβ).  Mutating the predicted GANT61 binding sites in GLI1 significantly inhibits GANT61-GLI binding and GLI-luciferase activity.  Data establish the specificity of GANT61 for targeting GLI, and substantiate the critical role of GLI in cancer cell survival.  Thus, targeting GLI in cancer therapeutics may be of high impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHnxetXWD6STAEfvC7EH1LfW6udTcc2eZoqoB4yiH7h7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfmtlGgug%253D%253D&md5=c3c16d3abd686bcc736af4a3ac1f7327</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2046%26sid%3Dliteratum%253Aachs%26aulast%3DAgyeman%26aufirst%3DA.%26aulast%3DJha%26aufirst%3DB.%2BK.%26aulast%3DMazumdar%26aufirst%3DT.%26aulast%3DHoughton%26aufirst%3DJ.%2BA.%26atitle%3DMode%2520and%2520specificity%2520of%2520binding%2520of%2520the%2520small%2520molecule%2520gant61%2520to%2520gli%2520determines%2520inhibition%2520of%2520gli-DNA%2520binding%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D4492%26epage%3D4503%26doi%3D10.18632%2Foncotarget.2046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calcaterra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iovine, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Acquarica, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciogli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iazzetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lospinoso Severini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span> <span> </span><span class="NLM_article-title">Chemical, computational and functional insights into the chemical stability of the hedgehog pathway inhibitor gant61</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1080/14756366.2017.1419221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1080%2F14756366.2017.1419221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29338454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVajt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=349-358&author=A.+Calcaterraauthor=V.+Iovineauthor=B.+Bottaauthor=D.+Quaglioauthor=I.+D%E2%80%99Acquaricaauthor=A.+Ciogliauthor=A.+Iazzettiauthor=R.+Alfonsiauthor=L.+Lospinoso+Severiniauthor=P.+Infanteauthor=L.+Di+Marcotullioauthor=M.+Moriauthor=F.+Ghirga&title=Chemical%2C+computational+and+functional+insights+into+the+chemical+stability+of+the+hedgehog+pathway+inhibitor+gant61&doi=10.1080%2F14756366.2017.1419221"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61</span></div><div class="casAuthors">Calcaterra, Andrea; Iovine, Valentina; Botta, Bruno; Quaglio, Deborah; D'Acquarica, Ilaria; Ciogli, Alessia; Iazzetti, Antonia; Alfonsi, Romina; Lospinoso Severini, Ludovica; Infante, Paola; Di Marcotullio, Lucia; Mori, Mattia; Ghirga, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">349-358</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">This work aims at elucidating the mechanism and kinetics of hydrolysis of GANT61, the first and most-widely used inhibitor of the Hedgehog (Hh) signaling pathway that targets Glioma-assocd. oncogene homolog (Gli) proteins, and at confirming the chem. nature of its bioactive form.  GANT61 is poorly stable under physiol. conditions and rapidly hydrolyzes into an aldehyde species (GANT61-A), which is devoid of the biol. activity against Hh signaling, and a diamine deriv. (GANT61-D), which has shown inhibition of Gli-mediated transcription.  Here, the authors combined chem. synthesis, NMR spectroscopy, anal. studies, mol. modeling and functional cell assays to characterize the GANT61 hydrolysis pathway.  The authors' results show that GANT61-D is the bioactive form of GANT61 in NIH3T3 Shh-Light II cells and SuFu-/- mouse embryonic fibroblasts, and clarify the structural requirements for GANT61-D binding to Gli1.  This study paves the way to the design of GANT61 derivs. with improved potency and chem. stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNtq0nozn517Vg90H21EOLACvtfcHk0lilTbTyje6YQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVajt7s%253D&md5=050642aa38026bd31449c13fd5ded885</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1080%2F14756366.2017.1419221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2017.1419221%26sid%3Dliteratum%253Aachs%26aulast%3DCalcaterra%26aufirst%3DA.%26aulast%3DIovine%26aufirst%3DV.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DQuaglio%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Acquarica%26aufirst%3DI.%26aulast%3DCiogli%26aufirst%3DA.%26aulast%3DIazzetti%26aufirst%3DA.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DLospinoso%2BSeverini%26aufirst%3DL.%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DGhirga%26aufirst%3DF.%26atitle%3DChemical%252C%2520computational%2520and%2520functional%2520insights%2520into%2520the%2520chemical%2520stability%2520of%2520the%2520hedgehog%2520pathway%2520inhibitor%2520gant61%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D349%26epage%3D358%26doi%3D10.1080%2F14756366.2017.1419221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingallina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Po, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello Barretta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span> <span> </span><span class="NLM_article-title">Gli1/DNA interaction is a druggable target for hedgehog-dependent tumors</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.15252/embj.201489213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.15252%2Fembj.201489213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25476449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislSitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=200-217&author=P.+Infanteauthor=M.+Moriauthor=R.+Alfonsiauthor=F.+Ghirgaauthor=F.+Aielloauthor=S.+Toscanoauthor=C.+Ingallinaauthor=M.+Silerauthor=D.+Cucchiauthor=A.+Poauthor=E.+Mieleauthor=D.+D%E2%80%99Amicoauthor=G.+Canettieriauthor=E.+De+Smaeleauthor=E.+Ferrettiauthor=I.+Screpantiauthor=G.+Uccello+Barrettaauthor=M.+Bottaauthor=B.+Bottaauthor=A.+Gulinoauthor=L.+Di+Marcotullio&title=Gli1%2FDNA+interaction+is+a+druggable+target+for+hedgehog-dependent+tumors&doi=10.15252%2Fembj.201489213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors</span></div><div class="casAuthors">Infante, Paola; Mori, Mattia; Alfonsi, Romina; Ghirga, Francesca; Aiello, Federica; Toscano, Sara; Ingallina, Cinzia; Siler, Mariangela; Cucchi, Danilo; Po, Agnese; Miele, Evelina; D'Amico, Davide; Canettieri, Gianluca; De Smaele, Enrico; Ferretti, Elisabetta; Screpanti, Isabella; Barretta, Gloria Uccello; Botta, Maurizio; Botta, Bruno; Gulino, Alberto; Di Marcotullio, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-217</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Hedgehog signaling is essential for tissue development and stemness, and its deregulation has been obsd. in many tumors.  Aberrant activation of Hedgehog signaling is the result of genetic mutations of pathway components or other Smo-dependent or independent mechanisms, all triggering the downstream effector Gli1.  For this reason, understanding the poorly elucidated mechanism of Gli1-mediated transcription allows to identify novel mols. blocking the pathway at a downstream level, representing a crit. goal in tumor biol.  Here, we clarify the structural requirements of the pathway effector Gli1 for binding to DNA and identify Glabrescione B as the first small mol. binding to Gli1 zinc finger and impairing Gli1 activity by interfering with its interaction with DNA.  Remarkably, as a consequence of its robust inhibitory effect on Gli1 activity, Glabrescione B inhibited the growth of Hedgehog-dependent tumor cells in vitro and in vivo as well as the self-renewal ability and clonogenicity of tumor-derived stem cells.  The identification of the structural requirements of Gli1/DNA interaction highlights their relevance for pharmacol. interference of Gli signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2YShhrICegbVg90H21EOLACvtfcHk0lgzvGp0R0HY-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislSitLY%253D&md5=9aae45acbf9e3a723bf85bf52a474ec1</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.15252%2Fembj.201489213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201489213%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DGhirga%26aufirst%3DF.%26aulast%3DAiello%26aufirst%3DF.%26aulast%3DToscano%26aufirst%3DS.%26aulast%3DIngallina%26aufirst%3DC.%26aulast%3DSiler%26aufirst%3DM.%26aulast%3DCucchi%26aufirst%3DD.%26aulast%3DPo%26aufirst%3DA.%26aulast%3DMiele%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DD.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DDe%2BSmaele%26aufirst%3DE.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DUccello%2BBarretta%26aufirst%3DG.%26aulast%3DBotta%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DGulino%26aufirst%3DA.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26atitle%3DGli1%252FDNA%2520interaction%2520is%2520a%2520druggable%2520target%2520for%2520hedgehog-dependent%2520tumors%26jtitle%3DEMBO%2520J.%26date%3D2015%26volume%3D34%26spage%3D200%26epage%3D217%26doi%3D10.15252%2Fembj.201489213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slusarz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenouda, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakla, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenkhahn, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narula, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besch-Williford, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubahn, D. B.</span></span> <span> </span><span class="NLM_article-title">Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3390</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-09-3012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20395211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslSgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3382-3390&author=A.+Slusarzauthor=N.+S.+Shenoudaauthor=M.+S.+Saklaauthor=S.+K.+Drenkhahnauthor=A.+S.+Narulaauthor=R.+S.+MacDonaldauthor=C.+L.+Besch-Willifordauthor=D.+B.+Lubahn&title=Common+botanical+compounds+inhibit+the+hedgehog+signaling+pathway+in+prostate+cancer&doi=10.1158%2F0008-5472.CAN-09-3012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer</span></div><div class="casAuthors">Slusarz, Anna; Shenouda, Nader S.; Sakla, Mary S.; Drenkhahn, Sara K.; Narula, Acharan S.; MacDonald, Ruth S.; Besch-Williford, Cynthia L.; Lubahn, Dennis B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3390</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Many botanical compds. have been proposed to prevent cancer.  We investigated the cancer treatment and prevention abilities of apigenin, baicalein, curcumin, epigallocatechin 3-gallate (EGCG), genistein, quercetin, and resveratrol both in vivo in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice as well as in vitro in prostate cancer cell lines.  In our expts., these seven compds. act similarly to the Hedgehog antagonist cyclopamine, a teratogenic plant alkaloid, which had been previously shown to "cure" prostate cancer in a mouse xenograft model.  With IC50 values ranging from <1 to 25 μmol/L, these compds. can inhibit Gli1 mRNA concn. by up to 95% and downregulate Gli reporter activity by 80%.  We show that four compds., genistein, curcumin, EGCG, and resveratrol, inhibit Hedgehog signaling as monitored by real-time reverse transcription-PCR anal. of Gli1 mRNA concn. or by Gli reporter activity.  Three compds., apigenin, baicalein, and quercetin, decreased Gli1 mRNA concn. but not Gli reporter activity.  Our results show that these compds. are also able to reduce or delay prostate cancer in vivo in TRAMP mice.  All seven compds., when fed in combination as pure compds. or as crude plant exts., inhibit well-differentiated carcinoma of the prostate by 58% and 81%, resp.  In vitro, we show that all seven compds. also inhibit growth in human and mouse prostate cancer cell lines.  Mechanistically, we propose the Hedgehog signaling pathway to be a direct or indirect target of these compds.  These botanicals at pharmacol. concns. are potentially safer and less expensive alternatives to cyclopamine and its pharmaceutical analogs for cancer therapy.  Cancer Res; 70(8); 3382-90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmU2Nuo81_QbVg90H21EOLACvtfcHk0lgzvGp0R0HY-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslSgsrY%253D&md5=2f50f1f660c52fe4cce666579216b763</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3012%26sid%3Dliteratum%253Aachs%26aulast%3DSlusarz%26aufirst%3DA.%26aulast%3DShenouda%26aufirst%3DN.%2BS.%26aulast%3DSakla%26aufirst%3DM.%2BS.%26aulast%3DDrenkhahn%26aufirst%3DS.%2BK.%26aulast%3DNarula%26aufirst%3DA.%2BS.%26aulast%3DMacDonald%26aufirst%3DR.%2BS.%26aulast%3DBesch-Williford%26aufirst%3DC.%2BL.%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26atitle%3DCommon%2520botanical%2520compounds%2520inhibit%2520the%2520hedgehog%2520signaling%2520pathway%2520in%2520prostate%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3382%26epage%3D3390%26doi%3D10.1158%2F0008-5472.CAN-09-3012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namgung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span> <span> </span><span class="NLM_article-title">Daidzein suppresses tumor necrosis factor-alpha induced migration and invasion by inhibiting hedgehog/gli1 signaling in human breast cancer cells</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3759</span>– <span class="NLM_lpage">3767</span>, <span class="refDoi"> DOI: 10.1021/jf500231t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf500231t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVWhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=3759-3767&author=C.+Baoauthor=H.+Namgungauthor=J.+Leeauthor=H.+C.+Parkauthor=J.+Koauthor=H.+Moonauthor=H.+W.+Koauthor=H.+J.+Lee&title=Daidzein+suppresses+tumor+necrosis+factor-alpha+induced+migration+and+invasion+by+inhibiting+hedgehog%2Fgli1+signaling+in+human+breast+cancer+cells&doi=10.1021%2Fjf500231t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Daidzein Suppresses Tumor Necrosis Factor-α Induced Migration and Invasion by Inhibiting Hedgehog/Gli1 Signaling in Human Breast Cancer Cells</span></div><div class="casAuthors">Bao, Cheng; Namgung, Hyeju; Lee, Jaehoo; Park, Hyun-Chang; Ko, Jiwon; Moon, Heejung; Ko, Hyuk Wan; Lee, Hong Jin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3759-3767</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In breast cancer, the cytokine tumor necrosis factor-α (TNF-α) induces cell invasion, although the mol. basis of it has not been clearly elucidated.  In this study, we investigated the role of daidzein in regulating TNF-α induced cell invasion and the underlying mol. mechanisms.  Daidzein inhibited TNF-α induced cellular migration and invasion in estrogen receptor (ER) neg. MCF10DCIS.com human breast cancer cells.  TNF-α activated Hedgehog (Hh) signaling by enhancing Gli1 nuclear translocation and transcriptional activity, which resulted in increased invasiveness; these effects were blocked by daidzein and the Hh signaling inhibitors, cyclopamine and vismodegib.  Moreover, these compds. suppressed TNF-α induced matrix metalloproteinase (MMP)-9 mRNA expression and activity.  Taken together, mammary tumor cell invasiveness was stimulated by TNF-α induced activation of Hh signaling; these effects were abrogated by daidzein, which suppressed Gli1 activation, thereby inhibiting migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtJ0_E32sKf7Vg90H21EOLACvtfcHk0lhQb8vJPavKQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVWhur0%253D&md5=18061ec361aa566c6f63e55432c586ec</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjf500231t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf500231t%26sid%3Dliteratum%253Aachs%26aulast%3DBao%26aufirst%3DC.%26aulast%3DNamgung%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%2BC.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DMoon%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26atitle%3DDaidzein%2520suppresses%2520tumor%2520necrosis%2520factor-alpha%2520induced%2520migration%2520and%2520invasion%2520by%2520inhibiting%2520hedgehog%252Fgli1%2520signaling%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2014%26volume%3D62%26spage%3D3759%26epage%3D3767%26doi%3D10.1021%2Fjf500231t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berardozzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingallina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Paolis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonsi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caimano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghirga, F.</span></span> <span> </span><span class="NLM_article-title">Synergistic inhibition of the hedgehog pathway by newly designed smo and gli antagonists bearing the isoflavone scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ejmech.2018.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30025349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCmsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=554-562&author=S.+Berardozziauthor=F.+Bernardiauthor=P.+Infanteauthor=C.+Ingallinaauthor=S.+Toscanoauthor=E.+De+Paolisauthor=R.+Alfonsiauthor=M.+Caimanoauthor=B.+Bottaauthor=M.+Moriauthor=L.+Di+Marcotullioauthor=F.+Ghirga&title=Synergistic+inhibition+of+the+hedgehog+pathway+by+newly+designed+smo+and+gli+antagonists+bearing+the+isoflavone+scaffold&doi=10.1016%2Fj.ejmech.2018.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold</span></div><div class="casAuthors">Berardozzi, Simone; Bernardi, Flavia; Infante, Paola; Ingallina, Cinzia; Toscano, Sara; De Paolis, Elisa; Alfonsi, Romina; Caimano, Miriam; Botta, Bruno; Mori, Mattia; Di Marcotullio, Lucia; Ghirga, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">554-562</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Aberrant activation of the Hedgehog (Hh) pathway is responsible for the onset and progression of several malignancies.  Small mols. able to block the pathway at the upstream receptor Smoothened (Smo) or the downstream effector Gli1 have thus emerged recently as valuable anticancer agents.  Here, we have designed, synthesized, and tested new Hh inhibitors taking advantage by the highly versatile and privileged isoflavone scaffold.  The introduction of specific substitutions on the isoflavone's ring B allowed the identification of mols. targeting preferentially Smo or Gli1.  Biol. assays coupled with mol. modeling corroborated the design strategy, and provided new insights into the mechanism of action of these mols.  The combined administration of two different isoflavones behaving as Smo and Gli antagonists, resp., in primary medulloblastoma (MB) cells highlighted the synergistic effects of these agents, thus paving the way to further and innovative strategies for the pharmacol. inhibition of Hh signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRYMtkDfh-Z7Vg90H21EOLACvtfcHk0lhQb8vJPavKQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCmsLfF&md5=6b7f4e1d1fef4dae2d4a56ff1fb0f8e1</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DBerardozzi%26aufirst%3DS.%26aulast%3DBernardi%26aufirst%3DF.%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DIngallina%26aufirst%3DC.%26aulast%3DToscano%26aufirst%3DS.%26aulast%3DDe%2BPaolis%26aufirst%3DE.%26aulast%3DAlfonsi%26aufirst%3DR.%26aulast%3DCaimano%26aufirst%3DM.%26aulast%3DBotta%26aufirst%3DB.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DGhirga%26aufirst%3DF.%26atitle%3DSynergistic%2520inhibition%2520of%2520the%2520hedgehog%2520pathway%2520by%2520newly%2520designed%2520smo%2520and%2520gli%2520antagonists%2520bearing%2520the%2520isoflavone%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D554%26epage%3D562%26doi%3D10.1016%2Fj.ejmech.2018.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ocasio, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rack, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solow-Cordero, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowitch, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors reveal multiple strategies for hedgehog pathway blockade</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">14132</span>– <span class="NLM_lpage">14137</span>, <span class="refDoi"> DOI: 10.1073/pnas.0907134106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.0907134106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=19666565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=14132-14137&author=J.+M.+Hymanauthor=A.+J.+Firestoneauthor=V.+M.+Heineauthor=Y.+Zhaoauthor=C.+A.+Ocasioauthor=K.+Hanauthor=M.+Sunauthor=P.+G.+Rackauthor=S.+Sinhaauthor=J.+J.+Wuauthor=D.+E.+Solow-Corderoauthor=J.+Jiangauthor=D.+H.+Rowitchauthor=J.+K.+Chen&title=Small-molecule+inhibitors+reveal+multiple+strategies+for+hedgehog+pathway+blockade&doi=10.1073%2Fpnas.0907134106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors reveal multiple strategies for hedgehog pathway blockade</span></div><div class="casAuthors">Hyman, Joel M.; Firestone, Ari J.; Heine, Vivi M.; Zhao, Yun; Ocasio, Cory A.; Han, Kyuho; Sun, Mark; Rack, Paul G.; Sinha, Surajit; Wu, Jason J.; Solow-Cordero, David E.; Jiang, Jin; Rowitch, David H.; Chen, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">14132-14137, S14132/1-S14132/21</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inappropriate activation of the Hedgehog (Hh) signaling pathway has been implicated in a diverse spectrum of cancers, and its pharmacol. blockade has emerged as an anti-tumor strategy.  While nearly all known Hh pathway antagonists target the trans-membrane protein Smoothened (Smo), small mols. that suppress downstream effectors could more comprehensively remediate Hh pathway-dependent tumors.  The authors report here four Hh pathway antagonists that are epistatic to the nucleocytoplasmic regulator Suppressor of Fused [Su(fu)], including two that can inhibit Hh target gene expression induced by overexpression of the Gli transcription factors.  Each inhibitor has a unique mechanism of action, and their phenotypes reveal that Gli processing, Gli activation, and primary cilia formation are pharmacol. targetable.  The authors further establish the ability of certain compds. to block the proliferation of cerebellar granule neuron precursors expressing an oncogenic form of Smo, and the authors demonstrate that Hh pathway inhibitors can have tissue-specific activities.  These antagonists therefore constitute a valuable set of chem. tools for interrogating downstream Hh signaling mechanisms and for developing chemotherapies against Hh pathway-related cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZXrIN2SzvLVg90H21EOLACvtfcHk0lhQb8vJPavKQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWksLrF&md5=2c0e1c6017b5a86a138c1a192667af0a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907134106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907134106%26sid%3Dliteratum%253Aachs%26aulast%3DHyman%26aufirst%3DJ.%2BM.%26aulast%3DFirestone%26aufirst%3DA.%2BJ.%26aulast%3DHeine%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DOcasio%26aufirst%3DC.%2BA.%26aulast%3DHan%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DRack%26aufirst%3DP.%2BG.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26aulast%3DSolow-Cordero%26aufirst%3DD.%2BE.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DRowitch%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26atitle%3DSmall-molecule%2520inhibitors%2520reveal%2520multiple%2520strategies%2520for%2520hedgehog%2520pathway%2520blockade%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D14132%26epage%3D14137%26doi%3D10.1073%2Fpnas.0907134106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Naturally occurring small-molecule inhibitors of hedgehog/gli-mediated transcription</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1082</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1002/cbic.200700511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcbic.200700511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18357592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVWiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1082-1092&author=T.+Hosoyaauthor=M.+A.+Araiauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=M.+Ishibashi&title=Naturally+occurring+small-molecule+inhibitors+of+hedgehog%2Fgli-mediated+transcription&doi=10.1002%2Fcbic.200700511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription</span></div><div class="casAuthors">Hosoya, Takahiro; Arai, Midori A.; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1082-1092</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors.  To search for Hh/GLI inhibitors, we screened for naturally occurring inhibitors of the transcriptional activator GLI1 by using a cell-based assay.  We identified zerumbone (1), zerumbone epoxide (2), staurosporinone (9), 6-hydroxystaurosporinone (10), arcyriaflavin C (11) and 5,6-dihydroxyarcyriaflavin A (12) as inhibitors of GLI-mediated transcription.  In addn., we isolated physalins F (17) and B (18) from Physalis min., which are also potent inhibitors.  These compds. also inhibited GLI2-mediated transactivation.  Semi-quant. RT-PCR and Western blotting anal. further revealed that 1, 9, 17, and 18 decreased Hh-related component expressions.  We also show that inhibitors of GLI-mediated transactivation reduce the level of the anti-apoptosis Bcl2 expression.  Finally, these identified compds. were cytotoxic to PANC1 pancreatic cancer cells, which express Hh/GLI components.  These results strongly suggest that the cytotoxicity of the compds. to PANC1 cells correlates with their inhibition of GLI-mediated transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdnhvedOW82bVg90H21EOLACvtfcHk0ljAohfRZ2ThSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVWiur4%253D&md5=35ca60bee419aa5b14f45b04082dad9a</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700511%26sid%3Dliteratum%253Aachs%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DNaturally%2520occurring%2520small-molecule%2520inhibitors%2520of%2520hedgehog%252Fgli-mediated%2520transcription%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D1082%26epage%3D1092%26doi%3D10.1002%2Fcbic.200700511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashizume, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodeoka, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of the right-side structure of type b physalins</span>. <i>Isr. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1002/ijch.201600110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fijch.201600110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28659646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGjt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2017&pages=309-318&author=M.+Moritaauthor=S.+Kojimaauthor=M.+Ohkuboauthor=H.+Koshinoauthor=D.+Hashizumeauthor=G.+Hiraiauthor=K.+Maruokaauthor=M.+Sodeoka&title=Synthesis+of+the+right-side+structure+of+type+b+physalins&doi=10.1002%2Fijch.201600110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the Right-Side Structure of Type B Physalins</span></div><div class="casAuthors">Morita, Masaki; Kojima, Shuntaro; Ohkubo, Megumi; Koshino, Hiroyuki; Hashizume, Daisuke; Hirai, Go; Maruoka, Keiji; Sodeoka, Mikiko</div><div class="citationInfo"><span class="NLM_cas:title">Israel Journal of Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">309-318</span>CODEN:
                <span class="NLM_cas:coden">ISJCAT</span>;
        ISSN:<span class="NLM_cas:issn">0021-2148</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A full account of our synthetic studies on the racemic DEFGH-ring moiety of physalins, featuring domino ring transformation of a tricyclic key intermediate was presented.  The results of a detailed mechanistic examn. of the domino ring transformation, as well as a reoptimization of the 2,3-Wittig rearrangement and methylation steps was also reported.  Furthermore, a method for the prepn. of an optically active synthetic intermediate by enzymic kinetic resoln was newly established.  This work provided access to both natural and nonnatural right-side physalin structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4HlzoYaXBsrVg90H21EOLACvtfcHk0ljAohfRZ2ThSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGjt77L&md5=56f1941393750397a703fb4d9ff58391</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1002%2Fijch.201600110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijch.201600110%26sid%3Dliteratum%253Aachs%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DKojima%26aufirst%3DS.%26aulast%3DOhkubo%26aufirst%3DM.%26aulast%3DKoshino%26aufirst%3DH.%26aulast%3DHashizume%26aufirst%3DD.%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DMaruoka%26aufirst%3DK.%26aulast%3DSodeoka%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520the%2520right-side%2520structure%2520of%2520type%2520b%2520physalins%26jtitle%3DIsr.%2520J.%2520Chem.%26date%3D2017%26volume%3D57%26spage%3D309%26epage%3D318%26doi%3D10.1002%2Fijch.201600110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Hedgehog/gli-mediated transcriptional inhibitors from zizyphus cambodiana</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">9420</span>– <span class="NLM_lpage">9424</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmc.2008.09.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=18842418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KltrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9420-9424&author=M.+A.+Araiauthor=C.+Tatenoauthor=T.+Hosoyaauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=M.+Ishibashi&title=Hedgehog%2Fgli-mediated+transcriptional+inhibitors+from+zizyphus+cambodiana&doi=10.1016%2Fj.bmc.2008.09.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana</span></div><div class="casAuthors">Arai, Midori A.; Tateno, Chikashi; Hosoya, Takahiro; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9420-9424</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors.  By screening tropical plant exts. by using our screening system, Zizyphus cambodiana was found to include Hh/GLI signaling inhibitors.  Bioassay-guided fractionation of this plant ext. led to the isolation of three active pentacyclic triterpenes, colubrinic acid (1), betulinic acid (2) and alphitolic acid (3), as potent inhibitors.  The inhibition of GLI-related protein expression with 1 or 2 was obsd. in HaCaT cells with exogenous GLI1, or human pancreatic cancer cells (PANC1), which express Hh/GLI components aberrantly.  The expressions of GLI-related proteins PTCH and BCL2 were clearly inhibited by 1 or 2.  We also examd. the cytotoxicity of these active compds. against PANC1, human prostate cancer cells (DU145) and mouse embryo fibroblast cells (C3H10T1/2).  The cytotoxicity against cancer cells (PANC1 and DU145) by 1 or 2 would be caused by inhibition of the expression of the anti-apoptosis protein BCL2.  These pentacyclic triterpene inhibitors showed an important relationship between Hh/GLI signaling inhibition, the decrease of BCL2, and cytotoxicity against cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIWCUSB2F5SrVg90H21EOLACvtfcHk0ljAohfRZ2ThSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KltrnO&md5=2253f7234ec1aee0e631cb5a972fc837</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DHedgehog%252Fgli-mediated%2520transcriptional%2520inhibitors%2520from%2520zizyphus%2520cambodiana%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D9420%26epage%3D9424%26doi%3D10.1016%2Fj.bmc.2008.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rifai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhu, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">New hedgehog/gli signaling inhibitors from excoecaria agallocha</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">722</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2010.11.126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21190854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=718-722&author=Y.+Rifaiauthor=M.+A.+Araiauthor=S.+K.+Sadhuauthor=F.+Ahmedauthor=M.+Ishibashi&title=New+hedgehog%2Fgli+signaling+inhibitors+from+excoecaria+agallocha&doi=10.1016%2Fj.bmcl.2010.11.126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha</span></div><div class="casAuthors">Rifai, Yusnita; Arai, Midori A.; Sadhu, Samir K.; Ahmed, Firoj; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">718-722</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The inhibition of the Hedgehog (Hh) signaling pathway has emerged as an anti-cancer strategy.  Three flavonoid glycosides, including 2 new compds. (1-2), were isolated from Excoecaria agallocha as Hedgehog/GLI1-mediated transcriptional inhibitors and exhibited cytotoxicity against human pancreatic (PANC1) and prostate (DU145) cancer cells.  The data revealed that compd. 1 clearly inhibited the expression of GLI-related proteins (PTCH and BCL-2) and blocked the translocation of GLI1 transcription factors into the nucleus in PANC1.  Deleting the Smoothened (Smo) function in PANC1 treated with compd. 1 led to downregulation of the mRNA expression of Ptch.  This study describes the first Hh signaling inhibitor which blocks GLI1 movement into the nucleus without interfering with Smo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpioNJrbW8TcbVg90H21EOLACvtfcHk0liy8qJrhHHu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOjsQ%253D%253D&md5=cc5028e73f195856a5dd14d18d95eea1</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.126%26sid%3Dliteratum%253Aachs%26aulast%3DRifai%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DSadhu%26aufirst%3DS.%2BK.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DNew%2520hedgehog%252Fgli%2520signaling%2520inhibitors%2520from%2520excoecaria%2520agallocha%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D718%26epage%3D722%26doi%3D10.1016%2Fj.bmcl.2010.11.126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">New hedgehog/gli-signaling inhibitors from adenium obesum</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1133</span>– <span class="NLM_lpage">1139</span>, <span class="refDoi"> DOI: 10.1039/C0OB00677G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1039%2FC0OB00677G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21170436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1133-1139&author=M.+A.+Araiauthor=C.+Tatenoauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=S.+Kawabeauthor=M.+Ishibashi&title=New+hedgehog%2Fgli-signaling+inhibitors+from+adenium+obesum&doi=10.1039%2FC0OB00677G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">New hedgehog/GLI-signaling inhibitors from Adenium obesum</span></div><div class="casAuthors">Arai, Midori A.; Tateno, Chikashi; Koyano, Takashi; Kowithayakorn, Thaworn; Kawabe, Seiichiro; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1133-1139</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors.  We recently constructed a cell-based screening system to search for Hh/GLI signaling inhibitors from natural resources.  Using our screening system, Adenium obesum was found to include Hh/GLI signaling inhibitors from our tropical plant ext. libraries.  Bioassay-guided fractionation of this plant ext. led to the isolation of 17 cardiac glycosides, including 3 new compds.  These compds. showed strong inhibitory activities, e.g., IC50 of 0.11 μM.  The inhibition of GLI-related protein expression with some compds. was obsd. in human pancreatic cancer cells (PANC1), which express Hh/GLI components aberrantly.  The expressions of GLI-related proteins PTCH and BCL2 were clearly inhibited.  These compds. also showed selective cytotoxicity against two cancer cell lines, with less effect against normal cells (C3H10T1/2).  RT-PCT examns. showed that Ptch mRNA expression was inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow1yfIaOz9OrVg90H21EOLACvtfcHk0liy8qJrhHHu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCjtL0%253D&md5=37745174dbc52e54c0e7074d5cbb3ff5</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC0OB00677G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0OB00677G%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DTateno%26aufirst%3DC.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DKawabe%26aufirst%3DS.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DNew%2520hedgehog%252Fgli-signaling%2520inhibitors%2520from%2520adenium%2520obesum%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D1133%26epage%3D1139%26doi%3D10.1039%2FC0OB00677G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suganami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhu, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Gli1 inhibitors identified by target protein oriented natural products isolation (tpo-napi) with hedgehog inhibition</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2551</span>– <span class="NLM_lpage">2559</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00492</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00492" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Witb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2551-2559&author=M.+A.+Araiauthor=F.+Ochiauthor=Y.+Makitaauthor=T.+Chibaauthor=K.+Higashiauthor=A.+Suganamiauthor=Y.+Tamuraauthor=T.+Toidaauthor=A.+Iwamaauthor=S.+K.+Sadhuauthor=F.+Ahmedauthor=M.+Ishibashi&title=Gli1+inhibitors+identified+by+target+protein+oriented+natural+products+isolation+%28tpo-napi%29+with+hedgehog+inhibition&doi=10.1021%2Facschembio.8b00492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition</span></div><div class="casAuthors">Arai, Midori A.; Ochi, Fumie; Makita, Yoshinori; Chiba, Tetsuhiro; Higashi, Kyohei; Suganami, Akiko; Tamura, Yutaka; Toida, Toshihiko; Iwama, Atsushi; Sadhu, Samir K.; Ahmed, Firoj; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2551-2559</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes the development of a target-protein-oriented natural-products-isolation (TPO-NAPI) method for Hedgehog inhibitors and the direct GLI1 inhibitor, 5'-O-methyl-3-hydroxyflemingin A , which inhibited hedgehog (Hh) signal transduction and diminished characteristics of cancer stem cells.  Eight natural products (including three newly described products) that directly bind to GLI1 were rapidly obtained via the TPO-NAPI method developed using GLI1 protein-immobilized beads.  5'-O-Methyl-3-hydroxyflemingin A inhibited Hh signaling (IC50 7.3 μM), leading to decreasing prodn. of the Hh target proteins BCL2, PTCH1, and BMI1.  5'-O-Methyl-3-hydroxyflemingin A was cytotoxic to Hh-related cancer cells.  CD expts. revealed that 5'-O-methyl-3-hydroxyflemingin A directly bound GLI1 (Kd = 7.7 μM).  Moreover, 5'-O-methyl-3-hydroxyflemingin A diminished cancer stem cell characters of Huh7 such as sphere formation and prodn. of the cancer stem cell marker EpCAM.  These results suggest that Hh inhibitors can efficiently suppress the activity of cancer stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppt1O3xio1XLVg90H21EOLACvtfcHk0liy8qJrhHHu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Witb%252FP&md5=1f0605e92e3aaff4616c13d7fd3ede66</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00492%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DOchi%26aufirst%3DF.%26aulast%3DMakita%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DHigashi%26aufirst%3DK.%26aulast%3DSuganami%26aufirst%3DA.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DToida%26aufirst%3DT.%26aulast%3DIwama%26aufirst%3DA.%26aulast%3DSadhu%26aufirst%3DS.%2BK.%26aulast%3DAhmed%26aufirst%3DF.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DGli1%2520inhibitors%2520identified%2520by%2520target%2520protein%2520oriented%2520natural%2520products%2520isolation%2520%2528tpo-napi%2529%2520with%2520hedgehog%2520inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D2551%26epage%3D2559%26doi%3D10.1021%2Facschembio.8b00492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span> <span> </span><span class="NLM_article-title">Solasonine, a natural glycoalkaloid compound, inhibits gli-mediated transcriptional activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1364</span>, <span class="refDoi"> DOI: 10.3390/molecules21101364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.3390%2Fmolecules21101364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1364&author=J.+Yangauthor=W.+Huangauthor=W.+Tan&title=Solasonine%2C+a+natural+glycoalkaloid+compound%2C+inhibits+gli-mediated+transcriptional+activity&doi=10.3390%2Fmolecules21101364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Solasonine, a natural glycoalkaloid compound, inhibits Gli-mediated transcriptional activity</span></div><div class="casAuthors">Yang, Jun; Huang, Wenjing; Tan, Wenfu</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1364/1-1364/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The major obstacle limiting the efficacy of current Smoothened (Smo) inhibitors is the primary and acquired resistance mainly caused by Smo mutations and Gli amplification.  In this context, developing Hh inhibitors targeting Gli, the final effector of this signaling pathway, may combat the resistance.  In this study we found that solasonine, a natural glycoalkaloid compd., significantly inhibited the hedgehog (Hh) pathway activity.  Meanwhile, solasonine may obviously inhibit the alk. phosphatase (ALP) activity in C3H10T1/2 cells, concomitantly with redns. of the mRNA expression of Gli1 and Ptch1.  However, we found that solasonine exhibited no effect on the transcriptional factors activities provoked by TNF-α and PGE2, thus suggesting its selectivity against Hh pathway activity.  Furthermore, we identified that solasonine inhibited the Hh pathway activity by acting on its transcriptional factor Gli using a series of complementary data.  We also obsd. that solasonine obviously inhibited the Gli-luciferase activity provoked by ectopic expression of Smo mutants which may cause the resistance to the current Smo inhibitors.  Our study suggests that solasonine may significantly inhibit the Hh pathway activity by acting on Gli, therefore indicating the possibility to use solasonine as a lead compd. to develop anticancer drugs for combating the resistance of current Smo inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEmcclfDKCLVg90H21EOLACvtfcHk0liy8qJrhHHu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSqurc%253D&md5=a3ba5ced46c9fce513b722721a86889c</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21101364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21101364%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DW.%26atitle%3DSolasonine%252C%2520a%2520natural%2520glycoalkaloid%2520compound%252C%2520inhibits%2520gli-mediated%2520transcriptional%2520activity%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D1364%26doi%3D10.3390%2Fmolecules21101364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayank</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaitak, V.</span></span> <span> </span><span class="NLM_article-title">Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy</span>. <i>Comput. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.compbiolchem.2015.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.compbiolchem.2015.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26278973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCrtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=145-154&author=+Mayankauthor=V.+Jaitak&title=Molecular+docking+study+of+natural+alkaloids+as+multi-targeted+hedgehog+pathway+inhibitors+in+cancer+stem+cell+therapy&doi=10.1016%2Fj.compbiolchem.2015.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking study of natural alkaloids as multi-targeted hedgehog pathway inhibitors in cancer stem cell therapy</span></div><div class="casAuthors">Mayank; Jaitak, Vikas</div><div class="citationInfo"><span class="NLM_cas:title">Computational Biology and Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-154</span>CODEN:
                <span class="NLM_cas:coden">CBCOCH</span>;
        ISSN:<span class="NLM_cas:issn">1476-9271</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer is responsible for millions of deaths throughout the world every year.  Increased understanding as well as advancements in the therapeutic aspect seems suboptimal to restrict the huge deaths assocd. with cancer.  The major cause responsible for this is high resistance as well as relapse rate assocd. with cancers.  Several evidences indicated that cancer stem cells (CSC) are mainly responsible for the resistance and relapses assocd. with cancer.  Furthermore, agents targeting a single protein seem to have higher chances of resistance than multitargeting drugs.  According to the concept of network model, partial inhibition of multiple targets is more productive than single hit agents.  Thus, by fusing both the premises that CSC and single hit anticancer drugs, both are responsible for cancer related resistances and screened alkaloids for the search of leads having CSC targeting ability as well as the capability to modulating multiple target proteins.  The in silico exptl. data indicated that emetine and cortistatin have the ability to modulate hedgehog (Hh) pathway by binding to sonic hedgehog (Hh), smoothened (Smo) and Gli protein, involved in maintenance CSCs.  Furthermore, solamargine, solasonine and tylophorine are also seems to be good lead mols. targeting towards CSCs by modulating Hh pathway.  Except solamargine and solasonine, other best lead mols. also showed acceptable in silico ADME profile.  The predicted lead mols. can be suitably modified to get multitargeting CSC targeting agent to get rid of assoc. resistances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPPPzg7_ziIrVg90H21EOLACvtfcHk0liKM0mxp_61Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCrtbvP&md5=ece6a2ab494621b64cda1fe1d5500cdc</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiolchem.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiolchem.2015.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DMayank%26aulast%3DJaitak%26aufirst%3DV.%26atitle%3DMolecular%2520docking%2520study%2520of%2520natural%2520alkaloids%2520as%2520multi-targeted%2520hedgehog%2520pathway%2520inhibitors%2520in%2520cancer%2520stem%2520cell%2520therapy%26jtitle%3DComput.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D62%26spage%3D145%26epage%3D154%26doi%3D10.1016%2Fj.compbiolchem.2015.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. P.</span></span> <span> </span><span class="NLM_article-title">Cynanbungeigenin c and d, a pair of novel epimers from cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of gli</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>420</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2018.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.canlet.2018.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29425683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtFalt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2018&pages=195-207&author=X.+Y.+Liauthor=L.+F.+Zhouauthor=L.+J.+Gaoauthor=Y.+Weiauthor=S.+F.+Xuauthor=F.+Y.+Chenauthor=W.+J.+Huangauthor=W.+F.+Tanauthor=Y.+P.+Ye&title=Cynanbungeigenin+c+and+d%2C+a+pair+of+novel+epimers+from+cynanchum+bungei%2C+suppress+hedgehog+pathway-dependent+medulloblastoma+by+blocking+signaling+at+the+level+of+gli&doi=10.1016%2Fj.canlet.2018.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Cynanbungeigenin C and D, a pair of novel epimers from Cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of Gli</span></div><div class="casAuthors">Li, Xiao-Yu; Zhou, Li-Fei; Gao, Li-Juan; Wei, Yang; Xu, Shi-Fang; Chen, Feng-Yang; Huang, Wen-Jing; Tan, Wen-Fu; Ye, Yi-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">420</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Uncontrolled excessive activation of Hedgehog (Hh) signaling pathway is linked to a no. of human malignant tumorigenesis.  To obtain valuable Hh pathway inhibitors from natural product, in present study, a pair of novel epimers, Cynanbungeigenin C (CBC) and D (CBD) from the plant Cynanchum bungei Decne were chem. characterized by multiple spectroscopic data and chem. derivatization, and evaluated for their inhibition on Hh pathway.  Mechanistically, CBC and CBD block Hh pathway signaling not through targeting Smo and Sufu, but at the level of Gli.  In addn., both eipmers significantly suppress Hh pathway-dependent Ptch+/-; p53-/- medulloblastoma in vitro and in vivo.  Furthermore, both CBC and CBD inhibited two Smo mutants induced Hh pathway activation, which suggested that they are potential compds. for the treatment of medulloblastoma with primary or acquired resistance to current Smo inhibitors.  These results highlight the potential of CBC and CBD as effective lead compds. in the treatment of medulloblastoma and other Hh-dependent malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_aSZZQU9cS7Vg90H21EOLACvtfcHk0liKM0mxp_61Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtFalt7w%253D&md5=4320747c048909c3c2fcb85dd295ece9</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2018.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2018.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DZhou%26aufirst%3DL.%2BF.%26aulast%3DGao%26aufirst%3DL.%2BJ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DF.%2BY.%26aulast%3DHuang%26aufirst%3DW.%2BJ.%26aulast%3DTan%26aufirst%3DW.%2BF.%26aulast%3DYe%26aufirst%3DY.%2BP.%26atitle%3DCynanbungeigenin%2520c%2520and%2520d%252C%2520a%2520pair%2520of%2520novel%2520epimers%2520from%2520cynanchum%2520bungei%252C%2520suppress%2520hedgehog%2520pathway-dependent%2520medulloblastoma%2520by%2520blocking%2520signaling%2520at%2520the%2520level%2520of%2520gli%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D420%26spage%3D195%26epage%3D207%26doi%3D10.1016%2Fj.canlet.2018.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rifai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowithayakorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, M.</span></span> <span> </span><span class="NLM_article-title">Terpenoids and a flavonoid glycoside from acacia pennata leaves as hedgehog/gli-mediated transcriptional inhibitors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1021/np1000818</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np1000818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=995-997&author=Y.+Rifaiauthor=M.+A.+Araiauthor=T.+Koyanoauthor=T.+Kowithayakornauthor=M.+Ishibashi&title=Terpenoids+and+a+flavonoid+glycoside+from+acacia+pennata+leaves+as+hedgehog%2Fgli-mediated+transcriptional+inhibitors&doi=10.1021%2Fnp1000818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenoids and a Flavonoid Glycoside from Acacia pennata Leaves as Hedgehog/GLI-Mediated Transcriptional Inhibitors</span></div><div class="casAuthors">Rifai, Yusnita; Arai, Midori A.; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">995-997</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Overexpression of glioma-assocd. oncogene 1 (GLI1), which has been characterized as a terminal effector and a target gene of the Hedgehog (Hh) signaling pathway, is assocd. with the development of cancer.  A cellular screen was applied utilizing of a GLI-dependent luciferase reporter in human keratinocyte cells (HaCaT) and identified two terpenoids (1 and 2) and a flavonoid glycoside (5) from Acacia pennata as Hh/GLI inhibitors.  Compds. 1, 2, and 5 exhibited selective cytotoxicity against human pancreatic (PANC1) and prostate (DU145) cancer cells with no toxic effect on normal cells.  This result was consistent with a dose-dependent redn. of the protein levels of antiapoptotic BCL-2 and the tumor suppressor patched 1 protein (PTCH).  Addnl., treatment of 1 downregulated mRNA expression of Ptch in PANC1, suggesting that the compd. has an inhibitory effect on the transcription of Hh/GLI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotwdWjuBo6oLVg90H21EOLACvtfcHk0liKM0mxp_61Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslehu70%253D&md5=8cc75a560b2d9825a1af1b16e7e1fed5</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fnp1000818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp1000818%26sid%3Dliteratum%253Aachs%26aulast%3DRifai%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DM.%2BA.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DKowithayakorn%26aufirst%3DT.%26aulast%3DIshibashi%26aufirst%3DM.%26atitle%3DTerpenoids%2520and%2520a%2520flavonoid%2520glycoside%2520from%2520acacia%2520pennata%2520leaves%2520as%2520hedgehog%252Fgli-mediated%2520transcriptional%2520inhibitors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D995%26epage%3D997%26doi%3D10.1021%2Fnp1000818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span> <span> </span><span class="NLM_article-title">Three new alkaloids from veratrum grandiflorum loes with inhibition activities on hedgehog pathway</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4735</span>– <span class="NLM_lpage">4738</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.bmcl.2016.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27567371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVaksbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4735-4738&author=L.+Gaoauthor=F.+Chenauthor=X.+Liauthor=S.+Xuauthor=W.+Huangauthor=Y.+Ye&title=Three+new+alkaloids+from+veratrum+grandiflorum+loes+with+inhibition+activities+on+hedgehog+pathway&doi=10.1016%2Fj.bmcl.2016.08.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Three new alkaloids from Veratrum grandiflorum Loes with inhibition activities on Hedgehog pathway</span></div><div class="casAuthors">Gao, Lijuan; Chen, Fengyang; Li, Xiaoyu; Xu, Shifang; Huang, Wenhai; Ye, Yiping</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4735-4738</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three new steroidal alkaloids 1-3, together with four known compds. 4-7, were isolated from the ethanol ext. of Veratrum grandiflorum Loes.  Their structures were elucidated by NMR (1D and 2D NMR) and MS spectroscopic data.  The inhibition activities on Hedgehog (Hh) pathway were evaluated using a cell-based bioassay system (Shh-LIGHT 2 cells).  The results showed that compds. 1-3 and 5 displayed inhibitory activities obviously with the IC50 values of 0.63-3.11 μM.  Among them, compd. 5 showed the most prominent inhibition activity (IC50 = 0.63 ± 0.02 μM).  Thus, these active alkaloids may be potent natural compds. as Hh pathway inhibitors for the treatment of various cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGputceyD7hQELVg90H21EOLACvtfcHk0lhkLVc3sN5BBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVaksbfO&md5=ba913c39e62a7c88da88c32f3e12969d</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DY.%26atitle%3DThree%2520new%2520alkaloids%2520from%2520veratrum%2520grandiflorum%2520loes%2520with%2520inhibition%2520activities%2520on%2520hedgehog%2520pathway%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4735%26epage%3D4738%26doi%3D10.1016%2Fj.bmcl.2016.08.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span> <span> </span><span class="NLM_article-title">Steroidal aglycones from stems of Marsdenia tenacissima that inhibited the hedgehog signaling pathway</span>. <i>Nat. Prod. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1177/1934578X1400900204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1177%2F1934578X1400900204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24689277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1arsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=155-156&author=L.+Zhangauthor=F.+Y.+Chenauthor=S.+F.+Xuauthor=Y.+P.+Yeauthor=X.+Y.+Li&title=Steroidal+aglycones+from+stems+of+Marsdenia+tenacissima+that+inhibited+the+hedgehog+signaling+pathway&doi=10.1177%2F1934578X1400900204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Steroidal aglycones from stems of Marsdenia tenacissima that inhibited the hedgehog signaling pathway</span></div><div class="casAuthors">Zhang, Lin; Chen, Feng-yang; Xu, Shi-fang; Ye, Yi-ping; Li, Xiao-yu</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-156</span>CODEN:
                <span class="NLM_cas:coden">NPCACO</span>;
        ISSN:<span class="NLM_cas:issn">1934-578X</span>.
    
            (<span class="NLM_cas:orgname">Natural Product Inc.</span>)
        </div><div class="casAbstract">Two novel steroidal aglycons, together with four known ones, were isolated from the hydrolysis ext. of the CHCl3 sol. ext. of the stems of Marsdenia tenacissima.  Their structures were detd. on the basis of chem. evidence and extensive spectroscopic methods, including 1D and 2D NMR spectroscopy.  These compds. displayed inhibition of the Hedgehog signaling pathway in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppt5G82BLxIrVg90H21EOLACvtfcHk0ljrZ7iMOwrA8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1arsr0%253D&md5=8c7cf085055ce5e133d0368037928c3b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1177%2F1934578X1400900204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1934578X1400900204%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DF.%2BY.%26aulast%3DXu%26aufirst%3DS.%2BF.%26aulast%3DYe%26aufirst%3DY.%2BP.%26aulast%3DLi%26aufirst%3DX.%2BY.%26atitle%3DSteroidal%2520aglycones%2520from%2520stems%2520of%2520Marsdenia%2520tenacissima%2520that%2520inhibited%2520the%2520hedgehog%2520signaling%2520pathway%26jtitle%3DNat.%2520Prod.%2520Commun.%26date%3D2014%26volume%3D9%26spage%3D155%26epage%3D156%26doi%3D10.1177%2F1934578X1400900204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Y.</span></span> <span> </span><span class="NLM_article-title">The loss of a sugar chain at c(3) position enhances stemucronatoside k-induced apoptosis, cell cycle arrest, and hedgehog pathway inhibition in ht-29 cells</span>. <i>Chem. Biodiversity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1484</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1002/cbdv.201600054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fcbdv.201600054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27449706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1eisr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=1484-1492&author=X.+Zhouauthor=L.+F.+Zhouauthor=B.+Yangauthor=H.+J.+Zhaoauthor=Y.+Q.+Wangauthor=X.+Y.+Liauthor=Y.+P.+Yeauthor=F.+Y.+Chen&title=The+loss+of+a+sugar+chain+at+c%283%29+position+enhances+stemucronatoside+k-induced+apoptosis%2C+cell+cycle+arrest%2C+and+hedgehog+pathway+inhibition+in+ht-29+cells&doi=10.1002%2Fcbdv.201600054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">The loss of a sugar chain at C(3) position enhances stemucronatoside K-induced apoptosis, cell cycle arrest, and Hedgehog pathway inhibition in HT-29 cells</span></div><div class="casAuthors">Zhou, Xia; Zhou, Li-Fei; Yang, Bo; Zhao, Hua-Jun; Wang, Yi-Qi; Li, Xiao-Yu; Ye, Yi-Ping; Chen, Feng-Yang</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1484-1492</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Stemucronatoside K (SMK) and its aglycon stephanthraniline A (STA) are the most representative of a series of novel C21 steriodal compds. that we have previously isolated from Asclepiadaceae plants.  The objectives of this study were to investigate the antitumor activity of SMK and STA, and clarify the effect of the sugar chain at the C(3) position.  Our results showed that both SMK and STA decreased the growth of HT-29 cells in a dose- and time-dependent manner.  Meanwhile, STA showed much stronger inhibitory effect than SMK.  Treatment of HT-29 cells with STA increased the apoptotic cell nos. and the protein expression of cleaved caspase 3 and cleaved-PARP.  G1 phase cell cycle arrest and decreased expression of cyclin D1 and cyclin-dependent kinases 4 were also obsd. after STA treatment.  Furthermore, STA reduced the mRNA levels of four Hedgehog pathway components (GLI1, GLI2, GLI3, and PTCH1) and suppressed Shh-induced Hedgehog pathway activation in a concn.-dependent manner.  These results indicated that SMK and STA could inhibit the growth of HT-29 cells by inducing apoptosis, cell cycle arrest, and hedgehog pathway inhibition.  The loss of sugar chain at C(3) position could enhance SMK's activity.  This study is beneficial to understand the use of natural C21 steroids as antitumor lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2a7zKGqCPrVg90H21EOLACvtfcHk0lh8N_P60-w-ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1eisr3L&md5=30e02977af1966fb22574fdddb247eb3</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201600054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201600054%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DL.%2BF.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DH.%2BJ.%26aulast%3DWang%26aufirst%3DY.%2BQ.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DYe%26aufirst%3DY.%2BP.%26aulast%3DChen%26aufirst%3DF.%2BY.%26atitle%3DThe%2520loss%2520of%2520a%2520sugar%2520chain%2520at%2520c%25283%2529%2520position%2520enhances%2520stemucronatoside%2520k-induced%2520apoptosis%252C%2520cell%2520cycle%2520arrest%252C%2520and%2520hedgehog%2520pathway%2520inhibition%2520in%2520ht-29%2520cells%26jtitle%3DChem.%2520Biodiversity%26date%3D2016%26volume%3D13%26spage%3D1484%26epage%3D1492%26doi%3D10.1002%2Fcbdv.201600054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrosanti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinkuhler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitagliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinin, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulino, A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase and cullin3-ren(kctd11) ubiquitin ligase interplay regulates hedgehog signalling through gli acetylation</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1038/ncb2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncb2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20081843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=132-142&author=G.+Canettieriauthor=L.+Di+Marcotullioauthor=A.+Grecoauthor=S.+Coniauthor=L.+Antonucciauthor=P.+Infanteauthor=L.+Pietrosantiauthor=E.+De+Smaeleauthor=E.+Ferrettiauthor=E.+Mieleauthor=M.+Pelloniauthor=G.+De+Simoneauthor=E.+M.+Pedoneauthor=P.+Gallinariauthor=A.+Giorgiauthor=C.+Steinkuhlerauthor=L.+Vitaglianoauthor=C.+Pedoneauthor=M.+E.+Schininauthor=I.+Screpantiauthor=A.+Gulino&title=Histone+deacetylase+and+cullin3-ren%28kctd11%29+ubiquitin+ligase+interplay+regulates+hedgehog+signalling+through+gli+acetylation&doi=10.1038%2Fncb2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation</span></div><div class="casAuthors">Canettieri, Gianluca; Di Marcotullio, Lucia; Greco, Azzura; Coni, Sonia; Antonucci, Laura; Infante, Paola; Pietrosanti, Laura; De Smaele, Enrico; Ferretti, Elisabetta; Miele, Evelina; Pelloni, Marianna; De Simone, Giuseppina; Pedone, Emilia Maria; Gallinari, Paola; Giorgi, Alessandra; Steinkuehler, Christian; Vitagliano, Luigi; Pedone, Carlo; Schinin, M. Eugenia; Screpanti, Isabella; Gulino, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog signalling is crucial for development and is deregulated in several tumors, including medulloblastoma.  Regulation of the transcriptional activity of Gli (glioma-assocd. oncogene) proteins, effectors of the Hedgehog pathway, is poorly understood.  We show here that Gli1 and Gli2 are acetylated proteins and that their HDAC-mediated deacetylation promotes transcriptional activation and sustains a pos. autoregulatory loop through Hedgehog-induced upregulation of HDAC1.  This mechanism is turned off by HDAC1 degrdn. through an E3 ubiquitin ligase complex formed by Cullin3 and REN, a Gli antagonist lost in human medulloblastoma.  Whereas high HDAC1 and low REN expression in neural progenitors and medulloblastomas correlates with active Hedgehog signalling, loss of HDAC activity suppresses Hedgehog-dependent growth of neural progenitors and tumor cells.  Consistent with this, abrogation of Gli1 acetylation enhances cellular proliferation and transformation.  These data identify an integrated HDAC- and ubiquitin-mediated circuitry, where acetylation of Gli proteins functions as an unexpected key transcriptional checkpoint of Hedgehog signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxrrIzZx1MebVg90H21EOLACvtfcHk0lh8N_P60-w-ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqtbw%253D&md5=03f90e14b156c34af5e19858d8463623</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2Fncb2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2013%26sid%3Dliteratum%253Aachs%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DGreco%26aufirst%3DA.%26aulast%3DConi%26aufirst%3DS.%26aulast%3DAntonucci%26aufirst%3DL.%26aulast%3DInfante%26aufirst%3DP.%26aulast%3DPietrosanti%26aufirst%3DL.%26aulast%3DDe%2BSmaele%26aufirst%3DE.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DMiele%26aufirst%3DE.%26aulast%3DPelloni%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DPedone%26aufirst%3DE.%2BM.%26aulast%3DGallinari%26aufirst%3DP.%26aulast%3DGiorgi%26aufirst%3DA.%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DVitagliano%26aufirst%3DL.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DSchinin%26aufirst%3DM.%2BE.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DGulino%26aufirst%3DA.%26atitle%3DHistone%2520deacetylase%2520and%2520cullin3-ren%2528kctd11%2529%2520ubiquitin%2520ligase%2520interplay%2520regulates%2520hedgehog%2520signalling%2520through%2520gli%2520acetylation%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D132%26epage%3D142%26doi%3D10.1038%2Fncb2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhans, S. A.</span></span> <span> </span><span class="NLM_article-title">Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e71455</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0071455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1371%2Fjournal.pone.0071455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23951168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlams7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e71455&author=S.+J.+Leeauthor=S.+Lindseyauthor=B.+Gravesauthor=S.+Yooauthor=J.+M.+Olsonauthor=S.+A.+Langhans&title=Sonic+hedgehog-induced+histone+deacetylase+activation+is+required+for+cerebellar+granule+precursor+hyperplasia+in+medulloblastoma&doi=10.1371%2Fjournal.pone.0071455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Sonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma</span></div><div class="casAuthors">Lee, Seung Joon; Lindsey, Stephan; Graves, Bruce; Yoo, Soonmoon; Olson, James M.; Langhans, Sigrid A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e71455</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Medulloblastoma, the most common pediatric brain tumor, is thought to arise from deregulated proliferation of cerebellar granule precursor (CGP) cells.  Sonic hedgehog (Shh) is the primary mitogen that regulates proliferation of CGP cells during the early stages of postnatal cerebellum development.  Aberrant activation of Shh signaling during this time has been assocd. with hyperplasia of CGP cells and eventually may lead to the development of medulloblastoma.  The mol. targets of Shh signaling involved in medulloblastoma formation are still not well-understood.  Here, we show that Shh regulates sustained activation of histone deacetylases (HDACs) and that this activity is required for continued proliferation of CGP cells.  Suppression of HDAC activity not only blocked the Shh-induced CGP proliferation in primary cell cultures, but also ameliorated aberrant CGP proliferation at the external germinal layer (EGL) in a medulloblastoma mouse model.  Increased levels of mRNA and protein of several HDAC family members were found in medulloblastoma compared to wild type cerebellum suggesting that HDAC activity is required for the survival/progression of tumor cells.  The identification of a role of HDACs in the early steps of medulloblastoma formation suggests there may be a therapeutic potential for HDAC inhibitors in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6reSdRZ2TsrVg90H21EOLACvtfcHk0lh8N_P60-w-ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlams7rE&md5=8ad5c8bc973ffba643a0c98e0da19171</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0071455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0071455%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DLindsey%26aufirst%3DS.%26aulast%3DGraves%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DS.%26aulast%3DOlson%26aufirst%3DJ.%2BM.%26aulast%3DLanghans%26aufirst%3DS.%2BA.%26atitle%3DSonic%2520hedgehog-induced%2520histone%2520deacetylase%2520activation%2520is%2520required%2520for%2520cerebellar%2520granule%2520precursor%2520hyperplasia%2520in%2520medulloblastoma%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De71455%26doi%3D10.1371%2Fjournal.pone.0071455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mirza, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKellar, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urman, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollmig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aasi, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span> <span> </span><span class="NLM_article-title">Lap2 proteins chaperone gli1 movement between the lamina and chromatin to regulate transcription</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.cell.2018.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=30503211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlOktb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=198-212&author=A.+N.+Mirzaauthor=S.+A.+McKellarauthor=N.+M.+Urmanauthor=A.+S.+Brownauthor=T.+Hollmigauthor=S.+Z.+Aasiauthor=A.+E.+Oro&title=Lap2+proteins+chaperone+gli1+movement+between+the+lamina+and+chromatin+to+regulate+transcription&doi=10.1016%2Fj.cell.2018.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">LAP2 Proteins Chaperone GLI1 Movement between the Lamina and Chromatin to Regulate Transcription</span></div><div class="casAuthors">Mirza, Amar N.; McKellar, Siegen A.; Urman, Nicole M.; Brown, Alexander S.; Hollmig, Tyler; Aasi, Sumaira Z.; Oro, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">198-212.e15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Understanding transcription factor navigation through the nucleus remains crit. for developing targeted therapeutics.  The GLI1 transcription factor must maintain maximal Hedgehog pathway output in basal cell carcinomas (BCCs), and we have previously shown that resistant BCCs increase GLI1 deacetylation through atypical protein kinase Cι/λ (aPKC) and HDAC1.  Here we identify a lamina-assocd. polypeptide 2 (LAP2) isoform-dependent nuclear chaperoning system that regulates GLI1 movement between the nuclear lamina and nucleoplasm to achieve maximal activation.  LAP2β forms a two-site interaction with the GLI1 zinc-finger domain and acetylation site, stabilizing an acetylation-dependent reserve on the inner nuclear membrane (INM).  By contrast, the nucleoplasmic LAP2α competes with LAP2β for GLI1 while scaffolding HDAC1 to deacetylate the secondary binding site. aPKC functions to promote GLI1 assocn. with LAP2α, promoting egress off the INM.  GLI1 intranuclear trafficking by LAP2 isoforms represents a powerful signal amplifier in BCCs with implications for zinc finger-based signal transduction and therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6fzq2atvYurVg90H21EOLACvtfcHk0lhX9eJGYVrmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlOktb3K&md5=a281eb2bc4cb7a2cc3d41e5eee1b0a63</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DMirza%26aufirst%3DA.%2BN.%26aulast%3DMcKellar%26aufirst%3DS.%2BA.%26aulast%3DUrman%26aufirst%3DN.%2BM.%26aulast%3DBrown%26aufirst%3DA.%2BS.%26aulast%3DHollmig%26aufirst%3DT.%26aulast%3DAasi%26aufirst%3DS.%2BZ.%26aulast%3DOro%26aufirst%3DA.%2BE.%26atitle%3DLap2%2520proteins%2520chaperone%2520gli1%2520movement%2520between%2520the%2520lamina%2520and%2520chromatin%2520to%2520regulate%2520transcription%26jtitle%3DCell%26date%3D2019%26volume%3D176%26spage%3D198%26epage%3D212%26doi%3D10.1016%2Fj.cell.2018.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmer, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Burgo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neureiter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberger, F.</span></span> <span> </span><span class="NLM_article-title">Targeting class i histone deacetylases by the novel small molecule inhibitor 4sc-202 blocks oncogenic hedgehog-gli signaling and overcomes smoothened inhibitor resistance</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1002/ijc.31117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1002%2Fijc.31117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=29055107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2018&pages=968-975&author=W.+Gruberauthor=E.+Peerauthor=D.+P.+Elmerauthor=C.+Sternbergauthor=S.+Tesanovicauthor=P.+Del+Burgoauthor=S.+Coniauthor=G.+Canettieriauthor=D.+Neureiterauthor=R.+Bartzauthor=H.+Kohlhofauthor=D.+Vittauthor=F.+Aberger&title=Targeting+class+i+histone+deacetylases+by+the+novel+small+molecule+inhibitor+4sc-202+blocks+oncogenic+hedgehog-gli+signaling+and+overcomes+smoothened+inhibitor+resistance&doi=10.1002%2Fijc.31117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance</span></div><div class="casAuthors">Gruber, Wolfgang; Peer, Elisabeth; Elmer, Dominik P.; Sternberg, Christina; Tesanovic, Suzana; del Burgo, Pedro; Coni, Sonia; Canettieri, Gianluca; Neureiter, Daniel; Bartz, Rene; Kohlhof, Hella; Vitt, Daniel; Aberger, Fritz</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">968-975</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Aberrant activation of Hedgehog (HH)/GLI signaling is causally involved in numerous human malignancies, including basal cell carcinoma (BCC) and medulloblastoma.  HH pathway antagonists targeting smoothened (SMO), an essential effector of canonical HH/GLI signaling, show significant clin. success in BCC patients and have recently been approved for the treatment of advanced and metastatic BCC.  However, rapid and frequent development of drug resistance to SMO inhibitors (SMOi) together with severe side effects caused by prolonged SMOi treatment call for alternative treatment strategies targeting HH/GLI signaling downstream of SMO.  In this study, we report that 4SC-202, a novel clin. validated inhibitor of class I histone deacetylases (HDACs), efficiently blocks HH/GLI signaling.  Notably, 4SC-202 treatment abrogates GLI activation and HH target gene expression in both SMOi-sensitive and -resistant cells.  Mechanistically, we propose that the inhibition of HDACs 1/2/3 is crucial for targeting oncogenic HH/GLI signaling, and that class I HDAC inhibitors either in combination with SMOi or as second-line therapy may improve the treatment options for HH-assocd. malignancies with SMOi resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCfqA0SMfaXLVg90H21EOLACvtfcHk0lhX9eJGYVrmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslGqs7jI&md5=9783d863f1c0991e0f0d8c03c6eb064a</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1002%2Fijc.31117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.31117%26sid%3Dliteratum%253Aachs%26aulast%3DGruber%26aufirst%3DW.%26aulast%3DPeer%26aufirst%3DE.%26aulast%3DElmer%26aufirst%3DD.%2BP.%26aulast%3DSternberg%26aufirst%3DC.%26aulast%3DTesanovic%26aufirst%3DS.%26aulast%3DDel%2BBurgo%26aufirst%3DP.%26aulast%3DConi%26aufirst%3DS.%26aulast%3DCanettieri%26aufirst%3DG.%26aulast%3DNeureiter%26aufirst%3DD.%26aulast%3DBartz%26aufirst%3DR.%26aulast%3DKohlhof%26aufirst%3DH.%26aulast%3DVitt%26aufirst%3DD.%26aulast%3DAberger%26aufirst%3DF.%26atitle%3DTargeting%2520class%2520i%2520histone%2520deacetylases%2520by%2520the%2520novel%2520small%2520molecule%2520inhibitor%25204sc-202%2520blocks%2520oncogenic%2520hedgehog-gli%2520signaling%2520and%2520overcomes%2520smoothened%2520inhibitor%2520resistance%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2018%26volume%3D142%26spage%3D968%26epage%3D975%26doi%3D10.1002%2Fijc.31117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Magno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sdruscia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiombi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bufalieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusio-Kobialka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smaele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferretti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capalbo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niewiadomski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Screpanti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marcotullio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canettieri, G.</span></span> <span> </span><span class="NLM_article-title">Selective targeting of hdac1/2 elicits anticancer effects through gli1 acetylation in preclinical models of shh medulloblastoma</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">44079</span>, <span class="refDoi"> DOI: 10.1038/srep44079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fsrep44079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28276480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC1czksFShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=44079&author=S.+Coniauthor=A.+B.+Mancusoauthor=L.+Di+Magnoauthor=G.+Sdrusciaauthor=S.+Manniauthor=S.+M.+Serraoauthor=D.+Rotiliauthor=E.+Spiombiauthor=F.+Bufalieriauthor=M.+Petroniauthor=M.+Kusio-Kobialkaauthor=E.+De+Smaeleauthor=E.+Ferrettiauthor=C.+Capalboauthor=A.+Maiauthor=P.+Niewiadomskiauthor=I.+Screpantiauthor=L.+Di+Marcotullioauthor=G.+Canettieri&title=Selective+targeting+of+hdac1%2F2+elicits+anticancer+effects+through+gli1+acetylation+in+preclinical+models+of+shh+medulloblastoma&doi=10.1038%2Fsrep44079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma</span></div><div class="casAuthors">Coni Sonia; Mancuso Anna Barbara; Manni Simona; Serrao Silvia Maria; Spiombi Eleonora; Capalbo Carlo; Screpanti Isabella; Di Marcotullio Lucia; Canettieri Gianluca; Di Magno Laura; Sdruscia Giulia; Bufalieri Francesca; Petroni Marialaura; Rotili Dante; Mai Antonello; Kusio-Kobialka Monika; Niewiadomski Pawel; De Smaele Enrico; Ferretti Elisabetta; Ferretti Elisabetta; Mai Antonello; Di Marcotullio Lucia; Canettieri Gianluca</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44079</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SHH Medulloblastoma (SHH-MB) is a pediatric brain tumor characterized by an inappropriate activation of the developmental Hedgehog (Hh) signaling.  SHH-MB patients treated with the FDA-approved vismodegib, an Hh inhibitor that targets the transmembrane activator Smoothened (Smo), have shown the rapid development of drug resistance and tumor relapse due to novel Smo mutations.  Moreover, a subset of patients did not respond to vismodegib because mutations were localized downstream of Smo.  Thus, targeting downstream Hh components is now considered a preferable approach.  We show here that selective inhibition of the downstream Hh effectors HDAC1 and HDAC2 robustly counteracts SHH-MB growth in mouse models.  These two deacetylases are upregulated in tumor and their knockdown inhibits Hh signaling and decreases tumor growth.  We demonstrate that mocetinostat (MGCD0103), a selective HDAC1/HDAC2 inhibitor, is a potent Hh inhibitor and that its effect is linked to Gli1 acetylation at K518.  Of note, we demonstrate that administration of mocetinostat to mouse models of SHH-MB drastically reduces tumor growth, by reducing proliferation and increasing apoptosis of tumor cells and prolongs mouse survival rate.  Collectively, these data demonstrate the preclinical efficacy of targeting the downstream HDAC1/2-Gli1 acetylation in the treatment of SHH-MB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRzPPj8gFbG6FWTCLT8lX9SfW6udTcc2ebSGfMZP-yA2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czksFShuw%253D%253D&md5=094368d17cf31727cb69622ee498830b</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fsrep44079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep44079%26sid%3Dliteratum%253Aachs%26aulast%3DConi%26aufirst%3DS.%26aulast%3DMancuso%26aufirst%3DA.%2BB.%26aulast%3DDi%2BMagno%26aufirst%3DL.%26aulast%3DSdruscia%26aufirst%3DG.%26aulast%3DManni%26aufirst%3DS.%26aulast%3DSerrao%26aufirst%3DS.%2BM.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DSpiombi%26aufirst%3DE.%26aulast%3DBufalieri%26aufirst%3DF.%26aulast%3DPetroni%26aufirst%3DM.%26aulast%3DKusio-Kobialka%26aufirst%3DM.%26aulast%3DDe%2BSmaele%26aufirst%3DE.%26aulast%3DFerretti%26aufirst%3DE.%26aulast%3DCapalbo%26aufirst%3DC.%26aulast%3DMai%26aufirst%3DA.%26aulast%3DNiewiadomski%26aufirst%3DP.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DDi%2BMarcotullio%26aufirst%3DL.%26aulast%3DCanettieri%26aufirst%3DG.%26atitle%3DSelective%2520targeting%2520of%2520hdac1%252F2%2520elicits%2520anticancer%2520effects%2520through%2520gli1%2520acetylation%2520in%2520preclinical%2520models%2520of%2520shh%2520medulloblastoma%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D44079%26doi%3D10.1038%2Fsrep44079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gholamin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandopadhayay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergthold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masoud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balansay, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnuswami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monje, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwood, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheshier, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beroukhim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wechsler-Reya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oro, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. J.</span></span> <span> </span><span class="NLM_article-title">Epigenetic targeting of hedgehog pathway transcriptional output through bet bromodomain inhibition</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">740</span>, <span class="refDoi"> DOI: 10.1038/nm.3613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnm.3613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24973920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKlsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=732-740&author=Y.+Tangauthor=S.+Gholaminauthor=S.+Schubertauthor=M.+I.+Willardsonauthor=A.+Leeauthor=P.+Bandopadhayayauthor=G.+Bergtholdauthor=S.+Masoudauthor=B.+Nguyenauthor=N.+Vueauthor=B.+Balansayauthor=F.+Yuauthor=S.+Ohauthor=P.+Wooauthor=S.+Chenauthor=A.+Ponnuswamiauthor=M.+Monjeauthor=S.+X.+Atwoodauthor=R.+J.+Whitsonauthor=S.+Mitraauthor=S.+H.+Cheshierauthor=J.+Qiauthor=R.+Beroukhimauthor=J.+Y.+Tangauthor=R.+Wechsler-Reyaauthor=A.+E.+Oroauthor=B.+A.+Linkauthor=J.+E.+Bradnerauthor=Y.+J.+Cho&title=Epigenetic+targeting+of+hedgehog+pathway+transcriptional+output+through+bet+bromodomain+inhibition&doi=10.1038%2Fnm.3613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition</span></div><div class="casAuthors">Tang, Yujie; Gholamin, Sharareh; Schubert, Simone; Willardson, Minde I.; Lee, Alex; Bandopadhayay, Pratiti; Bergthold, Guillame; Masoud, Sabran; Nguyen, Brian; Vue, Nujsaubnusi; Balansay, Brianna; Yu, Furong; Oh, Sekyung; Woo, Pamelyn; Chen, Spenser; Ponnuswami, Anitha; Monje, Michelle; Atwood, Scott X.; Whitson, Ramon J.; Mitra, Siddhartha; Cheshier, Samuel H.; Qi, Jun; Beroukhim, Rameen; Tang, Jean Y.; Wechsler-Reya, Rob; Oro, Anthony E.; Link, Brian A.; Bradner, James E.; Cho, Yoon-Jae</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">732-740</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog signaling drives oncogenesis in several cancers, and strategies targeting this pathway have been developed, most notably through inhibition of Smoothened (SMO).  However, resistance to Smoothened inhibitors occurs by genetic changes of Smoothened or other downstream Hedgehog components.  Here we overcome these resistance mechanisms by modulating GLI transcription through inhibition of bromo and extra C-terminal (BET) bromodomain proteins.  We show that BRD4 and other BET bromodomain proteins regulate GLI transcription downstream of SMO and suppressor of fused (SUFU), and chromatin immunopptn. studies reveal that BRD4 directly occupies GLI1 and GLI2 promoters, with a substantial decrease in engagement of these sites after treatment with JQ1, a small-mol. inhibitor targeting BRD4.  Globally, genes assocd. with medulloblastoma-specific GLI1 binding sites are downregulated in response to JQ1 treatment, supporting direct regulation of GLI activity by BRD4.  Notably, patient- and GEMM (genetically engineered mouse model)-derived Hedgehog-driven tumors (basal cell carcinoma, medulloblastoma and atypical teratoid rhabdoid tumor) respond to JQ1 even when harboring genetic lesions rendering them resistant to Smoothened antagonists.  Altogether, our results reveal BET proteins as crit. regulators of Hedgehog pathway transcriptional output and nominate BET bromodomain inhibitors as a strategy for treating Hedgehog-driven tumors with emerged or a priori resistance to Smoothened antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7oydLPh9X7Vg90H21EOLACvtfcHk0lgk8xGdhjalnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKlsrfJ&md5=2d976901600f4a1bba99cea25f099f28</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fnm.3613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3613%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DGholamin%26aufirst%3DS.%26aulast%3DSchubert%26aufirst%3DS.%26aulast%3DWillardson%26aufirst%3DM.%2BI.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DBandopadhayay%26aufirst%3DP.%26aulast%3DBergthold%26aufirst%3DG.%26aulast%3DMasoud%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DVue%26aufirst%3DN.%26aulast%3DBalansay%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DWoo%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DPonnuswami%26aufirst%3DA.%26aulast%3DMonje%26aufirst%3DM.%26aulast%3DAtwood%26aufirst%3DS.%2BX.%26aulast%3DWhitson%26aufirst%3DR.%2BJ.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DCheshier%26aufirst%3DS.%2BH.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DWechsler-Reya%26aufirst%3DR.%26aulast%3DOro%26aufirst%3DA.%2BE.%26aulast%3DLink%26aufirst%3DB.%2BA.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DCho%26aufirst%3DY.%2BJ.%26atitle%3DEpigenetic%2520targeting%2520of%2520hedgehog%2520pathway%2520transcriptional%2520output%2520through%2520bet%2520bromodomain%2520inhibition%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26spage%3D732%26epage%3D740%26doi%3D10.1038%2Fnm.3613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijichi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokudo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, K.</span></span> <span> </span><span class="NLM_article-title">Stromal remodeling by the bet bromodomain inhibitor jq1 suppresses the progression of human pancreatic cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">61469</span>– <span class="NLM_lpage">61484</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.11129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.18632%2Foncotarget.11129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27528027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC2szgvFyrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=61469-61484&author=K.+Yamamotoauthor=K.+Tateishiauthor=Y.+Kudoauthor=M.+Hoshikawaauthor=M.+Tanakaauthor=T.+Nakatsukaauthor=H.+Fujiwaraauthor=K.+Miyabayashiauthor=R.+Takahashiauthor=Y.+Tanakaauthor=H.+Ijichiauthor=Y.+Nakaiauthor=H.+Isayamaauthor=Y.+Morishitaauthor=T.+Aokiauthor=Y.+Sakamotoauthor=K.+Hasegawaauthor=N.+Kokudoauthor=M.+Fukayamaauthor=K.+Koike&title=Stromal+remodeling+by+the+bet+bromodomain+inhibitor+jq1+suppresses+the+progression+of+human+pancreatic+cancer&doi=10.18632%2Foncotarget.11129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer</span></div><div class="casAuthors">Yamamoto Keisuke; Tateishi Keisuke; Kudo Yotaro; Nakatsuka Takuma; Fujiwara Hiroaki; Miyabayashi Koji; Takahashi Ryota; Tanaka Yasuo; Ijichi Hideaki; Nakai Yousuke; Isayama Hiroyuki; Koike Kazuhiko; Hoshikawa Mayumi; Aoki Taku; Sakamoto Yoshihiro; Hasegawa Kiyoshi; Kokudo Norihiro; Tanaka Mariko; Morishita Yasuyuki; Fukayama Masashi; Morishita Yasuyuki; Aoki Taku</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">61469-61484</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibitors of bromodomain and extraterminal domain (BET) proteins, a family of chromatin reader proteins, have therapeutic efficacy against various malignancies.  However, the detailed mechanisms underlying the anti-tumor effects in distinct tumor types remain elusive.  Here, we show a novel antitumor mechanism of BET inhibition in pancreatic ductal adenocarcinoma (PDAC).  We found that JQ1, a BET inhibitor, decreased desmoplastic stroma, a hallmark of PDAC, and suppressed the growth of patient-derived tumor xenografts (PDX) of PDACs.  In vivo antitumor effects of JQ1 were not always associated with the JQ1 sensitivity of respective PDAC cells, and were rather dependent on the suppression of tumor-promoting activity in cancer-associated fibroblasts (CAFs).  JQ1 inhibited Hedgehog and TGF-β pathways as potent regulators of CAF activation and suppressed the expression of α-SMA, extracellular matrix, cytokines, and growth factors in human primary CAFs.  Consistently, conditioned media (CM) from CAFs promoted the proliferation of PDAC cells along with the activation of ERK, AKT, and STAT3 pathways, though these effects were suppressed when CM from JQ1-treated CAFs was used.  Mechanistically, chromatin immunoprecipitation experiments revealed that JQ1 reduced TGF-β-dependent gene expression by disrupting the recruitment of the transcriptional machinery containing BET proteins.  Finally, combination therapy with gemcitabine plus JQ1 showed greater efficacy than gemcitabine monotherapy against PDAC in vivo.  Thus, our results reveal BET proteins as the critical regulators of CAF-activation and also provide evidence that stromal remodeling by epigenetic modulators can be a novel therapeutic option for PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRROnImGd4gmQvupmecNw_lfW6udTcc2eYnX47_lQdzvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szgvFyrtA%253D%253D&md5=bcee0a19bc8383b79d6797ce2fc8007a</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.11129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.11129%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DTateishi%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DHoshikawa%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNakatsuka%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DMiyabayashi%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DIjichi%26aufirst%3DH.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DIsayama%26aufirst%3DH.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKokudo%26aufirst%3DN.%26aulast%3DFukayama%26aufirst%3DM.%26aulast%3DKoike%26aufirst%3DK.%26atitle%3DStromal%2520remodeling%2520by%2520the%2520bet%2520bromodomain%2520inhibitor%2520jq1%2520suppresses%2520the%2520progression%2520of%2520human%2520pancreatic%2520cancer%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D61469%26epage%3D61484%26doi%3D10.18632%2Foncotarget.11129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varghese, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena-Llopis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babinski, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, E. D.</span></span> <span> </span><span class="NLM_article-title">A small molecule modulates jumonji histone demethylase activity and selectively inhibits cancer growth</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2035</span>, <span class="refDoi"> DOI: 10.1038/ncomms3035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fncomms3035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23792809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A280%3ADC%252BC3sjksV2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2035&author=L.+Wangauthor=J.+Changauthor=D.+Vargheseauthor=M.+Dellingerauthor=S.+Kumarauthor=A.+M.+Bestauthor=J.+Ruizauthor=R.+Bruickauthor=S.+Pena-Llopisauthor=J.+Xuauthor=D.+J.+Babinskiauthor=D.+E.+Frantzauthor=R.+A.+Brekkenauthor=A.+M.+Quinnauthor=A.+Simeonovauthor=J.+Easmonauthor=E.+D.+Martinez&title=A+small+molecule+modulates+jumonji+histone+demethylase+activity+and+selectively+inhibits+cancer+growth&doi=10.1038%2Fncomms3035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth</span></div><div class="casAuthors">Wang Lei; Chang Jianjun; Varghese Diana; Dellinger Michael; Kumar Subodh; Best Anne M; Ruiz Julio; Bruick Richard; Pena-Llopis Samuel; Xu Junjie; Babinski David J; Frantz Doug E; Brekken Rolf A; Quinn Amy M; Simeonov Anton; Easmon Johnny; Martinez Elisabeth D</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2035</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmacological inhibition of general transcriptional regulators has the potential to block growth through targeting multiple tumorigenic signalling pathways simultaneously.  Here, using an innovative cell-based screen, we identify a structurally unique small molecule (named JIB-04) that specifically inhibits the activity of the Jumonji family of histone demethylases in vitro, in cancer cells, and in tumours in vivo.  Unlike known inhibitors, JIB-04 is not a competitive inhibitor of α-ketoglutarate.  In cancer, but not in patient-matched normal cells, JIB-04 alters a subset of transcriptional pathways and blocks viability.  In mice, JIB-04 reduces tumour burden and prolongs survival.  Importantly, we find that patients with breast tumours that overexpress Jumonji demethylases have significantly lower survival.  Thus, JIB-04, a novel inhibitor of Jumonji demethylases in vitro and in vivo, constitutes a unique potential therapeutic and research tool against cancer, and validates the use of unbiased cellular screens to discover chemical modulators with disease relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ5QxHbn8WTZg20zIbnCCI3fW6udTcc2eYbI7jhShtnLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjksV2iug%253D%253D&md5=37aa303d173d027fd711bc4ef7fd841b</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1038%2Fncomms3035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DVarghese%26aufirst%3DD.%26aulast%3DDellinger%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DBest%26aufirst%3DA.%2BM.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBruick%26aufirst%3DR.%26aulast%3DPena-Llopis%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DBabinski%26aufirst%3DD.%2BJ.%26aulast%3DFrantz%26aufirst%3DD.%2BE.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DQuinn%26aufirst%3DA.%2BM.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DEasmon%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DE.%2BD.%26atitle%3DA%2520small%2520molecule%2520modulates%2520jumonji%2520histone%2520demethylase%2520activity%2520and%2520selectively%2520inhibits%2520cancer%2520growth%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2035%26doi%3D10.1038%2Fncomms3035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brockmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deubzer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rycak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thway, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roels, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of aurora-a induce proteasomal degradation of n-myc in childhood neuroblastoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2013.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2013.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23792191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVymurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=75-89&author=M.+Brockmannauthor=E.+Poonauthor=T.+Berryauthor=A.+Carstensenauthor=H.+E.+Deubzerauthor=L.+Rycakauthor=Y.+Jaminauthor=K.+Thwayauthor=S.+P.+Robinsonauthor=F.+Roelsauthor=O.+Wittauthor=M.+Fischerauthor=L.+Cheslerauthor=M.+Eilers&title=Small+molecule+inhibitors+of+aurora-a+induce+proteasomal+degradation+of+n-myc+in+childhood+neuroblastoma&doi=10.1016%2Fj.ccr.2013.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma</span></div><div class="casAuthors">Brockmann, Markus; Poon, Evon; Berry, Teeara; Carstensen, Anne; Deubzer, Hedwig E.; Rycak, Lukas; Jamin, Yann; Thway, Khin; Robinson, Simon P.; Roels, Frederik; Witt, Olaf; Fischer, Matthias; Chesler, Louis; Eilers, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-89</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Amplification of MYCN is a driver mutation in a subset of human neuroendocrine tumors, including neuroblastoma.  No small mols. that target N-Myc, the protein encoded by MYCN, are clin. available.  N-Myc forms a complex with the Aurora-A kinase, which protects N-Myc from proteasomal degrdn.  Although stabilization of N-Myc does not require the catalytic activity of Aurora-A, we show here that 2 Aurora-A inhibitors, MLN8054 and MLN8237, disrupt the Aurora-A/N-Myc complex and promote degrdn. of N-Myc mediated by the Fbxw7 ubiquitin ligase.  Disruption of the Aurora-A/N-Myc complex inhibits N-Myc-dependent transcription, correlating with tumor regression and prolonged survival in a mouse model of MYCN-driven neuroblastoma.  We conclude that Aurora-A is an accessible target that makes destabilization of N-Myc a viable therapeutic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09vD68WUraLVg90H21EOLACvtfcHk0lg0HS2kpoAbQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVymurY%253D&md5=0b53df3d2aaaad8c9a46c07e06227b2c</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2013.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2013.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBrockmann%26aufirst%3DM.%26aulast%3DPoon%26aufirst%3DE.%26aulast%3DBerry%26aufirst%3DT.%26aulast%3DCarstensen%26aufirst%3DA.%26aulast%3DDeubzer%26aufirst%3DH.%2BE.%26aulast%3DRycak%26aufirst%3DL.%26aulast%3DJamin%26aufirst%3DY.%26aulast%3DThway%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DS.%2BP.%26aulast%3DRoels%26aufirst%3DF.%26aulast%3DWitt%26aufirst%3DO.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DChesler%26aufirst%3DL.%26aulast%3DEilers%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520aurora-a%2520induce%2520proteasomal%2520degradation%2520of%2520n-myc%2520in%2520childhood%2520neuroblastoma%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D24%26spage%3D75%26epage%3D89%26doi%3D10.1016%2Fj.ccr.2013.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richards, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carstensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayliss, R.</span></span> <span> </span><span class="NLM_article-title">Structural basis of n-myc binding by aurora-a and its destabilization by kinase inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">13726</span>– <span class="NLM_lpage">13731</span>, <span class="refDoi"> DOI: 10.1073/pnas.1610626113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1610626113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=27837025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCiur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=13726-13731&author=M.+W.+Richardsauthor=S.+G.+Burgessauthor=E.+Poonauthor=A.+Carstensenauthor=M.+Eilersauthor=L.+Cheslerauthor=R.+Bayliss&title=Structural+basis+of+n-myc+binding+by+aurora-a+and+its+destabilization+by+kinase+inhibitors&doi=10.1073%2Fpnas.1610626113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors</span></div><div class="casAuthors">Richards, Mark W.; Burgess, Selena G.; Poon, Evon; Carstensen, Anne; Eilers, Martin; Chesler, Louis; Bayliss, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">13726-13731</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Myc family proteins promote cancer by inducing widespread changes in gene expression.  Their rapid turnover by the ubiquitin-proteasome pathway is regulated through phosphorylation of Myc Box I and ubiquitination by E3 ubiquitin ligase SCFFbxW7.  However, N-Myc protein (the product of the MYCN oncogene) is stabilized in neuroblastoma by the protein kinase Aurora-A in a manner that is sensitive to certain Aurora-A-selective inhibitors.  Here, the authors identified a direct interaction between the catalytic domain of Aurora-A kinase and a site flanking Myc Box I that also binds SCFFbxW7.  The authors detd. the crystal structure of the complex between Aurora-A kinase and this region of N-Myc to 1.72-Å resoln.  The structure indicated that the conformation of Aurora-A induced by compds. such as alisertib and CD532 was not compatible with the binding of N-Myc, explaining the activity of these compds. in neuroblastoma cells and providing a rational basis for the design of cancer therapeutics optimized for destabilization of the complex.  The authors also proposed a model for the stabilization mechanism in which binding to Aurora-A alters how N-Myc interacts with SCFFbxW7 to disfavor the generation of Lys-48-linked polyubiquitin chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAK31pqP6M4bVg90H21EOLACvtfcHk0lg0HS2kpoAbQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCiur7I&md5=0aa2b960303f040d9685fb16fb8ea980</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1610626113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1610626113%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DM.%2BW.%26aulast%3DBurgess%26aufirst%3DS.%2BG.%26aulast%3DPoon%26aufirst%3DE.%26aulast%3DCarstensen%26aufirst%3DA.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DChesler%26aufirst%3DL.%26aulast%3DBayliss%26aufirst%3DR.%26atitle%3DStructural%2520basis%2520of%2520n-myc%2520binding%2520by%2520aurora-a%2520and%2520its%2520destabilization%2520by%2520kinase%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D13726%26epage%3D13731%26doi%3D10.1073%2Fpnas.1610626113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerowitz, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nekritz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonds, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthay, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertz, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, W. A.</span></span> <span> </span><span class="NLM_article-title">Drugging mycn through an allosteric transition in aurora kinase a</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2014.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=25175806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKmsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=414-427&author=W.+C.+Gustafsonauthor=J.+G.+Meyerowitzauthor=E.+A.+Nekritzauthor=J.+Chenauthor=C.+Benesauthor=E.+Charronauthor=E.+F.+Simondsauthor=R.+Seegerauthor=K.+K.+Matthayauthor=N.+T.+Hertzauthor=M.+Eilersauthor=K.+M.+Shokatauthor=W.+A.+Weiss&title=Drugging+mycn+through+an+allosteric+transition+in+aurora+kinase+a&doi=10.1016%2Fj.ccr.2014.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Drugging MYCN through an Allosteric Transition in Aurora Kinase A</span></div><div class="casAuthors">Gustafson, William Clay; Meyerowitz, Justin Gabriel; Nekritz, Erin A.; Chen, Justin; Benes, Cyril; Charron, Elise; Simonds, Erin F.; Seeger, Robert; Matthay, Katherine K.; Hertz, Nicholas T.; Eilers, Martin; Shokat, Kevan M.; Weiss, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-427</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">MYC proteins are major drivers of cancer, yet are considered undruggable because their DNA binding domains are composed of two extended alpha helixes with no apparent surfaces for small-mol. binding.  Proteolytic degrdn. of MYCN protein is regulated in part by a kinase-independent function of Aurora A.  We describe a class of inhibitors that disrupts the native conformation of Aurora A and drives the degrdn. of MYCN protein across MYCN-driven cancers.  Comparison of cocrystal structures with structure-activity relationships across multiple inhibitors and chemotypes, coupled with mechanistic studies and biochem. assays, delineates an Aurora A conformation-specific effect on proteolytic degrdn. of MYCN, rather than simple nanomolar-level inhibition of Aurora A kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8At2LNPE-ubVg90H21EOLACvtfcHk0lie7rhFMWhIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKmsLnJ&md5=20944894851fe5466422c149a0a0b266</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DMeyerowitz%26aufirst%3DJ.%2BG.%26aulast%3DNekritz%26aufirst%3DE.%2BA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DCharron%26aufirst%3DE.%26aulast%3DSimonds%26aufirst%3DE.%2BF.%26aulast%3DSeeger%26aufirst%3DR.%26aulast%3DMatthay%26aufirst%3DK.%2BK.%26aulast%3DHertz%26aufirst%3DN.%2BT.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DDrugging%2520mycn%2520through%2520an%2520allosteric%2520transition%2520in%2520aurora%2520kinase%2520a%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D26%26spage%3D414%26epage%3D427%26doi%3D10.1016%2Fj.ccr.2014.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulut, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajwan, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peaceman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozdemirli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toretsky, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uren, A.</span></span> <span> </span><span class="NLM_article-title">Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking hedgehog/gli pathway</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1172/JCI42874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1172%2FJCI42874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=21183792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1yntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=148-160&author=E.+M.+Beauchampauthor=L.+Ringerauthor=G.+Bulutauthor=K.+P.+Sajwanauthor=M.+D.+Hallauthor=Y.+C.+Leeauthor=D.+Peacemanauthor=M.+Ozdemirliauthor=O.+Rodriguezauthor=T.+J.+Macdonaldauthor=C.+Albaneseauthor=J.+A.+Toretskyauthor=A.+Uren&title=Arsenic+trioxide+inhibits+human+cancer+cell+growth+and+tumor+development+in+mice+by+blocking+hedgehog%2Fgli+pathway&doi=10.1172%2FJCI42874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway</span></div><div class="casAuthors">Beauchamp, Elspeth M.; Ringer, Lymor; Bulut, Gulay; Sajwan, Kamal P.; Hall, Michael D.; Lee, Yi-Chien; Peaceman, Daniel; Ozdemirli, Metin; Rodriguez, Olga; MacDonald, Tobey J.; Albanese, Chris; Toretsky, Jeffrey A.; Uren, Aykut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">148-160</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The Hedgehog (Hh) pathway is activated in some human cancers, including medulloblastoma.  The glioma-assocd. oncogene homolog (GLI) transcription factors are crit. mediators of the activated Hh pathway, and their expression may be elevated in some tumors independent of upstream Hh signaling.  Thus, therapies targeting GLI transcription factors may benefit a wide spectrum of patients with mutations at different nodal points of the Hh pathway.  In this study, we present evidence that arsenic trioxide (ATO) suppresses human cancer cell growth and tumor development in mice by inhibiting GLI1.  Mechanistically, ATO directly bound to GLI1 protein, inhibited its transcriptional activity, and decreased expression of endogenous GLI target genes.  Consistent with this, ATO inhibited the growth of human cancer cell lines that depended on upregulated GLI expression in vitro and in vivo in a xenograft model of Ewing sarcoma.  Furthermore, ATO improved survival of a clin. relevant spontaneous mouse model of medulloblastoma with activated Hh pathway signaling.  Our results establish ATO as a Hh pathway inhibitor acting at the level of GLI1 both in vitro and in vivo.  These results warrant the clin. investigation of ATO for tumors with activated Hh/GLI signaling, in particular patients who develop resistance to current therapies targeting the Hh pathway upstream of GLI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5klZh1rqPQLVg90H21EOLACvtfcHk0lie7rhFMWhIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1yntQ%253D%253D&md5=1c9ec64353bc73b01a0843c8e4a94f95</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1172%2FJCI42874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI42874%26sid%3Dliteratum%253Aachs%26aulast%3DBeauchamp%26aufirst%3DE.%2BM.%26aulast%3DRinger%26aufirst%3DL.%26aulast%3DBulut%26aufirst%3DG.%26aulast%3DSajwan%26aufirst%3DK.%2BP.%26aulast%3DHall%26aufirst%3DM.%2BD.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DPeaceman%26aufirst%3DD.%26aulast%3DOzdemirli%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DO.%26aulast%3DMacdonald%26aufirst%3DT.%2BJ.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DToretsky%26aufirst%3DJ.%2BA.%26aulast%3DUren%26aufirst%3DA.%26atitle%3DArsenic%2520trioxide%2520inhibits%2520human%2520cancer%2520cell%2520growth%2520and%2520tumor%2520development%2520in%2520mice%2520by%2520blocking%2520hedgehog%252Fgli%2520pathway%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D148%26epage%3D160%26doi%3D10.1172%2FJCI42874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span> <span> </span><span class="NLM_article-title">Arsenic antagonizes the hedgehog pathway by preventing ciliary accumulation and reducing stability of the gli2 transcriptional effector</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">13432</span>– <span class="NLM_lpage">13437</span>, <span class="refDoi"> DOI: 10.1073/pnas.1006822107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1073%2Fpnas.1006822107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20624968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1GrurbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=13432-13437&author=J.+Kimauthor=J.+J.+Leeauthor=J.+Kimauthor=D.+Gardnerauthor=P.+A.+Beachy&title=Arsenic+antagonizes+the+hedgehog+pathway+by+preventing+ciliary+accumulation+and+reducing+stability+of+the+gli2+transcriptional+effector&doi=10.1073%2Fpnas.1006822107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector</span></div><div class="casAuthors">Kim, Jynho; Lee, John J.; Kim, James; Gardner, Dale; Beachya, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">13432-13437, S13432/1-S13432/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant Hedgehog (Hh) pathway activation has been implicated in cancers of diverse tissues and organs, and the tumor growth-inhibiting effects of pathway antagonists in animal models have stimulated efforts to develop pathway antagonists for human therapeutic purposes.  These efforts have focused largely on cyclopamine derivs. or other compds. that mimic cyclopamine action in binding to and antagonizing Smoothened, a membrane transductory component.  We report here that arsenicals, in contrast, antagonize the Hh pathway by targeting Gli transcriptional effectors; in the short term, arsenic blocks Hh-induced ciliary accumulation of Gli2, the primary activator of Hh-dependent transcription, and with prolonged incubation arsenic reduces steady-state levels of Gli2.  Arsenicals active in Hh pathway antagonism include arsenic trioxide (ATO), a curative agent in clin. use for acute promyelocytic leukemia (APL); in our studies, ATO inhibited growth of Hh pathway-driven medulloblastoma allografts derived from Ptch+/-p53-/- mice within a range of serum levels comparable to those achieved in treatment of human APL.  Arsenic thus could be tested rapidly as a therapeutic agent in malignant diseases assocd. with Hh pathway activation and could be particularly useful in such diseases that are inherently resistant or have acquired resistance to cyclopamine mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyuJxKjzbqxLVg90H21EOLACvtfcHk0lie7rhFMWhIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1GrurbO&md5=08445246bd4e58e5d87522ac3b752646</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1006822107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1006822107%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DD.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26atitle%3DArsenic%2520antagonizes%2520the%2520hedgehog%2520pathway%2520by%2520preventing%2520ciliary%2520accumulation%2520and%2520reducing%2520stability%2520of%2520the%2520gli2%2520transcriptional%2520effector%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D13432%26epage%3D13437%26doi%3D10.1073%2Fpnas.1006822107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aftab, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezaee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borodovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, E. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beachy, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span> <span> </span><span class="NLM_article-title">Itraconazole and arsenic trioxide inhibit hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.11.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ccr.2012.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23291299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvV2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=23-34&author=J.+Kimauthor=B.+T.+Aftabauthor=J.+Y.+Tangauthor=D.+Kimauthor=A.+H.+Leeauthor=M.+Rezaeeauthor=J.+Kimauthor=B.+Chenauthor=E.+M.+Kingauthor=A.+Borodovskyauthor=G.+J.+Rigginsauthor=E.+H.+Epsteinauthor=P.+A.+Beachyauthor=C.+M.+Rudin&title=Itraconazole+and+arsenic+trioxide+inhibit+hedgehog+pathway+activation+and+tumor+growth+associated+with+acquired+resistance+to+smoothened+antagonists&doi=10.1016%2Fj.ccr.2012.11.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists</span></div><div class="casAuthors">Kim, James; Aftab, Blake T.; Tang, Jean Y.; Kim, Daniel; Lee, Alex H.; Rezaee, Melika; Kim, Jynho; Chen, Baozhi; King, Emily M.; Borodovsky, Alexandra; Riggins, Gregory J.; Epstein, Ervin H.; Beachy, Philip A.; Rudin, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-34</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Recognition of the multiple roles of Hedgehog signaling in cancer has prompted intensive efforts to develop targeted pathway inhibitors.  Leading inhibitors in clin. development act by binding to a common site within Smoothened, a crit. pathway component.  Acquired Smoothened mutations, including SMOD477G, confer resistance to these inhibitors.  Here, we report that itraconazole and arsenic trioxide, two agents in clin. use that inhibit Hedgehog signaling by mechanisms distinct from that of current Smoothened antagonists, retain inhibitory activity in vitro in the context of all reported resistance-conferring Smoothened mutants and GLI2 overexpression.  Itraconazole and arsenic trioxide, alone or in combination, inhibit the growth of medulloblastoma and basal cell carcinoma in vivo, and prolong survival of mice with intracranial drug-resistant SMOD477G medulloblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJIF4ZyQQOh7Vg90H21EOLACvtfcHk0lhNBeCDQFHWIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvV2iuw%253D%253D&md5=ea44c59e02099478f5cb351bcaedecd9</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAftab%26aufirst%3DB.%2BT.%26aulast%3DTang%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DA.%2BH.%26aulast%3DRezaee%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DKing%26aufirst%3DE.%2BM.%26aulast%3DBorodovsky%26aufirst%3DA.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DEpstein%26aufirst%3DE.%2BH.%26aulast%3DBeachy%26aufirst%3DP.%2BA.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26atitle%3DItraconazole%2520and%2520arsenic%2520trioxide%2520inhibit%2520hedgehog%2520pathway%2520activation%2520and%2520tumor%2520growth%2520associated%2520with%2520acquired%2520resistance%2520to%2520smoothened%2520antagonists%26jtitle%3DCancer%2520Cell%26date%3D2013%26volume%3D23%26spage%3D23%26epage%3D34%26doi%3D10.1016%2Fj.ccr.2012.11.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozul, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosse, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Activation of hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1981</span>– <span class="NLM_lpage">1988</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2898</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-09-2898" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20179202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFWisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=1981-1988&author=D.+L.+Feiauthor=H.+Liauthor=C.+D.+Kozulauthor=K.+E.+Blackauthor=S.+Singhauthor=J.+A.+Gosseauthor=J.+DiRenzoauthor=K.+A.+Martinauthor=B.+Wangauthor=J.+W.+Hamiltonauthor=M.+R.+Karagasauthor=D.+J.+Robbins&title=Activation+of+hedgehog+signaling+by+the+environmental+toxicant+arsenic+may+contribute+to+the+etiology+of+arsenic-induced+tumors&doi=10.1158%2F0008-5472.CAN-09-2898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Hedgehog Signaling by the Environmental Toxicant Arsenic May Contribute to the Etiology of Arsenic-Induced Tumors</span></div><div class="casAuthors">Fei, Dennis Liang; Li, Hua; Kozul, Courtney D.; Black, Kendall E.; Singh, Samer; Gosse, Julie A.; Di Renzo, James; Martin, Kathleen A.; Wang, Baolin; Hamilton, Joshua W.; Karagas, Margaret R.; Robbins, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1981-1988</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Exposure to the environmental toxicant arsenic, through both contaminated water and food, contributes to significant health problems worldwide.  In particular, arsenic exposure is thought to function as a carcinogen for lung, skin, and bladder cancer via mechanisms that remain largely unknown.  More recently, the Hedgehog signaling pathway has also been implicated in the progression and maintenance of these same cancers.  Based on these similarities, we tested the hypothesis that arsenic may act in part through activating Hedgehog signaling.  Here, we show that arsenic is able to activate Hedgehog signaling in several primary and established tissue culture cells as well as in vivo.  Arsenic activates Hedgehog signaling by decreasing the stability of the repressor form of GLI3, one of the transcription factors that ultimately regulate Hedgehog activity.  We also show, using tumor samples from a cohort of bladder cancer patients, that high levels of arsenic exposure are assocd. with high levels of Hedgehog activity.  Given the important role Hedgehog signaling plays in the maintenance and progression of a variety of tumors, including bladder cancer, these results suggest that arsenic exposure may in part promote cancer through the activation of Hedgehog signaling.  Thus, we provide an important insight into the etiol. of arsenic-induced human carcinogenesis, which may be relevant to millions of people exposed to high levels of arsenic worldwide.  Cancer Res; 70(5); 1981-8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1bMwqxGWi9bVg90H21EOLACvtfcHk0lhNBeCDQFHWIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFWisrs%253D&md5=dada08bf0777cca2ea4592479767f4ca</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2898%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKozul%26aufirst%3DC.%2BD.%26aulast%3DBlack%26aufirst%3DK.%2BE.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DGosse%26aufirst%3DJ.%2BA.%26aulast%3DDiRenzo%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHamilton%26aufirst%3DJ.%2BW.%26aulast%3DKaragas%26aufirst%3DM.%2BR.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DActivation%2520of%2520hedgehog%2520signaling%2520by%2520the%2520environmental%2520toxicant%2520arsenic%2520may%2520contribute%2520to%2520the%2520etiology%2520of%2520arsenic-induced%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D1981%26epage%3D1988%26doi%3D10.1158%2F0008-5472.CAN-09-2898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giambelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterbottom, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbarayan, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardalan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Arsenic attenuates gli signaling, increasing or decreasing its transcriptional program in a context-dependent manner</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1124/mol.115.100867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1124%2Fmol.115.100867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=26573582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVOjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=226-232&author=B.+Liauthor=C.+Giambelliauthor=B.+Tangauthor=E.+Winterbottomauthor=J.+Longauthor=K.+Jinauthor=Z.+Wangauthor=D.+L.+Feiauthor=D.+M.+Nguyenauthor=M.+Atharauthor=B.+Wangauthor=P.+R.+Subbarayanauthor=L.+Wangauthor=P.+Raiauthor=B.+Ardalanauthor=A.+J.+Capobiancoauthor=D.+J.+Robbins&title=Arsenic+attenuates+gli+signaling%2C+increasing+or+decreasing+its+transcriptional+program+in+a+context-dependent+manner&doi=10.1124%2Fmol.115.100867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic attenuates GLI signaling, increasing or decreasing its transcriptional program in a context-dependent manner</span></div><div class="casAuthors">Li, Bin; Giambelli, Camilla; Tang, Bo; Winterbottom, Emily; Long, Jun; Jin, Ke; Wang, Zhiqiang; Fei, Dennis Liang; Nguyen, Dao M.; Athar, Mohammad; Wang, Baolin; Subbarayan, Pochi R.; Wang, Lily; Rai, Priyamvada; Ardalan, Bach; Capobianco, Anthony J.; Robbins, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-232</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The metalloid arsenic is a worldwide environmental toxicant, exposure to which is assocd. with many adverse outcomes.  Arsenic is also an effective therapeutic agent in certain disease settings.  Arsenic was recently shown to regulate the activity of the Hedgehog (HH) signal transduction pathway, and this regulation of HH signaling was proposed to be responsible for a subset of arsenic's biol. effects.  Surprisingly, these sep. reports proposed contradictory activities for arsenic, as either an agonist or antagonist of HH signaling.  Here we provide in vitro and in vivo evidence that arsenic acts as a modulator of the activity of the HH effector protein glioma-assocd. oncogene family zinc finger (GLI), activating or inhibiting GLI activity in a context-dependent manner.  This arsenic-induced modulation of HH signaling is obsd. in cultured cells, patients with colorectal cancer who have received arsenic-based therapy, and a mouse colorectal cancer xenograft model.  Our results show that arsenic activates GLI signaling when the intrinsic GLI activity is low but inhibits signaling in the presence of high-level GLI activity.  Furthermore, we show that this modulation occurs downstream of primary cilia, evidenced by expts. in suppressor of fused homolog (SUFU) deficient cells.  Combining our findings with previous reports, we present an inclusive model in which arsenic plays dual roles in GLI signaling modulation: when GLIs are primarily in their repressor form, arsenic antagonizes their repression capacity, leading to low-level GLI activation, but when GLIs are primarily in their activator form, arsenic attenuates their activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqPL8AUeY24bVg90H21EOLACvtfcHk0ljOKj_G95C7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVOjtb0%253D&md5=bf444d2e5a1d7856522d9217f57a6542</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.100867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.100867%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DGiambelli%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DWinterbottom%26aufirst%3DE.%26aulast%3DLong%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DNguyen%26aufirst%3DD.%2BM.%26aulast%3DAthar%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DSubbarayan%26aufirst%3DP.%2BR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRai%26aufirst%3DP.%26aulast%3DArdalan%26aufirst%3DB.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DArsenic%2520attenuates%2520gli%2520signaling%252C%2520increasing%2520or%2520decreasing%2520its%2520transcriptional%2520program%2520in%2520a%2520context-dependent%2520manner%26jtitle%3DMol.%2520Pharmacol.%26date%3D2016%26volume%3D89%26spage%3D226%26epage%3D232%26doi%3D10.1124%2Fmol.115.100867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaveny, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahmane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baubet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Blanco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capobianco, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, D. J.</span></span> <span> </span><span class="NLM_article-title">Pyrvinium attenuates hedgehog signaling downstream of smoothened</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">4811</span>– <span class="NLM_lpage">4821</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-0317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1158%2F0008-5472.CAN-14-0317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=24994715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVOisbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=4811-4821&author=B.+Liauthor=D.+L.+Feiauthor=C.+A.+Flavenyauthor=N.+Dahmaneauthor=V.+Baubetauthor=Z.+Wangauthor=F.+Baiauthor=X.+H.+Peiauthor=J.+Rodriguez-Blancoauthor=B.+Hangauthor=D.+Ortonauthor=L.+Hanauthor=B.+Wangauthor=A.+J.+Capobiancoauthor=E.+Leeauthor=D.+J.+Robbins&title=Pyrvinium+attenuates+hedgehog+signaling+downstream+of+smoothened&doi=10.1158%2F0008-5472.CAN-14-0317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened</span></div><div class="casAuthors">Li, Bin; Fei, Dennis Liang; Flaveny, Colin A.; Dahmane, Nadia; Baubet, Valerie; Wang, Zhiqiang; Bai, Feng; Pei, Xin-Hai; Rodriguez-Blanco, Jezabel; Hang, Brian; Orton, Darren; Han, Lu; Wang, Baolin; Capobianco, Anthony J.; Lee, Ethan; Robbins, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4811-4821</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The Hedgehog (HH) signaling pathway represents an important class of emerging developmental signaling pathways that play crit. roles in the genesis of a large no. of human cancers.  The pharmaceutical industry is currently focused on developing small mols. targeting Smoothened (Smo)1 a key signaling effector of the HH pathway that regulates the levels and activity of the Gli family of transcription factors.  Although one of these compds., vismodegib, is now FDA-approved for patients with advanced basal cell carcinoma, acquired mutations in Smo can result in rapid relapse.  Furthermore, many cancers also exhibit a Smo-independent activation of Gli proteins, an observation that may underlie the limited efficacy of Smo inhibitors in clin. trials against other types of cancer.  Thus, there remains a crit. need for HH inhibitors with different mechanisms of action, particularly those that act downstream of Smo.  Recently, we identified the FDA-approved anti-pinworm compd. pyrvinium as a novel, potent (IC50, 10 nmol/L) casein kinase-α (CK1α) agonist.  We show here that pyrvinium is a potent inhibitor of HH signaling, which acts by reducing the stability of the Gli family of transcription factors.  Consistent with CK1α agonists acting on these most distal components of the HH signaling pathway, pyrvinium is able to inhibit the activity of a clin. relevant, vismodegib -resistant Smo mutant, as well as the Gli activity resulting from loss of the neg. regulator suppressor of fused.  We go on to demonstrate the utility of this small mol. in vivo, against the HH-dependent cancer medulloblastoma, attenuating its growth and reducing the expression of HH biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1CUJVX_j4NrVg90H21EOLACvtfcHk0ljOKj_G95C7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVOisbzE&md5=7d7699bb877ac6499496230a15df2f65</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-0317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-0317%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DFei%26aufirst%3DD.%2BL.%26aulast%3DFlaveny%26aufirst%3DC.%2BA.%26aulast%3DDahmane%26aufirst%3DN.%26aulast%3DBaubet%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DPei%26aufirst%3DX.%2BH.%26aulast%3DRodriguez-Blanco%26aufirst%3DJ.%26aulast%3DHang%26aufirst%3DB.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DCapobianco%26aufirst%3DA.%2BJ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DRobbins%26aufirst%3DD.%2BJ.%26atitle%3DPyrvinium%2520attenuates%2520hedgehog%2520signaling%2520downstream%2520of%2520smoothened%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D4811%26epage%3D4821%26doi%3D10.1158%2F0008-5472.CAN-14-0317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahinci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cselenyi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jernigan, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hang, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidu, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulikowski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFleur, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. M.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of wnt signaling through activation of casein kinase 1alpha</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">836</span>, <span class="refDoi"> DOI: 10.1038/nchembio.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1038%2Fnchembio.453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=20890287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=829-836&author=C.+A.+Thorneauthor=A.+J.+Hansonauthor=J.+Schneiderauthor=E.+Tahinciauthor=D.+Ortonauthor=C.+S.+Cselenyiauthor=K.+K.+Jerniganauthor=K.+C.+Meyersauthor=B.+I.+Hangauthor=A.+G.+Watersonauthor=K.+Kimauthor=B.+Melanconauthor=V.+P.+Ghiduauthor=G.+A.+Sulikowskiauthor=B.+LaFleurauthor=A.+Salicauthor=L.+A.+Leeauthor=D.+M.+Millerauthor=E.+Lee&title=Small-molecule+inhibition+of+wnt+signaling+through+activation+of+casein+kinase+1alpha&doi=10.1038%2Fnchembio.453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α</span></div><div class="casAuthors">Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M.; Lee, Ethan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-836</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Wnt/β-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease.  Using Xenopus laevis egg ext. to screen for compds. that both stabilize Axin and promote β-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC50 of ∼ 10 nM).  We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concns. and pyrvinium selectively potentiates casein kinase 1α (CK1α) kinase activity.  CK1α knockdown abrogates the effects of pyrvinium on the Wnt pathway.  In addn. to its effects on Axin and β-catenin levels, pyrvinium promotes degrdn. of Pygopus, a Wnt transcriptional component.  Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation.  Our findings reveal allosteric activation of CK1α as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr7QzU0tiGpLVg90H21EOLACvtfcHk0ljOKj_G95C7Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1elu7zO&md5=1412b6b25b26689f9191145151e91608</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.453%26sid%3Dliteratum%253Aachs%26aulast%3DThorne%26aufirst%3DC.%2BA.%26aulast%3DHanson%26aufirst%3DA.%2BJ.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DTahinci%26aufirst%3DE.%26aulast%3DOrton%26aufirst%3DD.%26aulast%3DCselenyi%26aufirst%3DC.%2BS.%26aulast%3DJernigan%26aufirst%3DK.%2BK.%26aulast%3DMeyers%26aufirst%3DK.%2BC.%26aulast%3DHang%26aufirst%3DB.%2BI.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DMelancon%26aufirst%3DB.%26aulast%3DGhidu%26aufirst%3DV.%2BP.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DLaFleur%26aufirst%3DB.%26aulast%3DSalic%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BA.%26aulast%3DMiller%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DE.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520wnt%2520signaling%2520through%2520activation%2520of%2520casein%2520kinase%25201alpha%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D829%26epage%3D836%26doi%3D10.1038%2Fnchembio.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cigna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrokhi Moshai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchal-Somme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wemeau-Stervinou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leseche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehoux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crestani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailleux, A. A.</span></span> <span> </span><span class="NLM_article-title">The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: Involvement in idiopathic pulmonary fibrosis</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2137</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2012.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1016%2Fj.ajpath.2012.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=23031257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFShsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2012&pages=2126-2137&author=N.+Cignaauthor=E.+Farrokhi+Moshaiauthor=S.+Brayerauthor=J.+Marchal-Sommeauthor=L.+Wemeau-Stervinouauthor=A.+Fabreauthor=H.+Malauthor=G.+Lesecheauthor=M.+Dehouxauthor=P.+Solerauthor=B.+Crestaniauthor=A.+A.+Mailleux&title=The+hedgehog+system+machinery+controls+transforming+growth+factor-beta-dependent+myofibroblastic+differentiation+in+humans%3A+Involvement+in+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.ajpath.2012.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Cigna, Natacha; Moshai, Elika Farrokhi; Brayer, Stephanie; Marchal-Somme, Joelle; Wemeau-Stervinou, Lidwine; Fabre, Aurelie; Mal, Herve; Leseche, Guy; Dehoux, Monique; Soler, Paul; Crestani, Bruno; Mailleux, Arnaud A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2126-2137</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown cause.  Key signaling developmental pathways are aberrantly expressed in IPF.  The hedgehog pathway plays a key role during fetal lung development and may be involved in lung fibrogenesis.  We detd. the expression pattern of several Sonic hedgehog (SHH) pathway members in normal and IPF human lung biopsies and primary fibroblasts.  The effect of hedgehog pathway inhibition was assayed by lung fibroblast proliferation and differentiation with and without transforming growth factor (TGF)-β1.  We showed that the hedgehog pathway was reactivated in the IPF lung.  Importantly, we deciphered the cross talk between the hedgehog and TGF-β pathway in human lung fibroblasts.  TGF-β1 modulated the expression of key components of the hedgehog pathway independent of Smoothened, the obligatory signal transducer of the pathway.  Smoothened was required for TGF-β1-induced myofibroblastic differentiation of control fibroblasts, but differentiation of IPF fibroblasts was partially resistant to Smoothened inhibition.  Furthermore, functional hedgehog pathway machinery from the primary cilium, as well as GLI-dependent transcription in the nucleus, was required for the TGF-β1 effects on normal and IPF fibroblasts during myofibroblastic differentiation.  These data identify the GLI transcription factors as potential therapeutic targets in lung fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY8yHz01sZs7Vg90H21EOLACvtfcHk0lj3AeDZkE8JjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFShsL%252FL&md5=defc9548531066303f933fb4deb38031</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DCigna%26aufirst%3DN.%26aulast%3DFarrokhi%2BMoshai%26aufirst%3DE.%26aulast%3DBrayer%26aufirst%3DS.%26aulast%3DMarchal-Somme%26aufirst%3DJ.%26aulast%3DWemeau-Stervinou%26aufirst%3DL.%26aulast%3DFabre%26aufirst%3DA.%26aulast%3DMal%26aufirst%3DH.%26aulast%3DLeseche%26aufirst%3DG.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DSoler%26aufirst%3DP.%26aulast%3DCrestani%26aufirst%3DB.%26aulast%3DMailleux%26aufirst%3DA.%2BA.%26atitle%3DThe%2520hedgehog%2520system%2520machinery%2520controls%2520transforming%2520growth%2520factor-beta-dependent%2520myofibroblastic%2520differentiation%2520in%2520humans%253A%2520Involvement%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D181%26spage%3D2126%26epage%3D2137%26doi%3D10.1016%2Fj.ajpath.2012.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Didiasova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwapiszewska, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wujak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakrzewicz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaefer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markart, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wygrecka, M.</span></span> <span> </span><span class="NLM_article-title">Pirfenidone exerts antifibrotic effects through inhibition of gli transcription factors</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1916</span>– <span class="NLM_lpage">1928</span>, <span class="refDoi"> DOI: 10.1096/fj.201600892RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=10.1096%2Ffj.201600892RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=28148565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1916-1928&author=M.+Didiasovaauthor=R.+Singhauthor=J.+Wilhelmauthor=G.+Kwapiszewskaauthor=L.+Wujakauthor=D.+Zakrzewiczauthor=L.+Schaeferauthor=P.+Markartauthor=W.+Seegerauthor=M.+Lauthauthor=M.+Wygrecka&title=Pirfenidone+exerts+antifibrotic+effects+through+inhibition+of+gli+transcription+factors&doi=10.1096%2Ffj.201600892RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors</span></div><div class="casAuthors">Didiasova, Miroslava; Singh, Rajeev; Wilhelm, Jochen; Kwapiszewska, Grazyna; Wujak, Lukasz; Zakrzewicz, Dariusz; Schaefer, Liliana; Markart, Philipp; Seeger, Werner; Lauth, Matthias; Wygrecka, Malgorzata</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1916-1928</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Pirfenidone is an antifibrotic drug, recently approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF).  Although pirfenidone exhibits anti-inflammatory, antioxidant, and antifibrotic properties, the mol. mechanism underlying its protective effects remains unknown.  Here, we link pirfenidone action with the regulation of the profibrotic hedgehog (Hh) signaling pathway.  We demonstrate that pirfenidone selectively destabilizes the glioma-assocd. oncogene homolog (GLI)2 protein, the primary activator of Hh-mediated gene transcription.  Consequently, pirfenidone decreases overall Hh pathway activity in patients with IPF and in patient-derived primary lung fibroblasts and leads to diminished levels of Hh target genes, such as GLI1, Hh receptor Patched-1, α-smooth muscle actin, and fibronectin, and to reduced cell migration and proliferation.  Interestingly, Hh-triggered TGF-β1 expression potentiated Hh responsiveness of primary lung fibroblasts by elevating the available pool of glioma-assocd. oncogene homolog (GLI)1/GLI2, thus creating a vicious cycle of amplifying fibrotic processes.  Because GLI transcription factors are not only crucial for Hh-mediated changes but are also required as mediators of TGF-β signaling, our findings suggest that pirfenidone exerts its clin. beneficial effects through dual Hh/TGF-β inhibition by targeting the GLI2 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcpe0tW-jZxrVg90H21EOLACvtfcHk0lj3AeDZkE8JjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKls7%252FE&md5=d136b619b3e8974002ec4c017b6903d9</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1096%2Ffj.201600892RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201600892RR%26sid%3Dliteratum%253Aachs%26aulast%3DDidiasova%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DWilhelm%26aufirst%3DJ.%26aulast%3DKwapiszewska%26aufirst%3DG.%26aulast%3DWujak%26aufirst%3DL.%26aulast%3DZakrzewicz%26aufirst%3DD.%26aulast%3DSchaefer%26aufirst%3DL.%26aulast%3DMarkart%26aufirst%3DP.%26aulast%3DSeeger%26aufirst%3DW.%26aulast%3DLauth%26aufirst%3DM.%26aulast%3DWygrecka%26aufirst%3DM.%26atitle%3DPirfenidone%2520exerts%2520antifibrotic%2520effects%2520through%2520inhibition%2520of%2520gli%2520transcription%2520factors%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D1916%26epage%3D1928%26doi%3D10.1096%2Ffj.201600892RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O9R','PDB','4O9R'); return false;">PDB: 4O9R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L7I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L7I','PDB','5L7I'); return false;">PDB: 5L7I</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00188&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-18%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00188%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00188" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aaf361b793c34","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
